ID Species ncRNA ncRNA type Environmental factor (EF) Phenotype Sample Condition of EF Evidence PubMed ID 1 Mouse mmu-let-7 miRNA high tidal volume ventilation (HVTV) lung injury lung tissues high tidal volume ventilation (HVTV) treatment upregulated 22659882 2 Mouse mmu-let-7 miRNA "hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)" tumorigenesis brain and liver tissue cells "hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) treatment" downregulated 19270793 3 Mouse mmu-let-7 miRNA morphine contractility of vascular smooth muscle cells brain tissues morphine treatment morphine significantly upregulated let-7 expression in SH-SY5Y cells and in a mouse model of opioid tolerance. 20668208 4 Mouse mmu-let-7 miRNA antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) diabetic nephropathy (DN) diabetic CD-1 mice antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) treatment upregulated 24783220 5 Mouse mmu-let-7 miRNA synthetic preimplantation factor (sPIF) duchenne muscular dystrophy (DMD) myoblast Synthetic preimplantation factor (sPIF) treatment downregulated 30692507 6 Mouse mmu-let-7 miRNA concanamycin A (Con A) hepatitis mice liver tissues con A infection upregulated 23184091 7 Mouse mmu-let-7 miRNA Staphylococcus aureus inflammation mouse mammary tissue intramammary infection of Globally Staphylococcus aureus treatment differently regulated 25075227 8 Mouse mmu-let-7 miRNA maternal H. bakeri maternal H. bakeri infection brain tissues maternal protein deficiency and/or nematode infection upregulated in the developing fetal brain 28903026 9 Mouse mmu-let-7 miRNA lipopolysaccharide (LPS) regeneration of the intestinal epithelia intestinal tissues lipopolysaccharide (LPS) treatment downregulated 29621481 10 Mouse mmu-let-7a miRNA high fat diet (HFD) acute myocardial infarction (AMI) liver tissue high fat diet (HFD) feed downregulated 19835573 11 Mouse mmu-let-7a miRNA ethanol (EtOH) alcoholic liver disease (ALD) mouse mouse liver ethanol treatment downregulated in mouse liver 28536261 12 Mouse mmu-let-7a miRNA alcohol alcoholic liver disease (ALD) liver tissues alcohol exposure downregulated 31734308 13 Mouse mmu-let-7a miRNA ethanol (EtOH) alcoholic liver disease (ALD) mice hepatocytes EtOH treatment downregulated 31734308 14 Mouse mmu-let-7a miRNA folate apoptosis mouse embryonic stem cells (mESCs) folate deficiency induced upregulated 22828209 15 Mouse mmu-let-7a miRNA blast blast traumatic brain injury (bTBI) Balb/c mice blast treatment dysregulated 29020847 16 Mouse mmu-let-7a miRNA diethylnitrosamine (DEN) chronic cholestasis and cholangiocarcinoma liver tissues diethylnitrosamine (DEN) treatment downregulated 21440549 17 Mouse mmu-let-7a miRNA estradiol embryo implantation mouse dormant blastocysts estradiol treatment downregulated 24419497 18 Mouse mmu-let-7a miRNA calcitonin (CT) endometrial receptivity uterine tissue calcitonin (CT) treatment upregulated 30536902 19 Mouse mmu-let-7a miRNA calcitonin (CT) endometrial receptivity uterine tissue samples calcitonin (CT) treatment CT injection increased the expression of LIF and miRNA Let-7a in ovarian stimulation similar to that in normal ovarian cycles. 30536902 20 Mouse mmu-let-7a miRNA dichloroacetate (DCA) energy metabolism MDA-MB-231 cells dichloroacetate (DCA) treatment upregulated 32248711 21 Mouse mmu-let-7a miRNA gold nanoparticles (AuNPs) epithelial-mesenchymal transition and peritoneal fibrosis liver and lung of mouse fetuses gold nanoparticles (AuNP) treatment upregulated 24004569 22 Mouse mmu-let-7a miRNA honeysuckle (HS) enterovirus 71 (EV71) infection brain tissues Honeysuckle treatment "Moreover, honeysuckle-induced?let-7a?suppression of EV71 RNA and protein expression as well as viral replication were investigated both in vitro and in vivo." 33669264 23 Mouse mmu-let-7a miRNA lipopolysaccharide (LPS) inflammation "Kupffer cells, RAW264.7 cells" lipopolysaccharide (LPS) treatment let-7a regulates LPS-induced inflammatory responses by targeting TLR4. 31344555 24 Mouse mmu-let-7a miRNA Japanese Encephalitis virus (JEV) Japanese Encephalitis virus (JEV) infection mouse neuronal (Neuro2a) cells or primary cortical neurons Japanese Encephalitis virus (JEV) infection upregulated 30556910 25 Mouse mmu-let-7a miRNA hypoxia melanoma Mouse melanoma B16-F0 cells hypoxia induce downregulated 30872795 26 Mouse mmu-let-7a miRNA hypoxia melanoma Mouse melanoma B16-F0 cell exosomes hypoxia induce upregulated 30872795 27 Mouse mmu-let-7a miRNA ethanolic extract of an herbal formula comprising Sophorae Flos and Lonicerae Japonicae Flos (SLE) metastasized melanoma "B16F10 melanoma tissues, B16F10 melanoma lung metastasis in mice" SLE treatment upregulated 31514083 28 Mouse mmu-let-7a miRNA coronary artery ligation myocardial ischaemic injury heart subjected to coronary artery ligation downregulated 26655604 29 Mouse mmu-let-7a miRNA sevoflurane (SEV) neurodegeneration (ND) mouse embryonic stem cells (mESCs) sevoflurane treatment upregulated 27022747 30 Mouse mmu-let-7a miRNA lipopolysaccharide (LPS) osteoarthritis (OA) ATDC5 cells lipopolysaccharide (LPS) treatment upregulated 31322277 31 Mouse mmu-let-7a miRNA ¦Á-Synuclein (¦Á-Syn) parkinson's disease (PD) PD mice substantia nigra pars compacta (SNpc) or BV-2 microglia cells in vitro ¦Á-Synuclein (¦Á-Syn) treatment downregulated 31547989 32 Mouse mmu-let-7a miRNA plasmodium chabaudi malaria peak parasitemia liver of mice Plasmodium chabaudi malaria infection treatment downregulated 21085987 33 Mouse mmu-let-7a miRNA testosterone prostate cancer female mouse liver Testosterone treatment "upregulation of the 6 miRNAs miR-22, miR-690, miR-122, let-7A, miR-30D and let-7D" 20600201 34 Mouse mmu-let-7a miRNA arsenite lung fibrosis murine bone marrow-derived macrophages (BMDMs) arsenic (As) exposure downregulated of H19 or upregulated of let-7a reversed the arsenite-induced M2 polarization of macrophages. 33162208 35 Mouse mmu-let-7a miRNA arsenite lung fibrosis lung tissues; bone marrow-derived macrophages (BMDMs) arsenite exposure downregulated 33162208 36 Mouse mmu-let-7a miRNA laparotomy and exposure of the junc_x0002_tion between the large and small intestines sepsis mouse large and small intestines laparotomy and exposure of the junc_x0002_tion between the large and small intestines treatment downregulated 25043848 37 Mouse mmu-let-7a miRNA social defeat stress sex differences of social defeat stress female mice social defeat stress treatment upregulated 33358922 38 Mouse mmu-let-7a miRNA fludrocortisone uterine receptivity epithelial endometrium fludrocortisone treatment upregulated 30968418 39 Mouse mmu-let-7a miRNA bone morphogenetic protein 2 (BMP2) chondrogenesis Mouse embryonic fibroblasts (MEFs) bone morphogenetic protein 2 (BMP2) treatment upregulated 23519980 40 Mouse mmu-let-7a-1-3p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce upregulated 30936699 41 Mouse mmu-let-7a-1-3p miRNA dexmedetomidine (DEX) spinal cord ischemia/reperfusion injury (SCII) hypoxia-induced isolated activated microglia from SCIRI mice dexamethasone (DEX) treatment upregulated 31190218 42 Mouse mmu-let-7a-1-3p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) spinal cord ischemia/reperfusion injury (SCII) isolated activated microglia from SCIRI mice oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 31190218 43 Mouse mmu-let-7a-2-3p miRNA dexmedetomidine (DEX) spinal cord ischemia/reperfusion injury (SCII) hypoxia-induced isolated activated microglia from SCIRI mice dexamethasone (DEX) treatment upregulated 31190218 44 Mouse mmu-let-7a-2-3p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) spinal cord ischemia/reperfusion injury (SCII) isolated activated microglia from SCIRI mice oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 31190218 45 Mouse mmu-let-7a-5p miRNA ¦¤9-tetrahydrocannabinol (THC) acute respiratory distress syndrome (ARDS) lung-infiltrated mononuclear cells (MNCs) ¦¤9Tetrahydrocannabinol (THC) treatment downregulated 32612530 46 Mouse mmu-let-7a-5p miRNA house dust mite (HDM) asthma C57BL/6J mice airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF) HDM treatment dysregulated in airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF) 28859242 47 Mouse mmu-let-7a-5p miRNA anoxia/reoxygenation (A/R) cardiovascular disease (CVD) primary cardiomyocytes anoxia/reoxygenation (A/R) treatment downregulated 31894303 48 Mouse mmu-let-7a-5p miRNA tumor necrosis factor alpha (TNF-¦Á) catecholamine resistance Adipocytes differentiated from 3T3-L1 preadipocytes tumor necrosis factor alpha (TNF-¦Á) treatment downregulated 30933434 49 Mouse mmu-let-7a-5p miRNA high glucose (HG) diabetic nephropathy (DN) renal mesangial cells high glucose treatment downregulated 30896854 50 Mouse mmu-let-7a-5p miRNA fluke Fasciola gigantica (FgESPs) F. gigantica infection liver tissues fluke Fasciola gigantica (FgESPs) infection downregulated 33332355 51 Mouse mmu-let-7a-5p miRNA schistosoma japonicum liver fibrosis serum exosomes S. japonicum infection treatment downregulated 32443549 52 Mouse mmu-let-7a-5p miRNA lipopolysaccharide (LPS) inflammation RAW 264.7 cells lipopolysaccharide (LPS) treatment upregulated 32153563 53 Mouse mmu-let-7a-5p miRNA anoxia/reoxygenation (A/R) myocardial infarction (MI) Primary cardiomyocyte anoxia/reoxygenation (A/R) treatment "Let-7a-5p inhibition enhanced A/R-induced apoptosis, Let-7a-5p inhibits cardiomyocytes death by targeting IGF2BP3." 31894303 54 Mouse mmu-let-7a-5p miRNA Yiqi-Bushen-Tiaozhi (YBT) nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) liver tissues Yiqi-Bushen-Tiaozhi (YBT) treatment upregulated 33281601 55 Mouse mmu-let-7a-5p miRNA Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria plasmodium chabaudi infection Balb/c Mice liver infect with Vaccination treatment downregulated in the Liver 28123381 56 Mouse mmu-let-7b miRNA high fat diet (HFD) acute myocardial infarction (AMI) liver tissue high fat diet (HFD) feed downregulated 19835573 57 Mouse mmu-let-7b miRNA ethanol (EtOH) alcoholic liver disease (ALD) mouse mouse liver ethanol treatment downregulated in mouse liver 28536261 58 Mouse mmu-let-7b miRNA blast blast traumatic brain injury (bTBI) Balb/c mice blast treatment dysregulated 29020847 59 Mouse mmu-let-7b miRNA melatonin cell proliferation hippocampus dentate gyrus tissues melatonin treatment upregulated 31169197 60 Mouse mmu-let-7b miRNA TGF-¦Â diabetic nephropathy (DN) mouse mesangial cells (MMCs) TGF-¦Â treatment downregulated 25354942 61 Mouse mmu-let-7b miRNA trans-pellitorine "fatty acid synthase, fatty acid uptake" 3T3-L1 cells trans-pellitorine upregulated 28620299 62 Mouse mmu-let-7b miRNA di(2-ethylhexyl) phthalate (DEHP) follicular development ovarian di(2-ethylhexyl) phthalate (DEHP) treatment upregulated 29385306 63 Mouse mmu-let-7b miRNA lipopolysaccharide (LPS) inflammation RAW 264.7 cells lipopolysaccharide (LPS) treatment dysregulated 24792623 64 Mouse mmu-let-7b miRNA lithium (Li) inflammation primary cultures and in rat frontal cortex Lithium?treatment downregulated 21676127 65 Mouse mmu-let-7b miRNA Japanese Encephalitis virus (JEV) Japanese Encephalitis virus (JEV) infection mouse neuronal (Neuro2a) cells or primary cortical neurons Japanese Encephalitis virus (JEV) infection upregulated 30556910 66 Mouse mmu-let-7b miRNA epigallocatechin-3-gallate (EGCG) melanoma "Mouse melanoma B16, human melanoma Mewo and A375 cells" Green tea polyphenol (-)-epigallocatechin-3-O-gallate (EGCG) treatment upregulated 26754091 67 Mouse mmu-let-7b miRNA prion neurodegeneration (ND) the brains tissues prion infection treatment upregulated 18987751 68 Mouse mmu-let-7b miRNA arsenite lung fibrosis lung tissues arsenite exposure downregulated 33162208 69 Mouse mmu-let-7b-5p miRNA acetaminophen (APAP) drug-induced liver injury (DILI) plasma acetaminophen (APAP) treatment upregulated 30125006 70 Mouse mmu-let-7b-5p miRNA aerobic exercise energy homeostasis skeletal muscle aerobic exercise training (AET) treatment 8 wk of aerobic training (Tr) markedly decreased let-7b-5p expression in murine skeletal muscle 32697599 71 Mouse mmu-let-7b-5p miRNA Yiqi-Bushen-Tiaozhi (YBT) nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) liver tissues Yiqi-Bushen-Tiaozhi (YBT) treatment upregulated 33281601 72 Mouse mmu-let-7b-5p miRNA bis-enoxacin osteoclastogenesis 4T1 murine breast cancer cells bis-enoxacin treatment downregulated 30385810 73 Mouse mmu-let-7b-5p miRNA enoxacin osteoclastogenesis 4T1 murine breast cancer cells Enoxacin treatment downregulated 30385810 74 Mouse mmu-let-7b-5p miRNA Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria plasmodium chabaudi infection Balb/c Mice liver infect with Vaccination treatment downregulated in the Liver 28123381 75 Mouse mmu-let-7c miRNA high fat diet (HFD) acute myocardial infarction (AMI) liver tissue high fat diet (HFD) feed downregulated 19835573 76 Mouse mmu-let-7c miRNA angiotensin II (Ang II) allergic airway inflammation murine bone marrow-derived macrophages (BMDMs) angiotensin II (Ang II) treatment downregulated 32458348 77 Mouse mmu-let-7c miRNA lipoxin A4 (LXA4) bronchopulmonary dysplasia (BPD) mouse lung epithelial cells (MLE-12) cells "5S,6R-methyl-LXA4 treatment" upregulated 28819748 78 Mouse mmu-let-7c miRNA lipopolysaccharide (LPS) chronic obstructive pulmonary disease (COPD) alveolar macrophages lipopolysaccharide (LPS) treatment downregulated 26851791 79 Mouse mmu-let-7c miRNA TGF-¦Â diabetic nephropathy (DN) mouse mesangial cells (MMCs) TGF-¦Â treatment downregulated 25354942 80 Mouse mmu-let-7c miRNA lipopolysaccharide (LPS) endometriosis LPS-induced mouse endometritis tissues lipopolysaccharide (LPS) treatment downregulated 30406463 81 Mouse mmu-let-7c miRNA IFN-¦Ã and lipopolysaccharide (LPS) inflammation RAW264.7 cells "LPS , IFN-¦Ã treatment" downregulated 25215948 82 Mouse mmu-let-7c miRNA metformin (Met) pancreatic cancer (PC) human pancreatic cancer cells metformin treatment upregulated 22245693 83 Mouse mmu-let-7c miRNA lithium (Li) inflammation primary cultures and in rat frontal cortex Lithium?treatment downregulated 21676127 84 Mouse mmu-let-7c-1-3p miRNA echinococcus multilocularis metacestodes echinococcus multilocularis infection RAW 264.7 cells E. multilocularis metacestodes treatment downregulated 30322806 85 Mouse mmu-let-7c-1-3p miRNA E. multilocularis metacestodes infection and immunity of E. multilocularis RAW264¡¤7 macrophage cells E. multilocularis metacestodes for 6 and 12 h treatment "upregulated (mmu-miR-378d,mmu-miR-155-5p, mmu-miR-146a-5p, mmu-miR-21a-5p , mmu-miR-125a-5p) and downregulated(mmu-miR-1981-5p , mmu-miR-let-7c-1-3p)" 28942753 86 Mouse mmu-let-7c-1-3p miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharide (LPS) treatment downregulated 32955644 87 Mouse mmu-let-7c-5p miRNA quercetin chronic inflammatory diseases LPS-treated murine bone marrow¨Cderived DCs (BMDCs) quercetin treatment upregulated 31338984 88 Mouse mmu-let-7c-5p miRNA bilateral surgical destabilization of the medial meniscus (DMM) osteoarthritis (OA) male C57BL6 mice bilateral surgical destabilization of the medial meniscus (DMM) treatment dysregulated 29255152 89 Mouse mmu-let-7c-5p miRNA Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria plasmodium chabaudi infection Balb/c Mice liver infect with Vaccination treatment downregulated in the Liver 28123381 90 Mouse mmu-let-7c-5p miRNA oxygen glucose deprivation (OGD) stroke microglia oxygen-glucose deprivation (OGD) treatment downregulated 25934573 91 Mouse mmu-let-7c-5p miRNA hypoxia traumatic brain injury (TBI) Primary mouse microglia oxygen/glucose deprivation (OGD) treatment downregulated 29408500 92 Mouse mmu-let-7c-5p miRNA lipopolysaccharide (LPS) traumatic brain injury (TBI) Primary mouse microglia lipopolysaccharides (LPS) treatment downregulated 29408500 93 Mouse mmu-let-7d miRNA arsenite atherosclerosis (AS) liver arsenic (As) exposure downregulated 22719926 94 Mouse mmu-let-7d miRNA TGF-¦Â diabetic nephropathy (DN) mouse mesangial cells (MMCs) TGF-¦Â treatment downregulated 25354942 95 Mouse mmu-let-7d miRNA cyclosporine A (CsA) nephrotoxicity mouse kidney cyclosporine A treatment upregulated 28414804 96 Mouse mmu-let-7d miRNA berberine (BBR) obesity mouse primary preadipocytes isolated from epididymal white adipose tissue (eWAT) berberine (BBR) treatment upregulated 31527742 97 Mouse mmu-let-7d miRNA 6-hydroxydopamine (6-OHDA) parkinson's disease (PD) MN9D Cells 6-hydroxydopamine (6-OHDA) treatment downregulated 29082467 98 Mouse mmu-let-7d miRNA testosterone prostate cancer female mouse liver Testosterone treatment "upregulation of the 6 miRNAs miR-22, miR-690, miR-122, let-7A, miR-30D and let-7D" 20600201 99 Mouse mmu-let-7d miRNA bleomycin (BLM) lung fibrosis exosomes of broncho-alveolar lavage fluids bleomycin (BLM) treatment downregulated 33179861 100 Mouse mmu-let-7d miRNA diesel exhaust particle (DEP) pulmonary inflammatory response lung tissues diesel exhaust particle (DEP) exposure downregulated 30172002 101 Mouse mmu-let-7d-3p miRNA licochalcone A (LA) lung cancer MLE-12 cells Licochalcone A (lico A) treatment upregulated 32505917 102 Mouse mmu-let-7d-5p miRNA nonivamide adipogenesis 3T3©\L1 pre©\adipocytes cells nonivamide treatment upregulated 25704235 103 Mouse mmu-let-7d-5p miRNA tanshinone IIA (Tan IIA) atherosclerosis (AS) RAW 264.7 cells Tanshinone IIA (Tan) treatment upregulated 32337768 104 Mouse mmu-let-7d-5p miRNA schistosoma japonicum liver fibrosis serum exosomes S. japonicum infection treatment downregulated 32443549 105 Mouse mmu-let-7d-5p miRNA Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria plasmodium chabaudi infection Balb/c Mice liver infect with Vaccination treatment downregulated in the Liver 28123381 106 Mouse mmu-let-7e miRNA staphylococcal enterotoxin B (SEB) acute inflammatory lung injury lung staphylococcal enterotoxin B treatment upregulated 25564423 107 Mouse mmu-let-7e miRNA lipopolysaccharide (LPS) acute lung injury (ALI) bone marrow-derived macrophages (BMDMs) lipopolysaccharide (LPS) treatment LPS-induced microRNA lethal-7e ( let-7e) expression was significantly increased in MK2 -/- macrophages. 29770701 108 Mouse mmu-let-7e miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues and bronchoalveolar lavage fluid (BALF) lipopolysaccharide (LPS) treatment upregulated 33392621 109 Mouse mmu-let-7e miRNA lipopolysaccharide (LPS) cell proliferation CD11b+ Gr1+ cells sorted from the bone marrow (BM) lipopolysaccharide (LPS) treatment upregulated 30221399 110 Mouse mmu-let-7e miRNA lipopolysaccharide (LPS) immune response Myeloid-derived suppressor cells (MDSCs) lipopolysaccharide (LPS) treatment "let-7e was highly upregulated in the LPS-treated group," 30221399 111 Mouse mmu-let-7e miRNA smoking smoking-related interstitial fibrosis (SRIF) C57 mice circulating 6 months of chronic mainstream smoking exposure treatment downregulated 22782705 112 Mouse mmu-let-7e-5p miRNA dexamethasone (DEX) asthma lung tissues dexamethasone (Dex) treatment let-7e-5p was downregulated in the Dex group compared with that in the Model group. 32222886 113 Mouse mmu-let-7e-5p miRNA ¦Â-glycerophosphate (¦Â-GP) and pyruvic acid coronary artery calcification (CAC) mouse smooth muscle cell line (MOVAS-1) ¦Â-glycerophosphate (¦Â-GP) and pyruvic acid treatment downregulated 31733402 114 Mouse mmu-let-7e-5p miRNA ¦Â-glycerophosphate (¦Â-GP) and pyruvic acid coronary artery calcification (CAC) exosomes from mouse vascular smooth muscle cells line MOVAS-1 "To induce calcification, the MOVAS-1 cells were maintained in normal cell culture medium supplied with 10 mM ¦Â-glycerophosphate (¦Â-GP) (Sigma, UK) and 10 nM pyruvic acid for 21 d successively, and the culture medium was renewed every 3 d." downregulated 31733402 115 Mouse mmu-let-7e-5p miRNA estradiol-17¦Â (E2) systemic lupus erythematosus (SLE) murine B cells estradiol-17¦Â (E2) treatment downegulated 25912736 116 Mouse mmu-let-7f miRNA ethanol (EtOH) alcoholic liver injury mouse mitochondrial and cellular damage induced by repeated ethanol withdrawal (EW) treatment upregulated 25406171 117 Mouse mmu-let-7f miRNA metformin (Met) anti-cancer therapy mice with 4-months-exposure of smoke oral metformin was used at a dose of 800 mg/kg diet treatment upregulated 24683044 118 Mouse mmu-let-7f miRNA high glucose (HG) diabetic nephropathy (DN) MPC5 cells high glucose (HG) treatment LncRNA MALAT1/microRNA let-7f/KLF5 axis regulates podocyte injury in diabetic nephropathy 33232688 119 Mouse mmu-let-7f miRNA ischemia ischemia/reperfusion (I/R) injury cerebral cortex and hippocampus Ischemic preconditioning and ischemic postconditioning (IPostC) treatment downregulated 27485299 120 Mouse mmu-let-7f miRNA ethanolic extract of an herbal formula comprising Sophorae Flos and Lonicerae Japonicae Flos (SLE) metastasized melanoma "B16F10 melanoma tissues, B16F10 melanoma lung metastasis in mice" SLE treatment upregulated 31514083 121 Mouse mmu-let-7f miRNA cigarette smoke (CS) neovascularization mouse ischemic muscles cigarette smoke (CS)?exposure downregulated 28345812 122 Mouse mmu-let-7f miRNA social defeat stress sex differences of social defeat stress female mice social defeat stress treatment upregulated 33358922 123 Mouse mmu-let-7f-2-3p miRNA high glucose (HG) diabetic nephropathy (DN) mouse podocytes high glucose (HG) treatment upregulated 33224036 124 Mouse mmu-let-7f-5p miRNA azoxymethane (AOM) and dextran sulfate sodium (DSS) colitis-associated colon cancer (CAC) colon tissues azoxymethane (AOM) and dextran sulfate sodium (DSS) treatment downregulated 31275360 125 Mouse mmu-let-7f-5p miRNA lipopolysaccharide (LPS) inflammation RAW 264.7 cells lipopolysaccharide (LPS) treatment upregulated 32153563 126 Mouse mmu-let-7f-5p miRNA polymethylmethacrylate (PMMA) osteolysis RAW264.7 cells polymethylmethacrylate treatment The expression of let-7f-5p was increased in the process of M1 macrophage polarization that induced by PMMA 30176162 127 Mouse mmu-let-7f-5p miRNA Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria plasmodium chabaudi infection Balb/c Mice liver infect with Vaccination treatment downregulated in the Liver 28123381 128 Mouse mmu-let-7g miRNA blast blast traumatic brain injury (bTBI) Balb/c mice blast treatment dysregulated 29020847 129 Mouse mmu-let-7g miRNA house dust mite (HDM) chronic allergic asthma C57BL/6 mice HDM treatment downregulated 24610935 130 Mouse mmu-let-7g miRNA TGF-¦Â diabetic nephropathy (DN) mouse mesangial cells (MMCs) TGF-¦Â treatment downregulated 25354942 131 Mouse mmu-let-7g miRNA binase lymphosarcoma RLS40 cells binase treatment downregulated 33147876 132 Mouse mmu-let-7g miRNA doxorubicin (DOX) myocardial injury animal issues and cardiac cells antibiotics treatment The downregulated of let-7g in the myocardial-injury model suggests that let-7g may play an important role in the development of cardiac disease 22301161 133 Mouse mmu-let-7g miRNA plasmodium chabaudi malaria peak parasitemia liver of mice Plasmodium chabaudi malaria infection treatment downregulated 21085987 134 Mouse mmu-let-7g miRNA arsenite lung fibrosis lung tissues arsenite exposure downregulated 33162208 135 Mouse mmu-let-7g miRNA diesel exhaust particle (DEP) pulmonary inflammatory response lung tissues diesel exhaust particle (DEP) exposure downregulated 30172002 136 Mouse mmu-let-7g-3p miRNA Yiqi-Bushen-Tiaozhi (YBT) nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) liver tissues Yiqi-Bushen-Tiaozhi (YBT) treatment upregulated 33281601 137 Mouse mmu-let-7g-5p miRNA oxysterol 27-hydroxycholesterol (27-OHC) Alzheimer's disease (AD) brain tissues oxysterol 27-hydroxycholesterol (27-OHC) treatment downregulated 30582229 138 Mouse mmu-let-7g-5p miRNA ursolic acid (UA) osteogenesis RANKL-treated RAW264.7 cells ursolic acid treatment downregulated 30827108 139 Mouse mmu-let-7g-5p miRNA Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria plasmodium chabaudi infection Balb/c Mice liver infect with Vaccination treatment downregulated in the Liver 28123381 140 Mouse mmu-let-7i miRNA TGF-¦Â diabetic nephropathy (DN) mouse mesangial cells (MMCs) TGF-¦Â treatment downregulated 25354942 141 Mouse mmu-let-7i miRNA arsenite lung fibrosis lung tissues arsenite exposure downregulated 33162208 142 Mouse mmu-let-7i miRNA cyclosporine A (CsA) urinary tract infections (UTIs) uropathogenic Escherichia coli (UPEC) infected kidneys cyclosporine A treatment upregulated 29069656 143 Mouse mmu-let-7i-5p miRNA carbon tetrachloride (CCl4) liver fibrosis liver CCl4 treatment upregulated 27322257 144 Mouse mmu-let-7i-5p miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues carbon tetrachloride (CCl4) treatment upregulated 29557526 145 Mouse mmu-let-7i-5p miRNA Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria plasmodium chabaudi infection Balb/c Mice liver infect with Vaccination treatment downregulated in the Liver 28123381 146 Mouse mmu-let-7k miRNA Psychosocial stress mesenchymal stem cell transplantation (MSCT) mouse bone marrow mesenchymal stem cells (MSCs) Psychosocial stress treatment Psychological stress attenuates therapeutic effects of MSCT in a DSS-induced colitis mouse model by elevating the levels of exosomal Mir7k/mmu-let-7 k (microRNA 7 k) in circulation 32910719 147 Mouse mmu-let-7k miRNA oxygen retinopathy of prematurity (ROP) retinas tissue "For OIR model construction, 7-day-old mice and their nursing mothers were maintained in 75% oxygen for 5 continuous days. On postnatal day (P) 12, the pups were returned to normoxic air and kept with their mothers for another 5 days. treatment" downregulated in the OIR samples 31452702 148 Mouse mmu-let-7k miRNA alpinia oxyphylla extract (AOE) type 2 diabetes mellitus (T2DM) db-/db- mouse kidney A. oxyphylla extract (AOE) treatment upregulated 28249617 149 Mouse mmu-miR-1 miRNA heat stress ischemia/reperfusion (I/R) injury the hearts and livers tissue cells heat-shock (HS) "Mice subjected to cytoprotective heat-shock (HS) showed a significant increase of miRNA-1, miRNA-21 and miRNA-24 in the heart." 19041309 150 Mouse mmu-miR-1 miRNA IFN-¦Â autophagy mouse cortical neurons IFN-¦Â treatment upregulated 31799933 151 Mouse mmu-miR-1 miRNA 2-acetyl-5-tetrahydroxybutyl imidazole (THI) breast cancer C2C12 cells 2-acetyl-5-tetrahydroxybutyl imidazole (THI) treatment upregulated 24077965 152 Mouse mmu-miR-1 miRNA sphingosine-1-phosphate (S1P) breast cancer C2C12 cells sphingosine-1-phosphate (S1P) treatment upregulated 24077965 153 Mouse mmu-miR-1 miRNA metformin (Met) cardiac conduction delay cardiomyocytes; heart tissues metformin (Met) treatment Met can noticeably inhibit miR-1 upregulation. 32450177 154 Mouse mmu-miR-1 miRNA doxorubicin (DOX) cardiotoxicity BALB/c mice injected C-26 tumor cells doxorubicin treatment upregulated 28560697 155 Mouse mmu-miR-1 miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral palsy N2A neurons oxygen-glucose deprivation and reoxygenation (OGD/R) treatment upregulated 31500509 156 Mouse mmu-miR-1 miRNA tamoxifen (TAM) chronic pain dorsal root ganglion (DRG) neurons completed tamoxifen treatment downregulated 27346077 157 Mouse mmu-miR-1 miRNA bortezomib congenital muscular dystrophy dy(3K)/dy(3K) mice bortezomib? treatment downregulated 24631023 158 Mouse mmu-miR-1 miRNA streptozocin (STZ) diabetes mellitus (DM) hearts of diabetic mice streptozotocin (STZ) treatment downregulated 21584493 159 Mouse mmu-miR-1 miRNA streptozocin (STZ) diabetes mellitus (DM) CD1 mice of both genders streptozocin (STZ) treatment upregulated 24685144 160 Mouse mmu-miR-1 miRNA lycium barbarum polysaccharide (LBP) heart failure (HF) neonatal rat ventricular cardiomyocytes (NRVCs) lycium barbarum polysaccharides (LBPs) treatment LBPs significantly reduced the expression of myocardial miR-1. 30117672 161 Mouse mmu-miR-1 miRNA AICAR hypertrophy C2C12 cells were incubat AMPK activator 5-aminoimidazole-4- carboxamide-1-_x0003-D-ribonucleoside treatment upregulated 24347059 162 Mouse mmu-miR-1 miRNA hypoxia hypoxic pulmonary hypertension (HPH) mouse lung tissues hypoxia treatment downregulated in mouse lung tissues 29167124 163 Mouse mmu-miR-1 miRNA synthetic Sulfonyl-Hydrazone-1 iPSC-derived cardiac differentiation Murine fibroblast-derived iPSCs Synthetic Sulfonyl-Hydrazone-1 treatment "small chemical compounds, such as SHZ, can constitute a novel and clinically feasible strategy to improve iPSC-derived cardiac differentiation" 21445862 164 Mouse mmu-miR-1 miRNA ischemia ischemia/reperfusion (I/R) injury cerebral cortex and hippocampus Ischemic preconditioning and ischemic postconditioning (IPostC) treatment downregulated 27485299 165 Mouse mmu-miR-1 miRNA botulinum toxin A (BTXA) muscle atrophy quadriceps muscle botulinum toxin A (BTXA) treatment downregulated 30427927 166 Mouse mmu-miR-1 miRNA dexamethasone (DEX) muscle atrophy Murine C2C12 myoblast cells dexamethasone (DEX) treatment upregulated 23716137 167 Mouse mmu-miR-1 miRNA prolonged aerobic exercise muscle hypertrophy plasma "impact of extended-duration, submaximal aerobic exercise treatment" upregulated 24436293 168 Mouse mmu-miR-1 miRNA heme oxygenase-1 (HMOX1) myoblast differentiation C2C12 cells Heme oxygenase-1 (HMOX1) treatment downregulated 21827279 169 Mouse mmu-miR-1 miRNA Soluble epoxide hydrolase inhibitors (sEHIs) myocardial infarction (MI) MI mouse ischemic myocaridum "sEHI t-AUCB (0.2, 1, 5 mg/L in drinking-water) was administered daily seven days before MI treatment" downregulated in ischemic myocaridum 29212255 170 Mouse mmu-miR-1 miRNA ischemia myocardial ischaemic injury mouse cardiomyocytes ischemic pre-conditioning (IPC) treatment "IPC-induced miRNAs trigger cardioprotection similar to the delayed phase of IPC, possibly through upregulating eNOS, HSP70, and the HSP70 transcription factor HSF-1." 19213952 171 Mouse mmu-miR-1 miRNA sciatic nerve partial ligation pain mouse dorsal root ganglion (DRG) sciatic nerve partial ligation therapy treatment downregulated 21385380 172 Mouse mmu-miR-1 miRNA hypoxia pulmonary arterial hypertension (PAH) mouse lung tissues hypoxia induce downregulated 29167124 173 Mouse mmu-miR-1 miRNA cyclopamine regulating the activity of Shh signaling embryonic lung cultures cyclopamine treatment dysregulated 24617895 174 Mouse mmu-miR-1 miRNA statins skeletal muscle injury skeletal muscle cells statins? treatment "In cultured skeletal muscle cells, statin increased the levels of miR-1a but decreased the levels of mitogen-activated protein kinase kinase kinase 1 (MAP3K1) in a time or dose dependent manner" 33864447 175 Mouse mmu-miR-1 miRNA astragalus Root dry extract (ARDE) viral myocarditis (VM) CVB3-infected mouse heart tissues and HL-1 cells astragalus Root dry extract (ARDE) treatment downregulated 30097120 176 Mouse mmu-miR-1 miRNA coxsackievirus B3 (CVB3) viral myocarditis (VM) mouse heart tissues and HL-1 cells CVB3 infection upregulated 30097120 177 Mouse mmu-miR-100 miRNA H2O2 apoptosis cardiomyocytes H2O2 treatment upregulated 26191255 178 Mouse mmu-miR-100 miRNA 1-methyl-4-phenylpyridinium (MPP+) parkinson's disease (PD) mouse midbrain tissues 1-methyl-4-phenylpyridinium (MPP+) treatment downregulated 31298038 179 Mouse mmu-miR-100 miRNA retinoic acid (RA) cell proliferation mouse spermatogonial stem cells (SSCs) retinoic acid treatment downregulated 28569396 180 Mouse mmu-miR-100-5p miRNA amyloid-¦Â (A¦Â) Alzheimer's disease (AD) Cortexes of the brains amyloid-¦Â (A¦Â) treatment downregulated 26635599 181 Mouse mmu-miR-100-5p miRNA influenza virus H5N2 influenza virus infection lung tissues H5N2 treatment upregulated 25266911 182 Mouse mmu-miR-100a miRNA rapamycin HIV-associated nephropathy(HIVAN) mice renal tissues Rapamycin treatment downregulated 23611955 183 Mouse mmu-miR-101 miRNA bleomycin (BLM) acute lung injury (ALI) lung bleomycin (BLM) treatment downregulated 26402323 184 Mouse mmu-miR-101 miRNA celecoxib anti-inflammatory responses male A/J mice "celecoxib (30 mg/kg/d, administered by gavage) treatment" upregulated 27562754 185 Mouse mmu-miR-101 miRNA geniposide (GEN) atherosclerosis (AS) LPS-treated RAW264.7 macrophage cell line geniposide treatment downregulated 30630636 186 Mouse mmu-miR-101 miRNA geniposide (GEN) atherosclerosis (AS) Atherosclerosis (AS) mouse aorta tissues geniposide treatment downregulated 30630636 187 Mouse mmu-miR-101 miRNA geniposide (GEN) atherosclerosis (AS) high fat diet fed ApoE-/- mice aorta tissues geniposide (GEN) treatment downregulated 30630636 188 Mouse mmu-miR-101 miRNA high fat diet (HFD) atherosclerosis (AS) ApoE-/- mice aorta tissues high fat diet (HFD) feed upregulated 30630636 189 Mouse mmu-miR-101 miRNA high fat diet (HFD) atherosclerosis (AS) aorta tissues high fat diet (HFD) feed upregulated 30630636 190 Mouse mmu-miR-101 miRNA lipopolysaccharide (LPS) atherosclerosis (AS) RAW264.7 macrophage cell line lipopolysaccharide (LPS) treatment upregulated 30630636 191 Mouse mmu-miR-101 miRNA IL-10 colonic inflammation colonic intraepithelial lymphocytes IL-10 treatment downregulated 22043014 192 Mouse mmu-miR-101 miRNA IL-10 epithelial-mesenchymal transition (EMT) colonic intraepithelial lymphocytes IL-10 treatment upregulated 22043014 193 Mouse mmu-miR-101 miRNA kaempferol fracture healing MC3T3-E1 cells kaempferol treatment upregulated 30942633 194 Mouse mmu-miR-101 miRNA tumor necrosis factor alpha (TNF-¦Á) osteoarthritis (OA) ?ATDC5 cells tumor necrosis factor alpha (TNF-¦Á) treatment ?HULC protected ATDC5 cells against TNF-¦Á-induced inflammatory injury by repression of miR-101 30981080 195 Mouse mmu-miR-101 miRNA phyllanthus emblica L (PEL) extract precancerous lung lesion male A/J mice phyllanthus emblica L (PEL) extract treatment upregulation 27562754 196 Mouse mmu-miR-101 miRNA bleomycin (BLM) lung fibrosis mouse lung tissues bleomycin (BLM) treatment downregulated in lung tissues 28726637 197 Mouse mmu-miR-101 miRNA salvianolic acid A (Sal A) spinal cord injury (SCI) RBMECs cells Sal A treatment upregulated 28011395 198 Mouse mmu-miR-101-3p miRNA Iodine-131 (131I) papillary thyroid cancer (PTC) PTC tissues 131I treatment NEAT1 suppression could inhibit 131I resistance of PTC by upregulating miR-101-3p/FN1 expression and inactivated PI3K/AKT signaling pathway both in vitro and in vivo. 30596336 199 Mouse mmu-miR-101-3p miRNA oxygen bronchopulmonary dysplasia (BPD) lung tissues oxygen treatment silencing of Xist suppressed BPD development by binding to miR-101-3p and downregulating HMGB3 and the TGF-b1/Smad3 axis. 33070148 200 Mouse mmu-miR-101-5p miRNA schisandrin B (Sch B) liver fibrosis liver tissues Schisandrin B (Sch B) treatment Sch B can attenuate liver fibrosis by upregulating the expression of miR-101-5p 31975615 201 Mouse mmu-miR-101a miRNA lipopolysaccharide (LPS) acute aortic dissection (AAD) aorta lipopolysaccharide (LPS) treatment downregulated 32634201 202 Mouse mmu-miR-101a miRNA mangiferin endoplasmic reticulum stress (ERS) primary mouse hepatocytes mangiferin treatment downregulated 32413114 203 Mouse mmu-miR-101a miRNA angiotensin II (Ang II) hypertensive nephropathy (HN) kidney tissues angiotensin II (Ang II) treatment downregulated 30304543 204 Mouse mmu-miR-101a miRNA dietary methyl deficiency hepatocellular carcinoma (HCC) the liver tissues Dietary methyl deficiency treatment downregulated 20436259 205 Mouse mmu-miR-101a miRNA "2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD)" liver damage mouse liver cells "2, 3, 7, 8-tetrachlorodi-benzo-p-dioxin (TCDD) treatment" "TCDD dysregulates the expression of miR101a and miR122 and that COX-2, a target gene of miR101a, plays a significant role in liver damage in mice exposed to TCDD." 21602190 206 Mouse mmu-miR-101a miRNA IL-1¦Â ¦Â-cell dysfunction MIN6 cells IL-1¦Â treatment upregulated 26367486 207 Mouse mmu-miR-101a-3p miRNA hypoxia myocardial infarction (MI) neonatal mice cardiomyocytes (NMCMs) hypoxia treatment downregulated 32315985 208 Mouse mmu-miR-101b miRNA oral gavage anti-inflammatory responses dextran sodium sulfate (DSS)-induced colitis-associated tumorigenesis Apc(Min/+) mouse via oral gavage for 5 weeks treatment upregulated 24817032 209 Mouse mmu-miR-101b miRNA high glucose (HG) diabetic nephropathy (DN) mouse mesangial cells (MES13 cells) high glucose (HG) treatment circ_0000491 aggravates the extracellular matrix of diabetic nephropathy glomerular mesangial cells through suppressing miR-101b by targeting TGF¦ÂRI. 32901868 210 Mouse mmu-miR-101b miRNA dietary methyl deficiency hepatocellular carcinoma (HCC) the liver tissues Dietary methyl deficiency treatment downregulated 20436259 211 Mouse mmu-miR-101b miRNA metformin (Met) nonalcoholic steatohepatitis (NASH) liver tissues metformin treatment downregulated 25672270 212 Mouse mmu-miR-101b miRNA metformin (Met) nonalcoholic steatohepatitis (NASH) liver tissues metformin treatment downregulated 25672270 213 Mouse mmu-miR-101b miRNA plasmodium chabaudi malaria peak parasitemia liver of mice Plasmodium chabaudi malaria infection treatment downregulated 21085987 214 Mouse mmu-miR-103 miRNA tetrabromobisphenol-A (TBBPA) adipogenesis 3T3-L1 and C3H10T1/2 cells TBBPA treatment upregulated 28329833 215 Mouse mmu-miR-103 miRNA high fat diet (HFD) adipose inflammation mouse adipose tissues high fat diet (HFD) feed Overexpressing TRAF3 attenuated miR-103-induced inflammation by accelerating mitophagy. 30623853 216 Mouse mmu-miR-103 miRNA adjuvant adjuvant-induced arthritis (AIA) cartilage adjuvant treatment Long noncoding RNA-GAS5 siRNA prevented cartilage destruction by inhibiting miR-103 expression. 33343265 217 Mouse mmu-miR-103 miRNA baicalin (BAI) asthma ovalbumin (OVA)-induced asthma mouse lung tissues baicalin (BAI) treatment miR-103 was significantly upregulated after BA treatment. 33730981 218 Mouse mmu-miR-103 miRNA baicalin (BAI) asthma mouse bronchial smooth muscle cells (SMCs) baicalin (BAI) treatment upregulated 33730981 219 Mouse mmu-miR-103 miRNA platelet derived growth factor-BB (PDGF-BB) asthma mouse bronchial smooth muscle cells (SMCs) platelet derived growth factor-BB (PDGF-BB)?treatment treatment downregulated 33730981 220 Mouse mmu-miR-103 miRNA high fat diet (HFD) atherosclerosis (AS) thoracic aorta high fat diet (HFD) feed upregulated 31232476 221 Mouse mmu-miR-103 miRNA high fat diet (HFD) atherosclerosis (AS) Apolipoprotein E knockout (ApoE-/- ) mice thoracic aorta tissues ?high-fat-diet (HFD)?feed treatment upregulated 31232476 222 Mouse mmu-miR-103 miRNA carboxymethyllysine (CML) diabetes mellitus (DM) fibroblast cell line 3T3©\L1 carboxymethyllysine (CML) treatment upregulated 27137869 223 Mouse mmu-miR-103 miRNA trans-pellitorine "fatty acid synthase, fatty acid uptake" 3T3-L1 cells trans-pellitorine upregulated 28620299 224 Mouse mmu-miR-103 miRNA high fat diet (HFD) inflammatory response skeletal muscle of mice high fat diet (HFD) feed "miR-375, miR-29, miR-320, miR-103/107 and miR-126, play a crucial role in the regulation of glucose and lipid metabolism through the control of pancreatic islet cell function" 22395471 225 Mouse mmu-miR-103 miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) ischemic neuronal injury murine hippocampal neurons oxygen-glucose deprivation and reoxygenation (OGD/R) treatment OGDR downregulated miR-103 and miR-107 to induce NKILA upregulation in neuronal cells 30007440 226 Mouse mmu-miR-103 miRNA apigenin hepatocellular carcinoma (HCC) Huh7 cells; Hep3B cells apigenin treatment downregulated 23989853 227 Mouse mmu-miR-103 miRNA resveratrol hepatic steatosis Sprague-Dawley rats resveratrol (RS) treatment downregulated 28375178 228 Mouse mmu-miR-103 miRNA insulin-like growth factor 1 (IGF-1) metastatic colorectal cancer (mCRC) mouse intestinal crypt cells insulin-like growth factors(IGF-1) treatment downregulated 20886090 229 Mouse mmu-miR-103 miRNA morphine morphine tolerance mouse brain chronic morphine men treatment upregulated 24302561 230 Mouse mmu-miR-103 miRNA isoprenaline myocardial infarction (MI) hearts of the treated mice isoprenaline treatment Significant inhibition of miR-103 accompanied by increased FADD expression and markedly decreased expression of the other biomarkers were observed in the hearts of the treated mice. 33577038 231 Mouse mmu-miR-103 miRNA high fat diet (HFD) prenatal inflammation ovarian tissue high fat diet (HFD) feed "Obese mouse ovaries had decreased Irs1, Foxo3a, Cyp2e1, MiR-103, and MiR-21" 23954404 232 Mouse mmu-miR-103-1-5p miRNA apigenin acute myocardial infarction (AMI) mouse myocardial cells apigenin treatment downregulated 32515357 233 Mouse mmu-miR-103-3p miRNA fenofibrate obesity C57BL/6J male mice visceral adipose tissue fenofibrate treatment upregulated 28926107 234 Mouse mmu-miR-103a miRNA cyclic mechanical stretch (CMS) osteoblast differentiation and bone formation bone cyclic mechanical stretch (CMS) treatment downregulated 25195535 235 Mouse mmu-miR-103a-3p miRNA bilateral surgical destabilization of the medial meniscus (DMM) osteoarthritis (OA) male C57BL6 mice bilateral surgical destabilization of the medial meniscus (DMM) treatment dysregulated 29255152 236 Mouse mmu-miR-103a-3p miRNA angiotensin II (Ang II) renal inflammation and fibrosis Urinary and serum angiotensin II (Ang II) treatment upregulated 31086184 237 Mouse mmu-miR-103a-3p miRNA lipopolysaccharide (LPS) sepsis Bone marrow-derived macrophages lipopolysaccharide (LPS) treatment downregulated 33333289 238 Mouse mmu-miR-103a-3p miRNA lipopolysaccharide (LPS) sepsis bone marrow-derived macrophages lipopolysaccharide (LPS) treatment miR-103a-3p was decreased while HMGB1 was increased in sepsis. 33333289 239 Mouse mmu-miR-103a-3p miRNA lipopolysaccharide (LPS) sepsis-induced liver injury liver tissues lipopolysaccharide (LPS) treatment miR-103a-3p was elevated in the septic liver of LPS-induced mice. 32369227 240 Mouse mmu-miR-105 miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated 26639663 241 Mouse mmu-miR-105 miRNA chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) plvic inflammatory disease mouse two Chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) infection were upregulated during CmVar004 infection compared to CmVar001 infection 24961692 242 Mouse mmu-miR-106 miRNA thyroid hormone brain development mouse fetal cortex inject TH 12 h before sacrifice on GD 16 treatment downregulated 24436321 243 Mouse mmu-miR-106 miRNA bone morphogenetic protein 9 (BMP9) osteogenesis The conditionally immortalized mouse multipotent adipose-derived cells iMADs bone morphogenetic protein 9 (BMP9) treatment downregulated 31825894 244 Mouse mmu-miR-106a miRNA lipopolysaccharide (LPS) acute lung injury (ALI) mouse lung tissues and RAW264.7 cells lipopolysaccharides (LPS) treatment downregulated 31595149 245 Mouse mmu-miR-106a miRNA ovalbumin (OVA) asthma lung tissues ovalbumin (OVA) treatment upregulated 27418244 246 Mouse mmu-miR-106a miRNA "anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE)" bronchial epithelial cell cancer 16HBE-T cells "anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE) treatment" upregulated 19462682 247 Mouse mmu-miR-106a miRNA streptozocin (STZ) diabetic peripheral neuropathy (DPN) mouse dorsal root ganglion (DRG) STZ treatment downregulated in dorsal root ganglion (DRG) 28393703 248 Mouse mmu-miR-106a miRNA tumor necrosis factor alpha (TNF-¦Á) inflammatory bowel disease (IBD) colon tissues tumor necrosis factor alpha (TNF-¦Á) treatment upregulated 30327532 249 Mouse mmu-miR-106a miRNA high glucose (HG) podocyte injury MPC5 cells high glucose (HG) treatment MiR-106a was downregulated in HG-induced MPC5 podocytes. 33116706 250 Mouse mmu-miR-106a miRNA isoflurane postoperative cognitive dysfunction (POCD) hippocampus isoflurane treatment upregulated 31933141 251 Mouse mmu-miR-106a miRNA cecal ligation and puncture (CLP) sepsis whole blood cecal ligation and puncture (CLP) treatment upregulated 24205035 252 Mouse mmu-miR-106a miRNA lipopolysaccharide (LPS) sepsis-induced acute kidney injury TCMK-1 cells lipopolysaccharides (LPS) treatment upregulated 31432993 253 Mouse mmu-miR-106a-5p miRNA folic acid Alzheimer's disease (AD) APP/PS1 mice brains and N2a cells Folic acid deficiency treatment downregulated 26345540 254 Mouse mmu-miR-106a-5p miRNA streptozocin (STZ) diabetic retinopathy (DR) retina and serum of diabetic mice streptozotocin treatment downregulated 30883703 255 Mouse mmu-miR-106b miRNA high fat diet (HFD) brown adipocyte differentiation brown adipose tissues high fat diet (HFD) feed upregulated 23954633 256 Mouse mmu-miR-106b miRNA bovine type II collagen containing Freund's adjuvant collagen-induced arthritis (CIA) DAB/1 mice bovine type II collagen containing Freund's adjuvant upregulated 28957555 257 Mouse mmu-miR-106b miRNA high glucose (HG) diabetes mellitus (DM) mouse pancreatic beta-cell line NIT-1 cells 30 mM high glucose downregulated 28436095 258 Mouse mmu-miR-106b miRNA isoflurane drug-induced liver injury (DILI) liver tissues isoflurane treatment downregulated 24598351 259 Mouse mmu-miR-106b miRNA isoniazid (INH) liver damage liver tissues isoniazid (INH) treatment upregulated 29554950 260 Mouse mmu-miR-106b miRNA glucocorticoid (GC) osteoporosis C57BL/6 mice glucocorticoid upregulated 28108317 261 Mouse mmu-miR-106b miRNA puerarin osteoporosis MC3T3-E1 cells puerarin treatment upregulated 29375675 262 Mouse mmu-miR-106b miRNA puerarin osteoporosis MC3T3-E1 cells with 20 ?M puerarin treatment upregulated 29375675 263 Mouse mmu-miR-106b miRNA propofol (PPF) propofol-induced developmental neurotoxicity hippocampus propofol treatment downregulated 30242182 264 Mouse mmu-miR-106b miRNA collagen rheumatoid arthritis (RA) synovial fibroblasts (SFs) collagen treatment upregulated 32152704 265 Mouse mmu-miR-106b miRNA cecal ligation and puncture (CLP) sepsis whole blood cecal ligation and puncture (CLP) treatment upregulated 24205035 266 Mouse mmu-miR-106b miRNA palmitic acid (PA) skeletal muscle insulin resistance C2C12 myocytes palmitic acid (PA) treatment upregulated 25529328 267 Mouse mmu-miR-106b-3p miRNA Yiqi-Bushen-Tiaozhi (YBT) nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) liver tissues Yiqi-Bushen-Tiaozhi (YBT) treatment downregulated 33281601 268 Mouse mmu-miR-106b-3p miRNA paraquat (PQ) paraquat (PQ)-induced acute lung injury and pulmonary fibrosis MLE-12 cells paraquat (PQ) treatment downregulated 32741895 269 Mouse mmu-miR-106b-5p miRNA ovalbumin (OVA) asthma lung tissues ovalbumin (OVA) treatment The present study revealed downregulated miR-106b-5p expression and upregulated SIX1 expression in asthmatic mice and TGF-¦Â1-induced BEAS-2B cells. 33495833 270 Mouse mmu-miR-106b-5p miRNA bone marrow transplantation (BMT) diabetes mellitus (DM) mice with insulin-deficient diabetes bone marrow transplantation (BMT) treatment upregulated 27974246 271 Mouse mmu-miR-106b-5p miRNA radiation radiation-induced injury blood radiation treatment downregulated 29799276 272 Mouse mmu-miR-107 miRNA tetrabromobisphenol-A (TBBPA) adipogenesis 3T3-L1 and C3H10T1/2 cells TBBPA treatment upregulated 28329833 273 Mouse mmu-miR-107 miRNA amyloid-¦Â (A¦Â) 1-42 Alzheimer's disease (AD) brain tissues amyloid ¦Â1-42?(A¦Â) treatment downregulated 29286086 274 Mouse mmu-miR-107 miRNA amyloid-¦Â (A¦Â) 1-42 Alzheimer's disease (AD) mouse amyloid ¦Â1-42?(A¦Â) treatment downregulated 29286086 275 Mouse mmu-miR-107 miRNA high fat diet (HFD) atherosclerosis (AS) vascular endothelial cells (VECs) in coronary atherosclerosis mice ?high-fat-diet (HFD)?feed treatment downregulated 30548623 276 Mouse mmu-miR-107 miRNA high fat diet (HFD) coronary atherosclerosis (CAS) Vascular endothelial cells (VECs) high fat diet (HFD) feed downregulated 30548623 277 Mouse mmu-miR-107 miRNA high fat diet (HFD) inflammatory response skeletal muscle of mice high fat diet (HFD) feed "miR-375, miR-29, miR-320, miR-103/107 and miR-126, play a crucial role in the regulation of glucose and lipid metabolism through the control of pancreatic islet cell function" 22395471 278 Mouse mmu-miR-107 miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) ischemic neuronal injury murine hippocampal neurons oxygen-glucose deprivation and reoxygenation (OGD/R) treatment OGDR downregulated miR-103 and miR-107 to induce NKILA upregulation in neuronal cells 30007440 279 Mouse mmu-miR-107 miRNA resveratrol hepatic steatosis Sprague-Dawley rats resveratrol (RS) treatment downregulated 28375178 280 Mouse mmu-miR-107 miRNA morphine morphine tolerance mouse brain chronic morphine men treatment upregulated 24302561 281 Mouse mmu-miR-107 miRNA 177lu-octreotate neuroendocrine tumors Female BALB/c nude mice "inject 1.3, 3.6, 14, 45, or 140 MBq 177Lu-octreotate treatment" "miR-194, miR-107, miR-3090, and miR-3077 were commonly regulated" 25386939 282 Mouse mmu-miR-107 miRNA oxygen glucose deprivation (OGD) neuron apoptosis HT-22 hippocampal neuron cell oxygen-glucose deprivation (OGD) treatment RMST/hnRNPK/p53/miR-107/Bcl2l2 axis plays an important role in regulating neuronal apoptosis 31852624 283 Mouse mmu-miR-107 miRNA diet obesity murine hepatic cells diet treatment downregulated 21120623 284 Mouse mmu-miR-107 miRNA agrimonia pilos polysaccharide (APP-AW) and its sulphated derivatives (S2) steroid-induced osteonecrosis of femoral head (ONFH) femoral head tissues agrimonia pilos polysaccharide (APP-AW) and its sulphated derivatives (S2) treatment APP-AW or S2 reversed the decreased miR- 107 level in rats suffering SANFH. 31786295 285 Mouse mmu-miR-107 miRNA agrimonia pilos polysaccharide (APP-AW) and its sulphated derivatives (S2) steroid-induced osteonecrosis of femoral head (ONFH) MC3T3-E1 cells agrimonia pilos polysaccharide (APP-AW) and its sulphated derivatives (S3) treatment upregulated 31786295 286 Mouse mmu-miR-107 miRNA agrimonia pilos polysaccharide (APP-AW) and its sulphated derivatives (S2) steroid-induced osteonecrosis of femoral head (ONFH) dexamethasone (DEX)-treated MC3T3-E1 cells agrimonia pilos polysaccharide (APP-AW) and its sulphated derivatives (S4) treatment upregulated 31786295 287 Mouse mmu-miR-107 miRNA agrimonia pilos polysaccharide (APP-AW) and its sulphated derivatives (S2) steroid-induced osteonecrosis of femoral head (ONFH) femoral head tissues Agrimonia pilos polysaccharide (APP-AW)'s sulphated derivatives (S2) treatment APP-AW or S2 reversed the decreased miR- 107 level in rats suffering SANFH. 31786295 288 Mouse mmu-miR-107 miRNA agrimonia pilos polysaccharide (APP-AW) and its sulphated derivatives (S2) steroid-induced osteonecrosis of femoral head (ONFH) MC3T3-E1 cells Agrimonia pilos polysaccharide (APP-AW)'s sulphated derivatives (S2) treatment upregulated 31786295 289 Mouse mmu-miR-107 miRNA dexamethasone (DEX) steroid-induced osteonecrosis of femoral head (ONFH) MC3T3-E1 cells dexamethasone (DEX) treatment downregulated 31786295 290 Mouse mmu-miR-107 miRNA cortical impact traumatic brain injury (TBI) cortex cortical impact downregulated 26426744 291 Mouse mmu-miR-10a miRNA high fat diet (HFD) atherosclerosis (AS) blood plasma from apolipoprotein E-deficient (ApoE-/-) mice high fat diet (HFD) feed downregulated 29459264 292 Mouse mmu-miR-10a miRNA "anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE)" bronchial epithelial cell cancer 16HBE-T cells "anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE) treatment" downregulated 19462682 293 Mouse mmu-miR-10a miRNA retinoic acid (RA) cystic fibrosis (CF) smooth muscle cell retinoid acid treatment downregulated 20118242 294 Mouse mmu-miR-10a miRNA neurotoxicant sodium valproate (VPA) developmental toxicity murine embryonic stem cells (mESCs) neurotoxicant sodium valproate (VPA) treatment upregulated 24896083 295 Mouse mmu-miR-10a miRNA concanamycin A (Con A) fulminant hepatitis Balb/c mice conA injections of concanavalin A treatment upregulation 25034766 296 Mouse mmu-miR-10a miRNA retinoic acid (RA) host defense and immunoregulation na?ve CD4+ T cells retinoic acid treatment upregulated 22544395 297 Mouse mmu-miR-10a miRNA angelica polysaccharide (AP) inflammation LPS-treated HT22 cells angelica polysaccharide (AP) treatment upregulated 31353963 298 Mouse mmu-miR-10a miRNA lipopolysaccharide (LPS) inflammation HT22 cells lipopolysaccharide (LPS) treatment downregulated 31353963 299 Mouse mmu-miR-10a miRNA olfactory discrimination training olfactory discrimination mouse hippocampal somatic cells olfactory discrimination training treatment dynamic and co-ordinated changes in miRNA expression accompany early stages of learning 20309390 300 Mouse mmu-miR-10a miRNA bone morphogenetic proteins (BMPs) osteogenesis pluripotent stem (iPS) cells bone morphogenetic proteins (BMPs) treatment downregulated 22937097 301 Mouse mmu-miR-10a miRNA ethanol (EtOH) teratogenesis fetal brains of mice Ethanol?treatment upregulated 19091803 302 Mouse mmu-miR-10a miRNA high fat diet (HFD) and streptozotocin (STZ) type 2 diabetes mellitus (T2DM) ICR strain mice high fat diet (HFD); streptozotocin (STZ) treatment downregulated 27292126 303 Mouse mmu-miR-10a-5p miRNA lipopolysaccharide (LPS) acute lung injury (ALI) ALI lung tissues and mouse pulmonary microvascular endothelial cells (MPMVECs) lipopolysaccharides (LPS) treatment downregulated 31174540 304 Mouse mmu-miR-10a-5p miRNA hypoxia acute myocardial infarction (AMI) The mouse cardiomyocyte cell line HL-1 cells hypoxia induce "MIAT and EGR2 were subsequently determined to be highly-expressed, whereas miR-10a-5p was found to be poorly-expressed in cardiomyocytes exposed to hypoxia as well as in MI mice using RT-qPCR and Western blot assay." 33819189 305 Mouse mmu-miR-10a-5p miRNA high fat diet (HFD) adipose tissue remodeling adipose tissue macrophages (ATMs) in gonadal white adipose tissue (gWAT) high fat diet (HFD) feed downregulated 31668395 306 Mouse mmu-miR-10a-5p miRNA "¦Â3-adrenergic receptor agonist CL316,243 (CL)" adipose tissue remodeling adipose tissue macrophages (ATMs) and PDGFR¦Á+ adipocyte stem cells (ASCs) in gonadal white adipose tissue (gWAT) "¦Â3-adrenergic receptor agonist CL316,243 (CL) treatment" upregulated 31668395 307 Mouse mmu-miR-10a-5p miRNA fluke Fasciola gigantica (FgESPs) F. gigantica infection liver tissues fluke Fasciola gigantica (FgESPs) infection downregulated 33332355 308 Mouse mmu-miR-10a-5p miRNA gut bacterial metabolite Urolithin A (UA) immune response murine CD4+ T cells gut bacterial metabolite Urolithin A (UA) treatment upregulated 31417547 309 Mouse mmu-miR-10a-5p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce upregulated 30936699 310 Mouse mmu-miR-10a-5p miRNA porcine hemagglutinating encephalomyelitis virus (PHEV) porcine hemagglutinating encephalomyelitis virus (PHEV) infection N2a cells; brain tissues porcine hemagglutinating encephalomyelitis virus (PHEV) infection treatment miR-10a-5p was constitutively upregulated by PHEV in both the N2a cells in vitro and mice brain in vivo 32153518 311 Mouse mmu-miR-10b miRNA "hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)" tumorigenesis brain and liver tissue cells "hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) treatment" downregulated 19270793 312 Mouse mmu-miR-10b miRNA binase lymphosarcoma RLS40 cells binase treatment downregulated 33147876 313 Mouse mmu-miR-10b miRNA isoproterenol cardiac fibrosis heart tissues isoproterenol (ISO) treatment downregulated 27174579 314 Mouse mmu-miR-10b miRNA streptozocin (STZ) nonalcoholic steatohepatitis-hepatocellular carcinoma (NASH-HCC) high fat dietmouse liver STZ treatment upregulated in liver 28345673 315 Mouse mmu-miR-10b miRNA bone morphogenetic proteins (BMPs) osteogenesis pluripotent stem (iPS) cells bone morphogenetic proteins (BMPs) treatment downregulated 22937097 316 Mouse mmu-miR-10b miRNA ethanol (EtOH) teratogenesis fetal brains of mice Ethanol?treatment upregulated 19091803 317 Mouse mmu-miR-10b-5p miRNA lipopolysaccharide (LPS) acute lung injury (ALI) ALI lung tissues and mouse pulmonary microvascular endothelial cells (MPMVECs) lipopolysaccharides (LPS) treatment downregulated 31174540 318 Mouse mmu-miR-10b-5p miRNA high fat diet (HFD) hepatic insulin resistance mouse liver tissues high fat diet (HFD) feed downregulated 30820263 319 Mouse mmu-miR-10b-5p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce upregulated 30936699 320 Mouse mmu-miR-10b-5p miRNA hypoxia myocardial infarction (MI) primary mouse cardiomyocyte hypoxia induce downregulated 31480879 321 Mouse mmu-miR-10b-5p miRNA oxygen glucose deprivation (OGD) neuronal cell injury HT22 hippocampal neurons oxygen-glucose deprivation (OGD) treatment upregulated 32323054 322 Mouse mmu-miR-10b-5p miRNA dexamethasone (DEX) oxygen-glucose deprivation (OGD) induced neuron damage HT22 hippocampal neurons dexamethasone (Dex) treatment downregulated 32323054 323 Mouse mmu-miR-1188 miRNA clamping the renal pedicle bilateral renal ischemia C57Bl/6 mice plasma and kidneys clamping the renal pedicle treatment upregulated 24695114 324 Mouse mmu-miR-1192 miRNA runt-related transcription factor-2 (Runx2) tumorigenesis C2C12 cells Runt-related transcription factor-2 (Runx2) treatment upregulated 24136232 325 Mouse mmu-miR-1192 miRNA dexamethasone (DEX) muscle atrophy Murine C2C12 myoblast cells dexamethasone (DEX) treatment downregulated 23716137 326 Mouse mmu-miR-1192 miRNA swimming myocardial infarction (MI) hypoxia-induced neonatal cardiomyocytes 4-wk swim training treatment upregulated 31733833 327 Mouse mmu-miR-1192 miRNA swimming myocardial infarction (MI) plasma swim training treatment miR-1192 was increased after exercise 31733833 328 Mouse mmu-miR-1192 miRNA estradiol vulvovaginal candidiasis (VVC) female mouse vaginal tissues estradiol treatment downregulated 30355939 329 Mouse mmu-miR-1192 miRNA oil vulvovaginal candidiasis (VVC) female mouse vaginal tissues oil treatment downregulated 30355939 330 Mouse mmu-miR-1198 miRNA clozapine (CLZ) psychotic disorders mouse brain clozapine treatment upregulated 23318695 331 Mouse mmu-miR-1199-5p miRNA lipopolysaccharide (LPS) neuroinflammation BV2 cells lipopolysaccharide (LPS) treatment upregulated 33301806 332 Mouse mmu-miR-122 miRNA "4-phenylbutyric acid (PBA, endoplasmic reticulum stress inhibitor)" acute alcoholic liver injury ethanol-treated mice serum exosomes 4-phenylbutyric acid (PBA) treatment downregulated 31361816 333 Mouse mmu-miR-122 miRNA ethanol (EtOH) acute alcoholic liver injury serum exosomes ethanol treatment upregulated 31361816 334 Mouse mmu-miR-122 miRNA concanamycin A (Con A) acute hepatitis liver injury mice plasma Con A (ConA) treatment upregulated 30867286 335 Mouse mmu-miR-122 miRNA cisplatin (DDP) acute kidney injury (AKI) kidney cisplatin treatment downregulated 24759152 336 Mouse mmu-miR-122 miRNA acetaminophen (APAP) acute liver failure (ALF) mouse liver tissues acetaminophen (APAP) treatment upregulated 28616908 337 Mouse mmu-miR-122 miRNA acetaminophen (APAP) acute liver failure (ALF) mouse liver tissues acetaminophen (APAP) treatment upregulated in liver 28963035 338 Mouse mmu-miR-122 miRNA alcohol alcoholic hepatitis (AH) sera alcohol exposure upregulated 26264599 339 Mouse mmu-miR-122 miRNA alcohol alcoholic liver disease (ALD) mouse liver Lieber-DeCarli alcohol treatment downregulated in liver 28987423 340 Mouse mmu-miR-122 miRNA ethanol (EtOH) alcoholic liver disease (ALD) liver tissues ethanol treatment downregulated 28987423 341 Mouse mmu-miR-122 miRNA ethanol (EtOH) alcoholic liver disease (ALD) Kupffer cells from the livers and RAW 264.7 cells ethanol treatment downregulated 31325635 342 Mouse mmu-miR-122 miRNA rhinoviruses (RVs) asthma infant mice lung tissues rhinoviruses (RVs) infection treatment "Here, we found that RV infection induced the expression of miRNA 122 (miR-122) in mouse lungs and in human airway epithelial cells" 33830082 343 Mouse mmu-miR-122 miRNA high fat diet (HFD) atherosclerosis (AS) mouse aortic Endothelial cells high fat diet (HFD) feed upregulated 31228514 344 Mouse mmu-miR-122 miRNA diethylnitrosamine (DEN) chronic hepatitis liver injury mice plasma diethylnitrosamine (DEN) treatment upregulated 30867286 345 Mouse mmu-miR-122 miRNA "2,4,6-trinitrobenzene sulfonic acid (TNBS)" crohn disease (CD) mice colitis tissues "2,4,6-trinitro-benzene-sulfonic acid (TNBS) treatment" downregulated 31019652 346 Mouse mmu-miR-122 miRNA high glucose (HG) diabetic nephropathy (DN) Mouse podocytes (MPC5) high glucose treatment upregulated 30095204 347 Mouse mmu-miR-122 miRNA high doses of acetaminophen (APAP) drug-induced liver injury (DILI) mouse liver tissues high doses of acetaminophen (APAP) treatment upregulated 30381674 348 Mouse mmu-miR-122 miRNA high fat diet (HFD) epithelial-mesenchymal transition (EMT) aortic tissues; serum high fat diet (HFD) feed MiR-122 is upregulated in aortic tissues of ApoE-/- mice fed with HFD. 33278397 349 Mouse mmu-miR-122 miRNA short form augmenter of liver regeneration (sfALR) fatty liver disease The BALB/c mouse liver parenchymal cells short form augmenter of liver regeneration (sfALR) treatment upregulated 26476698 350 Mouse mmu-miR-122 miRNA carbon tetrachloride (CCl4) fibrosis liver tissue of mice CCl4 treatment downregulated 23178710 351 Mouse mmu-miR-122 miRNA ischemia liver damage liver tissues serum levels hepatic ischaemia and reperfusion (I/R) injury treatment upregulated 25039534 352 Mouse mmu-miR-122 miRNA TGF-¦Â hepatic fibrogenesis "hepatic stellate cells (HSCs) and fibroblasts, the major sources of fibrogenic cells in liver tissues" TNF-¦Átreatment treatment downregulated 25909171 353 Mouse mmu-miR-122 miRNA methionine choline-deficient diet (MCD) liver damage liver tissues MCD treatment upregulated 24217942 354 Mouse mmu-miR-122 miRNA leptin hepatic stellate cell (HSC) activation hepatic stellate cell (HSC) leptin treatment leptin reduced miR-122 level. 29248466 355 Mouse mmu-miR-122 miRNA ethanol (EtOH) liver damage liver mononuclear cells and Kupffer cells ethanol treatment upregulated 25973575 356 Mouse mmu-miR-122 miRNA acetaminophen (APAP) hepatotoxicity C57BL/6J mice serum acetaminophen (APAP) treatment upregulated in early and progressively up to 6 h in the serum 28755860 357 Mouse mmu-miR-122 miRNA paracetamol hepatotoxicity Pentoject-culled C57BL/6J mice serum paracetamol treatment upregulated in serum 30090508 358 Mouse mmu-miR-122 miRNA high fat diet (HFD) high fat diet?influence liver tissue high fat diet (HFD) feed upregulated 19835573 359 Mouse mmu-miR-122 miRNA angiotensin II (Ang II) hypertension kidney tissues angiotensin II (Ang II) treatment upregulated 30256768 360 Mouse mmu-miR-122 miRNA lychee pulp phenolics (LPPs) hypolipidemic mechanism high-fat diet (HFD) mouse hepatocytes lychee pulp phenolics (LPPs) treatment downregulated in mouse hepatocytes 28121324 361 Mouse mmu-miR-122 miRNA penetrating keratoplasty (PKP) corneal transplantation rejection BALB/c mice "the recipients were BALB/s mice, and the donors were C57BL/6 mice. The diameter of the corneal graft was 2?mm treatment" downregulated 28540063 362 Mouse mmu-miR-122 miRNA lipopolysaccharide (LPS) inflammation blood lipopolysaccharide (LPS) treatment upregulated 27477940 363 Mouse mmu-miR-122 miRNA dextran-iron iron overload (IO) C57BL/6 mice feeding mice a 3% dextran-iron diet downregulated 29176318 364 Mouse mmu-miR-122 miRNA oxygen glucose deprivation (OGD) ischemic brain injury mouse N2A neuroblastoma (N2A) cells oxygen-glucose deprivation (OGD) treatment miR-122 expression was significantly decreased in both N2A cells after OGD 29715465 365 Mouse mmu-miR-122 miRNA oxygen glucose deprivation (OGD) ischemic stroke (IS) N2a cells oxygen and glucose deprivation (OGD) treatment downregulated 33177827 366 Mouse mmu-miR-122 miRNA leishmania leishmaniasis "the liver and J774 macrophages, and in spleens from infected mice" Leishmania infection upregulated 29943317 367 Mouse mmu-miR-122 miRNA dietary methyl deficiency hepatocellular carcinoma (HCC) the liver tissues Dietary methyl deficiency treatment downregulated 20436259 368 Mouse mmu-miR-122 miRNA silymarin (Sm) liver damage blood and liver tissues silymarin (Sm) treatment upregulated 31811641 369 Mouse mmu-miR-122 miRNA "2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD)" liver damage mouse liver cells "2, 3, 7, 8-tetrachlorodi-benzo-p-dioxin (TCDD) treatment" "TCDD dysregulates the expression of miR101a and miR122 and that COX-2, a target gene of miR101a, plays a significant role in liver damage in mice exposed to TCDD." 21602190 370 Mouse mmu-miR-122 miRNA leptin liver fibrosis HCS were isolated from adult Kunming mice leptin treatment downregulated 29054053 371 Mouse mmu-miR-122 miRNA "1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP)" liver growth C57BL/6J male mice liver "1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) treatment" upregulated in liver 28095325 372 Mouse mmu-miR-122 miRNA acetaminophen (APAP) liver damage liver tissues acetaminophen (APAP) treatment upregulated 19246379 373 Mouse mmu-miR-122 miRNA bile duct ligation (BDL) liver damage Serum bile-duct ligation (BDL) treatment Serum miR-122 increased significantly after BDL-induced cholestatic injury 24086271 374 Mouse mmu-miR-122 miRNA isoniazid (INH) liver damage liver tissues isoniazid treatment downregulated 26535639 375 Mouse mmu-miR-122 miRNA isoniazid (INH) liver damage liver tissues isoniazid (INH) treatment downregulated 27446292 376 Mouse mmu-miR-122 miRNA isoniazid (INH) liver damage liver tissues isoniazid (INH) treatment upregulated 29554950 377 Mouse mmu-miR-122 miRNA resveratrol hepatic steatosis Sprague-Dawley rats resveratrol (RS) treatment downregulated 28375178 378 Mouse mmu-miR-122 miRNA free fatty acids (FFAs) inducer CL316243 metabolic syndrome C57BL/6 mice livers CL316243 treatment upregulated 28802563 379 Mouse mmu-miR-122 miRNA ischemia/reperfusion (I/R) myocardial ischaemic injury mouse plasma;Bone marrow-derived macrophage (BMDM);Rat neonatal CMs ischemia/reperfusion (I/R) treatment differently regulated 28768728 380 Mouse mmu-miR-122 miRNA "berberis aristata, elaeis guineensis?and?coffea canephora" nonalcoholic fatty liver disease (NAFLD) mouse liver tissues "Berberis Aristata, Elaeis Guineensis?and?Coffea Canephora treatment" both these miRNAs had similar levels to SD-mice in HFD+E-mice 33924725 381 Mouse mmu-miR-122 miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver tissues high fat diet (HFD) feed upregulated 31126802 382 Mouse mmu-miR-122 miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) mouse liver tissues high fat diet (HFD) feed both these miRNAs had similar levels to SD-mice in HFD+E-mice 33924725 383 Mouse mmu-miR-122 miRNA methionine choline-deficient diet (MCD) nonalcoholic fatty liver disease (NAFLD) liver tissue methionine and choline-deficient treatment MiR-122 levels increased 24217942 384 Mouse mmu-miR-122 miRNA silybin nonalcoholic fatty liver disease (NAFLD) FaO cells silybin treatment upregulated 31816412 385 Mouse mmu-miR-122 miRNA isochlorogenic acid B (ICAB) nonalcoholic steatohepatitis (NASH) NASH mouse liver tissues Isochlorogenic acid B (ICAB) treatment upregulated 30180301 386 Mouse mmu-miR-122 miRNA methionine choline-deficient diet (MCD) nonalcoholic steatohepatitis (NASH) liver tissues methionine- and choline-deficient (MCD) diet feed downregulated 30180301 387 Mouse mmu-miR-122 miRNA high concentration of free fatty acids nonalcoholic steatohepatitis (NASH) NCTC-1469 cells high concentration of free fatty acids treatment miR-122 levels was downregulated in HFFA-induced NASH cell-like model. 32054840 388 Mouse mmu-miR-122 miRNA isochlorogenic acid B (ICAB) nonalcoholic steatohepatitis (NASH) non-alcoholic steatohepatitis (NASH) rats liver tissues Isochlorogenic acid B (ICAB) treatment upregulated 30180301 389 Mouse mmu-miR-122 miRNA metformin (Met) nonalcoholic steatohepatitis (NASH) liver tissues metformin treatment downregulated 25672270 390 Mouse mmu-miR-122 miRNA methionine choline-deficient diet (MCD) nonalcoholic steatohepatitis (NASH) liver tissues methionine- and choline-deficient (MCD) diet feed downregulated 30180301 391 Mouse mmu-miR-122 miRNA methionine choline-deficient diet (MCD) nonalcoholic steatohepatitis (NASH) liver tissues were fed a methionine-choline-deficient (MCD) diet for eight weeks treatment upregulated 25269746 392 Mouse mmu-miR-122 miRNA streptozocin (STZ) nonalcoholic steatohepatitis (NASH) high-fat diet mouse STZ treatment downregulated 29216638 393 Mouse mmu-miR-122 miRNA streptozocin (STZ) nonalcoholic steatohepatitis-hepatocellular carcinoma (NASH-HCC) high fat dietmouse liver STZ treatment upregulated in liver 28345673 394 Mouse mmu-miR-122 miRNA aerobic training obesity exosomes of serum aerobic training downregulated 32744099 395 Mouse mmu-miR-122 miRNA monosodium glutamate (MSG) obesity liver tissues monosodium glutamate (MSG)-injected mice with developed central obesity treatment dysregulated 24465854 396 Mouse mmu-miR-122 miRNA hepatocarcinogen diethylnitrosamine (DEN) pathological changes in the brain liver tissue of mice hepatocarcinogen diethylnitrosamine (DEN) treatment upregulated 24113455 397 Mouse mmu-miR-122 miRNA testosterone prostate cancer female mouse liver Testosterone treatment "upregulation of the 6 miRNAs miR-22, miR-690, miR-122, let-7A, miR-30D and let-7D" 20600201 398 Mouse mmu-miR-122 miRNA soluble egg antigen (SEA)of Schistosoma japonicum schistosomiasis mouse hepatocytes (AML12) SEA treatment upregulated 29469324 399 Mouse mmu-miR-122 miRNA streptozocin (STZ) smooth muscle cell differentiation mouse liver streptozotocin (STZ) treatment Upregulation of miR-34a and downregulated of miR-122 was found in livers of STZ-induced diabetic mice 19372595 400 Mouse mmu-miR-122 miRNA "TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin)" thymic atrophy and alterations in T cell differentiation fetal thymocytes of mice "TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) treatment" upregulated 23024791 401 Mouse mmu-miR-122 miRNA atorvastatin type 2 diabetes mellitus (T2DM) C57Bl/6 mice injected once a day with 20 mg/kg atorvastatin intraperitoneally for 5 days downregulated 27899485 402 Mouse mmu-miR-122-3p miRNA acetaminophen (APAP) liver damage mouse serum acetaminophen (APAP) treatment upregulated 30844585 403 Mouse mmu-miR-122-3p miRNA diosbuibin B (DB) liver damage mouse serum diosbuibin B (DB) treatment upregulated 30844585 404 Mouse mmu-miR-122-3p miRNA ethyl acetate fraction of airpotato yam liver damage ICR and C57BL/6 mice treat with ethyl acetate fraction of airpotato yam significantly upregulated with no significant elevation of serum ALT/AST activity 28844483 405 Mouse mmu-miR-122-3p miRNA monocrotaline (MCT) liver damage mouse serum monocrotaline (MCT) treatment upregulated 30844585 406 Mouse mmu-miR-122-3p miRNA toosendanin (TSN) liver damage mouse serum toosendanin (TSN) treatment upregulated 30844585 407 Mouse mmu-miR-1224 miRNA alcohol alcoholic liver disease (ALD) mouse liver cells Lieber-DeCarli alcohol treatment upragulated 19572984 408 Mouse mmu-miR-1224 miRNA methionine choline-deficient diet (MCD) alcoholic liver disease (ALD) liver tissues methionine-choline-deficient (MCD) diets treatment upragulated 19572984 409 Mouse mmu-miR-1224 miRNA clamping the renal pedicle bilateral renal ischemia C57Bl/6 mice plasma and kidneys clamping the renal pedicle treatment upregulated 24695114 410 Mouse mmu-miR-1224 miRNA lipopolysaccharide (LPS) glioblastoma multiforme (GBM) spleens of mice lipopolysaccharide (LPS)? treatment upregulated 21320120 411 Mouse mmu-miR-1224 miRNA dopamine neurodegeneration (ND) N2a cells dopamine treatment downregulated 30738894 412 Mouse mmu-miR-1224 miRNA total-body irradiation (TBI) radiation nephropathy mouse urinary a single LD50 of total-body irradiation (TBI) or clinically relevant fractionated doses (2 Gy twice daily for 3 days) treatment upregulated in mouse urinary 28977780 413 Mouse mmu-miR-1224-5p miRNA "2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD)" bordetella pertussis infection Pertussis Toxin (PTX) treated mice CD4+ T cells "2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) treatment" downregulated 31681214 414 Mouse mmu-miR-1225-5p miRNA nuclear factor kappa-¦¢ ligand (RANKL) osteoclastogenesis bone marrow-derived macrophages (BMMs) nuclear factor kappa-¦¢ ligand (RANKL) treatment downregulated 31017694 415 Mouse mmu-miR-1225-5p miRNA streptozocin (STZ) type 1 diabetes mellitus (T1DM) serum streptozocin (STZ) treatment Secretions of miR-1225-5p was significantly increased in streptozotocin-treated mice 29370422 416 Mouse mmu-miR-122-5p miRNA acetaminophen (APAP) acetaminophen (APAP)-induced liver injury (AILI) serums acetaminophen (APAP) treatment upregulated 32779042 417 Mouse mmu-miR-122-5p miRNA lipopolysaccharide (LPS) acute kidney injury (AKI) renal cortex lipopolysaccharide (LPS) treatment upregulated 33782973 418 Mouse mmu-miR-122-5p miRNA concanamycin A (Con A) acute liver failure (ALF) RAW264.7 cells concanavalin A (Con A) treatment upregulated 32739513 419 Mouse mmu-miR-122-5p miRNA lipopolysaccharide (LPS) acute lung injury (ALI) Murine lung vascular endothelial cells (MLECs); lung tissues lipopolysaccharide (LPS) treatment upregulated 32470454 420 Mouse mmu-miR-122-5p miRNA apigenin cardiac fibrosis TGF-¦Â1-treated mouse cardiac fibroblasts apigenin treatment upregulated 33607460 421 Mouse mmu-miR-122-5p miRNA TGF-¦Â1 cardiac fibrosis Mouse cardiac fibroblasts TGF-¦Â1 treatment downregulated 33607460 422 Mouse mmu-miR-122-5p miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity Plasma doxorubicin (DOX) treatment downregulated 30627229 423 Mouse mmu-miR-122-5p miRNA acetaminophen (APAP) drug-induced liver injury (DILI) plasma acetaminophen (APAP) treatment miR-122-5p and miR-192-5p were consistently upregulated in early to late stages of all the liver injury models. 30125006 424 Mouse mmu-miR-122-5p miRNA ¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) experimental autoimmune encephalomyelitis (EAE) murine brain-derived CD4+ T cells ¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) combination treatment downregulated 31497013 425 Mouse mmu-miR-122-5p miRNA fluke Fasciola gigantica (FgESPs) F. gigantica infection liver tissues fluke Fasciola gigantica (FgESPs) infection downregulated 33332355 426 Mouse mmu-miR-122-5p miRNA perfluorooctanoic acid hepatotoxicity liver tissues Perfluorooctanoic acid (PFOA) exposure treatment upregulated 24459700 427 Mouse mmu-miR-122-5p miRNA Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria plasmodium chabaudi infection Balb/c Mice liver infect with Vaccination treatment downregulated in the Liver 28123381 428 Mouse mmu-miR-122-5p miRNA cadmium (Cd) toxic effects of cadmium rat kidneys; NRK-52E cadmium (Cd) treatment upregulated 31626960 429 Mouse mmu-miR-122-5p miRNA 5-chloro-N-[4-chloro-3-(trifluoromethyl)phenyl]thiophene-2-sulfonamide (FX5) type 2 diabetes mellitus (T2DM) mouse primary hepatocytes 5-chloro-N-[4-chloro-3-(trifluoromethyl)phenyl]thiophene-2-sulfonamide (FX5) treatment FX5 antagonized Dex or glucagon- induced enhancement on miR122-5p expression. 33316780 430 Mouse mmu-miR-122-5p miRNA dexamethasone (DEX) type 2 diabetes mellitus (T2DM) mouse primary hepatocytes dexamethasone (DEX) treatment upregulated 33316780 431 Mouse mmu-miR-122-5p miRNA glucagon type 2 diabetes mellitus (T2DM) mouse primary hepatocytes glucagon treatment upregulated 33316780 432 Mouse mmu-miR-122?5p miRNA carbon tetrachloride (CCl4) hepatotoxicity blood carbon tetrachloride (CCl4) treatment upregulated 32528856 433 Mouse mmu-miR-122a miRNA tumor necrosis factor alpha (TNF-¦Á) intestinal inflammation mice enterocytes tumor necrosis factor alpha (TNF-¦Á) treatment upregulated 21763238 434 Mouse mmu-miR-122a miRNA tert-butyl hydroperoxide (TBHP) oxidative stress adult male mice strain Balb/c TBHP treatment differently regulated 25141839 435 Mouse mmu-miR-124 miRNA candida albicans (C. albicans) acute kidney injury (AKI) kidney tissues candida albicans infection downregulated 29568906 436 Mouse mmu-miR-124 miRNA itraconazole (ITR) acute kidney injury (AKI) candidiasis-induced acute kidney injury (AKI) mouse kidney tissues itraconazole (ITR) treatment upregulated 29568906 437 Mouse mmu-miR-124 miRNA d-galactosamine and lipopolysaccharide (LPS) acute liver injury (ALI) liver tissues and cells d-galactosamine and lipopolysaccharide treatment upregulated 31628693 438 Mouse mmu-miR-124 miRNA sedum sarmentosum extract acute liver injury (ALI) liver tissues S. sarmentosum extract treatment miR-124 was increased in liver tissues after S sarmentosum extract was administered 32178661 439 Mouse mmu-miR-124 miRNA forsythoside A (FA) acute lung injury (ALI) MLE-12 cells forsythoside A (FA) treatment miR-124 expression was upregulated after FA treatment. 32987027 440 Mouse mmu-miR-124 miRNA H2O2 acute lung injury (ALI) primary mouse lung epithelial cells (LECs) H2O2 treatment downregulated 31938089 441 Mouse mmu-miR-124 miRNA hyperoxia acute lung injury (ALI) primary mouse lung epithelial cells (LECs) hyperoxia treatment downregulated 31938089 442 Mouse mmu-miR-124 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues lipopolysaccharides (LPS) treatment downregulated 31476692 443 Mouse mmu-miR-124 miRNA Mito-TEMPO acute lung injury (ALI) hyperoxia-/H2O2-treated primary mouse lung epithelial cells (LECs) Mito-TEMPO treatment upregulated 31938089 444 Mouse mmu-miR-124 miRNA N-acetyl-L-cysteine (NAC) acute lung injury (ALI) hyperoxia-/H2O2-treated primary mouse lung epithelial cells (LECs) N-acetyl-L-cysteine (NAC) treatment upregulated 31938089 445 Mouse mmu-miR-124 miRNA lithium (Li) acute poststroke brain tissues lithium (1 mg/kg bolus followed by 2 mg/kg/day over up to 7 days) was intraperitoneally administered starting 0-9 h after reperfusion onset upregulated in brain 27126323 446 Mouse mmu-miR-124 miRNA insulin adipogenesis 3T3-L1 cells Insulin treatment "insulin-induced miR-124 plays a pivotal role in post-transcriptional regulation of Dlx5 during adipogenic differentiation and that miR-124 exerts pro-adipogenic effects by targeting Dlx5, at least in part" 23648570 447 Mouse mmu-miR-124 miRNA "3,4-dihydroxyphenylethanol (DOPET)" Alzheimer's disease (AD) oA42i (oligomeric amyloid ¦Â1-42 plus ibotenic acid) induced AD mouse hippocampi "3,4-dihydroxyphenylethanol (DOPET) treatment" upregulated 29901389 448 Mouse mmu-miR-124 miRNA bilateral common carotid artery occlusion (2-VO) Alzheimer's disease (AD) hippocampus tissues of AD mouse bilateral common carotid artery?occlusion (2VO) induce The expression of miR-124 was significantly downregulated in 2VO-induced AD mice models 31743528 449 Mouse mmu-miR-124 miRNA H2O2 Alzheimer's disease (AD) N2a mouse neuroblastoma cells Hydrogen peroxide (H2O2)?treatment The expression of miR-124 was significantly downregulated in H2O2-treated N2a cells 31743528 450 Mouse mmu-miR-124 miRNA oA42i (oligomeric amyloid ¦Â1-42 plus ibotenic acid) Alzheimer's disease (AD) hippocampi oA42i (oligomeric amyloid ¦Â1-42 plus ibotenic acid) treatment downregulated 29901389 451 Mouse mmu-miR-124 miRNA streptozocin (STZ) Alzheimer's disease (AD) mouse brain tissues streptozocin treatment downregulated 31014193 452 Mouse mmu-miR-124 miRNA H2O2 Alzheimer's disease (AD) N2a cells Hydrogen peroxide (H2O2 ) treatment miR-124 expression level was upregulated in H2O2-treated N2a cells. 31743528 453 Mouse mmu-miR-124 miRNA ischemia apoptosis brain tissues ischemia?treatment upregulated 23826665 454 Mouse mmu-miR-124 miRNA folate apoptosis mouse embryonic stem cells (mESCs) folate deficiency induced upregulated 22828209 455 Mouse mmu-miR-124 miRNA arsenite arsenic induted deficits in differentiation prenatal C57BL/6 mouse brain arsenic (As) exposure downregulated 27751817 456 Mouse mmu-miR-124 miRNA metformin (Met) atherosclerosis (AS) carotid Metformin treatment Administration of metformin reduced miR-124 expression. 29502204 457 Mouse mmu-miR-124 miRNA IL-4 and IL-13 breast cancer macrophages IL-4 and IL-13 treatment upregulated 24358127 458 Mouse mmu-miR-124 miRNA doxorubicin (DOX) cardiac injury heart sissues; primary cardiomyocytes doxorubicin treatment MiR-124 was downregulated in Dox-induced cardiac injury. 31672275 459 Mouse mmu-miR-124 miRNA doxorubicin (DOX) cardiotoxicity heart tissues and primary cardiomyocytes doxorubicin treatment downregulated 31672275 460 Mouse mmu-miR-124 miRNA melatonin cell proliferation hippocampus dentate gyrus tissues melatonin treatment upregulated 31169197 461 Mouse mmu-miR-124 miRNA paclitaxel (PTX) chemotherapy-induced peripheral neuropathy (CiPN) mouse dorsal root ganglion (DRG) and sciatic nerve tissues Paclitaxel treatment upregulated 30677061 462 Mouse mmu-miR-124 miRNA lipopolysaccharide (LPS) cholinergic anti-inflammatory action Mouse macrophage cell line RAW264.7 ;human HEK293 cell line lipopolysaccharide (LPS) treatment miR-124 is upregulated by cholinergic agonists in LPS-exposed cells and mice 23979021 463 Mouse mmu-miR-124 miRNA "5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)" chondrogenesis C3H10T1/2 cells "5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment" upregulated 28979686 464 Mouse mmu-miR-124 miRNA hypoxia chondrogenesis C3H10T1/2 cells under hypoxic conditions (2% O2) downregulated 28979686 465 Mouse mmu-miR-124 miRNA collagen collagen-induced arthritis (CIA) synovial tissues collagen treatment downregulated 33337986 466 Mouse mmu-miR-124 miRNA vitamin D collagen-induced arthritis (CIA) Th17 cells vitamin D (VD) treatment upregulated 30792721 467 Mouse mmu-miR-124 miRNA kainic acid (KA) convulsive seizures hippocampal neural stem/progenitor cells (NSPCs) kainic acid (KA) treatment upregulated 30837840 468 Mouse mmu-miR-124 miRNA oxidized low density lipoprotein (ox-LDL) coronary artery disease (CAD) RAW264.7 cells oxidized low-density lipoprotein (ox-LDL) treatment downregulated 32611832 469 Mouse mmu-miR-124 miRNA resveratrol experimental autoimmune encephalomyelitis (EAE) encephalitogenic CD4+ T cells from EAE mice "Resveratrol (3,5,4'-trihydroxy-trans-stilbene) (RES) treatment" upregulated 30941623 470 Mouse mmu-miR-124 miRNA TGF-¦Â1 fibrogenesis Lung resident mesenchymal stem cells (LR-MSCs) transforming growth factor (TGF)-¦Â1 treatment upregulated 30802451 471 Mouse mmu-miR-124 miRNA angiotensin II (Ang II) heart failure (HF) heart tissues angiotensin II (Ang II) treatment upregulated 29581851 472 Mouse mmu-miR-124 miRNA shikonin heart failure (HF) heart tissues Shikonin treatment downregulated 31604527 473 Mouse mmu-miR-124 miRNA morphine immune response microglia morphine treatment upregulated 25539811 474 Mouse mmu-miR-124 miRNA IL-1¦Â inflammation ATDC5 cells interleukin-1¦Â treatment downregulated 31608709 475 Mouse mmu-miR-124 miRNA lipopolysaccharide (LPS) inflammation Mouse macrophage cell line RAW264.7 lipopolysaccharide (LPS) treatment upregulated 27063215 476 Mouse mmu-miR-124 miRNA lipopolysaccharide (LPS) inflammation ATDC5 cells lipopolysaccharide (LPS) treatment downregulated 31190561 477 Mouse mmu-miR-124 miRNA lycium barbarum polysaccharide (LBP) inflammation interleukin-1¦Â-treated ATDC5 cells Lycium barbarum polysaccharide (LBP) treatment upregulated 31608709 478 Mouse mmu-miR-124 miRNA bacillus calmette-guerin (BCG) inflammatory response RAW264.7 AM cells bacillus calmette-guerin (BCG) treatment upregulated 24995397 479 Mouse mmu-miR-124 miRNA ischemia ischemia/reperfusion (I/R) injury cerebral cortex and hippocampus Ischemic preconditioning and ischemic postconditioning (IPostC) treatment downregulated 27485299 480 Mouse mmu-miR-124 miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) hippocampus tissues chronic unpredictable mild stress (CUMS) treatment downregulated 31626919 481 Mouse mmu-miR-124 miRNA lipopolysaccharide (LPS) major depressive disorder (MDD) BV2 cells lipopolysaccharide (LPS) treatment downregulated 31626919 482 Mouse mmu-miR-124 miRNA methamphetamine (METH) methamphetamine (METH) addiction precursors methamphetamine (METH) treatment downregulated 29516602 483 Mouse mmu-miR-124 miRNA mycobacterium bovis bacille Calmette-Gu¨¦rin (BCG) mycobacterium tuberculosis (Mtb) infection female C57/BL6 mice infect with Mycobacterium bovis BCG treatment upregulated in lungs 24705038 484 Mouse mmu-miR-124 miRNA H2O2 myocardial infarction (MI) neonatal rat ventricular myocytes (NRVMs) H2O2 treatment miR-124 was significantly upregulated in a mice model of MI and in neonatal rat ventricular myocytes (NRVMs) with H2O2 treatment. 30439699 485 Mouse mmu-miR-124 miRNA H2O2 myocardial infarction (MI) primary cardiomyocyte H2O2 treatment upregulated 31100313 486 Mouse mmu-miR-124 miRNA hypoxia myocardial infarction (MI) primary cardiomyocyte hypoxia induce upregulated 31100313 487 Mouse mmu-miR-124 miRNA hypoglossal nerve injury nerve injury injured hypoglossal motor neurons injury mouse nerve treatment downregulated 24184980 488 Mouse mmu-miR-124 miRNA retinoic acid (RA) cell differentiation L929 cells retinoic acid? treatment upregulated 31823894 489 Mouse mmu-miR-124 miRNA ketamine neurodegeneration (ND) murine hippocampus high-dosage ketamine treatment upregulated 24825585 490 Mouse mmu-miR-124 miRNA lipopolysaccharide (LPS) neuroinflammation N9 microglia lipopolysaccharide (LPS) treatment downregulated 28096568 491 Mouse mmu-miR-124 miRNA cocaine neuronal adaptations NG-108-15 cells£» HEK293T cells cocaine treatment "LV-miR-124 and let-7d expression in the NAc attenuates cocaine CPP, whereas LV-miR-181a enhances it" 21307844 492 Mouse mmu-miR-124 miRNA cocaine neuronal function mouse nucleus accumbens (NAc) cocaine treatment cocaine treatment persistently downregulated miR-124 in NAc. 32641757 493 Mouse mmu-miR-124 miRNA extra-virgin olive oil rich in phenols (H-EVOO) neuronal function cortex H-EVOO treatment upregulated 26695409 494 Mouse mmu-miR-124 miRNA ketamine neurotoxicity Hippocampal ketamine treatment upregulated 24825585 495 Mouse mmu-miR-124 miRNA morphine opioid-induced damage to microglia mouse BV2 cells morphin treatment upregulated 25539811 496 Mouse mmu-miR-124 miRNA IL-6 osteoclastogenesis M-CSF stimulated mouse bone marrow-derived macrophages IL-6 treatment downregulated 30547186 497 Mouse mmu-miR-124 miRNA tumor necrosis factor alpha (TNF-¦Á) osteoclastogenesis M-CSF stimulated mouse bone marrow-derived macrophages tumor necrosis factor alpha (TNF-¦Á) treatment downregulated 30547186 498 Mouse mmu-miR-124 miRNA macrophage colony stimulating factor (M-CSF) osteoporosis bone marrow monocytes (BMMs) from OVX mice co-cultured with RANKL (50 ng/ml) containing M-CSF (20ng/ml) downregulated 29045940 499 Mouse mmu-miR-124 miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) mouse brain tissues "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" downregulated 30995872 500 Mouse mmu-miR-124 miRNA lipopolysaccharide (LPS) parkinson's disease (PD) immortalized murine microglial cell line BV2 cells lipopolysaccharide (LPS) treatment downregulated 30995872 501 Mouse mmu-miR-124 miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) brian tissues "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" downregulated in the expression of brain-enriched miR-124 24792712 502 Mouse mmu-miR-124 miRNA lipopolysaccharide (LPS) parkinson's disease (PD) BV2 cells lipopolysaccharide (LPS) treatment Brain-specific miR-124 was downregulated in the LPS- stimulated BV2 cells. 29329581 503 Mouse mmu-miR-124 miRNA docosahexaenoic acid (DHA) spinal cord injury (SCI) BV-2 mouse microglial cells Docosahexaenoic acid (DHA) treatment upregulated 30972415 504 Mouse mmu-miR-124 miRNA H2O2 spinal cord injury (SCI) BV-2 cells H2O2 treatment downregulated 30720072 505 Mouse mmu-miR-124 miRNA nicotine ulcerative colitis (UC) ulcerative colon Nicotine treatment upregulated 27709266 506 Mouse mmu-miR-124-3p miRNA lipopolysaccharide (LPS) acute respiratory distress syndrome (ARDS) lung tissues lipopolysaccharide (LPS) treatment downregulated 32391561 507 Mouse mmu-miR-124-3p miRNA lipopolysaccharide (LPS) acute respiratory distress syndrome (ARDS) serum lipopolysaccharide (LPS) treatment downregulated 32934950 508 Mouse mmu-miR-124-3p miRNA myostatin adipogenesis 3T3-L1 cells myostatin treatment upregulated 30576242 509 Mouse mmu-miR-124-3p miRNA myostatin adipogenesis 3T3-L1 cells myostatin treatment upregulated 30576242 510 Mouse mmu-miR-124-3p miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues carbon tetrachloride (CCl4) treatment downregulated 30673982 511 Mouse mmu-miR-124-3p miRNA rosiglitazone liver fibrosis TGF-¦Â1 treated primary mouse hepatic stellate cells (HSCs) Rosiglitazone (RGZ) treatment upregulated 30673982 512 Mouse mmu-miR-124-3p miRNA rosiglitazone liver fibrosis carbon tetrachloride (CCl4) treated mouse liver tissues Rosiglitazone (RGZ) treatment upregulated 30673982 513 Mouse mmu-miR-124-3p miRNA TGF-¦Â1 liver fibrosis Primary mouse hepatic stellate cells (HSCs) TGF-¦Â1 treatment downregulated 30673982 514 Mouse mmu-miR-124-3p miRNA repetitive traumatic brain injury (rTBI) mouse model brain extracts nerve injury BV2 microglia repetitive traumatic brain injury (rTBI) mouse model brain extracts treatment upregulated 31190315 515 Mouse mmu-miR-124-3p miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver tissues high fat diet (HFD) feed "In response to high-fat diet (HFD), expression of miR-124-3p was increased in the liver." 33324345 516 Mouse mmu-miR-124-3p miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) substantia nigra (SN) area "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" "?HOXA11-AS promoted MPTP-mediated SH-SY5Y neuronal injury and LPS-induced microglia activation, while miR-124-3p had the opposite effects." 33839699 517 Mouse mmu-miR-124-3p miRNA lipopolysaccharide (LPS) parkinson's disease (PD) BV2 cells lipopolysaccharide (LPS) treatment downregulated 33839699 518 Mouse mmu-miR-124-3p miRNA hypoxia pulmonary hypertension (PH) pulmonary arterial smooth muscle cells (PASMCs) hypoxia treatment downregulated 33657879 519 Mouse mmu-miR-124-3p miRNA lipopolysaccharide (LPS) severe community-acquired pneumonia (SCAP) Ana-1 macrophages lipopolysaccharide (LPS) treatment downregulated 30535475 520 Mouse mmu-miR-124-3p miRNA lipopolysaccharide (LPS) severe community-acquired pneumonia (SCAP) Ana-1 macrophages lipopolysaccharide (LPS) treatment downregulated 30535475 521 Mouse mmu-miR-1244 miRNA curcumin (Cur) nasopharyngeal carcinoma (NPC) mice injected into the tumour centre at a concentration of 150 mg/kg treatment dysregulated 24896104 522 Mouse mmu-miR-124-5p miRNA lipopolysaccharide (LPS) acute lung injury (ALI) mouse Alveolar Type 2 Epithelial Cells. lipopolysaccharide (LPS) treatment MiR-124-5p is increased in the LPS-induced ALI cell model. 32190682 523 Mouse mmu-miR-124-5p miRNA tanshinone IIA (Tan IIA) acute myocardial infarction (AMI) H9c2 cells Tanshinone IIA (TSA) treatment "TSA exerts the protective role against H/R induced apoptosis, oxidative and MMP loss of cardiomyocytes via regulating AK003290 and miR-124-5p signaling" 32220226 524 Mouse mmu-miR-124-5p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce downregulated 30936699 525 Mouse mmu-miR-1246 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues lipopolysaccharide (LPS) treatment "In ALI mice, miRNA-1246 expression is effectively upregulated." 30253370 526 Mouse mmu-miR-1246 miRNA alcohol alcoholic hepatitis (AH) sera alcohol exposure upregulated 26264599 527 Mouse mmu-miR-1247 miRNA carbon tetrachloride (CCl4) acute kidney injury (AKI) mouse liver carbon tetrachloride (CCl4) treatment upregulated 28285099 528 Mouse mmu-miR-1247-3p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) stroke neuro2a (N2a) cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 30779911 529 Mouse mmu-miR-1249 miRNA chronic intermittent hypoxia (CIH) obstructive sleep apnoea-hypopnoea syndrome (OSAHS) mouse aortic endothelial cells (MAECs) chronic intermittent hypoxia (CIH) treatment upregulated 29108914 530 Mouse mmu-miR-1249-5p miRNA Sphingosine-1-phosphate (S1P) liver disease liver tissues; liver macrophages sphingosine 1-phosphate (S1P) treatment downregulated 32672363 531 Mouse mmu-miR-1249-5p miRNA X-rays radiation-induced injury bone marrow stem cells X-ray treatment "mmu-circRNA_016901 affects the expression of TGF-¦Â3 through miRNA1249-5p, and thus participates in the regulation of the radiation damage mechanism of bone marrow mesenchymal stem cells" 32552977 532 Mouse mmu-miR-124a miRNA duloxetine depression frontal lobe and hippocampus duloxetine treatment downregulated 26823914 533 Mouse mmu-miR-124a miRNA neurotoxicant sodium valproate (VPA) developmental toxicity murine embryonic stem cells (mESCs) neurotoxicant sodium valproate (VPA) treatment downregulated 24896083 534 Mouse mmu-miR-124a miRNA exenatide (EXA) insulin sensitivity pancreas exenatide treatment "The levels of miRNA-15a, 29c, 124a, and 375 in the pancreas were significantly increased in HFD control mice.These effects were reversed by treatment with exenatide." 26314504 535 Mouse mmu-miR-124a miRNA exenatide (EXA) insulin sensitivity liver exenatide treatment "the levels of miRNA-29c, 124a, and 146a in the liver were significantly increased. These effects were reversed by treatment with exenatide." 26314504 536 Mouse mmu-miR-124a miRNA exenatide (EXA) insulin sensitivity muscle exenatide treatment "The levels of miRNA-15a, 29c, 124a, and 146a in the muscle were significantly increased. These effects were reversed by treatment with exenatide." 26314504 537 Mouse mmu-miR-124a miRNA exenatide (EXA) insulin sensitivity serum exenatide treatment "the levels of miRNA-15a, 29c, 124a, and 375 in the serum were significantly decreased. These effects were reversed by treatment with exenatide." 26314504 538 Mouse mmu-miR-124a miRNA high fat diet (HFD) insulin sensitivity pancreas high fat diet (HFD) feed upregulated 26314504 539 Mouse mmu-miR-124a miRNA high fat diet (HFD) insulin sensitivity liver high fat diet (HFD) feed upregulated 26314504 540 Mouse mmu-miR-124a miRNA high fat diet (HFD) insulin sensitivity muscle high fat diet (HFD) feed upregulated 26314504 541 Mouse mmu-miR-124a miRNA high fat diet (HFD) insulin sensitivity serum high fat diet (HFD) feed downregulated 26314504 542 Mouse mmu-miR-124a miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver tissues high fat diet (HFD) feed upregulated 30861258 543 Mouse mmu-miR-124a miRNA liraglutide nonalcoholic fatty liver disease (NAFLD) high fat diet-fed mice liver tissues liraglutide treatment downregulated 30861258 544 Mouse mmu-miR-124a miRNA bone morphogenetic proteins (BMPs) osteogenesis pluripotent stem (iPS) cells bone morphogenetic proteins (BMPs) treatment downregulated 22937097 545 Mouse mmu-miR-125 miRNA xanthomicrol breast cancer 4T1 cells xanthomicrol treatment downregulated 33217075 546 Mouse mmu-miR-125 miRNA carbon tetrachloride (CCl4) liver fibrosis hepatic tissue carbon tetrachloride (CCl4) treatment Exos delivery of mmu_circ_0000623 inhibited liver fibrosis protein expression by promoting miR- 125/ATG4D-mediated autophagy. 32633558 547 Mouse mmu-miR-125a miRNA pristane (PS) "acute ""SLE-like"" lung inflammation" lung tissues pristane treatment downregulated 30089723 548 Mouse mmu-miR-125a miRNA candida albicans (C. albicans) Alzheimer's disease (AD) mouse macrophages candida albicans infection upregulated 21060679 549 Mouse mmu-miR-125a miRNA histone deacetylase inhibitors (HDIs) short-chain fatty acid (SCFA) butyrate antibody-mediated systemic autoimmunity B cells SCFA HDI butyrate treatment upregulated 32265934 550 Mouse mmu-miR-125a miRNA mycobacterium tuberculosis (Mtb) autophagy lungs tissues;spleens tissues;liver tissues M. tuberculosis treatment upregulated 25917095 551 Mouse mmu-miR-125a miRNA bilobalide (BB) inflammation IL-17-treated ATDC5 cells bilobalide (BIL) treatment downregulated 31593333 552 Mouse mmu-miR-125a miRNA IL-17 inflammation ATDC5 cells ?interleukin (IL)-17 treatment upregulated 31593333 553 Mouse mmu-miR-125a miRNA high fat diet (HFD) obesity liver tissues high fat diet (HFD) feed miR-125a levels was downregulated in livers of mice fed chow or HF diet. 31988048 554 Mouse mmu-miR-125a miRNA high fat diet (HFD) obesity BALB/c and C57BL/6J mice adipose tissue high fat diet (HFD) feed upregulated 24675842 555 Mouse mmu-miR-125a miRNA bone morphogenetic protein 9 (BMP9) osteogenesis The conditionally immortalized mouse multipotent adipose-derived cells iMADs bone morphogenetic protein 9 (BMP9) treatment downregulated 31825894 556 Mouse mmu-miR-125a-3p miRNA MOG 35-55 peptide experimental autoimmune encephalomyelitis (EAE) oligodendrocyte precursor cells (OPCs) MOG35-55 treatment miR-125a-3p is upregulated in OPCs isolated from the spinal cord of chronic experimental autoimmune encephalomyelitis (EAE) mice. 32163190 557 Mouse mmu-miR-125a-3p miRNA Legionella pneumophila (L. pneumophila) Legionella pneumophila (L. pneumophila) infection WT and MyD88-/- murine bone marrow-derived macrophages (BMM) infected with L. pneumophila downregulated 28445535 558 Mouse mmu-miR-125a-3p miRNA urocortin 1 (Ucn-1) myocardial ischemia/reperfusion (I/R) injury (MIRI) I/R mosue administration of Ucn-1 at the beginning of reperfusion treatment upregulated 28827743 559 Mouse mmu-miR-125a-3p miRNA silica lung fibrosis lung tissues silica treatment downregulated 30658076 560 Mouse mmu-miR-125a-3p miRNA TGF-¦Â1 lung fibrosis NIH/3T3 cells TGF-¦Â1 treatment downregulated 30658076 561 Mouse mmu-miR-125a-5p miRNA lipopolysaccharide (LPS) acute kidney injury (AKI) RAW264.7 macrophages lipopolysaccharide (LPS) treatment downregulated 32388658 562 Mouse mmu-miR-125a-5p miRNA inorganic nitrite acute myocardial infarction (AMI) heart tissues single-dose of nitrite downregulated 28090786 563 Mouse mmu-miR-125a-5p miRNA ischemia/reperfusion (I/R) acute myocardial infarction (AMI) heart tissues ischemia/reperfusion (I/R) treatment upregulated 28090786 564 Mouse mmu-miR-125a-5p miRNA folate apoptosis mouse embryonic stem cells (mESCs) folate deficiency induced upregulated 22828209 565 Mouse mmu-miR-125a-5p miRNA histone deacetylase inhibitor (HDACi) B cell differentiation B cells of C57BL/6J "stimulated with LPS and IL-4 and treated with HDI (VPA, 500 ?M) or nil for 60 h" upregulated 28994753 566 Mouse mmu-miR-125a-5p miRNA high glucose (HG) diabetic nephropathy (DN) Mouse podocytes (MPC5) high glucose treatment downregulated 30095204 567 Mouse mmu-miR-125a-5p miRNA echinococcus multilocularis metacestodes echinococcus multilocularis infection RAW 264.7 cells E. multilocularis metacestodes treatment upregulated 30322806 568 Mouse mmu-miR-125a-5p miRNA myelin oligodendrocyte glycoprotein experimental autoimmune encephalomyelitis (EAE) spinal ventral horn of EAE mice myelin oligodendrocyte glycoprotein 35-55 peptides treatment upregulated 31428926 569 Mouse mmu-miR-125a-5p miRNA myelin oligodendrocyte glycoprotein experimental autoimmune encephalomyelitis (EAE) lumbosacral spinal cord myelin oligodendrocyte glycoprotein 35-55 peptides treatment upregulated 31428926 570 Mouse mmu-miR-125a-5p miRNA high fat diet (HFD) hepatocellular carcinoma (HCC) plasma and hepatic tissues high fat diet (HFD) feed upregulated 26728044 571 Mouse mmu-miR-125a-5p miRNA E. multilocularis metacestodes infection and immunity of E. multilocularis RAW264¡¤7 macrophage cells E. multilocularis metacestodes for 6 and 12 h treatment "upregulated (mmu-miR-378d,mmu-miR-155-5p, mmu-miR-146a-5p, mmu-miR-21a-5p , mmu-miR-125a-5p) and downregulated(mmu-miR-1981-5p , mmu-miR-let-7c-1-3p)" 28942753 572 Mouse mmu-miR-125a-5p miRNA curcumin (Cur) nasopharyngeal carcinoma (NPC) mice injected into the tumour centre at a concentration of 150 mg/kg treatment dysregulated 24896104 573 Mouse mmu-miR-125a-5p miRNA gefitinib nasopharyngeal carcinoma (NPC) NPC tumor bearing-mice serum geftinib treatment upregulated 24602316 574 Mouse mmu-miR-125a-5p miRNA high fat diet (HFD) obesity obesity high fat diet (HFD) feed downregulated 29393878 575 Mouse mmu-miR-125a-5p miRNA macrophage colony-stimulating factor (M-CSF) and receptor activator of NF-¦ÊB ligand (RANKL) osteoclastogenesis RAW 264.7 osteoclast precursor cell RANKL plus M-CSF treatment upregulated 30976285 576 Mouse mmu-miR-125a-5p miRNA paraquat (PQ) paraquat (PQ)-induced acute lung injury and pulmonary fibrosis MLE-12 cells paraquat (PQ) treatment downregulated 32741895 577 Mouse mmu-miR-125a-5p miRNA anandamide (AEA) pro-inflammatory activity mouse anandamide treatment AEA differentil regulate the expression of miRNA 24699635 578 Mouse mmu-miR-125a-5p miRNA triptolide (TPL) systemic lupus erythematosus (SLE) MRL/lpr mice serum triptolide (TPL) treatment upregulated 30861393 579 Mouse mmu-miR-125a-5p miRNA dioscin type 2 diabetes mellitus (T2DM) high-fat diet-induced T2DM KK-Ay mice tissues dioscin treatment upregulated 31881477 580 Mouse mmu-miR-125a-5p miRNA high fat diet (HFD) type 2 diabetes mellitus (T2DM) liver tissues streptozotocin treatment downregulated 31881477 581 Mouse mmu-miR-125a-5p miRNA palmitic acid (PA) type 2 diabetes mellitus (T2DM) AML12 cells palmitic acid treatment downregulated 30555566 582 Mouse mmu-miR-125a-5p miRNA dioscin type 2 diabetes mellitus (T2DM) AML12 cells dioscin treatment Dioscin was found to markedly elevate miR-125a-5p level and decrease STAT3 expression. 31881477 583 Mouse mmu-miR-125b miRNA amyloid-¦Â (A¦Â) Alzheimer's disease (AD) Mouse primary hippocampal neurons amyloid-¦Â (A¦Â) treatment upregulated 30706990 584 Mouse mmu-miR-125b miRNA melatonin Alzheimer's disease (AD) A¦Â-treated mouse primary hippocampal neurons melatonin treatment downregulated 30706990 585 Mouse mmu-miR-125b miRNA epigallocatechin-3-gallate (EGCG) Alzheimer's disease (AD) AD mouse serum EGCG treatment groups (2 mg/kg/day) upregulated 28731435 586 Mouse mmu-miR-125b miRNA estradiol-17¦Â (E2) Alzheimer's disease (AD) Primary cortical neurons estradiol-17¦Â (E2) treatment upregulated 27235580 587 Mouse mmu-miR-125b miRNA ethanol (EtOH) apoptosis neural crest cells (NCCs) ethanol treatment downregulated 26024858 588 Mouse mmu-miR-125b miRNA alcohol brain injury and neurodegeneration cerebral cortex chronic alcohol administration upregulated 30374194 589 Mouse mmu-miR-125b miRNA androgen receptor (ASC-J9 ?) cardiac fibrosis cardiac fibroblasts (CFs) androgen receptor (ASC-J9 ?) treatment ASC-J9 ? attenuates the expression of miR-125b. 30340830 590 Mouse mmu-miR-125b miRNA interleukin-1 receptor antagonist protein (IRAP) cartilage impact injury porcine knee joint Interleukin-1 Receptor Antagonist Protein (IRAP) treatment upregulated 26521750 591 Mouse mmu-miR-125b miRNA oxyELITE pro-new formula (OEP-NF) drug-induced liver injury (DILI) female B6C3F1 mice liver administering 10X and 3X mouse-equivalent doses (MED) of OEP-NF treatment upregulated in the liver 28843594 592 Mouse mmu-miR-125b miRNA cocaine effects of cocaine action dopaminergic neuronal cells and nucleus accumbens (NAc) of mice acute and chronic cocaine exposure downregulated 28828398 593 Mouse mmu-miR-125b miRNA cyclophosphamide embryonic maldevelopment the fore- and hindlimbs of mice cyclophosphamide treatment downregulated 20170545 594 Mouse mmu-miR-125b miRNA estrogen (ES) hepatic steatosis liver estrogen treatment upregulated 26272872 595 Mouse mmu-miR-125b miRNA ganoderma lucidum polysaccharides (GLPs) hepatocellular carcinoma (HCC) mouse hepatoma H22 cell line Ganoderma lucidum polysaccharides (GLPS) treatment upregulated 25889022 596 Mouse mmu-miR-125b miRNA aluminum-sulfate inflammatory neurodegeneration C57BL/6J mice blood serum exposure to a standard mouse diet that included aluminum-sulfate upregulated 29354323 597 Mouse mmu-miR-125b miRNA ¦Ã-rays irradiation-induced tumors bone marrow (BM) low-power long-term ¦Ã-irradiation downregulated 32483710 598 Mouse mmu-miR-125b miRNA hypoxia ischemic injury bone marrow mesenchymal stem cells (BM-MSCs) hypoxia treatment upregulated 30613290 599 Mouse mmu-miR-125b miRNA ultraviolet (UV) irradiation ischemic tolerance mouse embryonic fibroblast cells ultraviolet radiation (UV) treatment UV radiation induces upregulated of miR-125b 22854965 600 Mouse mmu-miR-125b miRNA isoniazid (INH) liver damage liver tissues isoniazid (INH) treatment upregulated 29554950 601 Mouse mmu-miR-125b miRNA ischemia/reperfusion (I/R) myocardial ischemia/reperfusion (I/R) injury (MIRI) heart tissues ischemia/reperfusion (I/R) treatment upregulated 24576954 602 Mouse mmu-miR-125b miRNA retinoic acid (RA) cell differentiation Neuro-2A cells retinoic acid? treatment downregulated 31823894 603 Mouse mmu-miR-125b miRNA streptozocin (STZ) nonalcoholic steatohepatitis-hepatocellular carcinoma (NASH-HCC) high fat dietmouse liver STZ treatment upregulated in liver 28345673 604 Mouse mmu-miR-125b miRNA lipopolysaccharide (LPS) osteoarthritis (OA) ATDC5 cells lipopolysaccharides (LPS) treatment downregulated 29550827 605 Mouse mmu-miR-125b miRNA lipopolysaccharide (LPS) osteoarthritis (OA) ATDC5 cells lipopolysaccharide (LPS) treatment Overexpression of THRIL promoted LPS-induced ATDC5 cell inflammatory injury by down-regulating miR-125b and then activating JAK1/STAT3 and NF-¦ÊB pathways. 30521964 606 Mouse mmu-miR-125b miRNA H2O2 oxidative stress mouse hippocampal HT22 cells ?H2O2 treatment "Following stimulation with H2O2, we observed downregulated of miR-125b expression, upregulation of p53 expression, mitochondria were damaged and increased cell death" 33475982 607 Mouse mmu-miR-125b miRNA SDF-1¦Á analog CTCE-0214 (CTCE) sepsis mouse with polymicrobial sepsis EPC therapy treatment upregulated in endothelial progenitor cells (EPCs) 24707934 608 Mouse mmu-miR-125b miRNA high fat diet (HFD) type 2 diabetes mellitus (T2DM) liver tissues high fat diet (HFD) feed upregulated 29319168 609 Mouse mmu-miR-125b-1-3p miRNA rutin (RUT) pirarubicin (THP) cardiotoxicity HL-1 cells rutin (RUT) treatment Rutin protects against pirarubicin-induced cardiotoxicity by adjusting microRNA-125b-1-3p-mediated JunD signaling pathway 32016695 610 Mouse mmu-miR-125b-5p miRNA hypoxia/reoxygenation (H/R) acute myocardial infarction (AMI) The mouse cardiomyocyte cell line HL-1 hypoxia/reperfusion induce downregulated 32010261 611 Mouse mmu-miR-125b-5p miRNA amyloid-¦Â (A¦Â) Alzheimer's disease (AD) primary mouse cortical neurons (MCN) and Neuro2a (N2a) cells amyloid-¦Â (A¦Â) treatment downregulated 32251872 612 Mouse mmu-miR-125b-5p miRNA melatonin anti-inflammatory responses RAW264.7 cells (a murine macrophage cell line) and mouse bone marrow-derived macrophages (BMDMs) metformin treatment Metformin might show anti-inflammatory effects in macrophages through the induction of Dicer and the subsequent upregulation of miR-34a-5p and miR-125b-5p. 31102492 613 Mouse mmu-miR-125b-5p miRNA brucella.suis brucellosis The RAW264.7 macrophage Brucella infection treatment downregulated 27473222 614 Mouse mmu-miR-125b-5p miRNA high glucose (HG) diabetic nephropathy (DN) Mouse podocytes (MPC5) high glucose treatment downregulated 30095204 615 Mouse mmu-miR-125b-5p miRNA high fat diet (HFD) insulin resistance (IR) heart tissue high fat diet (HFD) feed downregulated 30632304 616 Mouse mmu-miR-125b-5p miRNA oxygen glucose deprivation (OGD) ischemic stroke (IS) HT-22 cells oxygen-glucose deprivation treatment Overexpression of circRNA circUCK2 Attenuates Cell Apoptosis in Cerebral Ischemia-Reperfusion Injury via miR-125b-5p/GDF11 Signaling 33230465 617 Mouse mmu-miR-125b-5p miRNA hypoxia/reoxygenation (H/R) myocardial infarction (MI) HL-1 cells hypoxia/reoxygenation (H/R) treatment LncRNA MALAT1 prevents the protective effects of miR-125b-5p against acute myocardial infarction through positive regulation of NLRC5. 32010261 618 Mouse mmu-miR-125b-5p miRNA manganese (Mn) parkinson's disease (PD) MN9D dopaminergic cell exosomes Mn exposure (300¦ÌM MnCl2) for 24h upregulated in exosomes 28450057 619 Mouse mmu-miR-125b-5p miRNA learning persistent memory C57BL/6J mouse hippocampal Object-location memory task upregulated 28927503 620 Mouse mmu-miR-125b-5p miRNA high fat diet (HFD) and streptozotocin (STZ) type 2 diabetes mellitus (T2DM) pancreatic ¦Â-cells high-fat diet plus low dosage of streptozotocin treatment downregulated 30684546 621 Mouse mmu-miR-125b-5p miRNA metformin (Met) type 2 diabetes mellitus (T2DM) RAW264.7 cells metformin (Met) treatment Metformin might show anti-inflammatory effects in macrophages through the induction of Dicer and the subsequent upregulation of miR-34a-5p and miR-125b-5p. 31102492 622 Mouse mmu-miR-126 miRNA CTCE-0214 (CTCE) acute respiratory distress syndrome (ARDS) lung CTCE-0214 (CTCE) treatment upregulated 27031787 623 Mouse mmu-miR-126 miRNA atorvastatin atherosclerosis (AS) ApoE-/- mice carotid arterial wall atorvastatin treatment upregulated in carotid arterial wall 26886754 624 Mouse mmu-miR-126 miRNA cigarette smoke (CS) atherosclerosis (AS) aortic tissues of ApoE KO mice cigarette smoke (CS) exposure downregulated 29642385 625 Mouse mmu-miR-126 miRNA high fat diet (HFD) atherosclerosis (AS) apolipoprotein E-knockout mice high fat diet (HFD) feed downregulated 28713948 626 Mouse mmu-miR-126 miRNA notoginsenoside R1 (NGR1) atherosclerosis (AS) serum;aorta notoginsenoside R1 (NGR3) treatment downregulated 24933211 627 Mouse mmu-miR-126 miRNA E26 transformation-specific variant 2 (ETV2; also known as ER71) cardiovascular lineage development mouse embryonic stem cells (mESCs) E26 transformation-specific variant 2 (ETV2; also known as ER71) treatment upregulated 31744543 628 Mouse mmu-miR-126 miRNA training dexamethasone (DEX)-induced microvascular rarefaction muscle training upregulated 31991160 629 Mouse mmu-miR-126 miRNA high glucose (HG) diabetic atherosclerosis aorta high glucose treatment downregulated 27993686 630 Mouse mmu-miR-126 miRNA ischemia diabetic retinopathy (DR) retina tissues ischemia induced miR-126 was significantly decreased in retina from OIR mice 21586283 631 Mouse mmu-miR-126 miRNA high glucose (HG) inflammation macrophage high glucose treatment downregulated 27827458 632 Mouse mmu-miR-126 miRNA high glucose (HG) inflammation human gingival fibroblasts high (25 mmol/L) glucose downregulated 28598282 633 Mouse mmu-miR-126 miRNA high fat diet (HFD) inflammatory response skeletal muscle of mice high fat diet (HFD) feed "miR-375, miR-29, miR-320, miR-103/107 and miR-126, play a crucial role in the regulation of glucose and lipid metabolism through the control of pancreatic islet cell function" 22395471 634 Mouse mmu-miR-126 miRNA danhong injection (DHI) myocardial infarction (MI) myocardial infarction (MI) mouse heart tissues danhong injection (DHI) treatment upregulated 31629250 635 Mouse mmu-miR-126 miRNA exercise training (ET) myocardial infarction (MI) Bone marrow-derived endothelial progenitor cells (EPCs) were isolated from the MI mice after 4 weeks of exercise Exercise training (ET) induce upregulated 29265525 636 Mouse mmu-miR-126 miRNA exercise training (ET) myocardial infarction (MI) MI. C57BL/6 mice bone marrow-derived endothelial progenitor cells (EPCs) r 4 weeks of exercise upregulated 29265525 637 Mouse mmu-miR-126 miRNA ischemia myocardial ischemia/reperfusion (I/R) injury (MIRI) Plasma left anterior descending artery (LAD) ligation HOTAIR aggravates myocardial IR by competitively binding SRSF1 with microRNA-126. 32964995 638 Mouse mmu-miR-126 miRNA maternal diet obesity and obesity-associated insulin resistance adipose tissues maternal diet-induced obesity on offspring adipose tissue insulin signalling treatment expression in the aetiology of insulin resistance in later life is upregulated 24749062 639 Mouse mmu-miR-126 miRNA exogenous ghrelin peripheral arterial disease (PAD) ischemic gastrocnemius tissues exogenous ghrelin treatment upregulated 32788622 640 Mouse mmu-miR-126 miRNA mycobacterium tuberculosis (Mtb) pulmonary tuberculosis (PTB) lung tissues mycobacterium tuberculosis (Mtb) treatment downregulated 33089914 641 Mouse mmu-miR-126 miRNA pSTAT3-specific inhibitor AG-490 pulmonary tuberculosis (PTB) lung tissues pSTAT3-specific inhibitor AG-490 treatment upregulated 33089914 642 Mouse mmu-miR-126 miRNA SDF-1¦Á analog CTCE-0214 (CTCE) sepsis mouse with polymicrobial sepsis EPC therapy treatment upregulated in endothelial progenitor cells (EPCs) 24707934 643 Mouse mmu-miR-126 miRNA resveratrol type 2 diabetes mellitus (T2DM) mouse insulinoma cell line Min6 resveratrol (RSV) treatment The expression level of miR-126 was upregulated by RSV 29710530 644 Mouse mmu-miR-1264 miRNA ischemia/reperfusion (I/R) acute ischemic and hemorrhagic stroke mouse circulation ischemia/reperfusion (I/R) treatment upregulated 28193834 645 Mouse mmu-miR-126-5p miRNA lipopolysaccharide (LPS) acute lung injury (ALI) alveolar type II (ATII) cells lipopolysaccharide (LPS) treatment upregulated 27146208 646 Mouse mmu-miR-126-5p miRNA lipopolysaccharide (LPS) inflammation RAW 264.7 cells lipopolysaccharide (LPS) treatment dysregulated 24792623 647 Mouse mmu-miR-126a miRNA Shexiang Tongxin dropping pill (STDP) atherosclerosis (AS) serial transverse aortic sections Shexiang Tongxin dropping pill (STDP) treatment downregulated 25449459 648 Mouse mmu-miR-126a miRNA Shexiang Tongxin dropping pill (STDP) atherosclerosis (AS) (ApoE(-/-)) mice aortic STDP (30 mg/kg/day) on atherosclerotic lesions treatment downregulated 25449459 649 Mouse mmu-miR-126a miRNA doxorubicin (DOX) breast cancer breast tumor-bearing mice doxorubicin treatment upregulated 27345402 650 Mouse mmu-miR-126a miRNA whole grain highland barley (WGH) type 2 diabetes mellitus (T2DM) liver tissues whole grain highland barley (WGH) treatment downregulated 33104141 651 Mouse mmu-miR-126a-3p miRNA lipopolysaccharide (LPS) endotoxemia-induced vascular injury aortas tissues lipopolysaccharide (LPS) treatment downregulated 26968021 652 Mouse mmu-miR-126a-5p miRNA angiotensin II (Ang II) abdominal aortic aneurysm (AAA) aortas angiotensin II (Ang II) treatment miR-126a-5p expression was significantly lower in AAA tissues than in control aortas. 32291538 653 Mouse mmu-miR-126a-5p miRNA ischemia/reperfusion (I/R) ischemia/reperfusion (I/R) injury mouse serum ischemia/reperfusion (I/R) treatment upregulated in the serum 29212219 654 Mouse mmu-miR-127 miRNA blast blast traumatic brain injury (bTBI) Balb/c mice blast treatment dysregulated 29020847 655 Mouse mmu-miR-127 miRNA doxorubicin (DOX) heart failure (HF) myocardial tissues doxorubicin (DOX) treatment upregulated 30272299 656 Mouse mmu-miR-127 miRNA ginkgo biloba extract (GBE) hepatocellular carcinoma (HCC) non-tumor (ENT) liver ginkgo biloba extract (GBE) treatment upregulated 32306082 657 Mouse mmu-miR-127 miRNA tumor necrosis factor alpha (TNF-¦Á) irritable bowel syndrome (IBS) mouse interstitial cells of Cajal (ICC) tumor necrosis factor alpha (TNF-¦Á) treatment MiR-127 upregulated largely reversed the effects of TUG1 on TNF-¦Á-treated ICC. 30657572 658 Mouse mmu-miR-127 miRNA lipopolysaccharide (LPS) lung injury "mouse bronchoalveolar lavage fluid, serum and lung tissue" lipopolysaccharide (LPS) treatment "upregulated in bronchoalveolar lavage fluid, serum and lung tissue" 28765901 659 Mouse mmu-miR-127 miRNA metformin (Met) nonalcoholic steatohepatitis (NASH) liver tissues metformin treatment upregulated 25672270 660 Mouse mmu-miR-127 miRNA piperine osteoarthritis (OA) ATDC5 cells piperine treatment Piperine reduced the expression of miR-127 in ATDC5 cells 29710511 661 Mouse mmu-miR-127 miRNA lipopolysaccharide (LPS) spinal cord injury (SCI) ?PC-12 cell lipopolysaccharide (LPS) treatment "miR-127 was negatively regulated by TUG1. Effects of TUG1 on LPS-treated PC-12 cells were reversed by miR-127 overexpression. Besides, TUG1 inactivated NF-¦ÊB and p38MAPK pathways in LPS-treated PC-12 cells via down-regulating miR-127. Dynactin 4 and protein tyrosine phosphatase (PTP) were the target genes of miR-127. miR-127 regulated the NF-¦ÊB and p38MAPK pathways in PC-12 cells at least by targeting dynactin 4 and PTP." 31326411 662 Mouse mmu-miR-1271 miRNA huaier extract acute kidney injury (AKI) kidney tissues Huaier extract (HE) treatment HE appreciably reduced the degree of kidney injury and fibrosis and restored the expression of the microRNA miR-1271 after IRI. 33457422 663 Mouse mmu-mir-127-3p miRNA recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) bacterial infection blood recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) treatment upregulated 25563241 664 Mouse mmu-miR-127-3p miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity Plasma doxorubicin (DOX) treatment downregulated 30627229 665 Mouse mmu-miR-127-5p miRNA arctigenin endotoxic shock Splenic myeloid-derived suppressor cells (MDSCs) were isolated from spleen of mice challenged by LPS (10 ¦Ìg/g) arctigenin treatment upregulated 30143931 666 Mouse mmu-miR-127-5p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce downregulated 30936699 667 Mouse mmu-miR-1278 miRNA H2O2 myocardial infarction (MI) newborn murine ventricular cardiomyocytes (NMVCs) H2O2 treatment "miR-1278 is low in H2O2-treated NMVCs and post-MI cardiac tissues, and the overexpression of miR-1278 in these protects against cell death by modulating IL-22 and CXCL14 expression." 33275986 668 Mouse mmu-miR-1278 miRNA H2O2 myocardial infarction (MI) newborn murine ventricular cardiomyocytes (NMVCs) H2O2 treatment The levels of miR-1278 were reduced in the infarct regions of heart tissues of the MI mouse model and in H2O2-treated newborn murine ventricular cardiomyocytes (NMVCs) compared to those in the heart tissues of healthy mice and non-treated NMVCs. 33275986 669 Mouse mmu-miR-128 miRNA ischemia acute kidney injury (AKI) renal tubules ischemia treatment upregulated 27959449 670 Mouse mmu-miR-128 miRNA Staphylococcus aureus acute lung injury (ALI) mouse lung tissues and RAW264.7 cells Staphylococcus aureus (S. aureus) infection treatment downregulated 30802676 671 Mouse mmu-miR-128 miRNA amyloid-¦Â (A¦Â) Alzheimer's disease (AD) primary mouse cortical neurons (MCN) and Neuro2a (N2a) cells amyloid-¦Â (A¦Â) treatment upregulated 30328325 672 Mouse mmu-miR-128 miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) mouse macrophages atherogenic Evs oxidized low-density lipoprotein (ox-LDL) treatment enrichment in atherogenic EVs 28882869 673 Mouse mmu-miR-128 miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) peritoneal macrophages; Bone-marrow derived macrophages (BMDMs) oxidized low-density lipoprotein (ox-LDL) treatment upregulated 28882869 674 Mouse mmu-miR-128 miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) RAW264.7 cells oxidized low-density lipoprotein (ox-LDL) treatment miR-128 expression was remarkably decreased in ox-LDL-incubated RAW264.7 cells. 30203508 675 Mouse mmu-miR-128 miRNA neurotoxicant sodium valproate (VPA) developmental toxicity murine embryonic stem cells (mESCs) neurotoxicant sodium valproate (VPA) treatment downregulated 24896083 676 Mouse mmu-miR-128 miRNA high glucose (HG) diabetic nephropathy (DN) Mouse podocytes (MPC5) high glucose treatment downregulated 30095204 677 Mouse mmu-miR-128 miRNA dexmedetomidine (DEX) hypoxic/ischemic brain damage (HIBD) hypoxia induced neonatal mice brain tissues dexamethasone (DEX) treatment upregulated 30875657 678 Mouse mmu-miR-128 miRNA hypoxia hypoxic/ischemic brain damage (HIBD) neonatal mice brain tissues hypoxia induce downregulated 30875657 679 Mouse mmu-miR-128 miRNA methamphetamine (METH) methamphetamine (METH)-induced locomotor sensitization nucleus accumbens (NAc) repeated-intermittent METH exposure A significant increase of miR-128 in the NAc of mice upon repeated-intermittent METH exposure but not acute METH administration. 32058631 680 Mouse mmu-miR-128 miRNA prion neurodegeneration (ND) the brains tissues prion infection treatment upregulated 18987751 681 Mouse mmu-miR-128 miRNA spinal cord segment-derived conditioned medium (CM) of SCI (CM-SCI) neuropathic pain (NP) mouse microglial cell line BV2 CM-SCI treatment downregulated 28114268 682 Mouse mmu-miR-128 miRNA methamphetamine (METH) neuroplasticity mouse nucleus accumbens (NAc) Methamphetamine (METH) treatment We identified a significant increase of miR-128 in the NAc of mice upon repeated-intermittent METH exposure but not acute METH administration. 32058631 683 Mouse mmu-miR-128 miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver tissues high fat diet (HFD) feed downregulated 31889412 684 Mouse mmu-miR-128 miRNA hypoxia stress response mouse myogenic C2C12 cells hypoxia (2% O2) for 4?h downregulated 29138682 685 Mouse mmu-miR-1281 miRNA mycobacterium tuberculosis (Mtb) pulmonary tuberculosis (PTB) lung tissues mycobacterium tuberculosis (Mtb) treatment downregulated 33089914 686 Mouse mmu-miR-1281 miRNA pSTAT3-specific inhibitor AG-490 pulmonary tuberculosis (PTB) lung tissues pSTAT3-specific inhibitor AG-490 treatment upregulated 33089914 687 Mouse mmu-miR-128-1-5p miRNA anandamide and norgestimate depression chronic mild stress (CMS) model of depression mouse anandamide and norgestimate treatment upregulated 28716528 688 Mouse mmu-miR-128-1-5p miRNA manganese (Mn) parkinson's disease (PD) MN9D dopaminergic cell exosomes Mn exposure (300¦ÌM MnCl2) for 24h upregulated in exosomes 28450057 689 Mouse mmu-miR-128-3p miRNA lipopolysaccharide (LPS) acute kidney injury (AKI) TCMK-1 cells lipopolysaccharide (LPS) treatment upregulated 32500307 690 Mouse mmu-miR-128-3p miRNA angiotensin II (Ang II) atrial fibrosis mouse atrial tissues angiotensin II (Ang II) treatment LncRNA PVT1 promotes atrial fibrosis via miR-128-3p-SP1-TGF-¦Â1-Smad axis in atrial fibrillation. 30894138 691 Mouse mmu-miR-128-3p miRNA doxorubicin (DOX) liver damage Alpha mouse liver 12 (AML-12) cells doxorubicin (Dox)?treatment upregulated 31112750 692 Mouse mmu-miR-128-3p miRNA FTY720-C2 parkinson's disease (PD) dopaminergic MN12D cells FTY720-C2 treatment upregulated 30359694 693 Mouse mmu-miR-128-3p miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) hippocampus "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" "We found that Axin1 was upregulated in hippocampal tissues and cells of the MPTP-lesioned mouse model of PD, while Hif1a and miR-128-3p were downregulated." 32167488 694 Mouse mmu-miR-128-3p miRNA FTY720-C2 parkinson's disease (PD) MN9D cells FTY720-C2 treatment upregulated 30359694 695 Mouse mmu-miR-128-3p miRNA learning persistent memory C57BL/6J mouse hippocampal Object-location memory task upregulated 28927503 696 Mouse mmu-miR-1286 miRNA GANT61 osteosarcoma (OS) "OS cells (SaOS-2 , U2OS)" GANT61 treatment "In vivo experiments further confirmed that GANT61 inhibited tumor growth and RAB13 expression, but enhanced miRNA-1286. The study demonstrated that GANT61 inhibited cell aggressive phenotype and tumor growth by inducing oxidative stress through the miRNA-1286/RAB31 axis." 32936498 697 Mouse mmu-miR-129 miRNA amyloid-¦Â (A¦Â) 25-35 Alzheimer's disease (AD) brain tissues amyloid-¦Â (A¦Â) 25-35 treatment "Elevated H19, HMGB1 and decreased miR-129 were found in A¦Â25-35-treated PC12 cells as well as in brain tissues of AD mice." 33410377 698 Mouse mmu-miR-129 miRNA dexamethasone (DEX) Alzheimer's disease (AD) hippocampal tissues dexamethasone (DEX) treatment Dex administration resulted in the enhancement of miR-129 expression with declined hippocampal neuron apoptosis and attenuated cognitive impairment in A¦Â1-42-injected mice. 32839917 699 Mouse mmu-miR-129 miRNA "anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE)" bronchial epithelial cell cancer 16HBE-T cells "anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE) treatment" upregulated 19462682 700 Mouse mmu-miR-129 miRNA angiotensin II (Ang II) hypertensive nephropathy (HN) Wild-type (C57BL/6J) mice angiotensin II (Ang II) treatment downregulated 28213404 701 Mouse mmu-miR-129 miRNA GYY4137 hypertensive nephropathy (HN) Wild-type (C57BL/6J) mice were treated with GYY4137 for 4 wk upregulated 28213404 702 Mouse mmu-miR-129 miRNA trinitrobenzene sulfonic acid (TNBS) inflammatory bowel disease (IBD) colon tissues trinitrobenzene sulphonic acid (TNBS) treatment downregulated 31945730 703 Mouse mmu-miR-129 miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) midbrain samples "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" downregulated 30260025 704 Mouse mmu-miR-129 miRNA resveratrol parkinson's disease (PD) Parkinson's disease (PD) mice midbrain samples resveratrol (RS) treatment upregulated 30260025 705 Mouse mmu-miR-129 miRNA particulate matter (PM2.5) PM2.5 exposure mosue bronchoalveolar lavage fluid (BALF) "were subjected to intratracheal instillation of 2.5, 10, or 20mg/kg PM2.5 treatment" upregulated in bronchoalveolar lavage fluid (BALF) 29107863 706 Mouse mmu-miR-129 miRNA particulate matter (PM2.5) pulmonary toxicological lung tissues particulate matter (PM2.5) exposure treatment upregulated 29107863 707 Mouse mmu-miR-1291 miRNA manganese (Mn) parkinson's disease (PD) MN9D dopaminergic cell exosomes Mn exposure (300¦ÌM MnCl2) for 24h upregulated in exosomes 28450057 708 Mouse mmu-miR-129-1-3p miRNA doxycycline c-Src-mediated tumor progression HCT116 cells; HT29 cells doxycycline treatment c-Src promotes tumor progression through downregulated of microRNA-129-1-3p 31799727 709 Mouse mmu-miR-129-1-3p miRNA pirarubicin (THP) pirarubicin (THP) cardiotoxicity HL-1 cells Pirarubicin (THP) treatment downregulated 31957170 710 Mouse mmu-miR-129-1-3p miRNA alpinia oxyphylla extract (AOE) type 2 diabetes mellitus (T2DM) db-/db- mouse kidney A. oxyphylla extract (AOE) treatment downregulated 28249617 711 Mouse mmu-miR-129-3p miRNA osteopontin (OPN) rheumatoid arthritis (RA) Osteoblasts Osteopontin (OPN)treatment downregulated 27851983 712 Mouse mmu-miR-129-5p miRNA lipopolysaccharide (LPS) acute lung injury (ALI) murine alveolar epithelial cell line (MLE)-12 cells lipopolysaccharide (LPS) treatment downregulated 32682121 713 Mouse mmu-miR-129-5p miRNA physical exercise Alzheimer's disease (AD) hippocampus physical exercise treatment miR-129-5p is significantly upregulated by physical exercise 32434194 714 Mouse mmu-miR-129-5p miRNA trichostatin A (TSA) cell division hearts trichostatin A (TSA) treatment upregulated 26946427 715 Mouse mmu-miR-129-5p miRNA ultraviolet (UV) irradiation corneal epithelium impairment corneal epithelial cells (CECs) ultraviolet ray treatment upregulated 30515795 716 Mouse mmu-miR-129-5p miRNA ultraviolet (UV) irradiation corneal epithelium impairment corneal epithelial cells (CECs) ultraviolet ray treatment upregulated 30515795 717 Mouse mmu-miR-129-5p miRNA anandamide and norgestimate depression chronic mild stress (CMS) model of depression mouse anandamide and norgestimate treatment downregulated 28716528 718 Mouse mmu-miR-129-5p miRNA lipopolysaccharide (LPS) LPS-induced podocyte apoptosis MPC5 cells lipopolysaccharide (LPS) treatment Podocytes with LPS significantly inhibits the expression of miR-129-5p. 33039954 719 Mouse mmu-miR-129-5p miRNA low choline (LC) neural progenitor cell (NPC) self-renewal Neural progenitor cells were isolated from embryonic ED 14 brains low choline (LC) treatment upregulated 30521373 720 Mouse mmu-miR-129-5p miRNA low choline (LC) neurogenesis cortical neural progenitor cell (NPC) low choline (LC) treatment upregulated 30521373 721 Mouse mmu-miR-129-5p miRNA alcohol nonalcoholic fatty liver disease (NAFLD) AML-12 cells Lieber-DeCarli alcohol treatment NEAT1/microRNA-129-5p/SOCS2 axis regulates liver fibrosis in alcoholic steatohepatitis 33228663 722 Mouse mmu-miR-129-5p miRNA methionine choline-deficient diet (MCD) nonalcoholic steatohepatitis (NASH) mouse liver tissues methionine-choline-deficient (MCD) treatment Liver tissues from mice fed a methionine-choline-deficient (MCD) diet exhibited increased expression of NEAT1 and PEG3 along with lower miR-129-5p expression. 33574830 723 Mouse mmu-miR-129-5p miRNA lipopolysaccharide (LPS) secondary injury after spinal cord injury (SCI) BV-2 cells lipopolysaccharide (LPS) treatment miR-129-5p alleviated SCI in mice via suppressing the apoptosis and inflammatory response through HMGB1//TLR4/NF-¦ÊB pathway. 32096822 724 Mouse mmu-miR-129-5p miRNA laparotomy and exposure of the junc_x0002_tion between the large and small intestines sepsis mouse large and small intestines laparotomy and exposure of the junc_x0002_tion between the large and small intestines treatment downregulated 25043848 725 Mouse mmu-miR-1297 miRNA sevoflurane (SEV) neurotoxicity mouse neurons sevoflurane treatment "In sevoflurane-exposed mice, miR-1297 expression was upregulated compared with the control group" 33843359 726 Mouse mmu-miR-1298 miRNA ischemia/reperfusion (I/R) acute ischemic and hemorrhagic stroke mouse circulation ischemia/reperfusion (I/R) treatment upregulated 28193834 727 Mouse mmu-miR-130 miRNA cyclosporine A (CsA) nephrotoxicity mouse kidney cyclosporine A treatment upregulated 28414804 728 Mouse mmu-miR-130 miRNA tumor necrosis factor alpha (TNF-¦Á) hepatocellular carcinoma (HCC) white adipose tissues TNF¦Á treatment "Primary transcripts of miR-130 were increased after TNF¦Á stimulation,p65 binding to the promoter regions of miR-130 was enhanced after TNF¦Á treatment" 24396868 729 Mouse mmu-miR-1306-5p miRNA manganese (Mn) parkinson's disease (PD) MN9D dopaminergic cell exosomes Mn exposure (300¦ÌM MnCl2) for 24h upregulated in exosomes 28450057 730 Mouse mmu-miR-130a miRNA alcohol alcoholic hepatitis (AH) sera alcohol exposure upregulated 26264599 731 Mouse mmu-miR-130a miRNA antibiotics allergic airway diseases (AAD) bronchoalveolar lavage fluid (BALF) antibiotics treatment downregulated 29702281 732 Mouse mmu-miR-130a miRNA angiotensin II (Ang II) cardiac fibrosis mice angiotensin II (Ang II) treatment upregulated 29114000 733 Mouse mmu-miR-130a miRNA adherent-invasive escherichia coli (AIEC) crohn disease (CD) mouse enterocytes adherent invasive escherichia coli (AIEC) treatment upregulated 24148619 734 Mouse mmu-miR-130a miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity heart tissues doxorubicin (Dox) treatment The expression of miR-130a increases sharply upon Dox treatment. 29988029 735 Mouse mmu-miR-130a miRNA iron iron deficiency liver tissues iron-deficient diet? treatment liver expression of the microRNA is upregulated 25002578 736 Mouse mmu-miR-130a miRNA free fatty acids (FFA) nonalcoholic fatty liver disease (NAFLD) cultured mouse primary hepatocytes free fatty acid (FFA) treatment downregulated 31064820 737 Mouse mmu-miR-130a miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver tissues high fat diet (HFD) feed downregulated 31064820 738 Mouse mmu-miR-130a miRNA monocrotaline (MCT) pulmonary arterial hypertension (PAH) pulmonary arterial endothelial cells (PAEC) MCT treated 3M upregulated 28755990 739 Mouse mmu-miR-130a-3p miRNA ovalbumin (OVA) asthma pulmonary macrophages ovalbumin (OVA) treatment downregulated 32524675 740 Mouse mmu-miR-130a-3p miRNA high glucose (HG) glomerulonephritis Mice MPC5 podocytes high glucose (HG) treatment downregulated 29434693 741 Mouse mmu-miR-130a-3p miRNA paraquat (PQ) paraquat (PQ)-induced acute lung injury and pulmonary fibrosis MLE-12 cells paraquat (PQ) treatment downregulated 32741895 742 Mouse mmu-miR-130a-3p miRNA high glucose (HG) podocyte injury mouse podocytes high glucose (HG) treatment Ablation of lncRNA MIAT mitigates high glucose-stimulated inflammation and apoptosis of podocyte via miR-130a-3p/TLR4 signaling axis. 32972755 743 Mouse mmu-miR-130a-3p miRNA hypoxia postmyocardial infarction AC16 cells hypoxia treatment miR-130a-3p was underexpressed in post-MI myocardial cells. 29226319 744 Mouse mmu-miR-130a-3p miRNA oxygen retinopathy of prematurity (ROP) C57BL/6 neonatal mice retinal tissue 7-day-old mice were maintained in 75% oxygen conditions for 5 days treatment dysregulatedin retinal tissue 27922698 745 Mouse mmu-miR-130a-5p miRNA influenza virus H5N2 influenza virus infection lung tissues H5N2 treatment upregulated 25266911 746 Mouse mmu-miR-130a-5p miRNA oxygen glucose deprivation (OGD) ischemic stroke (IS) Mouse brain microvascular endothelial cells (BMECs) oxygen glucose deprivation (OGD) treatment downregulated 32627090 747 Mouse mmu-miR-130b miRNA H2O2 Alzheimer's disease (AD) Primary hippocampal neuron cells H2O2 treatment upregulated 24423585 748 Mouse mmu-miR-130b miRNA H2O2 Alzheimer's disease (AD) senescence accelerated mouse prone 8 (SAMP8) and prone 10 (SAMP10) "different concentrations (0, 100, 200, 400 and 800 ¦ÌM) of H2O2 treatment" upregulated 24423585 749 Mouse mmu-miR-130b miRNA folate apoptosis mouse embryonic stem cells (mESCs) folate deficiency induced upregulated 22828209 750 Mouse mmu-miR-130b miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) RAW264.7 cells oxidized low-density lipoprotein (ox-LDL) treatment downregulated 29172088 751 Mouse mmu-miR-130b miRNA hypoxia cerebral ischemia/reperfusion (I/R) injury brain tissues middle cerebral artery occlusion (MCAO) treatment downregulated 28804561 752 Mouse mmu-miR-130b miRNA TGF-¦Â1 diabetic nephropathy (DN) glomerular mesangial cells (MC) TGF-¦Â1 treatment downregulated 25204661 753 Mouse mmu-miR-130b miRNA particle osteolysis MC3T3-E1 cells particle treatment upregulated 28382864 754 Mouse mmu-miR-130b miRNA ortho-silicic acid osteoporosis MC3T3-E1 cell; C2C12 cells ortho-silicic acid treatment MiR-130b is upregulated during the osteogenesis by the applicationof ortho-silicic acid. 33130075 755 Mouse mmu-miR-130b miRNA Co-Cr-Mo alloy particles periprosthetic osteolysis Raw264.7 cells and bone marrowderived macrophages (BMM) Co-Cr-Mo alloy particles treatment upregulated 30488739 756 Mouse mmu-miR-130b-3p miRNA extracellular cold-inducible RNA-binding protein (eCIRP) inflammation serum extracellular cold-inducible RNA-binding protein (eCIRP) treatment upregulated 31724825 757 Mouse mmu-miR-130b-3p miRNA IFN-¦Ã and lipopolysaccharide (LPS) macrophage polarization RAW 264.7 cells interferon-¦Ã (IFN-¦Ã) and lipopolysaccharide (LPS) treatment downregulated 32853398 758 Mouse mmu-miR-130b-3p miRNA aldosterone renal fibrosis mouse cortical collecting duct cells aldosterone treatment (10-6 M; 3 days) upregulated 29070573 759 Mouse mmu-miR-130b-3p miRNA aldosterone renal fibrosis mouse cortical collecting duct cells aldosterone treatment (10-6 M; 3 days) dysregulated 29070573 760 Mouse mmu-miR-132 miRNA staphylococcal enterotoxin B (SEB) acute inflammatory lung injury lung staphylococcal enterotoxin B treatment upregulated 25564423 761 Mouse mmu-miR-132 miRNA soluble A¦Â oligomers Alzheimer's disease (AD) cultured primary neurons soluble A¦Â oligomers treatment downregulated 31669733 762 Mouse mmu-miR-132 miRNA amyloid-¦Â (A¦Â) Alzheimer's disease (AD) primary neurons amyloid-¦Â (A¦Â) treatment Soluble A¦Â oligomers decreased miR-132 expression and increased HDAC3 levels in cultured primary neurons. 31669733 763 Mouse mmu-miR-132 miRNA melatonin Alzheimer's disease (AD) primary cortical neurons melatonin treatment A¦Â25-35 exposure significantly decreased the expression of miR-132. 29322615 764 Mouse mmu-miR-132 miRNA oleanolic acid (OLA) anhedonic and anxiogenic behaviours hippocampal neuronal 3-week oleanolic acid treatment upregulated 25079084 765 Mouse mmu-miR-132 miRNA Shexiang Tongxin dropping pill (STDP) atherosclerosis (AS) serial transverse aortic sections Shexiang Tongxin dropping pill (STDP) treatment downregulated 25449459 766 Mouse mmu-miR-132 miRNA Shexiang Tongxin dropping pill (STDP) atherosclerosis (AS) (ApoE(-/-)) mice aortic STDP (30 mg/kg/day) on atherosclerotic lesions treatment downregulated 25449459 767 Mouse mmu-miR-132 miRNA hypoxia blood-brain barrier (BBB) dysfunction mouse brain microvascular endothelial cells (BMEC) hypoxia induce upregulated 30617994 768 Mouse mmu-miR-132 miRNA angiotensin II (Ang II) cardiac remodeling mice heart tissues angiotensin II (Ang II) treatment upregulated 31325434 769 Mouse mmu-miR-132 miRNA klotho cardiac remodeling Ang II-treated mice heart tissues klotho treatment downregulated 31325434 770 Mouse mmu-miR-132 miRNA TGF-¦Â1 inhibitor LY364947 cardiac remodeling Ang II-treated mice heart tissues TGF-¦Â1 inhibitor LY364947 treatment downregulated 31325434 771 Mouse mmu-miR-132 miRNA melatonin cell proliferation hippocampus dentate gyrus tissues melatonin treatment upregulated 31169197 772 Mouse mmu-miR-132 miRNA "2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD)" colitis-associated colon cancer (CAC) "colon, spleen and lymph nodes" "2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) treatment" upregulated 29017096 773 Mouse mmu-miR-132 miRNA "3,3'-diindolylmethane (DIM)" colitis-associated colon cancer (CAC) "mouse colon, spleen and lymph nodes" "3,3'-diindolylmethane (DIM) treatment" upregulated 29017096 774 Mouse mmu-miR-132 miRNA duloxetine depression frontal lobe and hippocampus duloxetine treatment upregulated 26823914 775 Mouse mmu-miR-132 miRNA lipopolysaccharide (LPS) depression lateral ventricle lipopolysaccharide (LPS) treatment downregulated 27378528 776 Mouse mmu-miR-132 miRNA gallic acid (GA) experimental autoimmune encephalomyelitis (EAE) "The CD4+CD62L+ T cells were isolated from the spleen and cultured under Th17-polarizing conditions, and peritoneal macrophages were stimulated with LPS" ?gallic acid (GA)?treatment treatment upregulated 31026283 777 Mouse mmu-miR-132 miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated 26639663 778 Mouse mmu-miR-132 miRNA lipopolysaccharide (LPS) inflammatory injury HT-22 cells lipopolysaccharide (LPS) treatment miR-132 was downregulated by LPS in HT-22 cells 29377244 779 Mouse mmu-miR-132 miRNA ¦Ã-rays ionizing radiation (IR) injury mouse hippocampal neuronal HT22 cells ¦Ã-rays treatment downregulated 25329592 780 Mouse mmu-miR-132 miRNA ischemia ischemic injury mouse cortex ischaemic preconditioning (IP) treatment downregulated 20010955 781 Mouse mmu-miR-132 miRNA deoxycorticosterone acetate (DOCA) kidney damage hypertensive mice kidneys and urine injection of Deoxycorticosterone acetate (Doca) upregulated in the kidneys and urine 29255279 782 Mouse mmu-miR-132 miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues carbon tetrachloride (CCl4) treatment downregulated 29100790 783 Mouse mmu-miR-132 miRNA TGF-¦Â liver fibrosis Isolated primary cultured mouse hepatocytes TGF-¦Â treatment downregulated 29100790 784 Mouse mmu-miR-132 miRNA cAMP-response element binding protein (CREB) neuronal morphogenesis PC12 cells and neonatal rat cortical neurons cAMP-response element binding protein (CREB) treatment CREB-regulated miRNA regulates neuronal morphogenesis by responding to extrinsic trophic cues 16260724 785 Mouse mmu-miR-132 miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) C57bl/6J mice liver high fat diet (HFD) feed upregulated 28381526 786 Mouse mmu-miR-132 miRNA H2O2 oxidative stress mouse oocytes were exposed to 25 ?M H2O2 treatment downregulated 24963165 787 Mouse mmu-miR-132 miRNA glutamate pain primary neurons in the spinal cord of mouse embryos 100 ¦Ìmol/L glutamate upregulated 28244951 788 Mouse mmu-miR-132 miRNA exogenous ghrelin peripheral arterial disease (PAD) ischemic gastrocnemius tissues exogenous ghrelin treatment upregulated 32788622 789 Mouse mmu-miR-132 miRNA anandamide (AEA) pro-inflammatory activity mouse anandamide treatment AEA differentil regulate the expression of miRNA 24699635 790 Mouse mmu-miR-132 miRNA CREB activator forskolin renin-angiotensin-aldosterone system regulation MMDD-1 cells CREB activator Forskolin treatment CREB activator Forskolin induces miR-132 expression after 24 h. 32409785 791 Mouse mmu-miR-132 miRNA CREB-inhibitor 666-15 renin-angiotensin-aldosterone system regulation MMDD-1 cells CREB-inhibitor 666-15 treatment CREB-inhibitor 666-15 reduces low salt induced miR-132 expression. 32409785 792 Mouse mmu-miR-132 miRNA Salt inducible kinase inhibitor MRT67307 renin-angiotensin-aldosterone system regulation MMDD-1 cells Salt inducible kinase inhibitor MRT67307 treatment Salt inducible kinase inhibitor MRT67307 increases high-salt-reduced miR-132 expression 32409785 793 Mouse mmu-miR-132 miRNA brain-derived neurotrophic factor (BDNF) retinocollicular/tectal map formation retinal ganglion cell (RGC) brain-derived neurotrophic factor (BDNF) treatment upregulated 24431455 794 Mouse mmu-miR-132 miRNA cigarette smoke (CS) rheumatoid arthritis (RA) Th17 cells cigarette smoke (CS) exposure CS markedly increased the expression of miR-132 in the Th17 cells from the lymph nodes of AIA mice. 33443169 795 Mouse mmu-miR-132 miRNA cigarette smoke extract (CSE) rheumatoid arthritis (RA) Th17 cells cigarette smoke extract (CSE) treatment we show that?microRNA-132?is specifically induced in Th17 cells in the presence of either AhR agonist or CS-enriched medium. 33443169 796 Mouse mmu-miR-132-3p miRNA H2O2 acute myocardial infarction (AMI) primary cardiomyocytes H2O2 treatment LncRNA TUG1 mediates ischemic myocardial injury by targeting miR-132-3p/HDAC3 axis. 31858814 797 Mouse mmu-miR-132-3p miRNA H2O2 acute myocardial infarction (AMI) mouse primary cardiomyocytes hydrogen peroxide (H2O2) treatment "miR-132-3p was downregulated, whereas TUG1 upregulated in H2O2-challenged cardiomyocytes." 31858814 798 Mouse mmu-miR-132-3p miRNA gravitational mechanical unloading disuse osteopenia bone marrow-derived mesenchymal stem cells (BMSCs) gravitational mechanical unloading upregulated 32054528 799 Mouse mmu-miR-132-3p miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated 32955644 800 Mouse mmu-miR-132-3p miRNA angiostrongylus cantonensis (A. cantonensis) inflammation male Balb/c mice angiostrongylus cantonensis (A. cantonensis) infection upregulated 24142285 801 Mouse mmu-miR-132-3p miRNA folic acid kidney injury and fibrosis kidney cortex folic acid treatment upregulated 26707937 802 Mouse mmu-miR-132-3p miRNA chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) plvic inflammatory disease mouse two Chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) infection were upregulated during CmVar004 infection compared to CmVar001 infection 24961692 803 Mouse mmu-miR-133 miRNA hydrocinnamoyl-L-valyl pyrrolidine (AS-1) cardiac hypertrophy hypertrophic cardiomyocytes hydrocinnamoyl-L-valyl pyrrolidine (AS-1) treatment downregulated 31015570 804 Mouse mmu-miR-133 miRNA streptozocin (STZ) congenital heart disease (CHD) C57BL/6 mice blood injection of streptozotocin before mating treatment dysregulated 27998767 805 Mouse mmu-miR-133 miRNA sEHI t-AUCB (trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid) myocardial infarction (MI) muscle sEHI t-AUCB (trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid) treatment downregulated 29843720 806 Mouse mmu-miR-133-3p miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity plasma doxorubicin (DOX) treatment upregulated 30453253 807 Mouse mmu-miR-133a miRNA lipopolysaccharide (LPS) acute aortic dissection (AAD) aorta lipopolysaccharide (LPS) treatment downregulated 32634201 808 Mouse mmu-miR-133a miRNA lipopolysaccharide (LPS) acute kidney injury (AKI) TCMK-1 cells lipopolysaccharide (LPS) treatment The miR-133a expression was decreased in TCMK-1 cells treated with LPS. 32196613 809 Mouse mmu-miR-133a miRNA fluticasone asthma chronic asthma mouse fluticasone treatment downregulated 29191361 810 Mouse mmu-miR-133a miRNA ovalbumin (OVA) asthma lung tissues Ovalbumin treatment downregulated 30146725 811 Mouse mmu-miR-133a miRNA ovalbumin (OVA) asthma lung tissues ovalbumin (OVA) treatment miR-133a was downregulated in asthma. 30146725 812 Mouse mmu-miR-133a miRNA high fat diet (HFD) atherosclerosis (AS) aortas high fat diet (HFD) feed downregulated 29268138 813 Mouse mmu-miR-133a miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) RAW264.7 and MOVAS cells ox-LDL treatment downregulated 29268138 814 Mouse mmu-miR-133a miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) RAW264.7 cells; MOVAS cells oxidized low-density lipoprotein (ox-LDL) treatment downregulated 29268138 815 Mouse mmu-miR-133a miRNA reversine browning of white adipocytes differentiated adipocytes from 3T3©\L1 cells reversine treatment downregulated 30132867 816 Mouse mmu-miR-133a miRNA reversine browning of white adipocytes 3T3©\L1 cells reversine treatment downregulated 30132867 817 Mouse mmu-miR-133a miRNA hydrogen sulfide (H2S) cardiac hypertrophy HL1 cardiomyocytes cell line Na2S treatment upregulated 28623294 818 Mouse mmu-miR-133a miRNA fibroblast growth factor 18 (FGF18) cell differentiation mouse preosteoblasts collagen membranes (CMs) containing FGF-18 treatment downregulated 29544382 819 Mouse mmu-miR-133a miRNA cigarette smoke (CS) chronic obstructive pulmonary disease (COPD) airway epithelial cells cigarette smoke (CS) exposure upregulated 30341388 820 Mouse mmu-miR-133a miRNA high carbon dioxide (CO2) chronic obstructive pulmonary disease (COPD) mouse airway smooth muscle cells High carbon dioxide (CO2) treatment downregulated 30185650 821 Mouse mmu-miR-133a miRNA sevoflurane (SEV) cognitive impairment primary hippocampal neuron cells sevoflurane exposure treatment The expression of miR-133a was increased with increasing concentrations of sevoflurane exposure 31264218 822 Mouse mmu-miR-133a miRNA sevoflurane (SEV) cognitive impairment Primary hippocampal neuron cells "To establish an in vitro sevoflurane©\ induced neurotoxicity model, the primary hippocampal neuron cells were treated with different concentrations of sevoflurane for 6 hr treatment" "miR-133a was the direct target of lncRNA Gm15621 In addition, we also found that Sox4 was a downstream target of miR-133a and lncRNA Gm15621 exerted its biological functions by regulating the expression of Sox4 In summary, our findings revealed that lncRNA Gm15621 ameliorated the sevoflurane-induced neurotoxicity and the important role of Gm15621/miR-133a/Sox4 axis in cognitive disorder" 31264218 823 Mouse mmu-miR-133a miRNA azoxymethane (AOM) and dextran sulfate sodium (DSS) colorectal cancer (CRC) mouse colon tissues azoxymethane (AOM) and dextran sulfate sodium (DSS) treatment downregulated 24464560 824 Mouse mmu-miR-133a miRNA azoxymethane (AOM) and dextran sulfate sodium (DSS) colorectal cancer (CRC) mouse colon tissues azoxymethane (AOM) and dextran sulfate sodium (DSS) treatment downregulated 24464560 825 Mouse mmu-miR-133a miRNA bortezomib congenital muscular dystrophy dy(3K)/dy(3K) mice bortezomib? treatment downregulated 24631023 826 Mouse mmu-miR-133a miRNA TGF-¦Â coronary heart disease (CHD) primary murine HSC TGF-¦Â treatment Treatment of primary murine and human HSC with transforming growth factor (TGF)-¦Â resulted in a significant downregulated of miR-133a in these cells 23183523 827 Mouse mmu-miR-133a miRNA neurotoxicant sodium valproate (VPA) developmental toxicity murine embryonic stem cells (mESCs) neurotoxicant sodium valproate (VPA) treatment upregulated 24896083 828 Mouse mmu-miR-133a miRNA high glucose (HG) diabetes mellitus (DM) wild type (WT) mice smooth muscle treated with 30 mM glucose (HG) downregulated 28678840 829 Mouse mmu-miR-133a miRNA streptozocin (STZ) diabetes mellitus (DM) heart expression in the hearts of streptozotocin-induced diabetic animals treatment downregulated in the hearts 24428157 830 Mouse mmu-miR-133a miRNA concanamycin A (Con A) fulminant hepatitis Balb/c mice conA injections of concanavalin A treatment dysregulated 25034766 831 Mouse mmu-miR-133a miRNA regular physical activity healthy metabolic profile circulating exosomes regular physical activity treatment upregulated 33199621 832 Mouse mmu-miR-133a miRNA castrated impaired metabolic flexibility in elderly individuals male C57BL/6J mice castrated treatment upregulated 24478708 833 Mouse mmu-miR-133a miRNA dextran sodium sulfate (DSS) inflammatory bowel disease (IBD) C57BL/6 mice colonic tissue dextran-sulfate-sodium (DSS) treatment downregulated 28104982 834 Mouse mmu-miR-133a miRNA synthetic Sulfonyl-Hydrazone-1 iPSC-derived cardiac differentiation Murine fibroblast-derived iPSCs Synthetic Sulfonyl-Hydrazone-1 treatment "small chemical compounds, such as SHZ, can constitute a novel and clinically feasible strategy to improve iPSC-derived cardiac differentiation" 21445862 835 Mouse mmu-miR-133a miRNA granulocyte-macrophage colony stimulating factor (GM-CSF) lung injury normal alveolar epithelial cells alveolar epithelial cells GM-CSF during hyperoxia treatment downregulated 24371146 836 Mouse mmu-miR-133a miRNA botulinum toxin A (BTXA) muscle atrophy quadriceps muscle botulinum toxin A (BTXA) treatment downregulated 30427927 837 Mouse mmu-miR-133a miRNA prolonged aerobic exercise muscle hypertrophy plasma "impact of extended-duration, submaximal aerobic exercise treatment" upregulated 24436293 838 Mouse mmu-miR-133a miRNA heme oxygenase-1 (HMOX1) myoblast differentiation C2C12 cells Heme oxygenase-1 (HMOX1) treatment downregulated 21827279 839 Mouse mmu-miR-133a miRNA hypoxia myocardial ischemia/reperfusion (I/R) injury (MIRI) I/R mice myocardial tissues The myocardial I/R injury was induced by temporary ligation of the left anterior descending coronary artery. downregulated 31734557 840 Mouse mmu-miR-133a miRNA ischemia/reperfusion (I/R) myocardial ischaemic injury mouse plasma;Bone marrow-derived macrophage (BMDM);Rat neonatal CMs ischemia/reperfusion (I/R) treatment differently regulated 28768728 841 Mouse mmu-miR-133a miRNA erythropoietin (EPO) obesity and glucose homeostasis high-fat diet (HFD) C57BL/6J mice intraperitoneal injection of recombinant human EPO (200 IU/kg)thrice a week for four weeks downregulated 28288167 842 Mouse mmu-miR-133a miRNA dietary methionine restriction (MR) osteoblast differentiation and function "male C57BL/6J mice bone marrow,plasma and liver" fed diets containing 0.86% or 0.12% methionine for 5 weeks "upregulated (miR-31 in plasma and liver, and miR-133a, miR-335-5p, and miR-204 in the bone marrow" 27191548 843 Mouse mmu-miR-133a miRNA Sodium Tanshinone IIA Sulfonate (STS) peripheral arterial disease (PAD) ischemic hindlimb in diabetic mice Sodium Tanshinone IIA Sulfonate (STS) treatment downregulated 31623833 844 Mouse mmu-miR-133a miRNA cecal ligation and puncture (CLP) polymicrobial sepsis C57Bl/6 mice cecal ligation and puncture (CLP) treatment different regulation 24413579 845 Mouse mmu-miR-133a miRNA progesterone (P4) cell proliferation mouse endometrial epithelial cells progesterone treatment upregulated 27458709 846 Mouse mmu-miR-133a miRNA progesterone (P4) cell proliferation endometrial epithelial cells progesterone treatment upregulated 27458709 847 Mouse mmu-miR-133a miRNA low salt (LS) expression regulation kidney tissues low salt (LS) treatment Expression of miR-133a was decreased in mice given LS. 33131307 848 Mouse mmu-miR-133a miRNA lipopolysaccharide (LPS) sepsis RAW264.7 macrophages lipopolysaccharide (LPS) treatment MiRNA-133a aggravates inflammatory responses in sepsis by targeting SIRT1. 32771944 849 Mouse mmu-miR-133a miRNA reversine reversine-induced dedifferentiation C2C12 murine myoblasts reversine treatment downregulated 24513286 850 Mouse mmu-miR-133a miRNA growth factor-1 receptor vascular smooth muscle cell migration and proliferation vascular smooth muscle cell growth factor-1 receptor? treatment "In atherosclerosis induced by ApoE deficiency, reduced miR-133a expression is associated with lower IGF-1R levels and suppressive VSMC growth" 24401233 851 Mouse mmu-miR-133a* miRNA granulocyte-macrophage colony stimulating factor (GM-CSF) lung injury normal alveolar epithelial cells alveolar epithelial cells GM-CSF during hyperoxia treatment downregulated 24371146 852 Mouse mmu-miR-133a* miRNA dexamethasone (DEX) muscle atrophy Murine C2C12 myoblast cells dexamethasone (DEX) treatment upregulated 23716137 853 Mouse mmu-mir-133a-1-3p miRNA recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) bacterial infection blood recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) treatment upregulated 25563241 854 Mouse mmu-mir-133a-1-5p miRNA recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) bacterial infection blood recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) treatment upregulated 25563241 855 Mouse mmu-mir-133a-2-3p miRNA recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) bacterial infection blood recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) treatment upregulated 25563241 856 Mouse mmu-miR-133a-3p miRNA intranasal instillation asthma lung and bronchial tissues intranasal instillation treatment downregulated 28267638 857 Mouse mmu-miR-133a-3p miRNA guanidinoacetic acid (GAA) cell differentiation C2C12 cells Guanidinoacetic acid (GAA) treatment downregulated 30235878 858 Mouse mmu-miR-133a-3p miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity Plasma doxorubicin (DOX) treatment downregulated 30627229 859 Mouse mmu-miR-133a-3p miRNA pilocarpine epilepsy blood and brain pilocarpine treatment upregulated 32590288 860 Mouse mmu-miR-133a-3p miRNA cold obesity brown adipose tissue (BAT) cold treatment downregulated 33015181 861 Mouse mmu-miR-133b miRNA ovalbumin (OVA) allergic rhinitis (AR) Nasal mucosa tissues;serum intraperitoneal sensitization and intranasal challenge with ovalbumin (OVA) downregulated 28662502 862 Mouse mmu-miR-133b miRNA oxygen glucose deprivation (OGD) cerebral ischemia/reperfusion (I/R) injury HT22 cells oxygen-glucose deprivation (OGD) treatment "Circ_HECTD1 knockdown inhibited the expression of TRAF3 by targeting miR-133b, thereby attenuating neuronal injury caused by cerebral ischemia" 33148417 863 Mouse mmu-miR-133b miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral ischemia/reperfusion (I/R) injury HT22 cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment "The results showed that the expression of circ-HECTD1 and tumor necrosis factor receptor-associated factor 3 (TRAF3) was remarkably upregulated, while miR-133b was downregulated in oxygen-glucose deprivation (OGD)-induced HT22 cells and mouse middle cerebral artery occlusion (MCAO) model circ-HECTD1 knockdown relieved OGD-caused neuronal cell death in vitro Simultaneously, circ-HECTD1 knockdown improved cerebral infarction volume and neuronal apoptosis in MCAO mice" 33148417 864 Mouse mmu-miR-133b miRNA regular physical activity healthy metabolic profile circulating exosomes regular physical activity treatment upregulated 33199621 865 Mouse mmu-miR-133b miRNA low pH hypoxia-induced extracellular acidosis RAW 264.7 cells low pH treatment Only the upregulated of the miR-133b by low pH was seen in all normal cells. 30178347 866 Mouse mmu-miR-133b miRNA castrated impaired metabolic flexibility in elderly individuals male C57BL/6J mice castrated treatment upregulated 24478708 867 Mouse mmu-miR-133b miRNA 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) lung cancer lung cancer cells drug treatment lung carcinogen NNK exposure changes the expression of serum miRNAs. Serum miR-206 and miR-133b could be associated with lung carcinogenesis induced by NNK 23337359 868 Mouse mmu-miR-133b miRNA granulocyte-macrophage colony stimulating factor (GM-CSF) lung injury normal alveolar epithelial cells alveolar epithelial cells GM-CSF during hyperoxia treatment downregulated 24371146 869 Mouse mmu-miR-133b miRNA botulinum toxin A (BTXA) muscle atrophy quadriceps muscle botulinum toxin A (BTXA) treatment downregulated 30427927 870 Mouse mmu-miR-133b miRNA heme oxygenase-1 (HMOX1) myoblast differentiation C2C12 cells Heme oxygenase-1 (HMOX1) treatment downregulated 21827279 871 Mouse mmu-miR-133b miRNA rotenone (ROT) parkinson's disease (PD) mouse MN9D cells rotenone treatment "Interference of SNHG14 reduced rotenone-induced DA neuron damage through miR-133b in MN9D cells and ¦Á-syn was responsible for the protective effect of miR-133b Similarly, interference of SNHG14 mitigated neuron injury in PD mouse model" 31683259 872 Mouse mmu-miR-133b miRNA coxsackievirus B3 (CVB3) viral myocarditis (VM) neonatal mouse cardiomyocytes infect with CVB virus downregulated 29096746 873 Mouse mmu-mir-133b-3p miRNA recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) bacterial infection blood recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) treatment upregulated 25563241 874 Mouse mmu-miR-133b-3p miRNA murine cytomegalovirus (MCMV) murine cytomegalovirus (MCMV) infection peripheral blood monocytes murine cytomegalovirus (MCMV) infection downregulated 33245094 875 Mouse mmu-miR-133b-3p miRNA perfluorooctanoic acid testicular toxicity BALB/c mice testes tissue Perfluorooctanoic acid (PFOA) exposure treatment upregulated 28126411 876 Mouse mmu-miR-134 miRNA bisphenol A (BPA) aging mouse embryoid bodies (mEB) bisphenol A (BPA) treatment downregulated 24090592 877 Mouse mmu-miR-134 miRNA hypoxia cerebral ischemia injury (CII) brain tissues middle cerebral artery occlusion (MCAO) treatment dysregulated 25003713 878 Mouse mmu-miR-134 miRNA duloxetine depression frontal lobe and hippocampus duloxetine treatment downregulated 26823914 879 Mouse mmu-miR-134 miRNA pilocarpine epilepsy hippocampus pilocarpine treatment upregulated 24874920 880 Mouse mmu-miR-134 miRNA pilocarpine epilepsy intracerebroventricular pilocarpine treatment status epilepticus induced by pilocarpine was associated with upregulation of miR-134 within the hippocampus of mice 24874920 881 Mouse mmu-miR-134 miRNA triclosan (TCS) general cytotoxicity mouse embryonic stem cells (mESC) were acutely exposed to TCS for 24 h treatment upregulated 24879426 882 Mouse mmu-miR-134 miRNA oxygen glucose deprivation (OGD) ischemic stroke (IS) mouse brain tissues oxygen-glucose deprivation (OGD) treatment upregulated 25304362 883 Mouse mmu-miR-134 miRNA choline- and folate-deficient (CFD) diet liver damage plasma choline- and folate-deficient (CFD) diet treatment upregulated 26878785 884 Mouse mmu-miR-134 miRNA prolonged aerobic exercise muscle hypertrophy plasma "impact of extended-duration, submaximal aerobic exercise treatment" upregulated 24436293 885 Mouse mmu-miR-134 miRNA choline- and folate-deficient (CFD) diet nonalcoholic fatty liver disease (NAFLD) plasma choline- and folate-deficient (CFD) treatment upregulated 26878785 886 Mouse mmu-miR-134 miRNA retinoic acid (RA) susceptibility of tumour cells to natural killer cell-mediated cytotoxicity mouse embryonic stem cells (mESCs) ?retinoic acid treatment upregulated 17916804 887 Mouse mmu-miR-134-5p miRNA hypoxia/reoxygenation (H/R) myocardial infarction (MI) cardiomyocytes hypoxia/reoxygenation (H/R) treatment upregulated 32684588 888 Mouse mmu-miR-134-5p miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) "ventral midbrains, mouse dopaminergic neuronal cell line MN9D" "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" "circDLGAP4 exerted its functions via regulating miR-134-5p, circDLGAP4 exerts neuroprotective effects via modulating miR-134-5p/CREB pathway both in human and mouse." 31761328 889 Mouse mmu-miR-134-5p miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) midbrain tissues "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" miR-134-5p was verified to be increased in PD animal. 31761328 890 Mouse mmu-miR-134-5p miRNA angiotensin II (Ang II) thoracic aortic dissection (TAD) aorta specimens angiotensin II (Ang II) treatment downregulated 30951965 891 Mouse mmu-miR-135-5p miRNA cold obesity brown adipose tissue (BAT) cold treatment downregulated 33015181 892 Mouse mmu-miR-135a miRNA chronic intermittent hypoxia (CIH) aortic endothelial function aortic endothelial cells chronic intermittent hypoxia (CIH) treatment MEG3 suppresses the apoptosis of aortic endothelial cells in mice with chronic intermittent hypoxia via downregulated of HIF-1¦Á by competitively binding to microRNA-135a. 32642094 893 Mouse mmu-miR-135a miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) RAW264.7 cells oxidized low-density lipoprotein (ox-LDL) treatment downregulated 29663503 894 Mouse mmu-miR-135a miRNA fibroblast growth factor 18 (FGF18) cell differentiation mouse preosteoblasts collagen membranes (CMs) containing FGF-18 treatment downregulated 29544382 895 Mouse mmu-miR-135a miRNA antidepressant depression and anxiety disorders adult mouse antidepressant treatment upregulated 24952960 896 Mouse mmu-miR-135a miRNA high glucose (HG) diabetic nephropathy (DN) mouse mesangial cells; mouse tubular epithelial cells high glucose (HG) treatment miR-135a expression was markedly upregulated in tubular epithelial cells cultured in high-glucose conditions. 33203695 897 Mouse mmu-miR-135a miRNA adriamycin (ADR) focal segmental glomerulosclerosis (FSGS) mouse adriamycin (ADR) treatment upregulated 28949388 898 Mouse mmu-miR-135a miRNA dextran sodium sulfate (DSS) inflammatory bowel disease (IBD) colon tissues dextran sodium sulfate (DSS) treatment downregulated 29636643 899 Mouse mmu-miR-135a miRNA H2O2 oxidative stress hippocampal HT-22 cells H2O2 treatment upregulated 31728857 900 Mouse mmu-miR-135a miRNA paeoniflorin oxidative stress H2O2-treated hippocampal HT-22 cells Paeoniflorin (PF) treatment downregulated 31728857 901 Mouse mmu-miR-135a miRNA ovalbumin (OVA) and urban particulate matter (PM) pulmonary arterial hypertension (PAH) mouse lung "exposure to combined Th2 antigen (Ovalbumin, OVA) and urban particulate matter (PM) treatment" upregulated 28415675 902 Mouse mmu-miR-135a* miRNA nonylphenol (NP) tumorigenesis Sertoli TM5 cells nonylphenol (NP) treatment upregulated 21914226 903 Mouse mmu-miR-135a-1* miRNA H1N1 influenza virus endometriosis and endometrial carcinoma mouse lung?tissues H1N1 influenza virus infection upregulated 24066118 904 Mouse mmu-miR-135a-5p miRNA Physical exercise age-related cognitive decline neural precursor cells (NPCs) of the mouse dentate gyrus (DG) Physical exercise treatment downregulated 31130358 905 Mouse mmu-miR-135a-5p miRNA doxorubicin (DOX) cardiotoxicity heart tissues doxorubicin (DOX) treatment CircRNA-Arhgap12 could sponge miR-135a-5p in mouse cardiomyocytes during DOX-induced cardiotoxicity. 33245966 906 Mouse mmu-miR-135a-5p miRNA hydrogen sulfide (H2S) MPTP-induced mouse subacute astrocytic H2S treatment downregulated 27842305 907 Mouse mmu-miR-135a-5p miRNA chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) plvic inflammatory disease mouse two Chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) infection were upregulated during CmVar004 infection compared to CmVar001 infection 24961692 908 Mouse mmu-miR-135b miRNA angiotensin II (Ang II) cardiac hypertrophy Neonatal mice cardiomyocytes angiotensin II (Ang II) treatment downregulated 30037628 909 Mouse mmu-miR-135b miRNA azoxymethane (AOM) colorectal cancer (CRC) plasma and colon tissues azoxymethane (AOM) treatment upregulated 30311185 910 Mouse mmu-miR-135b miRNA lactobacillus acidophilus and bifidobacterium bifidum probiotics colorectal cancer (CRC) plasma and colon tissues from azoxymethane (AOM)-treated mice Lactobacillus acidophilus and Bifidobacterium bifidum probiotics treatment downregulated 30311185 911 Mouse mmu-miR-135b miRNA helicobacter pylori (H. pylori) gastric MALT lymphoma (GML) GML-developing d3Tx mice stomachs infect with H. pylori upregulated 28560185 912 Mouse mmu-miR-135b miRNA N-ethyl-N-nitrosourea (ENU) hepatocellular carcinoma (HCC) liver tissues N-ethyl-N-nitrosourea (ENU) treatment downregulated 21029445 913 Mouse mmu-miR-135b miRNA cigarette smoke or nontypeable Haemophilus influenzae (NTHi) cell proliferation lung tissue cigarette smoke or nontypeable Haemophilus influenzae (NTHi) treatment upregulated 23440414 914 Mouse mmu-miR-135b miRNA H2O2 myocardial infarction (MI) Primary cultured neonatal mice ventricular cardiomyocytes (NMVCs) hydrogen peroxide (H2O2) treatment downregulated 31870781 915 Mouse mmu-miR-135b-5p miRNA dexamethasone (DEX) asthma lung tissues dexamethasone (Dex) treatment miR-135b-5p was upregulated in the Dex group compared with that in the Model group. 32222886 916 Mouse mmu-miR-135b-5p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral ischemia/reperfusion (I/R) injury HT22 cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment miR-135b-5p expression was significantly decreased in hippocampal neurons receiving OGD/R treatment 30002689 917 Mouse mmu-miR-135b-5p miRNA helicobacter pylori (H. pylori) gastric cancer (GC) mouse gastric tissue Helicobacter pylori infection upregulated 29985646 918 Mouse mmu-miR-135b-5p miRNA osteogenic differentiation medium osteoporosis MC3T3-E1 cells osteogenic differentiation medium induction downregulated 32010267 919 Mouse mmu-miR-135b-5p miRNA dextran sodium sulfate (DSS) ulcerative colitis (UC) colonic tissues dextran sulfate sodium (DSS) treatment upregulated 32779953 920 Mouse mmu-miR-136 miRNA high-content hydrogen water (HHW) nonalcoholic fatty liver disease (NAFLD) liver tissues high-content hydrogen water (HHW) treatment MiR-136 was downregulated in NAFLD mice model after HHW treatment. 29261513 921 Mouse mmu-miR-136 miRNA polyinosinic-polycytidilic acid (Poly(I:C)) orchitis testicular cells poly I:C treatment downregulated 31195953 922 Mouse mmu-miR-136 miRNA lipopolysaccharide (LPS) osteoarthritis (OA) ?murine chondrogenic ATDC5 cell lipopolysaccharide (LPS) treatment upregulated 30074264 923 Mouse mmu-miR-136-5p miRNA IL-17 inflammation C57BL/6 mouse astrocytes IL-17 (100ng/ml) for various periods of time (0-48 hours) and at various doses (0-200 ng) upregulated 28355611 924 Mouse mmu-miR-136-5p miRNA barium chloride muscle injury C2C12 cells barium chloride treatment upregulated 32954829 925 Mouse mmu-miR-137 miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) ischemic stroke (IS) Mouse hippocampal neuron HT22 cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 33746585 926 Mouse mmu-miR-137 miRNA qingda granule (QDG) ischemic stroke (IS) oxygen-glucose deprivation/reoxygenation (OGD/R) treated HT22 cells Qingda granule (QDG) treatment upregulated 33746585 927 Mouse mmu-miR-137 miRNA amyloid-¦Â (A¦Â) Alzheimer's disease (AD) Neuro2a (N2a) cells amyloid-¦Â (A¦Â) treatment downregulated 28655611 928 Mouse mmu-miR-137 miRNA isorhapontigenin (ISO) bladder cancer Human bladder cancer cell line UMUC3 isorhapontigenin (ISO)treatment upregulated 26832795 929 Mouse mmu-miR-137 miRNA H2O2 cardiomyocyte apoptosis cardiomyocyte H2O2 treatment upregulated 26566162 930 Mouse mmu-miR-137 miRNA propofol (PPF) cell apoptosis and autophagy HT-22 cells Propofol treatment upregulated 31678238 931 Mouse mmu-miR-137 miRNA kainic acid (KA) convulsive seizures hippocampal neural stem/progenitor cells (NSPCs) kainic acid (KA) treatment upregulated 30837840 932 Mouse mmu-miR-137 miRNA neurotoxicant sodium valproate (VPA) developmental toxicity murine embryonic stem cells (mESCs) neurotoxicant sodium valproate (VPA) treatment downregulated 24896083 933 Mouse mmu-miR-137 miRNA pentylenetetrazol (PTZ) epilepsy temporal neocortex; hippocampus pentylenetetrazol (PTZ) treatment downregulated 29894770 934 Mouse mmu-miR-137 miRNA pilocarpine epilepsy temporal neocortex; hippocampus pilocarpine treatment downregulated 29894770 935 Mouse mmu-miR-137 miRNA vaccinium bracteatum Thunb.(VBT) gluconeogenesis mouse liver VBT treatment downregulated in liver 28946187 936 Mouse mmu-miR-137 miRNA olive leaf extract (OLE) hypertension and inappropriate antidiuretic hormone secretion (SIADH) kidneys tissues Olive Leaf Extract (OLE) treatment ?In vivo experiments revealed that treatment with OLE increases the expression of the CaSR mRNA and decreases AQP2 mRNA paralleled by an increase of the AQP2-targeting miRNA-137. 33633156 937 Mouse mmu-miR-137 miRNA oxygen glucose deprivation (OGD) ischemic stroke (IS) mouse primary brain neurons oxygen-glucose deprivation (OGD) treatment miR-137 expression was significantly decreased in neurons exposed to OGD compared with their control groups 29307821 938 Mouse mmu-miR-137 miRNA resveratrol neuroblastoma (NB) neuroblastoma cell line Neuro-2a (N-2a) cells RSV treatment upregulated 25505154 939 Mouse mmu-miR-137 miRNA extra-virgin olive oil rich in phenols (H-EVOO) neuronal function cortex H-EVOO treatment upregulated 26695409 940 Mouse mmu-miR-137 miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) mouse serum exosomes "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" upregulated 31301273 941 Mouse mmu-miR-137 miRNA H2O2 spinal cord injury (SCI) C8-D1A and C8-B4 cells hydrogen peroxide downregulated 29125882 942 Mouse mmu-miR-137 miRNA H2O2 spinal cord injury (SCI) C8-D1A and C8-B4 cells H2O2 treatment downregulated 29125882 943 Mouse mmu-miR-137 miRNA cortical impact traumatic brain injury (TBI) cortex cortical impact downregulated 26426744 944 Mouse mmu-miR-137-3p miRNA oxygen glucose deprivation (OGD) myocardial infarction (MI) primary cardiomyocytes oxygen glucose deprivation (OGD) treatment downregulated 32371945 945 Mouse mmu-miR-137-3p miRNA bupivacaine neurotoxicity C57BL/6 mice dorsal root ganglion neurons (DRGNs) bupivacaine treatment downregulated 28899795 946 Mouse mmu-miR-138 miRNA concanamycin A (Con A) acute liver injury (ALI) liver macrophage Concanamycin A (Con A)?treatment upregulated 31152110 947 Mouse mmu-miR-138 miRNA H2O2 acute spinal cord injury (ASCI) BV-2 cells H2O2 treatment "After treatment of various concentrations of H2O2, the cell viabilities were reduced, and miR-138 expression was downregulated." 29749242 948 Mouse mmu-miR-138 miRNA coxsackievirus B3 (CVB3) acute viral myocarditis (VM) mouse myocardium; primary cardiomyocytes Coxsackievirus B3 (CVB3) infection lncRNA HIF1A-AS1 promotes NF-¦ÊB signaling and subsequently aggravates cardiomyocyte apoptosis and inflammation via targeting miR-138. 33224748 949 Mouse mmu-miR-138 miRNA P. aeruginosa strain PAO1 bacterial infection lung tissues P. aeruginosa strain PAO1 treatment upregulated 29945883 950 Mouse mmu-miR-138 miRNA hypoxia/reoxygenation (H/R) hypoxia/reoxygenation (H/R) injury H9C2 cells hypoxia/reoxygenation (H/R) treatment lncRNA ROR sponges miR-138 to aggravate H/R-induced myocardial cell injury by upregulating the expression of Mst1. 32240614 951 Mouse mmu-miR-138 miRNA hyperoside hypoxia-induced cardiac dysfunctions H9C2 cells Hyperoside (Hyp) treatment The expression levels of miR-138 were increased in the hypoxic myocardium in the presence of Hyp 33649812 952 Mouse mmu-miR-138 miRNA lipopolysaccharide (LPS) inflammation RAW264.7 macrophages lipopolysaccharide (LPS) treatment upregulated 30157481 953 Mouse mmu-miR-138 miRNA morphine morphine induced neuroinflammation mouse primary astrocytes morphine treatment upregulated 33304479 954 Mouse mmu-miR-138 miRNA hypoxia myocardial ischemia/reperfusion (I/R) injury (MIRI) heart tissues The left anterior descending branch of LCA was ligated. downregulated 31602205 955 Mouse mmu-miR-138 miRNA H2O2 osteoporotic injury of osteoblasts MC3T3-E1 cells H2O2 treatment upregulated 29291636 956 Mouse mmu-miR-138-5p miRNA gentamicin acute kidney injury (AKI) urine gentamicin treatment upregulated 27074385 957 Mouse mmu-miR-138-5p miRNA lipopolysaccharide (LPS) acute respiratory distress syndrome (ARDS) serum lipopolysaccharide (LPS) treatment upregulated 32934950 958 Mouse mmu-miR-138-5p miRNA propofol (PPF) cognitive function Primary neonatal mouse oligodendrocyte (OLGs) propofol treatment upregulated 33411226 959 Mouse mmu-miR-138-5p miRNA oxygen glucose deprivation (OGD) ischemic stroke (IS) Primary astrocyte oxygen-glucose deprivation (OGD)-induce treatment downregulated 31485266 960 Mouse mmu-miR-138-5p miRNA cigarette smoke extract (CSE) male infertility Leydig and Sertoli cells cigarette smoke?extract?(CSE) treatment Quantitative polymerase chain reaction and Western blot assays showed a negative correlation between miR-138-5p and Caspase-3 expression. 33856081 961 Mouse mmu-miR-138-5p miRNA dexmedetomidine (DEX) myocardial ischemia/reperfusion (I/R) injury (MIRI) mouse myocardial tissues ?dexmedetomidine (Dex)? treatment "Dex improved cardiac function, alleviated myocardial damage, reduced inflammatory factor contents, collagen fibers, and Ltb4r1 expression while increased miR-138-5p expression in myocardial tissues of mice with MI/RI" 33509010 962 Mouse mmu-miR-138-5p miRNA high fat diet (HFD) obesity preadipocyte high fat diet (HFD) feed "CircSAMD4A regulated preadipocyte differentiation by acting as a miR-138-5p sponge, and thus increasing EZH2 expression." 32292524 963 Mouse mmu-miR-138-5p miRNA IL-1¦Â osteoarthritis (OA) mouse chondrocytes IL-1¦Â treatment downregulated 29305974 964 Mouse mmu-miR-138-5p miRNA IL-1¦Â osteoarthritis (OA) ATDC5 cells IL-1¦Â treatment MiR-138-5p was downregulated in ATDC5 cells. 31486753 965 Mouse mmu-miR-139 miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral ischemia/reperfusion (I/R) injury BV-2 cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment MiR-139 was significantly downregulated whereas c-Jun was obviously upregulated after OGD/R treatment. 32807449 966 Mouse mmu-miR-139 miRNA particulate matter (PM2.5) PM2.5 exposure mosue bronchoalveolar lavage fluid (BALF) "were subjected to intratracheal instillation of 2.5, 10, or 20mg/kg PM2.5 treatment" upregulated in bronchoalveolar lavage fluid (BALF) 29107863 967 Mouse mmu-miR-139 miRNA particulate matter (PM2.5) pulmonary toxicological lung tissues particulate matter (PM2.5) exposure treatment upregulated 29107863 968 Mouse mmu-miR-139-3p miRNA mechanical unloading bone loss MC3T3-E1 cells Mechanical unloading treatment LncRNA ODSM-mediated regulation of osteoblast apoptosis and differentiation partially depends on miR-139-3p under MG unloading conditions. 32071307 969 Mouse mmu-miR-139-3p miRNA urocortin 1 (Ucn-1) myocardial ischemia/reperfusion (I/R) injury (MIRI) I/R mosue administration of Ucn-1 at the beginning of reperfusion treatment downregulated 28827743 970 Mouse mmu-miR-139-5p miRNA high fat diet (HFD) atherosclerosis (AS) arterial tissues of mice high fat diet (HFD) feed downregulated 33331071 971 Mouse mmu-miR-139-5p miRNA Jiang Tang Xiao Ke Granule diabetes mellitus (DM) KKAy diabetic mice Jiang Tang Xiao Ke Granule treatment dysregulated 29163176 972 Mouse mmu-miR-139-5p miRNA high glucose (HG) diabetes mellitus (DM) Min6 cells high glucose (HG) treatment upregulated 31735337 973 Mouse mmu-miR-139-5p miRNA H1N1 influenza virus endometriosis and endometrial carcinoma mouse lung?tissues H1N1 influenza virus infection upregulated 24066118 974 Mouse mmu-miR-139-5p miRNA fructus meliae toosendan (FMT) liver damage eft lateral liver lobe Fructus Meliae Toosendan (FMT) treatment downregulated 26539117 975 Mouse mmu-miR-139-5p miRNA prion neurodegeneration (ND) the brains tissues prion infection treatment upregulated 18987751 976 Mouse mmu-miR-139-5p miRNA 25-hydroxycholesterol (25-HC) osteoclastogenesis mouse bone marrow macrophages (BMMs) cultured in receptor activator of NF-¦ÊB ligand (RANKL) and monocyte macrophage colony-stimulating factor (M-CSF) 25-hydroxycholesterol (25-HC) treatment downregulated 28257846 977 Mouse mmu-miR-13a miRNA azoxymethane (AOM) colorectal cancer (CRC) plasma and colon tissues azoxymethane (AOM) treatment downregulated 30311185 978 Mouse mmu-miR-13a miRNA lactobacillus acidophilus and bifidobacterium bifidum probiotics colorectal cancer (CRC) plasma and colon tissues from azoxymethane (AOM)-treated mice Lactobacillus acidophilus and Bifidobacterium bifidum probiotics treatment upregulated 30311185 979 Mouse mmu-miR-1-3p miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity Plasma doxorubicin (DOX) treatment downregulated 30627229 980 Mouse mmu-miR-1-3p miRNA acetaminophen (APAP) drug-induced liver injury (DILI) plasma acetaminophen (APAP) treatment upregulated 30125006 981 Mouse mmu-miR-140 miRNA ethanol (EtOH) brain growth deficits associated with prenatal alcohol exposure extracellular vesicles from neural stem cells (NSCs) ethanol (EtOH) exposure upregulated 31009095 982 Mouse mmu-miR-140 miRNA TGF-¦Â3 cartilage defection C3H10T1/2 mesenchymal stem cells (MSCs) TGF-¦Â3 treatment upregulated 29067438 983 Mouse mmu-miR-140 miRNA interleukin-1 receptor antagonist protein (IRAP) cartilage impact injury porcine knee joint Interleukin-1 Receptor Antagonist Protein (IRAP) treatment upregulated 26521750 984 Mouse mmu-miR-140 miRNA lipopolysaccharide (LPS) hepatitis liver tissues lipopolysaccharide (LPS) treatment ?Microarray showed that lncRNA TUG1 was upregulated in LPS-induced hepatocyte inflammation. 33644034 985 Mouse mmu-miR-140 miRNA high fat diet (HFD) myofibroblast differentiation mosue mammary adipose tissue high fat diet (HFD) feed downregulated in mammary adipose tissue 27895151 986 Mouse mmu-miR-140 miRNA fluid shear stress (FSS) osteoblastic differentiation MC3T3-E1 cells fluid shear stress (FSS)treatment downregulated 23595392 987 Mouse mmu-miR-140 miRNA endotoxin sepsis skeletal muscle tissue endotoxin treatment downregulated 31042421 988 Mouse mmu-miR-140-3p miRNA ovalbumin (OVA) allergic bronchial asthma bronchial smooth muscles (BSMs) ovalbumin antigen treatment downregulated 33121100 989 Mouse mmu-miR-140-3p miRNA X-rays bystander effect C57BL/6 mice extracellular vesicles (EVs) otal-body irradiated with X-rays downregulated 28396668 990 Mouse mmu-miR-140-3p miRNA angiotensin II (Ang II) cardiac hypertrophy neonatal mouse ventricular cardiomyocytes (NMVCs) angiotensin II (Ang II) treatment miR-140-3p was markedly decreased in NMVCs with overexpression of circRNA_000203. 31397837 991 Mouse mmu-miR-140-3p miRNA ethanol (EtOH) and nicotine chronic hepatitis C virus (HCV) infection mouse fetal murine cerebral cortical ethanol and nicotine treatment downregulated 22458409 992 Mouse mmu-miR-140-3p miRNA lentivirus collagen-induced arthritis (CIA) synovial lentivirus (LV) treatment downregulated 26473405 993 Mouse mmu-miR-140-3p miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity plasma doxorubicin (DOX) treatment downregulated 30453253 994 Mouse mmu-miR-140-3p miRNA bilateral surgical destabilization of the medial meniscus (DMM) osteoarthritis (OA) male C57BL6 mice bilateral surgical destabilization of the medial meniscus (DMM) treatment dysregulated 29255152 995 Mouse mmu-miR-140-5p miRNA apigenin acute kidney injury (AKI) hypoxia/reoxygenation (H/R)-treated mouse renal tubular epithelial cells (mRTECs) apigenin treatment upregulated 33653497 996 Mouse mmu-miR-140-5p miRNA cisplatin (DDP) acute kidney injury (AKI) mouse kidney cisplatin treatment upregulated 28928081 997 Mouse mmu-miR-140-5p miRNA hypoxia/reoxygenation (H/R) acute kidney injury (AKI) mouse renal tubular epithelial cells (mRTECs) hypoxia/reoxygenation (H/R) treatment downregulated 33653497 998 Mouse mmu-miR-140-5p miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues lipopolysaccharide (LPS) treatment downregulated 30344669 999 Mouse mmu-miR-140-5p miRNA lipopolysaccharide (LPS) acute lung injury (ALI) MLE-12 cells lipopolysaccharide (LPS) treatment downregulated 31769066 1000 Mouse mmu-miR-140-5p miRNA shikonin acute lung injury (ALI) mouse MLE©\12 cell Shikonin treatment "Shikonin could improve acute lung injury induced by sepsis The mechanism might be correlation miRNA-140-5p expression increasing, and regulated targeted gene TLR4, with TLR4 expression depressing, the downstream myeloid differentiation protein 88 and nuclear factor ¦ÊB proteins expression were suppressed" 31769066 1001 Mouse mmu-miR-140-5p miRNA shikonin acute lung injury (ALI) MLE-12 cells Shikonin treatment upregulated 31769066 1002 Mouse mmu-miR-140-5p miRNA "1,25-dihydroxyvitamin D 3 (calcitriol)" bone development murine primary osteoblasts and MC3T3 cells "1,25-dihydroxyvitamin D 3 (calcitriol) treatment" upregulated 29604361 1003 Mouse mmu-miR-140-5p miRNA lentivirus collagen-induced arthritis (CIA) synovial lentivirus (LV) treatment downregulated 26473405 1004 Mouse mmu-miR-140-5p miRNA catalpol diabetic cardiomyopathy (DCM) high glucose (HG) treated mouse cardiomyocytes catalpol treatment "upregulated, overexpression of miR-140-5p or silencing of HDAC4 rescued Neat1-induced cardiomyocyte apoptosis" 31078585 1005 Mouse mmu-miR-140-5p miRNA xuebijing (XBJ) lung fibrosis lung tissues xuebijing (XBJ) treatment XBJ administration upregulated miR-140-5p expression in mice with PQ-induced pulmonary fibrosis. 32462952 1006 Mouse mmu-miR-140-5p miRNA IL-1¦Â osteoarthritis (OA) primary mandibular condylar chondrocytes (MCCs) IL-1¦Â treatment upregulated 30728776 1007 Mouse mmu-miR-140-5p miRNA fluid shear stress (FSS) osteogenesis MC3T3-E1 cells Fluid shear stress (FSS)? treatment miR-140-5p was significantly downregulated when MC3T3-E1 cells were exposed to FSS. 33588662 1008 Mouse mmu-miR-140-5p miRNA Xuebijing (XBJ) paraquat (PQ)-induced pulmonary fibrosis lung tissues Xuebijing (XBJ) treatment XBJ administration upregulated miR-140-5p expression in mice with PQ-induced pulmonary fibrosis 32462952 1009 Mouse mmu-miR-141 miRNA melatonin cardiac fibrosis high glucose (HG)-treated cardiac fibroblasts (CFs) Melatonin treatment melatonin produces an antifibrotic effect via inhibiting lncR-MALAT1/miR-141-mediated NLRP3 inflammasome activation and TGF-¦Â1/Smads signaling 32067273 1010 Mouse mmu-miR-141 miRNA kainic acid (KA) epilepsy brain tissues kainic acid treatment miRNA-141 expression levels were increased in epilepsy mice. 30548678 1011 Mouse mmu-miR-141 miRNA shikonin epithelial-mesenchymal transition (EMT) mouse skin tissues Shikonin treatment downregulated 23861701 1012 Mouse mmu-miR-141 miRNA alcohol intestinal injury and intestinal endotoxemia of alcoholic hepatitis intestinal tissues Lieber-Decarli alcohol feed downregulated 31173169 1013 Mouse mmu-miR-141 miRNA methionine choline-deficient diet (MCD) nonalcoholic steatohepatitis (NASH) liver tissues fed a methionine and choline deficient (MCD) diet for 2 week upregulated in liver 29093267 1014 Mouse mmu-miR-141 miRNA bone morphogenetic protein 2 (BMP2) preosteoblast differentiation pre-osteoblast bone morphogenetic protein 2 (BMP2) treatment downregulated 19454767 1015 Mouse mmu-miR-141 miRNA X-rays radiation-induced oral mucositis (RIOM) tongue tissues 25 Gy X-ray irradiation treatment upregulated 31346357 1016 Mouse mmu-miR-141 miRNA streptozocin (STZ) type 1 diabetes mellitus (T1DM) diabetic heart tissues ?streptozotocin treatment upregulated 23034391 1017 Mouse mmu-miR-141 miRNA "2,4,6-trinitrobenzene sulfonic acid (TNBS)" crohn disease (CD) colon tissues "2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol treatment" downregulated 24000293 1018 Mouse mmu-miR-141-3p miRNA fatty acid amide hydrolase inhibitor (FAAH-II) colitis colitis mouse colon tissues FAAH-II treatment dysregulated 27327245 1019 Mouse mmu-miR-141-3p miRNA aldose reductase diabetic nephropathy (DN) renal mesangial cells aldose reductase treatment upregulated 24161443 1020 Mouse mmu-miR-141-3p miRNA high glucose (HG) diabetic nephropathy (DN) mesangial cells high glucose (HG) treatment LncRNA SNHG16 induces proliferation and fibrogenesis via modulating miR-141-3p and CCND1 in diabetic nephropathy. 32504027 1021 Mouse mmu-miR-141-3p miRNA porcine cardiac myosin (PCM) experimental autoimmune myocarditis (EAM) heart tissues porcine cardiac myosin (PCM) induce downregulated 31225989 1022 Mouse mmu-miR-141-3p miRNA D-glucose osteoarthritis (OA) ATDC5 cells D-glucose treatment downregulated 29319178 1023 Mouse mmu-miR-141-3p miRNA coix seed Oil (CSO) triple negative breast cancer (TNBC) mouse triple-negative breast cancer (TNBC) tissues coix Seed Oil (CSO) treatment upregulated 33101013 1024 Mouse mmu-miR-142 miRNA Klebsiella pneumoniae acute lung injury (ALI) Bronchoalveolar lavage fluid (BALF) microvesicles (MVs) Klebsiella pneumoniae infection upregulated 31331947 1025 Mouse mmu-miR-142 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) Bronchoalveolar lavage fluid (BALF) microvesicles (MVs) lipopolysaccharide (LPS) treatment upregulated 31331947 1026 Mouse mmu-miR-142 miRNA amyloid-¦Â (A¦Â) 1-40 age-related macular degeneration (AMD) C57BL/6 mice eye tissues amyloid-¦Â (A¦Â) 1-40 treatment upregulated 28324113 1027 Mouse mmu-miR-142 miRNA Glabridin (GLA) breast cancer MDA-MB-231 and BT-551 breast cancer cells Glabridin (GLA) treatment upregulation 24754877 1028 Mouse mmu-miR-142 miRNA doxycycline colitis colon tissues doxycycline (DXC) treatment upregulated 30076847 1029 Mouse mmu-miR-142 miRNA minocycline (MNC) colitis colon tissues minocycline (MNC) treatment upregulated 30076847 1030 Mouse mmu-miR-142 miRNA tigecycline (TGC) colitis colon tissues tigecycline (TGC) treatment upregulated 30076847 1031 Mouse mmu-miR-142 miRNA IL-15 innate immune response type 1 innate lymphoid cells (ILCs) isolated from spleen tissues Interleukin-15 (IL-15) treatment upregulated 31402259 1032 Mouse mmu-miR-142 miRNA artesunate (ART) ovarian cancer (OC) peripheral CD4+ T cells and Th1 differentiation from CD4+ T cells Artesunate treatment upregulated 31038546 1033 Mouse mmu-miR-142 miRNA cecal ligation and puncture (CLP) sepsis mouse cecal ligation and puncture (CLP) treatment downregulated 29793310 1034 Mouse mmu-miR-142 miRNA catalpol spinal cord injury (SCI) BV2 cells catalpol treatment CTP was found to be upregulated miR-142 and the protective effects of CTP on apoptosis 33628189 1035 Mouse mmu-miR-142-3p miRNA H2O2 acute myocardial infarction (AMI) primary cultured cardiomyocytes H2O2 treatment downregulated 31145943 1036 Mouse mmu-miR-142-3p miRNA borneol asthma CD4 + T cells borneol treatment Borneol inhibited CD4 + T cells infiltration in vivo and proliferation in vitro by downregulating miR-26a and miR-142-3p. 33272847 1037 Mouse mmu-miR-142-3p miRNA borneol asthma CD4+ T cells isolated from the spleen of OVA-induced asthma mice borneol treatment Borneol inhibited CD4 + T cells infiltration in vivo and proliferation in vitro by downregulating miR-26a and miR-142-3p. 33272847 1038 Mouse mmu-miR-142-3p miRNA ovalbumin (OVA) asthma lung tissues ovalbumin treatment upregulated 29722559 1039 Mouse mmu-miR-142-3p miRNA lipopolysaccharide (LPS) cell death BM cells lipopolysaccharide (LPS) treatment Targeting of microRNA-142-3p in dendritic cells regulates endotoxin-induced mortality 21474672 1040 Mouse mmu-miR-142-3p miRNA cholic acid (CA) cholestasis mouse liver CA treatment upregulated 28153841 1041 Mouse mmu-miR-142-3p miRNA streptozocin (STZ) diabetes mellitus (DM) hearts of diabetic mice streptozotocin (STZ) treatment upregulated 21584493 1042 Mouse mmu-miR-142-3p miRNA prednisolone duchenne muscular dystrophy (DMD) diaphragm muscle prednisolone treatment downregulated 29883261 1043 Mouse mmu-miR-142-3p miRNA vamorolone duchenne muscular dystrophy (DMD) diaphragm muscle vamorolone treatment downregulated 29883261 1044 Mouse mmu-miR-142-3p miRNA IL-10 epithelial-mesenchymal transition (EMT) colonic intraepithelial lymphocytes IL-10 treatment upregulated 22043014 1045 Mouse mmu-miR-142-3p miRNA lipopolysaccharide (LPS) hirschsprung's disease (HSCR) neural precursor cells (NPCs) lipopolysaccharides (LPS) treatment downregulated 29956457 1046 Mouse mmu-miR-142-3p miRNA flaxseed (FS) inflammation mouse exposed to X-ray fed 10% FS or a 0% FS isocaloric control diet treatment dysregulated 24755684 1047 Mouse mmu-miR-142-3p miRNA histone deacetylase inhibitor trichostatin A (TSA) inflammatory diseases LPS-treated macrophages histone deacetylase inhibitor trichostatin A treatment upregulated 27788393 1048 Mouse mmu-miR-142-3p miRNA licochalcone A (LA) melanoma B16 cells licochalcone A (LCA) treatment MiR- 142-3p level was significantly upregulated in LCA-treated B16 cells in a time- and dose-dependent manner 31793097 1049 Mouse mmu-miR-142-3p miRNA ischemia/reperfusion (I/R) myocardial injury cardiomyocyte M6200 cells ischemia/reperfusion (I/R) treatment downregulated 28025989 1050 Mouse mmu-miR-142-3p miRNA lipopolysaccharide (LPS) osteoarthritis (OA) chondrocytes lipopolysaccharide (LPS) treatment downregulated 27447821 1051 Mouse mmu-miR-142-3p miRNA Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria plasmodium chabaudi infection Balb/c Mice liver infect with Vaccination treatment downregulated in the Liver 28123381 1052 Mouse mmu-miR-142-3p miRNA chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) plvic inflammatory disease mouse two Chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) infection were upregulated during CmVar004 infection compared to CmVar001 infection 24961692 1053 Mouse mmu-miR-142-3p miRNA "5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)" cell proliferation mouse 3T3 cells "5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment" downregulated 25544846 1054 Mouse mmu-miR-142-3p miRNA high inorganic phosphate (Pi) uremia blood of DBA/2 mice high phosphate diet (HPD) feed downregulated 30453118 1055 Mouse mmu-miR-142-3p miRNA high inorganic phosphate (Pi) vascular relaxation blood of DBA/2 mice high phosphate diet (HPD) feed downregulated 30453118 1056 Mouse mmu-miR-142-5p miRNA ovalbumin (OVA) asthma pulmonary macrophages ovalbumin (OVA) treatment upregulated 32524675 1057 Mouse mmu-miR-142-5p miRNA oleanolic acid (OLA) diabetic nephropathy (DN) streptozotocin induced diabetic nephropathy (DN) mouse kidney tissues oleanolic acid (OLA) treatment downregulated 31410746 1058 Mouse mmu-miR-142-5p miRNA prednisolone duchenne muscular dystrophy (DMD) diaphragm muscle prednisolone treatment downregulated 29883261 1059 Mouse mmu-miR-142-5p miRNA vamorolone duchenne muscular dystrophy (DMD) diaphragm muscle vamorolone treatment downregulated 29883261 1060 Mouse mmu-miR-142-5p miRNA pilocarpine epilepsy male NMRI mice inject intraperitoneally with pilocarpine treatment downregulated 25078263 1061 Mouse mmu-miR-142-5p miRNA IL-10 epithelial-mesenchymal transition (EMT) colonic intraepithelial lymphocytes IL-10 treatment upregulated 22043014 1062 Mouse mmu-miR-142-5p miRNA retinoid binding protein peptide 161-180 experimental autoimmune uveoretinitis (EAU) ocular tissues retinoid binding protein peptide 161-180 treatment upregulated 20881307 1063 Mouse mmu-miR-142-5p miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver tissues high fat diet (HFD) feed upregulated 31889412 1064 Mouse mmu-miR-142-5p miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver tissues high fat diet (HFD) feed upregulated 31889412 1065 Mouse mmu-miR-142-5p miRNA plasmodium chabaudi malaria peak parasitemia liver of mice Plasmodium chabaudi malaria infection treatment downregulated 21085987 1066 Mouse mmu-miR-142-5p miRNA angiotensin II (Ang II) cell proliferation cardiac fibroblasts (CFs) angiotensin II (Ang II) treatment downregulated 32268073 1067 Mouse mmu-miR-142-5p miRNA TGF-¦Â1 cell proliferation cardiac fibroblasts (CFs) TGF-¦Â1 ttreatment treatment downregulated 32268073 1068 Mouse mmu-miR-142-5p miRNA smoking smoking-related interstitial fibrosis (SRIF) C57 mice circulating 6 months of chronic mainstream smoking exposure treatment downregulated 22782705 1069 Mouse mmu-miR-142-5p miRNA pilocarpine temporal lobe epilepsy (TLE) hippocampus pilocarpine treatment upregulated 32439493 1070 Mouse mmu-miR-142a miRNA helicobacter pylori (H. pylori) gastric MALT lymphoma (GML) GML-developing d3Tx mice stomachs infect with H. pylori upregulated 28560185 1071 Mouse mmu-miR-142a miRNA ischemia/reperfusion (I/R) myocardial ischaemic injury mouse plasma;Bone marrow-derived macrophage (BMDM);Rat neonatal CMs ischemia/reperfusion (I/R) treatment differently regulated 28768728 1072 Mouse mmu-miR-142a-3p miRNA lipopolysaccharide (LPS) acute lung injury (ALI) ALI mice lung tissues and RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated 31494298 1073 Mouse mmu-miR-142a-3p miRNA methamphetamine (METH) methamphetamine (METH)-mediated neurotoxicity BV2 cells and mouse brain Methamphetamine (METH) treatment downregulated 30914375 1074 Mouse mmu-miR-142a-5p miRNA genipin (GNP) hyperlipidemia obese mouse GNP liver upregulated 29197188 1075 Mouse mmu-miR-142a-5p miRNA genipin (GNP) hyperlipidemia high fat diet-induced obese mice genipin (GNP) treatment upregulated 29197188 1076 Mouse mmu-miR-143 miRNA "3-Isobutyl_x0002_l-methylxanthine (MIX), dexamethasone (DEX)" adipogenesis 3T3-L1cells "adding 10 lg/ml insulin, 1 lM DEX, and 0.5 mM MIX treatment" upregulated 25366176 1077 Mouse mmu-miR-143 miRNA angiotensin II (Ang II) aortic dissection (AD) mouse vascular smooth muscle cells (VSMCs) angiotensin II (Ang II) treatment downregulated 28167124 1078 Mouse mmu-miR-143 miRNA hepatic antigen S100 autoimmune hepatitis (AIH) mouse liver tissues hepatic antigen S100 treatment Infection or transfection of mir-143 in mice or hepatocytes significantly attenuated the development of alleviation of hepatocyte injury. 31808606 1079 Mouse mmu-miR-143 miRNA estradiol-17¦Â (E2) cervical cancer (CC) Osteosarcoma Saos2 cell line estradiol-17¦Â (E2) treatment downregulated 27278606 1080 Mouse mmu-miR-143 miRNA dextran sodium sulfate (DSS) colitis colon tissues dextran sodium sulfate (DSS) treatment downregulated 29867475 1081 Mouse mmu-miR-143 miRNA probiotic Escherichia coli Nissle 1917 (EcN) colitis dextran sodium sulfate (DSS)-induced colitis mouse colon tissues probiotic Escherichia coli Nissle 1917 (EcN) treatment upregulated 29867475 1082 Mouse mmu-miR-143 miRNA azoxymethane (AOM) and dextran sulfate sodium (DSS) colorectal cancer (CRC) mouse colon tissues azoxymethane (AOM) and dextran sulfate sodium (DSS) treatment downregulated 24464560 1083 Mouse mmu-miR-143 miRNA azoxymethane (AOM) and dextran sulfate sodium (DSS) colorectal cancer (CRC) mouse colon tissues azoxymethane (AOM) and dextran sulfate sodium (DSS) treatment downregulated 24464560 1084 Mouse mmu-miR-143 miRNA high fat diet (HFD) diabetes mellitus (DM) mouse liver cells high fat diet (HFD) treatment downregulated 21441927 1085 Mouse mmu-miR-143 miRNA streptozocin (STZ) diabetes mellitus (DM) hearts of diabetic mice streptozotocin (STZ) treatment downregulated 21584493 1086 Mouse mmu-miR-143 miRNA angelica polysaccharide (AP) diabetes mellitus (DM) TNF-¦Á-treated MIN6 cell line angelica polysaccharide (AP) treatment upregulated 31746030 1087 Mouse mmu-miR-143 miRNA carboxymethyllysine (CML) diabetes mellitus (DM) fibroblast cell line 3T3©\L1 carboxymethyllysine (CML) treatment upregulated 27137869 1088 Mouse mmu-miR-143 miRNA tumor necrosis factor alpha (TNF-¦Á) diabetes mellitus (DM) MIN6 cell line tumor necrosis factor alpha (TNF-¦Á) treatment downregulated 31746030 1089 Mouse mmu-miR-143 miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity heart tissues doxorubicin (Dox) treatment Doxorubicin treatment increased the expression of miR-143. 32170053 1090 Mouse mmu-miR-143 miRNA lipopolysaccharide (LPS) hepatocyte injury AML12 cells lipopolysaccharide (LPS) treatment Infection or transfection of mir-143 in mice or hepatocytes significantly attenuated the development of alleviation of hepatocyte injury. 31808606 1091 Mouse mmu-miR-143 miRNA dextran sodium sulfate (DSS) inflammatory bowel disease (IBD) colon tissues dextran sulfate sodium (DSS) treatment downregulated 30236870 1092 Mouse mmu-miR-143 miRNA oxygen glucose deprivation (OGD) ischemic stroke (IS) primary cortical neurons oxygen-glucose deprivation (OGD) treatment upregulated 30129112 1093 Mouse mmu-miR-143 miRNA listeria Listeria infection murine ileum tissues Listeria infection downregulated 24327339 1094 Mouse mmu-miR-143 miRNA high fat diet (HFD) metastatic colorectal cancer (mCRC) adipose tissue of mice ?high-fat diet treatment the expression of miR-143 in the mesenteric fat was upregulated in mice fed a high-fat diet 18809385 1095 Mouse mmu-miR-143 miRNA 6-Gingerol (6-G) myocardial ischemia/reperfusion (I/R) injury (MIRI) HL-1 cells 6-Gingerol (6-G) treatment we found that 6-G elevated cellular H19 expression in hypoxia/reoxygenation (H/R)-treated HL-1 cells. 33758383 1096 Mouse mmu-miR-143 miRNA methamphetamine (METH) neuroinflammation BV2 cells Methamphetamine treatment downregulated 30394308 1097 Mouse mmu-miR-143 miRNA methamphetamine (METH) neuroinflammation BV2 cells methamphetamine (METH) treatment downregulated 30394308 1098 Mouse mmu-miR-143 miRNA clozapine (CLZ) phencyclidine-induced schizophrenia-related locomotor hyperactivity "phencyclidine (PCP)-induced mice plasma, prefrontal cortex (PFC) and hippocampus" clozapine treatment upregulated 31233824 1099 Mouse mmu-miR-143 miRNA eticlopride phencyclidine-induced schizophrenia-related locomotor hyperactivity HT-22 neuronal cell line and primary cortical cultured neuronswere eticlopride treatment upregulated 31233824 1100 Mouse mmu-miR-143 miRNA phencyclidine (PCP) phencyclidine-induced schizophrenia-related locomotor hyperactivity "plasma, prefrontal cortex (PFC) and hippocampus" phencyclidine (PCP) treatment downregulated 31233824 1101 Mouse mmu-miR-143 miRNA quinpirole phencyclidine-induced schizophrenia-related locomotor hyperactivity HT-22 neuronal cell line and primary cortical cultured neuronswere quinpirole treatment downregulated 31233824 1102 Mouse mmu-miR-143 miRNA progesterone (P4) cell proliferation mouse endometrial epithelial cells progesterone (P4) treatment upregulated 29661100 1103 Mouse mmu-miR-143 miRNA cyclopamine regulating the activity of Shh signaling embryonic lung cultures cyclopamine treatment dysregulated 24617895 1104 Mouse mmu-miR-143 miRNA haloperidol schizophrenia (SZ) "phencyclidine (PCP)-induced mice plasma, prefrontal cortex (PFC) and hippocampus" haloperidol treatment upregulated 31233824 1105 Mouse mmu-miR-143 miRNA laparotomy and exposure of the junc_x0002_tion between the large and small intestines sepsis mouse large and small intestines laparotomy and exposure of the junc_x0002_tion between the large and small intestines treatment upregulated 25043848 1106 Mouse mmu-miR-143 miRNA radiation thymic lymphoma (RITL) BALB/c mice radiation treatment downregulated 28736328 1107 Mouse mmu-miR-143 miRNA mycobacterium tuberculosis (Mtb) tuberculosis (TB) M(IL-4/IL-13) macrophages Mycobacterium tuberculosis (Mtb) HN878 infection upregulated 30941122 1108 Mouse mmu-miR-143-3p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral ischemia/reperfusion (I/R) injury SH-SY5Y cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment MiR-143-3p was significantly upregulated during cerebral I/R injury both in vivo and in vitro 33709299 1109 Mouse mmu-miR-143-3p miRNA "4,4'-methylenedianiline (MDA)" cholestasis plasma "4,4'-Methylenedianiline (MDA) treatment" upregulated 30125006 1110 Mouse mmu-miR-143-3p miRNA thioacetamide (TAA) cholestasis plasma thiacetamide (TAA) treatment upregulated 30125006 1111 Mouse mmu-miR-143-3p miRNA ¦Á-naphthylisothiocyanate (ANIT) cholestasis plasma ¦Á-naphthylisothiocyanate (ANIT) treatment upregulated 30125006 1112 Mouse mmu-miR-143-3p miRNA collagen collagen-induced arthritis (CIA) RA rats blood and the dorsal root ganglion (DRG) collagen treatment downregulated 30066874 1113 Mouse mmu-miR-143-3p miRNA metformin (Met) diabetic nephropathy (DN) SV40-MES-13 cells Metformin (MET) treatment "Metformin inhibits extracellular matrix accumulation, inflammation and proliferation of mesangial cells in diabetic nephropathy by regulating H19/miR-143-3p/TGF-¦Â1 axis." 32391614 1114 Mouse mmu-miR-143-3p miRNA fluke Fasciola gigantica (FgESPs) F. gigantica infection liver tissues fluke Fasciola gigantica (FgESPs) infection downregulated 33332355 1115 Mouse mmu-miR-143-3p miRNA mycoplasma pneumoniae (M. pneumoniae) fibromyalgia lung tissues Mycoplasma pneumoniae (MP) infection "Compared with model group, model mice had upregulated miR-143-3p expression." 32597476 1116 Mouse mmu-miR-143-3p miRNA hypoxanthine (HX) hyperuricemia renal tissues The hyperuricemic mice mode were induced by combination of peritoneal injection of potassium oxonate (PO) at dose of 250 mg/kg and intragastric administration of hypoxanthine (HX) at dose of 300 mg/kg daily for 8 weeks. downregulated 31378369 1117 Mouse mmu-miR-143-3p miRNA potassium oxonate (PO) hyperuricemia renal tissues The hyperuricemic mice mode were induced by combination of peritoneal injection of potassium oxonate (PO) at dose of 250 mg/kg and intragastric administration of hypoxanthine (HX) at dose of 300 mg/kg daily for 8 weeks. downregulated 31378369 1118 Mouse mmu-miR-143-3p miRNA bilateral surgical destabilization of the medial meniscus (DMM) osteoarthritis (OA) male C57BL6 mice bilateral surgical destabilization of the medial meniscus (DMM) treatment dysregulated 29255152 1119 Mouse mmu-miR-143-5p miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues carbon tetrachloride (CCl4) treatment upregulated 29557526 1120 Mouse mmu-miR-144 miRNA angiotensin II (Ang II) cardiac fibrosis heart sissues angiotensin II (Ang II) treatment downregulated 32765685 1121 Mouse mmu-miR-144 miRNA erythropoietin (EPO) chronic kidney disease (CKD) renal fibroblasts Erythropoietin (EPO) treatment upregulated 26469975 1122 Mouse mmu-miR-144 miRNA cisplatin (DDP) cisplatin (DDP)-induced nephrotoxicity renal tissues cisplatin treatment downregulated 31781349 1123 Mouse mmu-miR-144 miRNA streptozocin (STZ) diabetic cardiomyopathy (DCM) heart sissues streptozocin (STZ) treatment MiR-144 was identified to be decreased in HG-induced cardiomyocytes and in streptozotocin (STZ)-challenged heart samples. 31907983 1124 Mouse mmu-miR-144 miRNA metformin (Met) endometrial hyperplasia (EH) endometrial tissues metformin (Met) treatment Met upregulateb the expression of miR-144 in a dose-dependent manner. 31894313 1125 Mouse mmu-miR-144 miRNA metformin (Met) endometrial hyperplasia (EH) endometrial hyperplasia (EH) mice uterus metformin (Met) treatment upregulated 31894313 1126 Mouse mmu-miR-144 miRNA tamoxifen (TAM) endometrial hyperplasia (EH) uterus tamoxifen treatment downregulated 31894313 1127 Mouse mmu-miR-144 miRNA streptozocin (STZ) hyperglycemia heart STZ-induced diabetic mice treatment downregulated 26164195 1128 Mouse mmu-miR-144 miRNA streptozocin (STZ) hyperglycemia-induced cardiac dysfunction heart tissues streptozotocin (STZ) treatment downregulated 31907983 1129 Mouse mmu-miR-144 miRNA chronic constriction injury (CCI) neuropathic pain (NP) dorsal root ganglions (DRGs) chronic constriction injury (CCI) treatment downregulated 31737949 1130 Mouse mmu-miR-144 miRNA cortical impact traumatic brain injury (TBI) cortex cortical impact upregulated 26426744 1131 Mouse mmu-miR-144-3p miRNA lipopolysaccharide (LPS) acute kidney injury (AKI) kidney tissues lipopolysaccharide (LPS) treatment miR-144-3p was upregulated at 24h. 32727087 1132 Mouse mmu-miR-144-3p miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues lipopolysaccharide (LPS) treatment upregulated 29492259 1133 Mouse mmu-miR-144-3p miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues lipopolysaccharide (LPS) treatment miR-144-3p was upregulated while Caveolin-2 was downregulated in response to LPS treatment. 33418009 1134 Mouse mmu-miR-144-3p miRNA 7-chlorokynurenic acid (7-CTKA) antidepressant mouse 7-CTKA intraperitoneal injection downregulated 25034119 1135 Mouse mmu-miR-144-3p miRNA dietary zinc restriction anxiety- and trauma-related disorders C57BL/6 (BL6) mice dietary zinc restriction upregulated 28104225 1136 Mouse mmu-miR-144-3p miRNA collagen arthritis mouse hind paws tissues collagen treatment downregulated 31396316 1137 Mouse mmu-miR-144-3p miRNA moxibustion collagen-induced arthritis (CIA) CIA mouse hind paws tissues Moxibustion treatment upregulated 31396316 1138 Mouse mmu-miR-144-3p miRNA chronic unpredictable mild stress (CUMS) depression prefrontal cortex chronic unpredictable mild stress (CUMS) treatment downregulated 27701406 1139 Mouse mmu-miR-144-3p miRNA chronic unpredictable mild stress (CUMS) depression NAc tissue chronic unpredictable mild stress (CUMS) treatment upregulated 31430030 1140 Mouse mmu-miR-144-3p miRNA electroacupuncture (EA) electroacupuncture (EA) CD4 T cells electroacupuncture (EA) treatment upregulated 32026263 1141 Mouse mmu-miR-144-3p miRNA dietary zinc restriction impaired fear extinction basolateral amygdala dietary zinc restriction upregulated 28104225 1142 Mouse mmu-miR-144-3p miRNA oxygen glucose deprivation (OGD) ischemia/reperfusion (I/R) injury N2a cells oxygen-glucose deprivation treatment Overexpression of long non-coding RNA Rian attenuates cell apoptosis from cerebral ischemia-reperfusion injury via Rian/miR-144-3p/GATA3 signaling 33294587 1143 Mouse mmu-miR-144-3p miRNA licochalcone A (LA) lung cancer MLE-12 cells Licochalcone A (lico A) treatment downregulated 32505917 1144 Mouse mmu-miR-144-3p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce upregulated 30936699 1145 Mouse mmu-miR-144-3p miRNA hypoxia/reoxygenation (H/R) myocardial infarction (MI) HL-1 cardiomyocytes hypoxia/reoxygenation (H/R) induce downregulated 31227612 1146 Mouse mmu-miR-144-3p miRNA oxygen glucose deprivation (OGD) myocardial infarction (MI) primary cardiomyocytes oxygen glucose deprivation (OGD) treatment downregulated 32371945 1147 Mouse mmu-miR-144-3p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) neuronal cell injury HT22 cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 29457851 1148 Mouse mmu-miR-144-3p miRNA lipopolysaccharide (LPS) sepsis-induced myocardial injury HL-1 cells lipopolysaccharide (LPS) treatment MiR-144-3p was downregulated in LPS-treated myocardial cells. 32016991 1149 Mouse mmu-miR-144-3p miRNA mycobacterium tuberculosis (Mtb) tuberculosis (TB) macrophage RAW264.7 cells Mycobacterium bovis Bacillus Calmette-Gu¨¦rin (BCG) upregulated 28636635 1150 Mouse mmu-miR-144-5p miRNA angiotensin II (Ang II) abdominal aortic aneurysm (AAA) aorta tissues angiotensin II (Ang II) treatment downregulated 32278833 1151 Mouse mmu-miR-144-5p miRNA oxidized low density lipoprotein (ox-LDL) abdominal aortic aneurysm (AAA) RAW 264.7 cells oxidized low-density lipoprotein (ox-LDL) treatment downregulated 32278833 1152 Mouse mmu-miR-145 miRNA JWH-133 acute liver failure (ALF) GalN/LPS-induced ALF JWH-133 treatment downregulated 25749929 1153 Mouse mmu-miR-145 miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) angiogenesis mouse brain microvascular endothelial cells (BMECs) oxygen-glucose deprivation and reoxygenation (OGD/R) treatment the levels of lncRNA-MALAT1 and miR-145 were upregulated in OGD-induced BMECs miR-145 functioned as an anti-angiogenic and pro-apoptotic factor in OGD treated BMECs via down-regulating VEGF-A and ANGPT2 directly 30038058 1154 Mouse mmu-miR-145 miRNA angiotensin II (Ang II) aortic dissection (AD) mouse vascular smooth muscle cells (VSMCs) angiotensin II (Ang II) treatment downregulated 28167124 1155 Mouse mmu-miR-145 miRNA sevoflurane (SEV) apoptosis hippocampal neural cell line HT22 treat with 4.1% sevoflurane treatment downregulated 31966430 1156 Mouse mmu-miR-145 miRNA angiotensin II (Ang II) cardiac fibrosis cardiac fibroblasts angiotensin II (Ang II) treatment downregulated 30146700 1157 Mouse mmu-miR-145 miRNA coronary artery ligation cardiac fibrosis heart subjected to coronary artery ligation miR-145 expression was downregulated at 3 days but was restored at 7 days 24001939 1158 Mouse mmu-miR-145 miRNA IL-10 cardiac fibrosis mouse bone marrow fibroblast progenitor cells (BM-FPCs) IL10 treatment downregulated 28667100 1159 Mouse mmu-miR-145 miRNA doxorubicin (DOX) cardiotoxicity BALB/c mice injected C-26 tumor cells doxorubicin treatment upregulated 28560697 1160 Mouse mmu-miR-145 miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral ischemia/reperfusion (I/R) injury MA-C cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment "TUG1 could interact directly with miR-145, and downregulated of miR-145 could efficiently reverse the function of TUG1 siRNA on AQP4 expression" 31709761 1161 Mouse mmu-miR-145 miRNA azoxymethane (AOM) and dextran sulfate sodium (DSS) colorectal cancer (CRC) mouse colon tissues azoxymethane (AOM) and dextran sulfate sodium (DSS) treatment downregulated 24464560 1162 Mouse mmu-miR-145 miRNA azoxymethane (AOM) and dextran sulfate sodium (DSS) colorectal cancer (CRC) mouse colon tissues azoxymethane (AOM) and dextran sulfate sodium (DSS) treatment downregulated 24464560 1163 Mouse mmu-miR-145 miRNA myostatin cell differentiation C2C12 cells 1 ¦Ìg of recombinant myostatin dysregulated 28691106 1164 Mouse mmu-miR-145 miRNA isoproterenol extracellular matrices (ECMs) homeostasis the hearts of TAC mice isoproterenol treatment downegulated 23624080 1165 Mouse mmu-miR-145 miRNA H2O2 granulosa cell (GC) apoptosis mouse granulosa cells (mGCs) H2O2 treatment downregulated 28564582 1166 Mouse mmu-miR-145 miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) ischemia/reperfusion (I/R) injury MA-C cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 31709761 1167 Mouse mmu-miR-145 miRNA fentanyl ischemia/reperfusion (I/R) injury "HL-1, a cardiac muscle cell line from the AT-1 mouse atrial cardiomyocyte" fentanyl treatment upregulated 27862640 1168 Mouse mmu-miR-145 miRNA carbon tetrachloride (CCl4) liver fibrosis liver CCl4 treatment downregulated 27289031 1169 Mouse mmu-miR-145 miRNA solar-simulated UV (ssUV) melanogenesis Murine melan-a melanocytes(from black mice) solar-simulated UV (ssUV) treatment downregulated 22895360 1170 Mouse mmu-miR-145 miRNA hypoxia myocardial infarction (MI) H9c2 cells;HL-1 cells hypoxia treatment upregulated 28980287 1171 Mouse mmu-miR-145 miRNA hypoxia myocardial infarction (MI) HL-1 cells hypoxia induce upregulated 28980287 1172 Mouse mmu-miR-145 miRNA hypoxia myocardial infarction (MI) cardiac fibroblasts hypoxia treatment downregulated 24001939 1173 Mouse mmu-miR-145 miRNA sevoflurane (SEV) myocardial ischemia/reperfusion (I/R) injury (MIRI) myocardial tissues of ischemia/reperfusion (I/R) mice sevoflurane treatment upregulated 30873621 1174 Mouse mmu-miR-145 miRNA hypoxia/reoxygenation (H/R) myocardial ischemia/reperfusion (I/R) injury (MIRI) HL-1 cells hypoxia-reoxygenation (H/R)treatment upregulated 27862640 1175 Mouse mmu-miR-145 miRNA salidroside (SAL) osteoarthritis (OA) LPS-induce inflammatory injury of ATDC5 cells salidroside (SAL) treatment "SAL significantly alleviated LPS-induced inflammatory injury Meanwhile, the expression of miR-145 was upregulated by SAL" 30586667 1176 Mouse mmu-miR-145 miRNA salidroside (SAL) osteoarthritis (OA) ATDC5 cells salidroside (SAL) treatment the expression of miR-145 was upregulated by SAL 30586667 1177 Mouse mmu-miR-145 miRNA receptor activator of nuclear factor-¦ÊB ligand (RANKL) osteoclastogenesis bone marrow-derived macrophages (BMDMs) receptor activator of nuclear factor-kB ligand (RANKL) treatment downregulated 29577879 1178 Mouse mmu-miR-145 miRNA oxygen oxygen-induced retinopathy (OIR) retinas tissues neonatal mice with their nursing mother were exposed to 75% oxygen at P7 for 5 days and then returned to room air at P12. treatment upregulated 30981984 1179 Mouse mmu-miR-145 miRNA progesterone (P4) cell proliferation mouse endometrial epithelial cells progesterone (P4) treatment upregulated 29661100 1180 Mouse mmu-miR-145 miRNA hypoxia pulmonary arterial hypertension (PAH) pulmonary artery smooth muscle cells (PASMCs) ?hypoxia treatment upregulated 22715469 1181 Mouse mmu-miR-145 miRNA monocrotaline (MCT) pulmonary hypertension (PH) lung tissues monocrotaline (MCT) treatment upregulated 26980205 1182 Mouse mmu-miR-145 miRNA lipopolysaccharide (LPS) sepsis-induced acute lung injury lung tissues lipopolysaccharide (LPS) treatment downregulated 30841464 1183 Mouse mmu-miR-145 miRNA hypoxia stroke mouse brain microvascular endothelial cells (BMECs) oxygen-glucose deprivation (OGD) induce the levels of lncRNA-MALAT1 and miR-145 were upregulated in OGD-induced BMECs. miR-145 functioned as an anti-angiogenic and pro-apoptotic factor in OGD treated BMECs via down-regulating VEGF-A and ANGPT2 directly. 30038058 1184 Mouse mmu-miR-145 miRNA ethanol (EtOH) teratogenesis fetal brains of mice Ethanol?treatment upregulated 19091803 1185 Mouse mmu-miR-145-5p miRNA H2O2 abdominal aortic aneurysm (AAA) vascular smooth muscle cell (VSMC) oxidative stress Silencing of long non-coding RNA Sox2ot inhibits oxidative stress and inflammation of vascular smooth muscle cells in abdominal aortic aneurysm via microRNA-145-mediated Egr1 inhibition. 32629426 1186 Mouse mmu-miR-145-5p miRNA lipopolysaccharide (LPS) acute lung injury (ALI) mouse lung tissues and mouse type II alveolar epithelial cells (AT II) ?lipopolysaccharide (LPS) treatment downregulated 31353880 1187 Mouse mmu-miR-145-5p miRNA house dust mite (HDM) extract asthma airway epithelial cells house dust mite (HDM) extract exposure upregulated 31264490 1188 Mouse mmu-miR-145-5p miRNA oxygen glucose deprivation (OGD) cerebral infarction (CI) BV-2 cells oxygen/glucose deprivation (OGD) treatment downregulated 28215748 1189 Mouse mmu-miR-145-5p miRNA cigarette smoke (CS) chronic obstructive pulmonary disease (COPD) lung tissues cigarette smoke (CS) exposure upregulated 30595527 1190 Mouse mmu-miR-145-5p miRNA fatty acid amide hydrolase inhibitor (FAAH-II) colitis colitis mouse colon tissues FAAH-II treatment dysregulated 27327245 1191 Mouse mmu-miR-145-5p miRNA high glucose (HG) diabetic nephropathy (DN) podocytes high glucose (HG) treatment MicroRNA-145-5p attenuates high glucose-induced apoptosis by targeting the Notch signaling pathway in podocytes. 32104249 1192 Mouse mmu-miR-145-5p miRNA high glucose (HG) diabetic retinopathy (DR) ?RGC-5 cells high glucose treatment upregulated 31272285 1193 Mouse mmu-miR-145-5p miRNA fatty acid amide hydrolase (FAAH) blockade experimental colitis colon Fatty acid amide hydrolase (FAAH) blockade treatment upregulated 27327245 1194 Mouse mmu-miR-145-5p miRNA mycobacterium tuberculosis (Mtb) pulmonary tuberculosis (PTB) RAW264.7 cells mycobacterium tuberculosis (MTB) infection miR-145-5p was lowly expressed in PTB. 33035634 1195 Mouse mmu-miR-145a miRNA progesterone (P4) anti-proliferative action In endometrial epithelial cells from endometrial epithelium of ovariectomized mice progesterone treatment upregulation 24925854 1196 Mouse mmu-miR-145a miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated 26639663 1197 Mouse mmu-miR-145a miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) ischemia/reperfusion (I/R) injury astrocyte cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment MALAT1 promotes cerebral ischemia-reperfusion injury by affecting AQP4 expression through competitively binding miR-145 32138732 1198 Mouse mmu-miR-145a miRNA lipopolysaccharide (LPS) sepsis Lung pericytes lipopolysaccharide (LPS) treatment miR-145a levels were decreased in lung pericytes in sepsis. 32285112 1199 Mouse mmu-miR-145a-5p miRNA fractionated radiation ionizing radiation (IR) injury LLC1 cells fractionated dose (FD) irradiation upregulated 28599420 1200 Mouse mmu-miR-145a-5p miRNA oxygen glucose deprivation (OGD) neuroinflammation BV-2 microglial cells oxygen-glucose deprivation (OGD) induce treatment downregulated 31551710 1201 Mouse mmu-miR-145a-5p miRNA estradiol-17¦Â (E2) systemic lupus erythematosus (SLE) murine B cells estradiol-17¦Â (E2) treatment downegulated 25912736 1202 Mouse mmu-miR-145b miRNA lipopolysaccharide (LPS) acute aortic dissection (AAD) aorta lipopolysaccharide (LPS) treatment downregulated 32634201 1203 Mouse mmu-miR-146 miRNA high tidal volume ventilation (HVTV) lung injury lung tissues high tidal volume ventilation (HVTV) treatment upregulated 22659882 1204 Mouse mmu-miR-146 miRNA TGF-¦Â acute contusion mouse C2C12 myoblasts TGF-¦Â treatment downregulated 28510617 1205 Mouse mmu-miR-146 miRNA candida albicans (C. albicans) Alzheimer's disease (AD) mouse macrophages candida albicans infection upregulated 21060679 1206 Mouse mmu-miR-146 miRNA "retinoic acid (RA), leukemia inhibitory factor (LIF) and basic fibroblast growth factor (bFGF)" cell differentiation mouse bone marrow mesenchymal stem cells (BMSCs) "retinoic acid (RA), leukemia inhibitory factor (LIF) and basic fibroblast growth factor (bFGF) treatment" downregulated 32195202 1207 Mouse mmu-miR-146 miRNA retinoic acid (RA) elevated level of homocysteine (Hcy) spermatogonial retinoic acid treatment downregulated 20177001 1208 Mouse mmu-miR-146 miRNA lipopolysaccharide (LPS) inner ear inflammatory scala tympani LPS was injected directly into treatment upregulated 24470395 1209 Mouse mmu-miR-146 miRNA schistosoma japonicum schistosomiasis liver macrophage exposed percutaneously to 16 S. japonicum cercaria treatment downregulated 27780686 1210 Mouse mmu-miR-146 miRNA clostridium difficile colitis colonic lamina propria of mice Clostridium difficile infection upregulated 23071818 1211 Mouse mmu-miR-146a miRNA lipopolysaccharide (LPS) acute lung injury (ALI) bronchoalveolar lavage fluid (BALF) lipopolysaccharide (LPS) treatment upregulated 29863671 1212 Mouse mmu-miR-146a miRNA ¦Â-Patchoulene (¦Â-PAE) acute lung injury (ALI) lipopolysaccharide (LPS) treated mouse lung ¦Â-PAE pretreatment treatment upregulated in lung 28711783 1213 Mouse mmu-miR-146a miRNA acetaminophen (APAP) alcoholic liver disease (ALD) mouse liver tissues acetaminophen(APAP) treatment upregulated 22684891 1214 Mouse mmu-miR-146a miRNA ovalbumin (OVA) allergic asthma (AA) Type II innate lymphoid cells (ILC2)?from asthma mice lung tissues ovalbumin (OVA) treatment upregulated 31435003 1215 Mouse mmu-miR-146a miRNA ragweed (SRW) allergic conjunctivitis (AC) corneal epithelium and conjunctiva ragweed (SRW) treatment downregulated 26166175 1216 Mouse mmu-miR-146a miRNA ovalbumin (OVA) allergic rhinitis (AR) AR mouse ovalbumin (OVA) treatment downregulated in nasal mucosa 26700406 1217 Mouse mmu-miR-146a miRNA lipopolysaccharide (LPS) Alzheimer's disease (AD) RAW264.7 cells lipopolysaccharide (LPS) treatment The isolated EVs derived from LPS-treated RAW cells contained significantly higher levels of miR-146a than those derived from PBS-treated RAW cells. 33185814 1218 Mouse mmu-miR-146a miRNA sulforaphane (SFN) Alzheimer's disease (AD) temporal cortex and hippocampus Sulforaphane treatment downregulated 26827637 1219 Mouse mmu-miR-146a miRNA "dimethyl fumarate (DMF) ,metabolite monomethyl fumarate (MMF)" anti-inflammatory responses primary astrocyte cultures derived from C57BL/6 mouse stimulated with IL-1¦Â "pretreat with DMF, MMF" downregulated 28589165 1220 Mouse mmu-miR-146a miRNA dexamethasone (DEX) asthma splenic CD4+ T lymphocytes dexamethasone (DEX) treatment downregulated 22580216 1221 Mouse mmu-miR-146a miRNA "IL-33, TSLP, and IL-7" asthma ILC2s "IL-33, TSLP, and IL-7 treatment" "During stimulation of ILC2s, miR-146a expression gradually increased with a decrease of cell proliferation." 31435003 1222 Mouse mmu-miR-146a miRNA ovalbumin (OVA) asthma lung tissues OVA (ovalbumin) treatment upregulated 31298396 1223 Mouse mmu-miR-146a miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) mouse macrophages atherogenic Evs oxidized low-density lipoprotein (ox-LDL) treatment enrichment in atherogenic EVs 28882869 1224 Mouse mmu-miR-146a miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) peritoneal macrophages; Bone-marrow derived macrophages (BMDMs) oxidized low-density lipoprotein (ox-LDL) treatment upregulated 28882869 1225 Mouse mmu-miR-146a miRNA "2,4,6-trinitrobenzene sulfonic acid (TNBS)" atopic dermatitis (AD) mouse skin "2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol treatment" upregulated 31545496 1226 Mouse mmu-miR-146a miRNA lipopolysaccharide (LPS) autoimmune lymphoproliferative syndrome heart tissues;liver tissues;lung tissues;kidney tissues; spleen tissues;lymph nodes lipopolysaccharide (LPS) treatment upregulated 23645835 1227 Mouse mmu-miR-146a miRNA hypoxia autophagy chondrocytes of C57BL/6J mouse hypoxia treatment upregulated 27845876 1228 Mouse mmu-miR-146a miRNA hypoxia autophagy Chondrocytes Hypoxia treatment upregulated 26492575 1229 Mouse mmu-miR-146a miRNA lipopolysaccharide (LPS) bone loss RAW 264.7 cells lipopolysaccharide (LPS) treatment upregulated 30387844 1230 Mouse mmu-miR-146a miRNA lipopolysaccharide (LPS) bone marrow transplantation mouse hematopoietic stem/progenitor cells lipopolysaccharide (LPS) treatment upregulated 20933052 1231 Mouse mmu-miR-146a miRNA hemoglobin (Hb) brain inflammation Primary microglial cells hemoglobin (Hb) treatment downregulated 32317924 1232 Mouse mmu-miR-146a miRNA epstein-barr virus (EBV) tumorigenesis "Lymphocyte cell lines (IB4, X50-7, Rael, Akata, JY, JC5, P3HR1, Mutu, and BL30)" Epstein-Barr virus (EBV) infection upregulated 18057241 1233 Mouse mmu-miR-146a miRNA celecoxib tumorigenesis wild-type (HPV16) mice celecoxib treatment upregulated 28551628 1234 Mouse mmu-miR-146a miRNA angiotensin II (Ang II) cell proliferation Mouse aortic vascular smooth muscle cell (VSMC) angiotensin II (Ang II) treatment upregulated 31009837 1235 Mouse mmu-miR-146a miRNA salvianolic acid B (Sal B) cell proliferation Ang II-treated mouse aortic vascular smooth muscle cell (VSMC) salvianolic acid B (Sal B) treatment downregulated 31009837 1236 Mouse mmu-miR-146a miRNA porphyromonas endodontalis lipopolysaccharide ( P. endodontalis LPS) chronic apical periodontitis (CAP) MC3T3-E1 cells Porphyromonas endodontalis lipopolysaccharide ( P. endodontalis LPS) treatment upregulated 30125982 1237 Mouse mmu-miR-146a miRNA porphyromonas endodontalis lipopolysaccharide ( P. endodontalis LPS) chronic apical periodontitis (CAP) MC3T3-E1 cells Porphyromonas endodontalis lipopolysaccharide ( P. endodontalis LPS) treatment upregulated 30125982 1238 Mouse mmu-miR-146a miRNA borrelia burgdorferi chronic infection mouse joint tissue infect Borrelia burgdorferi treatment upregulated 24967703 1239 Mouse mmu-miR-146a miRNA IL-1¦Â and TNF-¦Á diabetes mellitus (DM) MIN6 cells IL-1¦Â and TNF-¦Á treatment upregulated 20086228 1240 Mouse mmu-miR-146a miRNA streptozocin (STZ) diabetic osteoarthritis (OA) cartilage tissues streptozotocin (STZ) treatment "PVT1 expression was significantly increased, whereas miR-146a was markedly decreased in diabetic OA mice than in non-diabetic OA and control" 33569722 1241 Mouse mmu-miR-146a miRNA glucose diabetic peripheral neuropathy (DPN) DRG neurons incubat high glucose (45 mM) for 24h treatment downregulated 24316060 1242 Mouse mmu-miR-146a miRNA high glucose (HG) diabetic peripheral neuropathy (DPN) macrophage high glucose (HG) treatment LncRNA HCG18 was highly expressed in DPN model and HG-induced macrophages. 32996080 1243 Mouse mmu-miR-146a miRNA "(2E,6E)-2,6-bis(2-(trifluoromethyl)benzylidene)cyclohexanone (C66)" diabetic wound healing wounds "(2 E,6 E)-2,6-bis(2-(trifluoromethyl)benzylidene)cyclohexanone (C66) treatment" "miR-146a was significantly decreased in diabetic wounds, while C66 increased miR-146a in diabetic wounds." 32092902 1244 Mouse mmu-miR-146a miRNA [6]-gingerol-fractions (GF) diabetic wound healing diabetic skin wounds [6]-gingerol-fractions (GF) treatment upregulated 31428171 1245 Mouse mmu-miR-146a miRNA vitamin D diabetic wound healing diabetic skin wounds vitamin D treatment upregulated 31428171 1246 Mouse mmu-miR-146a miRNA prednisolone duchenne muscular dystrophy (DMD) diaphragm muscle prednisolone treatment downregulated 29883261 1247 Mouse mmu-miR-146a miRNA vamorolone duchenne muscular dystrophy (DMD) diaphragm muscle vamorolone treatment downregulated 29883261 1248 Mouse mmu-miR-146a miRNA ischemia/reperfusion (I/R) intestinal ischemia/reperfusion (I/R) injury m-ICcl2?cells ischemia/reperfusion (I/R) treatment downregulated 23143987 1249 Mouse mmu-miR-146a miRNA IL-10 epithelial-mesenchymal transition (EMT) colonic intraepithelial lymphocytes IL-10 treatment upregulated 22043014 1250 Mouse mmu-miR-146a miRNA high glucose (HG) experimental diabetic peripheral neuropathy dorsal root ganglion (DRG) neurons high glucose treatment downregulated 22499183 1251 Mouse mmu-miR-146a miRNA azilsartan medoxomil (AZL-M) heart failure (HF) plasma azilsartan medoxomil (AZL-M) treatment "MiR-146a, miR-149, miR-150, and miR-342-3p were reproducibly reduced in the plasma of CSQ-tg mice." 27321284 1252 Mouse mmu-miR-146a miRNA azilsartan medoxomil (AZL-M) heart failure (HF) calsequestrin (CSQ)-tg mouse azilsartan medoxomil (AZL-M) treatment upregulated 27321284 1253 Mouse mmu-miR-146a miRNA lactoferrin (LF) inflammation lipopolysaccharide (LPS)-treated RAW264.7 cells Lactoferrin treatment "?LF could induce a decrease in inflammatory selected miRNAs,?mmu-mir-155, and?mmu-mir-146a expression." 33435756 1254 Mouse mmu-miR-146a miRNA "limonin, (12S,12aS,Z)-8-((2-(diethylamino)ethoxy)imino)-12-(furan-3-yl)-6,6,8a,12a-tetramethyldodecahydro-1H,3H-oxireno[2,3-d]pyrano[4',3':3,3a]isobenzofuro[5,4-f]isochromene-3,10(9aH)-dione (V-A-4)" inflammation lipopolysaccharide (LPS)-stimulated RAW264.7 cells "limonin, (12S,12aS,Z)-8-((2-(diethylamino)ethoxy)imino)-12-(furan-3-yl)-6,6,8a,12a-tetramethyldodecahydro-1H,3H-oxireno[2,3-d]pyrano[4',3':3,3a]isobenzofuro[5,4-f]isochromene-3,10(9aH)-dione (V-A-4) treatment" upregulated 29477914 1255 Mouse mmu-miR-146a miRNA lipopolysaccharide (LPS) inflammation RAW264.7 macrophage cells lipopolysaccharide (LPS) treatment upregulated 23974950 1256 Mouse mmu-miR-146a miRNA lipopolysaccharide (LPS) inflammation RAW 264.7 cells lipopolysaccharide (LPS) treatment dysregulated 24792623 1257 Mouse mmu-miR-146a miRNA rare ginsenoside from ginseng(Rg6) inflammation LPS treated bone marrow-derived macrophages (BMDMs) Rg6 treatment upregulated 30867482 1258 Mouse mmu-miR-146a miRNA resveratrol and hydroxytyrosol inflammation LPS treated RAW 264.7 resveratrol and hydroxytyrosol 10¦ÌM treatment downregulated 27998828 1259 Mouse mmu-miR-146a miRNA resveratrol and hydroxytyrosol inflammation LPS treated RAW 264.7 resveratrol and hydroxytyrosol 10¦ÌM treatment downregulated 27998828 1260 Mouse mmu-miR-146a miRNA selenium (Se) inflammation mouse mammary epithelial cellsmouse mammary epithelial cells Se treatment upregulated 29340029 1261 Mouse mmu-miR-146a miRNA ¦¤9-tetrahydrocannabinol (THC) inflammation total lymph node cells and CD4(+) T cells ¦¤9-Tetrahydrocannabinol (THC) treatment upregulated 27268054 1262 Mouse mmu-miR-146a miRNA herpes simplex virus 1 (HSV-1) inflammation and innate immunity mouse brain tissue infect with HSV-1 upregulated 28045967 1263 Mouse mmu-miR-146a miRNA "1,25-dihydroxyvitamin D (1,25(OH)2D)" inflammation 3T3-L1 adipocytes;epididymal adipose tissue "1,25-dihydroxyvitamin D (1,25(OH)2D) treatment" downregulated 28055298 1264 Mouse mmu-miR-146a miRNA high fat diet (HFD) obesity C57BL/6J mice high fat diet (HFD) feed downregulated 28652200 1265 Mouse mmu-miR-146a miRNA aluminum-sulfate inflammatory neurodegeneration C57BL/6J mice blood serum exposure to a standard mouse diet that included aluminum-sulfate upregulated 29354323 1266 Mouse mmu-miR-146a miRNA influenza A virus (IAV) influenza A virus (IAV) infection mouse lung tissues Influenza A virus (IAV) infection upregulated 30611999 1267 Mouse mmu-miR-146a miRNA brucella.suis innate immune response RAW264.7 cells brucella.suis infection upregulated 29387067 1268 Mouse mmu-miR-146a miRNA cannabinoids innate immune response LPS-treated BV-2 microglial cells cannabinoids treatment downregulated 30742662 1269 Mouse mmu-miR-146a miRNA exenatide (EXA) insulin sensitivity liver exenatide treatment "the levels of miRNA-29c, 124a, and 146a in the liver were significantly increased. These effects were reversed by treatment with exenatide." 26314504 1270 Mouse mmu-miR-146a miRNA exenatide (EXA) insulin sensitivity muscle exenatide treatment "The levels of miRNA-15a, 29c, 124a, and 146a in the muscle were significantly increased. These effects were reversed by treatment with exenatide." 26314504 1271 Mouse mmu-miR-146a miRNA high fat diet (HFD) insulin sensitivity liver high fat diet (HFD) feed upregulated 26314504 1272 Mouse mmu-miR-146a miRNA high fat diet (HFD) insulin sensitivity muscle high fat diet (HFD) feed upregulated 26314504 1273 Mouse mmu-miR-146a miRNA listeria monocytogenes (L. monocytogenes) leishmaniasis "macrophage-like cell line RAW264.7 and murine primary bone marrow-derive macrophages (BMDMs), mouse spleen and liver" Listeria monocytogenes (L. monocytogenes) infection upregulated 29587465 1274 Mouse mmu-miR-146a miRNA integrin CD11b liver fibrosis "Dendritic cells (DCs),Bone marrow-derived DCs (BMDCs)" Integrin CD11b?treatment Integrin CD11b negatively regulates TLR9-triggered dendritic cell cross-priming by upregulating microRNA-146a 22551553 1275 Mouse mmu-miR-146a miRNA ischemia/reperfusion (I/R) hepatic ischemia/reperfusion injury (HIRI) mice Kupffer cells ischemia/reperfusion (I/R) treatment downregulated 24987958 1276 Mouse mmu-miR-146a miRNA lipopolysaccharide (LPS) macrophage inflammatory response RAW264.7 macrophage cells lipopolysaccharide (LPS) treatment upregulated 22415194 1277 Mouse mmu-miR-146a miRNA mycobacteria inflammatory response Mouse primary peritoneal macrophages and bone marrow-derived macrophages (BMDMs) mycobacteria infection mycobacteria-induced miR-146a could modulate inflammatoryresponse by targeting IRAK1 and TRAF6 and facilitate mycobacteria replication in macrophage 24358114 1278 Mouse mmu-miR-146a miRNA calophyllum inophyllum Linn. (Guttiferae) multiple myeloma (MM) RAW264.7 cells Calophyllum inophyllum L. treatment downregulated 22735972 1279 Mouse mmu-miR-146a miRNA "3,3'-diindolylmethane (DIM)" multiple sclerosis (MS) activated T cells during the development of experimental autoimmune encephalomyelitis (EAE) "3,3'-Diindolylmethane (DIM) treatment" upregulated 24898268 1280 Mouse mmu-miR-146a miRNA cuprizone (CPZ) multiple sclerosis (MS) corpus callosum cuprizone (CPZ) treatment miR-146a was increasingly upregulated during CPZ-induced de- and remyelination. 29593734 1281 Mouse mmu-miR-146a miRNA freeze-dried mouse spinal cord homogenate multiple sclerosis (MS) Biozzi ABH mice experimental autoimmune encephalomyelitis treatment upregulated 25515214 1282 Mouse mmu-miR-146a miRNA amyloid-¦Â (A¦Â) 42 murine scrapie murine brain amyloid-¦Â (A¦Â) 43 peptide metal treatment upregulated 22043907 1283 Mouse mmu-miR-146a miRNA neurotoxic metal murine scrapie murine brain neurotoxic metal treatment upregulated 22043907 1284 Mouse mmu-miR-146a miRNA proinflammatory cytokines murine scrapie murine brain pro-inflammatory cytokine treatment upregulated 22043907 1285 Mouse mmu-miR-146a miRNA ischemia/reperfusion (I/R) myocardial ischaemic injury mouse plasma;Bone marrow-derived macrophage (BMDM);Rat neonatal CMs ischemia/reperfusion (I/R) treatment differently regulated 28768728 1286 Mouse mmu-miR-146a miRNA prion neurodegeneration (ND) the brains tissues prion infection treatment upregulated 18987751 1287 Mouse mmu-miR-146a miRNA lipopolysaccharide (LPS) neuroinflammation N9 microglia lipopolysaccharide (LPS) treatment upregulated 28096568 1288 Mouse mmu-miR-146a miRNA lipopolysaccharide (LPS) neuroinflammation microvesicles (MVs) of BV2 cells treated with CHPG lipopolysaccharide (LPS) treatment downregulated in microvesicles (MVs) released 29170640 1289 Mouse mmu-miR-146a miRNA mGlu5 receptor agonist CHPG neuroinflammation microvesicles (MVs) released from microglia BV2 cells treat 24 h with the mGlu5 receptor agonist CHPG (200 ¦ÌM) upregulated in microvesicles (MVs) released from microglia BV2 cells 29170640 1290 Mouse mmu-miR-146a miRNA spirulina diet neuroinflammation cerebral cortex spirulina diet treatment Spirulina diet to lactating mothers preserved the LPS-induced increase in anti-inflammatory miR-146a 29845202 1291 Mouse mmu-miR-146a miRNA Japanese encephalitis virus (JEV) neuroinflammation mouse microglial C8-B4 cells infect with JEV upregulated 28190197 1292 Mouse mmu-miR-146a miRNA high fat diet (HFD) obesity nucleus accumbens high fat diet (HFD) feed Significant reductions in the levels of miR-155 (82%) and miR-146a (41%) levels were observed within the nucleus accumbens of HFD mice compared to CTL. 28652200 1293 Mouse mmu-miR-146a miRNA hypoxia osteoarthritis (OA) Chondrocytes hypoxia treatment upregulated 26492575 1294 Mouse mmu-miR-146a miRNA kaempferol osteoarthritis (OA) LPS-treated cultured chondrocyte-like ATDC5 cells kaempferol treatment downregulated 30776646 1295 Mouse mmu-miR-146a miRNA lipopolysaccharide (LPS) osteoarthritis (OA) ATDC5 cells lipopolysaccharide (LPS) treatment upregulated 29183039 1296 Mouse mmu-miR-146a miRNA lipopolysaccharide (LPS) osteoarthritis (OA) cultured chondrocyte-like ATDC5 cells lipopolysaccharide (LPS) treatment upregulated 30776646 1297 Mouse mmu-miR-146a miRNA tumor necrosis factor alpha (TNF-¦Á) osteoclast differentiation RAW264.7 cells tumor necrosis factor alpha (TNF-¦Á) treatment upregulated 23078176 1298 Mouse mmu-miR-146a miRNA tumor necrosis factor alpha (TNF-¦Á) osteoporosis MC3T3-E1 cells tumor necrosis factor alpha (TNF-¦Á) treatment Rtn4-Exos attenuated TNF-¦Á-induced cytotoxicity and apoptosis in murine MC3T3-E1 cells by sponging miR-146a 32400849 1299 Mouse mmu-miR-146a miRNA ovalbumin (OVA) allergic inflammation of dendritic cells (DCs) Bone marrow-derived DCs (BMDCs) OVA treatment OVA treatment significantly upregulated miR-146a in BMDCs in a dose- and time-dependent manner. 31957545 1300 Mouse mmu-miR-146a miRNA CpG autoimmune and inflammatory diseases murine bone marrow-derived dendritic cells ?CpG treatment upregulated 23244216 1301 Mouse mmu-miR-146a miRNA particulate matter (PM2.5) PM2.5 exposure mosue bronchoalveolar lavage fluid (BALF) "were subjected to intratracheal instillation of 2.5, 10, or 20mg/kg PM2.5 treatment" upregulated in bronchoalveolar lavage fluid (BALF) 29107863 1302 Mouse mmu-miR-146a miRNA lipopolysaccharide (LPS) postoperative cognitive dysfunction (POCD) BV-2 microglial cells lipopolysaccharide (LPS) treatment upregulated 30685530 1303 Mouse mmu-miR-146a miRNA probiotics (VSL#3) postoperative cognitive dysfunction (POCD) hippocampal tissues probiotics (VSL#3)?treatment treatment "Finally, VSL#3 treatment upregulated the expression of miR-146a to block BTG2/Bax axis and consequently inhibited neuronal apoptosis and reduced oxidative stress in POCD mice" 33725320 1304 Mouse mmu-miR-146a miRNA particulate matter (PM2.5) pulmonary toxicological lung tissues particulate matter (PM2.5) exposure treatment upregulated 29107863 1305 Mouse mmu-miR-146a miRNA prion retinoblastoma (RB) mouse brain tissues prion treatment over-expression 22363497 1306 Mouse mmu-miR-146a miRNA collagen rheumatoid arthritis (RA) splenocytes collagen treatment downregulated 32938348 1307 Mouse mmu-miR-146a miRNA Salmonella Typhimurium salmonella typhimurium infection Murine macrophages(murine RAW 264.7 cells) Salmonella Typhimurium infection treatment upregulated 21468030 1308 Mouse mmu-miR-146a miRNA schistosomiasis schistosomiasis liver inflammation mouse liver tissues schistosomiasis treatment 6W infected mice were significantly higher than those of the normal mice and of the 12W infected mice 25051829 1309 Mouse mmu-miR-146a miRNA lipopolysaccharide (LPS) sepsis peritoneal macrophages lipopolysaccharide (LPS) treatment microRNA-146a was upregulated in macrophage stimulated by lipopolysaccharide. 30103197 1310 Mouse mmu-miR-146a miRNA SiO2 silicosis NR8383 cells SiO2 treatment upregulated 26239160 1311 Mouse mmu-miR-146a miRNA aldara skin inflammation skin aldara treatment upregulated 25662483 1312 Mouse mmu-miR-146a miRNA IL-17 skin inflammation mouse keratinocytes IL-17 treatment upregulated 27568078 1313 Mouse mmu-miR-146a miRNA sunitinib (SU) sunitinib-induced cardiac dysfunction the myocardium of sunitinib-treated mice sunitinib treatment downregulated 31507414 1314 Mouse mmu-miR-146a miRNA mycobacteria tuberculosis (TB) RAW264.7 cells mycobacterial treatment upregulation 27025258 1315 Mouse mmu-miR-146a miRNA antioxidant of bamboo leaves (AOB) vascular development embryoid bodies (EBs) antioxidant of bamboo leaves (AOB) treatment miR-146a was markedly downregulated following AOB treatment compared with the control. 29207159 1316 Mouse mmu-miR-146a miRNA aerobic exercise vascular injury HUVECs aerobic exercise training (AET) treatment "aerobic exercise and statins may induce miR-146a expression, thereby reducing vascular TRAF and TLR4 signaling and vascular inflammatory injury in AS." 24022569 1317 Mouse mmu-miR-146a miRNA aerobic exercise vascular injury high-fat diet-E-null mice aerobic exercise training (AET) treatment aerobic exercise and statins may induce miR-146a expression 24022569 1318 Mouse mmu-miR-146a miRNA live L. acidophilus ¦Â-lactoglobulin (¦Â-Lg) allergy murine splenocytes live L. acidophilus treatment downregulated 30156972 1319 Mouse mmu-miR-146a miRNA IL-6 osteoarthritis (OA) ATDC5 cells IL-6 treatment miR©\146a level was negatively modulated by IL©\6 and lncRNA CHRF in ATDC5 cell 31026064 1320 Mouse mmu-miR-146a miRNA dexamethasone (DEX) osteonecrosis of femoral head (ONFH) MC3T3-E1 cells from murine osteoblastic dexamethasone (DEX) treatment upregulated 28975995 1321 Mouse mmu-miR-146a miRNA heme oxygenase-1 (HMOX1) myoblast differentiation C2C12 cells Heme oxygenase-1 (HMOX1) treatment upregulated 21827279 1322 Mouse mmu-miR-146a-3p miRNA particulate matter (PM2.5) macrophage polarization RAW264.7 cells Fine particulate matter (PM2.5) exposure treatment upregulated 30911272 1323 Mouse mmu-miR-146a-5p miRNA lipopolysaccharide (LPS) acute kidney injury (AKI) kidney tissues lipopolysaccharide (LPS) treatment miR-146a-5p was upregulated at 6h and 48h. 32727087 1324 Mouse mmu-miR-146a-5p miRNA house dust mite (HDM) asthma lung tissue house dust mite allergen treatment upregulated 31698144 1325 Mouse mmu-miR-146a-5p miRNA long-chain polyunsaturated fatty acids (LCPUFAs) asthma HDM mice lung tissue long-chain polyunsaturated fatty acids (LCPUFAs) treatment downregulated 31698144 1326 Mouse mmu-miR-146a-5p miRNA echinococcus multilocularis metacestodes echinococcus multilocularis infection RAW 264.7 cells E. multilocularis metacestodes treatment upregulated 30322806 1327 Mouse mmu-miR-146a-5p miRNA ethanol (EtOH) ethanol-induced neuroinflammation and brain damage brain cortices ethanol treatment upregulated 32937997 1328 Mouse mmu-miR-146a-5p miRNA ethanol (EtOH) ethanol-induced neuroinflammation and brain damage plasma exosomes ethanol treatment downregulated 32937997 1329 Mouse mmu-miR-146a-5p miRNA ¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) experimental autoimmune encephalomyelitis (EAE) murine brain-derived CD4+ T cells ¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) combination treatment downregulated 31497013 1330 Mouse mmu-miR-146a-5p miRNA schistosoma japonicum liver fibrosis serum exosomes S. japonicum infection treatment downregulated 32443549 1331 Mouse mmu-miR-146a-5p miRNA E. multilocularis metacestodes infection and immunity of E. multilocularis RAW264¡¤7 macrophage cells E. multilocularis metacestodes for 6 and 12 h treatment "upregulated (mmu-miR-378d,mmu-miR-155-5p, mmu-miR-146a-5p, mmu-miR-21a-5p , mmu-miR-125a-5p) and downregulated(mmu-miR-1981-5p , mmu-miR-let-7c-1-3p)" 28942753 1332 Mouse mmu-miR-146a-5p miRNA lipopolysaccharide (LPS) inflammation BV2 mouse microglial cells lipopolysaccharide (LPS) treatment upregulated 31530042 1333 Mouse mmu-miR-146a-5p miRNA resveratrol inflammation LPS-treated BV2 mouse microglial cells resveratrol (RSV) treatment upregulated 31530042 1334 Mouse mmu-miR-146a-5p miRNA angiostrongylus cantonensis (A. cantonensis) inflammation male Balb/c mice angiostrongylus cantonensis (A. cantonensis) infection upregulated 24142285 1335 Mouse mmu-miR-146a-5p miRNA isosteviol Sodium (STV-Na) ischemic stroke (IS) microglia/macrophage polarization in ischemic stroke Isosteviol Sodium (STV-Na) treatment upregulated 31434993 1336 Mouse mmu-miR-146a-5p miRNA Legionella pneumophila (L. pneumophila) Legionella pneumophila (L. pneumophila) infection WT and MyD88-/- murine bone marrow-derived macrophages (BMM) infected with L. pneumophila downregulated 28445535 1337 Mouse mmu-miR-146a-5p miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) mouse liver tissues high fat diet (HFD) feed downregulated 31484042 1338 Mouse mmu-miR-146a-5p miRNA methionine choline-deficient diet (MCD) nonalcoholic fatty liver disease (NAFLD) liver tissues methionine-choline deficient (MCD) treatment downregulated 26537990 1339 Mouse mmu-miR-146a-5p miRNA bis-enoxacin osteoclastogenesis 4T1 murine breast cancer cells bis-enoxacin treatment downregulated 30385810 1340 Mouse mmu-miR-146a-5p miRNA enoxacin osteoclastogenesis 4T1 murine breast cancer cells Enoxacin treatment downregulated 30385810 1341 Mouse mmu-miR-146a-5p miRNA aldosterone renal fibrosis mouse cortical collecting duct cells aldosterone treatment (10-6 M; 3 days) downregulated 29070573 1342 Mouse mmu-miR-146a-5p miRNA aldosterone renal fibrosis mouse cortical collecting duct cells aldosterone treatment (10-6 M; 3 days) dysregulated 29070573 1343 Mouse mmu-miR-146a-5p miRNA cisplatin (DDP) renal fibrosis kidney tissues cisplatin treatment upregulated 33664736 1344 Mouse mmu-miR-146a-5p miRNA TGF-¦Â1 renal fibrosis mouse renal tubular epithelial cells (mRTECs) TGF-¦Â1 treatment upregulated 33664736 1345 Mouse mmu-miR-146a-5p miRNA environmental toxin bisphenol A (BPA) testicular steroidogenesis dysfuction interstitial Leydig cells (LCs) environmental toxin bisphenol A (BPA) treatment upregulated 29746863 1346 Mouse mmu-miR-146a-5p miRNA H2O2 thymic stromal cells senescence thymic stromal cells oxidative stress downregulated 33002743 1347 Mouse mmu-miR-146a-5p miRNA trinitrobenzene sulfonic acid (TNBS) visceral pain in colitis lumbosacral spinal cord trinitrobenzene sulfonic acid (TNBS) treatment upregulated 29550454 1348 Mouse mmu-miR-146b miRNA lipopolysaccharide (LPS) acute lung injury (ALI) "Bronchial alveolar lavage (BAL), peripheral blood isolated serum, splenocytes and lung tissues" lipopolysaccharide (LPS) treatment upregulated 30500983 1349 Mouse mmu-miR-146b miRNA inorganic nitrite acute myocardial infarction (AMI) heart tissues single-dose of nitrite downregulated 28090786 1350 Mouse mmu-miR-146b miRNA ischemia/reperfusion (I/R) acute myocardial infarction (AMI) heart tissues ischemia/reperfusion (I/R) treatment upregulated 28090786 1351 Mouse mmu-miR-146b miRNA lipopolysaccharide (LPS) acute respiratory distress syndrome (ARDS) "bronchial alveolar lavage (BAL) fluid, peripheral blood, splenocytes and lung tissues" lipopolysaccharide (LPS) treatment upregulated 30500983 1352 Mouse mmu-miR-146b miRNA actinomycetemcomitans (Aa) atherosclerosis (AS) blood actinomycetemcomitans (Aa) treatment upregulated 25743474 1353 Mouse mmu-miR-146b miRNA IL-1¦Â atherosclerosis (AS) mouse aortic smooth muscle cell lines IL-1¦Â treatment upregulated 33084403 1354 Mouse mmu-miR-146b miRNA IL-6 atherosclerosis (AS) mouse aortic smooth muscle cell lines IL-6 treatment upregulated 33084403 1355 Mouse mmu-miR-146b miRNA tumor necrosis factor alpha (TNF-¦Á) atherosclerosis (AS) mouse aortic smooth muscle cell lines tumor necrosis factor alpha (TNF-¦Á) treatment upregulated 33084403 1356 Mouse mmu-miR-146b miRNA calorie restriction (CR) hepatic steatosis high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues calorie restriction (CR) treatment upregulated 31863770 1357 Mouse mmu-miR-146b miRNA exercise (Ex) hepatic steatosis high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues exercise (Ex) treatment upregulated 31863770 1358 Mouse mmu-miR-146b miRNA high fat diet (HFD) hepatic steatosis liver tissues high fat diet (HFD) feed upregulated 30776032 1359 Mouse mmu-miR-146b miRNA high fat diet (HFD) hepatic steatosis mice thyroid and liver tissues high fat diet (HFD) feed downregulated 31863770 1360 Mouse mmu-miR-146b miRNA low fat diet (LFD) hepatic steatosis high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues low-fat diet (LF) treatment upregulated 31863770 1361 Mouse mmu-miR-146b miRNA myricetin hepatic steatosis liver tissues myricetin treatment myricetin inhibited miR-146b upregulated induced by HFD. 30776032 1362 Mouse mmu-miR-146b miRNA quercetin hepatic steatosis high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues quercetin (Que) treatment upregulated 31863770 1363 Mouse mmu-miR-146b miRNA ginkgo biloba extract (GBE) hepatocellular carcinoma (HCC) non-tumor (ENT) liver ginkgo biloba extract (GBE) treatment upregulated 32306082 1364 Mouse mmu-miR-146b miRNA influenza A virus (IAV) immune response lung tissues influenza A virus infection downregulated 30513647 1365 Mouse mmu-miR-146b miRNA lipopolysaccharide (LPS) inflammation RAW 264.7 cells lipopolysaccharide (LPS) treatment dysregulated 24792623 1366 Mouse mmu-miR-146b miRNA deoxycorticosterone acetate (DOCA) kidney damage hypertensive mice kidneys and urine injection of Deoxycorticosterone acetate (Doca) upregulated in the kidneys and urine 29255279 1367 Mouse mmu-miR-146b miRNA dextran sodium sulfate (DSS) mucosal repair "mucosa, lamina propria cells or epithelial cells" dextran sulfate sodium (DSS) treatment upregulated 30445446 1368 Mouse mmu-miR-146b miRNA low fat diet (LFD) obesity thyroid low fat diet (LFD) treatment downregulated 31863770 1369 Mouse mmu-miR-146b miRNA low fat diet (LFD) obesity thyroid low fat diet (LFD) treatment upregulated 31863770 1370 Mouse mmu-miR-146b miRNA quercetin obesity thyroid quercetin (QUE) treatment upregulated 31863770 1371 Mouse mmu-miR-146b miRNA zerumbone obesity 3T3-L1 cells zerumbone treatment downregulated 28445161 1372 Mouse mmu-miR-146b miRNA resveratrol osteoarthritis (OA) ATDC5 cells resveratrol (Res) treatment miR-146b was upregulated by RSV 29843156 1373 Mouse mmu-miR-146b miRNA P. gingivalis P. gingivalis infection ApoE mice heart and aorta tissues infect with P. gingivalis treatment upregulated 28646427 1374 Mouse mmu-miR-146b miRNA tanshinone IIA (Tan IIA) P. gingivalis infection ApoE mice serum and in heart TSA (60 mg kg-/--/--1 day-1) treatment downregulated 28646427 1375 Mouse mmu-miR-146b miRNA particulate matter (PM2.5) PM2.5 exposure mosue bronchoalveolar lavage fluid (BALF) "were subjected to intratracheal instillation of 2.5, 10, or 20mg/kg PM2.5 treatment" upregulated in bronchoalveolar lavage fluid (BALF) 29107863 1376 Mouse mmu-miR-146b miRNA particulate matter (PM2.5) pulmonary toxicological lung tissues particulate matter (PM2.5) exposure treatment upregulated 29107863 1377 Mouse mmu-miR-146b miRNA schistosoma japonicum schistosomiasis murine liver Schistosoma japonicum infection treatment upregulated 23825609 1378 Mouse mmu-miR-146b miRNA high fat diet (HFD) visceral obesity and metabolic dysfunction C57BL/6N mice high fat diet (HFD) feed upregulated 24931160 1379 Mouse mmu-miR-146b miRNA dexamethasone (DEX) asthma splenic CD4+ T lymphocytes dexamethasone (DEX) treatment downregulated 22580216 1380 Mouse mmu-miR-146b-3p miRNA influenza virus H5N2 influenza virus infection lung tissues H5N2 treatment upregulated 25266911 1381 Mouse mmu-miR-146b-3p miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated 32955644 1382 Mouse mmu-miR-146b-5p miRNA 3¦Â-hydroxycholest-5-en-7-one anti-inflammatory responses RAW 264.7 cells 3¦Â-hydroxycholest-5-en-7-one treatment upregulated 32771556 1383 Mouse mmu-miR-146b-5p miRNA tanshinone IIA (Tan IIA) atherosclerosis (AS) RAW 264.7 cells Tanshinone IIA (Tan) treatment downregulated 32337768 1384 Mouse mmu-miR-146b-5p miRNA tensile cementoblastogenesis cementoblast cell line OCCM-30 cells tensile treatment upregulated 27941605 1385 Mouse mmu-miR-146b-5p miRNA folic acid kidney injury and fibrosis kidney cortex folic acid treatment upregulated 26707937 1386 Mouse mmu-miR-146b-5p miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues carbon tetrachloride (CCl4) treatment upregulated 29557526 1387 Mouse mmu-miR-146b-5p miRNA hypoxia myocardial infarction (MI) mouse infarcted myocardium hypoxia treatment "Herein, miR-146b-5p was found to be upregulated in the infarcted myocardium of mice and the serum of myocardial ischemia patients." 32845445 1388 Mouse mmu-miR-146b-5p miRNA FTY720-C2 parkinson's disease (PD) dopaminergic MN13D cells FTY720-C2 treatment upregulated 30359694 1389 Mouse mmu-miR-146b-5p miRNA FTY720-C2 parkinson's disease (PD) MN9D cells FTY720-C2 treatment upregulated 30359694 1390 Mouse mmu-miR-146b-5p miRNA platelet-derived growth factor (PDGF) vascular disease Vascular smooth muscle cells (VSMCs) PDGF treatment upregulated 26722482 1391 Mouse mmu-miR-147 miRNA elastase abdominal aortic aneurysm (AAA) murine aortic tissues elastase treatment "A 10-fold upregulated of microRNA (miR)-147, a key mediator of macrophage inflammatory responses, was observed in murine aortic tissue in elastase-treated mice compared with controls on d 14." 29812968 1392 Mouse mmu-miR-147 miRNA norcantharidin (NCTD) hepatocellular carcinoma (HCC) liver tissues intraperitoneal injection of different concentration of NCTD treatment upregulated 24719559 1393 Mouse mmu-miR-147 miRNA dexamethasone (DEX) muscle atrophy Murine C2C12 myoblast cells dexamethasone (DEX) treatment downregulated 23716137 1394 Mouse mmu-miR-147-3p miRNA chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) plvic inflammatory disease mouse two Chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) infection were upregulated during CmVar004 infection compared to CmVar001 infection 24961692 1395 Mouse mmu-miR-147a miRNA sildenafil diabetic peripheral neuropathy (DPN) mouse sildenafil at a dose of 10 mg/kg for 4 weeks treatment upregulated 24316060 1396 Mouse mmu-miR-147a miRNA praziquantel (PZQ) inflammation mouse liver schistosomiasis treatment increase in the PZQ-ed mice compared to the 12W infected mice 25051829 1397 Mouse mmu-miR-147a miRNA thymosin ¦Â4 (T¦Â4) neurological injury mouse N20.1 OPC cell line "T¦Â4, ranging from 25 to 100 ng/ml for 5 days treatment" upregulation 24828500 1398 Mouse mmu-miR-147a miRNA lipopolysaccharide (LPS) pneumonia TC-1 cells lipopolysaccharide (LPS) treatment downregulated 33318298 1399 Mouse mmu-miR-148a miRNA cerulein acute pancreatitis (AP) pancreatic tissues of mice cerulein treatment downregulated 31122822 1400 Mouse mmu-miR-148a miRNA ethanol (EtOH) alcoholic hepatitis (AH) "mouse liver tissues, AML cells, Mouse primary hepatocytes" Lieber-DeCarli alcohol diet or binge alcohol exposure downregulated 29475852 1401 Mouse mmu-miR-148a miRNA alcohol alcoholic liver disease (ALD) cultured hepatocytes and mouse livers alcohol exposure downregulated 29475852 1402 Mouse mmu-miR-148a miRNA arsenite atherosclerosis (AS) liver arsenic (As) exposure upregulated 22719926 1403 Mouse mmu-miR-148a miRNA high methionine diet atherosclerosis (AS) ApoE mice high methionine diet upregulated 28472596 1404 Mouse mmu-miR-148a miRNA hypoxia/reoxygenation (H/R) hepatic ischemia/reperfusion injury (HIRI) primary Kupffer cells (KCs) hypoxia/reoxygenation (H/R) treatment downregulated 30244246 1405 Mouse mmu-miR-148a miRNA listeria Listeria infection murine ileum tissues Listeria infection downregulated 24327339 1406 Mouse mmu-miR-148a miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues carbon tetrachloride (CCl4) treatment downregulated 30362572 1407 Mouse mmu-miR-148a miRNA carbon tetrachloride (CCl4) liver fibrosis mouse liver tissue carbon tetrachloride (CCl4) treatment downregulated 30362572 1408 Mouse mmu-miR-148a miRNA TGF-¦Â liver fibrosis "mouse Primary hepatic stellate cells (PHSCs), The human immortalized HSC line LX©\2,Human L©\02 hepatocytes" TGF-¦Â treatment downregulated 30362572 1409 Mouse mmu-miR-148a miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) substantia nigra tissue "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" upregulated 31059019 1410 Mouse mmu-miR-148a miRNA lithium (Li) parkinson's disease (PD) substantia nigra tissues Lithium treatment downregulated 31059019 1411 Mouse mmu-miR-148a-3p miRNA concanamycin A (Con A) acute liver failure (ALF) RAW264.7 cells concanavalin A (Con A) treatment upregulated 32739513 1412 Mouse mmu-miR-148a-3p miRNA adipogenesis medium adipocyte and osteoblast differentiation ST2 or C3H10T1/2 cells "adipogenic medium ((¦Á-MEM containing 10% FBS, 0.5 ¦ÌM dexamethasone, 0.25 mM methylisobutylxanthine, 5 ¦Ìg/ml insulin, and 50 ¦ÌM indomethacin) treatment" upregulated 30728459 1413 Mouse mmu-miR-148a-3p miRNA osteogenic differentiation medium adipogenesis ST2 or MC3T3-E1 cells "osteogenic medium (¦Á-MEM containing 10% FBS, 50 ¦Ìg/ml ascorbic acid, and 5 mM ¦Â-glycerophosphate) treatment" downregulated 30728459 1414 Mouse mmu-miR-148a-3p miRNA lipopolysaccharide (LPS) LPS-induced inflammation and sepsis RAW264.7 cells lipopolysaccharide (LPS) treatment "In the LPS induced macrophages, the increasing of miR-148a-3p was milder in the RBP-J-/- macrophages than in the wild type macrophages." 32719678 1415 Mouse mmu-miR-148a-3p miRNA metformin (Met) oxidative stress N2a cells metformin treatment metformin upregulated the expression of miR-148a-3p?in both MCAO/R-treated mice and OGD/R-treated N2a cells. 31934270 1416 Mouse mmu-miR-148b miRNA isoproterenol cardiac fibrosis heart tissues isoproterenol (ISO) treatment downregulated 27174579 1417 Mouse mmu-miR-148b-3p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral ischemia/reperfusion (I/R) injury HT22 cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment miR-148b-3p expression was significantly decreased in neurons in response to OGD/R exposure. 31868937 1418 Mouse mmu-miR-148b-3p miRNA hypoxia/reoxygenation (H/R) myocardial ischemia/reperfusion (I/R) injury (MIRI) primary mouse cardiomyocytes hypoxia/reoxygenation (H/R) treatment miR-148b-3p expression was significantly upregulated in response to H/R treatment in cardiomyocytes. 30308185 1419 Mouse mmu-miR-149 miRNA arsenite diabetes mellitus (DM) Min6 cells arsenite exposure upregulated 29905828 1420 Mouse mmu-miR-149 miRNA azilsartan medoxomil (AZL-M) heart failure (HF) plasma azilsartan medoxomil (AZL-M) treatment "MiR-146a, miR-149, miR-150, and miR-342-3p were reproducibly reduced in the plasma of CSQ-tg mice." 27321284 1421 Mouse mmu-miR-149 miRNA melatonin ischemic injury Primary myoblast Melatonin treatment Melatonin increases mitochondrial function under oxidative stress conditions by upregulating miR-149. 32089265 1422 Mouse mmu-miR-149 miRNA silica dust lung fibrosis mouse lung tissues silica dust treatment downregulated 24641842 1423 Mouse mmu-miR-149-3p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) ischemia/reperfusion (I/R) injury N2a cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 33216728 1424 Mouse mmu-miR-149-3p miRNA bilateral surgical destabilization of the medial meniscus (DMM) osteoarthritis (OA) male C57BL6 mice bilateral surgical destabilization of the medial meniscus (DMM) treatment dysregulated 29255152 1425 Mouse mmu-miR-149-5p miRNA 3¦Â-hydroxycholest-5-en-7-one anti-inflammatory responses RAW 264.7 cells 3¦Â-hydroxycholest-5-en-7-one treatment downregulated 32771556 1426 Mouse mmu-miR-149-5p miRNA high glucose (HG) diabetes mellitus (DM) pancreatic beta cell line (MIN6 cells) high-glucose (HG) treatment downregulated 31260649 1427 Mouse mmu-miR-149-5p miRNA high fat diet (HFD) hepatic insulin resistance mouse liver tissues high fat diet (HFD) feed upregulated 30820263 1428 Mouse mmu-miR-149-5p miRNA allopurinol hyperuricemia liver tissues allopurinol treatment "miR-149-5p was significantly upregulated in the livers of HFD-fed mice, while the expression was downregulated by allopurinol therapy." 32070295 1429 Mouse mmu-miR-149-5p miRNA ursolic acid (UA) hyperuricemia AML-12 cells uric acid treatment MiR-149-5p expression was also significantly upregulated in uric acid-stimulated hepatocytes 32070295 1430 Mouse mmu-miR-15 miRNA "hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)" tumorigenesis brain and liver tissue cells "hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) treatment" downregulated 19270793 1431 Mouse mmu-miR-15 miRNA monosodium luminol neurodegeneration (ND) central nervous system (CNS) tissues of?mice Monosodium luminol treatment downregulated 20201611 1432 Mouse mmu-miR-150 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues lipopolysaccharide (LPS) treatment downregulated 31398659 1433 Mouse mmu-miR-150 miRNA celecoxib tumorigenesis wild-type (HPV16) mice celecoxib treatment upregulated 28551628 1434 Mouse mmu-miR-150 miRNA dextran sodium sulfate (DSS) chronic inflammatory bowel diseases (IBDs) colon tissue of DSS-treated mice dextran sulphate sodium (DSS)? treatment upregulated 21590770 1435 Mouse mmu-miR-150 miRNA cigarette smoke (CS) chronic obstructive pulmonary disease (COPD) the lungs of CS-exposed mice cigarette smoke (CS) exposure downregulated 29205062 1436 Mouse mmu-miR-150 miRNA cigarette smoke (CS) chronic obstructive pulmonary disease (COPD) mouse lungs Cigarette smoke (CS) exposure downregulated 29205062 1437 Mouse mmu-miR-150 miRNA dextran sodium sulfate (DSS) colitis colon tissues dextran sodium sulfate (DSS) treatment upregulated 29867475 1438 Mouse mmu-miR-150 miRNA probiotic Escherichia coli Nissle 1917 (EcN) colitis dextran sodium sulfate (DSS)-induced colitis mouse colon tissues probiotic Escherichia coli Nissle 1917 (EcN) treatment downregulated 29867475 1439 Mouse mmu-miR-150 miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity male B6C3F1 mice were injected intravenously with 3mg/kg doxorubicin treatment downregulated 25448438 1440 Mouse mmu-miR-150 miRNA adriamycin (ADR) focal segmental glomerulosclerosis (FSGS) renal tissues adriamycin (ADR) treatment upregulated 31787235 1441 Mouse mmu-miR-150 miRNA adriamycin (ADR) focal segmental glomerulosclerosis (FSGS) kidney tissues adriamycin (ADR) treatment Renal miR-150 increased in adriamycin-induced FSGS mice. 31787235 1442 Mouse mmu-miR-150 miRNA helicobacter pylori (H. pylori) gastric MALT lymphoma (GML) GML-developing d3Tx mice stomachs infect with H. pylori upregulated 28560185 1443 Mouse mmu-miR-150 miRNA azilsartan medoxomil (AZL-M) heart failure (HF) plasma azilsartan medoxomil (AZL-M) treatment "MiR-146a, miR-149, miR-150, and miR-342-3p were reproducibly reduced in the plasma of CSQ-tg mice." 27321284 1444 Mouse mmu-miR-150 miRNA hypoxia hepatocyte proliferation mice Primary hepatocytes hypoxia treatment miR-150 expression is subject to negative regulation by HIF-1¦Á 23715613 1445 Mouse mmu-miR-150 miRNA oxygen glucose deprivation (OGD) hypoxic/ischemic brain damage (HIBD) brain microvascular endothelial cells (BMECs) oxygen-glucose deprivation (OGD) treatment OGD exposure augmented the level of Rmst while reduced the expression of miR-150 in bEnd3 cells 32728986 1446 Mouse mmu-miR-150 miRNA flaxseed (FS) inflammation mouse exposed to X-ray fed 10% FS or a 0% FS isocaloric control diet treatment dysregulated 24755684 1447 Mouse mmu-miR-150 miRNA "1,25-dihydroxyvitamin D (1,25(OH)2D)" inflammation epididymal adipose tissue "1,25-dihydroxyvitamin D (1,25(OH)2D) treatment" downregulated 28055298 1448 Mouse mmu-miR-150 miRNA oxygen glucose deprivation (OGD) ischemic stroke (IS) mouse brain microvascular endothelial (bEnd.3) cells oxygen-glucose deprivation (OGD) treatment "SNHG12 expression was elevated, whereas miR-150 reduced in OGD-exposed bEnd.3 cells." 30193860 1449 Mouse mmu-miR-150 miRNA hypoxia kidney damage tubular epithelial cells (TECs) hypoxia treatment Injured tubular epithelial cells activate fibroblasts to promote kidney fibrosis through miR-150-containing exosomes. 32315664 1450 Mouse mmu-miR-150 miRNA ¦Ã-rays leukemia the whole blood cells of mice Gy ¦Ã-rays treatment miRNA signatures induced by ionising radiation in mouse blood are radiation type- and radiation dose-specific 21271940 1451 Mouse mmu-miR-150 miRNA carbon tetrachloride (CCl4) liver fibrosis hepatic stellate cells (HSCs) CCl4 treatment downregulated 30548190 1452 Mouse mmu-miR-150 miRNA IL-4 macrophage polarization mouse peritoneal macrophages (MPMs) and MSF-differentiated mouse bone marrow-derived macrophages (BMDMs) IL-4 treatment upregulated 31647949 1453 Mouse mmu-miR-150 miRNA lipopolysaccharide (LPS) macrophage polarization mouse peritoneal macrophages (MPMs) and MSF-differentiated mouse bone marrow-derived macrophages (BMDMs) lipopolysaccharide (LPS) treatment downregulated 31647949 1454 Mouse mmu-miR-150 miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) mouse high fat diet (HFD) feed upregulated 31966555 1455 Mouse mmu-miR-150 miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) mouse liver high fat diet (HFD) feed "HFD-fed mice had downregulated expression of miR-150, whereas the expression level was upregulated after MIM or NaB treatment." 33721354 1456 Mouse mmu-miR-150 miRNA metabolites of intestinal microflora (MIM) nonalcoholic fatty liver disease (NAFLD) mouse liver metabolites of intestinal microflora (MIM) treatment "HFD-fed mice had downregulated expression of miR-150, whereas the expression level was upregulated after MIM or NaB treatment." 33721354 1457 Mouse mmu-miR-150 miRNA Sodium butyrate (NaB) nonalcoholic fatty liver disease (NAFLD) mouse liver Sodium butyrate (NaB) treatment "HFD-fed mice had downregulated expression of miR-150, whereas the expression level was upregulated after MIM or NaB treatment" 33721354 1458 Mouse mmu-miR-150 miRNA IL-1 osteoarthritis (OA) ATDC5 cells Interleukin-1 (IL-1) treatment upregulated 29996115 1459 Mouse mmu-miR-150 miRNA cecal ligation and puncture (CLP) polymicrobial sepsis C57Bl/6 mice cecal ligation and puncture (CLP) treatment different regulation 24413579 1460 Mouse mmu-miR-150 miRNA streptozocin (STZ) type 1 diabetes mellitus (T1DM) splenocytes; islet ¦Â cells streptozocin (STZ) treatment downregulated 32360624 1461 Mouse mmu-miR-150 miRNA high fat diet (HFD) type 2 diabetes mellitus (T2DM) blood; retina high fat diet (HFD) feed WT mice fed with an HFD for only 1?month had a significant decrease of miR-150 in the blood and retina. 32973073 1462 Mouse mmu-miR-150-3p miRNA cold obesity brown adipose tissue (BAT) cold treatment downregulated 33015181 1463 Mouse mmu-miR-150-5p miRNA high fat diet (HFD) atherosclerosis (AS) ApoE-/- mice heart tissues high fat diet (HFD) feed We found that ZFAS1 and Notch3 were upregulated while miR-150-5p was downregulated in atherosclerosis mice and ox-LDL-treated HUVECs. 33278458 1464 Mouse mmu-miR-150-5p miRNA angiotensin II (Ang II) cardiac fibrosis heart tissues angiotensin II (Ang II) treatment downregulated 31122130 1465 Mouse mmu-miR-150-5p miRNA enterovirus 71 (EV71) enterovirus 71 (EV71) infection mouse infect with EV71 downregulated 28469998 1466 Mouse mmu-miR-150-5p miRNA ¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) experimental autoimmune encephalomyelitis (EAE) murine brain-derived CD4+ T cells ¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) combination treatment downregulated 31497013 1467 Mouse mmu-miR-150-5p miRNA fluke Fasciola gigantica (FgESPs) F. gigantica infection liver tissues fluke Fasciola gigantica (FgESPs) infection upregulated 33332355 1468 Mouse mmu-miR-150-5p miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues carbon tetrachloride (CCl4) treatment downregulated 33342075 1469 Mouse mmu-miR-150-5p miRNA schistosoma japonicum liver fibrosis serum exosomes S. japonicum infection treatment downregulated 32443549 1470 Mouse mmu-miR-150-5p miRNA schistosomiasis japonica hepatic fibrogenesis serum S. japonicum infection treatment downregulated 30482723 1471 Mouse mmu-miR-150-5p miRNA "2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD)" inflammation myeloid-derived suppressor cells (MDSCs) "2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) treatment" downregulated 31492743 1472 Mouse mmu-miR-150-5p miRNA carbon tetrachloride (CCl4) liver fibrosis Liver tissue carbon tetrachloride (CCl4) treatment upregulated 31833387 1473 Mouse mmu-miR-150-5p miRNA carbon tetrachloride (CCl4) liver fibrosis hepatic stellate cells (HSCs) carbon tetrachloride (CCl4) treatment downregulated 31833387 1474 Mouse mmu-miR-150-5p miRNA carbon tetrachloride (CCl4) liver fibrosis hepatocytes carbon tetrachloride (CCl4) treatment upregulated 31833387 1475 Mouse mmu-miR-150-5p miRNA Rhein uric acid nephropathy (UAN) Mouse kidney epithelial cell line (TCMK-1) Rhein treatment rhein has a protective effect against UAN by inhibiting renal inflammatory injury via lincRNA-Cox2/miR-150-5p/STAT1 axis 32504995 1476 Mouse mmu-miR-151 miRNA di(2-ethylhexyl) phthalate (DEHP) follicular development ovarian di(2-ethylhexyl) phthalate (DEHP) treatment upregulated 29385306 1477 Mouse mmu-miR-151 miRNA high-dose ascorbate bears cytotoxic melanoma human melanoma cells with physiological (200 ¦ÌM) or pharmacological (8 mM) ascorbate for 1 h treatment the expression of miRNAs was altered 12 h after ascorbate ment of BLM cells in physiological or pharmacological doses. Pharmacological doses upregulated 32 miRNAs 25202679 1478 Mouse mmu-miR-151 miRNA anandamide (AEA) pro-inflammatory activity mouse anandamide treatment AEA differentil regulate the expression of miRNA 24699635 1479 Mouse mmu-miR-151-3p miRNA schistosoma japonicum liver fibrosis serum exosomes S. japonicum infection treatment miR-151-3p was decresed on 6 weeks after S japonicum infection 32443549 1480 Mouse mmu-miR-151-5p miRNA high fat diet (HFD) erectile dysfunction (ED) mouse high fat diet (HFD) feed dysregulated 25533598 1481 Mouse mmu-miR-151a-3p miRNA deflazacort inflammation RAW 264.7 cells deflazacort treatment downregulated 32153563 1482 Mouse mmu-miR-151a-3p miRNA lipopolysaccharide (LPS) inflammation RAW 264.7 cells lipopolysaccharide (LPS) treatment upregulated 32153563 1483 Mouse mmu-miR-151a-3p miRNA prednisolone inflammation RAW 264.7 cells lipopolysaccharide (LPS) treatment downregulated 32153563 1484 Mouse mmu-miR-152 miRNA hypoxia activation of hepatic stellate cells (HSCs) hepatic stellate cells (HSCs) hypoxia treatment Hypoxia induces the activation of hepatic stellate cells through the PVT1-miR-152-ATG14 signaling pathway. 31893334 1485 Mouse mmu-miR-152 miRNA salvia-Nelumbinis naturalis (SNN) anti-inflammatory responses Kupffer cells were isolated from C57BL/6 mice and treated with LPS SNN treatment upregulated 28167852 1486 Mouse mmu-miR-152 miRNA high fat diet (HFD) atherosclerosis (AS) aortic tissues high fat diet (HFD) feed downregulated 30551500 1487 Mouse mmu-miR-152 miRNA high methionine diet atherosclerosis (AS) ApoE mice high methionine diet upregulated 28472596 1488 Mouse mmu-miR-152 miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) RAW264.7 cell oxidized low-density lipoprotein (ox-LDL) treatment downregulated 30551500 1489 Mouse mmu-miR-152 miRNA high glucose (HG) diabetes mellitus (DM) Freshly isolated mouse pancreatic islets high glucose treatment upregulated 30106118 1490 Mouse mmu-miR-152 miRNA progesterone (P4) early embryonic development and implantation mouse endometrial epithelium progesterone treatment upregulated 30668148 1491 Mouse mmu-miR-152 miRNA progesterone (P4) endometrial cancer (EC) endometrial epithelial cells (EECs) P4 treatment upregulated 28122483 1492 Mouse mmu-miR-152 miRNA high fat diet (HFD) hepatic insulin resistance liver high fat diet (HFD) feed downregulated 26996529 1493 Mouse mmu-miR-152 miRNA hypoxia hepatic stellate cell (HSC) activation primary mouse HSCs hypoxia induce downregulated 31893334 1494 Mouse mmu-miR-152 miRNA glucose high glucose impairment mouse NCTC 1469 hepatocytes and mouse primary hepatocytes following exposure to 25 mM glucose for 48 h treatment downregulated 25070263 1495 Mouse mmu-miR-152 miRNA DNA methyltransferase 1 liver fibrosis liver DNA methyltransferase 1 treatment "miR-152 induced by Sal B, contributed to DNMT1 downregulated and epigenetically regulated PTCH1, resulting in the inhibition of EMT in liver fibrosis." 26257392 1496 Mouse mmu-miR-152 miRNA polyinosinic-polycytidilic acid (Poly(I:C)) myocardial infarction (MI) neonatal cardiomyocytes poly (I:C) treatment upregulated 29358670 1497 Mouse mmu-miR-152 miRNA gemcitabine (GEM) osteosarcoma (OS) MG63 cells gemcitabine treatment miR-152 level was significantly reduced in MG63/DOX cells. 30661902 1498 Mouse mmu-miR-152 miRNA "dietary 3,3'-diindolylmethane (DIM)" pancreatic cancer (PC) athymic BALB/c nude mice injected with PANC-1 and PANC-28 tumor cells diet containing 2000 ppm of Bio-DIM for 6w upregulated 28659310 1499 Mouse mmu-miR-152 miRNA ischemia renal fibrosis Renal tissues the left ureter was ligated at the lower pole level of kidney for 7 days downregulated 28285987 1500 Mouse mmu-miR-152 miRNA ethanol (EtOH) teratogenesis fetal brains of mice Ethanol?treatment upregulated 19091803 1501 Mouse mmu-miR-152-3p miRNA X-rays bystander effect C57BL/6 mice extracellular vesicles (EVs) otal-body irradiated with X-rays upregulated 28396668 1502 Mouse mmu-miR-152-3p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) ischemic stroke (IS) Murine hippocampal HT22 neurons oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 31326116 1503 Mouse mmu-miR-153 miRNA isoflurane neurotoxicity mouse neurocyte isoflurane induce "In isoflurane-induced mice, miRNA-153 expression was downregulated compared with in the control group. downregulated of miRNA-153 induced neurocyte apoptosis, reduced cell growth and promoted oxidative stress in an in vitro model." 30896808 1504 Mouse mmu-miR-153 miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver tissues high fat diet (HFD) feed upregulated 31889412 1505 Mouse mmu-miR-153 miRNA icariin (ICA) osteoporosis MC3T3-E1 cells icariin treatment upregulated 29904399 1506 Mouse mmu-miR-153 miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) oxygen-glucose deprivation/reoxygenation (OGD/R) injury primary hippocampal neurons oxygen-glucose deprivation and reoxygenation (OGD/R) treatment upregulated 28245071 1507 Mouse mmu-miR-153 miRNA laparotomy and exposure of the junc_x0002_tion between the large and small intestines sepsis mouse large and small intestines laparotomy and exposure of the junc_x0002_tion between the large and small intestines treatment upregulated 25043848 1508 Mouse mmu-miR-153 miRNA mifepristone (MIF) triple negative breast cancer (TNBC) patient-derived xenografts in NOD-SCID mice mifepristone (MIF) treatment upregulation in tumors 26941846 1509 Mouse mmu-miR-153 miRNA bilobalide (BB) type 1 diabetes mellitus (T1DM) TNF-¦Á-treated MIN6 cells Bilobalide (BB) treatment upregulated 31667906 1510 Mouse mmu-miR-153 miRNA bilobalide (BB) type 1 diabetes mellitus (T1DM) MIN6 cells Bilobalide (BB) treatment MiR-153 expression was elevated by BB when induced by TNF-¦Á. 31667906 1511 Mouse mmu-miR-153 miRNA tumor necrosis factor alpha (TNF-¦Á) type 1 diabetes mellitus (T1DM) MIN6 cells tumor necrosis factor alpha (TNF-¦Á) treatment downregulated 31667906 1512 Mouse mmu-miR-153-3p miRNA isoprenaline cardiac hypertrophy primary cardiac myocytes Isoprenaline (ISO) treatment ISO promoted mitochondrial fission and enhanced the expression of miR-153-3p in cardiomyocytes. 31903137 1513 Mouse mmu-miR-153-3p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral ischemia/reperfusion (I/R) injury primary mouse cerebral cortical neurons oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 32912499 1514 Mouse mmu-miR-154 miRNA hyperoxia bronchopulmonary dysplasia (BPD) alveolar type 2 cells (AT2) hyperoxia treatment Hyperoxia treatment maintains high levels of miR-154 in alveolar type 2 cells (AT2). 32252341 1515 Mouse mmu-miR-154 miRNA ethanol (EtOH) teratogenesis fetal brains of mice Ethanol?treatment downregulated 19091803 1516 Mouse mmu-miR-154-5p miRNA angiotensin II (Ang II) cardiac remodeling heart tissues angiotensin II (Ang II) treatment upregulated 31612078 1517 Mouse mmu-miR-154-5p miRNA telmisartan cardiac remodeling Angiotensin II (AngII)-induced cardiomyocytes telmisartan treatment downregulated 31612078 1518 Mouse mmu-miR-155 miRNA trinitrobenzene sulfonic acid (TNBS) colitis colons and in cells of LNs trinitrobenzene sulphonic acid (TNBS) treatment upregulated 20143464 1519 Mouse mmu-miR-155 miRNA high tidal volume ventilation (HVTV) lung injury lung tissues high tidal volume ventilation (HVTV) treatment upregulated 22659882 1520 Mouse mmu-miR-155 miRNA IL-10 acquired Immune Deficiency Syndrome (AIDS) TLR4-induced mouse B cells IL-10 treatment downregulated 25381386 1521 Mouse mmu-miR-155 miRNA monosodium urate (MSU) acute gout bone marrow-derived macrophages (BMDMs) monosodium urate (MSU) treatment MiR-155 expression was quickly upregulated in BMDMs from WT mice following MSU treatment in vitro. 29996893 1522 Mouse mmu-miR-155 miRNA chikusetsusaponin IVa (CsIVa) acute inflammatory response mouse liver; RAW264.7 cells chikusetsusaponin IVa (CsIVa) treatment "LPS induced high expression of miR-155, which was reversed by Chikusetsusaponin IVa (CsIVa)." 33110183 1523 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) acute inflammatory response murine macrophages lipopolysaccharide (LPS) treatment upregulated 19596814 1524 Mouse mmu-miR-155 miRNA staphylococcal enterotoxin B (SEB) acute inflammatory lung injury lung staphylococcal enterotoxin B treatment upregulated 25564423 1525 Mouse mmu-miR-155 miRNA concanamycin A (Con A) acute liver injury (ALI) liver tissues concanavalin A (ConA) treatment upregulated 29420849 1526 Mouse mmu-miR-155 miRNA D-galactosamine/lipopolysaccharide (D-GalN/LPS) acute liver injury (ALI) liver tissues D-GalN/LPS treatment upregulated 31061003 1527 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) acute liver injury (ALI) Raw264.7 cells LPS treatment upregulated 31061003 1528 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) murine alveolar macrophage cell line MH-S Isoflurane treatment downregulated 25553444 1529 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) bronchoalveolar lavage fluid (BALF) lipopolysaccharide (LPS) treatment upregulated 29863671 1530 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) bone marrow-derived lymphocytes lipopolysaccharide (LPS) treatment miR-155 expressed in bone marrow-derived lymphocytes promoted LPS-induced ALI through the modulation of the Ang-2-Tie-2 pathway. 30717971 1531 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) macrophages lipopolysaccharide (LPS) treatment upregulated 27371731 1532 Mouse mmu-miR-155 miRNA caerulein (Cae) acute pancreatitis (AP) pancreatic tissue caerulein (Cae) treatment upregulated 29937734 1533 Mouse mmu-miR-155 miRNA citrus aurantium L. dry extracts (CAde) adipogenesis 3T3-L1 pre-adipocytes Citrus aurantium L. dry extracts (CAde) treatment downregulated 31654716 1534 Mouse mmu-miR-155 miRNA tumor necrosis factor alpha (TNF-¦Á) adipogenesis 3T3-L1 preadipocytes tumor necrosis factor alpha (TNF-¦Á) treatment upregulated 21986534 1535 Mouse mmu-miR-155 miRNA amyloid-¦Â (A¦Â) 1-40 age-related macular degeneration (AMD) C57BL/6 mice eye tissues amyloid-¦Â (A¦Â) 1-40 treatment upregulated 28324113 1536 Mouse mmu-miR-155 miRNA acetaminophen (APAP) alcoholic liver disease (ALD) mouse liver tissues acetaminophen(APAP) treatment upregulated 22684891 1537 Mouse mmu-miR-155 miRNA alcohol alcoholic liver disease (ALD) liver tissue of mice alcohol exposure upregulated 21062749 1538 Mouse mmu-miR-155 miRNA alcohol alcoholic liver disease (ALD) liver tissues alcohol exposure upregulated 31090940 1539 Mouse mmu-miR-155 miRNA IL-33 allergic rhinitis (AR) nasal mucosal recombinant murine IL-33 treatment upregulated 32946865 1540 Mouse mmu-miR-155 miRNA alogliptin Alzheimer's disease (AD) LPS-treated rats brain tissues alogliptin treatment downregulated 33125461 1541 Mouse mmu-miR-155 miRNA candida albicans (C. albicans) Alzheimer's disease (AD) mouse macrophages candida albicans infection upregulated 21060679 1542 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) Alzheimer's disease (AD) brain tissues lpopolysaccharide (LPS) treatment upregulated 33125461 1543 Mouse mmu-miR-155 miRNA resveratrol anti-adipogenic 3T3-L1 maturing pre-adipocytes treat with 25 ¦ÌM of trans-resveratrol (RSV) treatment upregulated 28953910 1544 Mouse mmu-miR-155 miRNA histone deacetylase inhibitors (HDIs) short-chain fatty acid (SCFA) butyrate antibody-mediated systemic autoimmunity B cells SCFA HDI butyrate treatment upregulated 32265934 1545 Mouse mmu-miR-155 miRNA "dimethyl fumarate (DMF) ,metabolite monomethyl fumarate (MMF)" anti-inflammatory responses primary astrocyte cultures derived from C57BL/6 mouse stimulated with IL-1¦Â "pretreat with DMF, MMF" downregulated 28589165 1546 Mouse mmu-miR-155 miRNA ginsenoside Rb1 anti-inflammatory responses lipopolysaccharides (LPS) treated RAW264.7 cells Ginsenoside Rb1 treatemnt upregulated 28729651 1547 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) anti-inflammatory responses mouse macrophage RAW 264.7 cells lipopolysaccharide (LPS) treatment upregulated 24689881 1548 Mouse mmu-miR-155 miRNA mycobacterium bovis bacille Calmette-Gu¨¦rin (BCG) anti-mycobacterial response RAW264.7 cells BCG infection treatment upregulated 24937178 1549 Mouse mmu-miR-155 miRNA mycobacterium tuberculosis (Mtb) apoptosis RAW264.7 cells secreted antigenic target 6-kDa protein (ESAT-6) of Mycobacterium tuberculosis (Mtb)?treatment upregulated 25721573 1550 Mouse mmu-miR-155 miRNA IL-33 asthma type 2 innate lymphoid cells (ILC2s of wild-type (WT) mice IL-33 treatment upregulated 27492144 1551 Mouse mmu-miR-155 miRNA actinomycetemcomitans (Aa) atherosclerosis (AS) blood actinomycetemcomitans (Aa) treatment upregulated 25743474 1552 Mouse mmu-miR-155 miRNA cigarette smoke (CS) atherosclerosis (AS) aortic tissues of ApoE KO mice cigarette smoke (CS) exposure upregulated 29642385 1553 Mouse mmu-miR-155 miRNA conjugated linoleic acid (CLA) atherosclerosis (AS) aorta tissues conjugated linoleic acid (CLA) treatment 1% cholesterol diet increased miR-155 expression while CLA blend supplementation decreased miR-155 expression in the aorta during atherosclerosis regression in vivo. 33391256 1554 Mouse mmu-miR-155 miRNA high fat diet (HFD) atherosclerosis (AS) apolipoprotein E knock-out (apoE) mice aortas high fat diet (HFD) feed upregulated 27856635 1555 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) atherosclerosis (AS) RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated 26823719 1556 Mouse mmu-miR-155 miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) RAW264.7 cells oxidized low-density lipoprotein (ox-LDL) treatment upregulated 26823719 1557 Mouse mmu-miR-155 miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) RAW264.7 cells oxidized low-density lipoprotein (ox-LDL) treatment upregulation 27843203 1558 Mouse mmu-miR-155 miRNA paeonol (PAE) atherosclerosis (AS) M1 macrophage Paeonol treatment "Paeonol significantly reduced the LPS and IFN-¦Ã-induced high expression of F4/80 and CD86, the secretion of inflammatory factors IL-6 and TNF-¦Á(P<005 or P<001), decreased the expression level of miR-155" 32495566 1559 Mouse mmu-miR-155 miRNA Shexiang Tongxin dropping pill (STDP) atherosclerosis (AS) serial transverse aortic sections Shexiang Tongxin dropping pill (STDP) treatment downregulated 25449459 1560 Mouse mmu-miR-155 miRNA Shexiang Tongxin dropping pill (STDP) atherosclerosis (AS) (ApoE(-/-)) mice aortic STDP (30 mg/kg/day) on atherosclerotic lesions treatment downregulated 25449459 1561 Mouse mmu-miR-155 miRNA high fat diet (HFD) atherosclerosis (AS) aortas high fat diet (HFD) feed upregulated 27856635 1562 Mouse mmu-miR-155 miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) vascular endothelial cells (VECs); vascular smooth muscle cells (VSMCs); RAW 264.7 cells oxidized low-density lipoprotein (ox-LDL) treatment miR-155 inhibits oxidized low-density lipoprotein-induced apoptosis in different cell models by targeting the p85¦Á/AKT pathway 32081664 1563 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) Dendritic cell (DC) maturation ?Mouse Monocyte lipopolysaccharide (LPS) treatment upregulated 24198819 1564 Mouse mmu-miR-155 miRNA concanamycin A (Con A) autoimmune hepatitis (AIH) liver tissues concanavalin A (ConA) treatment miR-155 was raised in liver tissues after 48 h exposure to ConA. 30290123 1565 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) autophagy tibiae from LPS-injected mice and in osteoclasts (OC) stimulated by lipopolysaccharide (LPS) lipopolysaccharides (LPS) treatment upregulated 30144578 1566 Mouse mmu-miR-155 miRNA listeria monocytogenes (L. monocytogenes) bacterial infection brain tissues and microglia Listeria monocytogenes infection upregulated 30538705 1567 Mouse mmu-miR-155 miRNA bile acids bile-containing gastroesophageal reflux murine hypopharyngeal mucosa (HM) bile acids treatment upregulated 29529473 1568 Mouse mmu-miR-155 miRNA IFN-¦Á biliary atresia (BA) bile duct cells IFN-¦Á treatment upregulated 27817193 1569 Mouse mmu-miR-155 miRNA ischemia blindness retinal vascular networks ischemia treatment "Under ischemic conditions, dysregulated miR-155 and CCN1 expression increases the inflammatory load and microglial activation, prompting aberrant angiogenic responses" 26242736 1570 Mouse mmu-miR-155 miRNA selenium (Se) bone infection or osteomyelitis MC3T3-E1 cells selenium treatment downregulated 32511663 1571 Mouse mmu-miR-155 miRNA mycobacterium bovis bacille Calmette-Gu¨¦rin (BCG) breast cancer Murine macrophages Mycobacterium bovis BCG infection M. bovis BCG-driven miR-155 dictates cell fate decisions of infected macrophages 22473996 1572 Mouse mmu-miR-155 miRNA TGF-¦Â breast cancer normal murine mammary gland (NMuMG) epithelial cells TGF-¦Â treatment upregulated 18794355 1573 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) inflammation Raw264.7£» HEK293T cell lines lipopolysaccharide (LPS) treatment upregulated 24362029 1574 Mouse mmu-miR-155 miRNA angiotensin II (Ang II) cardiac hypertrophy primary cardiomyocyte angiotensin II (Ang II) treatment "CYTOR knockdown reduced IKKi protein levels while activated NF-kB signaling pathway, whereas miR-155 inhibition exerted an opposing effect; the effect of CYTOR could be partially attenuated by miR-155 inhibition." 30794866 1575 Mouse mmu-miR-155 miRNA polysaccharide from the roots of Actinidia eriantha (AEPS) cell activation RAW264.7 macrophages AEPS treatment "miR-155 inhibitor significantly downregulated the mRNA expression of proinflammatory factors (IL-1¦Â, IL-6, COX-2 and NOS2), and blocked the production of NO in RAW2647 cell induced by AEPS" 30914371 1576 Mouse mmu-miR-155 miRNA hypoxia cerebral ischemia injury (CII) N2a cells oxygen-glucose deprivation/reoxygenation (OGD/R) induce upregulated 29951932 1577 Mouse mmu-miR-155 miRNA minocycline (MNC) cerebral ischemia injury (CII) oxygen-glucose deprivation/reoxygenation (OGD/R) induced N2a cells Minocycline treatment downregulated 29951932 1578 Mouse mmu-miR-155 miRNA helicobacter pylori (H. pylori) chronic gastritis and colitis gastric mucosa of?mice Helicobacter pylori infection upregulated 21880981 1579 Mouse mmu-miR-155 miRNA hypoxia chronic kidney disease (CKD) renal tissues chronic intermittent hypoxia (CIH) treatment upregulated 29953588 1580 Mouse mmu-miR-155 miRNA cigarette smoke extract (CSE) chronic obstructive pulmonary disease (COPD) lung tissues; alveolar macrophages cigarette smoke extract (CSE) exposure upregulated 31819170 1581 Mouse mmu-miR-155 miRNA IL-10 clinical inflammatory lung disease BAL cells and splenocytes IL-10¨Csecreting M2-like macrophages "we report that C/EBPb, a target molecule of miR-155, was upregulated and associated with IL-10 secretion and M2-like phenotype of macrophages" 23514739 1582 Mouse mmu-miR-155 miRNA dextran sodium sulfate (DSS) colitis colon tissues dextran sodium sulfate (DSS) treatment upregulated 29867475 1583 Mouse mmu-miR-155 miRNA dextran sodium sulfate (DSS) colitis colon tissues dextran sulfate sodium (DSS) treatment upregulated 33770552 1584 Mouse mmu-miR-155 miRNA dextran sodium sulfate (DSS) colitis C57BL/6J mice colonic tissue dextran-sulfate-sodium (DSS) treatment upregulated 28752563 1585 Mouse mmu-miR-155 miRNA Lactobacillus fermentum (L. fermentum) colitis C57BL/7J mice colonic tissues infect with L. fermentum downregulated 28752563 1586 Mouse mmu-miR-155 miRNA pristimerin colitis DSS-induced colitis mice colon tissues pristimerin (Pris) treatment downregulated 33770552 1587 Mouse mmu-miR-155 miRNA probiotic Escherichia coli Nissle 1917 (EcN) colitis dextran sodium sulfate (DSS)-induced colitis mouse colon tissues probiotic Escherichia coli Nissle 1917 (EcN) treatment downregulated 29867475 1588 Mouse mmu-miR-155 miRNA ionizing radiation (IR) colorectal cancer (CRC) murine lymphocytes ionizing radiation?treatment upregulated 23496831 1589 Mouse mmu-miR-155 miRNA IL-10 colonic inflammation colonic intraepithelial lymphocytes IL-10 treatment downregulated 22043014 1590 Mouse mmu-miR-155 miRNA azoxymethane (AOM) colorectal cancer (CRC) plasma and colon tissues azoxymethane (AOM) treatment upregulated 30311185 1591 Mouse mmu-miR-155 miRNA lactobacillus acidophilus and bifidobacterium bifidum probiotics colorectal cancer (CRC) plasma and colon tissues from azoxymethane (AOM)-treated mice Lactobacillus acidophilus and Bifidobacterium bifidum probiotics treatment downregulated 30311185 1592 Mouse mmu-miR-155 miRNA "1,25-dihydroxyvitamin D 3 (calcitriol)" coronary heart disease (CHD) "HEK293T, L929 and RAW264.7 cells" "1,25-dihydroxyvitamin D 3 (calcitriol) treatment" downregulated 23436936 1593 Mouse mmu-miR-155 miRNA dengue virus (DENV) dengue virus (DENV) infection brain tissues dengue virus (DENV) infection miR-155 was time-dependently downregulated upon dengue virus (DENV) infection. 32277848 1594 Mouse mmu-miR-155 miRNA streptozocin (STZ) diabetes mellitus (DM) "kidney, heart, PBMCs" streptozotocin (STZ) treatment downregulated 25929727 1595 Mouse mmu-miR-155 miRNA high glucose (HG) diabetic nephropathy (DN) podocytes high glucose (HG) treatment "miRNA-155 was found to be highly expressed in serum and kidney tissue of mice with diabetic nephropathy and in cultured podocytes," 33748285 1596 Mouse mmu-miR-155 miRNA [6]-gingerol-fractions (GF) diabetic wound healing diabetic skin wounds [6]-gingerol-fractions (GF) treatment downregulated 31428171 1597 Mouse mmu-miR-155 miRNA vitamin D diabetic wound healing diabetic skin wounds vitamin D treatment downregulated 31428171 1598 Mouse mmu-miR-155 miRNA adiponectin metabolic processes RAW 264.7 cells adiponectin (ApN) treatment upregulated 24084329 1599 Mouse mmu-miR-155 miRNA pristane (PS) diffuse alveolar hemorrhage (DAH) lung pristane treatment upregulated 26556607 1600 Mouse mmu-miR-155 miRNA IFN-¦Ã inflammation DJ-1-KO cells IFN-¦Ã treatment upregulated 24963279 1601 Mouse mmu-miR-155 miRNA cyclophosphamide embryonic maldevelopment the fore- and hindlimbs of mice cyclophosphamide treatment downregulated 20170545 1602 Mouse mmu-miR-155 miRNA kainic acid (KA) epilepsy brain tissues kainic acid (KA) treatment upregulated 30928987 1603 Mouse mmu-miR-155 miRNA progesterone (P4) epithelial-mesenchymal transition (EMT) The murine macrophage cell line RAW264.7 progesterone treatment "progesterone suppresses TLRs-triggered immune response by regulating miR-155, and the decreased miR-155 contributes to inhibit TLR-induced IL-6 and IFN-¦Â via increased SOCS1 expression" 22546503 1604 Mouse mmu-miR-155 miRNA IL-10 epithelial-mesenchymal transition (EMT) colonic intraepithelial lymphocytes IL-10 treatment upregulated 22043014 1605 Mouse mmu-miR-155 miRNA ethanol (EtOH) and burn injury ethanol and burn injury mouse T cells ethanol and burn injury treatment downregulated 25126745 1606 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) experimental autoimmune prostatitis (EAP) prostatic tissues lipopolysaccharide (LPS) treatment LPS enhanced the upregulation of miR-155. 32436368 1607 Mouse mmu-miR-155 miRNA staphylococcal enterotoxin B (SEB) food poisoning lung exposure to SEB treatment upregulated 24778118 1608 Mouse mmu-miR-155 miRNA helicobacter pylori (H. pylori) gastric MALT lymphoma (GML) GML-developing d3Tx mice stomachs infect with H. pylori upregulated 28560185 1609 Mouse mmu-miR-155 miRNA influenza virus H9N2 influenza virus infection Dendritic cells (DCs) H9N2 avian influenza virus (H9N2 AIV) treatment upregulated 27285980 1610 Mouse mmu-miR-155 miRNA vitamin C loaded human serum albumin (HSA) nanoparticles healing of wounds 3T3 fibroblast cells vitamin C loaded human serum albumin (HSA) nanoparticles treatment downregulated 31035807 1611 Mouse mmu-miR-155 miRNA CoCl2 heart failure (HF) cardiac stem cells (CSCs) CoCl2 treatment downregulated 30362213 1612 Mouse mmu-miR-155 miRNA hepatitis B virus (HBV) hepatitis B virus (HBV) infection RAW264.7 cells HBsAg treatment upregulated 29349567 1613 Mouse mmu-miR-155 miRNA high fat diet (HFD) hepatocellular carcinoma (HCC) plasma and hepatic tissues high fat diet (HFD) feed upregulated 26728044 1614 Mouse mmu-miR-155 miRNA norcantharidin (NCTD) hepatocellular carcinoma (HCC) liver tissues intraperitoneal injection of different concentration of NCTD treatment upregulated 24719559 1615 Mouse mmu-miR-155 miRNA dextran sodium sulfate (DSS) humoral autoimmune intestinal injury Foxp3+ Treg cells dextran sulfate sodium (DSS) treatment upregulated 30927737 1616 Mouse mmu-miR-155 miRNA IL-10 immune response mouse bone marrow-derived mast cells (BMMC) IL-10 treatment upregulated 27183599 1617 Mouse mmu-miR-155 miRNA streptococcus pneumoniae Endopeptidase O (PepO) pneumococcal diseases peritoneal exudate macrophages (PEMs) PepO treatment upregulated 28193634 1618 Mouse mmu-miR-155 miRNA corticosterone immune response 100 ng/ml BAFF and 100 ng/ml IL4 in-vitro-induced germinal center B cells corticosterone (CORT) treatment downregulated 30414952 1619 Mouse mmu-miR-155 miRNA either yeasts or hyphal forms of Candida albicans immune response murine bone marrow-derived macrophages (BMDMs) either yeasts or hyphal forms of Candida albicans upregulated 27294852 1620 Mouse mmu-miR-155 miRNA granulocyte-macrophage colony stimulating factor (GM-CSF) and IL-6 immune response bone marrow cells GM-CSF£¬ IL-6 treatment upregulated 24391219 1621 Mouse mmu-miR-155 miRNA TGF-¦Â immune response bone marrow cells and spleen MDSC TGF-¦Â treatment upregulated 24391219 1622 Mouse mmu-miR-155 miRNA aflatoxin M1?(AFM1) immunotoxicity isolated T cells from spleens of mice aflatoxin M1?(AFM1)?exposure downregulated 30739504 1623 Mouse mmu-miR-155 miRNA "(R)-2-isobutyl 3-methyl 3,4-dihydro-1H-pyrido[3,4-b]indole-2,3(9H)-dicarboxylate" inflammation lipopolysaccharide (LPS)-stimulated RAW 264.7 cells "(R)-2-isobutyl 3-methyl 3,4-dihydro-1H-pyrido[3,4-b]indole-2,3(9H)-dicarboxylate treatment" downregulated 24299616 1624 Mouse mmu-miR-155 miRNA alcohol inflammation mouse chronic alcohol administration upregulated 28584078 1625 Mouse mmu-miR-155 miRNA CTB-UE inflammation H. pylori-induced gastric mouse CTB-UE treatment upregulated 25483699 1626 Mouse mmu-miR-155 miRNA curcumin (Cur) inflammation LPS-induced Raw264.7 curcumin treatment downregulated 28264607 1627 Mouse mmu-miR-155 miRNA heat stress inflammation BV-2 microglial cells (BV-2 cells) heat stress treatment upregulated 30778287 1628 Mouse mmu-miR-155 miRNA high fat diet (HFD) inflammation ApoE-/- mice vessel segments high fat diet (HFD) feed upregulated 30765689 1629 Mouse mmu-miR-155 miRNA lactoferrin (LF) inflammation lipopolysaccharide (LPS)-treated RAW264.7 cells Lactoferrin treatment "?LF could induce a decrease in inflammatory selected miRNAs,?mmu-mir-155, and?mmu-mir-146a expression." 33435756 1630 Mouse mmu-miR-155 miRNA "limonin, (12S,12aS,Z)-8-((2-(diethylamino)ethoxy)imino)-12-(furan-3-yl)-6,6,8a,12a-tetramethyldodecahydro-1H,3H-oxireno[2,3-d]pyrano[4',3':3,3a]isobenzofuro[5,4-f]isochromene-3,10(9aH)-dione (V-A-4)" inflammation lipopolysaccharide (LPS)-stimulated RAW264.7 cells "limonin, (12S,12aS,Z)-8-((2-(diethylamino)ethoxy)imino)-12-(furan-3-yl)-6,6,8a,12a-tetramethyldodecahydro-1H,3H-oxireno[2,3-d]pyrano[4',3':3,3a]isobenzofuro[5,4-f]isochromene-3,10(9aH)-dione (V-A-4) treatment" upregulated 29477914 1631 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) inflammation mice Bone marrow macrophage cells LPS treatment LPS induces KH-type splicing regulatory protein-dependent processing of microRNA-155 pre-cursors in macrophages 19423639 1632 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) inflammation mouse macrophages lipopolysaccharide (LPS) treatment upregulated 29133016 1633 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) inflammation "the BV2 cells, primary microglia and the mouse cortex" lipopolysaccharide (LPS) treatment upregulated 29805490 1634 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) inflammation Raw264.7 cells lipopolysaccharide (LPS) treatment upregulated 29854576 1635 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) inflammation bone marrow-derived macrophages (BMDMs) lipopolysaccharide (LPS) treatment upregulated 30721702 1636 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) inflammation BV-2 microglial cells lipopolysaccharide (LPS) treatment upregulated 30720115 1637 Mouse mmu-miR-155 miRNA oxidized low density lipoprotein (ox-LDL) inflammation RAW264.7 cells oxidized low-density lipoprotein (ox-LDL) treatment upregulated 28871950 1638 Mouse mmu-miR-155 miRNA oxidized low density lipoprotein (ox-LDL) inflammation RAW264.7 macrophages oxidized low-density lipoprotein (ox-LDL) treatment upregulated 29977930 1639 Mouse mmu-miR-155 miRNA tremella fuciformis polysaccharides (TFPS) inflammation LPS-treated Raw264.7 cells Tremella fuciformis polysaccharides (TFPS)treatment treatment downregulated 29854576 1640 Mouse mmu-miR-155 miRNA tumor necrosis factor alpha (TNF-¦Á) inflammation Vascular smooth muscle cells (VSMCs) tumor necrosis factor alpha (TNF-¦Á) treatment upregulated 30765689 1641 Mouse mmu-miR-155 miRNA ¦Á-mangostin inflammation macrophages ¦Á-mangostin treatment downregulated 31806859 1642 Mouse mmu-miR-155 miRNA herpes simplex virus 1 (HSV-1) inflammation and innate immunity mouse brain tissue infect with HSV-1 upregulated 28045967 1643 Mouse mmu-miR-155 miRNA "1,25-dihydroxyvitamin D (1,25(OH)2D)" inflammation 3T3-L1 adipocytes; epididymal adipose tissue "1,25-dihydroxyvitamin D (1,25(OH)2D) treatment" downregulated 28055298 1644 Mouse mmu-miR-155 miRNA praziquantel (PZQ) inflammation mouse liver schistosomiasis treatment increase in the PZQ-ed mice compared to the 12W infected mice 25051829 1645 Mouse mmu-miR-155 miRNA influenza A virus (IAV) inflammation C57BL/6 mice lung infect with influenza A/PR/8/34 upregulated 28193481 1646 Mouse mmu-miR-155 miRNA high fat diet (HFD) obesity C57BL/6J mice high fat diet (HFD) feed downregulated 28652200 1647 Mouse mmu-miR-155 miRNA dextran sodium sulfate (DSS) inflammatory bowel disease (IBD) colon tissues dextran sodium sulfate (DSS) treatment miR-155 expression was increased 4.74-fold in DSS-induced colon tissues compared with that in normal controls. 32713852 1648 Mouse mmu-miR-155 miRNA dextran sodium sulfate (DSS) inflammatory bowel disease (IBD) colon tissues dextran sulfate sodium (DSS) treatment upregulated 30236870 1649 Mouse mmu-miR-155 miRNA apigenin inflammatory diseases lungs from LPS-treated mice dietary apigenin treatment downregulated 25641956 1650 Mouse mmu-miR-155 miRNA resveratrol inflammatory diseases LPS-stimulated RAW264.7 murine macrophages resveratrol (RS) treatment downregulated 28004106 1651 Mouse mmu-miR-155 miRNA Sinomenine (SIN) inflammatory diseases RAW264.7 cells Sinomenine (SIN) treatment "SIN treatment significantly reduced LPS-induced inflammatory cytokine release, suppressed the expression of miR-155" 32116077 1652 Mouse mmu-miR-155 miRNA resveratrol inflammatory response lipopolysaccharide (LPS)-stimulated RAW264.7 murine macrophages resveratrol (RS) treatment downregulated 28004106 1653 Mouse mmu-mir-155 miRNA IL-10 inflammatory response RAW264.7 cells IL-10 treatment upregulated 32324763 1654 Mouse mmu-miR-155 miRNA dexamethasone (DEX) inflammatory therapeutics Raw264.7 cells dexamethasone (Dex) treatment Dexamethasone decreased expression of pro-inflammatory microRNA-155 in exosomes from LPS-induced RAW264.7 macrophages. 31949716 1655 Mouse mmu-miR-155 miRNA cannabinoids innate immune response LPS-treated BV-2 microglial cells cannabinoids treatment downregulated 30742662 1656 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) inner ear inflammatory scala tympani LPS was injected directly into treatment upregulated 24470395 1657 Mouse mmu-miR-155 miRNA alcohol intestinal inflammation and barrier dysfunction mouse acute binge and chronic alcohol feeding in the small bowel (SB) in mice treatment upregulated 25156614 1658 Mouse mmu-miR-155 miRNA dexamethasone (DEX) intracerebral haemorrhage (ICH) astrocytes dexamethasone (DEX) treatment downregulated 27601160 1659 Mouse mmu-miR-155 miRNA hypoxia ischemic stroke (IS) mouse brain tissues middle cerebral artery occlusion (MCAO) miR-155 is a direct target of lncRNA Oprm1. lncRNA Oprm1/miR-155/GATA3 axis plays an important role in cerebral I/R injury. 31187646 1660 Mouse mmu-miR-155 miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) ischemic stroke (IS) N2a cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment miR-155 is a direct target of lncRNA Oprm1 lncRNA Oprm1/miR-155/GATA3 axis plays an important role in cerebral I/R injury 31187646 1661 Mouse mmu-miR-155 miRNA gualou guizhi decoction (GLGZD) ischemic brain injury BV2 cells GuaLou GuiZhi Decoction (GLGZD) treatment GuaLou GuiZhi Decoction (GLGZD) might exert its anti-inflammatory action by inhibiting the expression of miR-155. 32173634 1662 Mouse mmu-miR-155 miRNA CoCl2 ischemic heart disease (IHD) cardiac stem cells (CSCs) CoCl 2 treatment A dose-dependent decrease of miR-155 expression in CSCs treated with CoCl2. 30362213 1663 Mouse mmu-miR-155 miRNA Japanese encephalitis virus (JEV) Japanese encephalitis virus (JEV) infection brain tissues infect with JEV treatment upregulated 24522920 1664 Mouse mmu-miR-155 miRNA deoxycorticosterone acetate (DOCA) kidney damage hypertensive mice kidneys and urine injection of Deoxycorticosterone acetate (Doca) upregulated in the kidneys and urine 29255279 1665 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) kidney damage mouse renal tissues intraperitoneally injected with LPS upregulated in renal tissues 31966808 1666 Mouse mmu-miR-155 miRNA leishmania leishmaniasis "the liver and J774 macrophages, and in spleens from infected mice" Leishmania infection upregulated 29943317 1667 Mouse mmu-miR-155 miRNA quercetin-3-glucuronide (Q3G) leukemia RAW264.7 macrophages quercetin-3-glucuronide (Q3G) treatment downregulated 20579867 1668 Mouse mmu-miR-155 miRNA dietary methyl deficiency hepatocellular carcinoma (HCC) the liver tissues Dietary methyl deficiency treatment upregulated 20436259 1669 Mouse mmu-miR-155 miRNA acetaminophen (APAP) liver damage liver£¬blood acetaminophen (APAP) treatment upregulated 27673475 1670 Mouse mmu-miR-155 miRNA Triggering receptors expressed on myeloid cell-1 (TREM-1) liver fibrosis macrophages and lungs Triggering receptors expressed on myeloid cell-1 (TREM-1) knockout treatment downregulated 26684249 1671 Mouse mmu-miR-155 miRNA "(R)-2-isobutyl 3-methyl 3,4-dihydro-1H-pyrido[3,4-b]indole-2,3(9H)-dicarboxylate" liver fibrosis RAW 264.7 cells "(R)-2-isobutyl 3-methyl 3,4-dihydro-1H-pyrido[3,4-b]indole-2,3(9H)-dicarboxylate (1) treatment" downregulated 24299616 1672 Mouse mmu-miR-155 miRNA leishmania RNA virus 1 (LRV1) leishmania RNA virus 1 (LRV1) infection macrophage of naive mice leishmania RNA virus 1 (LRV1) treatment upregulated 27593513 1673 Mouse mmu-miR-155 miRNA binase lymphosarcoma RLS40 cells binase treatment downregulated 33147876 1674 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) macrophage inflammatory response RAW264.7 macrophage cells lipopolysaccharide (LPS) treatment upregulated 22415194 1675 Mouse mmu-miR-155 miRNA cypermethrin (CYM) macrophage polarization LPS-treated RAW264.7 cells Cypermethrin (CYM) treatment downregulated 29471534 1676 Mouse mmu-miR-155 miRNA IFN-¦Ã and lipopolysaccharide (LPS) macrophage polarization RAW264.7 cells LPS/IFN-¦Ã treatment upregulated 30384539 1677 Mouse mmu-miR-155 miRNA IL-4 and IL-13 macrophage polarization RAW264.7 cells IL-4 and IL-13 treatment downregulated 30384539 1678 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) macrophage polarization RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated 29471534 1679 Mouse mmu-miR-155 miRNA the fraction of Hedyotis diffusa and Scutellaria barbata herb couple(YDW11) macrophage polarization LPS/IFN-¦Ã-induced M1 macrophage (RAW264.7 cells) the fraction of Hedyotis diffusa and Scutellaria barbata herb couple(YDW11) treatment downregulated 30384539 1680 Mouse mmu-miR-155 miRNA the fraction of Hedyotis diffusa and Scutellaria barbata herb couple(YDW11) macrophage polarization IL-4/IL-13-induced M2 macrophage (RAW264.7 cells) the fraction of Hedyotis diffusa and Scutellaria barbata herb couple(YDW11) treatment upregulated 30384539 1681 Mouse mmu-miR-155 miRNA genetically attenuated parasites (GAP) that arrest in the liver malaria mouse liver GAP-injected mice treatment upregulated 25189739 1682 Mouse mmu-miR-155 miRNA selenium (Se) mastitis Staphylococcus aureus (S. aureus)-infected mouse mammary tissues and primary mouse mammary epithelial cells (MMECs) Selenium (Se) supplementation treatment downregulated 31545328 1683 Mouse mmu-miR-155 miRNA Staphylococcus aureus mastitis mouse mammary tissues and primary mouse mammary epithelial cells (MMECs) Staphylococcus aureus (S. aureus) infection treatment upregulated 31545328 1684 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) microglial activation N9 microglial cells lipopolysaccharide (LPS) treatment upregulated 29410668 1685 Mouse mmu-miR-155 miRNA sulforaphane (SFN) microglial activation LPS-treated N9 microglial cells Sulforaphane (SFN) treatment downregulated 29410668 1686 Mouse mmu-miR-155 miRNA murine norovirus (MNV) murine norovirus (MNV) infection bone marrow derived macrophage (BMDM); RAW264.7 cells; BV-2 cells; caecum; colon tissues murine norovirus (MNV) infection downregulated 29900416 1687 Mouse mmu-miR-155 miRNA dexamethasone (DEX) muscle atrophy Murine C2C12 myoblast cells dexamethasone (DEX) treatment upregulated 23716137 1688 Mouse mmu-miR-155 miRNA sevoflurane (SEV) myocardial ischemia/reperfusion (I/R) injury (MIRI) myocardial tissues sevoflurane treatment "The treatment of sevoflurane could reduce miR-155 expression and increased SIRT1 expression in the myocardial tissues, under which conditions, cardiac functions were promoted, accompanied by reduced infarct size and inhibited cardiomyocyte apoptosis" 31099069 1689 Mouse mmu-miR-155 miRNA 3-acetyl-11-keto-¦Â-boswellic acid (AKBA) and dexamethasone (DEX) neuroinflammation brain tissues 3-acetyl-11-keto-¦Â-boswellic acid (AKBA) and dexamethasone (DEX) treatment "The treatment of LPS-injected mice with either AKBA or DEX led to a signif- icant decrease in the relative miR-155 expression by 2.52 ¡À 0.33 and 3.78 ¡À 0.44, respectively, compared to LPS group." 29079998 1690 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) neuroinflammation N9 microglia lipopolysaccharide (LPS) treatment upregulated 28096568 1691 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) neuroinflammation BV2 microglia lipopolysaccharides (LPS) treatment upregulated 28875362 1692 Mouse mmu-miR-155 miRNA propofol (PPF) neuroinflammation LPS-treated BV2 microglia Propofol treatment downregulated 28875362 1693 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) neuroinflammation mouse brain tissues lipopolysaccharide (LPS) treatment upregulated in the brain 29079998 1694 Mouse mmu-miR-155 miRNA alcohol neuronal survival and neurite growth primary or immortalized mouse microglia alcohol exposure upregulated 23951048 1695 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) neuropathic pain (NP) BV-2 cells lipopolysaccharide (LPS) treatment "LPS induced M1 polarization in BV-2 cells with increasing of CD86, iNOS and miR-155." 32337959 1696 Mouse mmu-miR-155 miRNA phorbol-12-myristate-13-acetate(PMA) neutrophil extracellular traps (NETs) generation Neutrophils were separated from bone marrow cells PMA treatment upregulated 31736940 1697 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) acute respiratory distress syndrome (ARDS) lung tissues lipopolysaccharide (LPS) treatment upregulated 26684249 1698 Mouse mmu-miR-155 miRNA green tea (GT) obesity adipose tissues green tea (GT) treatment GT reverses HFD-induced upregulated of miR-155 and -335 in epididymal adipose tissues. 29734116 1699 Mouse mmu-miR-155 miRNA high fat diet (HFD) obesity macrophage high fat diet (HFD) feed upregulated 27671445 1700 Mouse mmu-miR-155 miRNA high fat diet (HFD) obesity nucleus accumbens high fat diet (HFD) feed Significant reductions in the levels of miR-155 (82%) and miR-146a (41%) levels were observed within the nucleus accumbens of HFD mice compared to CTL. 28652200 1701 Mouse mmu-miR-155 miRNA high fat diet (HFD) obesity renal tissues high fat diet (HFD) feed upregulated 30715692 1702 Mouse mmu-miR-155 miRNA palmitic acid (PA) obesity The mouse renal microvascular endothelial cells (MECs) palmitic acid (PA) treatment upregulated 30715692 1703 Mouse mmu-miR-155 miRNA P. aeruginosa ocular infection Eight-week-old female C3H/HeJ mice corneas tissues infect with ?P. aeruginosa treatment ?miR-155 expression was upregulated 24403554 1704 Mouse mmu-miR-155 miRNA tumor necrosis factor alpha (TNF-¦Á) osteoclast differentiation RAW264.7 cells tumor necrosis factor alpha (TNF-¦Á) treatment upregulated 23078176 1705 Mouse mmu-miR-155 miRNA IFN-¦Â osteoclast-mediated diseases Murine macrophage cell line RAW26 Interferon-¦Â treatment upregulated 22771905 1706 Mouse mmu-miR-155 miRNA alendronate osteoporosis Osteoporosis mice osteoclasts alendronate treatment downregulated 31317664 1707 Mouse mmu-miR-155 miRNA manganese (Mn) oxidative stress neuronal CATH.a cell line Mn treatment downregulated 30090472 1708 Mouse mmu-miR-155 miRNA P. gingivalis P. gingivalis infection ApoE mice heart and aorta tissues infect with P. gingivalis treatment upregulated 28646427 1709 Mouse mmu-miR-155 miRNA tanshinone IIA (Tan IIA) P. gingivalis infection ApoE mice serum and in heart TSA (60 mg kg-/--/--1 day-1) treatment downregulated 28646427 1710 Mouse mmu-miR-155 miRNA F. novicida pancreatic cancer (PC) L929 cells F. novicida?infection downregulated 20041145 1711 Mouse mmu-miR-155 miRNA tumor necrosis factor alpha (TNF-¦Á) periodontitis OCCM-30 cells tumor necrosis factor alpha (TNF-¦Á) treatment upregulated 28692806 1712 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) peripheral and CNS inflammation primary murine microglia lipopolysaccharide (LPS) treatment upregulated 26134658 1713 Mouse mmu-miR-155 miRNA particulate matter (PM2.5) PM2.5 exposure mosue bronchoalveolar lavage fluid (BALF) "were subjected to intratracheal instillation of 2.5, 10, or 20mg/kg PM2.5 treatment" upregulated in bronchoalveolar lavage fluid (BALF) 29107863 1714 Mouse mmu-miR-155 miRNA cecal ligation and puncture (CLP) polymicrobial sepsis C57Bl/6 mice cecal ligation and puncture (CLP) treatment different regulation 24413579 1715 Mouse mmu-miR-155 miRNA dexamethasone (DEX) preadipocyte differentiation 3T3-L1 preadipocytes dexamethasone (Dex) treatment miR-155 levels were upregulated (2.4-fold) by glucocorticoids in differentiating 3T3-L1 preadipocytes. 29352275 1716 Mouse mmu-miR-155 miRNA salmonella programmed cell death RAW 264.7 cells salmonella treatment upregulated 29608690 1717 Mouse mmu-miR-155 miRNA pseudomonas aeruginosa (PA) pseudomonas aeruginosa lung infection sorted lung macrophages RP73 clinical strain of P. aeruginosa infection treatment downregulated 28422188 1718 Mouse mmu-miR-155 miRNA resolvin D1 (RvD1) pseudomonas aeruginosa lung infection sorted lung macrophages from RP73 clinical strain of P. aeruginosa infected mouse resolvin (Rv) D1 treatment upregulated 28422188 1719 Mouse mmu-miR-155 miRNA particulate matter (PM2.5) pulmonary toxicological lung tissues particulate matter (PM2.5) exposure treatment upregulated 29107863 1720 Mouse mmu-miR-155 miRNA photo-oxidative damage (PD) retinal degenerative diseases retinal tissues; serum photo-oxidative damage (PD) treatment "Upregulation of miR-155 was detected in retinal tissue, serum and s-mEVs in response to photo-oxidative damage, localising to the nucleus of a subset of retinal ganglion cells and glial cells and in the cytoplasm of photoreceptors" 33037565 1721 Mouse mmu-miR-155 miRNA schistosoma japonicum schistosomiasis murine liver Schistosoma japonicum infection treatment upregulated 23825609 1722 Mouse mmu-miR-155 miRNA schistosomiasis schistosomiasis liver inflammation mouse liver tissues schistosomiasis treatment 6W infected mice were significantly higher than those of the normal mice and of the 12W infected mice 25051829 1723 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) scleroderma fibrosis RAW 264.7 and 293T cells lipopolysaccharide (LPS) treatment upregulated 18299402 1724 Mouse mmu-miR-155 miRNA dexamethasone (DEX) sepsis liver tissues dexamethasone (DEX) treatment downregulated 24244697 1725 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) sepsis liver tissues lipopolysaccharide (LPS) treatment upregulated 24244697 1726 Mouse mmu-miR-155 miRNA SDF-1¦Á analog CTCE-0214 (CTCE) sepsis mouse with polymicrobial sepsis EPC therapy treatment upregulated in endothelial progenitor cells (EPCs) 24707934 1727 Mouse mmu-miR-155 miRNA lipopolysaccharide (LPS) septic shock Mouse Aorta and Left ventricular (LV) lipopolysaccharide (LPS) treatment upregulated 29979224 1728 Mouse mmu-miR-155 miRNA nuclear factor kappa-B (NF-¦ÊB) inhibitor Bay11-708211 supraesophageal bile reflux hypopharyngeal mucosa NF-¦ÊB inhibitor (BAY 11-7082) treatment "Pre- but not post-application of NF-¦ÊB inhibitor, significantly blocks overexpression of Il6 and prostaglandin H synthases 2 (Ptgs2), and reverses miR-21, miR-155, miR-99a phenotypes." 32934775 1729 Mouse mmu-miR-155 miRNA T. gondii T. gondii induced hepatic damage liver tissues T. gondii treatment revealed a significant elevation in miRNA-155 expression and a significant reduction of BChE activity in all the infected untreated groups compared to the uninfected mice 33840057 1730 Mouse mmu-miR-155 miRNA lithium chloride and pilocarpine temporal lobe epilepsy (TLE) brain tissues lithium-pilocarpine treatment upregulated 27303295 1731 Mouse mmu-miR-155 miRNA controlled cortical impact (CCI) traumatic brain injury (TBI) mouse hippocampus controlled cortical impact (CCI) upregulated 28804446 1732 Mouse mmu-miR-155 miRNA mycobacterium tuberculosis (Mtb) tuberculosis (TB) murine RAW264.7 cells and bone marrow-derived macrophages (BMDMs) Mycobacterium tuberculosis (M.tb.)? infection upregulated 22712528 1733 Mouse mmu-miR-155 miRNA triptolide (TPL) ileocolonic anastomosis inflammation lleum tissues; colon tissues triptolide (TPL) treatment downregulated 23911388 1734 Mouse mmu-miR-155 miRNA insulin type 2 diabetes mellitus (T2DM) liver tissues;adipose tissues;skeletal muscle tissues ?insulin? treatment upregulated 27711113 1735 Mouse mmu-miR-155 miRNA artesunate (ART) ulcerative colitis (UC) RAW264.7 cells artesunate (ART) treatment ART treatment also reduced the expressions of pro-inflammatory factors and miR-155. 33524272 1736 Mouse mmu-miR-155 miRNA cinnamaldehyde (CA) ulcerative colitis (UC) RAW264.7 cells Cinnamaldehyde (CA) treatment downregulated 30530166 1737 Mouse mmu-miR-155 miRNA cinnamaldehyde (CA) ulcerative colitis (UC) colon tissues Cinnamaldehyde (CA) treatment downregulated 30530166 1738 Mouse mmu-miR-155 miRNA dextran sodium sulfate (DSS) ulcerative colitis (UC) DSS-induced mice colon tissues Dextran sodium sulfate (DSS) treatment upregulated 30530166 1739 Mouse mmu-miR-155 miRNA dextran sodium sulfate (DSS) ulcerative colitis (UC) mouse colon tissues dextran-sulfate-sodium (DSS) treatment upregulated 28888763 1740 Mouse mmu-miR-155 miRNA propofol (PPF) unilateral ureteral obstruction (UUO) UUO mouse UUO mouse treatment downregulated in kidney 27158339 1741 Mouse mmu-miR-155 miRNA live L. acidophilus ¦Â-lactoglobulin (¦Â-Lg) allergy murine splenocytes live L. acidophilus treatment downregulated 30156972 1742 Mouse mmu-miR-155 miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) RAW264.7 cells oxidized low-density lipoprotein (ox-LDL) treatment upregulated 23797321 1743 Mouse mmu-miR-155 miRNA mycobacteria depression RAW264.7 cells mycobacteria?infection upregulated 24130493 1744 Mouse mmu-miR-155 miRNA IL-10 inflammation BMDM IL-10? treatment downregulated 20435894 1745 Mouse mmu-miR-155-3p miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated 32955644 1746 Mouse mmu-miR-155-5p miRNA angiostrongylus cantonensis (A. cantonensis) angiostrongylus cantonensis (A. cantonensis) infection mouse angiostrongylus cantonensis (A. cantonensis) infection upregulated 24682888 1747 Mouse mmu-miR-155-5p miRNA "IL-4, IL-13 and IL-33" allergic asthma (AA) RAW264.7 cells "IL-4,IL-13 and IL-33 treatment" upregulated 29621782 1748 Mouse mmu-mir-155-5p miRNA second-hand smoke (SHS) asthma lung second-hand smoke (SHS) treatment upregulated 26859758 1749 Mouse mmu-miR-155-5p miRNA histone deacetylase inhibitor (HDACi) B cell differentiation B cells of C57BL/6J "stimulated with LPS and IL-4 and treated with HDI (VPA, 500 ?M) or nil for 60 h" upregulated 28994753 1750 Mouse mmu-miR-155-5p miRNA apigenin cardiac fibrosis TGF-¦Â1-treated mouse cardiac fibroblasts (M6300) apigenin treatment downregulated 32800930 1751 Mouse mmu-miR-155-5p miRNA apigenin cardiac fibrosis M6300 cells apigenin treatment downregulated 32800930 1752 Mouse mmu-miR-155-5p miRNA TGF-¦Â1 cardiac fibrosis Mouse cardiac fibroblasts (M6300) TGF-¦Â1 treatment upregulated 32800930 1753 Mouse mmu-miR-155-5p miRNA geniposide and ginsenoside Rg1 cerebral ischemia injury (CII) oxygen-glucose deprivation (OGD) treated BV2 mouse microglial cells Geniposide+Ginsenoside Rg1 dual treatment downregulated 29257264 1754 Mouse mmu-miR-155-5p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral ischemia injury (CII) BV2 mouse microglial cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment upregulated 29257264 1755 Mouse mmu-miR-155-5p miRNA echinococcus multilocularis metacestodes echinococcus multilocularis infection RAW 264.7 cells E. multilocularis metacestodes treatment upregulated 30322806 1756 Mouse mmu-miR-155-5p miRNA angiostrongylus cantonensis (A. cantonensis) eosinophilic meningitis (EM) murine microglial cell line N9 angiostrongylus cantonensis (A. cantonensis) infection The current study confirmed that miR-155-5p peaked at 21 days after A. cantonensis infection. 32966836 1757 Mouse mmu-miR-155-5p miRNA ¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) experimental autoimmune encephalomyelitis (EAE) murine brain-derived CD4+ T cells ¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) combination treatment downregulated 31497013 1758 Mouse mmu-miR-155-5p miRNA fluke Fasciola gigantica (FgESPs) F. gigantica infection liver tissues fluke Fasciola gigantica (FgESPs) infection upregulated 33332355 1759 Mouse mmu-miR-155-5p miRNA deoxycorticosterone acetate-salt hypertension hypertensive nephropathy (HN) kidney tissues deoxycorticosterone acetate-salt hypertension treatment upregulated 31782248 1760 Mouse mmu-miR-155-5p miRNA E. multilocularis metacestodes infection and immunity of E. multilocularis RAW264¡¤7 macrophage cells E. multilocularis metacestodes for 6 and 12 h treatment "upregulated (mmu-miR-378d,mmu-miR-155-5p, mmu-miR-146a-5p, mmu-miR-21a-5p , mmu-miR-125a-5p) and downregulated(mmu-miR-1981-5p , mmu-miR-let-7c-1-3p)" 28942753 1761 Mouse mmu-miR-155-5p miRNA lactic acid (LA) inflammation bone marrow-derived mast cells (BMMC) of C57BL/6 mouse lactic acid (LA) treatment downregulated 27559047 1762 Mouse mmu-miR-155-5p miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated 32955644 1763 Mouse mmu-miR-155-5p miRNA dexamethasone (DEX) innate immune response immature DCs (iDCs) dexamethasone (DEX) treatment downregulated 30174602 1764 Mouse mmu-miR-155-5p miRNA IL-10 innate immune response immature DCs (iDCs) IL-10 treatment downregulated 30174602 1765 Mouse mmu-miR-155-5p miRNA methamphetamine (METH) methamphetamine (METH)-mediated neurotoxicity BV2 cells and mouse brain Methamphetamine (METH) treatment MiR-155-5p was significantly reduced by METH in vitro but increased in vivo. 30914375 1766 Mouse mmu-miR-155-5p miRNA preformed fibrils (PFFs) of human wild-type ¦ÁSyn microglial activation Mouse primary microglia preformed fibrils (PFFs) of human wild-type ¦ÁSyn treatment upregulated 31182996 1767 Mouse mmu-miR-155-5p miRNA triptolide (TPL) microglial activation preformed fibrils (PFFs) of human wild-type ¦ÁSyn-treated mouse primary microglia triptolide (T10) treatment downregulated 31182996 1768 Mouse mmu-miR-155-5p miRNA neurotoxicant cuprizone (CPZ) myelin abnormalities myelin Neurotoxicant cuprizone (CPZ) treatment miR-155-5p and miR-20a-5p upregulations enhanced NgR induction through Smad 2 and Smad 4 suppression in demyelination. 31963761 1769 Mouse mmu-miR-155-5p miRNA rosmarinic acid (RA) parkinson's disease (PD) ventral midbrain rosmarinic acid (RA) treatment MPTP injection increased the relative expression of miR-155-5p and RA treatment decreased its expression. 32946211 1770 Mouse mmu-miR-155-5p miRNA geniposide and ginsenoside Rg3 stroke BV2 mouse microglial cells exposed to geniposide (40 ?g/ml) + ginsenoside Rg1 (8 ?g/ml) upregulated 29257264 1771 Mouse mmu-miR-155-5p miRNA "chlorpromazine, procainamide, manganese" systemic lupus erythematosus (SLE) mouse "chlorpromazine, procainamide, manganese" dysregulated 29349090 1772 Mouse mmu-miR-155-5p miRNA T-2 toxin T-2 toxin-induced inflammatory response RAW264.7 cells T-2 toxin treatment upregulated 32240701 1773 Mouse mmu-miR-15a miRNA amyloid-¦Â (A¦Â) 25-35 Alzheimer's disease (AD) hippocampal neurons amyloid-¦Â (A¦Â) 25-35 treatment TUG1 knockdown restricts apoptosis of hippocampal neurons in AD by elevating miR-15a and suppressing ROCK1 expression. 32577774 1774 Mouse mmu-miR-15a miRNA folate apoptosis mouse embryonic stem cells (mESCs) folate deficiency induced upregulated 22828209 1775 Mouse mmu-miR-15a miRNA IL-22 colitis CT-26 cells Interleukin-22 (IL-22) treatment downregulated 29023933 1776 Mouse mmu-miR-15A miRNA IL-17A colorectal cancer (CRC) intestinal epithelial cells (IECs) of C57BL/B6 mice IL17A treatment downregulated 29031499 1777 Mouse mmu-miR-15a miRNA [6]-gingerol-fractions (GF) diabetic wound healing diabetic skin wounds [6]-gingerol-fractions (GF) treatment upregulated 31428171 1778 Mouse mmu-miR-15a miRNA vitamin D diabetic wound healing diabetic skin wounds vitamin D treatment upregulated 31428171 1779 Mouse mmu-miR-15a miRNA bleomycin (BLM) idiopathic pulmonary fibrosis (IPF) mouse lung tissues bleomycin (BLM) treatment downregulated 30644438 1780 Mouse mmu-miR-15a miRNA TGF-¦Â1 idiopathic pulmonary fibrosis (IPF) neonatal primary lung fibroblasts transforming growth factor (TGF)-¦Â1 treatment downregulated 30644438 1781 Mouse mmu-miR-15a miRNA TGF-¦Â1 idiopathic pulmonary fibrosis (IPF) mouse primary lung fibroblasts TGF-¦Â1 treatment "miR-15a antagonized the function of PFAR and inhibited PFAR induced extracellular collagen deposition, fibroblasts proliferation, migration and differentiation" 31273058 1782 Mouse mmu-miR-15a miRNA exenatide (EXA) insulin sensitivity pancreas exenatide treatment "The levels of miRNA-15a, 29c, 124a, and 375 in the pancreas were significantly increased in HFD control mice.These effects were reversed by treatment with exenatide." 26314504 1783 Mouse mmu-miR-15a miRNA exenatide (EXA) insulin sensitivity muscle exenatide treatment "The levels of miRNA-15a, 29c, 124a, and 146a in the muscle were significantly increased. These effects were reversed by treatment with exenatide." 26314504 1784 Mouse mmu-miR-15a miRNA exenatide (EXA) insulin sensitivity serum exenatide treatment "the levels of miRNA-15a, 29c, 124a, and 375 in the serum were significantly decreased. These effects were reversed by treatment with exenatide." 26314504 1785 Mouse mmu-miR-15a miRNA high fat diet (HFD) insulin sensitivity pancreas high fat diet (HFD) feed upregulated 26314504 1786 Mouse mmu-miR-15a miRNA high fat diet (HFD) insulin sensitivity muscle high fat diet (HFD) feed upregulated 26314504 1787 Mouse mmu-miR-15a miRNA high fat diet (HFD) insulin sensitivity serum high fat diet (HFD) feed downregulated 26314504 1788 Mouse mmu-miR-15a miRNA ischemia/reperfusion (I/R) keratinocyte migration and boosts re-epithelialization during skin wound healing heart tissues ischemia/reperfusion (I/R) treatment upregulated 22783320 1789 Mouse mmu-miR-15a miRNA dietary methyl deficiency hepatocellular carcinoma (HCC) the liver tissues Dietary methyl deficiency treatment downregulated 20436259 1790 Mouse mmu-miR-15a miRNA concanamycin A (Con A) liver damage liver tissues concanavalin A (ConA) treatment downregulated 29023933 1791 Mouse mmu-miR-15a miRNA high fat diet (HFD) obesity C57Bl/6 mice high fat diet (HFD) feed upregulated 28944834 1792 Mouse mmu-miR-15a miRNA peroxisome proliferator-activated receptor delta (PPARdelta) obstructive cholestasis mouse Cerebral vascular endothelial cell (CEC) peroxisome proliferator-activated receptor delta (PPARdelta)?treatment treatment upregulation of PPARdelta can alleviate ODG-activated microRNA-15a (miR-15a) expression in CECs 20445066 1793 Mouse mmu-miR-15a miRNA Tripterygium glycosides (TGs) premature ovarian failure (POF) ovarian granulosa cells (OGCs) Tripterygium glycosides (TGs) treatment upregulated 30092342 1794 Mouse mmu-miR-15a miRNA radiation radiation-induced fibrosis (RIF) "CH3 mice muscle, skin, and subcutaneous tissue" the right hind legs of 9-week old CH3 mice by a single-fraction dose of irradiation to 35 Gy treatment dysregulated 24986745 1795 Mouse mmu-miR-15a miRNA H2O2 spinal cord injury (SCI) C8-D1A and C8B4 cells H2O2 treatment downregulated 31773669 1796 Mouse mmu-miR-15a miRNA IFN systemic lupus erythematosus (SLE) splenic cellular and plasma interferon treatment upregulated 22578383 1797 Mouse mmu-miR-15a* miRNA recombinant Adeno-Cre viruses (AdV-Cre) lung adenocarcinoma (LUAD) lung recombinant Adeno-Cre viruses (AdV-Cre) treatment upregulated 25359683 1798 Mouse mmu-miR-15a-3p miRNA delvestidine (DLTD) bone marrow-derived dendritic cells (BMDCs) maturity bone marrow-derived dendritic cells (BMDCs) Delvestidine (DLTD) treatment upregulated 32871480 1799 Mouse mmu-miR-15a-5p miRNA lipopolysaccharide (LPS) acute kidney injury (AKI) Mouse podocytes (MPC5) MPC5 were treated with 100 ng/mL LPS (Sigma-Aldrich) for 48 h miR-15a-5p was significantly downregulated in LPS-treated MPCs. 31658856 1800 Mouse mmu-miR-15a-5p miRNA ozone (O3) asthma CD4+ T cells and ASMCs ozone treatment lncRNA PVT1-miR-15a-5p/miR-29c-3p-PI3K-Akt-mTOR axis was implicated in ozone-induced asthma development by promoting ASMC proliferation and Th1/Th2 imbalance 33223504 1801 Mouse mmu-miR-15a-5p miRNA phenylephrine (PE) cardiac hypertrophy cardiomyocytes phenylephrine [PE] treatment upregulated 31889385 1802 Mouse mmu-miR-15a-5p miRNA ischemia cerebral ischemia injury (CII) region of the gerbil hippocampus transient common carotid artery occlusion (tCCAO) treatment upregulated 25646661 1803 Mouse mmu-miR-15b miRNA Bortezomib acute allograft rejection (AR) after renal transplant AR renal tissues bortezomib? treatment upregulated 31377589 1804 Mouse mmu-miR-15b miRNA TNF acute liver failure (ALF) liver tissue TNF treatment upregulated 22374434 1805 Mouse mmu-miR-15b miRNA folate apoptosis mouse embryonic stem cells (mESCs) folate deficiency induced upregulated 22828209 1806 Mouse mmu-miR-15b miRNA puerarin cardiac hypertrophy Ang II-induced cardiac hypertrophy Puerarin treatment upregulated 27145790 1807 Mouse mmu-miR-15b miRNA rosemary colorectal cancer (CRC) nude mice CRC tissues rosemary treatment downregulated 24892299 1808 Mouse mmu-miR-15b miRNA herpes simplex virus 1 (HSV-1) inflammation and innate immunity mouse brain tissue infect with HSV-1 upregulated 28045967 1809 Mouse mmu-miR-15b miRNA epigallocatechin-3-gallate (EGCG) inflammation CD4 naive T cells isolated from C57BL/6 mice 10 ¦ÌM EGCG upregulated 27851983 1810 Mouse mmu-miR-15b miRNA ischemia/reperfusion (I/R) keratinocyte migration and boosts re-epithelialization during skin wound healing heart tissues ischemia/reperfusion (I/R) treatment upregulated 22783320 1811 Mouse mmu-miR-15b miRNA nicotine neurobehavioral effects of nicotine the spermatozoa of F0 mice;the brains of F1 mice nicotine both the spermatozoa of F0 mice and the brains of F1 mice downregulated in both the spermatozoa of F0 mice and the brains of F1 mice 28779169 1812 Mouse mmu-miR-15b miRNA Japanese encephalitis virus (JEV) neuroinflammation glial cells and mouse brains Japanese encephalitis virus (JEV) treatment upregulated 26202983 1813 Mouse mmu-miR-15b miRNA cigarette smoke (CS) ovarian toxicity ovarian tissues cigarette smoke (CS) treatment upregulated 29377183 1814 Mouse mmu-miR-15b miRNA lipopolysaccharide (LPS) sepsis and septic shock blood cells LPS treatment upregulated 23395002 1815 Mouse mmu-miR-15b miRNA cyclophosphamide (CP) premature ovarian failure (POF) mouse ovarian granulosa cells (mOGCs) cyclophosphamide treatment upregulated 31310795 1816 Mouse mmu-miR-15b-5p miRNA chronic unpredictable mild stress (CUMS) depression prefrontal cortex chronic unpredictable mild stress (CUMS) treatment downregulated 27701406 1817 Mouse mmu-miR-15b-5p miRNA chronic unpredictable mild stress (CUMS) depression NAc tissue chronic unpredictable mild stress (CUMS) treatment upregulated 31430030 1818 Mouse mmu-miR-15b-5p miRNA high glucose (HG) diabetic nephropathy (DN) The mouse podocytes high glucose (HG) treatment downregulated 31025335 1819 Mouse mmu-miR-15b-5p miRNA high glucose (HG) diabetic nephropathy (DN) mesangial cells (MCs) high glucose (HG) treatment HG elevated miR-15b-5p expression. 31991106 1820 Mouse mmu-miR-15b-5p miRNA sevoflurane (SEV) endoplasmic reticulum stress (ERS) HT22 cells Sev treatment upregulated 31966678 1821 Mouse mmu-miR-15b-5p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) brain chronic unpredictable mild stress (CUMS) treatment "microRNA-15b-5p play a critical role in chronic stress-induced depression by decreasing synaptic proteins, innervations, and activities in the nucleus accumbens." 32209659 1822 Mouse mmu-miR-15b-5p miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) midbrain tissues "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" downregulated 29217406 1823 Mouse mmu-miR-15b-5p miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) midbrain tissues "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" downregulated 29217406 1824 Mouse mmu-miR-1-5p miRNA lipopolysaccharide (LPS) myocardial dysfunction cardiomyocytes lipopolysaccharide (LPS) treatment The lncRNA RMRP axis acts as a sponge for miR-1-5p. RMRP inhibits LPS-induced apoptosis of cardiomyocytes and mitochondrial damage by suppressing the post-transcriptional regulatory function of miR-1-5p on HSPA4. 31900829 1825 Mouse mmu-miR-16 miRNA ischemia/reperfusion (I/R) acute kidney injury (AKI) C57BL/6 male mice ischemia/reperfusion (I/R) treatment upregulated 27297958 1826 Mouse mmu-miR-16 miRNA TNF acute liver failure (ALF) liver tissue TNF treatment upregulated 22374434 1827 Mouse mmu-miR-16 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues lipopolysaccharide (LPS) treatment downregulated 30784935 1828 Mouse mmu-miR-16 miRNA folate apoptosis mouse embryonic stem cells (mESCs) folate deficiency induced upregulated 22828209 1829 Mouse mmu-miR-16 miRNA thyroid hormone brain development mouse fetal cortex inject TH 12 h before sacrifice on GD 16 treatment downregulated 24436321 1830 Mouse mmu-miR-16 miRNA "hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)" tumorigenesis brain and liver tissue cells "hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) treatment" downregulated 19270793 1831 Mouse mmu-miR-16 miRNA angiotensin II (Ang II) cardiovascular disease (CVD) mouse VSMC line angiotensin II (Ang II) treatment downregulated 29104843 1832 Mouse mmu-miR-16 miRNA fluoxetine (Prozac) colorectal cancer (CRC) serotonergic raphe nuclei of mice fluoxetine (Prozac) treatment upregulated 20847275 1833 Mouse mmu-miR-16 miRNA fluoxetine (Prozac) Dendritic cell cross-priming serotonergic raphe neurons fluoxetine (Prozac) treatment "Fluoxetine, acting on serotonergic raphe neurons, decreases the amount of miR-16 in the hippocampus" 22833211 1834 Mouse mmu-miR-16 miRNA Deoxycorticosterone acetate (Doca) hypertensive heart disease (HHD) mouse HHD cells injection of Deoxycorticosterone acetate (Doca) upregulated in HHD cells 28531963 1835 Mouse mmu-miR-16 miRNA bleomycin (BLM) idiopathic pulmonary fibrosis (IPF) sera bleomycin (BLM) treatment Rictor-targeting exosomal microRNA-16 ameliorates lung fibrosis by inhibiting the mTORC2-SPARC axis. 33307020 1836 Mouse mmu-miR-16 miRNA dextran sodium sulfate (DSS) inflammatory bowel disease (IBD) rectal mucosa dextran sulfate sodium treatment upregulated 32361613 1837 Mouse mmu-miR-16 miRNA carbon tetrachloride (CCl4) liver fibrosis Liver tissues carbon tetrachloride (CCl4) treatment downregulated 29080810 1838 Mouse mmu-miR-16 miRNA lipopolysaccharide (LPS) lung injury lung tissues lipopolysaccharide (LPS) treatment downregulated 22185353 1839 Mouse mmu-miR-16 miRNA "3,3'-diindolylmethane (DIM)" multiple sclerosis (MS) activated T cells during the development of experimental autoimmune encephalomyelitis (EAE) "3,3'-Diindolylmethane (DIM) treatment" upregulated 24898268 1840 Mouse mmu-miR-16 miRNA monosodium glutamate (MSG) obesity liver tissues monosodium glutamate (MSG)-injected mice with developed central obesity treatment dysregulated 24465854 1841 Mouse mmu-miR-16 miRNA chronic intermittent hypoxia (CIH) obstructive sleep apnoea-hypopnoea syndrome (OSAHS) mouse aortic endothelial cells (MAECs) chronic intermittent hypoxia (CIH) treatment downregulated 29108914 1842 Mouse mmu-miR-16 miRNA lipopolysaccharide (LPS) sepsis and septic shock blood cells LPS treatment upregulated 23395002 1843 Mouse mmu-miR-16 miRNA plasmodium plasmodium infection exosomes derived from the plasma infect with Plasmodium treatment upregulated 28650446 1844 Mouse mmu-miR-16 miRNA cecal ligation and puncture (CLP) sepsis whole blood cecal ligation and puncture (CLP) treatment upregulated 24205035 1845 Mouse mmu-miR-16 miRNA epigallocatechin-3-gallate (EGCG) breast cancer "Murine breast cancer cell lines, 4T1" Epigallocatechin gallate (EGCG) EGCG upregulated miR-16 in 4T1 cells and in the exosomes 24044575 1846 Mouse mmu-miR-16-1 miRNA IL-22 colitis CT-26 cells Interleukin-22 (IL-22) treatment downregulated 29023933 1847 Mouse mmu-miR-16-1 miRNA IL-17A colorectal cancer (CRC) intestinal epithelial cells (IECs) of C57BL/B6 mice IL17A treatment downregulated 29031499 1848 Mouse mmu-miR-16-1 miRNA triptolide (TPL) crohn disease (CD) IL-10-/- mice undergoing ileocecal resection (ICR) triptolide (TPL) treatment downregulated 28627592 1849 Mouse mmu-miR-16-1 miRNA concanamycin A (Con A) liver damage liver tissues concanavalin A (ConA) treatment downregulated 29023933 1850 Mouse mmu-miR-16-2-3p miRNA delvestidine (DLTD) bone marrow-derived dendritic cells (BMDCs) maturity bone marrow-derived dendritic cells (BMDCs) Delvestidine (DLTD) treatment upregulated 32871480 1851 Mouse mmu-miR-16-5p miRNA anandamide and norgestimate depression chronic mild stress (CMS) model of depression mouse anandamide and norgestimate treatment downregulated 28716528 1852 Mouse mmu-miR-16-5p miRNA enterovirus 71 (EV71) hand-foot-mouth disease (HFMD) two-week old Kunming (KM) mice muscle intraperitoneally injected with high-virulence EV71 (GZ-CII strain) upregulated 29180670 1853 Mouse mmu-miR-16-5p miRNA manganese (Mn) parkinson's disease (PD) MN9D dopaminergic cell exosomes Mn exposure (300¦ÌM MnCl2) for 24h upregulated in exosomes 28450057 1854 Mouse mmu-miR-17 miRNA hydrochloric acid acute lung injury (ALI) C57BL/6 mice microvesicle (MV)release from lung epithelium "hydrochloric acid (0.1 N, pH 1.5) was intratracheally instilled into the mouse lung" upregulated in microvesicle (MV)release from lung epithelium 28674181 1855 Mouse mmu-miR-17 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues lipopolysaccharide (LPS) treatment "Using a lipopolysaccharide (LPS)-induced ALI mouse model, it was observed that miR-17 was significantly downregulated in lung tissues" 32626914 1856 Mouse mmu-miR-17 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) type II epithelial cells from 6-week-old mice lipopolysaccharide (LPS) treatment downregulated 24486549 1857 Mouse mmu-miR-17 miRNA hyperoxia bronchopulmonary dysplasia (BPD) lung tissues hyperoxia treatment downregulated 33143661 1858 Mouse mmu-miR-17 miRNA hyperoxia bronchopulmonary dysplasia (BPD) lung tissues hyperoxia (Hyp) treatment Downregulated lncRNA H19 relieved pulmonary injury via targeting miR-17 to downregulate STAT3 and reduced inflammatory response caused by p-STAT3 in BPD newborn mice. 33285606 1859 Mouse mmu-miR-17 miRNA "retinoic acid (RA), leukemia inhibitory factor (LIF) and basic fibroblast growth factor (bFGF)" cell differentiation mouse bone marrow mesenchymal stem cells (BMSCs) "retinoic acid (RA), leukemia inhibitory factor (LIF) and basic fibroblast growth factor (bFGF) treatment" downregulated 32195202 1860 Mouse mmu-miR-17 miRNA high glucose (HG) apoptosis uteri High glucose treatment downregulated 26660634 1861 Mouse mmu-miR-17 miRNA ischemia/reperfusion (I/R) head and neck squamous cell carcinoma (HNSCC) heart tissues ischemia/reperfusion (I/R) treatment the miR-17-92 cluster may protect the heart by diminishing the apoptosis and alleviating ischemia/reperfusion injury 23639284 1862 Mouse mmu-miR-17 miRNA high glucose (HG) inflammation RAW264.7 macrophages or mouse peritoneal macrophages high glucose treatment downregulated 29477089 1863 Mouse mmu-miR-17 miRNA lipopolysaccharide (LPS) inflammation RAW264.7 macrophages or mouse peritoneal macrophages lipopolysaccharide (LPS) treatment downregulated 29477089 1864 Mouse mmu-miR-17 miRNA ¦¤9-tetrahydrocannabinol (THC) inflammation total lymph node cells and CD4(+) T cells ¦¤9-Tetrahydrocannabinol (THC) treatment downregulated 27268054 1865 Mouse mmu-miR-17 miRNA retinoic acid (RA) neuroblastoma (NB) The SH-SY5Y cells retinoic acid treatment downregulated of miR-17 family 19666108 1866 Mouse mmu-miR-17 miRNA plasmodium plasmodium infection exosomes derived from the plasma infect with Plasmodium treatment upregulated 28650446 1867 Mouse mmu-miR-17 miRNA imiquimod (IMQ) psoriasis-like dermatitis the mouse skin tissues IMQ treatment dysregulated 27579777 1868 Mouse mmu-miR-17 miRNA cecal ligation and puncture (CLP) sepsis whole blood cecal ligation and puncture (CLP) treatment upregulated 24205035 1869 Mouse mmu-miR-17 miRNA di(2-ethylhexyl) phthalate (DEHP) skeletal muscle insulin resistance skeletal muscle cells di(2-ethylhexyl) phthalate (DEHP) treatment The miR-17/Keap1-Nrf2/miR-200a axis contributed to DEHP-induced insulin resistance. 32802189 1870 Mouse mmu-miR-17 miRNA genistein spermatogenesis ICR mice testis "different doses of GEN (0, 0.5, 5, 50 and 250 mg/kg/day) for 35 days" upregulated 28938591 1871 Mouse mmu-miR-17 miRNA IFN-¦Ã type 1 diabetes mellitus (T1DM) ¦Â-cells IFN¦Ãtreatment downregulated 26858253 1872 Mouse mmu-miR-17 miRNA cigarette smoke extract (CSE) ¦Â-cell dysfunction MIN6 cells cigarette smoke extract (CSE) treatment "cigarette smoke extract (CSE) downregulated the levels of the transcription factor, mafA, and microRNA (miR)-17." 29856480 1873 Mouse mmu-miR-17 miRNA high glucose (HG) neural tube defects (NTDs) "C17.2 mouse neural stem cells, newborn mouse cerebellar progenitor cells" High Glucose treatment downregulated 26660634 1874 Mouse mmu-miR-17-3p miRNA swimming cardiac hypertrophy C57BL/6 mice ventricle samples starting swimming from 10 minutes twice daily with 10 minutes increase each day until 90 minutes reached 14 for 21 days treatment upregulated in ventricle samples 28255358 1875 Mouse mmu-miR-17-3p miRNA high glucose (HG) diabetic nephropathy (DN) mesangial cells (MCs) high glucose (HG) treatment It was found that expression of circ_0037128 was significantly increased in mouse DN model and high glucose treated mesangial cells (MCs) 32860899 1876 Mouse mmu-miR-17-3p miRNA adrenaline heart failure (HF) Primary NMCMs (neonatal mouse cardiomyocytes) adrenaline treatment downregulated 31595165 1877 Mouse mmu-miR-175p miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" neurodegenerative diseases N2a cells "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" upregulated 29250806 1878 Mouse mmu-miR-17-5p miRNA ovalbumin (OVA) allergic rhinitis (AR) spleen cells ovalbumin (OVA) treatment miR-17-5p expression was higher in the OVA group. 31999672 1879 Mouse mmu-miR-17-5p miRNA high fat diet (HFD) atherosclerosis (AS) vascular smooth muscle cell (VSMC) high fat diet (HFD) feed "p53-dependent lincRNA-p21 expression downregulated miR-17-5p, whichconsequently protecting against AS progression via SIRT7 elevation." 33169349 1880 Mouse mmu-miR-17-5p miRNA high-cholesterol diet atherosclerosis (AS) macrophages of ApoE-/- mice high-cholesterol diet feed upregulated 30850242 1881 Mouse mmu-miR-17-5p miRNA high-cholesterol diet atherosclerosis (AS) macrophages of ApoE-/- mice fed with a high-cholesterol diet high-cholesterol diet feed upregulated 30850242 1882 Mouse mmu-miR-17-5p miRNA "paraquat (PQ) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" dopaminergic (DA) neuron differentiation neuro-2a cells "paraquat (PQ) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment" dysregulated 29250806 1883 Mouse mmu-miR-17-5p miRNA dexmedetomidine (DEX) doxorubicin (DOX)-induced cardiotoxicity cardiomyocytes dexmedetomidine (Dex) treatment upregulated 32190669 1884 Mouse mmu-miR-17-5p miRNA electroacupuncture (EA) electroacupuncture (EA) CD4 T cells electroacupuncture (EA) treatment upregulated 32026263 1885 Mouse mmu-miR-17-5p miRNA di(2-ethylhexyl) phthalate (DEHP) follicular development ovarian di(2-ethylhexyl) phthalate (DEHP) treatment upregulated 29385306 1886 Mouse mmu-miR-17-5p miRNA WY14643 hepatocellular carcinoma (HCC) Mycfl/fl mice "two days of Wy-14,643 treatment" upregulated 24096051 1887 Mouse mmu-miR-17-5p miRNA pinostilbene hydrate (PSH) liver fibrosis hepatic stellate cells (HSCs) Pinostilbene hydrate (PSH) treatment upregulated 32919323 1888 Mouse mmu-miR-17-5p miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" neurodegenerative diseases N2a cells "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" upregulated 29250806 1889 Mouse mmu-miR-17-5p miRNA paraquat (PQ) neurodegenerative diseases N2a cells paraquat (PQ) treatment downregulated 29250806 1890 Mouse mmu-miR-17-5p miRNA high fat diet (HFD) obesity and obesity-associated insulin resistance C57Bl/J mice high fat diet (HFD) feed downregulated 28265343 1891 Mouse mmu-miR-17-5p miRNA IL-1¦Â osteoarthritis (OA) murine induced pluripotent stem cell (miPSC) IL-1¦Â treatment "RNA-seq results show that miR-17-5p increase from 4 to 24 hours, but slightly decrease from 24 to 72 hours in IL-1¦Â stimulated pellets." 32767602 1892 Mouse mmu-miR-17-5p miRNA tumor necrosis factor alpha (TNF-¦Á) osteoarthritis (OA) murine induced pluripotent stem cell (miPSC) tumor necrosis factor alpha (TNF-¦Á) treatment "RNA-seq results show that miR-17-5p increase from 4 to 24 hours, but slightly decrease from 24 to 72 hours in TNF-¦Á stimulated pellets" 32767602 1893 Mouse mmu-miR-17-5p miRNA radiation radiation-induced injury blood radiation treatment downregulated 29799276 1894 Mouse mmu-miR-17-5p miRNA lipopolysaccharide (LPS) sepsis Peripheral Blood Mononuclear Cells from mouse peripheral blood and Raw264.7 macrophages lipopolysaccharide (LPS) treatment downregulated 30506107 1895 Mouse mmu-miR-17-5p miRNA schisandrin B (Sch B) sepsis LPS-treated mouse peripheral Blood Mononuclear Cells or Raw264.7 macrophages Schisandrin B (Sch B) treatment upregulated 30506107 1896 Mouse mmu-miR-17-92 miRNA ischemia/reperfusion (I/R) acute kidney injury (AKI) mouse renal tubular ischemia/reperfusion (I/R) treatment upregulated in renal tubular 29699633 1897 Mouse mmu-miR-17-92 miRNA mouse mammary tumor virus (MMTV) breast cancer mouse mammary HC11 cells infect with MMTV upregulated 29096160 1898 Mouse mmu-miR-17-92 miRNA "hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)" tumorigenesis brain and liver tissue cells "hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) treatment" downregulated 19270793 1899 Mouse mmu-miR-17-92 miRNA streptozocin (STZ) islet beta-cell repair Islets streptozotocin treatment MiR-17-92¦ÂKO mice showed dramatically elevated fasting blood glucose and impaired glucose tolerance after streptozotocin treatment 32038500 1900 Mouse mmu-miR-17-92 miRNA grape seed procyanidin extract (GSPE) lung cancer A549 cells grape seed procyanidin extract (GSE) treatment downregulated 27289489 1901 Mouse mmu-miR-17-92 miRNA rapamycin myocardial infarction (MI) cardiomyocytes rapamycin (RAPA) treatment STAT3-miR-17/20 signalling axis plays a critical role in attenuating myocardial infarction following rapamycin treatment in diabetic mice 31738412 1902 Mouse mmu-miR-18 miRNA IL-1¦Â diabetes mellitus (DM) MIN6 cells IL-1¦Â treatment upregulated 31258677 1903 Mouse mmu-miR-18 miRNA gold nanoparticles (AuNPs) epithelial-mesenchymal transition and peritoneal fibrosis liver and lung of mouse fetuses gold nanoparticles (AuNP) treatment upregulated 24004569 1904 Mouse mmu-miR-181 miRNA "hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)" tumorigenesis brain and liver tissue cells "hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) treatment" downregulated 19270793 1905 Mouse mmu-miR-181a miRNA curcumin (Cur) acute kidney injury (AKI) kidney tissues curcumin treatment Curcumin treatment decreased miR-181a expression level. 32338107 1906 Mouse mmu-miR-181a miRNA transglutaminase 2 (TG2) allergic inflammation B16F1 mouse melanoma cells TGaseII treatment downregulated 25202021 1907 Mouse mmu-miR-181a miRNA amyloid-¦Â (A¦Â) Alzheimer's disease (AD) primary hippocampal cells amyloid-¦Â (A¦Â) treatment A¦Â treatment inhibited cLTP-dependent induction of translin and subsequent reduction of miR-181a. 32087004 1908 Mouse mmu-miR-181a miRNA IL-1¦Â Alzheimer's disease (AD) primary murine astrocyte and neuron co-culture IL-1¦Â treatment microRNA-181a was significantly decreased following the IL-1¦Â treatment. 29710703 1909 Mouse mmu-miR-181a miRNA histone deacetylase inhibitors (HDIs) short-chain fatty acid (SCFA) butyrate antibody-mediated systemic autoimmunity B cells SCFA HDI butyrate treatment upregulated 32265934 1910 Mouse mmu-miR-181a miRNA dexamethasone (DEX) asthma splenic CD4+ T lymphocytes dexamethasone (DEX) treatment downregulated 22580216 1911 Mouse mmu-miR-181a miRNA TGF-¦Â cirrhosis and hepatocellular cancer liver TGF-¦Â treatment upregulated 24576072 1912 Mouse mmu-miR-181a miRNA streptozocin (STZ) diabetic corneal nerve trigeminal ganglion tissue (TG) streptozotocin (STZ) treatment 31926967 1913 Mouse mmu-miR-181a miRNA cocaine and amphetamines drug-induced synaptic plasticity Primary neuronal cells; synaptoneurosomes tissues cocaine and amphetamines treatment dysregulated 22144581 1914 Mouse mmu-miR-181a miRNA MOG 35-55 peptide emulsified and pertussis toxin "experimental autoimmune encephalomyelitis (EAE),multiple sclerosis (MS)" brain tissues wereinjected subcutaneously with MOG 35-55 peptide emulsified and pertussis toxin downregulated in brain 28769921 1915 Mouse mmu-miR-181a miRNA di(2-ethylhexyl) phthalate (DEHP) follicular development ovarian di(2-ethylhexyl) phthalate (DEHP) treatment upregulated 29385306 1916 Mouse mmu-miR-181a miRNA oxidized low density lipoprotein (ox-LDL) hyperlipidemia dendritic cells (DCs) oxidized low-density lipoprotein (ox-LDL) treatment upregulated 22956783 1917 Mouse mmu-miR-181a miRNA lipopolysaccharide (LPS) inflammation blood lipopolysaccharides (LPS) or streptozotocin treatment upregulated 23220232 1918 Mouse mmu-miR-181a miRNA streptozocin (STZ) inflammation blood lipopolysaccharides (LPS) or streptozotocin treatment upregulated 23220232 1919 Mouse mmu-miR-181a miRNA brucella.suis innate immune response RAW264.7 cells brucella.suis infection upregulated 29387067 1920 Mouse mmu-miR-181a miRNA morphine neurogenesis mouse morphine treatment upregulated 24964978 1921 Mouse mmu-miR-181a miRNA palmitic acid (PA) nonalcoholic fatty liver disease (NAFLD) primary mouse hepatocytes (PMH) palmitic acid (PA) treatment upregulated 30558790 1922 Mouse mmu-miR-181a miRNA bone morphogenetic proteins (BMPs) osteogenesis pluripotent stem (iPS) cells bone morphogenetic proteins (BMPs) treatment downregulated 22937097 1923 Mouse mmu-miR-181a miRNA 3-nitropropionic acid oxidative stress ovary tissues 3-nitropropionic acid treatment upregulated 31359035 1924 Mouse mmu-miR-181a miRNA H2O2 oxidative stress primary mouse mGC H2O2 upregulated 28981116 1925 Mouse mmu-miR-181a miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) oxidative stress N2a cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 30949956 1926 Mouse mmu-miR-181a miRNA sphingosine-1-phosphate (S1P) oxidative stress H2O2 treated primary mouse GCs (mGCs) sphingosine-1-phosphate (S1P) treatment downregulated 31359035 1927 Mouse mmu-miR-181a miRNA particulate matter (PM2.5) PM2.5 exposure mosue bronchoalveolar lavage fluid (BALF) "were subjected to intratracheal instillation of 2.5, 10, or 20mg/kg PM2.5 treatment" upregulated in bronchoalveolar lavage fluid (BALF) 29107863 1928 Mouse mmu-miR-181a miRNA particulate matter (PM2.5) pulmonary toxicological lung tissues particulate matter (PM2.5) exposure treatment upregulated 29107863 1929 Mouse mmu-miR-181a miRNA "TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin)" thymic atrophy and alterations in T cell differentiation fetal thymocytes of mice "TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) treatment" upregulated 23024791 1930 Mouse mmu-miR-181a miRNA high glucose (HG) wound healing granulation tissues streptozocin (STZ) treatment miR-181a was upregulated in the diabetic wound healing mouse model. 30565672 1931 Mouse mmu-miR-181a-1 miRNA ¦Â-elemene oxygen-induced retinopathy (OIR) Retinas tissues ¦Â-elemene treatment upregulated 30664207 1932 Mouse mmu-miR-181a-1-3p miRNA "15-deoxy-¦¤12, 14-prostaglandin J2 (15d-PGJ2)" liver damage bone marrow (BM)-derived macrophage (BMM) of liver injury mouse "15-deoxy-¦¤12, 14-prostaglandin J2 (15d-PGJ2) treatment" upregulated 28748390 1933 Mouse mmu-miR-181a-5p miRNA brucella abortus brucellosis "bone marrow-derived macrophages, spleens" brucella abortus infection upregulated 29942317 1934 Mouse mmu-miR-181a-5p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral ischemia injury (CII) Mouse N2a cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment "?miR-181a-5p was highly expressed in serum of ACI patients, MCAO mice, and OGD/R-induced N2a cells" 33360253 1935 Mouse mmu-miR-181a-5p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral ischemia injury (CII) N2a cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment miR-181a-5p was highly expressed in OGD/R-induced N2a cells 33360253 1936 Mouse mmu-miR-181a-5p miRNA high glucose (HG) diabetic cardiomyopathy (DCM) cardiomyocytes high glucose (HG) treatment downregulated 31353329 1937 Mouse mmu-miR-181a-5p miRNA high glucose (HG) diabetic cardiomyopathy (DCM) primary cultured cardiomyocyte high glucose treatment downregulated 31353329 1938 Mouse mmu-miR-181a-5p miRNA streptozocin (STZ) diabetic cardiomyopathy (DCM) myocardium streptozocin treatment downregulated 31353329 1939 Mouse mmu-miR-181a-5p miRNA streptozocin (STZ) diabetic cardiomyopathy (DCM) myocardial tissues streptozotocin (STZ) treatment downregulated 31353329 1940 Mouse mmu-miR-181a-5p miRNA lipopolysaccharide (LPS) sepsis RAW 264.7 cells lipopolysaccharide (LPS) treatment upregulated 31844680 1941 Mouse mmu-miR-181a-5p miRNA social defeat stress sex differences of social defeat stress female mice social defeat stress treatment upregulated 33358922 1942 Mouse mmu-miR-181b miRNA high fat diet (HFD) nervous and immune system diseases the aortic intima and plasma in mice high fat diet (HFD) feed MiR-181b expression was reduced in the aortic intima and plasma in apolipoprotein E-deficient mice fed a high-fat diet 24084690 1943 Mouse mmu-miR-181b miRNA angiotensin II (Ang II) abdominal aortic aneurysm (AAA) vascular smooth muscle cell and mouse-aorta-origin vascular smooth muscle (MOVAS) cells angiotensin II (Ang II) treatment upregulated 30417353 1944 Mouse mmu-miR-181b miRNA angiotensin II (Ang II) abdominal aortic aneurysm (AAA) angiotensin II (AngII) treated mouse-aorta-origin vascular smooth muscle (MOVAS) cells angiotensin II (Ang II) treatment upregulated 30417353 1945 Mouse mmu-miR-181b miRNA licochalcone A (LA) abdominal aortic aneurysm (AAA) angiotensin II (AngII)-treated mouse vascular smooth muscle cell and mouse-aorta-origin vascular smooth muscle (MOVAS) cells Licochalcone A (LA) treatment downregulated 30417353 1946 Mouse mmu-miR-181b miRNA licochalcone A (LA) abdominal aortic aneurysm (AAA) Mouse-aorta-origin vascular smooth muscle (MOVAS) cells Licochalcone A (LA) treatment downregulated 30417353 1947 Mouse mmu-miR-181b miRNA ovalbumin (OVA) asthma lung tissues ovalbumin (OVA) treatment miR-181b was found to be downregulated in lung tissues in the OVA-challenged mice. 33640857 1948 Mouse mmu-miR-181b miRNA high fat diet (HFD) atherosclerosis (AS) mouse high fat diet (HFD) feed downregulated 24084690 1949 Mouse mmu-miR-181b miRNA oxygen glucose deprivation (OGD) cerebral artery occlusion HT22 cell oxygen-glucose deprivation (OGD) treatment downregulated 27642276 1950 Mouse mmu-miR-181b miRNA CoCl2 cerebral ischemic stroke (CIS) N2A neuroblastoma cells CoCl2 treatment miR-181b expression was significantly decreased in N2A neuroblastoma cells after CoCl 2-induced hypoxic injury in vitro. 29807144 1951 Mouse mmu-miR-181b miRNA estrogen (ES) renal fibrosis mouse uterus tissues Estrogen treatment mirn451 was significantly increased by estrogen administration whereas mirn181b and mirn204 expression was significantly reduced 20720260 1952 Mouse mmu-miR-181b miRNA high-fat/high-cholesterol diet or a high-protein diet dyslipidemia DO mice a high-fat/high-cholesterol diet or a high-protein diet for 18 wk dysregulated 28916633 1953 Mouse mmu-miR-181b miRNA brucella.suis innate immune response RAW264.7 cells brucella.suis infection upregulated 29387067 1954 Mouse mmu-miR-181b miRNA erythrocyte lysates intracerebral haemorrhage (ICH) Primary cortical neurons from C57BL/6 mice erythrocyte lysates treatment downregulated 30503822 1955 Mouse mmu-miR-181b miRNA erythrocyte lysates intracerebral haemorrhage (ICH) Primary cortical neurons from C57BL/6 mice erythrocyte lysates treatment downregulated 30503822 1956 Mouse mmu-miR-181b miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues carbon tetrachloride (CCl4) treatment upregulated 31790896 1957 Mouse mmu-miR-181b miRNA liquiritigenin (LQ) liver fibrosis carbon tetrachloride (CCl4)-treated mice liver tissues Liquiritigenin (LQ) treatment downregulated 31790896 1958 Mouse mmu-miR-181b miRNA liquiritigenin (LQ) liver fibrosis hepatic stellate cells (HSC) Liquiritigenin (LQ) treatment LQ led to a significant reduction in miR-181b expression. 31790896 1959 Mouse mmu-miR-181b miRNA hypoxia apoptosis brain tissues MCAO surgical procedure downregulated 27642276 1960 Mouse mmu-miR-181b miRNA sevoflurane (SEV) neurotoxicity HT22 cells Sevoflurane treatment downregulated 32150149 1961 Mouse mmu-miR-181b miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) mouse high fat diet (HFD) feed upregulated 28899784 1962 Mouse mmu-miR-181b miRNA tert-butyl hydroperoxide (TBHP) oxidative stress adult male mice strain Balb/c TBHP treatment differently regulated 25141839 1963 Mouse mmu-miR-181b miRNA cecal ligation and puncture (CLP) sepsis late sepsis cecal ligation and puncture (CLP) treatment upregulated 24980967 1964 Mouse mmu-miR-181b miRNA SiO2 silicosis NR8383 cells SiO2 treatment downregulated 26239160 1965 Mouse mmu-miR-181-b miRNA MOG 35-55 peptide emulsified and pertussis toxin "experimental autoimmune encephalomyelitis (EAE),multiple sclerosis (MS)" brain tissues wereinjected subcutaneously with MOG 35-55 peptide emulsified and pertussis toxin downregulated in brain 28769921 1966 Mouse mmu-miR-181b miRNA lipopolysaccharide (LPS) neuropathic pain (NP) BV2 cells ?lipopolysaccharide (LPS) treatment "In this study, we found that lncRNA p21 and tumor necrosis factor alpha-induced protein 1 (Tnfaip1) expression were upregulated and miR-181b expression was downregulated in lipopolysaccharide (LPS)-induced and activated BV-2 microglia" 33774143 1967 Mouse mmu-miR-181b1 miRNA neuraminidase (NA) H9N2 influenza virus infection Dendritic cells (DCs) Neuraminidase (NA) treatment downregulated 27285980 1968 Mouse mmu-miR-181b-5p miRNA histone deacetylase inhibitor (HDACi) B cell differentiation B cells of C57BL/6J "stimulated with LPS and IL-4 and treated with HDI (VPA, 500 ?M) or nil for 60 h" upregulated 28994753 1969 Mouse mmu-miR-181b-5p miRNA high fat diet (HFD) hepatic insulin resistance serum and livers of diabetic mice high fat diet (HFD) feed downregulated 30627917 1970 Mouse mmu-miR-181b-5p miRNA deoxycorticosterone acetate-salt hypertension hypertensive nephropathy (HN) kidney tissues deoxycorticosterone acetate-salt hypertension treatment downregulated 31782248 1971 Mouse mmu-miR-181b-5p miRNA tumor necrosis factor alpha (TNF-¦Á) inflammation mouse cementoblast cell line OCCM©\30 tumor necrosis factor alpha (TNF-¦Á) treatment downregulated 31131439 1972 Mouse mmu-miR-181b-5p miRNA lipopolysaccharide (LPS) postoperative cognitive dysfunction (POCD) BV-2 cell lines lipopolysaccharide (LPS) treatment downregulated 31003188 1973 Mouse mmu-miR-181c miRNA H2O2 acute ischemic stroke (AIS) BV2 microglia H2O2 treatment miR-181c reduced proliferation but increased the apoptosis of these cells with or without LPS/H2O2 treatment. 28053821 1974 Mouse mmu-miR-181c miRNA lipopolysaccharide (LPS) acute ischemic stroke (AIS) BV2 microglia lipopolysaccharide (LPS) treatment miR-181c reduced proliferation but increased the apoptosis of these cells with or without LPS/H2O2 treatment. 28053821 1975 Mouse mmu-miR-181c miRNA ischemia acute kidney injury (AKI) renal tubules ischemia treatment upregulated 27959449 1976 Mouse mmu-miR-181c miRNA hypoxia cerebral hypoxic diseases primary microglia hypoxia treatment downregulated 25545945 1977 Mouse mmu-miR-181c miRNA cigarette smoke (CS) chronic obstructive pulmonary disease (COPD) mouse cigarette smoke (CS) exposure downregulated 28806967 1978 Mouse mmu-miR-181c miRNA high glucose (HG) diabetes mellitus (DM) endothelial cells (MAECs and END-D) high glucose downregulated 28223216 1979 Mouse mmu-miR-181c miRNA myelin oligodendrocyte glycoprotein experimental autoimmune encephalomyelitis (EAE) CD4+ T cells (MOG residues 35-55 treatment miR-181c expression was significantly increased in EAE mice. 29545117 1980 Mouse mmu-miR-181c miRNA high fat diet (HFD) obesity-induced cardiac dysfunction heart sissues high fat diet (HFD) feed HFD significantly upregulated heart levels of miR-181c and led to cardiac hypertrophy in wild-type mice. 32442661 1981 Mouse mmu-miR-181c-5p miRNA reconstituted high-density lipoproteins (rHDL) diabetes-impaired angiogenesis diabetic mice ischaemic hindlimb reconstituted high-density lipoproteins (rHDL) treatment downregulated 30206364 1982 Mouse mmu-miR-181c-5p miRNA oxygen glucose deprivation (OGD) ischemic stroke (IS) primary neuronal cells oxygen glucose deprivation (OGD)-induce treatment downregulated 31334597 1983 Mouse mmu-miR-181c-5p miRNA berberine (BBR) post-stroke inflammation ipsilateral cortex tissues berberine (BBR) treatment Malat1 functions as a ceRNA to contribute to berberine-mediated inhibition of HMGB1 by sponging miR-181c-5p in poststroke inflammation. 31431734 1984 Mouse mmu-miR-181c-5p miRNA berberine (BBR) post-stroke inflammation MCAO treated ipsilateral cortex tissues ?berberine (BBR)?treatment treatment upregulated 31431734 1985 Mouse mmu-miR-181d miRNA coxsackievirus B3 (CVB3) acute viral myocarditis (VM) mouse heart tissues Coxsackievirus B3 (CVB3) infection upregulated 30915768 1986 Mouse mmu-miR-181d miRNA losartan diabetic nephropathy (DN) kidney tissues losartan treatment downregulated 27770539 1987 Mouse mmu-miR-181d miRNA lipopolysaccharide (LPS) inflammation C57BL/6 mouse lipopolysaccharide (LPS) treatment downregulated 24416377 1988 Mouse mmu-miR-181d miRNA isoproterenol cardiac fibrosis heart tissues isoproterenol (ISO) treatment downregulated 27174579 1989 Mouse mmu-miR-181d-5p miRNA acupuncture with low-frequency electrical stimulation (Acu/LFES) muscle atrophy serum exosome acupuncture with low-frequency electrical stimulation (Acu/LFES) treatment miR-181d-5p is increased in the serum exosome of Acu/LFES-treated mice. 30132347 1990 Mouse mmu-miR-182 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) RAW264.7 cells lipopolysaccharide (LPS) treatment miR-182 is inhibited in RAW264.7 cells stimulated with LPS. 32003008 1991 Mouse mmu-miR-182 miRNA alcohol alcoholic liver disease (ALD) mouse liver cells Lieber-DeCarli alcohol treatment downregulated 19572984 1992 Mouse mmu-miR-182 miRNA methionine choline-deficient diet (MCD) alcoholic liver disease (ALD) liver tissues methionine-choline-deficient (MCD) diets treatment downregulated 19572984 1993 Mouse mmu-miR-182 miRNA CTLA4-Ig alloimmune CD4CD44 T cells CTLA4-Ig downregulated 27893611 1994 Mouse mmu-miR-182 miRNA oxygen glucose deprivation (OGD) blood-brain barrier (BBB) dysfunction N2a cells oxygen glucose deprivation (OGD) treatment MiR-182 expression was markedly upregulated and arrived at a peak 2 hours after OGD in N2a cells and was later downregulated. 32808351 1995 Mouse mmu-miR-182 miRNA oxygen glucose deprivation (OGD) blood-brain barrier (BBB) dysfunction bEnd.3 cells oxygen glucose deprivation (OGD) treatment "miR-182 in bEnd.3 cells began to increase at 4 hours after OGD, remained el- evated until 8 hours with a peak at 6 hours." 32808351 1996 Mouse mmu-miR-182 miRNA oxygen glucose deprivation (OGD) blood-brain barrier (BBB) dysfunction microglia; brain vascular pericytes oxygen glucose deprivation (OGD) treatment The level of miR-182 in microglia and brain vascular pericytes gradually decreased with the OGD time extension when compared with the respective control groups. 32808351 1997 Mouse mmu-miR-182 miRNA alcohol brain injury and neurodegeneration cerebral cortex chronic alcohol administration downregulated 30374194 1998 Mouse mmu-miR-182 miRNA dexamethasone (DEX) catabolic diseases mouse C2C12 myoblasts dexamethasone (Dex) treatment downregulated 24871856 1999 Mouse mmu-miR-182 miRNA tetramethylpyrazine (TMP) glaucoma mouse primary retinal ganglion cells (RGCs) Tetramethylpyrazine (TMP) treatment upregulated 31173163 2000 Mouse mmu-miR-182 miRNA cisplatin (DDP) hearing loss cochlea cisplatin treatment upregulated 27607577 2001 Mouse mmu-miR-182 miRNA high fat diet (HFD) hepatocellular carcinoma (HCC) plasma and hepatic tissues high fat diet (HFD) feed upregulated 26728044 2002 Mouse mmu-miR-182 miRNA lipopolysaccharide (LPS) innate immune response RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated 30625496 2003 Mouse mmu-miR-182 miRNA pseudomonas aeruginosa (PA) innate immune response RAW264.7 cells Pseudomonas aeruginosa (PA) infection treatment upregulated 30625496 2004 Mouse mmu-miR-182 miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) intestinal ischemia/reperfusion (I/R) injury mice intestinal mucosa epithelial (MIME) cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 31593847 2005 Mouse mmu-miR-182 miRNA "TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin)" kaposi's sarcoma (KS) fetal thymocytes of mice "TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) treatment" downregulated 23024791 2006 Mouse mmu-miR-182 miRNA narrow band noise noise-induced deafness outer hair cells 2-4 kHz narrow band noise at 100 dB SPL 6h per day for 3 consecutive days treatment downregulated 25026825 2007 Mouse mmu-miR-182 miRNA perfluorooctanoic acid perfluorooctanoic acid toxicity mouse liver tissues Perfluorooctanoic acid (PFOA) exposure treatment upregulated 25092180 2008 Mouse mmu-miR-182 miRNA peritoneal dialysis fluid (PDF) peritoneal fibrosis peritoneal tissues peritoneal dialysis fluid (PDF) treatment upregulated 25827714 2009 Mouse mmu-miR-182 miRNA soluble egg antigen (SEA)of Schistosoma japonicum schistosomiasis mouse hepatocytes (AML12) SEA treatment downregulated 29469324 2010 Mouse mmu-miR-182-5p miRNA cisplatin (DDP) acute kidney injury (AKI) kidney tissues cisplatin treatment upregulated 33647908 2011 Mouse mmu-miR-182-5p miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues; bronchoalveolar lavage fluid (BALF); RAW264.7 cells lipopolysaccharide (LPS) treatment "miR-182-5p was significantly downregulated in lung tissue and bronchoalveolar lavage fluid (BALF), as well as decreased in LPS-treated RAW264.7 cells." 31949658 2012 Mouse mmu-miR-182-5p miRNA tumor necrosis factor alpha (TNF-¦Á) asthma airway smooth muscle (ASM) cells tumor necrosis factor alpha (TNF-¦Á) treatment TNF-¦Á stimulation markedly reduced miR-182-5p expression in ASM cells 32283508 2013 Mouse mmu-miR-182-5p miRNA oxygen glucose deprivation (OGD) cerebral ischemia/reperfusion (I/R) injury BV2 cells oxygen-glucose deprivation (OGD) treatment downregulated 30292407 2014 Mouse mmu-miR-182-5p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral ischemia/reperfusion (I/R) injury HT22 (mouse hippocampal neuronal cells) oxygen-glucose deprivation and reoxygenation (OGD/R) treatment lncRNA SNHG14 promotes OGD/R-induced neuron injury by inducing excessive mitophagy via miR-182-5p/BINP3 axis in HT22 mouse hippocampal neuronal cells 32912324 2015 Mouse mmu-miR-182-5p miRNA ethanol (EtOH) ethanol-induced neuroinflammation and brain damage plasma exosomes ethanol treatment downregulated 32937997 2016 Mouse mmu-miR-182-5p miRNA fatty acid amide hydrolase (FAAH) blockade experimental colitis colon Fatty acid amide hydrolase (FAAH) blockade treatment upregulated 27327245 2017 Mouse mmu-miR-182-5p miRNA microcystin (MC) female mammals' reproductive toxicity mouse granulosa cells (mGCs) microcystin-LR (MC-LR) for 48 h dysregulated 28161121 2018 Mouse mmu-miR-182-5p miRNA trichloroethylene (TCE) hepatocarcinogenesis mouse liver tissues Trichloroethylene (TCE) treatment upregulated 31524101 2019 Mouse mmu-miR-182-5p miRNA trichloroethylene (TCE) hepatocellular carcinoma (HCC) mouse liver cell lines (BNL CL.2 and Hepa1-6) TCE at non-toxic doses (0.1 and/or 0.3 mM) treatment upregulated 28013219 2020 Mouse mmu-miR-182-5p miRNA bleomycin (BLM) idiopathic pulmonary fibrosis (IPF) pulmonary tissues bleomycin (BLM) treatment upregulated 31884830 2021 Mouse mmu-miR-182-5p miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharide (LPS) treatment downregulated 32955644 2022 Mouse mmu-miR-182-5p miRNA cyclosporine A (CsA) liver toxicity mouse hepatocytes cyclosporine A treatment upregulated 25047351 2023 Mouse mmu-miR-182-5p miRNA bleomycin (BLM) lung fibrosis lung tissues bleomycin (BLM) treatment miR-182-5p was upregulated in pulmonary fibrosis. 31884830 2024 Mouse mmu-miR-182-5p miRNA murine cytomegalovirus (MCMV) murine cytomegalovirus (MCMV) infection cardiac tissue murine cytomegalovirus (MCMV) infection downregulated 33245094 2025 Mouse mmu-miR-182-5p miRNA glial cell-derived neurotrophic factor (GDNF) parkinson's disease (PD) primary midbrain neurons (PMNs) glial cell line-derived neurotrophic factor (GDNF) treatment upregulated 29858093 2026 Mouse mmu-miR-182-5p miRNA staphylococcus aureus pneumonia sepsis ?intestinal tissues Staphylococcus aureus pneumonia infection treatment upregulated 31318050 2027 Mouse mmu-miR-182-5p miRNA H2O2 spinal cord injury (SCI) C8-D1A cells H2O2 treatment miR-182-5p was significantly reduced in a dose dependent manner under dif- ferent concentrations of H2O2 stimulation. 31938420 2028 Mouse mmu-miR-182-5p miRNA cyclophosphamide (CP) systemic lupus erythematosus (SLE) C3.MRL-Faslpr/J mice C3.MRL-Faslpr/J mice treatment downregulated 27924862 2029 Mouse mmu-miR-182-5p miRNA trichloroethylene (TCE) trichloroethylene (TCE) hepatocarcinogenesis liver tissues Trichloroethylene (TCE) treatment downregulated of lncRNA BACE1-AS inhibits iNOS activation in the substantial nigra and improve oxidative stress injury in PD rats by upregulating miR-34b-5p and downregulating BACE1 31942800 2030 Mouse mmu-miR-1827 miRNA house dust mite (HDM) asthma C57BL/6J mice airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF) HDM treatment dysregulated in airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF) 28859242 2031 Mouse mmu-miR-183 miRNA alcohol alcoholic liver disease (ALD) mouse liver cells Lieber-DeCarli alcohol treatment downregulated 19572984 2032 Mouse mmu-miR-183 miRNA methionine choline-deficient diet (MCD) alcoholic liver disease (ALD) liver tissues methionine-choline-deficient (MCD) diets treatment downregulated 19572984 2033 Mouse mmu-miR-183 miRNA HO-1 inducers bone resorption Raw264.7 cells HO-1 inducers treatment downregulated 26163109 2034 Mouse mmu-miR-183 miRNA alcohol brain injury and neurodegeneration cerebral cortex chronic alcohol administration downregulated 30374194 2035 Mouse mmu-miR-183 miRNA gentamicin hearing restoration hair cells from mouse cochlea. Gentamicin treatment downregulated 29901127 2036 Mouse mmu-miR-183 miRNA lipopolysaccharide (LPS) innate immune response RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated 30625496 2037 Mouse mmu-miR-183 miRNA pseudomonas aeruginosa (PA) innate immune response RAW264.7 cells Pseudomonas aeruginosa (PA) infection treatment upregulated 30625496 2038 Mouse mmu-miR-183 miRNA narrow band noise noise-induced deafness outer hair cells 2-4 kHz narrow band noise at 100 dB SPL 6h per day for 3 consecutive days treatment downregulated 25026825 2039 Mouse mmu-miR-183 miRNA perfluorooctanoic acid perfluorooctanoic acid toxicity mouse liver tissues Perfluorooctanoic acid (PFOA) exposure treatment upregulated 25092180 2040 Mouse mmu-miR-183-5p miRNA brucella.suis brucellosis CD14 knock-down RAW264.7 (224.3) macrophages brucella infection upregulated 28443393 2041 Mouse mmu-miR-183-5p miRNA oxygen glucose deprivation (OGD) cerebral ischemia injury (CII) N2a cells oxygen glucose deprivation (OGD) treatment downregulated 32901892 2042 Mouse mmu-miR-183-5p miRNA Sinomenine (SIN) cerebral ischemia/reperfusion (I/R) injury BV-2 cells sinomenine treatment Sinomenine pre- treatment increased miRNA-183-5p 30084807 2043 Mouse mmu-miR-183-5p miRNA adenine chronic kidney disease (CKD) kidney tissues adenine treatment upregulated 32526762 2044 Mouse mmu-miR-183-5p miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharide (LPS) treatment downregulated 32955644 2045 Mouse mmu-miR-183-5p miRNA collagenase VII-S intracerebral haemorrhage (ICH) brain tissues collagenase VII-Streatment downregulated 32602850 2046 Mouse mmu-miR-183-5p miRNA X rays ionizing radiation (IR) injury male Kunming mice blood 0.5-2 Gy total-body carbon-ion irradiation treatment dysregulatedin blood 28632432 2047 Mouse mmu-miR-183-5p miRNA palmitic acid (PA) myogenic differentiation C2C12 cells Long-chain SFA palmitic acid (PA) treatment miR-183-5p expression was found to be increased significantly in PA-treated C2C12 myo- blasts 33148375 2048 Mouse mmu-miR-183-5p miRNA palmitic acid (PA) nonalcoholic fatty liver disease (NAFLD) AML12 cell palmitic acid (PA) treatment Expression of miR-183-5p was increased in the livers of three murine models and also in the AML12 cell model 33421522 2049 Mouse mmu-miR-183-5p miRNA "4,4'-methylene diphenyl diisocyanate (MDI)" occupational asthma (OA) Female BALB/c mice blood "4,4'-methylene diphenyl diisocyanate (MDI) exposure" upregulated 30074411 2050 Mouse mmu-miR-183-5p miRNA "diisocyanate, 4,4'-methylene diphenyl diisocyanate (MDI)" occupational asthma (OA) Female BALB/c mice blood Female BALB/c mice were exposed to one of three exposure regimens: dermal exposure to 1% MDI in acetone; nose-only exposure to 4580?¡À?1497?¦Ìg/m3 MDI-aerosol for 60?minutes; or MDI dermal exposure/sensitization followed by MDI-aerosol inhalation challenge. upregulated 30074411 2051 Mouse mmu-miR-183-5p miRNA glial cell-derived neurotrophic factor (GDNF) parkinson's disease (PD) primary midbrain neurons (PMNs) glial cell line-derived neurotrophic factor (GDNF) treatment upregulated 29858093 2052 Mouse mmu-miR-183c miRNA dihydroartemisinin (DHA) asthma asthma mice lung tissues dihydroartemisinin (DHA) treatment downregulated 31115390 2053 Mouse mmu-miR-183c miRNA ovalbumin (OVA) asthma lung tissues ovalbumin (OVA) treatment upregulated 31115390 2054 Mouse mmu-miR-184 miRNA BAM8-22 bone cancer pain (BCP) LPS-treated BV-2 mouse microglial cells BAM8-22 treatment upregulated 31833017 2055 Mouse mmu-miR-184 miRNA lipopolysaccharide (LPS) bone cancer pain (BCP) BV-2 mouse microglial cells lipopolysaccharide (LPS) treatment downregulated 31833017 2056 Mouse mmu-miR-184 miRNA lipopolysaccharide (LPS) bone cancer pain (BCP) BV-2 cells lipopolysaccharide (LPS) treatment "After BAM8-22 treatment, increased miR-184 level was observed in both BCP mice and LPS-treated BV-2 cells." 31833017 2057 Mouse mmu-miR-184 miRNA phenylephrine (PE) cardiac hypertrophy cardiomyocytes phenylephrine (PE) treatment miR-184 was downregulated in the cardiomyocytes treated with phenylephrine (PE) 29616999 2058 Mouse mmu-miR-184 miRNA high fat diet (HFD) diabetic cardiomyopathy (DCM) heart sissues high fat diet (HFD) feed miR-184 decreased significantly during the 24 weeks of high fat diet exposure. 32229289 2059 Mouse mmu-miR-184 miRNA ketogenic insulin resistance (IR) pancreatic ¦Â cell ketogenic diet treatment upregulated 24361012 2060 Mouse mmu-miR-184 miRNA huagan tongluo Fang (HGTLF) liver fibrosis CD4+ T cells Huagan tongluo Fang (HGTLF) treatment miR-184 was most significantly expressed after HGTLF drug stimulation. 32380055 2061 Mouse mmu-miR-184 miRNA ischemia oxygen-induced retinopathy (OIR) retinas tissues ischemia treatment downregulated 25796186 2062 Mouse mmu-miR-184 miRNA ischemia renal fibrosis mouse renal tissues left anterior descending artery (LAD) ligation upregulated 30536131 2063 Mouse mmu-miR-184 miRNA cortical impact traumatic brain injury (TBI) cortex cortical impact upregulated 26426744 2064 Mouse mmu-miR-1843-3p miRNA propofol (PPF) propofol-induced developmental neurotoxicity hippocampus propofol treatment upregulated 30242182 2065 Mouse mmu-miR-184-3p miRNA 3¦Â-hydroxycholest-5-en-7-one anti-inflammatory responses RAW 264.7 cells 3¦Â-hydroxycholest-5-en-7-one treatment downregulated 32771556 2066 Mouse mmu-miR-184-3p miRNA microcystin-leucine arginine (MC-LR) male infertility Primary sertoli cells (SC) were isolated from 14-day-old ICR mouse testes Microcystin-leucine-arginine (MC-LR) treatment downregulated 29071384 2067 Mouse mmu-miR-184-3p miRNA microcystin-leucine arginine (MC-LR) male reproductive disorders primary SC were isolated from 14-day-old ICR mouse MC-LR at 500 nM on day 4 downregulated 29071384 2068 Mouse mmu-miR-184-5p miRNA streptozocin (STZ) diabetic neuropathic pain (DNP) mouse lumbar spinal dorsal horn STZ treatment differently regulated 25498543 2069 Mouse mmu-miR-184-5p miRNA oxygen glucose deprivation (OGD) ischemic stroke (IS) primary brain microvascular endothelial cells (bEnd.3) oxygen-glucose deprivation (OGD) treatment LncOGD-1006 might act as a ceRNA to inhibit apoptosis in bEnd3 cells by targeting miR-184-5p/CAAP1 pathway 33336752 2070 Mouse mmu-miR-185 miRNA resveratrol acute liver injury (ALI) liver mononuclear cells (MNCs) resveratrol (Res) treatment downregulated 30619104 2071 Mouse mmu-miR-185 miRNA hyperoxia acute lung injury (ALI) mouse primary lung epithelial cells mouse primary lung epithelial cells treatment upregulated 26747785 2072 Mouse mmu-miR-185 miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) mouse macrophages atherogenic Evs oxidized low-density lipoprotein (ox-LDL) treatment enrichment in atherogenic EVs 28882869 2073 Mouse mmu-miR-185 miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) peritoneal macrophages; Bone-marrow derived macrophages (BMDMs) oxidized low-density lipoprotein (ox-LDL) treatment upregulated 28882869 2074 Mouse mmu-miR-185 miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues CCl4 treatment downregulated 29499960 2075 Mouse mmu-miR-185 miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues intraperitoneally injected with CCl4 (0.5 mL/kg body weight) three times a week for 4 weeks downregulated 29499960 2076 Mouse mmu-miR-185-5p miRNA Jiang Tang Xiao Ke Granule diabetes mellitus (DM) liver tissues Jiang Tang Xiao Ke treatment downregulated 32210802 2077 Mouse mmu-miR-185-5p miRNA high glucose (HG) diabetic nephropathy (DN) mesangial cell ?high glucose (HG)?treatment treatment The expression of Gm26917 was induced by HG but weakened by RSG 33790061 2078 Mouse mmu-miR-185-5p miRNA rosiglitazone diabetic nephropathy (DN) mesangial cell Rosiglitazone (RSG) treatment The expression of Gm26917 was induced by HG but weakened by RSG 33790061 2079 Mouse mmu-miR-185-5p miRNA acetaminophen (APAP) liver damage AML12 cells acetaminophen (APAP) treatment circ-CBFB acts as a miRNA sponge of miR-185-5p to mediate p66Shc in APAP-induced liver injury. 33159035 2080 Mouse mmu-miR-186 miRNA dexamethasone (DEX) glucocorticoid-induced osteoporosis (GIOP) tibia of GIOP mice dexamethasone (DEX) treatment downregulated in the tibia of GIOP mice 29257214 2081 Mouse mmu-miR-186 miRNA icariin (ICA) glucocorticoid-induced osteoporosis (GIOP) tibia icariin treatment upregulated 29257214 2082 Mouse mmu-miR-186 miRNA monosodium glutamate (MSG) obesity liver tissues monosodium glutamate (MSG)-injected mice with developed central obesity treatment dysregulated 24465854 2083 Mouse mmu-miR-186 miRNA papain osteoarthritis (OA) OA cartilages papain treatment downregulated 30500068 2084 Mouse mmu-miR-186 miRNA papain osteoarthritis (OA) OA cartilages intra-articular injection of papain into mice downregulated 30500068 2085 Mouse mmu-miR-186 miRNA complete freund's adjuvant (CFA) trigeminal neuropathic pain trigeminal ganglions (TGs) complete Freund's adjuvant (CFA) treatment downregulated 30020320 2086 Mouse mmu-miR-186 miRNA aerobic exercise vascular cognitive impairment (VCI) HT22 cells aerobic exercise training (AET) treatment "Aerobic exercise could shorten the average time that mice reached the platform in the Morris water maze, increase the expression level of circRIMS2 and BDNF, reduce miR-186 expression, and inhibit neuronal apoptosis." 33413076 2087 Mouse mmu-miR-186-5p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) ischemic stroke (IS) BV2 cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment upregulated 33516048 2088 Mouse mmu-miR-186-5p miRNA fractionated radiation ionizing radiation (IR) injury LLC1 cells fractionated dose (FD) irradiation upregulated 28599420 2089 Mouse mmu-miR-187 miRNA glutamate oxidative stress RGC-5 cells glutamate treatment downregulated 30170060 2090 Mouse mmu-miR-187 miRNA H2O2 oxidative stress RGC-5 cells H2O2 treatment downregulated 30170060 2091 Mouse mmu-miR-188 miRNA amyloid-¦Â (A¦Â) Alzheimer's disease (AD) BV2;N2a cells amyloid-¦Â (A¦Â) treatment downregulated 32779043 2092 Mouse mmu-miR-188 miRNA arsenite atherosclerosis (AS) liver arsenic (As) exposure downregulated 22719926 2093 Mouse mmu-miR-188 miRNA homocysteine (Hcy) cardiac hypertrophy HL-1 cell line homocysteine treatment downregulated 19669742 2094 Mouse mmu-miR-188 miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver tissues high fat diet (HFD) feed miR-188 was upregulated in the liver of obese mice. 32252024 2095 Mouse mmu-miR-188-5p miRNA angiotensin II (Ang II) cardiac hypertrophy cardiomyocytes angiotensin II (Ang II) treatment DSCAM-AS1 mediates pro-hypertrophy role of GRK2 in cardiac hypertrophy aggravation via absorbing miR-188-5p. 32377998 2096 Mouse mmu-miR-188-5p miRNA hypoxia choroidal neovascularization (CNV)-related diseases "bone marrow-derived cells (BMCs), including mesenchymal stem cells (MSCs)" hypoxia induce downregulated 29908885 2097 Mouse mmu-miR-188-5p miRNA carbon tetrachloride (CCl4) liver fibrosis liver CCl4 treatment upregulated 27322257 2098 Mouse mmu-miR-1894-5p miRNA delvestidine (DLTD) bone marrow-derived dendritic cells (BMDCs) maturity bone marrow-derived dendritic cells (BMDCs) Delvestidine (DLTD) treatment downregulated 32871480 2099 Mouse mmu-miR-1896 miRNA IL-17 experimental autoimmune encephalomyelitis (EAE) astrocytes from EAE mice interleukin-17 (IL-17) treatment upregulated 30294880 2100 Mouse mmu-miR-1896 miRNA IL-17 multiple sclerosis (MS) Primary mouse astrocytes interleukin-17 (IL-17) treatment upregulated 30294880 2101 Mouse mmu-miR-1897-3p miRNA clamping the renal pedicle bilateral renal ischemia C57Bl/6 mice plasma and kidneys clamping the renal pedicle treatment upregulated 24695114 2102 Mouse mmu-miR-1897-5p miRNA cigarette smoke (CS) ovarian toxicity ovarian tissues cigarette smoke (CS) treatment upregulated 29377183 2103 Mouse mmu-miR-18a miRNA polyphyllin VI (PP-VI) breast cancer mouse mammary carcinoma 4T1 Polyphyllin VI (PP-VI) treatment downregulated 30817902 2104 Mouse mmu-miR-18a miRNA hyperoxia bronchopulmonary dysplasia (BPD) lung tissues hyperoxia treatment downregulated 33143661 2105 Mouse mmu-miR-18a miRNA panax notoginseng saponins (PNS) comanifestation of cancer heart tissues PNS treatment reduced expression of miR-18a in tumor and upregulated expression of miR-18a in heart 24903055 2106 Mouse mmu-miR-18a miRNA duloxetine depression frontal lobe and hippocampus duloxetine treatment upregulated 26823914 2107 Mouse mmu-miR-18a miRNA hyperoxia hyperoxia-induced acute lung injury (HALI) MLE-12 cells hyperoxia treatment downregulated 32084370 2108 Mouse mmu-miR-18a miRNA ¦¤9-tetrahydrocannabinol (THC) inflammatory lung injury splenocytes ¦¤(9) tetrahydrocannabinol (THC) treatment upregulated 25425209 2109 Mouse mmu-miR-18a miRNA panax notoginseng saponins (PNS) breast cancer mammary carcinoma 4T1 cells Panax Notoginseng Saponins (PNS) treatment downregulated 27641158 2110 Mouse mmu-miR-18a miRNA TGF-¦Â myofibroblast formation cortical bone derived stem cells (CBSCs) TGF-¦Â treatment The upregulation of miR-18a was validated in adult fibroblasts treated with CBSCs compared to control cells 32656212 2111 Mouse mmu-miR-18a miRNA oxygen glucose deprivation (OGD) neuronal cell injury Neuro-2a (N2a) oxygen-glucose deprivation (OGD) treatment "Silencing of SNHG15 led to CXCL13 upregulation through sequestering miR-18a and the following ERK/MEK activation, thus enhancing viability while reducing apoptosis of N2a cells." 32862188 2112 Mouse mmu-miR-18a miRNA acetylcholine (ACh) peripheral nerve injury (PNI) hematopoietic stem cells (HSCs) acetylcholine (ACh) treatment "The therapeutic agents can thus be targeted to the enzyme protein, its encoding mRNA transcripts, or the regulator microRNA-132, opening new venues for therapeutic interference with multiple nervous and immune system diseases" 22448158 2113 Mouse mmu-miR-18a miRNA mycobacterium tuberculosis (Mtb) tuberculosis (TB) RAW264.7 cells and secreted exosomes Mycobacterium tuberculosis (Mtb) infection upregulated 31845528 2114 Mouse mmu-miR-18a miRNA mycobacterium tuberculosis (Mtb) tuberculosis (TB) RAW264.7 cells mycobacterium tuberculosis (Mtb) treatment miR-18a was induced both in Mtb-infected RAW264.7 cells and its derived exosomes compared with the controls. 31845528 2115 Mouse mmu-mir-18a-5p miRNA second-hand smoke (SHS) asthma lung second-hand smoke (SHS) treatment upregulated 26859758 2116 Mouse mmu-miR-18a-5p miRNA resveratrol chronically diabetic nephropathy db/db mice renal tissues resveratrol (Res) treatment upregulated 29164562 2117 Mouse mmu-miR-18a-5p miRNA folic acid kidney injury and fibrosis kidney cortex folic acid treatment upregulated 26707937 2118 Mouse mmu-miR-18a-5p miRNA oxygen proliferative retinopathy (OIR) retinal tissues oxygen treatment upregulated 32210827 2119 Mouse mmu-miR-18b miRNA "TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin)" kaposi's sarcoma (KS) fetal thymocytes of mice "TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) treatment" downregulated 23024791 2120 Mouse mmu-miR-19 miRNA imiquimod (IMQ) psoriasis-like dermatitis the mouse skin tissues IMQ treatment dysregulated 27579777 2121 Mouse mmu-miR-190 miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) substantia nigra pars compacta (SNpc) "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" downregulated 31232472 2122 Mouse mmu-miR-190 miRNA lipopolysaccharide (LPS) parkinson's disease (PD) BV2 cells lipopolysaccharide (LPS) treatment downregulated 31232472 2123 Mouse mmu-miR-190 miRNA cortical impact traumatic brain injury (TBI) cortex cortical impact downregulated 26426744 2124 Mouse mmu-miR-1902 miRNA lipopolysaccharide (LPS) bacterial infection "the whole blood, serum and white blood cells (WBCs) of C57BL/6 and Tlr2-/- mice" lipopolysaccharide (LPS) treatment upregulated 23286671 2125 Mouse mmu-miR-1903 miRNA walnut colorectal cancer (CRC) colorectal tumor tissue walnut-containing diet treatment downregulated 25882694 2126 Mouse mmu-miR-1904 miRNA lipopolysaccharide (LPS) bacterial infection "the whole blood, serum and white blood cells (WBCs) of C57BL/6 and Tlr2-/- mice" lipopolysaccharide (LPS) treatment upregulated 23286671 2127 Mouse mmu-miR-1906 miRNA microcystin (MC) female mammals' reproductive toxicity mouse granulosa cells (mGCs) microcystin-LR (MC-LR) for 48 h dysregulated 28161121 2128 Mouse mmu-miR-1907 miRNA high fat diet (HFD) atherosclerosis (AS) ApoE (-/-) mice endothelial cell high fat diet (HFD) feed upregulated 28804559 2129 Mouse mmu-miR-190a-5p miRNA streptozocin (STZ) diabetic neuropathic pain (DNP) mouse lumbar spinal dorsal horn STZ treatment differently regulated 25498543 2130 Mouse mmu-miR-190b miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver tissues high fat diet (HFD) feed upregulated 29575055 2131 Mouse mmu-miR-190b miRNA ¦Â-elemene oxygen-induced retinopathy (OIR) Retinas tissues ¦Â-elemene treatment upregulated 30664207 2132 Mouse mmu-miR-191 miRNA ischemia/reperfusion (I/R) acute myocardial infarction (AMI) heart tissues ischemia/reperfusion (I/R) treatment upregulated 28090786 2133 Mouse mmu-miR-191 miRNA arsenite arsenicism liver tissues arsenite exposure upregulated 33743404 2134 Mouse mmu-miR-191* miRNA smoking smoking-related interstitial fibrosis (SRIF) C57 mice circulating 6 months of chronic mainstream smoking exposure treatment downregulated 22782705 2135 Mouse mmu-miR-1912-5p miRNA dioscorea bulbifera (DB) liver damage livers dioscoreae bulbifera (EF) treatment upregulated 27609015 2136 Mouse mmu-miR-191-5p miRNA amyloid-¦Â (A¦Â) 1-40 age-related macular degeneration (AMD) retinal pigment epithelium (RPE) cell amyloid-¦Â (A¦Â) 1-40 treatment A¦Â1-40?-mediated RPE damage by inducing a decrease in endogenous miR-191-5p expression. 33715208 2137 Mouse mmu-miR-191-5p miRNA epigallocatechin-3-gallate (EGCG) Alzheimer's disease (AD) AD mouse serum EGCG treatment groups (2 mg/kg/day) upregulated 28731435 2138 Mouse mmu-miR-191-5p miRNA house dust mite (HDM) asthma C57BL/6J mice airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF) HDM treatment dysregulated in airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF) 28859242 2139 Mouse mmu-miR-192 miRNA staphylococcal enterotoxin B (SEB) acute inflammatory lung injury lung staphylococcal enterotoxin B treatment upregulated 25564423 2140 Mouse mmu-miR-192 miRNA acetaminophen (APAP) acute liver failure (ALF) mouse liver tissues acetaminophen (APAP) treatment upregulated 28616908 2141 Mouse mmu-miR-192 miRNA alcohol alcoholic hepatitis (AH) sera alcohol exposure upregulated 26264599 2142 Mouse mmu-miR-192 miRNA TGF-¦Â chronic hepatitis C virus (HCV) infection Primary mouse MCs (MMCs) were cultured from renal glomeruli Transforming growth factor-¦Â treatment upregulated 23649518 2143 Mouse mmu-miR-192 miRNA alcohol extract of coreopsis tinctoria Nutt (AC) diabetic nephropathy (DN) db/db (DN) mice alcohol extract of Coreopsis tinctoria Nutt (AC) treatment downregulated 31032350 2144 Mouse mmu-miR-192 miRNA TGF-¦Â diabetic nephropathy (DN) diabetic glomeruli TGF-¦Â treatment upregulated 17360662 2145 Mouse mmu-miR-192 miRNA TGF-¦Â DNA damage tubular epithelial cells TGF-¦Â treatment downregulated 23207693 2146 Mouse mmu-miR-192 miRNA oxyELITE pro-new formula (OEP-NF) drug-induced liver injury (DILI) female B6C3F1 mice liver administering 10X and 3X mouse-equivalent doses (MED) of OEP-NF treatment upregulated in the liver 28843594 2147 Mouse mmu-miR-192 miRNA bisphenol A (BPA) hepatic steatosis and lipid accumulation male post-weaning C57BL/6 mice liver bisphenol A (BPA) treatment downregulated mouse liver 28483554 2148 Mouse mmu-miR-192 miRNA high fat diet (HFD) high fat diet?influence liver tissue high fat diet (HFD) feed upregulated 19835573 2149 Mouse mmu-miR-192 miRNA Sinomenine (SIN) inflammation ATDC5 cells injured by lipopolysaccharides (LPS) Sinomenine (SIN) treatment miR-192 was downregulated by SIN treatment 31094031 2150 Mouse mmu-miR-192 miRNA silymarin (Sm) liver damage blood and liver tissues silymarin (Sm) treatment upregulated 31811641 2151 Mouse mmu-miR-192 miRNA acetaminophen (APAP) liver damage liver tissues acetaminophen (APAP) treatment upregulated 19246379 2152 Mouse mmu-miR-192 miRNA dexamethasone (DEX) muscle atrophy Murine C2C12 myoblast cells dexamethasone (DEX) treatment upregulated 23716137 2153 Mouse mmu-miR-192 miRNA cyclosporine A (CsA) nephrotoxicity mouse kidney cyclosporine A treatment upregulated 28414804 2154 Mouse mmu-miR-192 miRNA pioglitazone nonalcoholic fatty liver disease (NAFLD) liver tissues of adiponectin knockout (adipoKO) mouse pioglitazone treatment resistance to pioglitazone treatment in adipoKO mice was associated with increased expression of miR-192 31176759 2155 Mouse mmu-miR-192 miRNA streptozocin (STZ) nonalcoholic steatohepatitis-hepatocellular carcinoma (NASH-HCC) high fat dietmouse liver STZ treatment upregulated in liver 28345673 2156 Mouse mmu-miR-192 miRNA aerobic training obesity exosomes of serum aerobic training downregulated 32744099 2157 Mouse mmu-miR-192 miRNA metformin (Met) pancreatic cancer (PC) human pancreatic cancer cells metformin treatment upregulated 22245693 2158 Mouse mmu-miR-192 miRNA plasmodium chabaudi malaria peak parasitemia liver of mice Plasmodium chabaudi malaria infection treatment downregulated 21085987 2159 Mouse mmu-miR-192 miRNA TGF-¦Â1 renal fibrosis kidneys of diabetic mice TGF-¦Â1 treatment TGF-¦Â1 upregulates microRNA-192 (miR-192) in cultured glomerular mesangial cells 22223877 2160 Mouse mmu-miR-192-5p miRNA ovalbumin (OVA) asthma lung tissues ovalbumin (OVA) treatment downregulated 31918268 2161 Mouse mmu-miR-192-5p miRNA lipopolysaccharide (LPS) autophagy RAW 264.7 cells lipopolysaccharide (LPS) treatment downregulated 29845275 2162 Mouse mmu-miR-192-5p miRNA chronic unpredictable mild stress (CUMS) depression Hippocampus chronic unpredictable mild stress (CUMS) treatment downregulated 30118321 2163 Mouse mmu-miR-192-5p miRNA Jiang Tang Xiao Ke Granule diabetes mellitus (DM) KKAy diabetic mice Jiang Tang Xiao Ke Granule treatment dysregulated 29163176 2164 Mouse mmu-miR-192-5p miRNA acetaminophen (APAP) drug-induced liver injury (DILI) plasma acetaminophen (APAP) treatment miR-122-5p and miR-192-5p were consistently upregulated in early to late stages of all the liver injury models. 30125006 2165 Mouse mmu-miR-192-5p miRNA perfluorooctanoic acid hepatotoxicity liver tissues Perfluorooctanoic acid (PFOA) exposure treatment upregulated 24459700 2166 Mouse mmu-miR-192-5p miRNA hypoxia immunological tumor escape B16F10 hypoxia treatment upregulated 33066331 2167 Mouse mmu-miR-192-5p miRNA carbon tetrachloride (CCl4) liver damage liver CCl4 treatment upregulated 27129188 2168 Mouse mmu-miR-192?5p miRNA carbon tetrachloride (CCl4) hepatotoxicity blood carbon tetrachloride (CCl4) treatment upregulated 32528856 2169 Mouse mmu-miR-1929-3p miRNA murine cytomegalovirus (MCMV) essential hypertension (EH) blood vessel murine cytomegalovirus (MCMV) infection "MCMV infection increased the blood pressure, promoted vascular remodeling, caused endothelial cell injury, and downregulated miR-1929-3p." 33416142 2170 Mouse mmu-miR-1929-3p miRNA murine cytomegalovirus (MCMV) murine cytomegalovirus (MCMV) infection thoracic aorta murine cytomegalovirus (MCMV) infection downregulated 33245094 2171 Mouse mmu-miR-1929-3p miRNA murine cytomegalovirus (MCMV) murine cytomegalovirus (MCMV) infection cardiac tissue murine cytomegalovirus (MCMV) infection downregulated 33245094 2172 Mouse mmu-miR-1929-3p miRNA murine cytomegalovirus (MCMV) vascular remodeling blood vessels murine cytomegalovirus (MCMV) infection "MCMV infection increased the blood pressure, promoted vascular remodeling, caused endothelial cell injury, and downregulated miR-1929-3p." 33416142 2173 Mouse mmu-miR-193 miRNA high fat diet (HFD) chondrogenesis white adipose tissues high fat diet (HFD) feed downregulated 22496873 2174 Mouse mmu-miR-193 miRNA TGF-¦Â liver fibrosis liver TGF-¦Â treatment downregulated 26120970 2175 Mouse mmu-miR-193 miRNA chronic intermittent hypoxia (CIH) obstructive sleep apnoea-hypopnoea syndrome (OSAHS) mouse aortic endothelial cells (MAECs) chronic intermittent hypoxia (CIH) treatment upregulated 29108914 2176 Mouse mmu-miR-193 miRNA clozapine (CLZ) psychotic disorders mouse brain clozapine treatment upregulated 23318695 2177 Mouse mmu-miR-193* miRNA staphylococcal enterotoxin B (SEB) acute inflammatory lung injury lung staphylococcal enterotoxin B treatment upregulated 25564423 2178 Mouse mmu-miR-1930-5p miRNA oxygen glucose deprivation (OGD) intracerebral haemorrhage (ICH) Primary brain microvascular endothelial cells (BMECs) oxygen-and-glucose-deprivation (OGD) treatment downregulated 33836898 2179 Mouse mmu-miR-193-3p miRNA apolipoprotein A-I mimetic peptide 4F pulmonary arterial hypertension (PAH) hypoxia mouse model lung tissue and serum apolipoprotein A-I mimetic peptide 4F treatment downregulated 24963038 2180 Mouse mmu-miR-1934 miRNA stretch myoblast proliferation C2C12 myoblasts stretch treatment downregulated 27840929 2181 Mouse mmu-miR-193-5p miRNA adenine chronic kidney disease (CKD) kidney tissues adenine treatment upregulated 32526762 2182 Mouse mmu-miR-1937a miRNA high fat diet (HFD) erectile dysfunction (ED) mouse high fat diet (HFD) feed dysregulated 25533598 2183 Mouse mmu-miR-1937c miRNA high fat diet (HFD) erectile dysfunction (ED) mouse high fat diet (HFD) feed dysregulated 25533598 2184 Mouse mmu-miR-193a miRNA insulin-like growth factor 2 (IGF-2) cell proliferation C-kit-positive cardiac stem cells (CSCs) Insulin-like growth factor (IGF)-1 treatment downregulated 29467020 2185 Mouse mmu-miR-193a miRNA streptozocin (STZ) diabetic nephropathy (DN) lumbar spinal dorsal horn streptozocin (STZ) treatment downregulated 31665716 2186 Mouse mmu-miR-193a miRNA oxyELITE pro-new formula (OEP-NF) drug-induced liver injury (DILI) female B6C3F1 mice liver administering 10X and 3X mouse-equivalent doses (MED) of OEP-NF treatment upregulated in the liver 28843594 2187 Mouse mmu-miR-193a miRNA melatonin leukemia U937T cells melatonin (MLT) treatment upregulated 31119862 2188 Mouse mmu-miR-193a miRNA ligustrazine (Lig) lung fibrosis paraquat (PQ)-exposed mice lung tissues Ligustrazine (Lig) treatment upregulated 30744607 2189 Mouse mmu-miR-193a miRNA paraquat (PQ) lung fibrosis lung tissues paraquat (PQ) exposure downregulated 30744607 2190 Mouse mmu-miR-193a-3p miRNA concanamycin A (Con A) liver fibrosis liver tissues concanavalin A (ConA) treatment downregulated 30945448 2191 Mouse mmu-miR-193a-3p miRNA plasmodium chabaudi malaria peak parasitemia liver of mice Plasmodium chabaudi malaria infection treatment downregulated 21085987 2192 Mouse mmu-miR-193a-5p miRNA resveratrol acute lung injury (ALI) lung tissues resveratrol (Res) treatment miR-193a was strongly induced by SEB and was downregulated by RES treatment 29512867 2193 Mouse mmu-miR-193a-5p miRNA diethylnitrosamine (DEN) hepatocellular carcinoma (HCC) liver tissues diethylnitrosamine (DEN) treatment downregulated 30165047 2194 Mouse mmu-miR-193a-5p miRNA diethylnitrosamine (DEN) hepatocellular carcinoma (HCC) liver tissues diethylnitrosamine (DEN) treatment downregulated 30165047 2195 Mouse mmu-miR-193b miRNA H2O2 Alzheimer's disease (AD) Primary hippocampal neuron cells H2O2 treatment upregulated 24423585 2196 Mouse mmu-miR-193b miRNA H2O2 Alzheimer's disease (AD) senescence accelerated mouse prone 8 (SAMP8) and prone 10 (SAMP10) "different concentrations (0, 100, 200, 400 and 800 ¦ÌM) of H2O2 treatment" upregulated 24423585 2197 Mouse mmu-miR-193b miRNA luteinising hormone (LH) functions of Leydig cells mouse TM3 Leydig cells luteinising hormone (LH) treatment upregulated 28762514 2198 Mouse mmu-miR-193b miRNA high fat diet (HFD) hepatocellular carcinoma (HCC) plasma and hepatic tissues high fat diet (HFD) feed upregulated 26728044 2199 Mouse mmu-miR-193b miRNA luteinising hormone (LH) steroidogenesis mouse TM3 Leydig cells luteinising hormone(LH) treatment dysregulated 28762514 2200 Mouse mmu-miR-193b* miRNA cecal ligation and puncture (CLP) polymicrobial sepsis C57Bl/6 mice cecal ligation and puncture (CLP) treatment different regulation 24413579 2201 Mouse mmu-miR-193b-3p miRNA concanamycin A (Con A) autoimmune hepatitis (AIH) liver tissues concanavalin A (Con A) treatment downregulated 32965791 2202 Mouse mmu-mir-193b-3p miRNA recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) bacterial infection blood recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) treatment upregulated 25563241 2203 Mouse mmu-miR-193b-3p miRNA concanamycin A (Con A) liver fibrosis liver tissues concanavalin A (ConA) treatment downregulated 30945448 2204 Mouse mmu-miR-194 miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues carbon tetrachloride (CCl4) treatment downregulated 31496625 2205 Mouse mmu-miR-194 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues lipopolysaccharide (LPS) treatment downregulated 32522221 2206 Mouse mmu-miR-194 miRNA high fat diet (HFD) acute myocardial infarction (AMI) liver tissue high fat diet (HFD) feed downregulated 19835573 2207 Mouse mmu-miR-194 miRNA ethanol (EtOH) alcoholic liver disease (ALD) liver tissues ethanol treatment "MiR-194 was upregulated in the alcoholic liver disease, which was significantly suppressed by Yangonin (Yan)." 33068587 2208 Mouse mmu-miR-194 miRNA yangonin (Yan) alcoholic liver disease (ALD) ethanol-induced liver injury rats liver tissues Yangonin (Yan) treatment "MiR-194 was upregulated in the alcoholic liver disease, which was significantly suppressed by Yangonin (Yan)" 33068587 2209 Mouse mmu-miR-194 miRNA bupivacaine bupivacaine-induced neurotoxicity mouse DRG neurons bupivacaine treatment lincRNA PADNA/miR-194/FBXW7 axis plays an important role in the neurotoxicity process. 32791990 2210 Mouse mmu-miR-194 miRNA replicative senescence and stress cell senescence NIH/3T3 cells replicative senescence and stress treatment upregulated 27981676 2211 Mouse mmu-miR-194 miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated 26639663 2212 Mouse mmu-miR-194 miRNA silymarin (Sm) liver damage blood and liver tissues silymarin (Sm) treatment upregulated 31811641 2213 Mouse mmu-miR-194 miRNA 177lu-octreotate neuroendocrine tumors Female BALB/c nude mice "inject 1.3, 3.6, 14, 45, or 140 MBq 177Lu-octreotate treatment" "miR-194, miR-107, miR-3090, and miR-3077 were commonly regulated" 25386939 2214 Mouse mmu-miR-194 miRNA green tea (GT) nonalcoholic fatty liver disease (NAFLD) liver tissues from Male C57Bl/6 mice were fed with a high-fat diet for 4 weeks green tea (GT) treatment upregulated 31885789 2215 Mouse mmu-miR-194 miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) male C57BL/6J mice liver high fat diet (HFD) feed upregulated 28951211 2216 Mouse mmu-miR-194 miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver tissues high fat diet (HFD) feed downregulated 31885789 2217 Mouse mmu-miR-194 miRNA metformin (Met) nonalcoholic steatohepatitis (NASH) liver tissues metformin treatment downregulated 25672270 2218 Mouse mmu-miR-1941 miRNA stretch myoblast proliferation C2C12 myoblasts stretch treatment upregulated 27840929 2219 Mouse mmu-miR-194-5p miRNA ethyl acetate fraction of airpotato yam liver damage ICR and C57BL/6 mice treat with ethyl acetate fraction of airpotato yam significantly upregulated with no significant elevation of serum ALT/AST activity 28844483 2220 Mouse mmu-miR-194-5p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce upregulated 30936699 2221 Mouse mmu-miR-194-5p miRNA liraglutide type 2 diabetes mellitus (T2DM) whole bone marrow exosomes liraglutide 0.2 mg/kg for 2 months dysregulated 29133778 2222 Mouse mmu-miR-1946a miRNA alcohol lung injury lung tissues; murine primary lung fibroblasts chronic alcohol administration Chronic alcohol ingestion attenuates miR-1946a in the murine lung. 33154445 2223 Mouse mmu-miR-195 miRNA lipopolysaccharide (LPS) acute aortic dissection (AAD) aorta lipopolysaccharide (LPS) treatment downregulated 32634201 2224 Mouse mmu-miR-195 miRNA carbon tetrachloride (CCl4) acute liver injury (ALI) liver tissues carbon tetrachloride (CCl4) treatment miR-195 was markedly increased in CCl4-induced ALI. 32277959 2225 Mouse mmu-miR-195 miRNA angiotensin II (Ang II) aortic aneurysmal disease C57BL6 mice angiotensin II (Ang II) treatment downregulated 25201911 2226 Mouse mmu-miR-195 miRNA palmitate apoptosis neonatal mouse cardiomyocytes palmitate drug treatment upregulated 21622680 2227 Mouse mmu-miR-195 miRNA streptozocin (STZ) apoptosis mouse podocytes?(diabetic nephropathy) streptozocin (STZ) treatment upregulated 22123611 2228 Mouse mmu-miR-195 miRNA oxytocin (OT) breast cancer Mouse mammary adenocarcinoma tumors Oxytocin (OT) treatment upregulated 30076862 2229 Mouse mmu-miR-195 miRNA puerarin cardiac hypertrophy Ang II-induced cardiac hypertrophy Puerarin treatment upregulated 27145790 2230 Mouse mmu-miR-195 miRNA thyroid stimulating hormone cell proliferation Rat FRTL-5 thyroid cells thyroid stimulating hormone treatment downregulated 22301781 2231 Mouse mmu-miR-195 miRNA cigarette smoke (CS) chronic obstructive pulmonary disease (COPD) lung tissues cigarette smoke (CS) exposure upregulated 29223853 2232 Mouse mmu-miR-195 miRNA cigarette smoke (CS) chronic obstructive pulmonary disease (COPD) mouse lung cigarette smoke (CS) exposure upregulated in the lung 29223853 2233 Mouse mmu-miR-195 miRNA streptozocin (STZ) diabetes mellitus (DM) hearts of diabetic mice streptozotocin (STZ) treatment upregulated 21584493 2234 Mouse mmu-miR-195 miRNA IFN-¦Â liver fibrosis hepatic stellate cells (HSCs) interferon-¦Â treatment upregulated 21792910 2235 Mouse mmu-miR-195 miRNA saturated fatty acid (SFA) and high fat diet (HFD) hepatic insulin sensitivity hepatocytes saturated fatty acid (SFA) and high fat diet (HFD) treatment significantly induce miR-195 expression in hepatocytes 25240198 2236 Mouse mmu-miR-195 miRNA diethylnitrosamine (DEN) hepatocellular carcinoma (HCC) liver tissues diethylnitrosamine (DEN) treatment upregulated 32216509 2237 Mouse mmu-miR-195 miRNA "5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)" muscle cell proliferation and differentiation mouse skeletal myoblast C2C12 cells "5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment" upregulated 28255268 2238 Mouse mmu-miR-195 miRNA lipopolysaccharide (LPS) parkinson's disease (PD) BV2 cells lipopolysaccharide (LPS) treatment downregulated 31059087 2239 Mouse mmu-miR-195 miRNA cecal ligation and puncture (CLP) sepsis whole blood cecal ligation and puncture (CLP) treatment upregulated 24205035 2240 Mouse mmu-miR-1953 miRNA lipopolysaccharide (LPS) spinal cord injury (SCI) BV2 cells lipopolysaccharide (LPS) treatment downregulated 33524472 2241 Mouse mmu-miR-1954 miRNA angiotensin II (Ang II) cardiac fibrosis heart tissues angiotensin II (Ang II) treatment downregulated 31640463 2242 Mouse mmu-miR-195-5p miRNA lipopolysaccharide (LPS) osteoarthritis (OA) ATDC5 cells lipopolysaccharide (LPS) treatment upregulated 30942447 2243 Mouse mmu-miR-195-5p miRNA orthodontic mechanical loading osteogenic differentiation and bone formation periodontal tissues of mice orthodontic mechanical loading downregulated 28181691 2244 Mouse mmu-miR-1959 miRNA eimeria papillata eimeria papillata infection mouse jejunum Eimeria papillata infection upregulated 21093440 2245 Mouse mmu-miR-195a-3p miRNA hypoxia angiogenesis mesenchymal stem cells (MSCs) hypoxia treatment downregulated 26989874 2246 Mouse mmu-miR-195a-3p miRNA heat shock factor 1 (HSF1) cardiac remodeling heart tissues and endothelial cells (ECs) Heat shock transcription factor 1 (HSF1) deficiency upregulated 29626503 2247 Mouse mmu-miR-196 miRNA hypoxic/ischemic hypoxic/ischemic brain damage (HIBD) primary hippocampal cells hypoxic/ischemic stress "Snhg3 acted as the sponge of miR-196 in the hippocampal cells by regulating the expression of miR-196 target genes, XIAP and CAAP1." 31751562 2248 Mouse mmu-miR-1960 miRNA propofol (PPF) propofol-induced developmental neurotoxicity hippocampus propofol treatment downregulated 30242182 2249 Mouse mmu-miR-196a miRNA "AhR agonists benzo[a]pyrene (B[a]P) and FICZ, AhR antagonist CH-223191" aryl hydrocarbon receptor (AhR) AhR(+/+) mouse lung fibroblasts "B[a]P and FICZ ,CH-223191 treatment" downregulated 25178717 2250 Mouse mmu-miR-196a miRNA ¦Â-adrenergic brown adipogenesis WAT-progenitor cells ¦Â-adrenergic treatment upregulated 22545021 2251 Mouse mmu-miR-196a miRNA losartan diabetic nephropathy (DN) kidney tissues losartan treatment downregulated 27770539 2252 Mouse mmu-miR-196a miRNA progesterone (P4) infertility uterine horn of 6-week-old female mice (C57BL/6) progesterone treatment dysregulated 30603515 2253 Mouse mmu-miR-197 miRNA lipopolysaccharide (LPS) inflammation The mouse immortalized podocyte cell line MPC5 lipopolysaccharide (LPS) treatment upregulated 31115515 2254 Mouse mmu-miR-1971 miRNA gentamicin acute kidney injury (AKI) urine gentamicin treatment upregulated 27074385 2255 Mouse mmu-miR-1971 miRNA fluoxetine (Prozac) post-traumatic stress disorder (PTSD) mouse prefrontal cortices (PFCs) Fluoxetine treatment downregulated 23847554 2256 Mouse mmu-miR-1981 miRNA brucella.suis chronic infection RAW264.7 cells brucella infection upregulated 22904669 2257 Mouse mmu-miR-1981-3p miRNA high glucose (HG) diabetic nephropathy (DN) mouse podocytes high glucose (HG) treatment downregulated 33224036 2258 Mouse mmu-miR-1981-5p miRNA echinococcus multilocularis metacestodes echinococcus multilocularis infection RAW 264.7 cells E. multilocularis metacestodes treatment downregulated 30322806 2259 Mouse mmu-miR-1981-5p miRNA E. multilocularis metacestodes infection and immunity of E. multilocularis RAW264¡¤7 macrophage cells E. multilocularis metacestodes for 6 and 12 h treatment "upregulated (mmu-miR-378d,mmu-miR-155-5p, mmu-miR-146a-5p, mmu-miR-21a-5p , mmu-miR-125a-5p) and downregulated(mmu-miR-1981-5p , mmu-miR-let-7c-1-3p)" 28942753 2260 Mouse mmu-miR-1983 miRNA adiponectin frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) ?adipose tissue (AT) adiponectin (ApN) treatment downregulated 23015294 2261 Mouse mmu-miR-199 miRNA sodium arsenite (NaAsO2) arsenic inhibited cellular differentiation pluripotent P19 mouse embryonal carcinoma cells sodium arsenite treatment downregulated 29121352 2262 Mouse mmu-miR-199 miRNA glucose diabetes mellitus (DM) mouse insulinoma cells (MIN6) and mouse pancreatic beta-cells glucose treatment upregulated 31882540 2263 Mouse mmu-miR-199 miRNA hypoxia hepatic ischemia/reperfusion injury (HIRI) BNL-CL2 hypoxia induce downregulated 31827704 2264 Mouse mmu-miR-199-3p miRNA ovalbumin (OVA) allergic rhinitis (AR) nasal tissues ovalbumin (OVA) treatment upregulated 31124216 2265 Mouse mmu-miR-199-3p miRNA high glucose (HG) pancreatic ¦Â-cell dysfunction mouse islets; mouse insulinoma cells (MIN6) high glucose (HG) treatment upregulated 31882540 2266 Mouse mmu-miR-199-5p miRNA high-fat high-fructose diet (HFHFD) nonalcoholic fatty liver disease (NAFLD) liver tissues High-fatty and high-frutose-diet feed upregulated 30347922 2267 Mouse mmu-miR-199-5p miRNA total saponins of Panax japonicas(TPSJ) nonalcoholic fatty liver disease (NAFLD) NAFLD mouse liver tissues total saponins of Panax japonicas(TPSJ) treatment downregulated 30347922 2268 Mouse mmu-miR-199-5p miRNA high glucose (HG) pancreatic ¦Â-cell dysfunction mouse islets; mouse insulinoma cells (MIN6) high glucose (HG) treatment upregulated 31882540 2269 Mouse mmu-miR-199a miRNA lipopolysaccharide (LPS) acute kidney injury (AKI) kidney tissues lipopolysaccharide (LPS) treatment The upregulation of ANRIL can reduce the expression of microRNA-199a and increases the number of apoptotic cells 32069473 2270 Mouse mmu-miR-199a miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) brain microvascular endothelial cell injury brain microvascular endothelial cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 30233065 2271 Mouse mmu-miR-199a miRNA tough decoys (TuDs) cardiac hypertrophy cardiac samples tough decoys (TuDs) treatment upregulated 33473326 2272 Mouse mmu-miR-199a miRNA high-fat/high-cholesterol diet or a high-protein diet dyslipidemia DO mice a high-fat/high-cholesterol diet or a high-protein diet for 18 wk dysregulated 28916633 2273 Mouse mmu-miR-199a miRNA rapamycin HIV-associated nephropathy(HIVAN) mice renal tissues Rapamycin treatment downregulated 23611955 2274 Mouse mmu-miR-199a miRNA progesterone (P4) infertility uterine horn of 6-week-old female mice (C57BL/6) progesterone treatment dysregulated 30603515 2275 Mouse mmu-miR-199a miRNA hypoxia ischemic stroke (IS) primary neuronal cells and N2a cells oxygen-glucose deprivation (OGD) treatment downregulated 30144542 2276 Mouse mmu-miR-199a miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) ischemic stroke (IS) brain microvascular endothelial cells (BMECs) oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 29883549 2277 Mouse mmu-miR-199a miRNA lipopolysaccharide (LPS) lung injury lung tissues lipopolysaccharide (LPS) treatment downregulated 22185353 2278 Mouse mmu-miR-199a miRNA pristane (PS) lupus nephritis (LN) kidney tissues pristane treatment upregulated 30316188 2279 Mouse mmu-miR-199a miRNA carbon tetrachloride (CCl4) multiple myeloma (MM) liver tissue of mouse CCl4 treatment upregulated 21283674 2280 Mouse mmu-miR-199a miRNA lipopolysaccharide (LPS) sepsis-induced acute respiratory distress syndrome mouse alveolar macrophages ?LPS?treatment treatment upregulated 29351405 2281 Mouse mmu-miR-199a* miRNA carbon tetrachloride (CCl4) multiple myeloma (MM) liver tissue of mouse CCl4 treatment upregulated 21283674 2282 Mouse mmu-miR-199a-3p miRNA high fat diet (HFD) adipogenesis mouse adipose tissue high fat diet (HFD) feed downregulated in adipose tissue 28803985 2283 Mouse mmu-miR-199a-3p miRNA alcohol alcoholic liver disease (ALD) mouse liver cells Lieber-DeCarli alcohol treatment downregulated 19572984 2284 Mouse mmu-miR-199a-3p miRNA methionine choline-deficient diet (MCD) alcoholic liver disease (ALD) liver tissues methionine-choline-deficient (MCD) diets treatment downregulated 19572984 2285 Mouse mmu-miR-199a-3p miRNA estradiol-17¦Â (E2) autophagy mouse osteocyte-like MLO-Y4 cells estradiol-17¦Â (E2) treatment downregulated 28708244 2286 Mouse mmu-miR-199a-3p miRNA CL 316243 disodium salt brown adipocyte differentiation mouse interscapular brown brown adipose tissues (iBAT) CL 316243 disodium salt treatment downregulated 29753771 2287 Mouse mmu-miR-199a-3p miRNA cold brown adipocyte differentiation mouse interscapular brown brown adipose tissues (iBAT) cold induce downregulated 29753771 2288 Mouse mmu-miR-199a-3p miRNA brucella.suis brucellosis CD14 knock-down RAW264.7 (224.3) macrophages brucella infection upregulated 28443393 2289 Mouse mmu-miR-199a-3p miRNA lipopolysaccharide (LPS) cervical remodeling cervical samples lipopolysaccharide (LPS) treatment downregulated 32468045 2290 Mouse mmu-miR-199a-3p miRNA sarpogrelate and telmisartan chronic kidney disease (CKD) urinary sarpogrelate and telmisartan treatment miR-199a-3p was commonly reduced by sarpogrelate and telmisartan treatment 33359069 2291 Mouse mmu-miR-199a-3p miRNA streptozocin (STZ) diabetes mellitus (DM) hearts of diabetic mice streptozotocin (STZ) treatment upregulated 21584493 2292 Mouse mmu-miR-199a-3p miRNA ¦Â-hydroxy-¦Â-methylbutyrate (HMB) cell differentiation muscle ¦Â-hydroxy-¦Â-methylbutyrate (HMB) treatment upregulated 31891490 2293 Mouse mmu-miR-199a-3p miRNA low-protein diet (LP0.5) glucose homeostasis ¦Â cells low-protein diet (LP0.5) downregulated 25180600 2294 Mouse mmu-miR-199a-3p miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues carbon tetrachloride (CCl4) treatment upregulated 29557526 2295 Mouse mmu-miR-199a-3p miRNA ¦Â-hydroxy-¦Â-methylbutyrate (HMB) myofiber specification "gastrocnemius, soleus muscle and C2C12 myotubes" ¦Â-hydroxy-¦Â-methylbutyrate (HMB) treatment upregulated 31891490 2296 Mouse mmu-miR-199a-3p miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) C57BL/6J mice liver high fat diet (HFD) feed downregulated in the livers 28469795 2297 Mouse mmu-miR-199a-5p miRNA qiliqiangxin (QL) acute myocardial infarction (AMI) PE induced cardiomyocytes Qiliqiangxin (QL) treatment the increase of miR-199a-5p in PE-treated cardiomyocytes was reversed by the treatment with QL 27161004 2298 Mouse mmu-miR-199a-5p miRNA X-rays bystander effect C57BL/6 mice extracellular vesicles (EVs) otal-body irradiated with X-rays upregulated 28396668 2299 Mouse mmu-miR-199a-5p miRNA receptor activator of nuclear factor-¦ÊB ligand (RANKL) cell differentiation bone marrow macrophages (BMMs) and RAW 264.7 cells receptor activator of nuclear factor kappa-B ligand (RANKL) treatment upregulated 30387167 2300 Mouse mmu-miR-199a-5p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral ischemia/reperfusion (I/R) injury HT22 cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment upregulated 31990992 2301 Mouse mmu-miR-199a-5p miRNA resolvin D1 (RvD1) extracellular matrix synthesis macrophages resolvin D1 (RvD1) treatment upregulated 24249635 2302 Mouse mmu-miR-199a-5p miRNA hyperoxia hyperoxia-induced acute lung injury (HALI) mice lungs and lung epithelial cells (MLE12) hyperoxia induce upregulated 31390652 2303 Mouse mmu-miR-199a-5p miRNA resolvin D1 (RvD1) insulin resistance and nonalcoholic steatohepatitis (NASH) obese mice with NASH resolvin D1 (RvD1) treatment upregulated 24249635 2304 Mouse mmu-miR-199a-5p miRNA oxygen glucose deprivation (OGD) ischemic stroke (IS) N-2a cells oxygen and glucose deprivation treatment ANRIL protects N-2a cells against ischemia induced injury by elevated CAV-1 by competitively interacting with miR-199a-5p 31907708 2305 Mouse mmu-miR-199a-5p miRNA ¦Á-Tocotrienol (TCT) ischemic stroke (IS) primary cortical neuronal cells ¦Á-Tocotrienol (TCT)?treatment treatment downregulated 21719775 2306 Mouse mmu-miR-199a-5p miRNA Japanese encephalitis virus (JEV) Japanese encephalitis virus (JEV) infection BV-2 cells; mouse neuroblastoma cell line NA; mouse brain endothelial cell line bEnd.3 Japanese encephalitis virus (JEV) infection downregulated 32461319 2307 Mouse mmu-miR-199a-5p miRNA fructus meliae toosendan (FMT) liver damage eft lateral liver lobe Fructus Meliae Toosendan (FMT) treatment downregulated 26539117 2308 Mouse mmu-miR-199a-5p miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) adipose tissues high fat diet (HFD) feed microRNA 199a-5p (miR-199a-5p) was significantly upregulated in high fat diet-induced steatosis mouse model. 33037981 2309 Mouse mmu-miR-199a-5p miRNA methionine choline-deficient diet (MCD) nonalcoholic steatohepatitis (NASH) liver tissues were fed a methionine-choline-deficient (MCD) diet for eight weeks treatment upregulated 25269746 2310 Mouse mmu-miR-199a-5p miRNA dexamethasone (DEX) osteoporosis osteoblasts dexamethasone (Dex) treatment upregulated 25878056 2311 Mouse mmu-miR-199a-5p miRNA bile acids sustained endoplasmic reticulum stress mouse liver tissue bile acids treatment upregulated 23598416 2312 Mouse mmu-miR-199b-3p miRNA hypoxia ischemic stroke (IS) ?brain tissues middle cerebral artery occlusion-reperfusion (MCAO-R)?induce downregulated 31204565 2313 Mouse mmu-miR-199b-5p miRNA atrasentan diabetic nephropathy (DN) mice renal proximal tubular epithelial cells atractylon (Atr)?treatment downregulated 29623952 2314 Mouse mmu-miR-199b-5p miRNA hypoxia myocardial infarction (MI) heart tiisues permanent ligation of the left coronary artery upregulated in heart 30159417 2315 Mouse mmu-miR-199b-5p miRNA curcumin (Cur) neuroinflammation LPS-treated BV2 microglial cells curcumin treatment upregulated 31862869 2316 Mouse mmu-miR-199b-5p miRNA lipopolysaccharide (LPS) neuroinflammation BV2 microglial cells lipopolysaccharide (LPS) treatment downregulated 31862869 2317 Mouse mmu-miR-199b-5p miRNA partial pancreatectomy (PPx) cell proliferation pancreas partial pancreatectomy (PPx) treatment upregulated 27280801 2318 Mouse mmu-miR-19a miRNA hyperoxia bronchopulmonary dysplasia (BPD) lung tissues hyperoxia treatment downregulated 33143661 2319 Mouse mmu-miR-19a miRNA high glucose (HG) cardiomyocyte senescence Neonatal mouse ventricular cells (NMVCs) high glucose (HG) treatment downregulated 33664669 2320 Mouse mmu-miR-19a miRNA IL-10 colonic inflammation colonic intraepithelial lymphocytes IL-10 treatment downregulated 22043014 2321 Mouse mmu-miR-19a miRNA lipopolysaccharide (LPS) endometriosis uterine tissues lipopolysaccharide (LPS) treatment downregulated 30673803 2322 Mouse mmu-miR-19a miRNA IL-10 epithelial-mesenchymal transition (EMT) colonic intraepithelial lymphocytes IL-10 treatment upregulated 22043014 2323 Mouse mmu-miR-19a miRNA ischemia ischemia/reperfusion (I/R) injury cerebral cortex and hippocampus Ischemic preconditioning and ischemic postconditioning (IPostC) treatment upregulated 27485299 2324 Mouse mmu-miR-19a miRNA grape seed procyanidin extract (GSPE) lung cancer A549 cells grape seed procyanidin extract (GSE) treatment downregulated 27289489 2325 Mouse mmu-miR-19a miRNA microwave microwave-induced adverse health outcomes mouse hippocampus 7 days after 30 mW/cm microwave exposure treatment downregulated 24748327 2326 Mouse mmu-miR-19a miRNA bleomycin and silica lung fibrosis fibroblasts bleomycin and silica treatment "qPCR revealed a significant increase of miR-19a, 19b, and 20a-expression in activated fibroblasts in the early phase of bleomycin and silica models." 29923329 2327 Mouse mmu-miR-19a miRNA smoking smoking-related interstitial fibrosis (SRIF) C57 mice circulating 6 months of chronic mainstream smoking exposure treatment downregulated 22782705 2328 Mouse mmu-miR-19a-3p miRNA angiotensin II (Ang II) cardiac hypertrophy neonatal mouse cardiomyocytes (NMCMs) angiotensin II (Ang II) treatment downregulated 29664809 2329 Mouse mmu-miR-19a-3p miRNA H2O2 myocardial infarction (MI) Primary neonatal mice cardiomyocytes (NMCMs) H2O2 treatment miR-19a-3p level was upregulated in response to H2O2 treatment. 33352533 2330 Mouse mmu-miR-19b miRNA short ragweed pollen allergic conjunctivitis (AC) conjunctiva; cornea; cervical lymph nodes (CLN) short ragweed pollen treatment "In the murine AC model, miR-19b was aberrantly downregulated" 32150250 2331 Mouse mmu-miR-19b miRNA hyperoxia bronchopulmonary dysplasia (BPD) lung tissues hyperoxia treatment downregulated 33143661 2332 Mouse mmu-miR-19b miRNA diosgenin (DIO) cholesterol metabolism and atherogenesis THP-1 macrophages diosgenin (DIO) treatment downregulated 25765596 2333 Mouse mmu-miR-19b miRNA pectin (fermented to butyrate in the colon) (FPA) colon tumorigenesis colonic stem cells (fermented to butyrate in the colon) (FPA) treatment upregulated 26493444 2334 Mouse mmu-miR-19b miRNA acetaminophen (APAP) drug-induced liver injury (DILI) mouse liver ?acetaminophen (APAP) treatment downregulated 31077331 2335 Mouse mmu-miR-19b miRNA myelin oligodendrocyte glycoprotein experimental autoimmune encephalomyelitis (EAE) EAE mouse brain tissues myelin oligodendrocyte glycoprotein (MOG35- 55) treatment downregulated 30289071 2336 Mouse mmu-miR-19b miRNA "5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)" gastric cancer (GC) balb/c nu-nu mice injected with 107 GC cells "5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment" upregulated 25270964 2337 Mouse mmu-miR-19b miRNA fibrinogen haemorrhagic shock lung tissue fibrinogen treatment "Pulmonary microRNA-19b was increased after haemorrhagic shock and lactated Ringers, but reduced to sham levels by plasma and fibrinogen." 33539284 2338 Mouse mmu-miR-19b miRNA Deoxycorticosterone acetate (Doca) hypertensive heart disease (HHD) mouse HHD cells injection of Deoxycorticosterone acetate (Doca) upregulated in HHD cells 28531963 2339 Mouse mmu-miR-19b miRNA hypoxia hypoxia-induced injury BV2 cells hypoxia induce downregulated 30767206 2340 Mouse mmu-miR-19b miRNA recombinant Adeno-Cre viruses (AdV-Cre) lung adenocarcinoma (LUAD) lung recombinant Adeno-Cre viruses (AdV-Cre) treatment downregulated 25359683 2341 Mouse mmu-miR-19b miRNA grape seed procyanidin extract (GSPE) lung cancer A549 cells grape seed procyanidin extract (GSE) treatment downregulated 27289489 2342 Mouse mmu-miR-19b miRNA dexamethasone (DEX) metabolic disease murine adipocytes dexamethasone (Dex) treatment "DEX treatment elevated miR-19b expression in SAT-and VAT-derived differentiated cells in a dose-dependent manner, and peak levels were observed at 1 ¦ÌM." 29077919 2343 Mouse mmu-miR-19b miRNA fluid shear stress (FSS) osteoblastic differentiation MC3T3-E1 cells fluid shear stress (FSS)treatment downregulated 23595392 2344 Mouse mmu-miR-19b miRNA bone morphogenetic proteins (BMPs) osteogenesis pluripotent stem (iPS) cells bone morphogenetic proteins (BMPs) treatment downregulated 22937097 2345 Mouse mmu-miR-19b miRNA bleomycin and silica lung fibrosis fibroblasts bleomycin and silica treatment "qPCR revealed a significant increase of miR-19a, 19b, and 20a-expression in activated fibroblasts in the early phase of bleomycin and silica models." 29923329 2346 Mouse mmu-miR-19b miRNA monocrotaline (MCT) pulmonary hypertension (PH) lung tissues monocrotaline (MCT) treatment upregulated 26980205 2347 Mouse mmu-miR-19b miRNA mycobacterium tuberculosis (Mtb) pulmonary tuberculosis (PTB) lung tissues mycobacterium tuberculosis (Mtb) treatment downregulated 33089914 2348 Mouse mmu-miR-19b miRNA pSTAT3-specific inhibitor AG-490 pulmonary tuberculosis (PTB) lung tissues pSTAT3-specific inhibitor AG-490 treatment upregulated 33089914 2349 Mouse mmu-miR-19b-1 miRNA hypoxia ischemia/reperfusion (I/R) injury mice heart tissues in vivo and primary murine cardiomyocytes in vitro hypoxia induce downregulated 30607541 2350 Mouse mmu-miR-19b-3p miRNA lipopolysaccharide (LPS) acute kidney injury (AKI) tubular epithelial cells (TECs)-derived exosomes lipopolysaccharide (LPS) treatment upregulated 31097789 2351 Mouse mmu-miR-19b-3p miRNA angiotensin II (Ang II) cardiac hypertrophy neonatal mouse cardiomyocytes (NMCMs) angiotensin II (Ang II) treatment downregulated 29664809 2352 Mouse mmu-miR-19b-3p miRNA adriamycin (ADR) chronic proteinuric kidney tubular epithelial cells (TECs)-derived exosomes adriamycin (ADR) treatment upregulated 31097789 2353 Mouse mmu-miR-19b-3p miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues carbon tetrachloride (CCl4) treatment downregulated 29572892 2354 Mouse mmu-miR-19b-3p miRNA glyphosate neurodevelopmental disorder prefrontal cortex of mouse offspring glyphosate dysregulated 29467848 2355 Mouse mmu-miR-19b-3p miRNA IL-1¦Â osteoarthritis (OA) Murine ATDC5 cells IL-1¦Â treatment downregulated 31227976 2356 Mouse mmu-miR-19b-3p miRNA paraquat (PQ) paraquat (PQ)-induced acute lung injury and pulmonary fibrosis MLE-12 cells paraquat (PQ) treatment downregulated 32741895 2357 Mouse mmu-miR-19b-3p miRNA lipopolysaccharide (LPS) sepsis-induced acute kidney injury mouse pulmonary microvascular endothelial cells (PMVECs) lipopolysaccharide (LPS) treatment The level of miR-19b-3p was determined to be downregulated in vitro and in vivo 33760339 2358 Mouse mmu-miR-19b-3p miRNA lipopolysaccharide (LPS) tubulointerstitial inflammation renal exosomes; tubule-derived exosomes lipopolysaccharide (LPS) treatment upregulated 31097789 2359 Mouse mmu-miR-1a miRNA urethane lung cancer mouse lung tissue cells urethane via ip injection treatment downregulated 23761296 2360 Mouse mmu-miR-1a miRNA high fat diet (HFD) obesity C57BL/6J male mice skeletal muscle high fat diet (HFD) feed upregulated 28926107 2361 Mouse mmu-miR-1a-1-5p miRNA streptozocin (STZ) diabetic pregnancy female mice hyperglycemic ED9.5 embryos streptozotocin treatment dysregulatedin hyperglycemic ED95 embryos 27908722 2362 Mouse mmu-miR-1a-3p miRNA guanidinoacetic acid (GAA) cell differentiation C2C12 cells Guanidinoacetic acid (GAA) treatment downregulated 30235878 2363 Mouse mmu-miR-1a-3p miRNA high fat diet (HFD) hepatic insulin resistance mouse liver tissues high fat diet (HFD) feed downregulated 30820263 2364 Mouse mmu-miR-2 miRNA torasemide cardiac fibrosis cardiac fibroblasts Torasemide treatment upregulated 26047574 2365 Mouse mmu-miR-20 miRNA western diet coronary artery disease (CAD) mouse fed with western diet treatment downregulated 28888922 2366 Mouse mmu-miR-20 miRNA Staphylococcus aureus inflammation mouse mammary tissue intramammary infection of Globally Staphylococcus aureus treatment differently regulated 25075227 2367 Mouse mmu-miR-200 miRNA TGF-¦Â1 epithelial-mesenchymal transition (EMT) Kidneys tissue TGF-¦Â1 treatment downregulated 22012804 2368 Mouse mmu-miR-200 miRNA rapamycin HIV-associated nephropathy(HIVAN) mice renal tissues Rapamycin treatment downregulated 23611955 2369 Mouse mmu-miR-200 miRNA cyclosporine A (CsA) nephrotoxicity mouse kidney cyclosporine A treatment upregulated 28414804 2370 Mouse mmu-miR-200 miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) serum high fat diet (HFD) feed upregulated 32324317 2371 Mouse mmu-miR-200a miRNA H2O2 acute myocardial infarction (AMI) mouse cardiomyocytes H2O2 treatment The expression of miR-200a was upregulated in H 2O 2-treated cardiomyocytes. 31896068 2372 Mouse mmu-miR-200a miRNA H2O2 acute myocardial infarction (AMI) primary cultured mouse?cardiomyocytes H2O2 treatment upregulated 31896068 2373 Mouse mmu-miR-200a miRNA isorhynchophylline (IRN) asthma ovalbumin (OVA)-induced asthma mice lung tissues Isorhynchophylline (IRN) treatment upregulated 31733831 2374 Mouse mmu-miR-200a miRNA isorhynchophylline (IRN) asthma TGF-¦Â1-treated airway smooth muscle cells (ASMCs) Isorhynchophylline (IRN) treatment upregulated 31733831 2375 Mouse mmu-miR-200a miRNA isorhynchophylline (IRN) asthma airway smooth muscle cells (ASMCs) Isorhynchophylline (IRN) treatment IRN administration inhibited miR-200a expression level. 31733831 2376 Mouse mmu-miR-200a miRNA ovalbumin (OVA) asthma airway smooth muscle cells (ASMCs) ovalbumin (OVA) treatment upregulated 30423573 2377 Mouse mmu-miR-200a miRNA ovalbumin (OVA) asthma lung tissues ovalbumin (OVA) treatment downregulated 31733831 2378 Mouse mmu-miR-200a miRNA TGF-¦Â1 asthma airway smooth muscle cells (ASMCs) TGF-¦Â1 treatment downregulated 31733831 2379 Mouse mmu-miR-200a miRNA piceatannol (PIC) atherosclerosis (AS) RAW 264.7 cells piceatannol (PIC) treatment PIC increased miR-200a level in RAW2647 cells 32886103 2380 Mouse mmu-miR-200a miRNA alcohol brain injury and neurodegeneration cerebral cortex chronic alcohol administration downregulated 30374194 2381 Mouse mmu-miR-200a miRNA Glabridin (GLA) breast cancer MDA-MB-231 and BT-549 breast cancer cells Glabridin (GLA) treatment upregulation 24754877 2382 Mouse mmu-miR-200a miRNA rosiglitazone cardiac hypertrophy adipocytes rosiglitazone (RSG) treatment upregulated 27734035 2383 Mouse mmu-miR-200a miRNA doxorubicin (DOX) cardiotoxicity primary cultured cardiomyocyte Doxorubicin (DOX) treatment downregulated 31781322 2384 Mouse mmu-miR-200a miRNA all-trans retinoic acid (ATRA) cell differentiation mouse hepatic progenitor cells (HPCs) all-trans retinoic acid (ATRA) treatment upregulated 31515718 2385 Mouse mmu-miR-200a miRNA astaxanthin colorectal cancer (CRC) Mouse colon cancer cell CT26 astaxanthin (ATX) treatment upregulated 31263239 2386 Mouse mmu-miR-200a miRNA dexamethasone (DEX) endometrial receptivity endometrium tissues dexamethasone (DEX) treatment upregulated 30993706 2387 Mouse mmu-miR-200a miRNA high glucose (HG) endothelial dysfunction aortic endothelial cells (ECs) high glucose (HG) treatment High glucose (HG) reduced miR-200a levels. 32031966 2388 Mouse mmu-miR-200a miRNA shikonin epithelial-mesenchymal transition (EMT) mouse skin tissues Shikonin treatment downregulated 23861701 2389 Mouse mmu-miR-200a miRNA calorie restriction (CR) hepatic steatosis high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues calorie restriction (CR) treatment upregulated 31863770 2390 Mouse mmu-miR-200a miRNA exercise (Ex) hepatic steatosis high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues exercise (Ex) treatment upregulated 31863770 2391 Mouse mmu-miR-200a miRNA high fat diet (HFD) hepatic steatosis mice thyroid and liver tissues high fat diet (HFD) feed downregulated 31863770 2392 Mouse mmu-miR-200a miRNA low fat diet (LFD) hepatic steatosis high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues low-fat diet (LF) treatment upregulated 31863770 2393 Mouse mmu-miR-200a miRNA quercetin hepatic steatosis high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues quercetin (Que) treatment upregulated 31863770 2394 Mouse mmu-miR-200a miRNA progesterone (P4) infertility uterine horn of 6-week-old female mice (C57BL/6) progesterone treatment dysregulated 30603515 2395 Mouse mmu-miR-200a miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues carbon tetrachloride (CCl4) treatment miR-200a was significantly reduced in liver tissues of a carbon tetrachloride (CCl4)-induced rat model. 32319630 2396 Mouse mmu-miR-200a miRNA triptolide (TPL) male hypogonadism MLTC-1 cells triptolide (TPL) treatment downregulated of miR-200a could protect MLTC-1 cells against TP by inducing autophagy 33204070 2397 Mouse mmu-miR-200a miRNA high glucose (HG) cell differentiation neural stem cells (NSCs) high glucose treatment downregulated 23776576 2398 Mouse mmu-miR-200a miRNA fructose metabolic disorders C57BL/6JNju mice fructose treatment upregulated 28732575 2399 Mouse mmu-miR-200a miRNA fructose metabolic disorders human-derived HepG2 cells fructose treatment upregulated 28732575 2400 Mouse mmu-miR-200a miRNA carbon tetrachloride (CCl4) multiple myeloma (MM) liver tissue of mouse CCl4 treatment upregulated 21283674 2401 Mouse mmu-miR-200a miRNA leptin obesity hypothalamus?tissues leptin treatment downregulated 24394757 2402 Mouse mmu-miR-200a miRNA low fat diet (LFD) obesity thyroid low fat diet (LFD) treatment downregulated 31863770 2403 Mouse mmu-miR-200a miRNA low fat diet (LFD) obesity thyroid low fat diet (LFD) treatment upregulated 31863770 2404 Mouse mmu-miR-200a miRNA monosodium glutamate (MSG) obesity liver tissues monosodium glutamate (MSG)-injected mice with developed central obesity treatment dysregulated 24465854 2405 Mouse mmu-miR-200a miRNA quercetin obesity thyroid quercetin (QUE) treatment upregulated 31863770 2406 Mouse mmu-miR-200a miRNA growth hormone (GH) osteosarcoma (OS) LM8 cells growth hormone (GH) treatment downregulated 26289744 2407 Mouse mmu-miR-200a miRNA bone morphogenetic protein 2 (BMP2) preosteoblast differentiation pre-osteoblast bone morphogenetic protein-2 treatment downregulated 19454767 2408 Mouse mmu-miR-200a miRNA X-rays radiation-induced oral mucositis (RIOM) tongue tissues 25 Gy X-ray irradiation treatment upregulated 31346357 2409 Mouse mmu-miR-200a miRNA di(2-ethylhexyl) phthalate (DEHP) skeletal muscle insulin resistance skeletal muscle cells di(2-ethylhexyl) phthalate (DEHP) treatment The miR-17/Keap1-Nrf2/miR-200a axis contributed to DEHP-induced insulin resistance. 32802189 2410 Mouse mmu-miR-200a miRNA ethanol (EtOH) teratogenesis fetal brains of mice Ethanol?treatment downregulated 19091803 2411 Mouse mmu-miR-200a-3 miRNA 7-chlorokynurenic acid (7-CTKA) antidepressant mouse 7-CTKA intraperitoneal injection downregulated 25034119 2412 Mouse mmu-miR-200a-3p miRNA TGF-¦Â breast cancer normal murine mammary gland epithelial (NMuMG) cells transforming growth factor (TGF)¦Â treatment downregulated 30285803 2413 Mouse mmu-miR-200a-3p miRNA aldose reductase diabetic nephropathy (DN) renal mesangial cells aldose reductase treatment upregulated 24161443 2414 Mouse mmu-miR-200a-3p miRNA high glucose (HG) diabetic nephropathy (DN) SV40-MES-13?cells high glucose treatment downregulated 31630796 2415 Mouse mmu-miR-200a-3p miRNA ethyl acetate extract isolated from rhizoma dioscoreae bulbifera hepatotoxicity mouse liver tissues treat with ethyl acetate extract isolated from rhizoma dioscoreae bulbifera (450 mg/kg) dysregulated 27609015 2416 Mouse mmu-miR-200a-3p miRNA carbon tetrachloride (CCl4) liver fibrosis carbon tetrachloride (CCl4) treatment lncRNA Gpr137b-ps/miR-200a-3p/CXCL14 axis that modulates HSC activation and might exert an effect on the pathogenesis of liver fibrosis. 33069761 2417 Mouse mmu-miR-200a-3p miRNA dioscorea bulbifera (DB) liver damage livers dioscoreae bulbifera (EF) treatment upregulated 27609015 2418 Mouse mmu-miR-200a-3p miRNA "chlorpromazine, procainamide, manganese" systemic lupus erythematosus (SLE) mouse "chlorpromazine, procainamide, manganese" dysregulated 29349090 2419 Mouse mmu-miR-200a-3p miRNA coix seed Oil (CSO) triple negative breast cancer (TNBC) mouse triple-negative breast cancer (TNBC) tissues coix Seed Oil (CSO) treatment upregulated 33101013 2420 Mouse mmu-miR-200b miRNA nicotine abnormal migration and proliferation mouse primary VSMCs nicotine treatment upregulated 28252009 2421 Mouse mmu-miR-200b miRNA amyloid-¦Â (A¦Â) Alzheimer's disease (AD) murine primary neurons amyloid-¦Â (A¦Â) treatment upregulated 29738527 2422 Mouse mmu-miR-200b miRNA alcohol brain injury and neurodegeneration cerebral cortex chronic alcohol administration downregulated 30374194 2423 Mouse mmu-miR-200b miRNA aspergillus fumigatus (A. fumigatus) bronchial asthma bronchoalveolar lavage cells aspergillus fumigatus infection downregulated 29778524 2424 Mouse mmu-miR-200b miRNA ovalbumin (OVA) bronchial asthma bronchoalveolar lavage cells ovalbumin (OVA) treatment downregulated 29778524 2425 Mouse mmu-miR-200b miRNA hypertonicity cellular responses to osmotic stress mouse renal medulla hypertonicity-induced induction upregulated 20852262 2426 Mouse mmu-miR-200b miRNA high fat diet (HFD) chondrogenesis white adipose tissues high fat diet (HFD) feed downregulated 22496873 2427 Mouse mmu-miR-200b miRNA bone morphogenetic protein 2 (BMP2) chronic pancreatitis (CP) AR42J cells bone morphogenetic protein 2 (BMP2) treatment upregulated 29303912 2428 Mouse mmu-miR-200b miRNA cerulein chronic pancreatitis (CP) pancreas cerulein treatment downregulated 29303912 2429 Mouse mmu-miR-200b miRNA TGF-¦Â1 chronic pancreatitis (CP) AR42J cells TGF-¦Â1 treatment downregulated 29303912 2430 Mouse mmu-miR-200b miRNA monocrotaline (MCT) cor pulmonale "lungs, right ventricle (RV) and left ventricle (LV) tissues" monocrotaline (MCT) treatment downregulated 31730233 2431 Mouse mmu-miR-200b miRNA alcohol extract of coreopsis tinctoria Nutt (AC) diabetic nephropathy (DN) db/db (DN) mice alcohol extract of Coreopsis tinctoria Nutt (AC) treatment downregulated 31032350 2432 Mouse mmu-miR-200b miRNA retinoic acid (RA) cell differentiation embryonic stem cells (mESCs) retinoic acid (RA) treatment downregulated 26162091 2433 Mouse mmu-miR-200b miRNA shikonin epithelial-mesenchymal transition (EMT) mouse skin tissues Shikonin treatment downregulated 23861701 2434 Mouse mmu-miR-200b miRNA carbon tetrachloride (CCl4) liver fibrosis hepatic tissues carbon tetrachloride (CCl4) treatment downregulated 30924172 2435 Mouse mmu-miR-200b miRNA listeria Listeria infection murine ileum tissues Listeria infection downregulated 24327339 2436 Mouse mmu-miR-200b miRNA dietary methyl deficiency hepatocellular carcinoma (HCC) the liver tissues Dietary methyl deficiency treatment upregulated 20436259 2437 Mouse mmu-miR-200b miRNA high glucose (HG) cell differentiation neural stem cells (NSCs) high glucose treatment downregulated 23776576 2438 Mouse mmu-miR-200b miRNA leptin obesity hypothalamus?tissues leptin treatment downregulated 24394757 2439 Mouse mmu-miR-200b miRNA lipopolysaccharide (LPS) lung fibrosis lung tissues lipopolysaccharide (LPS) treatment downregulated 29200203 2440 Mouse mmu-miR-200b miRNA X-rays radiation-induced oral mucositis (RIOM) tongue tissues 25 Gy X-ray irradiation treatment upregulated 31346357 2441 Mouse mmu-miR-200b miRNA carbon tetrachloride (CCl4) multiple myeloma (MM) liver tissue of mouse CCl4 treatment upregulated 21283674 2442 Mouse mmu-miR-200b-3p miRNA folic acid Alzheimer's disease (AD) APP/PS1 mice brains and N2a cells Folic acid deficiency treatment downregulated 26345540 2443 Mouse mmu-miR-200b-3p miRNA TGF-¦Â breast cancer normal murine mammary gland epithelial (NMuMG) cells transforming growth factor (TGF)¦Â treatment downregulated 30285803 2444 Mouse mmu-miR-200b-3p miRNA high glucose (HG) diabetic retinopathy (DR) retinal microvascular endothelial cells (RMECs) high glucose treatment downregulated 31313295 2445 Mouse mmu-miR-200b-3p miRNA streptozotocin injection and a high-glucose/high-fat diet diabetic retinopathy (DR) retinal microvascular endothelial cells (RMECs) streptozotocin injection and a high-glucose/high-fat diet treatment "YAP1 may exert some promotive effects on the development of DR through its regulation of the MALAT1/miR-200b-3p/VEGFA axis, highlighting that YAP1 silencing may be instrumental for the therapeutic targeting of DR" 31313295 2446 Mouse mmu-miR-200b-3p miRNA schistosoma japonicum liver fibrosis serum exosomes S. japonicum infection treatment downregulated 32443549 2447 Mouse mmu-miR-200b-3p miRNA schistosomiasis japonica hepatic fibrogenesis serum S. japonicum infection treatment downregulated 30482723 2448 Mouse mmu-miR-200b-3p miRNA arginine vasopressin osmoregulation mIMCD3 cells exposure to arginine vasopressin treatment downregulated 24389345 2449 Mouse mmu-miR-200b-5p miRNA fatty acid amide hydrolase inhibitor (FAAH-II) colitis colitis mouse colon tissues FAAH-II treatment dysregulated 27327245 2450 Mouse mmu-miR-200b-5p miRNA fatty acid amide hydrolase (FAAH) blockade experimental colitis colon Fatty acid amide hydrolase (FAAH) blockade treatment upregulated 27327245 2451 Mouse mmu-miR-200b-5p miRNA X rays ionizing radiation (IR) injury male Kunming mice blood 0.5-2 Gy total-body carbon-ion irradiation treatment dysregulatedin blood 28632432 2452 Mouse mmu-miR-200b-5p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce downregulated 30936699 2453 Mouse mmu-miR-200c miRNA ischemia/reperfusion (I/R) acute myocardial infarction (AMI) heart tissues ischemia/reperfusion (I/R) treatment upregulated 28090786 2454 Mouse mmu-miR-200c miRNA amyloid-¦Â (A¦Â) Alzheimer's disease (AD) murine primary neurons amyloid-¦Â (A¦Â) treatment upregulated 29738527 2455 Mouse mmu-miR-200c miRNA Glabridin (GLA) breast cancer MDA-MB-231 and BT-550 breast cancer cells Glabridin (GLA) treatment upregulation 24754877 2456 Mouse mmu-miR-200c miRNA aspergillus fumigatus (A. fumigatus) bronchial asthma bronchoalveolar lavage cells aspergillus fumigatus infection downregulated 29778524 2457 Mouse mmu-miR-200c miRNA ovalbumin (OVA) bronchial asthma bronchoalveolar lavage cells ovalbumin (OVA) treatment downregulated 29778524 2458 Mouse mmu-miR-200c miRNA R715 (B1R antagonist) cerebral ischemia/reperfusion (I/R) injury miR-200c in N9 cell and N9-derived MVs R715 (B1R antagonist) (500 ¦Ìg/kg) treatment downregulated in microvesicles (MVs) 28398146 2459 Mouse mmu-miR-200c miRNA high fat diet (HFD) chondrogenesis white adipose tissues high fat diet (HFD) feed downregulated 22496873 2460 Mouse mmu-miR-200c miRNA high glucose (HG) diabetic vasculopathy H5V cells high glucose stimulation upregulated 28627674 2461 Mouse mmu-miR-200c miRNA retinoic acid (RA) cell differentiation embryonic stem cells (mESCs) retinoic acid (RA) treatment downregulated 26162091 2462 Mouse mmu-miR-200c miRNA shikonin epithelial-mesenchymal transition (EMT) mouse skin tissues Shikonin treatment downregulated 23861701 2463 Mouse mmu-miR-200c miRNA silica particle epithelial-mesenchymal transition (EMT) lung tissues silica particles treatment miR-200c expression levels were decreased on days 14 and 28 compared with those in the saline group 30010033 2464 Mouse mmu-miR-200c miRNA high fat diet (HFD) hepatocellular carcinoma (HCC) plasma and hepatic tissues high fat diet (HFD) feed downregulated 26728044 2465 Mouse mmu-miR-200c miRNA listeria Listeria infection murine ileum tissues Listeria infection downregulated 24327339 2466 Mouse mmu-miR-200c miRNA "3,3'-diindolylmethane (DIM)" multiple sclerosis (MS) activated T cells during the development of experimental autoimmune encephalomyelitis (EAE) "3,3'-Diindolylmethane (DIM) treatment" upregulated 24898268 2467 Mouse mmu-miR-200c miRNA methionine choline-deficient diet (MCD) nonalcoholic steatohepatitis (NASH) liver tissues fed a methionine and choline deficient (MCD) diet for 2 week upregulated in liver 29093267 2468 Mouse mmu-miR-200c miRNA Porphyromonas gingivalis?lipopolysaccharide (Pg-LPS) periodontitis in obese subjects (PiOSs) gingival; adipose tissues Porphyromonas gingivalis?lipopolysaccharide (Pg-LPS) treatment downregulated 33664998 2469 Mouse mmu-miR-200c miRNA propofol (PPF) propofol-induced developmental neurotoxicity hippocampus propofol treatment upregulated 30242182 2470 Mouse mmu-miR-200c miRNA lipopolysaccharide (LPS) lung fibrosis lung tissues lipopolysaccharide (LPS) treatment downregulated 29200203 2471 Mouse mmu-miR-200c miRNA X-rays radiation-induced oral mucositis (RIOM) tongue tissues 25 Gy X-ray irradiation treatment upregulated 31346357 2472 Mouse mmu-miR-200c miRNA reactive oxygen species (ROS) spinal cord injury (SCI) BV-2 cells ROS treatment upregulated 26503985 2473 Mouse mmu-miR-200c miRNA split radiation thymic lymphoma (RITL) RITL samples split radiation treatment downregulated 25359176 2474 Mouse mmu-miR-200c miRNA wound back skin wound healing 8-week-old and 2-year-old mice full-thickness 3 mm wound was introduced by punch biopsy onto back skin treatment downregulated 28607463 2475 Mouse mmu-miR-200c miRNA wound back skin wound healing 8-week-old mice aged skin full-thickness 3 mm wound was introduced by punch biopsy onto back skin treatment upregulated at the early phase of wound healing in aged skin 28607463 2476 Mouse mmu-miR-200c miRNA resveratrol colorectal cancer (CRC) HCT-116 Colorectal Cancer Cells resveratrol (RS) treatment upregulated 27918105 2477 Mouse mmu-miR-200c* miRNA neuregulin-1£¨NRG1£© cell differentiation murine embryonic stem cell neuregulin-1£¨NRG1£© upregulated 21451102 2478 Mouse mmu-miR-200c-3p miRNA IL-1B intestinal inflammation enterocytes IL-1B treatment Compared with mice given vehicle; enterocytes isolated from mice given IL1B had increased expression of MIR200C-3p 32569770 2479 Mouse mmu-miR-200c-3p miRNA coix seed Oil (CSO) triple negative breast cancer (TNBC) mouse triple-negative breast cancer (TNBC) tissues coix Seed Oil (CSO) treatment upregulated 33101013 2480 Mouse mmu-miR-200c-5p miRNA X-rays bystander effect C57BL/6 mice extracellular vesicles (EVs) otal-body irradiated with X-rays downregulated 28396668 2481 Mouse mmu-miR-200s miRNA IL-6 insulin resistance (IR) hepatocytes of mice IL-6 treatment downregulated 23798681 2482 Mouse mmu-miR-202-3p miRNA carbon tetrachloride (CCl4) liver fibrosis liver CCl4 treatment downregulated 27322257 2483 Mouse mmu-miR-203 miRNA ischemia acute kidney injury (AKI) renal tubules ischemia treatment upregulated 27959449 2484 Mouse mmu-miR-203 miRNA alcohol alcoholic liver disease (ALD) liver tissues and AML-12 cell lines alcohol exposure downregulated 29670525 2485 Mouse mmu-miR-203 miRNA xiaoxianggou atherosclerosis (AS) serum xiaoxianggou treatment "Xiaoxianggou reverses the reduced miR-203 expression and the elevated Ets-2 expression induced by AngII," 27470353 2486 Mouse mmu-miR-203 miRNA pectin (fermented to butyrate in the colon) (FPA) colon tumorigenesis colonic stem cells (fermented to butyrate in the colon) (FPA) treatment upregulated 26493444 2487 Mouse mmu-miR-203 miRNA high glucose (HG) diabetic nephropathy (DN) mouse glomerular mesangial cells?M4200 cells high glucose treatment downregulated 30229838 2488 Mouse mmu-miR-203 miRNA estradiol differentiation capacity in mouse embryoid bodies vascular smooth muscle cells (VSMC) estradiol treatment upregulated 23175673 2489 Mouse mmu-miR-203 miRNA sodium arsenite (NaAsO2) DNA methylation liver tissues sodium arsenite treatment upregulated 32068019 2490 Mouse mmu-miR-203 miRNA eimeria papillata eimeria papillata infection mouse jejunum Eimeria papillata infection upregulated 21093440 2491 Mouse mmu-miR-203 miRNA high fat diet (HFD) glucose homeostasis adipose tissue high fat diet (HFD) feed downregulated 31327757 2492 Mouse mmu-miR-203 miRNA helicobacter pylori (H. pylori) hepatic insulin resistance primary hepatocytes H. pylori infection downregulated 25689935 2493 Mouse mmu-miR-203 miRNA bleomycin (BLM) idiopathic pulmonary fibrosis (IPF) lung tissues bleomycin (BLM) treatment circTADA2A repressed lung-fibroblasts activation via miR-526b/Cav1 and reduced lung-fibroblasts proliferation via miR-203/Cav2. 32694556 2494 Mouse mmu-miR-203 miRNA bacillus calmette-guerin (BCG) inflammatory response macrophage RAW264.7 cells bacille calmette-guerin (BCG) treatment upregulated 23522925 2495 Mouse mmu-miR-203 miRNA lipopolysaccharide (LPS) inflammatory response macrophage RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated 23522925 2496 Mouse mmu-miR-203 miRNA recombinant Adeno-Cre viruses (AdV-Cre) lung adenocarcinoma (LUAD) lung recombinant Adeno-Cre viruses (AdV-Cre) treatment upregulated 25359683 2497 Mouse mmu-miR-203 miRNA astragaloside IV (AS-IV) osteoarthritis (OA) ATDC5 cells astragaloside IV (AS-IV) treatment "AS-IV significantly reduces LPS-induced viability, apoptosis and the release of TNF-¦Á, IL-6 and iNOS mainly through up-regulating miR-203." 31906765 2498 Mouse mmu-miR-203 miRNA lipopolysaccharide (LPS) osteoarthritis (OA) ATDC5 cells lipopolysaccharide (LPS) treatment upregulated 29432995 2499 Mouse mmu-miR-203 miRNA lipopolysaccharide (LPS) osteoarthritis (OA) ATDC5 cells lipopolysaccharide (LPS) treatment upregulated 30550887 2500 Mouse mmu-miR-203 miRNA lipopolysaccharide (LPS) osteoarthritis (OA) mouse chondrogenic ATDC5 cells lipopolysaccharide (LPS) treatment miR-203 overexpression partially abolished the chondroprotective effects of PMS2L2. 30550887 2501 Mouse mmu-miR-203 miRNA IL-17 psoriasis mouse ears IL-17 treatment upregulated 29039484 2502 Mouse mmu-miR-203 miRNA butyric acid (BA) skin cancer mouse skin butyric acid (BA) treatment upregulated 24792773 2503 Mouse mmu-miR-203 miRNA calcium glucarate (CAG) skin cancer mouse skin calcium glucarate (CAG) treatment upregulated 24792773 2504 Mouse mmu-miR-203 miRNA nicotinamide skin cancer mouse skin nicotinamide(NA) treatment upregulated 24792773 2505 Mouse mmu-miR-203-3p miRNA oxygen retinopathy of prematurity (ROP) retinas tissue "For OIR model construction, 7-day-old mice and their nursing mothers were maintained in 75% oxygen for 5 continuous days. On postnatal day (P) 12, the pups were returned to normoxic air and kept with their mothers for another 5 days. treatment" downregulated in the OIR samples 31452702 2506 Mouse mmu-miR-203-3p miRNA alpinia oxyphylla extract (AOE) type 2 diabetes mellitus (T2DM) db-/db- mouse kidney A. oxyphylla extract (AOE) treatment downregulated 28249617 2507 Mouse mmu-miR-203-3p miRNA aerobic exercise whole-body metabolic adaptations adipocytes aerobic exercise training (AET) treatment upregulated 32900951 2508 Mouse mmu-miR-203a-3p miRNA oxygen diabetic retinopathy (DR) mouse retinal tissues oxygen induce treatment downregulated 31689123 2509 Mouse mmu-miR-203a-3p miRNA oxygen diabetic retinopathy (DR) retinal tissues oxygen treatment MALAT1 affect angiogenesis by sponging miR-203a-3p in DR 31689123 2510 Mouse mmu-miR-203a-3p miRNA carbon tetrachloride (CCl4) epithelial-mesenchymal transition (EMT) liver tissues carbon tetrachloride (CCl4) treatment miR-203a-3p was significantly downregulated in mice with liver fibrosis. 32659284 2511 Mouse mmu-miR-203a-3p miRNA carnosic acid (CA) liver fibrosis liver tissues carnosic acid (CA) treatment Inhibition of p66Shc Oxidative Signaling via CA-Induced Upregulation of miR-203a-3p Alleviates Liver Fibrosis Progression. 32781430 2512 Mouse mmu-miR-204 miRNA lipopolysaccharide (LPS) acute aortic dissection (AAD) aorta lipopolysaccharide (LPS) treatment downregulated 32634201 2513 Mouse mmu-miR-204 miRNA ischemia acute kidney injury (AKI) renal tubules ischemia treatment upregulated 27959449 2514 Mouse mmu-miR-204 miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) mouse Raw264.7 cells oxidized low-density lipoprotein (ox-LDL) treatment MEG3 sponged miR-204 in Raw264.7 cells treated with ox-LDL. MEG3 exerted its function via the regulation of the MEG3/miR-204/CDKN2A regulatory axis in Raw264.7 cells treated with ox-LDL. 30672051 2515 Mouse mmu-miR-204 miRNA puerarin autophagy MC3T3-E1 cells puerarin treatment The expression level of miR-204 was decreased by puerarin 32010248 2516 Mouse mmu-miR-204 miRNA puerarin cell differentiation MC3T3-E1 cells Puerarin treatment downregulated 32010248 2517 Mouse mmu-miR-204 miRNA puerarin cell proliferation MC3T3-E1 cells Puerarin treatment downregulated 29368357 2518 Mouse mmu-miR-204 miRNA puerarin cell viability mouse MC3T3-E1 osteoblast-like cells 0.1 mg/ml puerarin for 48 h treatment downregulated 28901520 2519 Mouse mmu-miR-204 miRNA estrogen (ES) renal fibrosis mouse uterus tissues Estrogen treatment mirn451 was significantly increased by estrogen administration whereas mirn181b and mirn204 expression was significantly reduced 20720260 2520 Mouse mmu-miR-204 miRNA ¦Â-glycerophosphate (¦Â-GP) colorectal cancer (CRC) mouse aortic VSMCs ¦Â-glycerophosphate treatment miR-204 was suppressed in mouse aortic VSMCs during ¦Â-glycerophosphate-induced calcification 22871591 2521 Mouse mmu-miR-204 miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity heart tissues doxorubicin (DOX) treatment downregulated 33274007 2522 Mouse mmu-miR-204 miRNA tunicamycin (TM) endoplasmic reticulum stress (ERS) mouse endothelial cells tunicamycin (TM) treatment upregulated 28839162 2523 Mouse mmu-miR-204 miRNA high fat diet (HFD) endoplasmic reticulum stress (ERS) C57Bl/6 mouse vascular high fat diet (HFD) feed upregulated 28181559 2524 Mouse mmu-miR-204 miRNA high glucose (HG) obesity 3T3-L1 cells high glucose treatment LncRNA TUG1 could negatively regulate miR-204 to alleviate inflammation and insulin tolerance via promoting SIRT1/GLUT4/PPAR¦Ã/AKT pathway. 32888158 2525 Mouse mmu-miR-204 miRNA dietary methionine restriction (MR) osteoblast differentiation and function "male C57BL/6J mice bone marrow,plasma and liver" fed diets containing 0.86% or 0.12% methionine for 5 weeks "upregulated (miR-31 in plasma and liver, and miR-133a, miR-335-5p, and miR-204 in the bone marrow" 27191548 2526 Mouse mmu-miR-204 miRNA oxaliplatin oxaliplatin induced-neuropathy primary cultured dorsal root ganglia neurons oxaliplatin treatment upregulated 30031110 2527 Mouse mmu-miR-204 miRNA oxibendazole (OBZ) prostate cancer 22Rv1 tumors in nude mice treated with OBZ (25 mg/kg/day) treatment upregulated 29434928 2528 Mouse mmu-miR-204 miRNA hypoxia spinal cord ischemia/reperfusion injury (SCII) neuronal cells hypoxia treatment upregulated 26350953 2529 Mouse mmu-miR-204 miRNA candida albicans (C. albicans) systemic Candidiasis C57BL/6 mice candida albicans infection downregulated 24641951 2530 Mouse mmu-miR-204 miRNA high fat diet (HFD) chondrogenesis white adipose tissues high fat diet (HFD) feed downregulated 22496873 2531 Mouse mmu-miR-204-3p miRNA methamphetamine (METH) drug addiction nucleus accumbens (NAc) methamphetamine (METH) treatment upregulated 31153969 2532 Mouse mmu-miR-204-3p miRNA high glucose (HG) renal and podocytes injuries MPC5 cells high glucose treatment downregulated 29940664 2533 Mouse mmu-miR-204-5p miRNA IL-11 aplastic anemia (AA) mouse hematopoietic stem cell (HSC) IL-11 treatment downregulated 29217821 2534 Mouse mmu-miR-204-5p miRNA melatonin calcific aortic valve disease (CAVD) valvular interstitial cells melatonin treatment melatonin ameliorates aortic valve calcification via the regulation of CircRIC3/miR-204-5p/DPP4 signaling in hVICs 32369647 2535 Mouse mmu-miR-204-5p miRNA murine cytomegalovirus (MCMV) murine cytomegalovirus (MCMV) infection peripheral blood monocytes murine cytomegalovirus (MCMV) infection downregulated 33245094 2536 Mouse mmu-miR-204-5p miRNA hypoxia myocardial ischemia/reperfusion (I/R) injury (MIRI) primary cultured cardiomyocyte hypoxia induce downregulated 31644943 2537 Mouse mmu-miR-204-5p miRNA hypoxia/reoxygenation (H/R) myocardial ischemia/reperfusion (I/R) injury (MIRI) cardiomyocytes hypoxia/reoxygenation (H/R) treatment "KCNQ1OT1 could promote the LGALS3 expression by binding to miR-204-5p, which led to aggravated myocardial IR injury." 31644943 2538 Mouse mmu-miR-204-5p miRNA high fat diet (HFD) obesity fat tissues from obese mice fed long-term with a high-fat diet (HFD) high fat diet (HFD) feed downregulated 29775748 2539 Mouse mmu-miR-204-5p miRNA morphine painful or stressful conditions hippocampal Morphine treatment downregulated 25844808 2540 Mouse mmu-miR-204-5p miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) serum and substantia nigra (SN) "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" upregulated 31572127 2541 Mouse mmu-miR-204c miRNA ischemia acute kidney injury (AKI) renal tubules ischemia treatment upregulated 27959449 2542 Mouse mmu-miR-204e miRNA ischemia acute kidney injury (AKI) renal tubules ischemia treatment upregulated 27959449 2543 Mouse mmu-miR-205 miRNA garcinol acute myocardial infarction (AMI) AMI mouse blood; heart tissues Garcinol treatment upregulated 33809417 2544 Mouse mmu-miR-205 miRNA isoproterenol acute myocardial infarction (AMI) blood; heart tissues isoproterenol treatment downregulated 33809417 2545 Mouse mmu-miR-205 miRNA lipopolysaccharide (LPS) acute respiratory distress syndrome (ARDS) lung tissues lipopolysaccharide (LPS) treatment "SNHG5 was downregulated, while miR-205 was upregulated in the serum of ARDS patients and lung tissues of LPS-induced mice." 33170429 2546 Mouse mmu-miR-205 miRNA sodium arsenite (NaAsO2) DNA methylation liver tissues sodium arsenite treatment upregulated 32068019 2547 Mouse mmu-miR-205 miRNA shikonin epithelial-mesenchymal transition (EMT) mouse skin tissues Shikonin treatment downregulated 23861701 2548 Mouse mmu-miR-205 miRNA high fat diet (HFD) erectile dysfunction (ED) mouse high fat diet (HFD) feed dysregulated 25533598 2549 Mouse mmu-miR-205 miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) mouse liver tissues high fat diet (HFD) feed upregulated 31799678 2550 Mouse mmu-miR-205 miRNA oleacein (OA) nonalcoholic fatty liver disease (NAFLD) mouse primary hepatocytes (PH) oleic acid (OA) treatment upregulated 31799678 2551 Mouse mmu-miR-205 miRNA erlotinib non-small cell lung cancer (NSCLC) murine NSCLC xenograft models erlotinib treatment downregulated 24911146 2552 Mouse mmu-miR-205 miRNA gefitinib non-small cell lung cancer (NSCLC) murine NSCLC xenograft models gefitinib treatment downregulated 24911146 2553 Mouse mmu-miR-205 miRNA kanamycin-furosemide ototoxic effects of kanamycin-furosemide serum kanamycin-furosemide treatment upregulated 30235835 2554 Mouse mmu-miR-205 miRNA baicalin (BAI) type 1 diabetes mellitus (T1DM) TNF-¦Á-treated pancreatic ¦Â-cell line Min6 baicalin (BAI) treatment upregulated 30058243 2555 Mouse mmu-miR-205 miRNA tumor necrosis factor alpha (TNF-¦Á) type 1 diabetes mellitus (T1DM) pancreatic ¦Â-cell line Min6 tumor necrosis factor alpha (TNF-¦Á) treatment downregulated 30058243 2556 Mouse mmu-miR-205 miRNA IL-32 vascular injury hIL-32¦Á-Tg and ApoE /hIL-32¦Á-Tg mice IL-32 treatment downregulated 28740544 2557 Mouse mmu-miR-205 miRNA high glucose (HG) diabetic nephropathy (DN) The mouse mesangial SV40©\Mes13 cells "SV40©\Mes13 cells were cultured under normal glucose condition (Con, 5.5 mM glucose), mannitol condition (MN, 5.5 mM glucose + 24.5 mM mannitol), or HG condition (30 mM glucose) for 24 hr. treatment" "miR-205 inhibits HG©\induced proliferation, oxidative stress, ECM accumulation, and inflammation in mesangial cells via targeting HMGB1" 31087368 2558 Mouse mmu-miR-205-3p miRNA oxygen glucose deprivation (OGD) ischemic stroke (IS) bEnd.3 cells Oxygen-glucose deprivation (OGD) treatment Long noncoding RNA MALAT1 regulates apoptosis in ischemic stroke by sponging miR-205-3p and modulating PTEN expression 32655805 2559 Mouse mmu-miR-205-5p miRNA curcumin (Cur) melanoma B78H1 cells curcumin treatment miRNA expression signature in tumors was substantially altered by curcumin intake with mmu-miR-205-5p over 100 times higher expressed when compared to controls. 24349037 2560 Mouse mmu-miR-205-5p miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) brain tissues "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" "The expression levels of MALAT1 and leucine-rich repeat kinase (LRRK2) were increased, and that of miR-205-5p was decreased in the midbrains of mice in which PD was induced by MPTP." 29511451 2561 Mouse mmu-miR-205-5p miRNA hypoxia pulmonary arterial hypertension (PAH) lung tissue hypoxia induce downregulated 30853343 2562 Mouse mmu-miR-205-5p miRNA coix seed Oil (CSO) triple negative breast cancer (TNBC) mouse triple-negative breast cancer (TNBC) tissues coix Seed Oil (CSO) treatment miR-205-5p was substantially altered in CSO treated tumor tissues. 33101013 2563 Mouse mmu-miR-206 miRNA lipopolysaccharide (LPS) Alzheimer's disease (AD) microglial BV-2 cells lipopolysaccharide (LPS) treatment upregulated 27277332 2564 Mouse mmu-miR-206 miRNA ovalbumin (OVA) asthma lung tissues ovalbumin (OVA) treatment "The expression of RMRP and CCL2 was elevated, while miR-206 was reduced in OVA-induced mice." 33511814 2565 Mouse mmu-miR-206 miRNA particulate matter (PM2.5) bronchial asthma lung tissue PM2.5 exposure treatment upregulated 31520993 2566 Mouse mmu-miR-206 miRNA Yes-associated protein (YAP) cardiac hypertrophy cardiomyocytes Yes-associated protein (YAP) treatment upregulated 26333362 2567 Mouse mmu-miR-206 miRNA neurotoxicant sodium valproate (VPA) developmental toxicity murine embryonic stem cells (mESCs) neurotoxicant sodium valproate (VPA) treatment upregulated 24896083 2568 Mouse mmu-miR-206 miRNA ethanol (EtOH) drinking "mouse different brain regions, including medial prefrontal cortex (mPFC) , central amygdala (CeA), and hippocampus (HPC)" ethanol treatment upregulated 30790666 2569 Mouse mmu-miR-206 miRNA forced swim stress (FSS) drinking "mouse different brain regions, including medial prefrontal cortex (mPFC) , central amygdala (CeA), and hippocampus (HPC)" the mice received either a single or 5 daily 10-min FSS sessions upregulated 30790666 2570 Mouse mmu-miR-206 miRNA TGF-¦Â epithelial-mesenchymal transition (EMT) C2C12 cells TGF-¦Â treatment downregulated 21324893 2571 Mouse mmu-miR-206 miRNA "fasting, denervation, diabetes, and cancer cachexia" fine-tuning the atrophy program mouse muscles "mouse muscles under wasting conditions such as fasting, denervation, diabetes, and cancer cachexia treatment" wasting conditions showed an induction of miRNA-206 and miRNA-21 expression 24891504 2572 Mouse mmu-miR-206 miRNA adriamycin (ADR) focal segmental glomerulosclerosis (FSGS) glomeruli adriamycin (ADR) treatment upregulated 27056206 2573 Mouse mmu-miR-206 miRNA high fat diet (HFD) hepatosteatosis and hyperglycemia mouse fatty livers high fat diet (HFD) feed downregulated 28025059 2574 Mouse mmu-miR-206 miRNA 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) lung cancer lung cancer cells drug treatment lung carcinogen NNK exposure changes the expression of serum miRNAs. Serum miR-206 and miR-133b could be associated with lung carcinogenesis induced by NNK 23337359 2575 Mouse mmu-miR-206 miRNA botulinum toxin A (BTXA) muscle atrophy quadriceps muscle botulinum toxin A (BTXA) treatment upregulated 30427927 2576 Mouse mmu-miR-206 miRNA heme oxygenase-1 (HMOX1) myoblast differentiation C2C12 cells Heme oxygenase-1 (HMOX1) treatment downregulated 21827279 2577 Mouse mmu-miR-206 miRNA sciatic nerve partial ligation pain mouse dorsal root ganglion (DRG) sciatic nerve partial ligation therapy treatment downregulated 21385380 2578 Mouse mmu-miR-206 miRNA "pioglitazone and L-buthionine-S,R-sulfoximine" skeletal muscle injury C57BL/6J mice plasma "pioglitazone with L-buthionine-S,R-sulfoximine, to C57BL/6J mice for 2days treatment" upregulated in plasma 28263783 2579 Mouse mmu-miR-206 miRNA 6-bromoindirubin-3'-oxime (BIO) skeletal muscle differentiation C2C12 cells 6-bromoindirubin-3'-oxime (BIO) treatment upregulated 31792344 2580 Mouse mmu-miR-206-3p miRNA angiostrongylus cantonensis (A. cantonensis) angiostrongylus cantonensis (A. cantonensis) infection mouse angiostrongylus cantonensis (A. cantonensis) infection upregulated 24682888 2581 Mouse mmu-miR-206-3p miRNA donepezil Alzheimer's disease (AD) APP/PS1 mice donepezil treatment downregulated in the hippocampus and cortex 28123152 2582 Mouse mmu-miR-206-3p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce upregulated 30936699 2583 Mouse mmu-miR-206-3p miRNA "4,4'-methylene diphenyl diisocyanate (MDI)" occupational asthma (OA) Female BALB/c mice blood "4,4'-methylene diphenyl diisocyanate (MDI) exposure" downregulated 30074411 2584 Mouse mmu-miR-206-3p miRNA "4,4'-methylene diphenyl diisocyanate (MDI)" occupational asthma (OA) bronchoalveolar lavage cells (BALCs) "4,4'-methylene diphenyl diisocyanate (MDI) treatment" downregulated 31609387 2585 Mouse mmu-miR-206-3p miRNA "diisocyanate, 4,4'-methylene diphenyl diisocyanate (MDI)" occupational asthma (OA) Female BALB/c mice blood Female BALB/c mice were exposed to one of three exposure regimens: dermal exposure to 1% MDI in acetone; nose-only exposure to 4580?¡À?1497?¦Ìg/m3 MDI-aerosol for 60?minutes; or MDI dermal exposure/sensitization followed by MDI-aerosol inhalation challenge. downregulated 30074411 2586 Mouse mmu-miR-206a-3p miRNA streptozocin (STZ) diabetic retinopathy (DR) retina and serum of diabetic mice streptozotocin treatment upregulated 30883703 2587 Mouse mmu-miR-208 miRNA IL-10 cardiac fibrosis mouse bone marrow fibroblast progenitor cells (BM-FPCs) IL10 treatment downregulated 28667100 2588 Mouse mmu-miR-208 miRNA streptozocin (STZ) diabetes mellitus (DM) hearts of diabetic mice streptozotocin (STZ) treatment upregulated 21584493 2589 Mouse mmu-miR-208 miRNA bone morphogenetic protein 2 (BMP2) impaired osteogenic differentiation MC3T3-E1 cells; Primary murine osteoblast cells bone morphogenetic protein 2 (BMP2) treatment downregulated 20576608 2590 Mouse mmu-miR-208 miRNA cardiac ischemia reperfusion (CIR) ischemia/reperfusion (I/R) injury mouse cardiac ischemia reperfusion (CIR) treatment downregulated 29442001 2591 Mouse mmu-miR-208a miRNA doxorubicin (DOX) cardiomyocyte apoptosis cardiomyocyte doxorubicin treatment upregulated 26137188 2592 Mouse mmu-miR-208a miRNA streptozocin (STZ) diabetes mellitus (DM) CD1 mice of both genders streptozocin (STZ) treatment upregulated 24685144 2593 Mouse mmu-miR-208a miRNA high glucose (HG) diabetes-induced cardiac remodelling HL-1 cardiomyocytes high-glucose (HG) treatment upregulated 30696455 2594 Mouse mmu-miR-208a miRNA synthetic Sulfonyl-Hydrazone-1 iPSC-derived cardiac differentiation Murine fibroblast-derived iPSCs Synthetic Sulfonyl-Hydrazone-1 treatment "small chemical compounds, such as SHZ, can constitute a novel and clinically feasible strategy to improve iPSC-derived cardiac differentiation" 21445862 2595 Mouse mmu-miR-208a miRNA isoproterenol isoproterenol-induced cardiac injury heart tissues ISO treatment upregulated 24713317 2596 Mouse mmu-miR-208a miRNA prolonged aerobic exercise muscle hypertrophy plasma "impact of extended-duration, submaximal aerobic exercise treatment" upregulated 24436293 2597 Mouse mmu-miR-208a miRNA ischemia/reperfusion (I/R) myocardial ischaemic injury mouse plasma;Bone marrow-derived macrophage (BMDM);Rat neonatal CMs ischemia/reperfusion (I/R) treatment differently regulated 28768728 2598 Mouse mmu-miR-208a miRNA angiotensin II (Ang II) weight gain HL-1 cells angiotensin II (Ang II) treatment upregulated 26381051 2599 Mouse mmu-miR-208b-3p miRNA luteolin myocardial ischemia/reperfusion (I/R) injury (MIRI) H9c2 cells Luteolin (LUT) treatment downregulated 26658785 2600 Mouse mmu-miR-20a miRNA H2O2 Alzheimer's disease (AD) Primary hippocampal neuron cells H2O2 treatment upregulated 24423585 2601 Mouse mmu-miR-20a miRNA H2O2 Alzheimer's disease (AD) senescence accelerated mouse prone 8 (SAMP8) and prone 10 (SAMP10) "different concentrations (0, 100, 200, 400 and 800 ¦ÌM) of H2O2 treatment" upregulated 24423585 2602 Mouse mmu-miR-20a miRNA notoginsenoside R1 (NGR1) atherosclerosis (AS) serum;aorta notoginsenoside R1 (NGR4) treatment upregulated 24933211 2603 Mouse mmu-miR-20a miRNA Shexiang Tongxin dropping pill (STDP) atherosclerosis (AS) serial transverse aortic sections Shexiang Tongxin dropping pill (STDP) treatment upregulated 25449459 2604 Mouse mmu-miR-20a miRNA Shexiang Tongxin dropping pill (STDP) atherosclerosis (AS) (ApoE(-/-)) mice aortic STDP (30 mg/kg/day) on atherosclerotic lesions treatment upregulated 25449459 2605 Mouse mmu-miR-20a miRNA hyperoxia bronchopulmonary dysplasia (BPD) lung tissues hyperoxia treatment downregulated 33143661 2606 Mouse mmu-miR-20a miRNA streptozocin (STZ) diabetes mellitus (DM) hearts of diabetic mice streptozotocin (STZ) treatment downregulated 21584493 2607 Mouse mmu-miR-20a miRNA high glucose (HG) diabetic retinopathy (DR) Mouse-derived retinal microvascular endothelial cells (RMECs) high glucose (HG) treatment miR-20a was significantly downregulated in HG-treated RMECs. 32776826 2608 Mouse mmu-miR-20a miRNA mangiferin endoplasmic reticulum stress (ERS) primary mouse hepatocytes mangiferin treatment downregulated 32413114 2609 Mouse mmu-miR-20a miRNA high fat diet (HFD) hepatocellular carcinoma (HCC) plasma and hepatic tissues high fat diet (HFD) feed downregulated 26728044 2610 Mouse mmu-miR-20a miRNA progesterone (P4) infertility uterine horn of 6-week-old female mice (C57BL/6) progesterone treatment dysregulated 30603515 2611 Mouse mmu-miR-20a miRNA fluid shear stress (FSS) osteoblastic differentiation MC3T3-E1 cells fluid shear stress (FSS)treatment downregulated 23595392 2612 Mouse mmu-miR-20a miRNA hypoxia osteoclast differentiation RAW264.7 cells "hypoxia caused induction of autophagy and osteoclast differentiation markers in . In addition, was significantly repressed treatment" downregulated 25485521 2613 Mouse mmu-miR-20a miRNA bleomycin and silica lung fibrosis fibroblasts bleomycin and silica treatment "qPCR revealed a significant increase of miR-19a, 19b, and 20a-expression in activated fibroblasts in the early phase of bleomycin and silica models." 29923329 2614 Mouse mmu-miR-20a miRNA hypoxia pulmonary hypertension (PH) right ventricular and pulmonary arterial vascular Hypoxia treatment upregulated 22450430 2615 Mouse mmu-miR-20a miRNA monocrotaline (MCT) pulmonary hypertension (PH) lung tissues monocrotaline (MCT) treatment upregulated 26980205 2616 Mouse mmu-miR-20a miRNA cecal ligation and puncture (CLP) sepsis whole blood cecal ligation and puncture (CLP) treatment upregulated 24205035 2617 Mouse mmu-miR-20a miRNA genistein spermatogenesis ICR mice testis "different doses of GEN (0, 0.5, 5, 50 and 250 mg/kg/day) for 35 days" upregulated 28938591 2618 Mouse mmu-miR-20a* miRNA plasmodium chabaudi malaria peak parasitemia liver of mice Plasmodium chabaudi malaria infection treatment downregulated 21085987 2619 Mouse mmu-miR-20a-3p miRNA streptozocin (STZ) diabetic retinopathy (DR) retina and serum of diabetic mice streptozotocin treatment downregulated 30883703 2620 Mouse mmu-miR-20a-5p miRNA streptozocin (STZ) diabetic retinopathy (DR) retina and serum of diabetic mice streptozotocin treatment downregulated 30883703 2621 Mouse mmu-miR-20a-5p miRNA high glucose (HG) hepatic glycogen synthesis NCTC1469 cells and Hep1-6 cells high glucose treatment downregulated 27019188 2622 Mouse mmu-miR-20a-5p miRNA licochalcone A (LA) lung cancer MLE-12 cells Licochalcone A (lico A) treatment downregulated 32505917 2623 Mouse mmu-miR-20a-5p miRNA neurotoxicant cuprizone (CPZ) myelin abnormalities myelin Neurotoxicant cuprizone (CPZ) treatment miR-155-5p and miR-20a-5p upregulations enhanced NgR induction through Smad 2 and Smad 4 suppression in demyelination. 31963761 2624 Mouse mmu-miR-20a-5p miRNA free fatty acids (FFA) nonalcoholic fatty liver disease (NAFLD) primary mouse hepatocytes free fatty acid (FFA) treatment downregulated 33344451 2625 Mouse mmu-miR-20a-5p miRNA IL-1¦Â osteoarthritis (OA) murine induced pluripotent stem cell (miPSC) IL-1¦Â treatment "RNA-seq results show that miR-20a-5p increase from 4 to 24 hours, but slightly decrease from 24 to 72 hours in IL-1¦Âstimulated pellets." 32767602 2626 Mouse mmu-miR-20a-5p miRNA tumor necrosis factor alpha (TNF-¦Á) osteoarthritis (OA) murine induced pluripotent stem cell (miPSC) tumor necrosis factor alpha (TNF-¦Á) treatment "RNA-seq results show that miR-20a-5p increase from 4 to 24 hours, but slightly decrease from 24 to 72 hours in TNF-¦Á stimulated pellets" 32767602 2627 Mouse mmu-miR-20a-5p miRNA radiation radiation-induced injury blood radiation treatment downregulated 29799276 2628 Mouse mmu-miR-20b miRNA staphylococcal enterotoxin B (SEB) acute inflammatory lung injury lung staphylococcal enterotoxin B treatment upregulated 25564423 2629 Mouse mmu-miR-20b miRNA high glucose (HG) diabetic nephropathy (DN) immortalized mouse podocytes HG upregulated 28849008 2630 Mouse mmu-miR-20b miRNA streptozocin (STZ) diabetic retinopathy (DR) retina and serum of diabetic mice streptozotocin treatment downregulated 30883703 2631 Mouse mmu-miR-20b miRNA IL-1¦Â osteoarthritis (OA) chondrocytes IL-1¦Â treatment downregulated 32315726 2632 Mouse mmu-miR-20b miRNA monocrotaline (MCT) pulmonary hypertension (PH) lung tissues monocrotaline (MCT) treatment upregulated 26980205 2633 Mouse mmu-miR-20b miRNA cecal ligation and puncture (CLP) sepsis whole blood cecal ligation and puncture (CLP) treatment upregulated 24205035 2634 Mouse mmu-miR-20b miRNA coxsackievirus B3 (CVB3) viral myocarditis (VM) mouse mouse heart tissues infect with CVB3 upregulated 28247213 2635 Mouse mmu-miR-20b2 miRNA tuberculosis (MTB) inflammation mouse lung infect with TB treatment downregulated in lung 28606793 2636 Mouse mmu-miR-20b-5p miRNA H2O2 hepatic ischemia/reperfusion injury (HIRI) Primary mouse hepatocytes culture H2O2 treatment ?HOTAIR regulates autophagy via the miR-20b-5p/ATG7 axis in hepatic I/R injury 30367982 2637 Mouse mmu-miR-20b-5p miRNA ischemia/reperfusion (I/R) myocardial ischemia/reperfusion (I/R) injury (MIRI) mouse cardiomyocytes ischemia/reperfusion (I/R) treatment The expression of circHIPK3 was upregulated during myocardial I/R injury and hypoxia/reoxygenation (H/R) injury of cardiomyocytes. 33824287 2638 Mouse mmu-miR-20b-5p miRNA radiation radiation-induced injury blood radiation treatment downregulated 29799276 2639 Mouse mmu-miR-20b-5p miRNA mycobacterium tuberculosis (Mtb) tuberculosis (TB) RAW 264.7 macrophages Mycobacterium tuberculosis (Mtb) infection downregulated 30378171 2640 Mouse mmu-miR-20b-5p miRNA mycobacterium tuberculosis (Mtb) tuberculosis (TB) RAW 264.7 macrophages Mycobacterium tuberculosis (Mtb) infection downregulated 30378171 2641 Mouse mmu-miR-21 miRNA TGF-¦Â pancreatic cancer (PC) mouse primary fibroblasts TGF¦Â treatment upregulated 23469132 2642 Mouse mmu-miR-21 miRNA hypoxia Alzheimer's disease (AD) exosomes derived from mesenchymal stromal cells (MSCs) hypoxia induce upregulated 28970251 2643 Mouse mmu-miR-21 miRNA red mud biological effects of red mud "CBA/Ca mice liver, spleen, lung, kidney and lymph nodes" "1, 3, 6 and 24 h after a single intraperitoneal injection of red mud treatment" "upregulated , but the level and the peak of the alteration differed according to examined tissue" 24425836 2644 Mouse mmu-miR-21 miRNA Tungsten carbide-cobalt (WC-Co) nanoparticle composites bipolar disorder type I (BD-I) JB6 P+ cells Tungsten carbide-cobalt (WC-Co) nanoparticle composites? treatment WC-Co nanoparticles induce miR-21 generation 23758151 2645 Mouse mmu-miR-21 miRNA high tidal volume ventilation (HVTV) lung injury lung tissues high tidal volume ventilation (HVTV) treatment upregulated 22659882 2646 Mouse mmu-miR-21 miRNA talcum powder atrial fibrillation (AF) heart talcum powder treatment upregulated 27406600 2647 Mouse mmu-miR-21 miRNA oxygen glucose deprivation (OGD) acute cerebral infarction mouse N2A neuroblastoma cells (N2A) oxygen-and-glucose-deprivation (OGD) treatment upregulated 24841240 2648 Mouse mmu-miR-21 miRNA ischemia/reperfusion (I/R) acute kidney injury (AKI) C57BL/6J mice ischemia/reperfusion (I/R) treatment upregulation in samples of kidney 26149640 2649 Mouse mmu-miR-21 miRNA ischemia acute kidney injury (AKI) renal tubules ischemia treatment upregulated 27959449 2650 Mouse mmu-miR-21 miRNA ischemia acute kidney injury (AKI) kidney tissues subjected to 35 min occlusion of bilateral renal pedicles 4 days following preconditioning upregulated 28677811 2651 Mouse mmu-miR-21 miRNA xenon (Xe) acute kidney injury (AKI) kidney Xenon treatment upregulated 25844699 2652 Mouse mmu-miR-21 miRNA lipopolysaccharide (LPS) acute liver injury (ALI) liver tissues lipopolysaccharide (LPS) treatment miR-21 exacerbate acute liver injury in sepsis mice by inhibiting PPAR¦Á expression. 33424957 2653 Mouse mmu-miR-21 miRNA Liang-Ge-San (LGS) acute lung injury (ALI) LPS-induced murine RAW264.7 cells Liang-Ge-San (LGS) treatment upregulated 31803051 2654 Mouse mmu-miR-21 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) Murine RAW264.7 cells lipopolysaccharide (LPS) treatment downregulated 31803051 2655 Mouse mmu-miR-21 miRNA caerulein (Cae) acute pancreatitis (AP) pancreata caerulein (Cae) treatment miR-21 was significantly lower following caerulein treatment. 30537729 2656 Mouse mmu-miR-21 miRNA ethanol (EtOH) alcoholic liver injury liver ethanol treatment upregulated 25118289 2657 Mouse mmu-miR-21 miRNA flavonol icariin apoptosis mouse pronuclear embryos icariin treatment upregulated 24948525 2658 Mouse mmu-miR-21 miRNA mouse growth differentiation factor-9 (GDF-9) or in pig oocyte-conditioned medium (POCM) apoptosis mouse oocytectomized cumulus oophorus complexes (OOXs) cultured with GDF-9 or in POCM upregulated 28486664 2659 Mouse mmu-miR-21 miRNA ¦Á-MEM medium apoptosis mouse oocytectomized cumulus oophorus complexes (OOXs) ¦Á-MEM medium treatment downregulated 28486664 2660 Mouse mmu-miR-21 miRNA budesonide asthma OVA-challenged asthma mice lung tissues budesonide treatment downregulated 29854030 2661 Mouse mmu-miR-21 miRNA calcitriol asthma OVA-challenged asthma mice lung tissues calcitrioltreatment downregulated 29854030 2662 Mouse mmu-miR-21 miRNA ovalbumin (OVA) asthma lung tissues ovalbumin (OVA) treatment upregulated 29854030 2663 Mouse mmu-miR-21 miRNA bosentan atherosclerosis (AS) endothelial cell from apolipoprotein E-deficient (ApoE-/-) mouse model of atherosclerosis bosentan treatment upregulated 31886257 2664 Mouse mmu-miR-21 miRNA cigarette smoke (CS) atherosclerosis (AS) aortic tissues of ApoE KO mice cigarette smoke (CS) exposure upregulated 29642385 2665 Mouse mmu-miR-21 miRNA lipopolysaccharide (LPS) atherosclerosis (AS) RAW 264.7;macrophage-like cell line lipopolysaccharide (LPS) treatment upregulated 24502419 2666 Mouse mmu-miR-21 miRNA notoginsenoside R1 (NGR1) atherosclerosis (AS) serum;aorta notoginsenoside R1 (NGR1) treatment downregulated 24933211 2667 Mouse mmu-miR-21 miRNA high glucose (HG) autophagy murine podocytes cell (MPC) lines high glucose upregulated 26567247 2668 Mouse mmu-miR-21 miRNA deoxycholic acid (DCA) bile acid-associated liver pathologies primary rat hepatocytes deoxycholic acid (DCA) treatment downregulated 26621219 2669 Mouse mmu-miR-21 miRNA bile acids bile-containing gastroesophageal reflux murine hypopharyngeal mucosa (HM) bile acids treatment upregulated 29529473 2670 Mouse mmu-miR-21 miRNA saline bile-containing gastroesophageal reflux murine hypopharyngeal mucosa (HM) saline treatment upregulated 29529473 2671 Mouse mmu-miR-21 miRNA fludioxonil andfenhexamid breast cancer MCF-7;T47D; MDA-MB-231 human breast cancer cells Fludioxonil and Fenhexamid treatment downregulated 23052036 2672 Mouse mmu-miR-21 miRNA xanthomicrol breast cancer 4T1 cells xanthomicrol treatment downregulated 33217075 2673 Mouse mmu-miR-21 miRNA doxorubicin (DOX) cardiac cytotoxicity heart tissue and H9C2 cells doxorubicin (DOX) treatment upregulated 26132560 2674 Mouse mmu-miR-21 miRNA angiotensin II (Ang II) cardiac fibroblast migration primary mouse cardiac fibroblasts (CFs) angiotensin II (Ang II) treatment upregulated 24447911 2675 Mouse mmu-miR-21 miRNA IL-10 cardiac fibrosis mouse bone marrow fibroblast progenitor cells (BM-FPCs) IL10 treatment downregulated 28667100 2676 Mouse mmu-miR-21 miRNA streptozocin (STZ) cardiac fibrosis myocardium of T1DM mice streptozotocin treatment upregulated 31680453 2677 Mouse mmu-miR-21 miRNA doxorubicin (DOX) cardiotoxicity BALB/c mice injected C-26 tumor cells doxorubicin treatment upregulated 28560697 2678 Mouse mmu-miR-21 miRNA collagen IV and vascular endothelial growth factor (VEGF) cardiovascular regeneration induced pluripotent stem cells (iPSC) collagen IV and VEGF treatment upregulated 24356956 2679 Mouse mmu-miR-21 miRNA IL-6 cell apoptosis in early mouse embryo development mouse blastocyst stage embryos cells interleukin-6 (IL-6) treatment "the induction of the Stat3 anti-apoptotic pathway by IL-6 is linked to miRNA-21 expression, which possibly results in the regulation of cell apoptosis in early mouse embryo development" 19437447 2680 Mouse mmu-miR-21 miRNA substance P (SP) cell proliferation Colonic epithelial exosomes were isolated from mice substance P (SP) treatment upregulated 31545921 2681 Mouse mmu-miR-21 miRNA hypoxia cerebral ischemic stroke (CIS) C57BL/6 J mice MCAO treatment downregulated 29238035 2682 Mouse mmu-miR-21 miRNA estradiol-17¦Â (E2) cervical cancer (CC) Osteosarcoma Saos2 cell line estradiol-17¦Â (E2) treatment downregulated 27278606 2683 Mouse mmu-miR-21 miRNA bile duct ligation (BDL) cholestasis wild-type (WT) mice bile duct ligation (BDL)treatment upregulated BDL wild-type (WT) mice 29229992 2684 Mouse mmu-miR-21 miRNA hyperoxia chronic lung disease (CLD) Lung and serum samples Hyperoxic exposure upregulated 32191117 2685 Mouse mmu-miR-21 miRNA cigarette smoke (CS) chronic obstructive pulmonary disease (COPD) lung tissues cigarette smoke (CS) treatment miR-21 was upregulated relative to the control in CS-exposed lungs. 30555555 2686 Mouse mmu-miR-21 miRNA cerulein chronic pancreatitis (CP) pancreas cerulein treatment upregulated 29303912 2687 Mouse mmu-miR-21 miRNA genistein chronic vascular inflammation aortae of LPS-treated mice genistein (GEN) treatment downregulated 33495831 2688 Mouse mmu-miR-21 miRNA lipopolysaccharide (LPS) chronic vascular inflammation aortae of LPS-treated mice lipopolysaccharide (LPS) treatment upregulated 33495831 2689 Mouse mmu-miR-21 miRNA trinitrobenzene sulfonic acid (TNBS) colitis colon tissues trinitrobenzene sulfonic acid (TNBS) treatment upregulated 29788092 2690 Mouse mmu-miR-21 miRNA ionizing radiation (IR) colorectal cancer (CRC) mouse hippocampal cells;brain tissues ionizing radiation treatment upregulated 21986536 2691 Mouse mmu-miR-21 miRNA IL-10 colonic inflammation colonic intraepithelial lymphocytes IL-10 treatment downregulated 22043014 2692 Mouse mmu-miR-21 miRNA NaOH corneal alkali burn Corneal neovascularization applying a paper disc (2.0-mm diameter) soaked with 2 ¦Ìl of 0.5 M NaOH in the right eye upregulated 28052006 2693 Mouse mmu-miR-21 miRNA coxsackievirus B3 (CVB3) coxsackievirus B3 (CVB3) infection disease male A/J mice intraperitoneally inoculation with 5¡Á103 plaque-forming unit (pfu) of CVB3 treatment upregulated 24722419 2694 Mouse mmu-miR-21 miRNA hypoxia Dendritic cell (DC) maturation mouse bone marrow-derived DCs (BMDCs) hypoxia induce upregulated 30840288 2695 Mouse mmu-miR-21 miRNA IL-1¦Â and TNF-¦Á diabetes mellitus (DM) MIN6 cells IL-1¦Â and TNF-¦Á treatment upregulated 20086228 2696 Mouse mmu-miR-21 miRNA streptozocin (STZ) diabetes mellitus (DM) hearts of diabetic mice streptozotocin (STZ) treatment upregulated 21584493 2697 Mouse mmu-miR-21 miRNA TGF-¦Â diabetic glomerulopathy murine podocytes TGF-¦Â treatment upregulated 25145934 2698 Mouse mmu-miR-21 miRNA losartan diabetic nephropathy (DN) kidney tissues losartan treatment downregulated 27770539 2699 Mouse mmu-miR-21 miRNA streptozocin (STZ) diabetic nephropathy (DN) renal tissues streptozotocin (STZ) treatment upregulated 31655195 2700 Mouse mmu-miR-21 miRNA TGF-¦Â1 diabetic foot ulcer (DFU) NIH-3T3 cells that are subjected to high glucose environment TGF¦Â1 treatment upregulated 25130469 2701 Mouse mmu-miR-21 miRNA lipopolysaccharide (LPS) diabetic wound impairment RAW264.7 cells lipopolysaccharide (LPS) treatment MiR-21 was highly induced in M1 macrophages. 32397166 2702 Mouse mmu-miR-21 miRNA delayed ischemic preconditioning differentiation and contractile phenotype of smooth muscle cells (SMCs) mouse kidney Delayed ischemic preconditioning treatment upregulated 22785173 2703 Mouse mmu-miR-21 miRNA TGF-¦Â DNA damage tubular epithelial cells TGF-¦Â treatment downregulated 23207693 2704 Mouse mmu-miR-21 miRNA synthetic preimplantation factor (sPIF) duchenne muscular dystrophy (DMD) myoblast Synthetic preimplantation factor (sPIF) treatment downregulated 30692507 2705 Mouse mmu-miR-21 miRNA high-fat/high-cholesterol diet or a high-protein diet dyslipidemia DO mice a high-fat/high-cholesterol diet or a high-protein diet for 18 wk dysregulated 28916633 2706 Mouse mmu-miR-21 miRNA eimeria papillata eimeria papillata infection mouse jejunum Eimeria papillata infection upregulated 21093440 2707 Mouse mmu-miR-21 miRNA ¦Ã-rays epithelial-mesenchymal transition (EMT) lung tissue irradiation with a single dose (20 Gy) of 60Co ¦Ã-rays. upregulated 31160967 2708 Mouse mmu-miR-21 miRNA IL-10 epithelial-mesenchymal transition (EMT) colonic intraepithelial lymphocytes IL-10 treatment upregulated 22043014 2709 Mouse mmu-miR-21 miRNA retinoid binding protein peptide 161-180 experimental autoimmune uveoretinitis (EAU) ocular tissues retinoid binding protein peptide 161-180 treatment upregulated 20881307 2710 Mouse mmu-miR-21 miRNA ginsenoside Rg3 gastric precancerous lesions (GPLs) stomach samples Ginsenoside Rg3 (Rg3) treatment Rg3 Ameliorates Gastric Precancerous Lesions in Atp4a -/- Mice via Inhibition of Glycolysis through PI3K/AKT/miRNA-21 Pathway 32076440 2711 Mouse mmu-miR-21 miRNA high fat diet (HFD) glioblastoma multiforme (GBM) white adipose tissues high fat diet (HFD) feed upregulated 21381024 2712 Mouse mmu-miR-21 miRNA astragaloside IV (AS-IV) glomerular diseases mesangial cell (MC); primary mouse podocytes; serum; kidney tissues astragaloside IV (AS-IV) treatment AS-IV decreased miR-21 levels. 30122901 2713 Mouse mmu-miR-21 miRNA sophocarpine (SC) head and neck squamous cell carcinoma (HNSCC) nude mouse injected with UM-SCC-22B cells "100 mm3, SC (5 mg/kg) was intravenously injection treatment" downregulated 28571917 2714 Mouse mmu-miR-21 miRNA X-rays hematopoietic toxicity following irradiation "spleen, thymus, bone marrow, small intestine, liver, lung, brain tissues" Mice were subjected to total body irradiation (TBI) at a dose of 6.5 Gy using a Pantak H-320 (320kV) Precision X-Ray "miR-21 expression was increased in radiosensitive tissues, but not in radioinsensitive tissues following TBI in wild-type mice, suggesting it may have a critical function in the normal tissue response to irradiation." 31039423 2715 Mouse mmu-miR-21 miRNA arsenite liver fibrosis primary hepatocytes ; L-02 cells arsenic (As) exposure The levels of miR-21 and HIF-1¦Á were also enhanced in primary hepatocytes and L-02 cells exposed to arsenite. 33310519 2716 Mouse mmu-miR-21 miRNA corilagin liver fibrosis liver tissue cordycepin treatment downregulated 26946098 2717 Mouse mmu-miR-21 miRNA bromodichloromethane (BDCM) hepatic fibrogenesis high-fat (60% kcal) diet-fed chronic mouse BDCM 2.0 mmol/kg treatment upregulated 25501551 2718 Mouse mmu-miR-21 miRNA leptin hepatic fibrogenesis liver tissues leptin treatment upregulated 25501551 2719 Mouse mmu-miR-21 miRNA betulinic acid (BA) hepatocellular carcinoma (HCC) HCC cells betulinic acid (BA) treatment upregulated 26222667 2720 Mouse mmu-miR-21 miRNA dehydroepiandrosterone (DHEA) hepatocellular carcinoma (HCC) mouse mouse liver DHEA treatment upregulated 24845419 2721 Mouse mmu-miR-21 miRNA high inorganic phosphate (Pi) hyperphosphatemia Mouse myocardial endothelial cells (MEC) high Pi treatment High Pi induced MEC apoptosis and upregulated microRNA-21 expression. 30257106 2722 Mouse mmu-miR-21 miRNA angiotensin II (Ang II) hypertension ACE2 knockout mouse kidney angiotensin II (Ang II) treatment upregulated in the mouse kidney 28808068 2723 Mouse mmu-miR-21 miRNA angiotensin II (Ang II) hypertensive heart disease (HHD) heart sissues angiotensin II (Ang II) treatment MiR-21 expression levels were significantly upregulated in the mice hearts after angiotensin II (Ang II) infusion. 32040481 2724 Mouse mmu-miR-21 miRNA rapamycin hypoxia/reoxygenation (H/R) injury islet rapamycin treatment upregulated 27683229 2725 Mouse mmu-miR-21 miRNA bleomycin (BLM) idiopathic pulmonary fibrosis (IPF) myofibroblasts bleomycin (BLM) treatment upregulated 20643828 2726 Mouse mmu-miR-21 miRNA granulocyte-macrophage colony stimulating factor (GM-CSF) and IL-6 immune response bone marrow cells GM-CSF£¬ IL-6 treatment upregulated 24391219 2727 Mouse mmu-miR-21 miRNA TGF-¦Â immune response bone marrow cells and spleen MDSC TGF-¦Â treatment upregulated 24391219 2728 Mouse mmu-miR-21 miRNA progesterone (P4) infertility uterine horn of 6-week-old female mice (C57BL/6) progesterone treatment dysregulated 30603515 2729 Mouse mmu-miR-21 miRNA lipopolysaccharide (LPS) inflammation postefferocytotic peripheral blood monocyte-derived macrophages lipopolysaccharide (LPS) treatment upregulated 24391209 2730 Mouse mmu-miR-21 miRNA pentraxin 3 (PTX3) inflammation wild-type brown adipocytes pentraxin 3 (PTX3) treatment "PTX3 plays an anti-inflammatory role, in part through regulating miR-21 expression and secretion" 31898407 2731 Mouse mmu-miR-21 miRNA sodium sulfide (Na2S) ischemic injury mouse heart Na2S treatment upregulated 24825878 2732 Mouse mmu-miR-21 miRNA intense light ischemic preconditioning (IPC) mouse cardiac tissues expose mice to intense light upregulated in cardiac tissue 28448534 2733 Mouse mmu-miR-21 miRNA rapamycin islets hypoxia/reoxygenation (H/R) injury male C57BL/6 islets with hypoxia/reoxygenation (H/R) injury rapamycin treatment upregulated 27683229 2734 Mouse mmu-miR-21 miRNA rosiglitazone kidney fibrosis obesity mouse kidney rosiglitazone treatment downregulated 28588299 2735 Mouse mmu-miR-21 miRNA deoxycorticosterone acetate (DOCA) kidney damage hypertensive mice kidneys and urine injection of Deoxycorticosterone acetate (Doca) upregulated in the kidneys and urine 29255279 2736 Mouse mmu-miR-21 miRNA hypoxia kidney ischemia injury mouse renal tubular epithelial cells (RTECs) hypoxia treatment upregulated 31632533 2737 Mouse mmu-miR-21 miRNA chlorogenic acid (CGA) liver fibrosis schistosome-infected mice hepatic tissue Chlorogenic acid (CGA) treatment downregulated in hepatic tissue 27872076 2738 Mouse mmu-miR-21 miRNA tamoxifen (TAM) liver regeneration liver tissues tamoxifen-induced Dicer1 deletion treatment upregulated 31306658 2739 Mouse mmu-miR-21 miRNA nitric oxide synthase (NOS2) lung cancer lung tissues nitric oxide synthase (NOS2) treatment downregulated 22618808 2740 Mouse mmu-miR-21 miRNA nickel nanoparticles (nano-Ni) lung fibrosis lung tissues nickel nanoparticles (Nano-Ni) treatment Nano-Ni resulted in upregulation of miR-21. 32924694 2741 Mouse mmu-miR-21 miRNA inositol hexaphosphate (IP6) lung tumorigenesis F1 mice lung tumor "Balb/c mice were exposed to the N-ethyl-N-nitrosourea (ENU) intraperitoneally on the 17th day of gestation. After weaning, half of the litters were fed with oral 2% IP6." downregulated 30806292 2742 Mouse mmu-miR-21 miRNA N-ethyl-N-nitrosourea (ENU) lung tumorigenesis F1 mice lung tumor Balb/c mice were exposed to the N-ethyl-N-nitrosourea (ENU) intraperitoneally on the 17th day of gestation. upregulated 30806292 2743 Mouse mmu-miR-21 miRNA rapamycin lymphangioleiomyomatosis (LAM) mouse embryonic fibroblasts medicine treatment MicroRNA-21 is induced by rapamycin in a model of tuberous sclerosis (TSC) and lymphangioleiomyomatosis (LAM)The regulation of miR-21 by Rapamycin is cell type independent 23555865 2744 Mouse mmu-miR-21 miRNA binase lymphosarcoma RLS40 cells binase treatment downregulated 33147876 2745 Mouse mmu-miR-21 miRNA high glucose (HG) macrophage apoptosis Raw 264.7 macrophages high glucose treatment "miR-21 is sensitive to high-concentration glucose treatment in macrophages, and appears to have a protective effect in macrophage apoptosis induced by high concentrations of glucose via PDCD4." 25738901 2746 Mouse mmu-miR-21 miRNA interval exercise training with tamoxifen breast cancer Mouse mammary adenocarcinoma cell line (MC4-L2) interval exercise training with tamoxifen treatment downregulated 26300395 2747 Mouse mmu-miR-21 miRNA curcumin analog EF24 melanoma B16 murine melanoma cells EF24? treatment downregulated 23940701 2748 Mouse mmu-miR-21 miRNA high intensity focused ultrasound (HIFU) melanoma melanoma cell High intensity focused ultrasound (HIFU) treatment downregulated 27391071 2749 Mouse mmu-miR-21 miRNA ischemia myocardial apoptosis myocardial of mice Ischemic postconditioning (IPost) upregulated 24098402 2750 Mouse mmu-miR-21 miRNA hypoxia myocardial infarction (MI) mouse infarcted zone left anterior descending coronary artery was permanently ligated upregulated in the infarcted zone 28817807 2751 Mouse mmu-miR-21 miRNA ischemia myocardial ischaemic injury mouse cardiomyocytes ischemic pre-conditioning (IPC) treatment "IPC-induced miRNAs trigger cardioprotection similar to the delayed phase of IPC, possibly through upregulating eNOS, HSP70, and the HSP70 transcription factor HSF-1." 19213952 2752 Mouse mmu-miR-21 miRNA cyclosporine A (CsA) nephrotoxicity mouse kidney cyclosporine A treatment upregulated 28414804 2753 Mouse mmu-miR-21 miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) renal tissues high fat diet (HFD) feed upregulated 29660503 2754 Mouse mmu-miR-21 miRNA high fructose nonalcoholic fatty liver disease (NAFLD) plasma High fructose feed upregulated 31030166 2755 Mouse mmu-miR-21 miRNA lycopene nonalcoholic fatty liver disease (NAFLD) mice liver tissue Lycopene treatment downregulated 22968990 2756 Mouse mmu-miR-21 miRNA microcystin (MC) nonalcoholic fatty liver disease (NAFLD) high-fat (60% KCal) supplemented methionine-choline-deficient (MCD-HFD) diet-induced NAFLD mice liver tissue microcystin (MC) treatment upregulated 31393787 2757 Mouse mmu-miR-21 miRNA microcystin-leucine arginine (MC-LR) nonalcoholic fatty liver disease (NAFLD) mouse kidney tissues and CRL-1927 cells Microcystin-LR (MC) treatment upregulated 31706246 2758 Mouse mmu-miR-21 miRNA ochratoxin A (OTA) ochratoxin A (OTA) toxicity Primary proximal tubular epithelial cell ochratoxin A treatment upregulated 28710020 2759 Mouse mmu-miR-21 miRNA astragaloside IV (AS-IV) optic nerve injury RGC-5 cells astragaloside (AS-IV) treatment The expression of miR-21 was significantly upregulated in OGD and AST-treated RGC-5 cells. 30551437 2760 Mouse mmu-miR-21 miRNA fluid shear stress (FSS) osteoblastic differentiation MC3T3-E1 cells fluid shear stress (FSS)treatment downregulated 23595392 2761 Mouse mmu-miR-21 miRNA tumor necrosis factor alpha (TNF-¦Á) osteoclast differentiation RAW264.7 cells tumor necrosis factor alpha (TNF-¦Á) treatment upregulated 23078176 2762 Mouse mmu-miR-21 miRNA estrogen (ES) osteoclastic apoptosis Primary mouse bone marrow-derived monocyte£»macrophage precursors (BMMs) Estrogen treatment downregulated 23238785 2763 Mouse mmu-miR-21 miRNA anthracycline glycoside aloin osteoclastogenesis Raw264.7 cells anthracycline glycoside aloin treatment downregulated 30116953 2764 Mouse mmu-miR-21 miRNA particle osteolysis osteoclast particle treatment upregulated 22508494 2765 Mouse mmu-miR-21 miRNA aloin osteopenic disorders RAW 264.7 cells aloin treatment Aloin caused a dose-dependent decrease in the expression of all forms of miR-21. 30116953 2766 Mouse mmu-miR-21 miRNA 1-methyl-4-phenylpyridinium (MPP+) parkinson's disease (PD) MES23.5 cells 1-methyl-4-phenylpyridinium (MPP+) treatment upregulated 31555359 2767 Mouse mmu-miR-21 miRNA porphyromonas endodontalis lipopolysaccharide ( P. endodontalis LPS) periodontitis RAW264.7 and bone marrow derived macrophages (BMDM) Porphyromonas gingivalis (P. gingivalis) lipopolysaccharide (LPS) treatment upregulated 29884447 2768 Mouse mmu-miR-21 miRNA lipopolysaccharide (LPS) peritoneal fibrosis peritoneal mesothelial cells lipopolysaccharide (LPS) treatment upregulated 29207016 2769 Mouse mmu-miR-21 miRNA ZCL-082 premature ovarian failure (POF) female germline stem cell (FGSC) ZCL-082 treatment upregulated 31319247 2770 Mouse mmu-miR-21 miRNA globular adiponectin programmed cell death RAW 264.7 macrophages Globular adiponectin treatment upregulated 23597671 2771 Mouse mmu-miR-21 miRNA astragalus saponin IV cell proliferation bone marrow mesenchymal cells(BMSCs) astragalus saponin IV(AS- IV) treatment upregulated 32381364 2772 Mouse mmu-miR-21 miRNA curcumin analog EF24 prostate cancer DU145 human prostate cancer cells EF24? treatment downregulated 23940701 2773 Mouse mmu-miR-21 miRNA castration prostate cancer CWR22 human prostate cancer xenograft mouse castration treatment downregulated 25216674 2774 Mouse mmu-miR-21 miRNA pseudomonas aeruginosa (PA) pseudomonas aeruginosa lung infection sorted lung macrophages RP73 clinical strain of P. aeruginosa infection treatment downregulated 28422188 2775 Mouse mmu-miR-21 miRNA resolvin D1 (RvD1) pseudomonas aeruginosa lung infection sorted lung macrophages from RP73 clinical strain of P. aeruginosa infected mouse resolvin (Rv) D1 treatment upregulated 28422188 2776 Mouse mmu-miR-21 miRNA hypoxia pulmonary vascular remodeling lung tissues chronic hypoxia treatment upregulated 22227207 2777 Mouse mmu-miR-21 miRNA total-body irradiation (TBI) radiation nephropathy mouse urinary a single LD50 of total-body irradiation (TBI) or clinically relevant fractionated doses (2 Gy twice daily for 3 days) treatment upregulated in mouse urinary 28977780 2778 Mouse mmu-miR-21 miRNA radiation radiation-induced fibrosis (RIF) "CH3 mice muscle, skin, and subcutaneous tissue" the right hind legs of 9-week old CH3 mice by a single-fraction dose of irradiation to 35 Gy treatment dysregulated 24986745 2779 Mouse mmu-miR-21 miRNA ¦Ã-rays radiation-induced pulmonary fibrosis (RIPF) lung tissue irradiation with a single dose (20 Gy) of 60Co ¦Ã-rays. upregulated 31160967 2780 Mouse mmu-miR-21 miRNA CoCl2 renal ischemia/reperfusion (I/R) injury renal I/R in mice CoCl2 was pretreated intraperitoneally 24 hours before renal I/R in mice upregulated 28737660 2781 Mouse mmu-miR-21 miRNA hypoxia/reoxygenation (H/R) renal ischemia/reperfusion (I/R) injury bone marrow-derived dendritic cells (BMDCs) hypoxia/reoxygenation (H/R) treatment "Treatment with hypoxia/reoxygenation (H/R) suppressed miR-21 expression in bone marrow-derived dendritic cells (BMDCs)," 32667078 2782 Mouse mmu-miR-21 miRNA total flavonoids (TFs) renal tubulointerstitial fibrosis (TIF) mouse tubular epithelial cells (mTECs) total flavonoids (TFs) treatment TFs reduced miR-21 expression in a time- and dose-dependent manner in mTECs. 30212825 2783 Mouse mmu-miR-21 miRNA Salmonella Typhimurium salmonella typhimurium infection Murine macrophages(murine RAW 264.7 cells) Salmonella Typhimurium infection treatment upregulated 21468030 2784 Mouse mmu-miR-21 miRNA praziquantel (PZQ) schistosomiasis M1-type macrophages Praziquantel (PZQ) treatment PZQ inhibited NLRP3 inflammasome in M1 macrophages and reduced the expression of miR-21 32118052 2785 Mouse mmu-miR-21 miRNA cecal ligation and puncture (CLP) sepsis late sepsis cecal ligation and puncture (CLP) treatment upregulated 24980967 2786 Mouse mmu-miR-21 miRNA IL-1¦Â sepsis macrophages IL-1¦Â treatment Exosomal miR-21 secreted by IL-1¦Â-primed-mesenchymal stem cells induces macrophage M2 polarization and ameliorates sepsis. 33115604 2787 Mouse mmu-miR-21 miRNA lipopolysaccharide (LPS) septic shock bone marrow derived macrophages (BMDMs) lipopolysaccharide (LPS) treatment "miR-21 deficiency inhibited the ASC pyroptosome, which restrained caspase-1 activation and GSDMD cleavage, thereby preventing LPS-induced pyroptosis and septic shock." 31189875 2788 Mouse mmu-miR-21 miRNA "chlamydia, haemophilus influenzae, influenza, and respiratory syncytial virus" steroid-insensitive allergic airway disease (SSIAAD) BALB/c mice lung infect with virus respiratory tract infections and ovalbumin upregulated in the lung 27448447 2789 Mouse mmu-miR-21 miRNA nuclear factor kappa-B (NF-¦ÊB) inhibitor Bay11-708211 supraesophageal bile reflux hypopharyngeal mucosa NF-¦ÊB inhibitor (BAY 11-7082) treatment "Pre- but not post-application of NF-¦ÊB inhibitor, significantly blocks overexpression of Il6 and prostaglandin H synthases 2 (Ptgs2), and reverses miR-21, miR-155, miR-99a phenotypes." 32934775 2790 Mouse mmu-miR-21 miRNA angiotensin II (Ang II) thoracic aortic aneurysm and dissection (TAAD) Smad3 (mothers against decapentaplegic homolog 3) heterozygous (S3+/-) mice angiotensin II (Ang II) treatment upregulated 29519942 2791 Mouse mmu-miR-21 miRNA radiation thymic lymphoma (RITL) thymic lymphoma tissue samples radiation treatment upregulated 21494432 2792 Mouse mmu-miR-21 miRNA controlled cortical impact (CCI) traumatic brain injury (TBI) adult (5-6 months) and aged (22-24 months) C57/BL6 mice controlled cortical impact (CCI) upregulated 25277076 2793 Mouse mmu-miR-21 miRNA controlled cortical impact (CCI) traumatic brain injury (TBI) mouse hippocampus controlled cortical impact (CCI) upregulated 28804446 2794 Mouse mmu-miR-21 miRNA bone morphogenetic proteins (BMPs) trichofolliculoma-like hair follicle-derived tumours Primary mouse epidermal keratinocytes (PMEKs) bone morphogenetic proteins (BMPs) treatment downregulated 21984808 2795 Mouse mmu-miR-21 miRNA streptozocin (STZ) type 1 diabetes mellitus (T1DM) NOD mice islets beta cell streptozocin (STZ) treatment upregulated in islets beta cell 28280903 2796 Mouse mmu-miR-21 miRNA high fat diet (HFD) type 2 diabetes mellitus (T2DM) mouse high fat diet (HFD) feed downregulated 28627440 2797 Mouse mmu-miR-21 miRNA "2,4,6-trinitrobenzene sulfonic acid (TNBS)" ulcerative colitis (UC) colon tissues "2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol treatment" upregulated 31378906 2798 Mouse mmu-miR-21 miRNA azacitidine (AZA) ulcerative colitis (UC) "2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol-induced ulcerative colitis (UC) mice colon tissues" azacitidine (AZA) treatment downregulated 31378906 2799 Mouse mmu-miR-21 miRNA cinnamaldehyde (CA) ulcerative colitis (UC) RAW264.7 cells Cinnamaldehyde (CA) treatment downregulated 30530166 2800 Mouse mmu-miR-21 miRNA cinnamaldehyde (CA) ulcerative colitis (UC) colon tissues Cinnamaldehyde (CA) treatment downregulated 30530166 2801 Mouse mmu-miR-21 miRNA dextran sodium sulfate (DSS) ulcerative colitis (UC) DSS-induced mice colon tissues Dextran sodium sulfate (DSS) treatment upregulated 30530166 2802 Mouse mmu-miR-21 miRNA mesalazine (MSLZ) ulcerative colitis (UC) "2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol-induced ulcerative colitis (UC) mice colon tissues" mesalazine (MSLZ) treatment downregulated 31378906 2803 Mouse mmu-miR-21 miRNA centrin gene deleted Leishmania donovani parasites (LdCen?/?) visceral leishmaniasis murine DC cells LdCen-/- parasites infection LdCen-/- infection suppresses the expression of microRNA-21 (miR-21) in human macrophages compared to LdWT infection. 31608064 2804 Mouse mmu-miR-21 miRNA hypoxia wound healing Corneal epithelial cells hypoxia induce upregulated 31529118 2805 Mouse mmu-miR-21 miRNA TGF-¦Â1 wound healing Corneal epithelial cells TGF-¦Â1?treatment treatment upregulated 31529118 2806 Mouse mmu-miR-21 miRNA xenon (Xe) xenon-conferred renal?of mice xenon treatment Xenon preconditioning significantly increased the expression of miR-21 in the mouse kidney 23681145 2807 Mouse mmu-miR-21 miRNA live L. acidophilus ¦Â-lactoglobulin (¦Â-Lg) allergy murine splenocytes live L. acidophilus treatment downregulated 30156972 2808 Mouse mmu-miR-21 miRNA "fasting, denervation, diabetes, and cancer cachexia" fine-tuning the atrophy program mouse muscles "mouse muscles under wasting conditions such as fasting, denervation, diabetes, and cancer cachexia treatment" wasting conditions showed an induction of miRNA-206 and miRNA-21 expression 24891504 2809 Mouse mmu-miR-21 miRNA high fat diet (HFD) prenatal inflammation ovarian tissue high fat diet (HFD) feed "Obese mouse ovaries had decreased Irs1, Foxo3a, Cyp2e1, MiR-103, and MiR-21" 23954404 2810 Mouse mmu-miR-21? miRNA high glucose (HG) diabetic nephropathy (DN) mouse podocytes high glucose (HG) treatment miR-21 expression was upregulated in HG-treated podocytes. 30212710 2811 Mouse mmu-miR-21* miRNA cortical impact traumatic brain injury (TBI) cortex cortical impact upregulated 26426744 2812 Mouse mmu-miR-210 miRNA hypoxia acute ischemic stroke (AIS) brain tissues middle cerebral artery occlusion (MCAO) treatment upregulated in the brain 29111308 2813 Mouse mmu-miR-210 miRNA hypoxia acute peripheral ischemia skeletal muscle of mice hypoxia treatment upregulated 23931770 2814 Mouse mmu-miR-210 miRNA "toluene 2,4-diisocyanate (TDI)" allergic disease draining lymph node (dLN) and Treg subsets Toluene diisocyanate (TDI) treatment upregulated 28035981 2815 Mouse mmu-miR-210 miRNA hypoxia apoptosis mouse GC-2spd (GC-2) cells hypoxia induce upregulated 30431115 2816 Mouse mmu-miR-210 miRNA hypoxia apoptosis A mouse neuroblastoma neuro-2a cell hypoxia treatment upregulated 23108914 2817 Mouse mmu-miR-210 miRNA high fat diet (HFD) atherosclerosis (AS) purified CD31+ endothelial cells from mouse aorta high fat diet (HFD) feed upregulated in purified CD31+ endothelial cells from mouse aorta 28536634 2818 Mouse mmu-miR-210 miRNA diethylnitrosamine (DEN) chronic cholestasis and cholangiocarcinoma liver tissues diethylnitrosamine (DEN) treatment upregulated 21440549 2819 Mouse mmu-miR-210 miRNA bupivacaine dorsal root ganglion neurons bupivacaine treatment downregulated 26708520 2820 Mouse mmu-miR-210 miRNA hypoxia hepatic ischemia/reperfusion injury (HIRI) primary mouse hepatocytes hypoxia treatment downregulated 32155285 2821 Mouse mmu-miR-210 miRNA hypoxia hypoxia-induced injury mouse GC-2spd (GC-2) cells hypoxia induce upregulated 30431115 2822 Mouse mmu-miR-210 miRNA epigallocatechin-3-gallate (EGCG) lung cancer lung cancer cells Green tea polyphenol EGCG treatment upregulated 21965273 2823 Mouse mmu-miR-210 miRNA hypoxia myocardial infarction (MI) mouse bone marrow-derived MSCs exosomes cultured under hypoxia for 24 h upregulated in exosomes from hypoxia-treated MSCs 29141446 2824 Mouse mmu-miR-210 miRNA cardiac shock wave therapy (SWT) myocardial ischemia/reperfusion (I/R) injury (MIRI) murine adult cardiomyocyte cell line HL-1 Cardiac shock wave therapy (SWT) treatment upregulated 31974607 2825 Mouse mmu-miR-210 miRNA hypoxia myocardial ischemia/reperfusion (I/R) injury (MIRI) murine adult cardiomyocyte cell line HL-1 hypoxia induce upregulated 31974607 2826 Mouse mmu-miR-210 miRNA hypoxia myocardial repair mesenchymal stem cells (MSCs) hypoxia treatment upregulated 29141446 2827 Mouse mmu-miR-210 miRNA curcumin (Cur) nasopharyngeal carcinoma (NPC) mice injected into the tumour centre at a concentration of 150 mg/kg treatment dysregulated 24896104 2828 Mouse mmu-miR-210 miRNA hypoxic/ischemic neonatal hypoxic-ischemic brain damage mouse pups tissues hypoxic-ischemic (HI) treatment "HI insult significantly upregulated miR-210, downregulated TET2 protein abundance, and increased NF-¦ÊB subunit p65 acetylation level and its DNA binding capacity to the interleukin 1 beta (IL-1¦Â) promoter in the brain of mouse pups." 33402183 2829 Mouse mmu-miR-210 miRNA bupivacaine neurotoxicity dorsal root ganglia bupivacaine treatment downregulated 26708520 2830 Mouse mmu-miR-210 miRNA erythropoietin (EPO) erythroid maturation mouse fetal liver cells erythropoietin treatment upregulated 18492109 2831 Mouse mmu-miR-210 miRNA tumor necrosis factor alpha (TNF-¦Á) osteoclast differentiation RAW264.7 cells tumor necrosis factor alpha (TNF-¦Á) treatment upregulated 23078176 2832 Mouse mmu-miR-210 miRNA lipopolysaccharide (LPS) production of proinflammatory cytokines murine macrophages lipopolysaccharide (LPS) treatment upregulated 22575656 2833 Mouse mmu-miR-210 miRNA IL-23 psoriasis skin lesions IL-23 treatment upregulated 29757188 2834 Mouse mmu-miR-210 miRNA imiquimod (IMQ) psoriasis skin lesions imiquimod treatment upregulated 29757188 2835 Mouse mmu-miR-210 miRNA high glucose (HG) type 2 diabetes mellitus (T2DM) exosome of RAW 264.7 cells high glucose (HG) treatment miR-210 was highly expressed in exosomes derived from high glucose-induced macrophage RAW264.7 cells. 32258168 2836 Mouse mmu-miR-210-3p miRNA "paraquat (PQ) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" dopaminergic (DA) neuron differentiation neuro-2a cells "paraquat (PQ) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment" dysregulated 29250806 2837 Mouse mmu-miR-210-3p miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" neurodegenerative diseases N2a cells "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" downregulated 29250806 2838 Mouse mmu-miR-210-3p miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" neurodegenerative diseases N2a cells "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" downregulated 29250806 2839 Mouse mmu-miR-210-3p miRNA paraquat (PQ) neurodegenerative diseases N2a cells paraquat (PQ) treatment downregulated 29250806 2840 Mouse mmu-miR-210-3p miRNA high fat diet (HFD) obesity liver tissues high fat diet (HFD) feed upregulated 32593682 2841 Mouse mmu-miR-210-5p miRNA manganese (Mn) parkinson's disease (PD) MN9D dopaminergic cell exosomes Mn exposure (300¦ÌM MnCl2) for 24h upregulated in exosomes 28450057 2842 Mouse mmu-miR-211 miRNA arsenite atherosclerosis (AS) liver arsenic (As) exposure downregulated 22719926 2843 Mouse mmu-miR-211 miRNA hypoxia hypoxic/ischemic injury Neuro2A cells hypoxia treatment miR-211 was upregulated in OGD-induced ischemic injury of Neuro2A cells. 30563429 2844 Mouse mmu-miR-211 miRNA cecal ligation and puncture (CLP) sepsis Monocytes were isolated from the spleens cecal ligation and puncture induce downregulated 31656541 2845 Mouse mmu-miR-211 miRNA lipopolysaccharide (LPS) sepsis RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated of NEAT1 level and downregulated of miR-495-3p/miR-211 level could aggravate inflammation in LPS-treated RAW264.7 cells. 31812793 2846 Mouse mmu-miR-211 miRNA candida albicans (C. albicans) systemic Candidiasis C57BL/6 mice candida albicans infection downregulated 24641951 2847 Mouse mmu-miR-211-5p miRNA atractylon (Atr) asthma asthma mouse lung tissues; TGF-¦Â1-treated TC-1 cells atractylon (Atr)?treatment Atr treatment suppressed OVA-induced circRNA-0000981 and TGFBR2 expression but promoted miR-211-5p expression. 33855682 2848 Mouse mmu-miR-211-5p miRNA ovalbumin (OVA) asthma lung tissues ovalbumin (OVA) treatment downregulated 33855682 2849 Mouse mmu-miR-211-5p miRNA TGF-¦Â1 asthma TC-1 cells TGF-¦Â1 treatment downregulated 33855682 2850 Mouse mmu-miR-211-5p miRNA dioscorea bulbifera (DB) liver damage livers dioscoreae bulbifera (EF) treatment downregulated 27609015 2851 Mouse mmu-miR-211-5p miRNA alpinetin (ALP) oral squamous cell carcinoma (OSCC) OSCC tumor tissues alpinetin (ALP) treatment miR-211-5p expression was significantly increased under ALP treatment in com- parison with control mice. 31403340 2852 Mouse mmu-miR-211-5p miRNA insulin-transferrin-selenite (ITS) osteoarthritis (OA) ATDC5 cells insulin-transferrin-selenite (ITS) treatment upregulated 31396630 2853 Mouse mmu-miR-212 miRNA high fat diet (HFD) atherosclerosis (AS) atherosclerotic lesions and macrophages from apoE-/- mice high fat diet (HFD) feed downregulated 29174964 2854 Mouse mmu-miR-212 miRNA high fat diet (HFD) atherosclerosis (AS) apoE mice macrophages high fat diet (HFD) feed downregulated 29174964 2855 Mouse mmu-miR-212 miRNA hypoxia blood-brain barrier (BBB) dysfunction mouse brain microvascular endothelial cells (BMEC) hypoxia induce upregulated 30617994 2856 Mouse mmu-miR-212 miRNA adenine chronic kidney disease (CKD) kidney tissues adenine treatment upregulated 32526762 2857 Mouse mmu-miR-212 miRNA gallic acid (GA) experimental autoimmune encephalomyelitis (EAE) "The CD4+CD62L+ T cells were isolated from the spleen and cultured under Th17-polarizing conditions, and peritoneal macrophages were stimulated with LPS" ?gallic acid (GA)?treatment treatment upregulated 31026283 2858 Mouse mmu-miR-212 miRNA lipopolysaccharide (LPS) inflammation RAW 264.7 cells lipopolysaccharide (LPS) treatment dysregulated 24792623 2859 Mouse mmu-miR-212 miRNA alcohol leaky gut intestinal alcohol exposure overexpression 26207424 2860 Mouse mmu-miR-212 miRNA methamphetamine (METH) methamphetamine (METH) addiction precursors methamphetamine (METH) treatment downregulated 29516602 2861 Mouse mmu-miR-212 miRNA glucose deprivation (GD) neurodegeneration (ND) cortical neuronal cultures from mouse brains at embryonic day 15.5 glucose deprivation treatment downregulated 28855274 2862 Mouse mmu-miR-212 miRNA fatty acid nonalcoholic fatty liver disease (NAFLD) HepG2 cells fatty acid treatment upregulated 26648452 2863 Mouse mmu-miR-212 miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) mouse high fat diet (HFD) feed upregulated 26648452 2864 Mouse mmu-miR-212 miRNA long-chain fatty acid nonalcoholic fatty liver disease (NAFLD) HepG2 cells long-chain fatty acid treatment upregulated 26648452 2865 Mouse mmu-miR-212 miRNA running nonalcoholic fatty liver disease (NAFLD) HF mouse liver HF mouse treatment downregulated in liver 26648452 2866 Mouse mmu-miR-212 miRNA glutamate pain primary neurons in the spinal cord of mouse embryos 100 ¦Ìmol/L glutamate upregulated 28244951 2867 Mouse mmu-miR-212-3p miRNA quercetin chronic inflammatory diseases LPS-treated murine bone marrow¨Cderived DCs (BMDCs) quercetin treatment upregulated 31338984 2868 Mouse mmu-miR-212-3p miRNA carbon tetrachloride (CCl4) liver fibrosis liver CCl4 treatment downregulated 27322257 2869 Mouse mmu-miR-212-3p miRNA angiostrongylus cantonensis (A. cantonensis) inflammation male Balb/c mice angiostrongylus cantonensis (A. cantonensis) infection upregulated 24142285 2870 Mouse mmu-miR-212-3p miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues carbon tetrachloride (CCl4) treatment upregulated 29557526 2871 Mouse mmu-miR-212-3p miRNA hepatitis B virus (HBV) liver damage RAW264.7 cells HBeAg treatment miR-212-3p expression was significantly elevated in HBeAg-treated macrophages. 32767729 2872 Mouse mmu-miR-212-3p miRNA lipopolysaccharide (LPS) sepsis RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated 27940320 2873 Mouse mmu-miR-212-5p miRNA immunoglobulin E (IgE) asthma-induced hypotension primary arterial smooth muscle cell (ASMC) of WT or Fc¦ÅR1-/- mice IgE treatment upregulated 28988887 2874 Mouse mmu-miR-212-5p miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharide (LPS) treatment downregulated 32955644 2875 Mouse mmu-miR-212-5p miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) hippocampus "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" downregulated 30364275 2876 Mouse mmu-miR-212-5p miRNA angiotensin II (Ang II) cell proliferation cardiac fibroblasts (CFs) angiotensin II (Ang II) treatment downregulated 32268073 2877 Mouse mmu-miR-212-5p miRNA TGF-¦Â1 cell proliferation cardiac fibroblasts (CFs) TGF-¦Â1 ttreatment treatment downregulated 32268073 2878 Mouse mmu-miR-2137 miRNA H1N1 influenza virus endometriosis and endometrial carcinoma mouse lung?tissues H1N1 influenza virus infection upregulated 24066118 2879 Mouse mmu-miR-2137 miRNA cortical impact traumatic brain injury (TBI) cortex cortical impact upregulated 26426744 2880 Mouse mmu-miR-21-3p miRNA caerulein and aurolithocholic acid 3-sulfate (TLC-S) acute pancreatitis (AP) mouse pancreatic acinar cells caerulein and TLC-S treatment upregulated 27686613 2881 Mouse mmu-mir-21-3p miRNA second-hand smoke (SHS) asthma lung second-hand smoke (SHS) treatment upregulated 26859758 2882 Mouse mmu-miR-21-3p miRNA nicotine atherosclerosis (AS) Raw264.7 cells nicotine treatment upregulated 31660076 2883 Mouse mmu-miR-21-3p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) blood-brain barrier (BBB) dysfunction bEnd.3 cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment upregulated 29695199 2884 Mouse mmu-miR-21-3p miRNA angiotensin II (Ang II) cardiac hypertrophy mouse angiotensin II (Ang II) treatment downregulated 25504627 2885 Mouse mmu-miR-21-3p miRNA angiotensin II (Ang II) cardiac hypertrophy cardiomyocyte angiotensin II (Ang II) treatment downregulated 24743145 2886 Mouse mmu-miR-21-3p miRNA lipopolysaccharide (LPS) inflammation RAW 264.7 cells lipopolysaccharide (LPS) treatment dysregulated 24792623 2887 Mouse mmu-miR-21-3p miRNA particulate matter (PM2.5) PM2.5 exposure mosue bronchoalveolar lavage fluid (BALF) "were subjected to intratracheal instillation of 2.5, 10, or 20mg/kg PM2.5 treatment" upregulated in bronchoalveolar lavage fluid (BALF) 29107863 2888 Mouse mmu-miR-21-3p miRNA particulate matter (PM2.5) pulmonary toxicological lung tissues particulate matter (PM2.5) exposure treatment upregulated 29107863 2889 Mouse mmu-miR-21-3p miRNA oxygen glucose deprivation (OGD) traumatic brain injury (TBI) bEnd.3 cells oxygen-glucose deprivation (OGD) treatment miR-21-3p level in bEnd.3 cells with OGD treatment was increased after injury. 29695199 2890 Mouse mmu-miR-21-3p miRNA wire-induced injury to carotid arteries vessel stenosis apolipoprotein E knockout (Apoe ) mice injury to carotid arteries of treatment upregulated 27622243 2891 Mouse mmu-miR-214 miRNA D-galactosamine (D-GalN) and TNF-¦Á acute liver failure (ALF) BNLCL2 cells D-galactosamine (D-GalN) andTnF-¦Á treatment miR214 was downregulated in D-GalN/LPS-stimulated mice and D-GalN/TNF-¦Á-stimulated BNLCL2 cells. 32377732 2892 Mouse mmu-miR-214 miRNA D-galactosamine/lipopolysaccharide (D-GalN/LPS) acute liver failure (ALF) liver tissues D-galactosamine (D-GalN) and lipopolysaccharide (LPS) treatment miR214 was downregulated in D-GalN/LPS-stimulated mice and D-GalN/TNF-¦Á-stimulated BNLCL2 cells. 32377732 2893 Mouse mmu-miR-214 miRNA angiotensin II (Ang II) cardiac hypertrophy cardiomyocytes angiotensin II (Ang II) treatment downregulated 29499950 2894 Mouse mmu-miR-214 miRNA angiotensin II (Ang II) cardiac hypertrophy neonatal mouse cardiomyocytes (NMCMs) angiotensin II (Ang II) treatment MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction 33247214 2895 Mouse mmu-miR-214 miRNA ginkgolide B (GB) cisplatin (DDP)-induced nephrotoxicity cisplatin-treated HEI-OC1 auditory cells cisplatin-treated HEI-OC1 auditory cells treatment upregulation 26768586 2896 Mouse mmu-miR-214 miRNA high glucose (HG) and lipopolysaccharide (LPS) diabetes-associated periodontitis MC3T3-E1 cells high glucose and lipopolysaccharide (LPS) co-stimulated upregulated 31090954 2897 Mouse mmu-miR-214 miRNA high glucose (HG) diabetic nephropathy (DN) mouse proximal tubular epithelial cells MCT high glucose (HG) treatment upregulated 31240704 2898 Mouse mmu-miR-214 miRNA indoxyl sulfate (IS) endothelial cell injury mouse aortic endothelial cells (MAECs) indoxyl sulfate (IS) treatment "Following IS treatment, miR-214 was significantly downregulated in MAECs in line with enhanced cell apoptosis." 31820187 2899 Mouse mmu-miR-214 miRNA ethanol (EtOH) fibrosis primary mouse HSC ethanol treatment downregulated 24122827 2900 Mouse mmu-miR-214 miRNA H2O2 fragility fracture MC3T3-E1 cells treat with 400 ¦ÌM H2O2 downregulated 291645892 2901 Mouse mmu-miR-214 miRNA high fat diet (HFD) hepatic insulin resistance mouse liver tissues high fat diet (HFD) feed downregulated 30431065 2902 Mouse mmu-miR-214 miRNA palmitate hepatic insulin resistance mouse primary hepatocytes palmitate treatment downregulated 30431065 2903 Mouse mmu-miR-214 miRNA hypoxia hepatic ischemia/reperfusion injury (HIRI) mouse hepatocyte AML12 hypoxia induce downregulated 30560327 2904 Mouse mmu-miR-214 miRNA hypoxia hepatic ischemia/reperfusion injury (HIRI) mouse hepatocyte AML12 hypoxia induce downregulated 30560327 2905 Mouse mmu-miR-214 miRNA norcantharidin (NCTD) hepatocellular carcinoma (HCC) liver tissues intraperitoneal injection of different concentration of NCTD treatment upregulated 24719559 2906 Mouse mmu-miR-214 miRNA bleomycin (BLM) idiopathic pulmonary fibrosis (IPF) mouse lungs; primary lung fibroblasts bleomycin (BLM) treatment FENDRR reduced pulmonary fibrosis by inhibiting fibroblast activation by reducing iron concentration and acting as a competing endogenous RNA of the profibrotic microRNA-214. 31697569 2907 Mouse mmu-miR-214 miRNA high fat diet (HFD) liver fibrosis liver tissues high fat diet (HFD) feed upregulated 29915227 2908 Mouse mmu-miR-214 miRNA sildenafil metabolic and functional derangements in the heart heart sissues sildenafil treatment Co-ingestion with sildenafil blunted the alcohol-induced increase in miR-214 32535704 2909 Mouse mmu-miR-214 miRNA methylglyoxal (MGO) MGO-induced endothelial insulin-resistance mouse aortic endothelial cells (MAECs) methylglyoxal (MGO) treatment downregulated 29425121 2910 Mouse mmu-miR-214 miRNA exercise (Ex) osteoporosis tibia tissues and primary osteoblasts mice were run on treadmill at moderate-intensity for five weeks or Flexcell-5000C? Tension System downregulated 31639865 2911 Mouse mmu-miR-214 miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) midbrain "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" downregulated 26349993 2912 Mouse mmu-miR-214 miRNA angiotensin II (Ang II) pathological perivascular fibrosis in hypertension perivascular tissue angiotensin II (Ang II) treatment miR-214 is increased in the vasculature in Ang II-induced hypertension. 32065054 2913 Mouse mmu-miR-214 miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) testicular ischemia-reperfusion injury (IRI) GC-1 cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 29870987 2914 Mouse mmu-miR-214 miRNA dextran sodium sulfate (DSS) ulcerative colitis (UC) colon tissues dextran sodiumsulfate (DSS) treatment upregulated 31382166 2915 Mouse mmu-miR-214 miRNA limonin ulcerative colitis (UC) Ulcerative colitis (UC) mice colon tissues limonin treatment downregulated 31382166 2916 Mouse mmu-miR-214 miRNA sulfasalazine ulcerative colitis (UC) Ulcerative colitis (UC) mice colon tissues sulfasalazine (SASP) treatment downregulated 31382166 2917 Mouse mmu-miR-214 miRNA mechanical ventilation (MV) ventilator-induced lung injury (VILI) lung tissues; macrophages; fibroblasts; epithelial cells; endothelial cells mechanical ventilation (MV) treatment "The expression of miR-214 was increased in lung tissues and macrophages, fibroblasts, epithelial cells, and endothelial cells isolated from lung tissues in VILI mice." 33389067 2918 Mouse mmu-miR-214-3p miRNA high fat diet (HFD) and sodium taurocholic acute pancreatitis (AP) kidney tissues high-fat diet and sodium taurocholic injection MiR-214-3p exacerbates kidney damages and inflammation induced by hyperlipidemic pancreatitis complicated with acute renal injury. 31790686 2919 Mouse mmu-miR-214-3p miRNA streptozocin (STZ) brain injury in diabetes mellitus (DM) brain tissues streptozocin (STZ) treatment MicroRNA-214-3p (miR-214-3p) was decreased in DM mice. 32910484 2920 Mouse mmu-miR-214-3p miRNA angiotensin II (Ang II) cardiac fibrosis myofibroblasts angiotensin II (Ang II) treatment downregulated 27823969 2921 Mouse mmu-miR-214-3p miRNA TGF-¦Â1 cardiac fibrosis primary cultured myofibroblasts TGF-¦Â1 treatment downregulated 31434695 2922 Mouse mmu-miR-214-3p miRNA angiotensin II (Ang II) cardiac hypertrophy hypertrophic myocardium angiotensin II (Ang II) treatment upregulated 27796324 2923 Mouse mmu-miR-214-3p miRNA high glucose (HG) diabetic cardiomyopathy (DCM) cardiac tissues high glucose (HG) treatment miR-214-3p was decreased in the HG-treated cardiac fibroblasts. 30250027 2924 Mouse mmu-miR-214-3p miRNA chronic social defeat stress (CSDS) major depressive disorder (MDD) medial prefrontal cortex (mPFC) tissues chronic social defeat stress (CSDS) induce upregulated 29522177 2925 Mouse mmu-miR-214-3p miRNA luteolin exerts obesity-associated comorbidities mesenteric vessels luteolin exerts treatment "In HFD mice, luteolin counteracted significantly the decreased expression of miR-214-3p." 30319424 2926 Mouse mmu-miR-214-3p miRNA bis-enoxacin osteoclastogenesis 4T1 murine breast cancer cells bis-enoxacin treatment upregulated 30385810 2927 Mouse mmu-miR-214-3p miRNA enoxacin osteoclastogenesis 4T1 murine breast cancer cells Enoxacin treatment upregulated 30385810 2928 Mouse mmu-miR-214-3p miRNA high glucose (HG) osteogenesis bone marrow mesenchymal stem cells (BMSCs) high glucose (HG) treatment upregulated 31728209 2929 Mouse mmu-miR-214-3p miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) midbrain tissues "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" downregulated 33071725 2930 Mouse mmu-miR-214-3p miRNA 1-methyl-4-phenylpyridinium (MPP+) parkinson's disease (PD) Primary Neuron 1-methyl-4-phenylpyridinium (MPP+) treatment downregulated 33071725 2931 Mouse mmu-miR-214-5p miRNA pressure overload heart failure (HF) heart sissues pressure overload treatment upregulated 33224746 2932 Mouse mmu-miR-214-5p miRNA lipopolysaccharide (LPS) inflammation BV2 microglia lipopolysaccharide (LPS) treatment downregulated 30584538 2933 Mouse mmu-miR-215 miRNA TGF-¦Â1 diabetic nephropathy (DN) mouse mesangial cell (MMC) TGF-¦Â1 treatment upregulated 23554908 2934 Mouse mmu-miR-215 miRNA sodium arsenite (NaAsO2) DNA methylation liver tissues sodium arsenite treatment upregulated 32068019 2935 Mouse mmu-miR-215 miRNA hypoxia ischemic stroke (IS) brain tissses middle cerebral artery occlusion (MCAO) treatment downregulated 29080697 2936 Mouse mmu-mir-215-5p miRNA recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) bacterial infection blood recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) treatment upregulated 25563241 2937 Mouse mmu-miR-215-5p miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity Plasma doxorubicin (DOX) treatment downregulated 30627229 2938 Mouse mmu-miR-21-5p miRNA lipopolysaccharide (LPS) acute respiratory distress syndrome (ARDS) serum lipopolysaccharide (LPS) treatment upregulated 32934950 2939 Mouse mmu-miR-21-5p miRNA tacrolimus (FK506) chronic allograft dysfunction renal proximal tubular epithelial cells (RPTECs) tacrolimus treatment upregulated 29362864 2940 Mouse mmu-miR-21-5p miRNA ethanol (EtOH) ethanol-induced neuroinflammation and brain damage plasma exosomes ethanol treatment downregulated 32937997 2941 Mouse mmu-miR-21-5p miRNA ethanol (EtOH) ethanol-induced neuroinflammation and brain damage brain cortices ethanol treatment upregulated 32937997 2942 Mouse mmu-miR-21-5p miRNA lipopolysaccharide (LPS) inflammation RAW 264.7 cells lipopolysaccharide (LPS) treatment upregulated 32153563 2943 Mouse mmu-miR-21-5p miRNA gastrodin and rhynchophylline ischemia/reperfusion (I/R) injury hypoxia-induced mouse brain tissues and BV2 cells combination of gastrodin and rhynchophylline treatment upregulated 31610203 2944 Mouse mmu-miR-21-5p miRNA hypoxia ischemia/reperfusion (I/R) injury mouse brain tissues and BV2 cells Middle cerebral artery occlusion (MCAO) mice and oxygen glucose deprivation (OGD)-treated BV2 cells were used as in vivo and in vitro models of ischaemia downregulated 31610203 2945 Mouse mmu-miR-21-5p miRNA hypoxia lung ischemia/reperfusion (I/R) injury mesenchymal stromal cell-secreted exosomes (MSC-Exo) hypoxia induce upregulated 30682335 2946 Mouse mmu-miR-21-5p miRNA lipopolysaccharide (LPS) neuroinflammation BV2 cells lipopolysaccharide (LPS) treatment upregulated 31707083 2947 Mouse mmu-miR-21-5p miRNA icariin (ICA) osteogenesis MC3T3-E1 cells icariin treatment upregulated 29500883 2948 Mouse mmu-miR-21-5p miRNA titanium (Ti) osteogenesis MC3T3-E1 cells titanium (Ti) particle treatment downregulated 29500883 2949 Mouse mmu-miR-21-5p miRNA particulate matter (PM2.5) PM2.5 exposure mosue bronchoalveolar lavage fluid (BALF) "were subjected to intratracheal instillation of 2.5, 10, or 20mg/kg PM2.5 treatment" upregulated in bronchoalveolar lavage fluid (BALF) 29107863 2950 Mouse mmu-miR-21-5p miRNA particulate matter (PM2.5) pulmonary toxicological lung tissues particulate matter (PM2.5) exposure treatment upregulated 29107863 2951 Mouse mmu-miR-21-5p miRNA lipopolysaccharide (LPS) spinal cord injury (SCI) BV2 cells lipopolysaccharide (LPS) treatment upregulated 32572900 2952 Mouse mmu-miR-21-5p miRNA TGF-¦Â1 spinal cord injury (SCI) Primary mouse spinal fibroblasts transforming growth factor (TGF)-¦Â1 treatment upregulated 29483836 2953 Mouse mmu-miR-21-5p miRNA "IL-1¦Â, IFN-¦Ã and TNF-¦Á" type 1 diabetes mellitus (T1DM) MIN6 cells "a mixture containing 10 ng/mL each of IL-1¦Â, IFN-¦Ã, and TNF-¦Á for 24 h" upregulated 29445851 2954 Mouse mmu-miR-216 miRNA cerulean acute pancreatitis (AP) mouse serum and pancreatic tissues cerulean treatment "upregulation of miR-216a and miR-216b in the serum, downregulated of miR-216a in pancreatic tissues" 28183420 2955 Mouse mmu-miR-216 miRNA amyloid-¦Â (A¦Â) 1-40 age-related macular degeneration (AMD) C57BL/6 mice eye tissues amyloid-¦Â (A¦Â) 1-40 treatment upregulated 28324113 2956 Mouse mmu-miR-216a miRNA lipopolysaccharide (LPS) acute lung injury (ALI) mouse lung tissues lipopolysaccharide (LPS) treatment downregulated 31784954 2957 Mouse mmu-miR-216a miRNA cerulean acute pancreatitis (AP) serum cerulean treatment upregulated 28183420 2958 Mouse mmu-miR-216a miRNA cerulean acute pancreatitis (AP) pancreatic cerulean treatment downregulated 28183420 2959 Mouse mmu-miR-216a miRNA TGF-¦Â cardiac fibrosis Adult mouse cardiac fibroblasts TGF-¦Â treatment upregulated 31059054 2960 Mouse mmu-miR-216a miRNA TGF-¦Â diabetic nephropathy (DN) glomerular mesangial cells TGF-¦Â treatment upregulated 19543271 2961 Mouse mmu-miR-216a miRNA TGF-¦Â vascular smooth muscle cell calcification kidney cells TGF-¦Â treatment upregulated 20713358 2962 Mouse mmu-miR-216b miRNA cerulean acute pancreatitis (AP) serum cerulean treatment upregulated 28183420 2963 Mouse mmu-miR-216b miRNA glyoxylate kidney tubular cell injury renal tubular epithelial cell glyoxylate treatment downregulated 31735555 2964 Mouse mmu-miR-216b miRNA glyoxylate kidney tubular cell injury oxidative stress glyoxylate treatment downregulated 31735555 2965 Mouse mmu-miR-217 miRNA silk ascending aorta proximal cardiac hypertrophy C57BL/6J mice cardiomyocytes silk suture was tightened around the ascending aorta proximal to the brachiocephalic trunk treatment downregulated in cardiomyocytes 27893464 2966 Mouse mmu-miR-217 miRNA fatty acid amide hydrolase inhibitor (FAAH-II) colitis colitis mouse colon tissues FAAH-II treatment dysregulated 27327245 2967 Mouse mmu-miR-217 miRNA streptozocin (STZ) diabetes mellitus (DM) skin streptozotocin (STZ) treatment "GAS5 was significantly downregulated whereas miR-217 was obviously upregulated in diabetic skin, HG-induced lymphatic endothelial cells (LECs) and diabetic mouse model." 33865922 2968 Mouse mmu-miR-217 miRNA high glucose (HG) diabetic nephropathy (DN) mouse podocytes feed with HG upregulated 28017719 2969 Mouse mmu-miR-217 miRNA TGF-¦Â diabetic nephropathy (DN) glomerular mesangial cells TGF-¦Â treatment upregulated 19543271 2970 Mouse mmu-miR-217 miRNA sodium arsenite (NaAsO2) DNA methylation liver tissues sodium arsenite treatment downregulated 32068019 2971 Mouse mmu-miR-217 miRNA ethanol (EtOH) genotoxic damage? cancer The mouse AML-12 hepatocyte cell line and mice liver tisssue ethanol treatment "In AML-12 hepatocytes and in mouse livers, chronic ethanol exposure drastically and specifically induced miR-217 levels and caused excess fat accumulation" 22308024 2972 Mouse mmu-miR-217 miRNA ethanol (EtOH) steatotic hepatocytes Kupffer cells ethanol treatment upregulated 25797648 2973 Mouse mmu-miR-217 miRNA coxsackievirus B3 (CVB3) viral myocarditis (VM) peripheral blood and myocardial tissues of viral myocarditis mice and in CVB3-infected cardiomyocytes Coxsackievirus B3 (CVB3) infection upregulated 31894309 2974 Mouse mmu-miR-217 miRNA coxsackievirus B3 (CVB3) viral myocarditis (VM) peripheral blood; myocardial tissues; cardiomyocytes. Coxsackievirus B3 (CVB3) infection upregulated 31894309 2975 Mouse mmu-miR-217-5p miRNA high fat diet (HFD) atherosclerosis (AS) atherosclerotic endothelial cells from apolipo protein E knockout ApoE(-/-) mice high fat diet (HFD) feed downregulated 31744714 2976 Mouse mmu-miR-218 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) MH-S cells; RAW264.7 cells lipopolysaccharide (LPS) treatment MicroRNA-218 was significantly downregulated in cells treated with LPS. 30556885 2977 Mouse mmu-miR-218 miRNA transglutaminase 2 (TG2) allergic inflammation B16F1 mouse melanoma cells TGaseII treatment downregulated 25202021 2978 Mouse mmu-miR-218 miRNA intermittent hypoxia (IH) apoptosis normal mice aortic endothelial cells under IH condition upregulated 29262646 2979 Mouse mmu-miR-218 miRNA high glucose (HG) diabetic nephropathy (DN) murine podocyte high glucose (HG) treatment downregulated 31549412 2980 Mouse mmu-miR-218 miRNA high glucose (HG) diabetic nephropathy (DN) mouse podocytes high glucose treatment downregulated 31549412 2981 Mouse mmu-miR-218 miRNA streptozocin (STZ) diabetic nephropathy (DN) kidney tissues streptozotocin (STZ) treatment downregulated 31549412 2982 Mouse mmu-miR-218 miRNA lopinavir/ritonavir (LPV/RTV) lipogenesis 3T3-L1 cells lopinavir/ritonavir (LPV/RTV) treatment upregulated 31133852 2983 Mouse mmu-miR-218 miRNA amphetamine regimen mesocortical dopamine development in adolescence male mice dopamine neurons amphetamine regimen treatment upregulated 31192517 2984 Mouse mmu-miR-218 miRNA isoproterenol cardiac fibrosis heart tissues isoproterenol (ISO) treatment downregulated 27174579 2985 Mouse mmu-miR-218 miRNA methionine choline-deficient diet (MCD) nonalcoholic steatohepatitis (NASH) liver tissues methionine-choline-deficient (MCD) diet feed downregulated 31850710 2986 Mouse mmu-miR-218 miRNA chronic intermittent hypoxia (CIH) obstructive sleep apnoea-hypopnoea syndrome (OSAHS) mouse aortic endothelial cells (MAECs) chronic intermittent hypoxia (CIH) treatment upregulated 29108914 2987 Mouse mmu-miR-218 miRNA oxygen oxygen-induced retinopathy (OIR) retinal tissues Oxygen treatment downregulated 27824019 2988 Mouse mmu-miR-218 miRNA RANKL (receptor activator of nuclear factor ¦ÊB ligand) postmenopausal osteoporosis (PMOP) osteoclastogenesis of RAW264.7 cells 50ng/mL RANKL treatment downregulated 29271983 2989 Mouse mmu-miR-218 miRNA oxygen retinal neovascularization (RNV) retinal tissues oxygen treatment downregulated 26935869 2990 Mouse mmu-miR-218 miRNA laparotomy and exposure of the junc_x0002_tion between the large and small intestines sepsis mouse large and small intestines laparotomy and exposure of the junc_x0002_tion between the large and small intestines treatment downregulated 25043848 2991 Mouse mmu-miR-218 miRNA Src tyrosine kinase (Src) tumorigenesis The nontransformed and v-Src-transformed mouse embryonic Cx43Ko brain cells Src tyrosine kinase (Src) treatment downregulated 19767772 2992 Mouse mmu-miR-218 miRNA glucose type 2 diabetes mellitus (T2DM) isolated mouse islets exposed to high levels of glucose within 1 h treatment downregulated 25489007 2993 Mouse mmu-miR-218-1-3p miRNA gentamicin acute kidney injury (AKI) urine gentamicin treatment upregulated 27074385 2994 Mouse mmu-miR-218-2* miRNA clozapine (CLZ) psychotic disorders mouse brain clozapine treatment upregulated 23318695 2995 Mouse mmu-miR-218-2* miRNA olanzapine (OLP) psychotic disorders brain tissues clozapine treatment upregulated 23318695 2996 Mouse mmu-miR-218-5p miRNA honokiol sepsis-induced acute kidney injury renal tissues of sepsis-induced acute kidney injury (AKI) rats honokiol treatment downregulated 30833971 2997 Mouse mmu-miR-218-5p miRNA ovalbumin (OVA) asthma Lung tissues ovalbumin (OVA) treatment downregulated 31520422 2998 Mouse mmu-miR-218a-5p miRNA "4,4'-methylenedianiline (MDA)" cholestasis plasma "4,4'-Methylenedianiline (MDA) treatment" upregulated 30125006 2999 Mouse mmu-miR-218a-5p miRNA ¦Á-naphthylisothiocyanate (ANIT) cholestasis plasma ¦Á-naphthylisothiocyanate (ANIT) treatment upregulated 30125006 3000 Mouse mmu-miR-219 miRNA arsenite arsenic-induced neurotoxicity hippocampus arsenic (As) exposure subchronic arsenic exposure induced impairment of learning and memory and significantly upregulated miRNA-219 (miR-219) expression in the mouse hippocampus. 29478199 3001 Mouse mmu-miR-219 miRNA complete freund's adjuvant (CFA) chronic inflammatory pain spinal neurons complete Freund's adjuvant (CFA) treatment downregulated 25031391 3002 Mouse mmu-miR-219 miRNA kainic acid (KA) epilepsy Hippocampal neurons kainic acid (KA) treatment downregulated 25394384 3003 Mouse mmu-miR-219 miRNA kainic acid (KA) epilepsy Hippocampal neurons KA treatment downregulated 25394384 3004 Mouse mmu-miR-219 miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues CCl4 treatment downregulated 30592264 3005 Mouse mmu-miR-219-5p miRNA resolvin D1 (RvD1) extracellular matrix synthesis macrophages resolvin D1 (RvD1) treatment upregulated 24249635 3006 Mouse mmu-miR-219-5p miRNA resolvin D1 (RvD1) insulin resistance and nonalcoholic steatohepatitis (NASH) obese mice with NASH resolvin D1 (RvD1) treatment upregulated 24249635 3007 Mouse mmu-miR-219-5p miRNA morphine macrophage apoptosis RAW264.7 cells morphine treatment downregulated 27253431 3008 Mouse mmu-miR-219-5p miRNA microwave microwave-induced adverse health outcomes mouse hippocampus 7 days after 30 mW/cm microwave exposure treatment downregulated 24748327 3009 Mouse mmu-miR-219a-2 miRNA hypoxia/reoxygenation (H/R) myocardial ischemia/reperfusion (I/R) injury (MIRI) HL-1 cells hypoxia/reoxygenation (H/R) treatment downregulated 32682013 3010 Mouse mmu-miR-219a-5p miRNA ethanol (EtOH) chronic alcoholic liver disease (ALD) AML-12 cells Ethanol exposure downregulated 31428222 3011 Mouse mmu-miR-219a-5p miRNA protocatechuic acid (PCA) chronic alcoholic liver disease (ALD) AML-12 cells Protocatechuic acid (PCA) treatment upregulated 31428222 3012 Mouse mmu-miR-219a-5p miRNA anandamide and norgestimate depression chronic mild stress (CMS) model of depression mouse anandamide and norgestimate treatment downregulated 28716528 3013 Mouse mmu-miR-219a-5p miRNA H2O2 hepatic ischemia/reperfusion injury (HIRI) AML-12 and NCTC1469 cells H2O2 treatment downregulated 30796685 3014 Mouse mmu-miR-219b-5p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce upregulated 30936699 3015 Mouse mmu-miR-21a miRNA Shexiang Tongxin dropping pill (STDP) atherosclerosis (AS) serial transverse aortic sections Shexiang Tongxin dropping pill (STDP) treatment downregulated 25449459 3016 Mouse mmu-miR-21a miRNA Shexiang Tongxin dropping pill (STDP) atherosclerosis (AS) (ApoE(-/-)) mice aortic STDP (30 mg/kg/day) on atherosclerotic lesions treatment downregulated 25449459 3017 Mouse mmu-miR-21a miRNA helicobacter pylori (H. pylori) gastric MALT lymphoma (GML) GML-developing d3Tx mice stomachs infect with H. pylori upregulated 28560185 3018 Mouse mmu-miR-21a-3p miRNA lipopolysaccharide (LPS) acute kidney injury (AKI) kidney tissues lipopolysaccharide (LPS) treatment upregulated 32727087 3019 Mouse mmu-miR-21a-3p miRNA lipopolysaccharide (LPS) acute respiratory distress syndrome (ARDS) Mouse primary pulmonary Telocytes (TCs) lipopolysaccharide (LPS) treatment upregulated 31878977 3020 Mouse mmu-miR-21a-3p miRNA fructus meliae toosendan (FMT) liver damage eft lateral liver lobe Fructus Meliae Toosendan (FMT) treatment upregulated 26539117 3021 Mouse mmu-miR-21a-5p miRNA lipopolysaccharide (LPS) acute kidney injury (AKI) kidney tissues lipopolysaccharide (LPS) treatment miR-21a-5p was upregulated at 24h and 48h. 32727087 3022 Mouse mmu-miR-21a-5p miRNA brucella abortus brucellosis "bone marrow-derived macrophages, spleens" brucella abortus infection downregulated 29942317 3023 Mouse mmu-miR-21a-5p miRNA kidney transplantation chronic renal allograft dysfunction (CAD) mouse kidney tissues allogenic kidney transplantation treatment upregulated in the mouse kidney 28396121 3024 Mouse mmu-miR-21a-5p miRNA echinococcus multilocularis metacestodes echinococcus multilocularis infection RAW 264.7 cells E. multilocularis metacestodes treatment upregulated 30322806 3025 Mouse mmu-miR-21a-5p miRNA ¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) experimental autoimmune encephalomyelitis (EAE) murine brain-derived CD4+ T cells ¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) combination treatment downregulated 31497013 3026 Mouse mmu-miR-21a-5p miRNA E. multilocularis metacestodes infection and immunity of E. multilocularis RAW264¡¤7 macrophage cells E. multilocularis metacestodes for 6 and 12 h treatment "upregulated (mmu-miR-378d,mmu-miR-155-5p, mmu-miR-146a-5p, mmu-miR-21a-5p , mmu-miR-125a-5p) and downregulated(mmu-miR-1981-5p , mmu-miR-let-7c-1-3p)" 28942753 3027 Mouse mmu-miR-21a-5p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce upregulated 30936699 3028 Mouse mmu-miR-21a-5p miRNA high fat diet (HFD) obesity liver tissues high fat diet (HFD) feed upregulated 32593682 3029 Mouse mmu-miR-21a-5p miRNA polymethylmethacrylate (PMMA) particle-induced osteolysis (PIO) primary bone marrow-derived macrophages (BMMs) polymethylmethacrylate (PMMA) treatment miR-21a-5p expression was promoted in PMMA-induced cells 29252185 3030 Mouse mmu-miR-21a-5p miRNA alpinia oxyphylla extract (AOE) type 2 diabetes mellitus (T2DM) db-/db- mouse kidney A. oxyphylla extract (AOE) treatment downregulated 28249617 3031 Mouse mmu-miR-21b-3p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral ischemia/reperfusion (I/R) injury NS2OY cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 31217870 3032 Mouse mmu-miR-22 miRNA simvastatin atherosclerosis (AS) RAW264.7 macrophages simvastatin treatment miR-22 was found to be one of the most significantly upregulated miRNAs in LPS-stimulated RAW2647 macrophages after treatment with simvastatin 31949780 3033 Mouse mmu-miR-22 miRNA lipopolysaccharide (LPS) Dendritic cell (DC) maturation ?Mouse Monocyte lipopolysaccharide (LPS) treatment upregulated 24198819 3034 Mouse mmu-miR-22 miRNA ultraviolet (UV) irradiation bacterial pneumonia Mouse embryonic fibroblast cells UV radiation treatment ?UV radiation induces a significant increase of miR-22 expression 22166214 3035 Mouse mmu-miR-22 miRNA Rhesus Rotavirus (RRV) biliary atresia (BA) mouse infect with Rhesus Rotavirus (RRV) treatment upregulated 24569080 3036 Mouse mmu-miR-22 miRNA angiotensin II (Ang II) cardiac hypertrophy neonatal mouse cardiac myocytes angiotensin II (Ang II) treatment The expression of lnc-FTX was associated with reduced hypertrophy of neonatal mouse cardiac myocytes and regulated the PTEN/PI3K/Akt signaling pathway by sponging miRNA-22 31840653 3037 Mouse mmu-miR-22 miRNA isoproterenol cardiac hypertrophy heart tissues prolongation of isoproterenol intervention treatment downregulated 24504502 3038 Mouse mmu-miR-22 miRNA doxorubicin (DOX) cardiotoxicity heart tissues "Mice were exposed to reduplicative injections of Dox (i.p., 4?mg/kg) weekly for consecutive 4 weeks to generate Dox-induced cardiotoxicity." upregulated 31677784 3039 Mouse mmu-miR-22 miRNA high glucose (HG) diabetic cardiomyopathy (DCM) mouse cardiomyocytes high glucose (HG) treatment MALAT1-mediated recruitment of the histone methyltransferase EZH2 to the microRNA-22 promoter leads to cardiomyocyte apoptosis in diabetic cardiomyopathy. 33097254 3040 Mouse mmu-miR-22 miRNA phosphodiesterase 5 (PDE5) inhibitor diabetic nephropathy (DN) diabetic kidney injury mouse PDE5is treatment downregulated 28294194 3041 Mouse mmu-miR-22 miRNA tongxinluo (TXL) diabetic nephropathy (DN) C57BL/6J mice TXL treatment downregulated 24370588 3042 Mouse mmu-miR-22 miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity heart tissues doxorubicin (Dox) treatment MicroRNA-22 inhibition prevents doxorubicin-induced cardiotoxicity via upregulating SIRT1. 31677784 3043 Mouse mmu-miR-22 miRNA puerarin facilitates t-tubule development murine embryonic stem cell-derived cardiomyocytes puerarin treatment downregulated 25059232 3044 Mouse mmu-miR-22 miRNA bleomycin (BLM) idiopathic pulmonary fibrosis (IPF) sera bleomycin (BLM) treatment Exosomal miR-22 modulates fibroblast-to-myofibroblast differentiation. 31776321 3045 Mouse mmu-miR-22 miRNA "3,3'-diindolylmethane (DIM)" multiple sclerosis (MS) activated T cells during the development of experimental autoimmune encephalomyelitis (EAE) "3,3'-Diindolylmethane (DIM) treatment" upregulated 24898268 3046 Mouse mmu-miR-22 miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver tissues high fat diet (HFD) feed upregulated 33159388 3047 Mouse mmu-miR-22 miRNA streptozocin (STZ) nonalcoholic steatohepatitis-hepatocellular carcinoma (NASH-HCC) high fat dietmouse liver STZ treatment upregulated in liver 28345673 3048 Mouse mmu-miR-22 miRNA aerobic training obesity exosomes of serum aerobic training downregulated 32744099 3049 Mouse mmu-miR-22 miRNA high fat diet (HFD) obesity mouse brown adipose tissue (BAT) high fat diet (HFD) feed "Here, we show that miR-22 expression is induced during white, beige, and brown adipocyte differentiation in vitro." 33549579 3050 Mouse mmu-miR-22 miRNA dexamethasone (DEX) osteoporosis murine osteoblastic MC3T3-E1 cells dexamethasone (DEX) treatment The results demonstrated that miR-22 expression was upregulated in DEX-treated osteoblastic cells compared with the control group. 33732309 3051 Mouse mmu-miR-22 miRNA ¦Â-elemene oxygen-induced retinopathy (OIR) Retinas tissues ¦Â-elemene treatment upregulated 30664207 3052 Mouse mmu-miR-22 miRNA testosterone prostate cancer female mouse liver Testosterone treatment "upregulation of the 6 miRNAs miR-22, miR-690, miR-122, let-7A, miR-30D and let-7D" 20600201 3053 Mouse mmu-miR-22 miRNA haloperidol psychotic disorders mouse brain clozapine treatment upregulated 23318695 3054 Mouse mmu-miR-22 miRNA olanzapine (OLP) psychotic disorders brain tissues clozapine treatment upregulated 23318695 3055 Mouse mmu-miR-22 miRNA bleomycin (BLM) lung fibrosis human lung fibroblasts bleomycin (BLM) treatment upregulated 31776321 3056 Mouse mmu-miR-22 miRNA TGF-¦Â1 skeletal muscle myogenesis mouse myoblast cell (C2C12 myoblast cell line) transforming growth factor beta 1 (TGF-¦Â1) treatment downregulated 29588073 3057 Mouse mmu-miR-220b miRNA streptozocin (STZ) diabetes mellitus (DM) hearts of diabetic mice streptozotocin (STZ) treatment downregulated 21584493 3058 Mouse mmu-miR-221 miRNA red mud biological effects of red mud "CBA/Ca mice liver, spleen, lung, kidney and lymph nodes" "1, 3, 6 and 24 h after a single intraperitoneal injection of red mud treatment" "upregulated , but the level and the peak of the alteration differed according to examined tissue" 24425836 3059 Mouse mmu-miR-221 miRNA hydrochloric acid acute lung injury (ALI) C57BL/6 mice microvesicle (MV)release from lung epithelium "hydrochloric acid (0.1 N, pH 1.5) was intratracheally instilled into the mouse lung" upregulated in microvesicle (MV)release from lung epithelium 28674181 3060 Mouse mmu-miR-221 miRNA lipopolysaccharide (LPS) asthma P815 mast cells lipopolysaccharide (LPS) treatment upregulated 26901347 3061 Mouse mmu-miR-221 miRNA ovalbumin (OVA) asthma mouse lung tissue cells OVA treatment miRNA-221 blockade resulted in a reduction of airway inflammation in the OV A-induced murine asthma model 22572970 3062 Mouse mmu-miR-221 miRNA ovalbumin (OVA) asthma lung tissues ovalbumin (OVA) treatment upregulated 32714925 3063 Mouse mmu-miR-221 miRNA lipopolysaccharide (LPS) bacterial pneumonia RAW 264.7 derived extracellular vesicles (EVs) lipopolysaccharide (LPS) treatment upregulated 28274991 3064 Mouse mmu-miR-221 miRNA bile acids bronchial epithelial inflammation in asthma EAC cells bile acids treatment upregulated 23933602 3065 Mouse mmu-miR-221 miRNA angiotensin II (Ang II) cardiac electrical remodeling heart tissues angiotensin II (Ang II) treatment upregulated 31312877 3066 Mouse mmu-miR-221 miRNA angiotensin II (Ang II) cardiac hypertrophy heart sissues angiotensin II (Ang II) treatment upregulated 31312877 3067 Mouse mmu-miR-221 miRNA adenine chronic kidney disease (CKD) kidney tissues adenine treatment upregulated 32526762 3068 Mouse mmu-miR-221 miRNA streptozocin (STZ) diabetes mellitus (DM) hearts of diabetic mice streptozotocin (STZ) treatment upregulated 21584493 3069 Mouse mmu-miR-221 miRNA streptozocin (STZ) diabetes mellitus (DM) hippocampal neuron streptozotocin induce treatment "miR-221 was highly expressed in the diabetic mice miR-221 could bind with both lincRNA p21 and FOS miR-221 silencing in the diabetes mice reduced the cell apoptosis rate, and the expression of Bax and cleaved Caspase-3, whereas increase the Bcl-2 expression" 31081202 3070 Mouse mmu-miR-221 miRNA hypoxia hypoxia-induced injury mouse hippocampal HT22 cells hypoxia treatment downregulated 31512791 3071 Mouse mmu-miR-221 miRNA magnesium (Mg2+ ) hypoxia-induced injury hypoxia-induced mouse hippocampal HT22 cells Magnesium (Mg2+ ) treatment upregulated 31512791 3072 Mouse mmu-miR-221 miRNA extracts from wild bitter gourd fruit (WBGE) inflammation TNF-¦Á-mouse lung tissues extracts from wild bitter gourd fruit (WBGE) treatment upregulated 29655703 3073 Mouse mmu-miR-221 miRNA tumor necrosis factor alpha (TNF-¦Á) inflammation lung tissues tumor necrosis factor alpha (TNF-¦Á) treatment downregulated 29655703 3074 Mouse mmu-miR-221 miRNA TGF-¦Â1 inflammation intestinal Th17 cells TGF-¦Â1 treatment Expression of miR-221 and miR-222 was induced by proinflammatory cytokines and repressed by the cytokine TGF-¦Â 33657395 3075 Mouse mmu-miR-221 miRNA vesicular stomatitis virus (VSV) innate immune response peritoneal macrophages vesicular stomatitis virus (VSV) infection treatment upregulated 30089112 3076 Mouse mmu-miR-221 miRNA high fat diet (HFD) insulin resistance (IR) C57BL/6 male mice liver and muscle high fat diet (HFD) feed upregulated 24130336 3077 Mouse mmu-miR-221 miRNA dietary methyl deficiency hepatocellular carcinoma (HCC) the liver tissues Dietary methyl deficiency treatment upregulated 20436259 3078 Mouse mmu-miR-221 miRNA nerve growth factor (NGF) neuronal differentiation rat pheochromocytoma PC12 cells nerve growth factor (NGF) regulated miR-221 was drastically upregulated 22465943 3079 Mouse mmu-miR-221 miRNA carbon tetrachloride (CCl4) nonalcoholic steatohepatitis (NASH) liver tissues carbon tetrachloride (CCl4) treatment Liver miR-221 was significantly increased in both fibrosis models compared to control mice. 30528086 3080 Mouse mmu-miR-221 miRNA choline deficient diet (MCDD) nonalcoholic steatohepatitis (NASH) liver tissues choline deficient diet (MCDD) treatment Liver miR-221 was significantly increased in both fibrosis models compared to control mice. 30528086 3081 Mouse mmu-miR-221 miRNA high fat diet (HFD) obesity obese adipose tissue high fat diet (HFD) feed upregulated 29236311 3082 Mouse mmu-miR-221/222 miRNA 1-methyl-4-phenylpyridinium (MPP+) parkinson's disease (PD) MN9D dopaminergic neurons N-methyl-4-phenylpyridinium (MPP +) treatment downregulated 31499060 3083 Mouse mmu-miR-221-3p miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues lipopolysaccharide (LPS) treatment upregulated 31208297 3084 Mouse mmu-miR-221-3p miRNA lipopolysaccharide (LPS) acute respiratory distress syndrome (ARDS) RAW 264.7 macrophages lipopolysaccharide (LPS) treatment LncRNA TUG1 reverses LPS-induced cell apoptosis and inflammation of macrophage via targeting MiR-221-3p/SPRED2 axis 32841583 3085 Mouse mmu-miR-221-3p miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) RAW 264.7 cells oxidized low-density lipoprotein (ox-LDL) treatment ox-LDL treatment remarkably suppressed the expression of miR-221-3p in a concentration-dependent and time-dependent manner. 30362166 3086 Mouse mmu-miR-221-3p miRNA "carbon-tetrachloride- and 3,5-di-diethoxycarbonyl-1,4-dihydrocollidine" liver fibrosis mouse hepatocytes "carbon-tetrachloride- and 3,5-di-diethoxycarbonyl-1,4-dihydrocollidine induce" upregulated 30582979 3087 Mouse mmu-miR-221-3p miRNA oxidized low density lipoprotein (ox-LDL) oxidative stress The RAW264.7 cell line oxidized low-density lipoprotein (ox-LDL) treatment downregulated 30362166 3088 Mouse mmu-miR-221-5p miRNA 3¦Â-hydroxycholest-5-en-7-one anti-inflammatory responses RAW 264.7 cells 3¦Â-hydroxycholest-5-en-7-one treatment upregulated 32771556 3089 Mouse mmu-miR-222 miRNA staphylococcal enterotoxin B (SEB) acute inflammatory lung injury lung staphylococcal enterotoxin B treatment upregulated 25564423 3090 Mouse mmu-miR-222 miRNA staphylococcal enterotoxin B (SEB) acute lung injury (ALI) lung-infiltrating mononuclear cells staphylococcal enterotoxin B (SEB) treatment upregulated 26818958 3091 Mouse mmu-miR-222 miRNA staphylococcal enterotoxin B (SEB) acute lung injury (ALI) lung infiltrating mononuclear cells staphylococcal Enterotoxin B (SEB) treatment MiR-222 was upregulated in SEB-induced inflammatory ALI. 32457280 3092 Mouse mmu-miR-222 miRNA arsenite atherosclerosis (AS) liver arsenic (As) exposure downregulated 22719926 3093 Mouse mmu-miR-222 miRNA lipopolysaccharide (LPS) bacterial pneumonia RAW 264.7 derived extracellular vesicles (EVs) lipopolysaccharide (LPS) treatment upregulated 28274991 3094 Mouse mmu-miR-222 miRNA celecoxib breast cancer ovariectomized athymic mice transplanted MCF-7 cells celecoxib treatment upregulated 24923427 3095 Mouse mmu-miR-222 miRNA bile acids bronchial epithelial inflammation in asthma EAC cells bile acids treatment upregulated 23933602 3096 Mouse mmu-miR-222 miRNA angiotensin II (Ang II) cardiac electrical remodeling heart tissues angiotensin II (Ang II) treatment upregulated 31312877 3097 Mouse mmu-miR-222 miRNA angiotensin II (Ang II) cardiac hypertrophy heart sissues angiotensin II (Ang II) treatment upregulated 31312877 3098 Mouse mmu-miR-222 miRNA high glucose (HG) cardiac remodeling mouse heart endothelial cells high glucose (HG) treatment downregulated 32396525 3099 Mouse mmu-miR-222 miRNA streptozocin (STZ) cardiac remodeling heart sissues streptozocin (STZ) treatment downregulated 32396525 3100 Mouse mmu-miR-222 miRNA streptozocin (STZ) diabetes mellitus (DM) heart tissues streptozotocin (STZ) treatment downregulated 31389030 3101 Mouse mmu-miR-222 miRNA gastrin gastric cancer (GC) AGSGR cells Gastrin treatment upregulated 27323780 3102 Mouse mmu-miR-222 miRNA ¦Ã-rays gastrointestinal acute radiation syndrome Macrophages (M?) with the M2b phenotype (Pheno2b-M?) 7-10 Gy of gamma rays treatment upregulated 29743312 3103 Mouse mmu-miR-222 miRNA estradiol-17¦Â (E2) gestational diabetes mellitus (GDM) 3T3-L1 adipocytes estradiol-17¦Â (E2) treatment upregulated 24601884 3104 Mouse mmu-miR-222 miRNA streptozocin (STZ) gestational diabetes mellitus (GDM) placenta tissues streptozocin treatment MiR-222 was increased while CXCR4 was decreased in GDM patients and mice 33278386 3105 Mouse mmu-miR-222 miRNA exercise (Ex) heart capacity heart Exercise treatment upregulated 25863248 3106 Mouse mmu-miR-222 miRNA fructus meliae toosendan (FMT) herb-induced liver injury (HILI) serum exosome Fructus Meliae Toosendan (FMT) treatment downregulated 31855734 3107 Mouse mmu-miR-222 miRNA fructus meliae toosendan (FMT) herb-induced liver injury (HILI) mouse serum exosomes Fructus Meliae Toosendan (FMT) treatment downregulated 31855734 3108 Mouse mmu-miR-222 miRNA extracts from wild bitter gourd fruit (WBGE) inflammation TNF-¦Á-mouse lung tissues extracts from wild bitter gourd fruit (WBGE) treatment upregulated 29655703 3109 Mouse mmu-miR-222 miRNA lipopolysaccharide (LPS) inflammation RAW 264.7 cells lipopolysaccharide (LPS) treatment dysregulated 24792623 3110 Mouse mmu-miR-222 miRNA tumor necrosis factor alpha (TNF-¦Á) inflammation lung tissues tumor necrosis factor alpha (TNF-¦Á) treatment downregulated 29655703 3111 Mouse mmu-miR-222 miRNA TGF-¦Â1 inflammation intestinal Th17 cells TGF-¦Â1 treatment Expression of miR-221 and miR-222 was induced by proinflammatory cytokines and repressed by the cytokine TGF-¦Â 33657395 3112 Mouse mmu-miR-222 miRNA panax notoginseng saponins (PNS) lung cancer Lewis lung carcinoma (LLC) cell line Panax notoginseng saponins (PNS) treatment downregulated 27566197 3113 Mouse mmu-miR-222 miRNA "arsenic (As), cadmium (Cd), and lead (Pb) (As-Cd-Pb)" metal-induced carcinogenesis Balb/c 3T3 cell As-Cd-Pb exposure upregulated 31769258 3114 Mouse mmu-miR-222 miRNA genistein muscle health C2C12 myoblasts genistein treatment The expression of miR-222 was decreased by genistein. 32361609 3115 Mouse mmu-miR-222 miRNA genistein myoblast differentiation C2C12 cells Genistein treatment Genistein treatment also downregulated the expression of miR-222. 29171786 3116 Mouse mmu-miR-222 miRNA tumor necrosis factor alpha (TNF-¦Á) neonatal necrotizing enterocolitis (NEC) M1 macrophages tumor necrosis factor alpha (TNF-¦Á) treatment We found that TNF-¦Á upregulated the expression of miRNA-222 and inhibited the expression of c-kit 33564933 3117 Mouse mmu-miR-222 miRNA carbon tetrachloride (CCl4) nonalcoholic steatohepatitis (NASH) liver tissues carbon tetrachloride (CCl4) treatment Liver miR-222 was significantly increased in both fibrosis models compared to control mice. 30528086 3118 Mouse mmu-miR-222 miRNA choline deficient diet (MCDD) nonalcoholic steatohepatitis (NASH) liver tissues choline deficient diet (MCDD) treatment Liver miR-222 was significantly increased in both fibrosis models compared to control mice. 30528086 3119 Mouse mmu-miR-222 miRNA high fat diet (HFD) obesity white adipose tissue high fat diet (HFD) feed upregulated 22496873 3120 Mouse mmu-miR-222 miRNA genistein obesity and diabetes mouse adipose tissues genistein treatment Genistein can inhibit obesity and downregulate the expression of miR-222 in mouse adipose tissue and 3T3-L1 cells. 32129363 3121 Mouse mmu-miR-222 miRNA genistein obesity and diabetes T3-L1 preadipocytes genistein treatment downregulated 32129363 3122 Mouse mmu-miR-222 miRNA wire-induced injury to carotid arteries vessel stenosis apolipoprotein E knockout (Apoe ) mice injury to carotid arteries of treatment upregulated 27622243 3123 Mouse mmu-miR-222 miRNA coxsackievirus B3 (CVB3) viral myocarditis (VM) mouse cardiomyocytes Coxsachievirus B3 infection upregulated 30669342 3124 Mouse mmu-miR-222-3p miRNA bone marrow transplantation (BMT) diabetes mellitus (DM) mice with insulin-deficient diabetes bone marrow transplantation (BMT) treatment upregulated 27974246 3125 Mouse mmu-miR-222-3p miRNA high fat diet (HFD) insulin resistance (IR) obese mice soleus muscle tissues high fat diet (HFD) feed upregulated 31770568 3126 Mouse mmu-miR-222-3p miRNA pioglitazone insulin resistance (IR) obese mice soleus muscle tissues pioglitazone (PGZ) treatment downregulated 31770568 3127 Mouse mmu-miR-222-3p miRNA hypoxia cardiomyocytes injury HL-1 Cells hypoxia exposure miR-222-3p could resume the functions of GAS5 in cell viabilities and apoptosis through protein regulation in PI3K and AKT signaling pathways. 32240616 3128 Mouse mmu-miR-222-5p miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharide (LPS) treatment downregulated 32955644 3129 Mouse mmu-miR-222-5p miRNA high fat diet (HFD) obesity liver tissues high fat diet (HFD) feed upregulated 32593682 3130 Mouse mmu-miR-223 miRNA hypoxia and load pulmonary hypertension (PH) murine lung;right ventricle hypoxia and load treatment downregulated 27013635 3131 Mouse mmu-miR-223 miRNA concanamycin A (Con A) acute liver failure (ALF) mouse Con A treatment dysregulated 25562161 3132 Mouse mmu-miR-223 miRNA Klebsiella pneumoniae acute lung injury (ALI) Bronchoalveolar lavage fluid (BALF) microvesicles (MVs) Klebsiella pneumoniae infection upregulated 31331947 3133 Mouse mmu-miR-223 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues lipopolysaccharide (LPS) treatment downregulated 30747229 3134 Mouse mmu-miR-223 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) Bronchoalveolar lavage fluid (BALF) microvesicles (MVs) lipopolysaccharide (LPS) treatment upregulated 31331947 3135 Mouse mmu-miR-223 miRNA differentiation medium (DM) adipogenesis 3T3-L1 cells "3T3-L1 cells were incubated in differentiation medium (DM) supplemented with 10% FBS, 0.5 mM 3-isobutyl-1-methylxanthine, 250 nM dexamethasone, and 160 nM insulin." downregulated 31828146 3136 Mouse mmu-miR-223 miRNA amyloid-¦Â (A¦Â) 1-40 age-related macular degeneration (AMD) C57BL/6 mice eye tissues amyloid-¦Â (A¦Â) 1-40 treatment upregulated 28324113 3137 Mouse mmu-miR-223 miRNA ethanol (EtOH) alcoholic liver disease (ALD) mouse both serum and neutrophils chronic-plus-binge ethanol feeding upregulated in both serum and neutrophils 27679493 3138 Mouse mmu-miR-223 miRNA vesicular stomatitis virus (VSV) antiviral immune response murine macrophages vesicular stomatitis virus (VSV) treatment upregulated 27226534 3139 Mouse mmu-miR-223 miRNA high fat diet (HFD) atherosclerosis (AS) endothelium high fat diet (HFD) feed miR-223 was remarkably upregulated in the melatonin-treated HFD group. 29024030 3140 Mouse mmu-miR-223 miRNA lipopolysaccharide (LPS) atherosclerosis (AS) RAW 264.7 cells lipopolysaccharide (LPS) treatment downregulated 26492242 3141 Mouse mmu-miR-223 miRNA tumor necrosis factor alpha (TNF-¦Á) atherosclerosis (AS) male C57BL/6J mice tumor necrosis factor alpha (TNF-¦Á) treatment downregulated 25463083 3142 Mouse mmu-miR-223 miRNA sevelamer chronic kidney disease (CKD) CKD mice sevelamer treatment upregulation 24140891 3143 Mouse mmu-miR-223 miRNA dextran sodium sulfate (DSS) colitis colon tissues dextran sodium sulfate (DSS) treatment upregulated 29867475 3144 Mouse mmu-miR-223 miRNA dextran sodium sulfate (DSS) colitis C57BL/6J mice colonic tissue dextran-sulfate-sodium (DSS) treatment upregulated 28752563 3145 Mouse mmu-miR-223 miRNA Lactobacillus fermentum (L. fermentum) colitis C57BL/7J mice colonic tissues infect with L. fermentum downregulated 28752563 3146 Mouse mmu-miR-223 miRNA probiotic Escherichia coli Nissle 1917 (EcN) colitis dextran sodium sulfate (DSS)-induced colitis mouse colon tissues probiotic Escherichia coli Nissle 1917 (EcN) treatment downregulated 29867475 3147 Mouse mmu-miR-223 miRNA IL-10 colonic inflammation colonic intraepithelial lymphocytes IL-10 treatment downregulated 22043014 3148 Mouse mmu-miR-223 miRNA azoxymethane (AOM) and dextran sulfate sodium (DSS) colorectal cancer (CRC) mouse colon tissues azoxymethane (AOM) and dextran sulfate sodium (DSS) treatment upregulated 24464560 3149 Mouse mmu-miR-223 miRNA high glucose (HG) diabetes mellitus (DM) murine Min6 ¦Â-cells high glucose (HG) treatment upregulated 31118273 3150 Mouse mmu-miR-223 miRNA tumor necrosis factor alpha (TNF-¦Á) diabetes mellitus (DM) murine Min6 ¦Â-cells tumor necrosis factor alpha (TNF-¦Á) treatment upregulated 31118273 3151 Mouse mmu-miR-223 miRNA H1N1 influenza virus endometriosis and endometrial carcinoma mouse lung?tissues H1N1 influenza virus infection upregulated 24066118 3152 Mouse mmu-miR-223 miRNA IL-10 epithelial-mesenchymal transition (EMT) colonic intraepithelial lymphocytes IL-10 treatment upregulated 22043014 3153 Mouse mmu-miR-223 miRNA lipopolysaccharide (LPS) inflammation ATDC5 cells lipopolysaccharide (LPS) treatment downregulated 30791741 3154 Mouse mmu-miR-223 miRNA tripterine inflammation LPS-treated ATDC5 cells Tripterine treatment upregulated 30791741 3155 Mouse mmu-miR-223 miRNA dextran sodium sulfate (DSS) inflammatory bowel disease (IBD) terminal ileum; colon dextran sodium sulfate (DSS) treatment miR-223 expression in the terminal ileum and colon was increased in the DSS group. 33332758 3156 Mouse mmu-miR-223 miRNA dextran sodium sulfate (DSS) inflammatory bowel disease (IBD) colon tissues dextran sulfate sodium (DSS) treatment upregulated 30236870 3157 Mouse mmu-miR-223 miRNA dextran sodium sulfate (DSS) inflammatory bowel disease (IBD) terminal ileum and colon dextran sodium sulfate (DSS) treatment miR-223 expression in the terminal ileum and colon was increased in the DSS group compared with the WT group. 33332758 3158 Mouse mmu-miR-223 miRNA histone deacetylase inhibitor trichostatin A (TSA) inflammatory diseases TLR-triggered RAW264.7 cells increased expression obviously in upregulated 28881218 3159 Mouse mmu-miR-223 miRNA schistosoma japonicum japonicum infection serum japonicum infection upregulated 24330517 3160 Mouse mmu-miR-223 miRNA acetaminophen (APAP) acetaminophen (APAP)-induced liver injury (AILI) mouse neutrophils acetaminophen (APAP) treatment upregulated in neutrophils 28295449 3161 Mouse mmu-miR-223 miRNA dexamethasone (DEX) macrophage inflammatory response Mouse bone marrow-derived macrophages (BMDMs) dexamethasone (DEX) treatment upregulated 31262200 3162 Mouse mmu-miR-223 miRNA IFN-¦Ã macrophage inflammatory response Mouse bone marrow-derived macrophages (BMDMs) IFN-¦Ã treatment downregulated 31262200 3163 Mouse mmu-miR-223 miRNA IL-10 macrophage inflammatory response Mouse bone marrow-derived macrophages (BMDMs) IL-10 treatment upregulated 31262200 3164 Mouse mmu-miR-223 miRNA IL-4 macrophage inflammatory response Mouse bone marrow-derived macrophages (BMDMs) IL-4 treatment upregulated 31262200 3165 Mouse mmu-miR-223 miRNA lipopolysaccharide (LPS) macrophage inflammatory response Mouse bone marrow-derived macrophages (BMDMs) lipopolysaccharide (LPS) treatment downregulated 31262200 3166 Mouse mmu-miR-223 miRNA rosiglitazone macrophage inflammatory response Mouse bone marrow-derived macrophages (BMDMs) rosiglitazone treatment upregulated 31262200 3167 Mouse mmu-miR-223 miRNA H2O2 myocardial infarction (MI) Primarily cultured cardiomyocytes H2O2 treatment upregulated 30280799 3168 Mouse mmu-miR-223 miRNA ovalbumin (OVA) neutrophilic asthma lung tissues OVA/CFA treatment The expression of miR-223 was upregulated in lung tissues of experimental mice model. 32423405 3169 Mouse mmu-miR-223 miRNA high fat diet (HFD) nonalcoholic steatohepatitis (NASH) hepatocytes in HFD-fed mice high fat diet (HFD) feed upregulated 30964207 3170 Mouse mmu-miR-223 miRNA clozapine (CLZ) psychotic disorders mouse brain clozapine treatment upregulated 23318695 3171 Mouse mmu-miR-223 miRNA olanzapine (OLP) psychotic disorders brain tissues clozapine treatment upregulated 23318695 3172 Mouse mmu-miR-223 miRNA photo-oxidative damage (PD) retinal degenerative diseases retina photo-oxidative damage (PD) treatment "During photo-oxidative damage (PD) in wild-type (WT) mice, miR-223 in the retina is significantly upregulated between 3 and 7 days, peaking at 5 days (P < 005), compared to dim-reared control levels" 32671067 3173 Mouse mmu-miR-223 miRNA leptin age-associated loss of muscle mass skeletal muscle ?leptin treatment ?leptin treatment increased the expression of miR-31 and miR-223 20800581 3174 Mouse mmu-miR-223 miRNA cecal ligation and puncture (CLP) sepsis mouse kidney homogenate cecal ligation and puncture (CLP) treatment upregulated in kidney homogenate 28515178 3175 Mouse mmu-miR-223 miRNA controlled cortical impact (CCI) traumatic brain injury (TBI) mouse hippocampus controlled cortical impact (CCI) upregulated 28804446 3176 Mouse mmu-miR-223 miRNA coxsackievirus B3 (CVB3) viral myocarditis (VM) heart tissues and heart-infiltrating macrophages Coxsackievirus B3 (CVB3) infection downregulated 29524390 3177 Mouse mmu-miR-223 miRNA coxsackievirus B3 (CVB3) viral myocarditis (VM) macrophages coxsackievirus B3 (CVB3) treatment "downregulated of MEG3 leads to the inhibition of inflammation and induces M2 macrophage polarization via miR-223/TRAF6/NF-¦ÊB axis, thus alleviating VMC." 33047847 3178 Mouse mmu-miR-223*-5p miRNA ecal ligation and puncture (CLP) severe septic mouse ligation and puncture treatment downregulated 24486439 3179 Mouse mmu-miR-223-3p miRNA angiostrongylus cantonensis (A. cantonensis) angiostrongylus cantonensis (A. cantonensis) infection mouse angiostrongylus cantonensis (A. cantonensis) infection upregulated 24682888 3180 Mouse mmu-miR-223-3p miRNA "fatty acid esters of 3-chloro-1, 2-propanediol (3-MCPD)" acute kidney injury (AKI) kidney tissues "Fatty acid esters of 3-chloro-1, 2-propanediol (3-MCPD) treatment" upregulated 29860048 3181 Mouse mmu-miR-223-3p miRNA lipopolysaccharide (LPS) acute kidney injury (AKI) kidney tissues lipopolysaccharide (LPS) treatment miR-223-3p was upregulated at 1.5h and 24h. 32727087 3182 Mouse mmu-miR-223-3p miRNA ovalbumin (OVA) asthma bone marrow-derived DCs (BMDCs) ovalbumin (OVA) treatment OVA treatment significantly downregulated miR-223-3p in BMDCs. 32656268 3183 Mouse mmu-miR-223-3p miRNA ¦Á-myosin H-chain peptide autoimmune myocarditis serum ¦Á-myosin H-chain peptide treatment miR-223-3p expression was significantly lower in EAM mice than that in normal mice 31743855 3184 Mouse mmu-miR-223-3p miRNA azoxymethane (AOM) and dextran sulfate sodium (DSS) colitis-associated colon cancer (CAC) colon tissues azoxymethane (AOM) and dextran sulfate sodium (DSS) treatment upregulated 31275360 3185 Mouse mmu-miR-223-3p miRNA pedunculoside colitis-associated colon cancer (CAC) CAC mice colon tissues pedunculoside treatment downregulated 31275360 3186 Mouse mmu-miR-223-3p miRNA reconstituted high-density lipoproteins (rHDL) diabetes-impaired angiogenesis diabetic mice HDL fraction reconstituted high-density lipoproteins (rHDL) treatment upregulated 30206364 3187 Mouse mmu-miR-223-3p miRNA reconstituted high-density lipoproteins (rHDL) diabetes-impaired angiogenesis diabetic mice plasma reconstituted high-density lipoproteins (rHDL) treatment downregulated 30206364 3188 Mouse mmu-miR-223-3p miRNA dexamethasone (DEX) endometrial receptivity endometrium tissues dexamethasone (DEX) treatment upregulated 30993706 3189 Mouse mmu-miR-223-3p miRNA ¦Á-myosin H-chain peptide experimental autoimmune myocarditis (EAM) EAM mice serum ¦Á-myosin H-chain peptide treatment downregulated 31743855 3190 Mouse mmu-miR-223-3p miRNA monosodium urate (MSU) gouty inflammation mice air pouch synovium monosodium urate treatment downregulated 33650318 3191 Mouse mmu-miR-223-3p miRNA dexamethasone (DEX) innate immune response immature DCs (iDCs) dexamethasone (DEX) treatment upregulated 30174602 3192 Mouse mmu-miR-223-3p miRNA low chromium (Cr) insulin resistance (IR) liver fed a control or LC diet for 13 weeks dysregulatedin liver 29286159 3193 Mouse mmu-miR-223-3p miRNA candida albicans (C. albicans) kaposi's sarcoma (KS) serum candida albicans infection upregulated 31396494 3194 Mouse mmu-miR-223-3p miRNA high fat diet (HFD) obesity liver tissues high fat diet (HFD) feed upregulated 32593682 3195 Mouse mmu-miR-223-3p miRNA bilateral surgical destabilization of the medial meniscus (DMM) osteoarthritis (OA) male C57BL6 mice bilateral surgical destabilization of the medial meniscus (DMM) treatment dysregulated 29255152 3196 Mouse mmu-miR-223-3p miRNA IL-1¦Â osteoarthritis (OA) Murine primary chondrocytes were isolated from postnatal mice IL-1¦Â treatment downregulated 30847744 3197 Mouse mmu-miR-223-3p miRNA Sinomenine (SIN) osteoarthritis (OA) IL-1¦Â-treated murine primary chondrocytes were isolated from postnatal mice Sinomenine (SIN) treatment upregulated 30847744 3198 Mouse mmu-miR-223-3p miRNA rotenone (ROT) parkinson's disease (PD) brain tissues rotenone treatment downregulated 32470877 3199 Mouse mmu-miR-223-3p miRNA chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) plvic inflammatory disease mouse two Chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) infection were upregulated during CmVar004 infection compared to CmVar001 infection 24961692 3200 Mouse mmu-miR-223-3p miRNA ?-glucan rheumatoid arthritis (RA) SKG mice plasma injection of ?-glucan treatment upregulated in plasma 28056105 3201 Mouse mmu-miR-223-3p miRNA ecal ligation and puncture (CLP) severe septic mouse ligation and puncture treatment downregulated 24486439 3202 Mouse mmu-miR-223-3p miRNA H2O2 spinal cord injury (SCI) primary spinal neurons culture H2O2 treatment downregulated 30821011 3203 Mouse mmu-miR-223-3p miRNA necrostatin-1 (Nec-1) spinal cord injury (SCI) H2O2 treated primary spinal neurons Necrostatin-1 (Nec-1) treatment upregulated 30821011 3204 Mouse mmu-miR-223-3p miRNA PP242 uterine receptivity epithelial endometrium PP242 treatment upregulated 30968418 3205 Mouse mmu-miR-223-5p miRNA IL-4 spinal cord injury (SCI) Microglia were first isolated from neonate rats interleukin-4 (IL-4) treatment downregulated 31799641 3206 Mouse mmu-miR-223-5p miRNA lipopolysaccharide (LPS) spinal cord injury (SCI) Microglia were first isolated from neonate rats lipopolysaccharide (LPS) treatment upregulated 31799641 3207 Mouse mmu-miR-22-3p miRNA light age-related macular degeneration (AMD) retinal tissues "high©\intensity (5,000 lux) blue©\light with the wavelength ranging from 460 to 490 nm exposure" downregulated 30927257 3208 Mouse mmu-miR-22-3p miRNA angiotensin II (Ang II) cardiac fibrosis Cardiac fibroblasts (CFs) angiotensin II (Ang II) treatment downregulated 32329883 3209 Mouse mmu-miR-22-3p miRNA nine hepatotoxic non-genotoxins (NGTXs) genotoxicity liver tissues nine hepatotoxic non-genotoxins (NGTXs) treatment downregulated 29777724 3210 Mouse mmu-miR-22-3p miRNA nine hepatotoxic non-genotoxins (NGTXs) genotoxicity plasma nine hepatotoxic non-genotoxins (NGTXs) treatment upregulated 29777724 3211 Mouse mmu-miR-22-3p miRNA monosodium urate (MSU) gouty inflammation mice air pouch synovium monosodium urate treatment downregulated 33650318 3212 Mouse mmu-miR-22-3p miRNA calcitonin gene-related peptide (CGRP) osteogenesis MC3T3 cells calcitonin gene-related peptide (CGRP) treatment "The expression of mm9_circ_009056 was upregulated in the CGRP-induced cells, whereas miR-22-3p was obviously decreased." 29709471 3213 Mouse mmu-miR-224 miRNA angiotensin II (Ang II) cardiac fibrosis rat cardiac fibroblasts angiotensin II (Ang II) treatment upregulated 24649028 3214 Mouse mmu-miR-224 miRNA lipopolysaccharide (LPS) inner ear inflammatory scala tympani LPS was injected directly into treatment upregulated 24470395 3215 Mouse mmu-miR-224 miRNA ischemic brain extract (IBE) ischemic injury Neuro-2a mouse neuronal cells IBE treatment upregulated 24999036 3216 Mouse mmu-miR-224 miRNA TGF-¦Â1 ovulation and subsequent embryo development mouse mural GCs and cumulus-oocyte complexes (COCs) "by TGF-¦Â1 , which was partially mediated by treatment" downregulated 24145127 3217 Mouse mmu-miR-224 miRNA Src tyrosine kinase (Src) tumorigenesis The nontransformed and v-Src-transformed mouse embryonic Cx43Ko brain cells Src tyrosine kinase (Src) treatment downregulated 19767772 3218 Mouse mmu-mir-224-2 miRNA bone morphogenetic protein 4 (BMP4) apoptosis mouse embryonic stem cells (ESCs) bone morphogenetic protein 4 (BMP4) treatment upregulated 25476774 3219 Mouse mmu-miR-224-3p miRNA oxygen glucose deprivation (OGD) cerebral ischemia/reperfusion (I/R) injury N2a cells Oxygen glucose deprivation treatment downregulated 31134677 3220 Mouse mmu-miR-224-5p miRNA pyrrolidinedithiocarbamic acid (PDTC) adipocyte apoptosis 3T3-L1 adipocytes "pyrrolidinedithiocarbamic acid (PDTC, 60??M) treatment" downregulated 28488777 3221 Mouse mmu-miR-224-5p miRNA tumor necrosis factor alpha (TNF-¦Á) adipocyte apoptosis 3T3-L1 adipocytes tumor necrosis factor alpha (TNF-¦Á) treatment miRNA-224-5p (miR-224) was upregulated by TNF¦Á exposure 28488777 3222 Mouse mmu-miR-224-5p miRNA pyrrolidinedithiocarbamic acid (PDTC) apoptosis 3T3-L1 adipocytes "Pyrrolidinedithiocarbamic acid (PDTC, 60 ?M) treatment" downregulated 28488777 3223 Mouse mmu-miR-224-5p miRNA tumor necrosis factor alpha (TNF-¦Á) apoptosis 3T3-L1 adipocytes TNF¦Á (20 ng/mL) treatment upregulated 28488777 3224 Mouse mmu-mir-227a miRNA bone morphogenetic protein 4 (BMP4) apoptosis mouse embryonic stem cells (ESCs) bone morphogenetic protein 4 (BMP4) treatment upregulated 25476774 3225 Mouse mmu-miR-23 miRNA laser angiogenesis endothelial cells and highly vascularized tissues laser treatment upregulated 21536891 3226 Mouse mmu-miR-23 miRNA streptozocin (STZ) congenital heart disease (CHD) C57BL/6 mice blood injection of streptozotocin before mating treatment dysregulated 27998767 3227 Mouse mmu-miR-23 miRNA pioglitazone macrophage polarization bone marrow-derived macrophages (BMDM) pioglitazone (PGZ) treatment upregulated 31091119 3228 Mouse mmu-mir-23a miRNA bone morphogenetic protein 4 (BMP4) apoptosis mouse embryonic stem cells (ESCs) bone morphogenetic protein 4 (BMP4) treatment upregulated 25476774 3229 Mouse mmu-miR-23a miRNA conjugated linoleic acid (CLA) apoptosis 3T3-L1 adipocytes Conjugated linoleic acids (CLAs) treatment downregulated 27898407 3230 Mouse mmu-miR-23a miRNA angiotensin II (Ang II) macrophage polarization RAW264.7 macrophages angiotensin II (Ang II) treatment NRON promotes M2 macrophage polarization and alleviates atrial fibrosis through suppressing exosomal miR-23a derived from atrial myocytes. 33246743 3231 Mouse mmu-miR-23a miRNA lipopolysaccharide (LPS) autophagy RAW 264.7 cells lipopolysaccharide (LPS) treatment downregulated 29845275 3232 Mouse mmu-miR-23a miRNA isoproterenol hydrochloride cardiac hypertrophy left ventricular specimens isoproterenol hydrochloride treatment upregulated 32023551 3233 Mouse mmu-miR-23a miRNA resistance exercise training chronic kidney disease (CKD) CKD mice muscle overload treatment upregulated 28400445 3234 Mouse mmu-miR-23a miRNA myostatin cell differentiation C2C12 cells 1 ¦Ìg of recombinant myostatin dysregulated 28691106 3235 Mouse mmu-miR-23a miRNA kainic acid (KA) epilepsy hippocampus kainic acid (KA) treatment upregulated 31336125 3236 Mouse mmu-miR-23a miRNA pilocarpine epilepsy hippocampal tissues pilocarpine treatment upregulated 31114485 3237 Mouse mmu-miR-23a miRNA berberine (BBR) inflammation LPS-treated RAW 264.7 macrophages berberine (BBR) treatment upregulated 30240693 3238 Mouse mmu-miR-23a miRNA endothelin-1 (ET-1) inflammation herat of mice endothelin-1 treatment upregulated 22084234 3239 Mouse mmu-miR-23a miRNA NQDI1 (apoptosis signal-regulating kinase 1 (ASK1) inhibitor) inflammation LPS-treated RAW 264.7 macrophages NQDI1 treatment upregulated 30240693 3240 Mouse mmu-miR-23a miRNA phenylephrine (PE) inflammation herat of mice phenylephrine treatment upregulated 22084234 3241 Mouse mmu-miR-23a miRNA TNF-¦Á and lipopolysaccharide (LPS) inflammation RAW 264.7 macrophages TNF-¦Á and lipopolysaccharide (LPS) treatment downregulated 30240693 3242 Mouse mmu-miR-23a miRNA chlorogenic acid (CGA) intestinal diseases intestinal epithelial cells chlorogenic acid (CGA) treatment CGA promotes autophagy and inhibits ST infection through the GAS5/miR-23a/PTEN axis and the p38 MAPK pathway. 33240872 3243 Mouse mmu-miR-23a miRNA "TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin)" kaposi's sarcoma (KS) fetal thymocytes of mice "TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) treatment" downregulated 23024791 3244 Mouse mmu-miR-23a miRNA delphinidin muscle atrophy dexamethasone-treated C2C12 cells delphinidin treatment upregulated 28000445 3245 Mouse mmu-miR-23a miRNA berberine coated mannosylated liposomes (ML-BBR) osteoclastogenesis RANKL-stimulated bone marrow-derived monocytes/macrophages (BMMs) berberine coated mannosylated liposomes (ML-BBR) treatment upregulated 31261037 3246 Mouse mmu-miR-23a miRNA receptor activator of nuclear factor-¦ÊB ligand (RANKL) osteoclastogenesis bone marrow-derived monocytes/macrophages (BMMs) RANKL treatment downregulated 31261037 3247 Mouse mmu-miR-23a miRNA bupivacaine painful diabetic neuropathy (PDN) mouse microglia bupivacaine treatment Low concentration of Bupivacaine inhibited inflammation and promoted miR-23a expression in mice with painful diabetic neuropathy and in microglia induced by HIGH GLUCOSE. 33144067 3248 Mouse mmu-miR-23a miRNA notoginsenoside R1 (NGR1) preosteoblast differentiation MC3T3-E1 cells Notoginsenoside R1 (NGR1) treatment upregulated 30831034 3249 Mouse mmu-miR-23a miRNA bovine type II collagen rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLSs) bovine type II collagen induction PBMC-derived exos contributes to RA development with the involvement of the miR-23a/MDM2/SIRT6 axis. 33042992 3250 Mouse mmu-miR-23a miRNA lipopolysaccharide (LPS) rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLSs) Lipopolysaccharide (LPS) treatment LncRNA NEAT1 shuttled by PBMC-derived exos promoted FLS proliferation and inflammation through regulating the MDM2/SIRT6 axis. 33042992 3251 Mouse mmu-miR-23a miRNA controlled cortical impact (CCI) traumatic brain injury (TBI) mouse brain controlled cortical impact (CCI) downregulated 25057207 3252 Mouse mmu-miR-23a miRNA etoposide (VP-16) traumatic brain injury (TBI) mouse primary cortical neurons etoposide treatment downregulated 31818176 3253 Mouse mmu-miR-23a miRNA hypoxia tubulointerstitial inflammation mouse tubular epithelial cells hypoxia induce upregulated 30551896 3254 Mouse mmu-miR-23a miRNA hypoxia tubulointerstitial inflammation mouse tubular epithelial cells (mTECs) hypoxia treatment upregulated 30551896 3255 Mouse mmu-miR-23a-3p miRNA Japanese encephalitis virus (JEV) Japanese encephalitis virus (JEV) infection brain tissues; BV2 cells Japanese encephalitis virus (JEV) infection downregulated 32552669 3256 Mouse mmu-miR-23a-3p miRNA hypoxia oxidative stress C57/BL6 mice transient middle cerebral artery occlusion (MCAO) for 1h treatment upregulated 25280466 3257 Mouse mmu-miR-23a-3p miRNA dexamethasone (DEX) stress response mouse C2C12 myotubes dexamethasone (DEX) treatment downregulated 31138100 3258 Mouse mmu-miR-23a-5p miRNA high NaCl hypertonic stress mouse inner medullary collecting duct cells (mIMCD3) high NaCl treatment The downregulated of miR-23a-5p facilitates cellular adaptation to hypertonic stress in mammalian renal cells through modulating HSPA1B. 33206547 3259 Mouse mmu-miR-23a-5p miRNA prostaglandin E2 (PGE2) liver fibrosis TGF-¦Â1-treated primary hepatic stellate cells (HSCs) PGE2 treatment downregulated 29109031 3260 Mouse mmu-miR-23a-5p miRNA TGF-¦Â1 liver fibrosis primary hepatic stellate cells (HSCs) TGF-¦Â1 treatment upregulated 29109031 3261 Mouse mmu-miR-23a-5p miRNA mycobacterium tuberculosis (Mtb) tuberculosis (TB) murine RAW264.7 cells Mycobacterium tuberculosis (M.tb) infection upregulated 28327409 3262 Mouse mmu-miR-23a-5p miRNA ganoderma lucidum extract (GLE) hepatocellular carcinoma (HCC) Hepa 1-6 cells Ganoderma lucidum extract (GLE) treatment upregulated 32106374 3263 Mouse mmu-miR-23b miRNA streptozocin (STZ) diabetic nephropathy (DN) C57BL/6J mice kindey streptozocin (STZ) treatment downregulated in peripheral blood 26839366 3264 Mouse mmu-miR-23b miRNA angiotensin II (Ang II) abdominal aortic aneurysm (AAA) mouse aortic vascular smooth muscle cell (VSMC); ApoE-/-?mouse aortas angiotensin II (Ang II) treatment The expression of miR-23b was significantly reduced in the aorta during the early onset of AAA in angiotensin II-treated ApoE-/-?mice and in human AAA samples. 33737086 3265 Mouse mmu-miR-23b miRNA lipopolysaccharide (LPS) acute aortic dissection (AAD) aorta lipopolysaccharide (LPS) treatment downregulated 32634201 3266 Mouse mmu-miR-23b miRNA lipopolysaccharide (LPS) acute lung injury (ALI) murine alveolar macrophage cell line MH-S lipopolysaccharide (LPS) treatment LPS treatment inhibited miR-23b expression 33415668 3267 Mouse mmu-miR-23b miRNA alcohol alcoholic liver fibrosis (ALF) mouse primary hepatic stellate cells alcohol treatment upregulated 29935035 3268 Mouse mmu-miR-23b miRNA TGF-¦Â1 asthma mouse airway smooth muscle cells (ASMCs) TGF-¦Â1 treatment upregulated 28062322 3269 Mouse mmu-miR-23b miRNA high glucose (HG) diabetic nephropathy (DN) kidney tissues of db/db mice high glucose (HG) treatment downregulated 26646104 3270 Mouse mmu-miR-23b miRNA myostatin cell differentiation C2C12 cells 1 ¦Ìg of recombinant myostatin dysregulated 28691106 3271 Mouse mmu-miR-23b miRNA TGF-¦Â epithelial-mesenchymal transition (EMT) MS-1 mouse pancreatic microvascular endothelial cells TGF-¦Â treatment upregulated 28338957 3272 Mouse mmu-miR-23b miRNA hemin neuroinflammation BV2 cells hemin treatment downregulated 31536904 3273 Mouse mmu-miR-23b miRNA bone morphogenetic protein 9 (BMP9) ossification C2C12 myoblasts bone morphogenetic protein 9 (BMP9) treatment downregulated 26820568 3274 Mouse mmu-miR-23b miRNA lipopolysaccharide (LPS) osteoarthritis (OA) ATDC5 cells lipopolysaccharide (LPS) treatment MiR-23b was downregulated after LPS treatment. 29922435 3275 Mouse mmu-miR-23b miRNA IL-17 osteoclastogenesis mouse primary kidney cells IL-17 treatment downregulated 22660635 3276 Mouse mmu-miR-23b miRNA lipopolysaccharide (LPS) osteogenesis preosteoblast MC3T3-E1 cells lipopolysaccharide (LPS) treatment downregulated 26961602 3277 Mouse mmu-miR-23b miRNA soluble egg antigen (SEA)of Schistosoma japonicum schistosomiasis mouse hepatocytes (AML12) SEA treatment downregulated 29469324 3278 Mouse mmu-miR-23b miRNA H2O2 spinal cord injury (SCI) BV2 cells H2O2 treatment Treatment of BV-2 cells with H2O2 decreased the levels of miR-23b. 31949662 3279 Mouse mmu-miR-23b miRNA retinoic acid (RA) rhinovirus 1B (RV1B) infection L929cells Retinoic acid treatment downregulated 21642441 3280 Mouse mmu-miR-23b miRNA ovalbumin (OVA) tolerogenic properties of dendritic cells Bone marrow-derived dendritic cells (BMDCs) ovalbumin (OVA) treatment upregulated 22229716 3281 Mouse mmu-miR-23b-3p miRNA high fat diet (HFD) insulin resistance (IR) soleus muscle tissues high fat diet (HFD) feed upregulated 31770568 3282 Mouse mmu-miR-23b-3p miRNA pioglitazone insulin resistance (IR) soleus muscle tissues pioglitazone (PGZ) treatment downregulated 31770568 3283 Mouse mmu-miR-23b-3p miRNA androgen muscle atrophy skeletal muscles androgen treatment downregulated 31958315 3284 Mouse mmu-miR-23b-3p miRNA paraquat (PQ) paraquat (PQ)-induced acute lung injury and pulmonary fibrosis MLE-12 cells paraquat (PQ) treatment downregulated 32741895 3285 Mouse mmu-miR-23b-3p miRNA dexamethasone (DEX) stress response mouse C2C12 myotubes dexamethasone (DEX) treatment downregulated 31138100 3286 Mouse mmu-miR-23b-5p miRNA hypoxia cardiac hypertrophy heart tissues thoracic aortic constriction (TAC) induce upregulated 31103821 3287 Mouse mmu-miR-23b-5p miRNA Jiang Tang Xiao Ke Granule diabetes mellitus (DM) liver tissues Jiang Tang Xiao Ke treatment downregulated 32210802 3288 Mouse mmu-miR-23b-5p miRNA cold obesity brown adipose tissue (BAT) cold treatment downregulated 33015181 3289 Mouse mmu-miR-24 miRNA heat stress ischemia/reperfusion (I/R) injury the hearts and livers tissue cells heat-shock (HS) "Mice subjected to cytoprotective heat-shock (HS) showed a significant increase of miRNA-1, miRNA-21 and miRNA-24 in the heart." 19041309 3290 Mouse mmu-miR-24 miRNA lipopolysaccharide (LPS) acute aortic dissection (AAD) aorta lipopolysaccharide (LPS) treatment downregulated 32634201 3291 Mouse mmu-miR-24 miRNA oxygen glucose deprivation (OGD) acute cerebral infarction mouse N2A neuroblastoma cells (N2A) oxygen-and-glucose-deprivation (OGD) treatment upregulated 24841240 3292 Mouse mmu-miR-24 miRNA ischemia/reperfusion (I/R) acute kidney injury (AKI) mouse kidney tissues ischemia/reperfusion (I/R) treatment upregulated 24854275 3293 Mouse mmu-miR-24 miRNA D-galactosamine/lipopolysaccharide (D-GalN/LPS) acute liver failure (ALF) mouse intraperitoneal injection of D-galactosamine/lipopolysaccharide (D-GalN/LPS) downregulated 29218090 3294 Mouse mmu-miR-24 miRNA alcohol alcoholic liver fibrosis (ALF) mouse primary hepatic stellate cells alcohol treatment upregulated 29935035 3295 Mouse mmu-miR-24 miRNA TGF-¦Â cardiac fibrosis cardiac fibroblasts (CFs) TGF-¦Â treatment upregulated 22260784 3296 Mouse mmu-miR-24 miRNA cholesterol cholesterol-induced inhibition of insulin secretion MIN6 cells cholesterol treatment upregulated 31173188 3297 Mouse mmu-miR-24 miRNA brucella.suis chronic brucella infection murine bone marrow derived macro- phages (BMDM) brucella infection Brucella infection upregulates miR-24. 33108406 3298 Mouse mmu-miR-24 miRNA streptozocin (STZ) diabetes mellitus (DM) hearts of diabetic mice streptozotocin (STZ) treatment upregulated 21584493 3299 Mouse mmu-miR-24 miRNA hyperglycemia diabetes mellitus (DM) plasma hyperglycemia treatment downregulated 25814526 3300 Mouse mmu-miR-24 miRNA high glucose (HG) diabetic nephropathy (DN) Mouse podocytes (MPC5) high glucose treatment downregulated 30095204 3301 Mouse mmu-miR-24 miRNA high-fat/high-cholesterol diet or a high-protein diet dyslipidemia DO mice a high-fat/high-cholesterol diet or a high-protein diet for 18 wk dysregulated 28916633 3302 Mouse mmu-miR-24 miRNA lipopolysaccharide (LPS) inflammation RAW 264.7 cells lipopolysaccharide (LPS) treatment dysregulated 24792623 3303 Mouse mmu-miR-24 miRNA ischemia myocardial ischaemic injury mouse cardiomyocytes ischemic pre-conditioning (IPC) treatment "IPC-induced miRNAs trigger cardioprotection similar to the delayed phase of IPC, possibly through upregulating eNOS, HSP70, and the HSP70 transcription factor HSF-1." 19213952 3304 Mouse mmu-miR-24 miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver high fat diet (HFD) feed microRNA-24 is significantly upregulated in the livers 24677249 3305 Mouse mmu-miR-24 miRNA high fat diet (HFD) obesity liver tissues high fat diet (HFD) feed upregulated 29787826 3306 Mouse mmu-miR-24 miRNA acetylcholine (ACh) peripheral nerve injury (PNI) hematopoietic stem cells (HSCs) acetylcholine (ACh) treatment "The therapeutic agents can thus be targeted to the enzyme protein, its encoding mRNA transcripts, or the regulator microRNA-132, opening new venues for therapeutic interference with multiple nervous and immune system diseases" 22448158 3307 Mouse mmu-miR-24 miRNA Staphylococcus aureus staphylococcus aureus infection mouse macrophage cell lines infect with S. aureus treatment downregulated 28303416 3308 Mouse mmu-miR-24-1 miRNA TGF-¦Â epithelial-mesenchymal transition (EMT) MS-1 mouse pancreatic microvascular endothelial cells TGF-¦Â treatment upregulated 28338957 3309 Mouse mmu-miR-24-1-5p miRNA black raspberry (BRB) anthocyanins colorectal cancer (CRC) colon tissue of azoxymethane/dextran sulphate sodium-induced mice black raspberry anthocyanins feed upregulated 30375302 3310 Mouse mmu-miR-24-2* miRNA H2O2 chronic inflammatory airway diseases RAW 264.7 cells H2O2 treatment downregulated 21350856 3311 Mouse mmu-miR-24-2-5p miRNA manganese (Mn) parkinson's disease (PD) MN9D dopaminergic cell exosomes Mn exposure (300¦ÌM MnCl2) for 24h upregulated in exosomes 28450057 3312 Mouse mmu-miR-24-3p miRNA leishmania major (MRHO/IR/75/ER) cutaneous Leishmaniasis (CL) RAW264.7 cells leishmania major (MRHO/IR/75/ER) treatment miR-24-3p was upregulated in L. major infectioned macrophages. 33082797 3313 Mouse mmu-miR-24-3p miRNA high glucose (HG) diabetic nephropathy (DN) Mouse mesangial cells (MCs) high glucose treatment downregulated 31680239 3314 Mouse mmu-miR-24-3p miRNA streptozocin (STZ) diabetic nephropathy (DN) kidney tissues streptozotocin treatment downregulated 31680239 3315 Mouse mmu-miR-24-3p miRNA hypoxia ischemia/reperfusion (I/R) injury mouse primary cardiomyocytes hypoxia induce downregulated 30622671 3316 Mouse mmu-miR-24-3p miRNA hypoxia ischemia/reperfusion (I/R) injury liver tissues "mice were ischemic for 1 h, and followed by reperfusion for 3, 6, 9, 12 h as needed." downregulated 31735332 3317 Mouse mmu-miR-24-3p miRNA Japanese encephalitis virus (JEV) Japanese encephalitis virus (JEV) infection brain tissues; BV2 cells Japanese encephalitis virus (JEV) infection downregulated 32552669 3318 Mouse mmu-miR-25 miRNA amyloid-¦Â (A¦Â) 1-42 Alzheimer's disease (AD) hippocampal tissues and cells amyloid ¦Â (A¦Â) peptide fragment 1 to 42 (A¦Â1-42) treatment upregulated 31144355 3319 Mouse mmu-miR-25 miRNA corticosterone apoptosis Primary mouse vascular smooth muscle cells (VSMCs) corticosterone (CORT) treatment downregulated 30992737 3320 Mouse mmu-miR-25 miRNA high glucose (HG) diabetic nephropathy (DN) mouse glomerular mesangial cells (MMCs) high glucose (HG) treatment upregulated 27941951 3321 Mouse mmu-miR-25 miRNA TGF-¦Â diabetic nephropathy (DN) mouse glomerular mesangial cells (MMCs) TGF-¦Â treatment upregulated 27941951 3322 Mouse mmu-miR-25 miRNA alcohol fetal alcohol spectrum disorders (FASD) brain tissues alcohol exposure downregulated 23580197 3323 Mouse mmu-miR-25 miRNA hypoxia heart failure (HF) heart tissues transverse aortic constriction (TAC) surgery upregulated 30771307 3324 Mouse mmu-miR-25 miRNA oxygen glucose deprivation (OGD) oxidative stress mouse retinal pigment epithelium (RPE) oxygen-and-glucose-deprivation (OGD) treatment upregulated 29210651 3325 Mouse mmu-miR-25 miRNA lipopolysaccharide (LPS) sepsis and septic shock blood cells LPS treatment upregulated 23395002 3326 Mouse mmu-miR-25 miRNA ginkgolide A (GA) sepsis-induced renal injury kidney tissues Ginkgolide A (GA) treatment The sepsis-induced decrease of miR-25 was enhanced by GA treatment. 33677255 3327 Mouse mmu-miR-25 miRNA lipopolysaccharide (LPS) sepsis-induced renal injury kidney tissues lipopolysaccharide (LPS) treatment The sepsis-induced decrease of miR-25 was enhanced by GA treatment. 33677255 3328 Mouse mmu-miR-25 miRNA laminectomy at the Th9 spinal vertebra spinal cord injury (SCI) spinal cords laminectomy at the Th9 spinal vertebra downregulated in injured spinal cords 28605990 3329 Mouse mmu-miR-25-3p miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) Primarily isolated coronary vascular endothelial cell (CVEC) oxidized low-density lipoprotein (ox-LDL) treatment downregulated 31632389 3330 Mouse mmu-miR-25-3p miRNA thrombin atherosclerosis (AS) peripheral blood platelet exosomes (PLT-Exo) thrombin treatment upregulated 31632389 3331 Mouse mmu-miR-25-3p miRNA oxygen glucose deprivation (OGD) myocardial infarction (MI) primary cardiomyocytes oxygen glucose deprivation (OGD) treatment downregulated 32371945 3332 Mouse mmu-miR-25-5p miRNA lipopolysaccharide (LPS) autophagy RAW 264.7 cells lipopolysaccharide (LPS) treatment downregulated 29845275 3333 Mouse mmu-miR-25-6p miRNA curcumin (Cur) nasopharyngeal carcinoma (NPC) mice injected into the tumour centre at a concentration of 150 mg/kg treatment dysregulated 24896104 3334 Mouse mmu-miR-26 miRNA "hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)" tumorigenesis brain and liver tissue cells "hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) treatment" downregulated 19270793 3335 Mouse mmu-miR-26 miRNA bushen yijing decoction (BSYJ) systemic sclerosis (SSc) skin tissues Bushen Yijing decoction (BSYJ)? treatment BSYJ-containing rat serum suppressed miR-26a expression 33843426 3336 Mouse mmu-miR-26a miRNA oxytocin (OT) "1-methyl-4-phenyl-1, 2, 3, 6- tetrahydropyridine (MPTP)-induced neurotoxicity" brain tissues Oxytocin (OXT) treatment The loss of miR-26a in MPTP mice 568 was fully restored by OXT 32083584 3337 Mouse mmu-miR-26a miRNA cisplatin (DDP) acute kidney injury (AKI) kidney tissues cisplatin treatment downregulated 31887787 3338 Mouse mmu-miR-26a miRNA H2O2 acute myocardial infarction (AMI) Neonatal mice cardiomyocytes (NMCMs) hydrogen peroxid (H2O2) treatment "forced expression of 2810403D21Rik/Mirf downregulated Mir26a to inhibit autophagy. In contrast, loss of 2810403D21Rik/Mirf resulted in upregulation of Mir26a to promote autophagy and alleviate cardiac injury, which in turn improved cardiac function in MI mice." 31512556 3339 Mouse mmu-miR-26a miRNA H2O2 acute myocardial infarction (AMI) primary neonatal mice ventricular cardiomyocytes H2O2 treatment MIRF contributed to cardiomyocyte apoptosis through modulating Bak1 by regulation of miR-26a. 32464547 3340 Mouse mmu-miR-26a miRNA high fat diet (HFD) acute myocardial infarction (AMI) liver tissue high fat diet (HFD) feed downregulated 19835573 3341 Mouse mmu-miR-26a miRNA estrogen (ES) antibody-mediated systemic autoimmunity B cells estrogen treatment downregulated 32265934 3342 Mouse mmu-miR-26a miRNA histone deacetylase inhibitors (HDIs) short-chain fatty acid (SCFA) butyrate antibody-mediated systemic autoimmunity B cells SCFA HDI butyrate treatment upregulated 32265934 3343 Mouse mmu-miR-26a miRNA borneol asthma CD4+ T cells isolated from the spleen of OVA-induced asthma mice borneol treatment Borneol inhibited CD4 + T cells infiltration in vivo and proliferation in vitro by downregulating miR-26a and miR-142-3p. 33272847 3344 Mouse mmu-miR-26a miRNA borneol asthma CD4 + T cells borneol treatment Borneol inhibited CD4 + T cells infiltration in vivo and proliferation in vitro by downregulating miR-26a and miR-142-3p. 33272847 3345 Mouse mmu-miR-26a miRNA ovalbumin (OVA) asthma lung tissues OVA (ovalbumin) treatment upregulated 31298396 3346 Mouse mmu-miR-26a miRNA high fat diet (HFD) atherosclerosis (AS) aortic intima high fat diet (HFD) feed downregulated 25801675 3347 Mouse mmu-miR-26a miRNA notoginsenoside R1 (NGR1) atherosclerosis (AS) serum;aorta notoginsenoside R1 (NGR2) treatment downregulated 24933211 3348 Mouse mmu-miR-26a miRNA bleomycin (BLM) idiopathic pulmonary fibrosis (IPF) C57BL/6 mice lung bleomycin (BLM) treatment downregulated 24594795 3349 Mouse mmu-miR-26a miRNA TGF-¦Â1 idiopathic pulmonary fibrosis (IPF) lung tissues; pulmonary fibroblasts TGF-¦Â1 treatment downregulated 29952219 3350 Mouse mmu-miR-26a miRNA puromycin autoimmune glomerulonephritis mouse podocytes puromycin treatment downregulated 25329154 3351 Mouse mmu-miR-26a miRNA bleomycin (BLM) lung injury lung tissues bleomycin (BLM) treatment Lung miR-26a was significantly decreased 7 days after bleomycin injury. 30024304 3352 Mouse mmu-miR-26a miRNA ginsenoside Rg3 male hypogonadism MLTC-1 cells Ginsenoside Rg3 treatment downregulated 31296984 3353 Mouse mmu-miR-26a miRNA triptolide (TPL) male hypogonadism MLTC-1 cells triptolide (TPL) treatment upregulated 31296984 3354 Mouse mmu-miR-26a miRNA RANKL (receptor activator of nuclear factor ¦ÊB ligand) cell differentiation Murine osteoclasts RANKL ischemia-reperfusion (I/R) treatment upregulated 25518928 3355 Mouse mmu-miR-26a miRNA bupivacaine nerve injury mouse dorsal root ganglia (DRG) neurons bupivacaine treatment downregulated 25808510 3356 Mouse mmu-miR-26a miRNA A23187 nonalcoholic fatty liver disease (NAFLD) Murine primary hepatocytes (MPHs) A23187 treatment upregulated 32567701 3357 Mouse mmu-miR-26a miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver tissues high fat diet (HFD) treatment upregulated 32567701 3358 Mouse mmu-miR-26a miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver tissues high fat diet (HFD) feed "Combining miRNA dot blot array and quantitative PCR, we find that miR-26a is specifically induced by ER stress in liver cells." 32567701 3359 Mouse mmu-miR-26a miRNA oleic acid (OA) nonalcoholic fatty liver disease (NAFLD) Murine primary hepatocytes (MPHs) oleate acid (OA) treatment upregulated 32567701 3360 Mouse mmu-miR-26a miRNA palmitic acid (PA) nonalcoholic fatty liver disease (NAFLD) Murine primary hepatocytes (MPHs) palmitate acid (PA) treatment upregulated 32567701 3361 Mouse mmu-miR-26a miRNA thapsigargin (Tg) nonalcoholic fatty liver disease (NAFLD) Murine primary hepatocytes (MPHs) thapsigargin (Tg) treatment upregulated 32567701 3362 Mouse mmu-miR-26a miRNA tunicamycin (TM) nonalcoholic fatty liver disease (NAFLD) Murine primary hepatocytes (MPHs) tunicamycin (Tu) treatment upregulated 32567701 3363 Mouse mmu-miR-26a miRNA streptozocin (STZ) nonalcoholic steatohepatitis-hepatocellular carcinoma (NASH-HCC) high fat dietmouse liver STZ treatment upregulated in liver 28345673 3364 Mouse mmu-miR-26a miRNA high fat diet (HFD) obesity adipose tissue high fat diet (HFD) feed downregulated 31488578 3365 Mouse mmu-miR-26a miRNA polyinosinic-polycytidilic acid (Poly(I:C)) orchitis testicular cells poly I:C treatment downregulated 31195953 3366 Mouse mmu-miR-26a miRNA metformin (Met) pancreatic cancer (PC) human pancreatic cancer cells metformin treatment upregulated 22245693 3367 Mouse mmu-miR-26a miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) substantia nigra "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" downregulated 30718039 3368 Mouse mmu-miR-26a miRNA Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria plasmodium chabaudi infection Balb/c Mice liver infect with Vaccination treatment downregulated in the Liver 28123381 3369 Mouse mmu-miR-26a miRNA cecal ligation and puncture (CLP) sepsis whole blood cecal ligation and puncture (CLP) treatment upregulated 24205035 3370 Mouse mmu-miR-26a miRNA high fat diet (HFD) type 2 diabetes mellitus (T2DM) mouse serum and islets high fat diet (HFD) feed downregulated in the serum and islets 29191656 3371 Mouse mmu-miR-26a miRNA high fat diet (HFD) type 2 diabetes mellitus (T2DM) serum and islets high fat diet (HFD) feed downregulated 29191656 3372 Mouse mmu-miR-26a miRNA whole grain highland barley (WGH) type 2 diabetes mellitus (T2DM) liver tissues whole grain highland barley (WGH) treatment upregulated 33104141 3373 Mouse mmu-miR-26a-1 miRNA streptozocin (STZ) nonalcoholic steatohepatitis-hepatocellular carcinoma (NASH-HCC) high fat dietmouse liver STZ treatment upregulated in liver 28345673 3374 Mouse mmu-miR-26a-5p miRNA histone deacetylase inhibitor (HDACi) B cell differentiation B cells of C57BL/6J "stimulated with LPS and IL-4 and treated with HDI (VPA, 500 ?M) or nil for 60 h" upregulated 28994753 3375 Mouse mmu-miR-26a-5p miRNA high glucose (HG) diabetic nephropathy (DN) MP5 cells high glucose (HG) treatment downregulated 32580945 3376 Mouse mmu-miR-26a-5p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) ischemic stroke (IS) neuro-2A (N2a) neuroblastoma cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 30703362 3377 Mouse mmu-miR-26a-5p miRNA hypoxia/reoxygenation (H/R) myocardial ischemia/reperfusion (I/R) injury (MIRI) primary cardiomyocytes hypoxia/reoxygenation (H/R) treatment downregulated 31994603 3378 Mouse mmu-miR-26b miRNA isoproterenol cardiac fibrosis cardiac tissues; cardiac fibroblasts (CFs) isoprenaline (ISO) tteatment downregulated 33209126 3379 Mouse mmu-miR-26b miRNA angiotensin II (Ang II) cardiac hypertrophy neonatal mouse ventricular cardiomyocytes angiotensin II (Ang II) treatment downregulated 31966813 3380 Mouse mmu-miR-26b miRNA pectin (fermented to butyrate in the colon) (FPA) colon tumorigenesis colonic stem cells (fermented to butyrate in the colon) (FPA) treatment upregulated 26493444 3381 Mouse mmu-miR-26b miRNA azoxymethane (AOM) colorectal cancer (CRC) plasma and colon tissues azoxymethane (AOM) treatment downregulated 30311185 3382 Mouse mmu-miR-26b miRNA lactobacillus acidophilus and bifidobacterium bifidum probiotics colorectal cancer (CRC) plasma and colon tissues from azoxymethane (AOM)-treated mice Lactobacillus acidophilus and Bifidobacterium bifidum probiotics treatment upregulated 30311185 3383 Mouse mmu-miR-26b miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) ischemic stroke (IS) brain microvascular endothelial cell (BMEC) of C57BL/6J mice oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 28433650 3384 Mouse mmu-miR-26b miRNA arsenite liver fibrosis mouse liver tissues arsenite exposure microRNA-26b is the target regulatory point of MALAT1 31513886 3385 Mouse mmu-miR-26b miRNA hypoxia pulmonary hypertension (PH) mouse PASMCs hypoxia treatment downregulated 28816418 3386 Mouse mmu-miR-26b miRNA cecal ligation and puncture (CLP) sepsis whole blood cecal ligation and puncture (CLP) treatment upregulated 24205035 3387 Mouse mmu-miR-26b-3p miRNA bone morphogenetic protein 2 (BMP2) cell differentiation MC3T3-E1 cells bone morphogenetic protein 2 (BMP2) treatment downregulated 29981839 3388 Mouse mmu-miR-26b-3p miRNA bone morphogenetic protein 2 (BMP2) cell differentiation MC3T3-E1 cells bone morphogenetic protein 2 (BMP2) treatment downregulated 29981839 3389 Mouse mmu-miR-26b-3p miRNA oxygen glucose deprivation (OGD) myocardial infarction (MI) primary cardiomyocytes oxygen glucose deprivation (OGD) treatment downregulated 32371945 3390 Mouse mmu-miR-26b-5p miRNA angiotensin II (Ang II) cardiac hypertrophy neonatal mouse ventricular cardiomyocytes (NMVCs) angiotensin II (Ang II) treatment miR-26b-5p was markedly decreased in NMVCs with overexpression of circRNA_000203. 31397837 3391 Mouse mmu-miR-26b-5p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral ischemia/reperfusion (I/R) injury Mouse N2a neuroblastoma cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 31751592 3392 Mouse mmu-miR-26b-5p miRNA perfluorooctanoic acid hepatotoxicity liver tissues Perfluorooctanoic acid (PFOA) exposure treatment upregulated 24459700 3393 Mouse mmu-miR-26b-5p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) intestinal hypoxia/reoxygenation injury intestinal mucosa oxygen-glucose deprivation and reoxygenation (OGD/R) treatment We found that the expression of miR-26b-5p in intestinal mucosa was markedly decreased during I/R injury 33839982 3394 Mouse mmu-miR-26b-5p miRNA methionine-choline-deficient and high-fat diet (MCDHF) liver fibrosis PDGFR-¦Â+ cells in the mouse fibrotic liver methionine-choline-deficient and high-fat (MCDHF) diet treatment downregulated 30901579 3395 Mouse mmu-miR-26b-5p miRNA hypoxia phenotypic switching of VSMCs mouse vascular smooth muscle cells(mVSMCs) hypoxia treatment downregulated 28487943 3396 Mouse mmu-miR-27 miRNA flavonoid derivative (Fla-CN) adipogenesis 3T3-L1 cells Fla-CN treatment upregulated 28088385 3397 Mouse mmu-miR-27 miRNA persimmon tannin adipogenesis 3T3-L1 preadipocytes persimmon tannin treatment upregulated 25510894 3398 Mouse mmu-miR-27 miRNA tumor necrosis factor alpha (TNF-¦Á) adipogenesis mouse embryonic fibroblast-derived 3T3-L1 preadipocytes tumor necrosis factor alpha (TNF-¦Á) treatment upregulated 24903074 3399 Mouse mmu-miR-27 miRNA laser angiogenesis endothelial cells and highly vascularized tissues laser treatment upregulated 21536891 3400 Mouse mmu-miR-27 miRNA high fat diet (HFD) atherosclerosis (AS) ApoE-/- mice serum high fat diet (HFD) feed downregulated 30041636 3401 Mouse mmu-miR-27 miRNA xanthomicrol breast cancer 4T1 cells xanthomicrol treatment downregulated 33217075 3402 Mouse mmu-miR-27 miRNA IL-1¦Â and IFN-¦Ã cytomegalovirus infection NIH-3T3;SVEC4-10;C127;TCMK-1 cells;Bone marrow-derived macrophages cytomegalovirus infection downregulated 20047990 3403 Mouse mmu-miR-27 miRNA granulocyte colony-stimulating factor (CSF3) cell differentiation 32D.cl3 cell granulocyte colony-stimulating factor (CSF3) treatment upregulated 19298589 3404 Mouse mmu-miR-27 miRNA cold metabolic disease mouse BAT and subcutaneous white adipose tissue (SAT) cold exposure treatment downregulated 24238035 3405 Mouse mmu-miR-27 miRNA extra-virgin olive oil rich in phenols (H-EVOO) neuronal function cortex H-EVOO treatment upregulated 26695409 3406 Mouse mmu-miR-27 miRNA flavonoid derivative (Fla-CN) obesity liver and adipose Fla-CN treatment upregulated 26598088 3407 Mouse mmu-miR-27-3p miRNA cigarette smoke (CS) chronic obstructive pulmonary disease (COPD) alveolar macrophages (AMs) and the lung tissues cigarette smoke (CS) exposure upregulated 29572385 3408 Mouse mmu-miR-27-3p miRNA lipopolysaccharide (LPS) chronic obstructive pulmonary disease (COPD) alveolar macrophages (AMs) and the lung tissues lipopolysaccharide (LPS) treatment upregulated 29572385 3409 Mouse mmu-miR-27-3p miRNA andrographolide osteoarthritis (OA) primary chondrocytes andrographolide (And) treatment "miR-27-3p was significant decrease in the mice with OA, but And treatment reversed OA-induced the downregulated of miR-27-3p." 32196852 3410 Mouse mmu-miR-27a miRNA red mud biological effects of red mud "CBA/Ca mice liver, spleen, lung, kidney and lymph nodes" "1, 3, 6 and 24 h after a single intraperitoneal injection of red mud treatment" "upregulated , but the level and the peak of the alteration differed according to examined tissue" 24425836 3411 Mouse mmu-miR-27a miRNA lipopolysaccharide (LPS) acute aortic dissection (AAD) aorta lipopolysaccharide (LPS) treatment downregulated 32634201 3412 Mouse mmu-miR-27a miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues lipopolysaccharide (LPS) treatment downregulated 30231673 3413 Mouse mmu-miR-27a miRNA lipopolysaccharide (LPS) acute lung injury (ALI) mouse lung tissues lipopolysaccharide (LPS) treatment downregulated 31173183 3414 Mouse mmu-miR-27a miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues; bronchoalveolar lavage fluid (BALF); splenocytes lipopolysaccharide (LPS) treatment downregulated 31938423 3415 Mouse mmu-miR-27a miRNA sevoflurane (SEV) acute lung injury (ALI) LPS-induced mice lung tissues sevoflurane treatment upregulated 31173183 3416 Mouse mmu-miR-27a miRNA CoCl2 adipogenesis murine preadipocyte 3T3-L1 cells CoCl2 treatment upregulated 27939617 3417 Mouse mmu-miR-27a miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) RAW264.7 macrophage oxidized low-density lipoprotein (ox-LDL) treatment downregulated 31518965 3418 Mouse mmu-miR-27a miRNA angiotensin II (Ang II) cardiovascular disease (CVD) Primary vascular smooth muscle cells (VSMCs) angiotensin II (Ang II) treatment upregulated 30654940 3419 Mouse mmu-miR-27a miRNA leucine cell proliferation The mouse myoblast cell line C2C12 (CRL-1772) Leucine treatment upregulated 23880856 3420 Mouse mmu-miR-27a miRNA resistance exercise training chronic kidney disease (CKD) CKD mice muscle overload treatment upregulated 28400445 3421 Mouse mmu-miR-27a miRNA curcumin and 3 acetyl-11-keto-¦Â-boswellic acid (AKBA) colorectal cancer (CRC) colorectal cancer cells curcumin and 3 acetyl-11-keto-¦Â-boswellic acid (AKBA) treatment downregulated 25712055 3422 Mouse mmu-miR-27a miRNA chronic social defeat stress (CSDS) depression serum or hippocampus chronic social defeat stress (CSDS) induce downregulated 33402173 3423 Mouse mmu-miR-27a miRNA isoliquiritin depression hippocampus of LPS-treated mice isoliquiritin treatment upregulated 33402173 3424 Mouse mmu-miR-27a miRNA isoliquiritin depression hippocampus of chronic social defeat stress (CSDS)-induced mice isoliquiritin treatment upregulated 33402173 3425 Mouse mmu-miR-27a miRNA lipopolysaccharide (LPS) depression serum or hippocampus lipopolysaccharide (LPS) treatment downregulated 33402173 3426 Mouse mmu-miR-27a miRNA high glucose (HG) diabetic embryopathy C17.2 mouse neural stem cells high glucose diet upregulated 29100869 3427 Mouse mmu-miR-27a miRNA high glucose (HG) diabetic nephropathy (DN) murine podocyte cell line high glucose(30?mM) upregulated 28277542 3428 Mouse mmu-miR-27a miRNA high-fat/high-cholesterol diet or a high-protein diet dyslipidemia DO mice a high-fat/high-cholesterol diet or a high-protein diet for 18 wk dysregulated 28916633 3429 Mouse mmu-miR-27a miRNA lithocholic acid (LCA) glutathione synthesis and antioxidant capacity Huh-7 cells lithocholic acid (LCA) treatment upregulated 25226451 3430 Mouse mmu-miR-27a miRNA hypoxia hepatic ischemia/reperfusion injury (HIRI) AML12 cells hypoxia induce upregulated 31485635 3431 Mouse mmu-miR-27a miRNA high fat diet (HFD) hepatocellular carcinoma (HCC) plasma and hepatic tissues high fat diet (HFD) feed upregulated 26728044 3432 Mouse mmu-miR-27a miRNA cerasus humilis polyphenol (CHP) HFD-induced obesity retroperitoneal white adipocytes cerasus humilis polyphenol (CHP) treatment CHP significantly inhibited the expression of miR-27a/b in mice retroperitoneal white adipocytes. 32227855 3433 Mouse mmu-miR-27a miRNA lipopolysaccharide (LPS) inflammation BMDMs lipopolysaccharide (LPS) treatment downregulated 24835395 3434 Mouse mmu-miR-27a miRNA high fat diet (HFD) obesity male C57BL/6 J mice serum high fat diet (HFD) feed upregulated 28365247 3435 Mouse mmu-miR-27a miRNA mycobacterium avium subspecies paratuberculosis (MAP) innate immune response "RAW264.7 and bone marrow-derived macrophage in vitro, intestine and spleen tissues in vivo" Mycobacterium avium subspecies paratuberculosis (MAP) infection downregulated 29375563 3436 Mouse mmu-miR-27a miRNA Pam3Cys-Ser-(Lys)4 [PAM toll-like receptor (TLR)1/2 agonist] innate immune response RAW264.7 and bone marrow-derived macrophage Pam3Cys-Ser-(Lys)4 [PAM toll-like receptor (TLR)1/2 agonist] treatment downregulated 29375563 3437 Mouse mmu-miR-27a miRNA high fat diet (HFD) insulin resistance (IR) "pancreas, liver, and white adipose tissue" high fat diet (HFD) feed upregulated 31562809 3438 Mouse mmu-miR-27a miRNA tumor necrosis factor alpha (TNF-¦Á) insulin resistance (IR) 3T3-L1 cells tumor necrosis factor alpha (TNF-¦Á) treatment upregulated 31562809 3439 Mouse mmu-miR-27a miRNA high fructose lipid metabolism hepatic tissues High fructose feed upregulated 31030166 3440 Mouse mmu-miR-27a miRNA lipopolysaccharide (LPS) liver damage liver tissues lipopolysaccharide (LPS) treatment "miR-27a was approximately 5-fold downregulated in LPS group, compared with the sham group." 29156532 3441 Mouse mmu-miR-27a miRNA lipopolysaccharide (LPS) and paclitaxel liver damage liver tissues lipopolysaccharide (LPS) and paclitaxel treatment "when paclitaxel was applied to septic mice (paclitaxel + LPS group), an approximately 4-fold increase of miR-27a was observed when compared with LPS group." 29156532 3442 Mouse mmu-miR-27a miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver tissues high fat diet (HFD) feed upregulated 31889412 3443 Mouse mmu-miR-27a miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver tissues high fat diet (HFD) feed upregulated 31889412 3444 Mouse mmu-miR-27a miRNA berberine (BBR) obesity 3T3-L1 cells berberine (BBR) treatment upregulated 27484069 3445 Mouse mmu-miR-27a miRNA high fat diet (HFD) obesity "serum, skeletal muscle" high fat diet (HFD) feed upregulated 29721071 3446 Mouse mmu-miR-27a miRNA palmitate obesity 3T3-L1 adipocytes palmitate treatment upregulated 29721071 3447 Mouse mmu-miR-27a miRNA persimmon tannin obesity 3T3-L1 preadipocytes Persimmon tannin treatment upregulated 25510894 3448 Mouse mmu-miR-27a miRNA Satb2 osteoblast differentiation and bone formation bone marrow stromal cells (BMSCs) Satb2 treatment downregulated 27142530 3449 Mouse mmu-miR-27a miRNA ¦Â-elemene oxygen-induced retinopathy (OIR) Retinas tissues ¦Â-elemene treatment upregulated 30664207 3450 Mouse mmu-miR-27a miRNA Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria plasmodium chabaudi infection Balb/c Mice liver infect with Vaccination treatment downregulated in the Liver 28123381 3451 Mouse mmu-miR-27a miRNA hypoxia pulmonary hypertension (PH) mouse lung tissues hypoxia treatment downregulated 24244514 3452 Mouse mmu-miR-27a miRNA Fc sepsis LPS induced sepsis mice model Fc treatment downregulated 26171875 3453 Mouse mmu-miR-27a miRNA laparotomy and exposure of the junc_x0002_tion between the large and small intestines sepsis mouse large and small intestines laparotomy and exposure of the junc_x0002_tion between the large and small intestines treatment upregulated 25043848 3454 Mouse mmu-miR-27a miRNA lipopolysaccharide (LPS) sepsis liver tissues lipopolysaccharide (LPS) treatment downregulated 29156532 3455 Mouse mmu-miR-27a miRNA paclitaxel (PTX) sepsis mouse liver tissues paclitaxel treatment upregulated 29156532 3456 Mouse mmu-miR-27a miRNA controlled cortical impact (CCI) traumatic brain injury (TBI) mouse brain controlled cortical impact (CCI) downregulated 25057207 3457 Mouse mmu-miR-27a miRNA high glucose (HG) type 1 diabetic embryopathy C17.2 neural stem cells High-glucose treatment upregulated 29100869 3458 Mouse mmu-miR-27a miRNA streptozocin (STZ) type 1 diabetic embryopathy embryos on embryonic day 8.5 from diabetic dams streptozotocin (STZ) treatment upregulated 29100869 3459 Mouse mmu-miR-27a* miRNA H2O2 chronic inflammatory airway diseases RAW 264.7 cells H2O2 treatment downregulated 21350856 3460 Mouse mmu-miR-27a* miRNA lipopolysaccharide (LPS) macrophage inflammatory response RAW264.7 macrophage cells lipopolysaccharide (LPS) treatment downregulated 22415194 3461 Mouse mmu-miR-27a-3p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral infarction (CI) HT22 cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment "Circ_HECTD1 and FSTL1 were highly expressed, and miR-27a-3p was decreased in OGD/R-treated HT22 cells" 33843447 3462 Mouse mmu-miR-27a-3p miRNA high glucose (HG) diabetic nephropathy (DN) podocytes high glucose (HG) treatment 4930556M19Rik overexpression slowed HG-induced podocyte injury by downregulating miR-27a-3p and upregulating TIMP3. 32896839 3463 Mouse mmu-miR-27a-3p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) ischemic stroke (IS) HT22 cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment MiR-27a-3p was downregulated in OGD/R-treated HT22 cells 33875617 3464 Mouse mmu-miR-27a-3p miRNA Japanese encephalitis virus (JEV) Japanese encephalitis virus (JEV) infection brain tissues; BV2 cells Japanese encephalitis virus (JEV) infection downregulated 32552669 3465 Mouse mmu-miR-27a-3p miRNA leptin liver fibrosis primary cultured hepatic stellate cell (HSC) leptin treatment upregulated 29548749 3466 Mouse mmu-miR-27a-3p miRNA sevoflurane (SEV) neurotoxicity neonatal mice sevoflurane treatment upregulated 28881034 3467 Mouse mmu-miR-27a-3p miRNA brown rice obesity serum; white adipose tissue (WAT); lleum brown rice treatment downregulated 32975270 3468 Mouse mmu-miR-27a-3p miRNA brown rice obesity liver tissues brown rice treatment upregulated 32975270 3469 Mouse mmu-miR-27a-3p miRNA high fat diet (HFD) obesity liver tissues high fat diet (HFD) feed upregulated 32593682 3470 Mouse mmu-miR-27a-3p miRNA whole grain diets obesity serum; white adipose tissue (WAT); lleum whole grain diets treatment downregulated 32975270 3471 Mouse mmu-miR-27a-3p miRNA whole grain diets obesity liver tissues whole grain diets treatment upregulated 32975270 3472 Mouse mmu-miR-27a-3p miRNA melatonin protecting neural stem cells (NSCs) from reactive oxygen species (ROS) neural stem cells Melatonin treatment melatonin appeared to protect NSCs from H2O2-induced ROS by modification of the MEG3/miRNA-27a-3p/MAP2K4 axis. 32599124 3473 Mouse mmu-miR-27a-3p miRNA H2O2 spinal cord injury (SCI) C8-D1A and C8-B4 cells hydrogen peroxide (H2O2) treatment downregulated 30229811 3474 Mouse mmu-miR-27a-5p miRNA streptozocin (STZ) diabetic retinopathy (DR) retina and serum of diabetic mice streptozotocin treatment upregulated 30883703 3475 Mouse mmu-miR-27a-5p miRNA lipopolysaccharide (LPS) inflammation RAW 264.7 cells lipopolysaccharide (LPS) treatment dysregulated 24792623 3476 Mouse mmu-miR-27b miRNA lipopolysaccharide (LPS) acute lung injury (ALI) bronchoalveolar lavage fluid (BALF) lipopolysaccharides (LPS) treatment upregulated 30584668 3477 Mouse mmu-miR-27b miRNA CoCl2 adipogenesis murine preadipocyte 3T3-L1 cells CoCl2 treatment upregulated 27939617 3478 Mouse mmu-miR-27b miRNA alcohol alcoholic liver fibrosis (ALF) mouse primary hepatic stellate cells alcohol treatment upregulated 29935035 3479 Mouse mmu-miR-27b miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) RAW264.7 macrophage oxidized low-density lipoprotein (ox-LDL) treatment downregulated 31518965 3480 Mouse mmu-miR-27b miRNA palmitic acid (PA) atrial arrhythmia atrial cardiomyocytes palmitic acid (PA) treatment upregulated 26654778 3481 Mouse mmu-miR-27b miRNA angiotensin II (Ang II) atrial fibrosis left atrium angiotensin II (Ang II) treatment The expression of miR-27b was significantly reduced after angiotensin II (AngII) infusion. 29671258 3482 Mouse mmu-miR-27b miRNA angiotensin II (Ang II) cardiac hypertrophy primary neonatal mouse cardiomyocytes (NMCMs) angiotensin II (Ang II) treatment MiR-27b was downregulated in cardiomyocyte was subjected to AngII treatment. 32439330 3483 Mouse mmu-miR-27b miRNA interleukin-1 receptor antagonist protein (IRAP) cartilage impact injury porcine knee joint Interleukin-1 Receptor Antagonist Protein (IRAP) treatment upregulated 26521750 3484 Mouse mmu-miR-27b miRNA dexamethasone (DEX) central fat accumulation primary SVF cells derived from mouse SAT and VAT dexamethasone (DEX) treatment upregulated 25187367 3485 Mouse mmu-miR-27b miRNA IFN-¦Ã chronic inflammatory diseases liver epithelial cells IFN-¦Ãtreatment downregulated 26631623 3486 Mouse mmu-miR-27b miRNA cerulein chronic pancreatitis (CP) pancreas cerulein treatment downregulated 29303912 3487 Mouse mmu-miR-27b miRNA streptozocin (STZ) critical limb ischemia (CLI) in diabetes mellitus ischemic hindlimbs streptozotocin (STZ) treatment downregulated 30972183 3488 Mouse mmu-miR-27b miRNA nitric oxide (NO) duchenne muscular dystrophy (DMD) FAP cells nitric oxide (NO) treatment upregulated 24170326 3489 Mouse mmu-miR-27b miRNA TGF-¦Â epithelial-mesenchymal transition (EMT) MS-1 mouse pancreatic microvascular endothelial cells TGF-¦Â treatment upregulated 28338957 3490 Mouse mmu-miR-27b miRNA complement C3a focal segmental glomerulosclerosis (FSGS) tubular cells C3a treatment downregulated 30679767 3491 Mouse mmu-miR-27b miRNA lithocholic acid (LCA) glutathione synthesis and antioxidant capacity Huh-7 cells lithocholic acid (LCA) treatment upregulated 25226451 3492 Mouse mmu-miR-27b miRNA cerasus humilis polyphenol (CHP) HFD-induced obesity retroperitoneal white adipocytes cerasus humilis polyphenol (CHP) treatment CHP significantly inhibited the expression of miR-27a/b in mice retroperitoneal white adipocytes. 32227855 3493 Mouse mmu-miR-27b miRNA mycobacterium tuberculosis (Mtb) innate immune response murine BMDMs and macrophage-like RAW264.7 cells Mycobacterium tuberculosis infection upregulated 29661829 3494 Mouse mmu-miR-27b miRNA high fat diet (HFD) insulin resistance (IR) Epididymal white adipose tissue (eWAT) high fat diet (HFD) feed upregulated 29455245 3495 Mouse mmu-miR-27b miRNA insulin insulin resistance (IR) The mouse 3T3-L1 preadipocyte cell line insulin treatment upregulated 29455245 3496 Mouse mmu-miR-27b miRNA ischemic brain extract (IBE) ischemic injury Neuro-2a mouse neuronal cells IBE treatment downregulated 24999036 3497 Mouse mmu-miR-27b miRNA ionizing radiation (IR) leukemia C57BL/6 mouse thymus tissue IR treatment downregulated 24974217 3498 Mouse mmu-miR-27b miRNA berberine (BBR) obesity 3T3-L1 cells berberine (BBR) treatment upregulated 27484069 3499 Mouse mmu-miR-27b miRNA persimmon tannin obesity 3T3-L1 preadipocytes Persimmon tannin treatment upregulated 25510894 3500 Mouse mmu-miR-27b miRNA puromycin aminonucleoside (PAN) podocyte protection non-human primates (NHPs) puromycin aminonucleoside (PAN) treatment "In NHP primary podocyte culture, significant downregulated of miR-27b was observed during treatment of puromycin aminonucleoside (PAN), a classic nephrotoxin" 30429458 3501 Mouse mmu-miR-27b miRNA ginsenoside Rb1 adipogenesis 3T3-L1 cells Ginsenoside-Rb1? treatment downregulated 22893262 3502 Mouse mmu-miR-27b miRNA soluble egg antigen (SEA)of Schistosoma japonicum schistosomiasis mouse hepatocytes (AML12) SEA treatment downregulated 29469324 3503 Mouse mmu-miR-27b miRNA methylglyoxal (MGO) type 2 diabetes mellitus (T2DM) mouse bone marrow progenitor cell (BMPCs ) 24 h of exposure to methylglyoxal (MGO) or oxidized low-density lipoprotein downregulated 28698281 3504 Mouse mmu-miR-27b miRNA oxidized low density lipoprotein (ox-LDL) type 2 diabetes mellitus (T2DM) mouse bone marrow progenitor cell (BMPCs ) oxidized low-density lipoprotein (ox-LDL) treatment downregulated 28698281 3505 Mouse mmu-miR-27b miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues lipopolysaccharide (LPS) treatment upregulated 30584668 3506 Mouse mmu-miR-27b miRNA cryptosporidium parvum cryptosporidium parvum infection biliary epithelial cells cryptosporidium parvum? infection upregulated 22615562 3507 Mouse mmu-miR-27b* miRNA H2O2 chronic inflammatory airway diseases RAW 264.7 cells H2O2 treatment downregulated 21350856 3508 Mouse mmu-miR-27b-3p miRNA reconstituted high-density lipoproteins (rHDL) diabetes-impaired angiogenesis diabetic mice HDL fraction reconstituted high-density lipoproteins (rHDL) treatment upregulated 30206364 3509 Mouse mmu-miR-27b-3p miRNA reconstituted high-density lipoproteins (rHDL) diabetes-impaired angiogenesis diabetic mice plasma reconstituted high-density lipoproteins (rHDL) treatment downregulated 30206364 3510 Mouse mmu-miR-27b-3p miRNA high glucose (HG) diabetic nephropathy (DN) mice mesangial cells high glucose (HG) treatment downregulated 30549040 3511 Mouse mmu-miR-27b-3p miRNA high glucose (HG) diabetic nephropathy (DN) mice mesangial cells high glucose (HG) treatment miR-27b-3p was decreased in high-glucose-induced mice mesangial cells. 30549040 3512 Mouse mmu-miR-27b-3p miRNA streptozocin (STZ) diabetic retinopathy (DR) retina and serum of diabetic mice streptozotocin treatment upregulated 30883703 3513 Mouse mmu-miR-27b-3p miRNA Rg3-enhanced red ginseng extract (Rg3E) endometriosis endometriosis mose endometriotic tissue 8 weeks of Rg3E treatment downregulated in endometriotic tissue 29247225 3514 Mouse mmu-miR-27b-3p miRNA high glucose (HG) epithelial-mesenchymal transition (EMT) mice mesangial cells high glucose (HG) treatment downregulated 30549040 3515 Mouse mmu-miR-27b-3p miRNA high glucose (HG) fibrosis mice mesangial cells high glucose (HG) treatment downregulated 30549040 3516 Mouse mmu-miR-27b-3p miRNA leptin liver fibrosis primary cultured hepatic stellate cell (HSC) leptin treatment upregulated 29548749 3517 Mouse mmu-miR-27b-3p miRNA "15-deoxy-¦¤12, 14-prostaglandin J2 (15d-PGJ2)" liver damage bone marrow (BM)-derived macrophage (BMM) of liver injury mouse "15-deoxy-¦¤12, 14-prostaglandin J2 (15d-PGJ2) treatment" upregulated 28748390 3518 Mouse mmu-miR-27b-3p miRNA retinoic acid (RA) myogenic hypoplasia C2C12 cells retinoic acid (RA) treatment upregulated 27889377 3519 Mouse mmu-miR-27b-3p miRNA retinoic acid (RA) myogenic hypoplasia C2C12 cells retinoic acid (RA) treatment upregulated 27889377 3520 Mouse mmu-miR-27b-3p miRNA high fat diet (HFD) obesity mice epididymal white adipose tissue (eWAT) high fat diet (HFD) feed upregulated 30778336 3521 Mouse mmu-miR-27b-5p miRNA ¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) experimental autoimmune encephalomyelitis (EAE) murine brain-derived CD4+ T cells ¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) combination treatment downregulated 31497013 3522 Mouse mmu-miR-28 miRNA H2O2 cardiovascular disease (CVD) cardiomyocytes H2O2 treatment upregulated 26364613 3523 Mouse mmu-miR-281 miRNA platelet derived growth factor-BB (PDGF-BB) pulmonary arterial hypertension (PAH) pulmonary artery smooth muscle cells (PASMCs) platelet-derived growth factor (PDGF)-BB treatment downregulated 29514810 3524 Mouse mmu-miR-28-5p miRNA perfluorooctanoic acid hepatotoxicity liver tissues Perfluorooctanoic acid (PFOA) exposure treatment upregulated 24459700 3525 Mouse mmu-miR-28-5p miRNA dexamethasone (DEX) stress response mouse C2C12 myotubes dexamethasone (DEX) treatment downregulated 31138100 3526 Mouse mmu-miR-2861 miRNA Silica nanoparticles (SiNPs) apoptosis Primary mouse spermatocyte cells (GC-2spd) SiNPs treatment "SiNPs could cause apoptosis of spermatocyte cells by inhibiting the expression of miRNA-2861, thereby resulting in the upregulation of mRNA expression of fas/fasl/ripk1 and activating the death receptor pathway of spermatocyte cells" 31071558 3527 Mouse mmu-miR-28a-5p miRNA prostaglandin E2 (PGE2) liver fibrosis TGF-¦Â1-treated primary hepatic stellate cells (HSCs) PGE2 treatment downregulated 29109031 3528 Mouse mmu-miR-28a-5p miRNA TGF-¦Â1 liver fibrosis primary hepatic stellate cells (HSCs) TGF-¦Â1 treatment upregulated 29109031 3529 Mouse mmu-miR-29 miRNA bleomycin (BLM) apoptosis lung tissues bleomycin (BLM) treatment miR-29 was a downstream target gene of Smad3 and negatively regulated by TGF-¦Â/Smad signaling in fibrosis 22395530 3530 Mouse mmu-miR-29 miRNA 2-acetyl-5-tetrahydroxybutyl imidazole (THI) breast cancer C2C12 cells 2-acetyl-5-tetrahydroxybutyl imidazole (THI) treatment upregulated 24077965 3531 Mouse mmu-miR-29 miRNA lipopolysaccharide (LPS) breast cancer lung tissues lipopolysaccharide (LPS) treatment micro-RNA-29 decreased 22718803 3532 Mouse mmu-miR-29 miRNA sphingosine-1-phosphate (S1P) breast cancer C2C12 cells sphingosine-1-phosphate (S1P) treatment upregulated 24077965 3533 Mouse mmu-miR-29 miRNA xanthomicrol breast cancer 4T1 cells xanthomicrol treatment upregulated 33217075 3534 Mouse mmu-miR-29 miRNA fundus photocoagulation with a krypton red laser choroidal neovascularization (CNV) C57BL/6 mice fundus photocoagulation with a krypton red laser treatment downregulated 24886609 3535 Mouse mmu-miR-29 miRNA dipeptidyl peptidase-4 (DPP-4) diabetes mellitus (DM) Streptozotocin-induced diabetic CD-1 mice DPP-4 treatment downregulated 24574044 3536 Mouse mmu-miR-29 miRNA IL-6 diabetic cardiomyopathy (DCM) heart tissues IL-6 treatment downregulated 26972749 3537 Mouse mmu-miR-29 miRNA streptozocin (STZ) diabetic retinopathy (DR) Mouse retinal tissues "Mice in the normal group were raised with normal diet each day, and those in the model group were fed with high-fat diet for 4 weeks. Then, mice in the normal group were intraperitoneally injected with normal saline and those in the model group were injected with 100 mg/kg STZ (streptozocin), for 4 consecutive weeks. treatment" downregulated 31114980 3538 Mouse mmu-miR-29 miRNA 2-acetyl-5-tetrahydroxybutyl imidazole (THI) duchenne muscular dystrophy (DMD) mdx mice 2-acetyl-5-tetrahydroxybutyl imidazole (THI) treatment downregulated 24077965 3539 Mouse mmu-miR-29 miRNA high fat diet (HFD) inflammatory response skeletal muscle of mice high fat diet (HFD) feed "miR-375, miR-29, miR-320, miR-103/107 and miR-126, play a crucial role in the regulation of glucose and lipid metabolism through the control of pancreatic islet cell function" 22395471 3540 Mouse mmu-miR-29 miRNA baicalin (BAI) keloids NIH-3T3 cells baicalin (BAI) treatment upregulated 31081145 3541 Mouse mmu-miR-29 miRNA estradiol liver fibrosis mice liver cells estradiol treatment estrogen can inhibit CCl4-induced hepatic injury through the induction of hepatic miR-29. 22393047 3542 Mouse mmu-miR-29 miRNA carbon tetrachloride (CCl4) liver inflammation and fibrogenesis macrophages carbon tetrachloride (CCl4) treatment Both HuR and miR-29s regulate expression of CB1 involved in infiltration of bone marrow monocyte/macrophage in chronic liver injury 31495934 3543 Mouse mmu-miR-29 miRNA cyclosporine A (CsA) nephrotoxicity mouse kidney cyclosporine A treatment upregulated 28414804 3544 Mouse mmu-miR-29 miRNA angiotensin II (Ang II) osteogenesis heart tissues angiotensin II (Ang II) treatment Smad7 plays a protective role in AngII-mediated cardiac remodeling via mechanisms involving the Sp1-TGF-¦Â/Smad3-NF.¦ÊB-miR-29 regulatory network 23894614 3545 Mouse mmu-miR-29 miRNA 16¦Á-hydroxyestrone (16¦ÁOHE) pulmonary arterial hypertension (PAH) lung tissues 16¦Á-hydroxyestrone (16¦ÁOHE) treatment upregulated 26487756 3546 Mouse mmu-miR-29 miRNA ionizing radiation (IR) pulmonary arterial hypertension (PAH) fibroblasts ionizing radiation treatment miR-29 family members were downregulated in irradiated mouse fibroblasts. 29230533 3547 Mouse mmu-miR-29 miRNA synthetic RNA duplexes lung fibrosis adult male C56Bl6 mice lung intravenous injection treatment upregulated 25239947 3548 Mouse mmu-miR-29 miRNA ionizing radiation (IR) radiation-induced fibrosis (RIF) mouse fibroblasts ionizing radiation treatment downregulated 29230533 3549 Mouse mmu-miR-29 miRNA high fat diet (HFD) type 2 diabetes mellitus (T2DM) female C57BL/6J mice high fat diet (HFD) feed upregulated 24722248 3550 Mouse mmu-miR-29 miRNA TGF-¦Â epithelial-mesenchymal transition (EMT) C2C12 cells TGF-¦Â treatment downregulated 21324893 3551 Mouse mmu-miR-290 miRNA folate cervical cancer (CC) mouse embryonic stem cells (mESCs folate deficiency induced downregulated 22828209 3552 Mouse mmu-miR-290-5p miRNA dextran sodium sulfate (DSS) crohn disease (CD) mouse peripheral blood CD4+ T cells dextran sodium salt (DSS) treatment downregulated 24356810 3553 Mouse mmu-miR-290-5p miRNA propofol (PPF) sepsis-induced renal injury kidney tissues Propofol treatment Propofol increased miR-290-5p expression and decreased CCL-2 and inflammatory cytokines levels in the kidney for septic mice 30328934 3554 Mouse mmu-miR-290b-5p miRNA embryo embryo implantation mouse uterine embryo implantation downregulated 29096585 3555 Mouse mmu-miR-291 miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" neurodegenerative diseases neuronal cells "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" downregulated 31658060 3556 Mouse mmu-miR-2911 miRNA honeysuckle (HS) influenza A virus (IAV) infection mouse mouse peripheral blood and lung drinking or gavage feeding of HS treatment upregulated 25287280 3557 Mouse mmu-miR-291a miRNA sodium arsenite (NaAsO2) arsenic inhibited cellular differentiation pluripotent P19 mouse embryonal carcinoma cells sodium arsenite treatment upregulated 29121352 3558 Mouse mmu-miR-291a-3p miRNA Jiang Tang Xiao Ke Granule diabetes mellitus (DM) KKAy diabetic mice Jiang Tang Xiao Ke Granule treatment dysregulated 29163176 3559 Mouse mmu-miR-291b miRNA hyaluronic acid 35 (HA35) alcoholic liver disease (ALD) C57BL6/J mice pretreate with ethanol Kupffer cells 15?mg/kg HA35 in sterile saline during the last three days of feeding downregulated 29142263 3560 Mouse mmu-miR-291b-3p miRNA metformin (Met) fatty liver disease liver tissues metformin treatment downregulated 27013659 3561 Mouse mmu-miR-291b-3p miRNA high fat diet (HFD) hyperglycemia and insulin resistance C57BL/6 J mouse liver high fat diet (HFD) feed upregulated in liver 28054586 3562 Mouse mmu-miR-291b-3p miRNA H2O2 oxdative stress EOMA mouse endothelial cells H2O2 treatment upregulated 30106126 3563 Mouse mmu-miR-291b-5p miRNA polyphenols cell function mice liver cells Polyphenols treatment downregulated 22253797 3564 Mouse mmu-miR-292 miRNA peritoneal dialysis fluid (PDF) peritoneal fibrosis peritoneal tissues peritoneal dialysis fluid (PDF) treatment upregulated 25827714 3565 Mouse mmu-miR-292-3p miRNA engrafting E6.5 embryos (wildtype or Gtl2((-/+))) teratomas mice engrafting E6.5 embryos (wildtype or Gtl2((-/+))) treatment downregulated 25355544 3566 Mouse mmu-miR-293 miRNA engrafting E6.5 embryos (wildtype or Gtl2((-/+))) teratomas mice engrafting E6.5 embryos (wildtype or Gtl2((-/+))) treatment downregulated 25355544 3567 Mouse mmu-miR-294 miRNA recombinant Adeno-Cre viruses (AdV-Cre) lung adenocarcinoma (LUAD) lung recombinant Adeno-Cre viruses (AdV-Cre) treatment upregulated 25359683 3568 Mouse mmu-miR-294-3p miRNA leishmania leishmaniasis Bone marrowderived macrophages (BMDMs) Leishmania infection upregulated 30949455 3569 Mouse mmu-miR-295 miRNA engrafting E6.5 embryos (wildtype or Gtl2((-/+))) teratomas mice engrafting E6.5 embryos (wildtype or Gtl2((-/+))) treatment downregulated 25355544 3570 Mouse mmu-miR-295* miRNA recombinant Adeno-Cre viruses (AdV-Cre) lung adenocarcinoma (LUAD) lung recombinant Adeno-Cre viruses (AdV-Cre) treatment upregulated 25359683 3571 Mouse mmu-miR-295-5p miRNA dendrobine liver damage liver tissues dendrobine treatment Dendrobine downregulated the levels of mmu-miR-295-5p 32633153 3572 Mouse mmu-miR-296 miRNA H2O2 Alzheimer's disease (AD) Primary hippocampal neuron cells H2O2 treatment upregulated 24423585 3573 Mouse mmu-miR-296 miRNA H2O2 Alzheimer's disease (AD) senescence accelerated mouse prone 8 (SAMP8) and prone 10 (SAMP10) "different concentrations (0, 100, 200, 400 and 800 ¦ÌM) of H2O2 treatment" upregulated 24423585 3574 Mouse mmu-miR-296 miRNA peritoneal dialysis fluid (PDF) peritoneal fibrosis peritoneal tissues peritoneal dialysis fluid (PDF) treatment upregulated 25827714 3575 Mouse mmu-miR-296 miRNA ethanol (EtOH) teratogenesis fetal brains of mice Ethanol?treatment downregulated 19091803 3576 Mouse mmu-miR-296-3p miRNA neuregulin-1£¨NRG1£© cell differentiation murine embryonic stem cell neuregulin-1£¨NRG1£© upregulated 21451102 3577 Mouse mmu-miR-296-3p miRNA destabilization of medial meniscus (DMM) osteoarthritis (OA) artilage tissues destabilization of medial meniscus (DMM) treatment CircCDH13 contributes to OA pathogenesis by functioning as a sponge of miR-296-3p and regulating the miR-296-3p-PTEN pathway. 33037617 3578 Mouse mmu-miR-296-5p miRNA polyphenols cell function mice liver cells Polyphenols treatment downregulated 22253797 3579 Mouse mmu-miR-296-5p miRNA barium chloride muscle injury C2C12 cells barium chloride treatment upregulated 32954829 3580 Mouse mmu-miR-297 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) serum lipopolysaccharide (LPS) treatment downregulated 31945608 3581 Mouse mmu-miR-297 miRNA Aluminum oxide nanoparticles (Al2O3 NPs) pulmonary inflammation bronchoalveolar lavage fluid (BALF) aluminum oxide nanoparticles (Al2O3 NPs) treatment upregulated 31918133 3582 Mouse mmu-miR-297a miRNA hypoxia/reoxygenation (H/R) myocardial injury HL-1 cells hypoxia/reoxygenation (H/R) treatment 1700020I14Rik/miR-297a/CGRP axis suppressed myocardial cell apoptosis in myocardial I/R injury. 32298875 3583 Mouse mmu-miR-297b-5p miRNA palmitic acid (PA) impaired insulin secretion ¦Â-TC-6 cells palmitic acid treatment downregulated 32302972 3584 Mouse mmu-miR-297b-5p miRNA stearic acid impaired insulin secretion ¦Â-TC-6 cells stearic acid treatment downregulated 32302972 3585 Mouse mmu-miR-297b-5p miRNA stearic acid type 2 diabetes mellitus (T2DM) ¦Â-TC6 cells; mouse islets stearic acid (C18:0) treatment miR-297b-5p expression was significantly lower in ¦Â-TC6 cells and mouse islets in stearic acid than in control group 31961705 3586 Mouse mmu-miR-298 miRNA hypoxia ischemic stroke (IS) N2a cells hypoxia induce downregulated 30021197 3587 Mouse mmu-mir-298-5p miRNA second-hand smoke (SHS) asthma lung second-hand smoke (SHS) treatment upregulated 26859758 3588 Mouse mmu-miR-298-5p miRNA chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) plvic inflammatory disease mouse two Chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) infection were upregulated during CmVar004 infection compared to CmVar001 infection 24961692 3589 Mouse mmu-miR-299-5p miRNA starvation Alzheimer's disease (AD) Hippocampal starvation treatment downregulated 27080144 3590 Mouse mmu-miR-299a-3p miRNA chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) plvic inflammatory disease mouse two Chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) infection were upregulated during CmVar004 infection compared to CmVar001 infection 24961692 3591 Mouse mmu-miR-29a miRNA lipopolysaccharide (LPS) sepsis myocardial tissue and heart infiltrating macrophages lipopolysaccharide (LPS) treatment downregulated 33840587 3592 Mouse mmu-miR-29a miRNA "7,12-dimethylbenz(¦Á)anthracene (DMBA)" "7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity" liver tissues "7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment" miR-29a was upregulated in the liver tissues of female mice. 32871758 3593 Mouse mmu-miR-29a miRNA "7,12-dimethylbenz(¦Á)anthracene (DMBA)" "7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity" spleen tissues "7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment" miR-29a was downregulated in the spleen tissues of male mice. 32871758 3594 Mouse mmu-miR-29a miRNA folate apoptosis mouse embryonic stem cells (mESCs) folate deficiency induced upregulated 22828209 3595 Mouse mmu-miR-29a miRNA cholesterol atherosclerosis (AS) "apoE-/- mice serum, endothelial, macrophages" cholesterol feed downregulated 29074464 3596 Mouse mmu-miR-29a miRNA IFN-¦Á autocrine and paracrine modulation thymic epithelial cell IFN-¦Á treatment The thymic epithelial microRNA network elevates the threshold for infection-associated thymic involution via miR-29a mediated suppression of the IFN-¦Á receptor 22179202 3597 Mouse mmu-miR-29a miRNA hyperoxia bronchopulmonary dysplasia (BPD) lung tissues of neonatal mice with hyperoxia-induced BPD and mouse alveolar epithelial cells (MLE-12) hyperoxia induce upregulated 31892308 3598 Mouse mmu-miR-29a miRNA curcumin (Cur) cell proliferation TGF¦Â1-induced NIH-3T3 cells curcumin (CUR) treatment upregulated 31710976 3599 Mouse mmu-miR-29a miRNA TGF-¦Â1 cell proliferation NIH-3T3 cells Transforming growth factor-¦Â (TGF¦Â1) treatment downregulated 31710976 3600 Mouse mmu-miR-29a miRNA hyperglycemia diabetes mellitus (DM) streptozotocin-induced diabetic mice hyperglycemia treatment downregulated 24578127 3601 Mouse mmu-miR-29a miRNA insulin diabetes mellitus (DM) mouse cardiomyocyte HL-1 cells insulin treatment downregulated 25062042 3602 Mouse mmu-miR-29a miRNA rapamycin diabetes mellitus (DM) mouse cardiomyocyte HL-1 cells rapamycin (Rap) treatment upregulated 25062042 3603 Mouse mmu-miR-29a miRNA streptozocin (STZ) diabetes mellitus (DM) hearts of diabetic mice streptozotocin (STZ) treatment downregulated 21584493 3604 Mouse mmu-miR-29a miRNA notoginsenoside R1 (NGR1) diabetes mellitus (DM) TNF-¦Á-treated Min6 cells Notoginsenoside R1 (NGR1) treatment upregulated 31184222 3605 Mouse mmu-miR-29a miRNA notoginsenoside R1 (NGR1) diabetes mellitus (DM) TNF-¦Á-treated rat primary islets ¦Â cells Notoginsenoside R1 (NGR1) treatment upregulated 31184222 3606 Mouse mmu-miR-29a miRNA tumor necrosis factor alpha (TNF-¦Á) diabetes mellitus (DM) Min6 cells tumor necrosis factor alpha (TNF-¦Á) treatment downregulated 31184222 3607 Mouse mmu-miR-29a miRNA tumor necrosis factor alpha (TNF-¦Á) diabetes mellitus (DM) rat primary islets ¦Â cells tumor necrosis factor alpha (TNF-¦Á) treatment downregulated 31184222 3608 Mouse mmu-miR-29a miRNA streptozocin (STZ) diabetic glomerulopathy glomeruli tissues streptozotocin (STZ) treatment downregulated 30642005 3609 Mouse mmu-miR-29a miRNA streptozocin (STZ) diabetic nephropathy (DN) kidney tissues streptozotocin treatment Knockdown of LncRNA-H19 Ameliorates Kidney Fibrosis in Diabetic Mice by Suppressing miR-29a-Mediated EndMT 33324218 3610 Mouse mmu-miR-29a miRNA streptozocin (STZ) diabetic retinopathy (DR) retina streptozocin (STZ) treatment downregulated 32182570 3611 Mouse mmu-miR-29a miRNA "2,4,6-trinitrobenzene sulfonic acid (TNBS)" diarrhea-predominant irritable bowel syndrome (IBS-D) Intestinal mucosa "2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol treatment" Inhibition of miRNA-29a regulates intestinal barrier function in diarrhea-predominant irritable bowel syndrome by upregulating ZO-1 and CLDN1 33093893 3612 Mouse mmu-miR-29a miRNA polychlorinated biphenyls (PCBs) cell differentiation P19 mouse embryonal carcinoma cells polychlorinated biphenyls (PCBs) treatment upregulated 23443104 3613 Mouse mmu-miR-29a miRNA high glucose (HG) high glucose (HG)-induced apoptosis mouse podocytes high glucose (HG) treatment The expression of miR-29a was significantly decreased in the HG-treated podocytes. 30575934 3614 Mouse mmu-miR-29a miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated 28811129 3615 Mouse mmu-miR-29a miRNA glucocorticoid (GC) inflammatory diseases Murine osteoblast glucocorticoid treatment upregulated 24096265 3616 Mouse mmu-miR-29a miRNA saturated fatty acids (SFA) palmitate (PA) insulin resistance (IR) L6 GLUT4myc saturated fatty acids (SFA) palmitate (PA) treatment upregulated 24844433 3617 Mouse mmu-miR-29a miRNA palmitic acid (PA) insulin resistance (IR) C2C12 myotubes palmitic acid (PA) treatment PA treatment increased the expression of miR-29a in a time-and dose-dependent manner 29693165 3618 Mouse mmu-miR-29a miRNA water avoidance stress (WAS) irritable bowel syndrome (IBS) mouse intestinal tissues water avoidance stress (WAS) induce treatment upregulated 30827505 3619 Mouse mmu-miR-29a miRNA "2,4,6-trinitrobenzene sulfonic acid (TNBS)" irritable bowel syndrome with diarrhea (IBS-D) C57BL/6 strain mouse "2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol treatment" upregulated 25277410 3620 Mouse mmu-miR-29a miRNA angiotensin II (Ang II) left ventricular (LV) remodeling heart sissues angiotensin II (Ang II) treatment "MicroRNA-29a attenuates angiotensin-II induced-left ventricular remodeling by inhibiting collagen, TGF-¦Â and SMAD2/3 expression" 32165882 3621 Mouse mmu-miR-29a miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues intraperitoneal injection of CCl4 upregulated 28768954 3622 Mouse mmu-miR-29a miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues CCl? treatment downregulated 30781750 3623 Mouse mmu-miR-29a miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) hepatic tissue high fat diet (HFD) feed downregulated 31652636 3624 Mouse mmu-miR-29a miRNA methionine choline-deficient diet (MCD) nonalcoholic steatohepatitis (NASH) liver tissues methionine-choline-deficient (MCD) diet feed downregulated 30917489 3625 Mouse mmu-miR-29a miRNA IL-2¦Â osteoarthritis (OA) cultured chondrocyte-like ATDC5 cells ?IL-1¦Â treatment downregulated 30993110 3626 Mouse mmu-miR-29a miRNA hypoxia oxidative stress Primary cultures of neonatal mouse cardiomyocytes hypoxia induce downregulated 31885817 3627 Mouse mmu-miR-29a miRNA Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria plasmodium chabaudi infection Balb/c Mice liver infect with Vaccination treatment downregulated in the Liver 28123381 3628 Mouse mmu-miR-29a miRNA fibroblast growth factor 2 (FGF2) regeneration of skeletal muscle Skeletal muscle fibroblast growth factor-2 (FGF2) treatment we demonstrate using microRNA (miRNA) profiling in mouse and human myoblasts that the capacity of FGF2 to stimulate myoblast proliferation is mediated by miR-29a. FGF2 induces miR-29a expression and inhibition of miR-29a using pharmacological or genetic deletion decreases myoblast proliferation. 26731484 3629 Mouse mmu-miR-29a miRNA streptozocin (STZ) renal fibrosis glomeruli streptozocin (STZ) treatment downregulated 27460630 3630 Mouse mmu-miR-29a miRNA retinoic acid (RA) retinal degenerative diseases primary retinal progenitor cells (RPCs) retinoic acid (RA) treatment upregulated 29670089 3631 Mouse mmu-miR-29a miRNA whole grain highland barley (WGH) type 2 diabetes mellitus (T2DM) liver tissues whole grain highland barley (WGH) treatment downregulated 33104141 3632 Mouse mmu-miR-29a miRNA dextran sodium sulfate (DSS) ulcerative colitis (UC) mouse dextran sodium sulfate (DSS) treatment upregulated 25674218 3633 Mouse mmu-miR-29a miRNA dextran sodium sulfate (DSS) ulcerative colitis (UC) colon tissues dextran sulfate sodium treatment upregulated 29916896 3634 Mouse mmu-miR-29a-3p miRNA angiotensin II (Ang II) myocardial infarction (MI) neonatal mouse cardiac fibroblasts (CFs) angiotensin II (Ang II) treatment downregulated 33235025 3635 Mouse mmu-miR-29a-3p miRNA leonurine (LE) myocardial infarction (MI) myocardial infarction (MI) mouse heart tissues; angiotensin II (AngII)-treated neonatal mouse cardiac fibroblasts (CFs) leonurine (LE)?treatment upregulated 33235025 3636 Mouse mmu-miR-29a-3p miRNA lipopolysaccharide (LPS) acute respiratory distress syndrome (ARDS) serum lipopolysaccharide (LPS) treatment upregulated 32934950 3637 Mouse mmu-miR-29a-3p miRNA hyperoxia bronchopulmonary dysplasia (BPD) MLE-12 cells hyperoxia treatment upregulated 33194901 3638 Mouse mmu-miR-29a-3p miRNA hypoxia cell differentiation mouse (GL261 and G422) glioma cell lines hypoxia induce upregulated 30536597 3639 Mouse mmu-miR-29a-3p miRNA astaxanthin colorectal cancer (CRC) Mouse colon cancer cell CT26 astaxanthin (ATX) treatment upregulated 31263239 3640 Mouse mmu-miR-29a-3p miRNA streptozocin (STZ) diabetic retinopathy (DR) retinal vessels streptozotocin (STZ) treatment downregulated 32343678 3641 Mouse mmu-miR-29a-3p miRNA fluke Fasciola gigantica (FgESPs) F. gigantica infection liver tissues fluke Fasciola gigantica (FgESPs) infection downregulated 33332355 3642 Mouse mmu-miR-29a-3p miRNA microcystin (MC) female mammals' reproductive toxicity mouse granulosa cells (mGCs) microcystin-LR (MC-LR) for 48 h dysregulated 28161121 3643 Mouse mmu-miR-29a-3p miRNA paraquat (PQ) paraquat (PQ)-induced acute lung injury and pulmonary fibrosis MLE-12 cells paraquat (PQ) treatment downregulated 32741895 3644 Mouse mmu-miR-29a-c miRNA angiotensin II (Ang II) cardiac fibrosis mouse heart angiotensin II (Ang II) treatment downregulated 24569834 3645 Mouse mmu-miR-29a-c miRNA high glucose (HG) hepatic gluconeogenesis primary mouse hepatocytes diet-induced obese (DIO) "Adenovirus-mediated overexpression of miR-29a-c in the livers of db/m, db/db, and DIO mice decreased fasting blood glucose levels and improved glucose tolerance" 23111009 3646 Mouse mmu-miR-29b miRNA high fat diet (HFD) apoptosis apoE knock-out mice high fat diet (HFD) feed upregulated 25131924 3647 Mouse mmu-miR-29b miRNA folate apoptosis mouse embryonic stem cells (mESCs) folate deficiency induced upregulated 22828209 3648 Mouse mmu-miR-29b miRNA ovalbumin (OVA) asthma lung and spleen tissues OVA treatment downregulated 31412349 3649 Mouse mmu-miR-29b miRNA high fat diet (HFD) atherosclerosis (AS) serum high fat diet (HFD) feed upregulated 29398368 3650 Mouse mmu-miR-29b miRNA insulin-like growth factor binding protein-related protein 1 (IGFBPrP1) autophagy hepatic stellate cell (HSC) IGFBPrP1 treatment downregulated 31610195 3651 Mouse mmu-miR-29b miRNA TGF-¦Â bone marrow transplantation mouse alveolar macrophage TGF-¦Â treatment upregulated 25361568 3652 Mouse mmu-miR-29b miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral ischemia/reperfusion (I/R) injury N2a cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment upregulated 30233687 3653 Mouse mmu-miR-29b miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral ischemia injury (CII) N2a cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment miR-29b in N2a neuroblastoma cells decreased following oxygen and glucose deprivation/reperfusion (OGD/R) treatment 29399057 3654 Mouse mmu-miR-29b miRNA insulin diabetes mellitus (DM) mouse cardiomyocyte HL-1 cells insulin treatment downregulated 25062042 3655 Mouse mmu-miR-29b miRNA rapamycin diabetes mellitus (DM) mouse cardiomyocyte HL-1 cells rapamycin (Rap) treatment upregulated 25062042 3656 Mouse mmu-miR-29b miRNA resveratrol diabetic retinopathy (DR) retinal cells resveratrol (Res) treatment diabetes-induced downregulated expression of miR-29b and upregulated expression of SP1 could be rescued by RSV in vivo and in vitro (P < 005) 27311771 3657 Mouse mmu-miR-29b miRNA streptozocin (STZ) diabetic retinopathy (DR) mouse retion STZ treatment downregulated 28246353 3658 Mouse mmu-miR-29b miRNA streptozocin (STZ) diabetic retinopathy (DR) retinal tissues streptozotocin (STZ) treatment downregulated 32497630 3659 Mouse mmu-miR-29b miRNA TGF-¦Â DNA damage tubular epithelial cells TGF-¦Â treatment downregulated 23207693 3660 Mouse mmu-miR-29b miRNA carbon tetrachloride (CCl4) extracellular-matrix (ECM) and fibril formation mouse CCl4 treatment downregulated 24650661 3661 Mouse mmu-miR-29b miRNA repeated social defeat (RSD) gastric cancer (GC) "male C57BL/6 (5 ¨C 6 weeks old) and CD-1 (12 months old, retired breeders) mice" intruder attack mice treatment significantly upregulated expression 25317829 3662 Mouse mmu-miR-29b miRNA supercritical-carbon dioxide fluid of C. indicum (CISCFE) hepatocellular carcinoma (HCC) mouse H22 CISCFE combined with Bleomycin (BLM) treatment upregulated 28245556 3663 Mouse mmu-miR-29b miRNA scald hypertrophic scars (HS) mouse thermal injury tissue scald skin treatment downregulated in thermal injury tissue 28092445 3664 Mouse mmu-miR-29b miRNA ICAT (inhibitor of ¦Â-catenin and T cell factor) fetal mouse neurogenesis neural stem cells (NSCs) ICAT treatment upregulated 25321480 3665 Mouse mmu-miR-29b miRNA "2,4,6-trinitrobenzene sulfonic acid (TNBS)" irritable bowel syndrome with diarrhea (IBS-D) C57BL/6 strain mouse "2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol treatment" upregulated 25277410 3666 Mouse mmu-miR-29b miRNA oxygen glucose deprivation (OGD) ischemic stroke (IS) HT22 cells oxygen-glucose deprivation (OGD) treatment Long non-coding RNA H19 inhibition ameliorates oxygen-glucose deprivation-induced cell apoptosis and inflammatory cytokine expression by regulating the microRNA-29b/SIRT1/PGC-1¦Á axis 33313940 3667 Mouse mmu-miR-29b miRNA Japanese encephalitis virus (JEV) Japanese encephalitis virus (JEV) infection Mouse microglia cell line (BV-2) Japanese encephalitis virus (JEV) treatment significant upregulated of miR-29b in JEV-infected mouse microglial cell line (BV-2) and primary microglial cells. 24236890 3668 Mouse mmu-miR-29b miRNA TGF-¦Â liver fibrosis primary hepatic stellate cells (HSCs) TGF-¦Â treatment downregulated 32893175 3669 Mouse mmu-miR-29b miRNA methamphetamine (METH) methamphetamine (METH) addiction precursors methamphetamine (METH) treatment downregulated 29516602 3670 Mouse mmu-miR-29b miRNA Japanese encephalitis virus (JEV) microglial activation mouse microglial cell line (BV-2) JEV infected treatment upregulated 24236890 3671 Mouse mmu-miR-29b miRNA urethane mouse lung tumors lung tissues urethane treatment downregulated 24361357 3672 Mouse mmu-miR-29b miRNA angiotensin II (Ang II) muscle atrophy C2C12 cells angiotensin II (Ang II) treatment miR-29b is elevated in AngII-induced muscle atrophy. 33614226 3673 Mouse mmu-miR-29b miRNA high fat diet (HFD) myocardial dysfunction heart tissues high fat diet (HFD) feed miRNA-29b was reduced in the heart of HF diet-fed mice. 30362585 3674 Mouse mmu-miR-29b miRNA berberine (BBR) myocardial infarction (MI) MI C57BL6 mice berberine (BBR) treatment upregulated 28722488 3675 Mouse mmu-miR-29b miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) neuroblastoma (NB) N2a neuroblastoma cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 29399057 3676 Mouse mmu-miR-29b miRNA high fat diet (HFD) obesity mouse heart tissues high fat diet (HFD) feed downregulated 30362585 3677 Mouse mmu-miR-29b miRNA tumor necrosis factor alpha (TNF-¦Á) osteoclast differentiation RAW264.7 cells tumor necrosis factor alpha (TNF-¦Á) treatment upregulated 23078176 3678 Mouse mmu-miR-29b miRNA lipopolysaccharide (LPS) osteoclastogenesis mouse tibiae and cultured osteoclasts (OCs) lipopolysaccharide (LPS) treatment upregulated 31093317 3679 Mouse mmu-miR-29b miRNA PD fluid (PDF) peritoneal fibrosis mosue renal tissue PDF day 14 treatment downregulated 25046436 3680 Mouse mmu-miR-29b miRNA platelet derived growth factor-BB (PDGF-BB) proliferative vascular diseases primary vascular smooth muscle cells (VSMCs) of aorta in mice platelet-derived growth factor-BB (PDGF-BB) treatment upregulated 30231015 3681 Mouse mmu-miR-29b miRNA hypoxia pulmonary arterial hypertension (PAH) pulmonary artery tissues hypoxia induce downregulated 29662889 3682 Mouse mmu-miR-29b miRNA astilbin lung fibrosis lung tissues astilbin induce "miR©\29b©\2©\5p increased under astilbin treatment compared with BLM treatment, Its expression was inversely correlated with circRNAs©\949 and 662." 31448882 3683 Mouse mmu-miR-29b miRNA angiotensin II (Ang II) renal inflammation and fibrosis kidney of mice angiotensin II (Ang II) treatment downregulated 23301086 3684 Mouse mmu-miR-29b miRNA di-n-butyl phthalate (DBP) reproductive toxicity "The mouse spermatogenesis pathway cell lines, GC-1 spg (catalog number: CRL-2053) and GC-2 spd (catalog number: CRL-2196)" Di-n-butyl phthalate (DBP) treatment upregulated 30952838 3685 Mouse mmu-miR-29b miRNA supernatants from silica-treated macrophages silicosis NIH-3T3 and MRC-5 supernatants from silica-treated macrophages treatment downregulated 30090550 3686 Mouse mmu-miR-29b miRNA silica silicosis lung tissue silica treatment downregulated 30529807 3687 Mouse mmu-miR-29b miRNA brucea javanica oil (BJO) temporal lobe epilepsy (TLE) HT22 cells brucea javanica oil (BJO) treatment BJO and BE-BJO significantly induced H22 cell apoptosis by upregulating the miRNA-29b gene level. 33341052 3688 Mouse mmu-miR-29b* miRNA H2O2 chronic inflammatory airway diseases RAW 264.7 cells H2O2 treatment downregulated 21350856 3689 Mouse mmu-miR-29b-1* miRNA H1N1 influenza virus endometriosis and endometrial carcinoma mouse lung?tissues H1N1 influenza virus infection upregulated 24066118 3690 Mouse mmu-miR-29b-1-5p miRNA H2O2 cardiovascular disease (CVD) cardiomyocytes hydrogen peroxide (H2O2 ) treatment The expression of miR-29b-1-5p was upregulated in I/R injured hearts and in hydrogen peroxide treated cardiomyocytes. 29117536 3691 Mouse mmu-miR-29b-1-5p miRNA methimazole (MTZ) liver damage liver tissues methimazole (MTZ) treatment upregulated 27421576 3692 Mouse mmu-miR-29b-3 miRNA cigarette smoke (CS) renal fibrosis 5/6th partial nephrectomy (PNx) surgery 5/6th partial nephrectomy (PNx) surgery treatment downregulated in renal and cardiac 27789733 3693 Mouse mmu-miR-29b-3p miRNA "1,2-dichloroethane (1,2-DCE)" brain edema brain parenchyma and around the vessels of the cerebral cortex "1,2-dichloroethane (1,2-DCE) treatment" upregulated 31734271 3694 Mouse mmu-miR-29b-3p miRNA "1,2-dichloroethane (1,2-DCE)" brain edema brain cortex "1,2-dichloroethane (1,2-DCE) treatment" upregulated 31734271 3695 Mouse mmu-miR-29b-3p miRNA angiotensin II (Ang II) cardiac fibrosis cardiac fibroblasts (CFs) angiotensin II (Ang II) treatment "?miR-29b-3p-induced inhibition of CFs proliferation and migration and alters the expression levels of miR-29b-3p targeting genes (a-SMA, COL1A1, COL3A1) in vitro." 30967276 3696 Mouse mmu-miR-29b-3p miRNA angiotensin II (Ang II) cardiac fibrosis myocardium of Ang-II-infused migration inhibitory factor (MIF)-KO mice angiotensin II (Ang II) treatment downregulated 31175931 3697 Mouse mmu-miR-29b-3p miRNA angiotensin II (Ang II) cardiac fibrosis mouse cardiac fibroblasts (CFs) with MIF overexpression or by treatment with MIF protein angiotensin II (Ang II) treatment upregulated 31175931 3698 Mouse mmu-miR-29b-3p miRNA microcystin (MC) female mammals' reproductive toxicity mouse granulosa cells (mGCs) microcystin-LR (MC-LR) for 48 h dysregulated 28161121 3699 Mouse mmu-miR-29b-3p miRNA luteinising hormone (LH) functions of Leydig cells mouse TM3 Leydig cells luteinising hormone (LH) treatment upregulated 28762514 3700 Mouse mmu-miR-29b-3p miRNA schistosoma japonicum liver fibrosis liver tissues Schistosoma japonicum infection treatment downregulated 29091295 3701 Mouse mmu-miR-29b-3p miRNA IL-1¦Â osteoarthritis (OA) ATDC5 cells IL-1¦Â treatment OIP5-AS1 was downregulated while miR-29b-3p was upregulated in OA models. 32037864 3702 Mouse mmu-miR-29b-3p miRNA cigarette smoke extract (CSE) smoke-induced lung injury (SILI) lung tissues cigarette smoke extract (CSE) treatment upregulated 33523607 3703 Mouse mmu-miR-29b-3p miRNA Rb3 smoke-induced lung injury (SILI) lung tissues Rb3 treatment downregulated 33523607 3704 Mouse mmu-miR-29b-3p miRNA luteinising hormone (LH) steroidogenesis mouse TM3 Leydig cells luteinising hormone(LH) treatment dysregulated 28762514 3705 Mouse mmu-miR-29b-3p miRNA dextran sodium sulfate (DSS) ulcerative colitis (UC) colon dextran sodium sulfate (DSS) exposure TUG1 inhibits IEC apoptosis and UC progression by regulating the balance of HuR and miR-29b-3p. 33047284 3706 Mouse mmu-miR-29b-3p miRNA dextran sodium sulfate (DSS) ulcerative colitis (UC) colon tissues dextran sodium sulfate (DSS) treatment upregulated 33047284 3707 Mouse mmu-miR-29b-3p miRNA tumor necrosis factor alpha (TNF-¦Á) ulcerative colitis (UC) YAMC cells tumor necrosis factor alpha (TNF-¦Á) treatment TUG1 inhibits IEC apoptosis and UC progression by regulating the balance of HuR and miR-29b-3p 33047284 3708 Mouse mmu-miR-29b-3p miRNA tumor necrosis factor alpha (TNF-¦Á) ulcerative colitis (UC) murine colonic epithelial YAMC cells tumor necrosis factor alpha (TNF-¦Á) treatment upregulated 33047284 3709 Mouse mmu-miR-29c miRNA lipopolysaccharide (LPS) cardiac fibrosis C57/Bl6 mice heart LPS (10 mg/kg)were injected intraperitoneally once a week for 1-4 weeks treatment downregulated 25233448 3710 Mouse mmu-miR-29c miRNA panax notoginseng saponins (PNS) cardiovascular disease (CVD) hearts Panax notoginseng saponins (PNS) treatment upregulated 28017695 3711 Mouse mmu-miR-29c miRNA insulin diabetes mellitus (DM) mouse cardiomyocyte HL-1 cells insulin treatment downregulated 25062042 3712 Mouse mmu-miR-29c miRNA rapamycin diabetes mellitus (DM) mouse cardiomyocyte HL-1 cells rapamycin (Rap) treatment upregulated 25062042 3713 Mouse mmu-miR-29c miRNA hypoxia inducible factor (HIF)-1 heart failure (HF) heart tissues hypoxia-inducible factor (HIF)-1 induce upregulated 30575439 3714 Mouse mmu-miR-29c miRNA influenza A virus (IAV) immune response lung tissues influenza A virus infection downregulated 30513647 3715 Mouse mmu-miR-29c miRNA exenatide (EXA) insulin sensitivity pancreas exenatide treatment "The levels of miRNA-15a, 29c, 124a, and 375 in the pancreas were significantly increased in HFD control mice.These effects were reversed by treatment with exenatide." 26314504 3716 Mouse mmu-miR-29c miRNA exenatide (EXA) insulin sensitivity liver exenatide treatment "the levels of miRNA-29c, 124a, and 146a in the liver were significantly increased. These effects were reversed by treatment with exenatide." 26314504 3717 Mouse mmu-miR-29c miRNA exenatide (EXA) insulin sensitivity muscle exenatide treatment "The levels of miRNA-15a, 29c, 124a, and 146a in the muscle were significantly increased. These effects were reversed by treatment with exenatide." 26314504 3718 Mouse mmu-miR-29c miRNA exenatide (EXA) insulin sensitivity serum exenatide treatment "the levels of miRNA-15a, 29c, 124a, and 375 in the serum were significantly decreased. These effects were reversed by treatment with exenatide." 26314504 3719 Mouse mmu-miR-29c miRNA high fat diet (HFD) insulin sensitivity pancreas high fat diet (HFD) feed upregulated 26314504 3720 Mouse mmu-miR-29c miRNA high fat diet (HFD) insulin sensitivity muscle high fat diet (HFD) feed upregulated 26314504 3721 Mouse mmu-miR-29c miRNA high fat diet (HFD) insulin sensitivity serum high fat diet (HFD) feed downregulated 26314504 3722 Mouse mmu-miR-29c miRNA high fat diet (HFD) insulin sensitivity liver high fat diet (HFD) feed upregulated 26314504 3723 Mouse mmu-miR-29c miRNA panax notoginseng saponins (PNS) myocardial injury myocardial injury C57BL/6J mice panax notoginseng saponins (PNS) treatment upregulated 28017695 3724 Mouse mmu-miR-29c miRNA isoproterenol myocardial injury heart tissues isoproterenol (ISO) treatment downregulated 28017695 3725 Mouse mmu-miR-29c miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) substantia nigra pars compacta (SNpc) "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" downregulated 31732967 3726 Mouse mmu-miR-29c miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) substantia nigra pars compacta (SNpc) "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" miR-29c was down-expressed but SP1 was high-expressed in substantia nigra pars compacta (SNpc) of MPTP-induced PD mice. 31732967 3727 Mouse mmu-miR-29c miRNA lipopolysaccharide (LPS) parkinson's disease (PD) BV-2 cells lipopolysaccharide (LPS) treatment miR-29c was downregulated in LPS-induced BV-2 cells. 32160394 3728 Mouse mmu-miR-29c miRNA silica silicosis lung tissues silica treatment downregulated 29216763 3729 Mouse mmu-miR-29c miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) stroke HT22 cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 31698040 3730 Mouse mmu-miR-29c miRNA ethanol (EtOH) teratogenesis fetal brains of mice Ethanol?treatment downregulated 19091803 3731 Mouse mmu-miR-29c* miRNA isoproterenol cardiac fibrosis heart tissues isoproterenol (ISO) treatment downregulated 27174579 3732 Mouse mmu-miR-29c-3p miRNA ozone (O3) asthma CD4+ T cells and ASMCs ozone treatment lncRNA PVT1-miR-15a-5p/miR-29c-3p-PI3K-Akt-mTOR axis was implicated in ozone-induced asthma development by promoting ASMC proliferation and Th1/Th2 imbalance 33223504 3733 Mouse mmu-miR-29c-3p miRNA angiotensin II (Ang II) cardiac fibrosis myocardium of Ang-II-infused migration inhibitory factor (MIF)-KO mice angiotensin II (Ang II) treatment downregulated 31175931 3734 Mouse mmu-miR-29c-3p miRNA angiotensin II (Ang II) cardiac fibrosis mouse cardiac fibroblasts (CFs) with MIF overexpression or by treatment with MIF protein angiotensin II (Ang II) treatment upregulated 31175931 3735 Mouse mmu-miR-29c-3p miRNA high glucose (HG) diabetic nephropathy (DN) Mouse primary kidney GEC (C57-6014G) and mouse glomerular mesangial cells (GMC) (SV40 MES 13) and derived exosomes high glucose (HG) treatment upregulated 31497190 3736 Mouse mmu-miR-29c-3p miRNA high glucose (HG) dysfunction of endothelial progenitor cells (EPCs) EPCs high glucose (HG) treatment TUG1 restores high glucose-treated EPC function by regulating miR-29c-3p/PDGF-BB/Wnt signaling. 33059750 3737 Mouse mmu-miR-29c-3p miRNA microcystin (MC) female mammals' reproductive toxicity mouse granulosa cells (mGCs) microcystin-LR (MC-LR) for 48 h dysregulated 28161121 3738 Mouse mmu-miR-29c-3p miRNA carbon tetrachloride (CCl4) hepatotoxicity blood carbon tetrachloride (CCl4) treatment upregulated 32528856 3739 Mouse mmu-miR-29c-3p miRNA licochalcone A (LA) lung cancer MLE-12 cells Licochalcone A (lico A) treatment downregulated 32505917 3740 Mouse mmu-miR-29c-3p miRNA alpinia oxyphylla extract (AOE) type 2 diabetes mellitus (T2DM) db-/db- mouse kidney A. oxyphylla extract (AOE) treatment downregulated 28249617 3741 Mouse mmu-miR-30 miRNA TGF-¦Â renal fibrosis podocytes in normal mice TGF-¦Â treatment downregulated 24086574 3742 Mouse mmu-miR-30 miRNA high fat diet (HFD) atherosclerosis (AS) endothelial cell high fat diet (HFD) feed upregulated 26488467 3743 Mouse mmu-miR-30 miRNA melatonin breast cancer mouse breast cancer cell lines 4T1 and MA-891 Melatonin treatment upregulated 31955008 3744 Mouse mmu-miR-30 miRNA melatonin breast cancer ?4T1 cells; 891 cells Melatonin treatment Melatonin regulated breast cancer progression by the lnc010561/miR-30/FKBP3 axis. 31955008 3745 Mouse mmu-miR-30 miRNA streptozocin (STZ) congenital heart disease (CHD) C57BL/6 mice blood injection of streptozotocin before mating treatment dysregulated 27998767 3746 Mouse mmu-miR-30 miRNA chronic social defeat stress (CSDS) depression neurogenic dentate gyrus (DG) region chronic social defeat stress (CSDS) induce downregulated 31440139 3747 Mouse mmu-miR-30 miRNA TGF-¦Â1 epithelial-mesenchymal transition (EMT) hepatocyte TGF-¦Â1 treatment downregulated 22227196 3748 Mouse mmu-miR-30 miRNA carbon tetrachloride (CCl4) liver fibrosis hepatic stellate cells (HSCs) CCl4 treatment downregulated 25912033 3749 Mouse mmu-miR-30 miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues carbon tetrachloride (CCl4) treatment downregulated in 28592847 3750 Mouse mmu-miR-30 miRNA TGF-¦Â liver fibrosis liver TGF-¦Â treatment downregulated 26120970 3751 Mouse mmu-miR-30 miRNA cyclosporine A (CsA) nephrotoxicity mouse kidney cyclosporine A treatment upregulated 28414804 3752 Mouse mmu-miR-30 miRNA extra-virgin olive oil rich in phenols (H-EVOO) neuronal function cortex H-EVOO treatment upregulated 26695409 3753 Mouse mmu-miR-30 miRNA angiotensin II (Ang II) podocyte injury mouse podocytes angiotensin II (Ang II) treatment downregulated in the podocytes 28540409 3754 Mouse mmu-miR-30 miRNA lipopolysaccharide (LPS) podocytopathy podocytes lipopolysaccharide (LPS) treatment downregulated 31127093 3755 Mouse mmu-miR-300 miRNA lipopolysaccharide (LPS) inflammation mouse blood lipopolysaccharide (LPS) treatment upregulated in the blood samples 29441890 3756 Mouse mmu-miR-300 miRNA dopamine neurodegeneration (ND) N2a cells dopamine treatment downregulated 30738894 3757 Mouse mmu-miR-300 miRNA metformin (Met) nonalcoholic steatohepatitis (NASH) liver tissues metformin treatment upregulated 25672270 3758 Mouse mmu-miR-301a miRNA notoginsenoside R1 (NGR1) ankylosing spondylitis (AS) ATDC5 cells Notoginsenoside R1 (NG-R1) treatment Notoginsenoside R1 suppresses miR-301a via NF-¦ÊB pathway in lipopolysaccharide-treated ATDC5 cells. 31837326 3759 Mouse mmu-miR-301a miRNA lipopolysaccharide (LPS) inflammation ATDC5 cells lipopolysaccharide (LPS) treatment upregulated 31837326 3760 Mouse mmu-miR-301a miRNA notoginsenoside R1 (NGR1) inflammation LPS-treated ATDC5 cells Notoginsenoside R1 (NG-R1) treatment downregulated 31837326 3761 Mouse mmu-miR-301a miRNA tumor necrosis factor alpha (TNF-¦Á) inflammatory bowel disease (IBD) CD4+ T cells tumor necrosis factor alpha (TNF-¦Á) treatment upregulated 26338824 3762 Mouse mmu-miR-301a miRNA Japanese encephalitis virus (JEV) Japanese encephalitis virus (JEV) infection mouse hippocampal neuronal cell line HT22 JEV (strain GP78) infection upregulated 28196914 3763 Mouse mmu-miR-301a miRNA lipopolysaccharide (LPS) osteoarthritis (OA) murine chondrogenic ATDC5 cells lipopolysaccharide (LPS) treatment upregulated 31966769 3764 Mouse mmu-miR-301a miRNA anandamide (AEA) pro-inflammatory activity mouse anandamide treatment AEA differentil regulate the expression of miRNA 24699635 3765 Mouse mmu-miR-301a miRNA TGF-¦Â lung fibrosis mouse embryonic fibroblasts (MEFs) TGF-¦Â treatment upregulated 32585629 3766 Mouse mmu-miR-301a miRNA Japanese encephalitis virus (JEV) viral-induced neuroinflammation BV2 cells and primary microglial cells were isolated from postnatal day 0 (P0) to P2 BALB/c mouse pups Japanese encephalitis virus (JEV) infection upregulated 31527198 3767 Mouse mmu-miR-301a-3p miRNA electroacupuncture (EA) electroacupuncture (EA) CD4 T cells electroacupuncture (EA) treatment upregulated 32026263 3768 Mouse mmu-miR-301a-3p miRNA high glucose (HG) glomerulonephritis Mice MPC5 podocytes high glucose (HG) treatment downregulated 29434693 3769 Mouse mmu-miR-301a-3p miRNA brucella.suis innate immune response RAW264.7 cells brucella.suis infection upregulated 29387067 3770 Mouse mmu-miR-301b-3p miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity plasma doxorubicin (DOX) treatment upregulated 30453253 3771 Mouse mmu-miR-301b-3p miRNA 6-hydroxydopamine (6-OHDA) parkinson's disease (PD) dopaminergic neuron 6-hydroxydopamine (6-OHDA) treatment LncRNA H19 diminishes dopaminergic neuron loss by mediating microRNA-301b-3p in Parkinson's disease via the HPRT1-mediated Wnt/¦Â-catenin signaling pathway. 32434961 3772 Mouse mmu-miR-302 miRNA Streptococcus pneumoniae (Sp) bacterial pneumonia alveolar epithelial cells (AEC) Streptococcus pneumoniae (Sp) infection treatment upregulated 30971494 3773 Mouse mmu-miR-302 miRNA alpinetin (ALP) colitis CD4+ T cells and colons of dextran sulfate sodium (DSS)-induced colitis mice alpinetin (ALP) treatment upregulated 30166541 3774 Mouse mmu-miR-302a miRNA folate cervical cancer (CC) mouse embryonic stem cells (mESCs folate deficiency induced downregulated 22828209 3775 Mouse mmu-miR-302a miRNA folate apoptosis mouse embryonic stem cells folate treatment MicroRNA-302a is involved in folate deficiency-induced apoptosis through the AKT-FOXO1-BIM pathway in mouse embryonic stem cells 33372619 3776 Mouse mmu-miR-302a miRNA engrafting E6.5 embryos (wildtype or Gtl2((-/+))) teratomas mice engrafting E6.5 embryos (wildtype or Gtl2((-/+))) treatment downregulated 25355544 3777 Mouse mmu-miR-302a-3p miRNA high glucagon diabetes mellitus (DM) primary hepatocytes high glucagon treatment Hmigh glucagon treatment could time-dependently decrease the mRNA expression of miR-302a-3p. 30260029 3778 Mouse mmu-miR-302a-3p miRNA high glucagon hepatic gluconeogenesis mouse primary hepatocytes high glucagon treatment "MEG3 served as a competing endogenous RNA (ceRNA) to upregulate CRTC2 by targeting miR-302a-3p in primary hepatocytes, thereby increasing PGC-1¦Á-PEPCK/G6Pc." 30260029 3779 Mouse mmu-miR-302a-3p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) ischemic stroke (IS) HT22 cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment "The SNHG15 and STAT1/NF-¦ÊB pathways were both distinctly upregulated, while miR-302a-3p was notably downregulated in the ischemia cortex" 33779086 3780 Mouse mmu-miR-302a-3p miRNA dioscorea bulbifera (DB) liver damage livers dioscoreae bulbifera (EF) treatment downregulated 27609015 3781 Mouse mmu-miR-302a-3p miRNA hypoxia/reoxygenation (H/R) myocardial ischemia/reperfusion (I/R) injury (MIRI) mouse cardiomyocytes hypoxia/reoxygenation (H/R) treatment MiR-302a-3p expression was significantly upregulated in mice subjected to MIRI and in H/R-treated mouse cardiomyocytes. 32866521 3782 Mouse mmu-miR-302b miRNA monosodium urate (MSU) gouty arthritis mouse air membranes monosodium urate (MSU) crystal treatment upregulated 29482609 3783 Mouse mmu-miR-302b miRNA pseudomonas aeruginosa (PA) respiratory bacterial infection alveolar macrophages (AMs) were obtained from bronchoalveolar lavage (BAL) of C57BL/6 mice Gram-negative bacterium Pseudomonas aeruginosa infection treatment upregulated 24717937 3784 Mouse mmu-miR-302b-5p miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) brain tissues "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" miR-302b-5p expression was remarkably decreased after the treatment of MPTP in comparison with Normal tissues. 32474958 3785 Mouse mmu-miR-302c miRNA carbon tetrachloride (CCl4) liver fibrosis hepatic stellate cells (HSCs) carbon tetrachloride (CCl4) treatment Induction of E6AP by microRNA-302c dysregulation inhibits TGF-¦Â-dependent fibrogenesis in hepatic stellate cells. 33037648 3786 Mouse mmu-miR-302c miRNA engrafting E6.5 embryos (wildtype or Gtl2((-/+))) teratomas mice engrafting E6.5 embryos (wildtype or Gtl2((-/+))) treatment downregulated 25355544 3787 Mouse mmu-miR-302d-3p miRNA leishmania leishmaniasis Bone marrowderived macrophages (BMDMs) Leishmania infection upregulated 30949455 3788 Mouse mmu-miR-302e miRNA lipopolysaccharide (LPS) infantile pneumonia (IP) Lung tissue from 1 week old C57BL/6 mice lipopolysaccharides (LPS) treatment downregulated 31115487 3789 Mouse mmu-miR-3061-3p miRNA propofol (PPF) propofol-induced developmental neurotoxicity hippocampus propofol treatment downregulated 30242182 3790 Mouse mmu-miR-3068 miRNA walnut colorectal cancer (CRC) colorectal tumor tissue walnut-containing diet treatment downregulated 25882694 3791 Mouse mmu-miR-3070-2-3p miRNA high fat diet (HFD) compensatory hyperplasia of islets hepatocellular extracellular vesicles (EVs) ?high-fat diet (HFD) feed treatment downregulated 31284955 3792 Mouse mmu-miR-3075-5p miRNA vorinostat (SAHA) atherosclerosis (AS) aortic tissues vorinostat treatment downregulated 30284929 3793 Mouse mmu-miR-3077 miRNA 177lu-octreotate neuroendocrine tumors Female BALB/c nude mice "inject 1.3, 3.6, 14, 45, or 140 MBq 177Lu-octreotate treatment" "miR-194, miR-107, miR-3090, and miR-3077 were commonly regulated" 25386939 3794 Mouse mmu-miR-3082-5p miRNA "2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD)" bordetella pertussis infection Pertussis Toxin (PTX) treated mice CD4+ T cells "2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) treatment" upregulated 31681214 3795 Mouse mmu-miR-3082-5p miRNA enterovirus 71 (EV71) enterovirus 71 (EV71) infection mouse infect with EV71 downregulated 28469998 3796 Mouse mmu-miR-3090 miRNA 177lu-octreotate neuroendocrine tumors Female BALB/c nude mice "inject 1.3, 3.6, 14, 45, or 140 MBq 177Lu-octreotate treatment" "miR-194, miR-107, miR-3090, and miR-3077 were commonly regulated" 25386939 3797 Mouse mmu-miR-3090-5p miRNA poly(ethylenimine) (PEI) cell death MEF cells poly(ethylenimine) (PEI) treatment upregulated 26158199 3798 Mouse mmu-miR-30a miRNA coxsackievirus B3 (CVB3) acute viral myocarditis (VM) mouse heart tissues Coxsackievirus B3 (CVB3) infection upregulated 30915768 3799 Mouse mmu-miR-30a miRNA alcohol alcoholic hepatitis (AH) sera alcohol exposure upregulated 26264599 3800 Mouse mmu-miR-30a miRNA ovalbumin (OVA) asthma lung tissues ovalbumin (OVA) treatment downregulated 31748850 3801 Mouse mmu-miR-30a miRNA diethylstilbestrol (DES) diethylstilbestrol (DES) triggers thymic atrophy mouse thymocytes Diethylstilbestrol (DES) treatment downregulated 30153466 3802 Mouse mmu-miR-30a miRNA hypoxia ischemic brain injury Neuronal Cells middle cerebral artery occlusion (MCAO) treatment downregulated 28854438 3803 Mouse mmu-miR-30a miRNA hypoxia ischemic stroke (IS) brain tissues 6 h middle cerebral artery occlusion without reperfusion treatment upregulation in the brain of mice 24771295 3804 Mouse mmu-miR-30a miRNA hypoxia ischemic stroke (IS) brain and N2A cells peri-infarct region of mice with 1 h MCAO/24 h reperfusion and in N2A cells after 1 h OGD/6-48 h reoxygenation treatment significantly downregulated 24771295 3805 Mouse mmu-miR-30a miRNA angiotensin-(1-7) mitochondrial fission HG-induced podocytes angiotensin-(1-7) treatment upregulated 27789249 3806 Mouse mmu-miR-30a miRNA oxygen glucose deprivation (OGD) neural ischemic injury cortical neurons oxygen-glucose deprivation (OGD) treatment downregulated 26301516 3807 Mouse mmu-miR-30a miRNA RANKL (receptor activator of nuclear factor ¦ÊB ligand) osteoclastogenesis mouse bone marrow-derived monocytes (BMMs) 30 ng/ml M-CSF and 100 ng/ml RANKL for 4 days treatment downregulated 29312525 3808 Mouse mmu-miR-30a miRNA Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria plasmodium chabaudi infection Balb/c Mice liver infect with Vaccination treatment downregulated in the Liver 28123381 3809 Mouse mmu-miR-30a miRNA radiation radiation-induced fibrosis (RIF) "CH3 mice muscle, skin, and subcutaneous tissue" the right hind legs of 9-week old CH3 mice by a single-fraction dose of irradiation to 35 Gy treatment dysregulated 24986745 3810 Mouse mmu-miR-30a miRNA ischemia renal fibrosis Renal tissues the left ureter was ligated at the lower pole level of kidney for 7 days downregulated 28285987 3811 Mouse mmu-miR-30a* miRNA high fat diet (HFD) chondrogenesis white adipose tissues high fat diet (HFD) feed downregulated 22496873 3812 Mouse mmu-miR-30a-3p miRNA deoxycorticosterone acetate-salt hypertension hypertensive nephropathy (HN) kidney tissues deoxycorticosterone acetate-salt hypertension treatment downregulated 31782248 3813 Mouse mmu-miR-30a-3p miRNA ethanol (EtOH) teratogenesis fetal brains of mice Ethanol?treatment upregulated 19091803 3814 Mouse mmu-miR-30a-5p miRNA alcohol alcohol toxicity male C57BL/6J mice mimics binge alcohol drinking in humans treatment upregulated 25330738 3815 Mouse mmu-miR-30a-5p miRNA pentachlorophenol (PCP) developmental toxicity pregnancy ICR mice placental chorionic villi Pentachlorophenol (PCP) exposure treatment downregulated 30597782 3816 Mouse mmu-miR-30a-5p miRNA pilocarpine epilepsy male NMRI mice inject intraperitoneally with pilocarpine treatment downregulated 25078263 3817 Mouse mmu-miR-30a-5p miRNA alcohol excessive alcohol intake medial PFC (mPFC) alcohol exposure upregulated 25330738 3818 Mouse mmu-miR-30a-5p miRNA high fat diet (HFD) obesity adipose tissue macrophages (ATMs) high fat diet (HFD) feed downregulated 29899524 3819 Mouse mmu-miR-30a-5p miRNA Co-Cr-Mo metal particles (CoPs) particle-induced osteolysis (PIO) MC3T3-E1 cells Co-Cr-Mo metal particles (CoPs) treatment "CoPs could up-regulate TSIX level, down-regulate miR-30a-5p expression." 29260905 3820 Mouse mmu-miR-30a-5p miRNA Co-Cr-Mo metal particles (CoPs) particle-induced osteolysis (PIO) MC3T3-E1 cells Co-Cr-Mo metal particles (CoPs) treatment downregulated 29260905 3821 Mouse mmu-miR-30a-5p miRNA pentachlorophenol (PCP) pentachlorophenol (PCP) developmental toxicity pregnancy ICR mice placenta Pentachlorophenol (PCP) treatment downregulated 30597782 3822 Mouse mmu-miR-30a-5p miRNA coxsackievirus B3 (CVB3) viral myocarditis (VM) heart tissues coxsackievirus B3 (CVB3) treatment miR-30a-5p was found to be highly expressed in VMC mice. 33416455 3823 Mouse mmu-miR-30b miRNA alcohol alcoholic hepatitis (AH) sera alcohol exposure upregulated 26264599 3824 Mouse mmu-miR-30b miRNA metformin (Met) anti-cancer therapy mice with 4-months-exposure of smoke oral metformin was used at a dose of 800 mg/kg diet treatment upregulated 24683044 3825 Mouse mmu-miR-30b miRNA fish oil brown adipose tissue thermogenesis brown adipocytes fish oil treatment upregulated 27489163 3826 Mouse mmu-miR-30b miRNA TGF-¦Â1 chondrocyte differentiation mouse embryo-derived stem cells C3H10T1/2 TGF-¦Â3 treatment downregulated 29285169 3827 Mouse mmu-miR-30b miRNA mechanical unloading disuse osteoporosis (DOP) MC3T3-E1 cells Mechanical unloading treatment upregulated 31757419 3828 Mouse mmu-miR-30b miRNA high glucose (HG) neural tube defects (NTDs) neural stem cells (NSCs) isolated from the forebrain of diabetic pregnancy embryos exposed to low or high glucose or hypoxia upregulated 28798665 3829 Mouse mmu-miR-30b miRNA hypoxia neural tube defects (NTDs) neural stem cells (NSCs) isolated from the forebrain of diabetic pregnancy embryos exposed to low or high glucose or hypoxia upregulated 28798665 3830 Mouse mmu-miR-30b miRNA low glucose (LG) neural tube defects (NTDs) neural stem cells (NSCs) isolated from the forebrain of diabetic pregnancy embryos exposed to low or high glucose or hypoxia upregulated 28798665 3831 Mouse mmu-miR-30b miRNA chronic intermittent hypoxia (CIH) obstructive sleep apnoea-hypopnoea syndrome (OSAHS) mouse aortic endothelial cells (MAECs) chronic intermittent hypoxia (CIH) treatment upregulated 29108914 3832 Mouse mmu-miR-30b miRNA tumor necrosis factor alpha (TNF-¦Á) osteoarthritis (OA) ADTC5 cells tumor necrosis factor alpha (TNF-¦Á) treatment upregulated 27941314 3833 Mouse mmu-miR-30b miRNA IL-1¦Â ¦Â-cell dysfunction MIN6 cells IL-1¦Â treatment upregulated 26367486 3834 Mouse mmu-miR-30b-3p miRNA angiotensin II (Ang II) cardiac hypertrophy HL-1 cells angiotensin II (Ang II) treatment downregulated 33130312 3835 Mouse mmu-miR-30b-3p miRNA angiotensin II (Ang II) cardiac hypertrophy The cardiomyocyte-like HL-1 cell lines angiotensin II (Ang II) treatment downregulated 33130312 3836 Mouse mmu-miR-30b-5p miRNA lipopolysaccharide (LPS) acute lung injury (ALI) "lung tissue, serum, and bronchoalveolar lavage fluid of mice" lipopolysaccharide (LPS) treatment downregulated 30600796 3837 Mouse mmu-miR-30b-5p miRNA angiotensin II (Ang II) cardiac fibrosis Cardiac fibroblasts (CFs) angiotensin II (Ang II) treatment downregulated 32329883 3838 Mouse mmu-miR-30b-5p miRNA high glucose (HG) diabetic nephropathy (DN) renal tissues high glucose (HG) treatment "In high glucose induced HK-2 cells, expression levels of miR-30b-5p and E-cadherin were decreased, while SNAI1, a-SMA and Vimentin were increased." 33383483 3839 Mouse mmu-miR-30c miRNA adherent-invasive escherichia coli (AIEC) crohn disease (CD) mouse enterocytes adherent invasive escherichia coli (AIEC) treatment upregulated 24148619 3840 Mouse mmu-miR-30c miRNA mechanical unloading disuse osteoporosis (DOP) MC3T3-E1 cells Mechanical unloading treatment upregulated 31757419 3841 Mouse mmu-miR-30c-1* miRNA polyphenols cell function mice liver cells Polyphenols treatment downregulated 22253797 3842 Mouse mmu-miR-30c-1* miRNA isoproterenol cardiac fibrosis heart tissues isoproterenol (ISO) treatment downregulated 27174579 3843 Mouse mmu-miR-30c-1-3p miRNA benzo(a)pyrene (BaP) lung fibrosis lung tissues benzo(a)pyrene (BaP) exposure downregulated 30543962 3844 Mouse mmu-miR-30c-1-3p miRNA benzo(a)pyrene (BaP) lung fibrosis lung tissues benzo(a)pyrene (BaP) exposure downregulated 30543962 3845 Mouse mmu-miR-30c-1-3p miRNA sulfur dioxide (SO2) lung fibrosis lung tissues SO2 treatment downregulated 30543962 3846 Mouse mmu-miR-30c-1-3p miRNA sulfur dioxide (SO2) lung fibrosis lung tissues sulfur dioxide (SO2)?exposure treatment downregulated 30543962 3847 Mouse mmu-miR-30c-2-3p miRNA tanshinone IIA (Tan IIA) atherosclerosis (AS) RAW 264.7 cells Tanshinone IIA (Tan) treatment upregulated 32337768 3848 Mouse mmu-miR-30c-5p miRNA cocaine cocaine abuse-related cardiovascular disease aortic smooth muscle cells Cocaine treatment upregulated 29483230 3849 Mouse mmu-miR-30c-5p miRNA cryptococcosis cryptococcal meningitis BV2 cells cryptococcosis infection downregulated 31958475 3850 Mouse mmu-miR-30c-5p miRNA high fat diet (HFD) obesity adipose tissue macrophages (ATMs) high fat diet (HFD) feed downregulated 29899524 3851 Mouse mmu-miR-30d miRNA mechanical unloading disuse osteoporosis (DOP) MC3T3-E1 cells Mechanical unloading treatment upregulated 31757419 3852 Mouse mmu-miR-30d miRNA lipopolysaccharide (LPS) epithelial-mesenchymal transition (EMT) hippocampus lipopolysaccharide (LPS) treatment LPS administration in mice significantly decreased miR-30d expression in the hippocampus. 29260931 3853 Mouse mmu-miR-30D miRNA testosterone prostate cancer female mouse liver Testosterone treatment "upregulation of the 6 miRNAs miR-22, miR-690, miR-122, let-7A, miR-30D and let-7D" 20600201 3854 Mouse mmu-miR-30d miRNA streptozocin (STZ) type 2 diabetes mellitus (T2DM) islet ¦Â-cell streptozotocin (STZ) treatment downregulated 29663360 3855 Mouse mmu-miR-30d-5p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral ischemia/reperfusion (I/R) injury Mouse N2a cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 33833132 3856 Mouse mmu-miR-30d-5p miRNA FTY720-mitoxy parkinson's disease (PD) dopaminergic MN16D cells FTY720-Mitoxy treatment upregulated 30359694 3857 Mouse mmu-miR-30d-5p miRNA FTY720-Mitoxy parkinson's disease (PD) MN9D cells FTY720-Mitoxy treatment upregulated 30359694 3858 Mouse mmu-miR-30e miRNA lipopolysaccharide (LPS) acute aortic dissection (AAD) aorta lipopolysaccharide (LPS) treatment downregulated 32634201 3859 Mouse mmu-miR-30e miRNA mechanical unloading disuse osteoporosis (DOP) MC3T3-E1 cells Mechanical unloading treatment upregulated 31757419 3860 Mouse mmu-miR-30e miRNA TGF-¦Â1 kidney fibrosis tubular epithelial cell TGF-¦Â1 treatment downregulated 23515048 3861 Mouse mmu-miR-30e miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) mouse substantia nigra pars compacta (SNpc) "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" downregulated in substantia nigra pars compacta (SNpc) 29274035 3862 Mouse mmu-miR-30e miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) substantia nigra pars compacta (SNpc) "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" downregulated 29274035 3863 Mouse mmu-miR-30e miRNA microwave microwave-induced adverse health outcomes mouse hippocampus 7 days after 30 mW/cm microwave exposure treatment downregulated 24748327 3864 Mouse mmu-miR-30e miRNA aldosterone podocyte apoptosis and mitochondrial dysfunction mouse proximal tubule cells (MPC5) aldosterone treatment downregulated 27974319 3865 Mouse mmu-miR-30e miRNA anandamide (AEA) pro-inflammatory activity mouse anandamide treatment AEA differentil regulate the expression of miRNA 24699635 3866 Mouse mmu-miR-30e miRNA melatonin radiation-induced injury 15 Gy irradiation exposured RAW 264.7 cells Melatonin treatment upregulated 30755784 3867 Mouse mmu-miR-30e miRNA ¦Ã-rays radiation-induced injury RAW 264.7 cells 15 Gy irradiation exposure treatment downregulated 30755784 3868 Mouse mmu-miR-30e* miRNA isoproterenol cardiac fibrosis heart tissues isoproterenol (ISO) treatment downregulated 27174579 3869 Mouse mmu-miR-30e* miRNA high fat diet (HFD) chondrogenesis white adipose tissues high fat diet (HFD) feed downregulated 22496873 3870 Mouse mmu-miR-30e-5p miRNA particulate matter (PM2.5) chronic obstructive pulmonary disease (COPD) lung tissues; blood; RAW264.7 cells Fine particulate matter (PM2.5) treatment downregulated 32707273 3871 Mouse mmu-miR-30e-5p miRNA "CB1 antagonist, AM251" diet-induced obesity (DIO) F4/80+ cells from stromal vascular fractions (SVF) of epididymal fat "CB1 antagonist, AM251 treatment" upregulated 31134094 3872 Mouse mmu-miR-30e-5p miRNA deflazacort inflammation RAW 264.7 cells deflazacort treatment downregulated 32153563 3873 Mouse mmu-miR-30e-5p miRNA lipopolysaccharide (LPS) inflammation RAW 264.7 cells lipopolysaccharide (LPS) treatment upregulated 32153563 3874 Mouse mmu-miR-30e-5p miRNA prednisolone inflammation RAW 264.7 cells lipopolysaccharide (LPS) treatment downregulated 32153563 3875 Mouse mmu-miR-30e-5p miRNA leishmania leishmaniasis Bone marrowderived macrophages (BMDMs) Leishmania infection upregulated 30949455 3876 Mouse mmu-miR-30e-5p miRNA high fat diet (HFD) obesity adipose tissue macrophages (ATMs) high fat diet (HFD) feed downregulated 29899524 3877 Mouse mmu-miR-30e-5p miRNA ethanol (EtOH) teratogenesis fetal brains of mice Ethanol?treatment downregulated 19091803 3878 Mouse mmu-miR-31 miRNA staphylococcal enterotoxin B (SEB) acute inflammatory lung injury lung staphylococcal enterotoxin B treatment upregulated 25564423 3879 Mouse mmu-miR-31 miRNA ovalbumin (OVA) allergic rhinitis (AR) nasal mucosa ovalbumin (OVA) treatment The expression levels of miR-31 were significantly decreased in the nasal mucosa of the AR group compared with those in the control group. 33179116 3880 Mouse mmu-miR-31 miRNA ovalbumin (OVA) asthma lung tissues OVA (ovalbumin) treatment upregulated 31298396 3881 Mouse mmu-miR-31 miRNA cerulein chronic pancreatitis (CP) pancreas cerulein treatment upregulated 29303912 3882 Mouse mmu-miR-31 miRNA "2,4,6-trinitrobenzene sulfonic acid (TNBS)" colitis CD4+ T cells "2,4,6-Trinitrobenzenesulfonic acid solution (TNBS) treatment" upregulated 31730734 3883 Mouse mmu-miR-31 miRNA resveratrol colitis CD4+ T cells resveratrol (RS) treatment downregulated 31730734 3884 Mouse mmu-miR-31 miRNA resveratrol colitis mesenteric lymph node (MLN) resveratrol (RS) treatment Resveratrol Downregulates miR-31 to Promote T Regulatory Cells during Prevention of TNBS-Induced Colitis 31730734 3885 Mouse mmu-miR-31 miRNA IL-10 colonic inflammation colonic intraepithelial lymphocytes IL-10 treatment downregulated 22043014 3886 Mouse mmu-miR-31 miRNA IL-10 epithelial-mesenchymal transition (EMT) colonic intraepithelial lymphocytes IL-10 treatment upregulated 22043014 3887 Mouse mmu-miR-31 miRNA high fat diet (HFD) hepatocellular carcinoma (HCC) plasma and hepatic tissues high fat diet (HFD) feed upregulated 26728044 3888 Mouse mmu-miR-31 miRNA angiotensin II (Ang II) hypertension "the aorta, splenic CD4+ T cells, and kidney leukocytes" angiotensin II (Ang II) treatment upregulated 30929511 3889 Mouse mmu-miR-31 miRNA oxygen glucose deprivation (OGD) ischemic stroke (IS) mouse brain and astrocytes "C57BL/6J mice were used to establish the middle cerebral artery occlusion (MCAO) model. Following the establishment of an oxygen-glucose deprivation (OGD) model, the astrocytes were cocultured with neuronal OGD.? treatment" downregulated 31517390 3890 Mouse mmu-miR-31 miRNA "TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin)" kaposi's sarcoma (KS) fetal thymocytes of mice "TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) treatment" downregulated 23024791 3891 Mouse mmu-miR-31 miRNA "indole-3-carbinol (I3C) and 3,3'-diindolylmethane (DIM)" liver damage SEB into D-galactosamine-sensitized female C57BL/6 mice "indole-3-carbinol (I3C) and 3,3'-diindolylmethane (DIM) treatment" downregulated 25706292 3892 Mouse mmu-miR-31 miRNA binase lymphosarcoma RLS40 cells binase treatment downregulated 33147876 3893 Mouse mmu-miR-31 miRNA stretch myoblast proliferation C2C12 myoblasts stretch treatment downregulated 27840929 3894 Mouse mmu-miR-31 miRNA dietary methionine restriction (MR) osteoblast differentiation and function "male C57BL/6J mice bone marrow,plasma and liver" fed diets containing 0.86% or 0.12% methionine for 5 weeks "upregulated (miR-31 in plasma and liver, and miR-133a, miR-335-5p, and miR-204 in the bone marrow" 27191548 3895 Mouse mmu-miR-31 miRNA nuclear factor kappa-B (NF-¦ÊB) psoriatic keratinocytes NF-¦ÊB treatment upregulated 26138368 3896 Mouse mmu-miR-31 miRNA clozapine (CLZ) psychotic disorders mouse brain clozapine treatment upregulated 23318695 3897 Mouse mmu-miR-31 miRNA leptin age-associated loss of muscle mass skeletal muscle ?leptin treatment ?leptin treatment increased the expression of miR-31 and miR-223 20800581 3898 Mouse mmu-miR-31 miRNA "2,4,6-trinitrobenzene sulfonic acid (TNBS)" ulcerative colitis (UC) colon tissues "2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol treatment" upregulated 31378906 3899 Mouse mmu-miR-31 miRNA azacitidine (AZA) ulcerative colitis (UC) "2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol-induced ulcerative colitis (UC) mice colon tissues" azacitidine (AZA) treatment downregulated 31378906 3900 Mouse mmu-miR-31 miRNA mesalazine (MSLZ) ulcerative colitis (UC) "2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol-induced ulcerative colitis (UC) mice colon tissues" mesalazine (MSLZ) treatment downregulated 31378906 3901 Mouse mmu-miR-3100-5p miRNA propofol (PPF) propofol-induced developmental neurotoxicity hippocampus propofol treatment upregulated 30242182 3902 Mouse mmu-miR-3102-3p miRNA Japanese encephalitis virus (JEV) Japanese encephalitis virus (JEV) infection brain tissues; BV2 cells Japanese encephalitis virus (JEV) infection upregulated 32552669 3903 Mouse mmu-miR-3102-3p miRNA ganoderma lucidum extract (GLE) hepatocellular carcinoma (HCC) Hepa 1-6 cells Ganoderma lucidum extract (GLE) treatment upregulated 32106374 3904 Mouse mmu-miR-3104-5p miRNA dioscorea bulbifera (DB) liver damage livers dioscoreae bulbifera (EF) treatment upregulated 27609015 3905 Mouse mmu-miR-3107* miRNA isoproterenol cardiac fibrosis heart tissues isoproterenol (ISO) treatment downregulated 27174579 3906 Mouse mmu-miR-3113 miRNA azoxymethane (AOM) colorectal cancer (CRC) mouse colon tissues azoxymethane (AOM) treatment upregulated in colon samples 29066742 3907 Mouse mmu-miR-31-3p miRNA dextran sodium sulfate (DSS) colitis male C57BL/6J mice colon DSS treatment upregulated 29253460 3908 Mouse mmu-miR-31-3p miRNA trinitrobenzene sulfonic acid (TNBS) colitis male C57BL/6J mice colon TNBS treatment upregulated 29253460 3909 Mouse mmu-miR-31-5p miRNA astaxanthin neuroinflammation Lipopolysaccharide (LPS)-treated BV2 cells astaxanthin (ATX) treatment downregulated 33359248 3910 Mouse mmu-miR-31-5p miRNA azoxymethane (AOM) and dextran sulfate sodium (DSS) colitis-associated colon cancer (CAC) colon tissue azoxymethane (AOM) and dextran sulfate sodium (DSS) treatment upregulated 31100679 3911 Mouse mmu-miR-31-5p miRNA azoxymethane (AOM) and dextran sulfate sodium (DSS) colitis-associated colon cancer (CAC) colon tissues azoxymethane (AOM) and dextran sulfate sodium (DSS) treatment upregulated 31275360 3912 Mouse mmu-miR-31-5p miRNA pedunculoside colitis-associated colon cancer (CAC) CAC mice colon tissues pedunculoside treatment downregulated 31275360 3913 Mouse mmu-miR-31-5p miRNA water extract of I. rotunda (WIR) colitis-associated colon cancer (CAC) CAC mice colon tissue water extract of I. rotunda (WIR) treatment downregulated 31100679 3914 Mouse mmu-miR-31-5p miRNA solar particle event (SPE) colorectal cancer (CRC) plasma of a colorectal cancer susceptible mouse solar particle event (SPE) treatment downregulated 26432591 3915 Mouse mmu-miR-31-5p miRNA ¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) experimental autoimmune encephalomyelitis (EAE) murine brain-derived CD4+ T cells ¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) combination treatment downregulated 31497013 3916 Mouse mmu-miR-31-5p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce upregulated 30936699 3917 Mouse mmu-miR-31-5p miRNA barium chloride muscle injury C2C12 cells barium chloride treatment upregulated 32954829 3918 Mouse mmu-miR-31-5p miRNA retinoic acid (RA) cell proliferation embryonic tongue and C2C12 myoblasts retinoid acid treatment upregulated 28526071 3919 Mouse mmu-miR-31-5p miRNA imiquimod (IMQ) psoriasis skin tissues imiquimod (IMQ) treatment upregulated 31278779 3920 Mouse mmu-miR-31-5p miRNA lipopolysaccharide (LPS) sepsis RAW264.7 cells lipopolysaccharide (LPS) treatment "NEAT1 and POU domain class 2 transcription factor 1 (POU2F1) were highly expressed in LPS-induced septic RAW264.7 cells, opposite to miR-31-5p expression." 33710444 3921 Mouse mmu-miR-31-5p miRNA L©\arginine severe acute pancreatitis (SAP) pancreatic tissues L-arginine treatment downregulated 33122522 3922 Mouse mmu-miR-3162-3p miRNA ovalbumin (OVA) asthma lung tissues ovalbumin treatment upregulated 32610326 3923 Mouse mmu-miR-3185 miRNA mechanical asphyxia asphyxial death heart tissues mechanical asphyxia treatment miR-3185 was upregulated in cardiac tissues among cases of mechanical asphyxia. 32320934 3924 Mouse mmu-miR-32 miRNA high glucose (HG) liver fibrosis AML12 cells high glucose (HG) treatment upregulated 30816482 3925 Mouse mmu-miR-32 miRNA high glucose (HG) mesenchymal stem cells (MSCs) dysfunction mice bone marrow-derived mesenchymal stem cells high glucose treatment downregulated 23524257 3926 Mouse mmu-miR-32 miRNA microwave microwave-induced adverse health outcomes mouse hippocampus 7 days after 30 mW/cm microwave exposure treatment downregulated 24748327 3927 Mouse mmu-miR-320 miRNA "anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE)" bronchial epithelial cell cancer 16HBE-T cells "anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE) treatment" upregulated 19462682 3928 Mouse mmu-miR-320 miRNA palmitic acid (PA) inflammation mature 3T3-L1 adipocytes palmitic acid (PA) treatment upregulated 31634961 3929 Mouse mmu-miR-320 miRNA high fat diet (HFD) inflammatory response skeletal muscle of mice high fat diet (HFD) feed "miR-375, miR-29, miR-320, miR-103/107 and miR-126, play a crucial role in the regulation of glucose and lipid metabolism through the control of pancreatic islet cell function" 22395471 3930 Mouse mmu-miR-320 miRNA metformin (Met) insulin resistance (IR) 3T3L1 cells Metformin treatment IR adipocytes downregulated miR-320 in response to Metformin graded concentrations. 32367399 3931 Mouse mmu-miR-320 miRNA prion neurodegeneration (ND) the brains tissues prion infection treatment upregulated 18987751 3932 Mouse mmu-miR-320 miRNA pregnant mare serum gonadotropin reproduction and some steroid-related disorders mouse ovarian granulosa cells pregnant mare serum gonadotropin treatment suppression of miR-320 expression in a time-dependent manner 24828505 3933 Mouse mmu-miR-3202 miRNA high glucose (HG) apoptosis endothelial cell line H5V high-glucose upregulated 28228635 3934 Mouse mmu-miR-320-3p miRNA Jiang Tang Xiao Ke Granule diabetes mellitus (DM) KKAy diabetic mice Jiang Tang Xiao Ke Granule treatment dysregulated 29163176 3935 Mouse mmu-miR-320-3p miRNA high glucose (HG) diabetic cardiomyopathy (DCM) newborn mouse cardiomyocyte (NMC) high glucose (HG) treatment Gas5/miR-320-3p/Tcf3 pathway was found to modulate the apoptosis of NMC. 32003049 3936 Mouse mmu-miR-320-3p miRNA glyphosate neurodevelopmental disorder prefrontal cortex of mouse offspring glyphosate dysregulated 29467848 3937 Mouse mmu-miR-320-3p miRNA busulphan sertoli cells-only syndrome (SCOS) murine testis busulphan treatment upregulated 30237478 3938 Mouse mmu-miR-320-3p miRNA carbon tetrachloride (CCl4) steatosis plasma carbon tetrachloride (CCl4) treatment upregulated 30125006 3939 Mouse mmu-miR-320-3p miRNA dexamethasone (DEX) steatosis plasma dexamethasone (DEX) treatment upregulated 30125006 3940 Mouse mmu-miR-320a miRNA hypoxia diabetic retinopathy (DR) Mu?ller cells hypoxia treatment miR-320a was reduced by hypoixa treatment. 32830348 3941 Mouse mmu-miR-320a miRNA IL-33 inflammatory bowel disease (IBD) intestinal epithelial cell (IEC) isolated from IL-33-treated dextran sodium sulfate (DSS) colitic mice IL-33 treatment upregulated 30224451 3942 Mouse mmu-miR-320c miRNA streptozocin (STZ) type 1 diabetes mellitus (T1DM) serum streptozocin (STZ) treatment Secretions of miR-320c was significantly increased in streptozotocin-treated mice 29370422 3943 Mouse mmu-miR-322 miRNA hypoxia hypoxia-induced cardiac dysfunctions cardiomyocytes hypoxia treatment upregulated 27398164 3944 Mouse mmu-miR-322 miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharide (LPS) treatment downregulated 27986864 3945 Mouse mmu-miR-322 miRNA dexamethasone (DEX) muscle atrophy Murine C2C12 myoblast cells dexamethasone (DEX) treatment upregulated 23716137 3946 Mouse mmu-miR-322 miRNA plasmodium plasmodium infection exosomes derived from the plasma infect with Plasmodium treatment upregulated 28650446 3947 Mouse mmu-miR-322 miRNA glucose type 2 diabetes mellitus (T2DM) isolated mouse islets exposed to high levels of glucose within 1 h treatment downregulated 25489007 3948 Mouse mmu-miR-322/424 miRNA carbon tetrachloride (CCl4) liver fibrosis mouse liver tissue CCl4 treatment "miR-322/424 level in liver cirrhosis patients, mouse liver fibrosis induced by CCl4?and BDL, and rat liver fibrosis induced by CCl4?and dimethylnitrosamine was increased." 33333053 3949 Mouse mmu-miR-322-3p miRNA liraglutide type 2 diabetes mellitus (T2DM) whole bone marrow exosomes liraglutide 0.2 mg/kg for 2 months dysregulated 29133778 3950 Mouse mmu-miR-322-5p miRNA angiotensin II (Ang II) cardiac hypertrophy primary cardiomyocytes (PCM) angiotensin II (Ang II) treatment downregulated 32436661 3951 Mouse mmu-miR-322-5p miRNA glyphosate neurodevelopmental disorder prefrontal cortex of mouse offspring glyphosate dysregulated 29467848 3952 Mouse mmu-miR-322-5p miRNA high fat diet (HFD) obesity liver tissues high fat diet (HFD) feed upregulated 32593682 3953 Mouse mmu-miR-324-3p miRNA ¦Â-glycerophosphate (¦Â-GP) and pyruvic acid coronary artery calcification (CAC) mouse smooth muscle cell line (MOVAS-1) ¦Â-glycerophosphate (¦Â-GP) and pyruvic acid treatment upregulated 31733402 3954 Mouse mmu-miR-324-3p miRNA ¦Â-glycerophosphate (¦Â-GP) and pyruvic acid coronary artery calcification (CAC) exosomes from mouse vascular smooth muscle cells line MOVAS-1 "To induce calcification, the MOVAS-1 cells were maintained in normal cell culture medium supplied with 10 mM ¦Â-glycerophosphate (¦Â-GP) (Sigma, UK) and 10 nM pyruvic acid for 21 d successively, and the culture medium was renewed every 3 d." upregulated 31733402 3955 Mouse mmu-miR-324-3p miRNA prednisolone duchenne muscular dystrophy (DMD) diaphragm muscle prednisolone treatment downregulated 29883261 3956 Mouse mmu-miR-324-3p miRNA vamorolone duchenne muscular dystrophy (DMD) diaphragm muscle vamorolone treatment downregulated 29883261 3957 Mouse mmu-miR-324-3p miRNA urocortin 1 (Ucn-1) myocardial ischemia/reperfusion (I/R) injury (MIRI) I/R mosue administration of Ucn-1 at the beginning of reperfusion treatment upregulated 28827743 3958 Mouse mmu-miR-324-5p miRNA high glucose (HG) diabetic nephropathy (DN) Mouse podocytes (MPC5) high glucose treatment upregulated 30095204 3959 Mouse mmu-miR-324-5p miRNA polychlorinated biphenyls (PCBs) cell differentiation P19 mouse embryonal carcinoma cells polychlorinated biphenyls (PCBs) treatment downregulated 23443104 3960 Mouse mmu-miR-325 miRNA anoxia/reoxygenation (A/R) heart failure (HF) cardiomyocytes were isolated from 1-2 days old mice anoxia(5% CO2 and 95% N2 )and subjected to reoxygenation (95% O2 and 5% CO2) treatment upregulated 24531537 3961 Mouse mmu-miR-325 miRNA ischemia/reperfusion (I/R) heart failure (HF) heart tissues ischemia/reperfusion (I/R) treatment upregulated 24531537 3962 Mouse mmu-miR-325-3p miRNA IL-1¦Â cementum regeneration "The cementoblast cell line, named OCCM©\30" interleukin 1¦Â (IL1¦Â) treatment upregulated 31680324 3963 Mouse mmu-miR-325-3p miRNA hypoxia myocardial infarction (MI) primary cultured cardiomyocytes hypoxia induce downregulated 31248365 3964 Mouse mmu-miR-325-3p miRNA chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) plvic inflammatory disease mouse two Chlamydia muridarum variants (C. muridarum Var001 [CmVar001] and CmVar004) infection were upregulated during CmVar004 infection compared to CmVar001 infection 24961692 3965 Mouse mmu-miR-325-3p miRNA lipopolysaccharide (LPS) spinal cord injury (SCI) primary microglia/BV2 cells lipopolysaccharide (LPS) treatment downregulated 30911940 3966 Mouse mmu-miR-325-3p miRNA lipopolysaccharide (LPS) spinal cord injury (SCI) BV2 cells lipopolysaccharides (LPS) treatment LncRNA H19 Regulates Lipopolysaccharide (LPS)-Induced Apoptosis and Inflammation of BV2 Microglia Cells Through Targeting miR-325-3p/NEUROD4 Axis. 33205379 3967 Mouse mmu-miR-325-3p miRNA mycobacterium tuberculosis (Mtb) tuberculosis (TB) RAW 264.7 cells M. tuberculosis infection microRNA-325-3p (miR-325-3p) is upregulated after M. tuberculosis infection. 32487755 3968 Mouse mmu-miR-325-5p miRNA manganese (Mn) parkinson's disease (PD) MN9D dopaminergic cell exosomes Mn exposure (300¦ÌM MnCl2) for 24h upregulated in exosomes 28450057 3969 Mouse mmu-miR-32-5p miRNA lipopolysaccharide (LPS) depression hippocampus and prefrontal cortex lipopolysaccharide (LPS) treatment upregulated 31698013 3970 Mouse mmu-miR-32-5p miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity plasma doxorubicin (DOX) treatment upregulated 30453253 3971 Mouse mmu-miR-32-5p miRNA perfluorooctanoic acid hepatotoxicity liver tissues Perfluorooctanoic acid (PFOA) exposure treatment upregulated 24459700 3972 Mouse mmu-miR-326 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues lipopolysaccharide (LPS) treatment upregulated 29727715 3973 Mouse mmu-miR-326 miRNA 0.05% NaI autoimmune thyroiditis (AIT) thyroid tissues 0.05% NaI treatment upregulated 29181619 3974 Mouse mmu-miR-326 miRNA NaI autoimmune thyroiditis (AIT) spleen tissues 0.05% NaI treatment upregulated 29181619 3975 Mouse mmu-miR-326 miRNA lipopolysaccharide (LPS) autophagy RAW 264.7 cells lipopolysaccharide (LPS) treatment downregulated 29845275 3976 Mouse mmu-miR-326 miRNA IL-10 epithelial-mesenchymal transition (EMT) colonic intraepithelial lymphocytes IL-10 treatment upregulated 22043014 3977 Mouse mmu-miR-326 miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues CCl4 treatment downregulated 31692098 3978 Mouse mmu-miR-326 miRNA natalizumab multiple sclerosis (MS) MS mouse CD4(+) T cells natalizumab treatment downregulated 25642434 3979 Mouse mmu-miR-326 miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) Parkinson's disease (PD) "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" downregulated 31135066 3980 Mouse mmu-miR-326 miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) Parkinson's disease (PD) "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" downregulated 31270675 3981 Mouse mmu-miR-326 miRNA natalizumab relapsing-remitting multiple sclerosis (RRMS) splenocytes natalizumab treatment downregulated 25642434 3982 Mouse mmu-miR-326 miRNA lipopolysaccharide (LPS) sepsis-induced acute lung injury murine lungs; RAW264.7 lipopolysaccharide (LPS) treatment miR-326 was downregulated in murine lungs and macrophages upon lipopolysaccharide (LPS) stimulation. 32530324 3983 Mouse mmu-miR-326 miRNA silicon dioxide (SiO2) silicosis HBE and A549 cells silicon dioxide (SiO2) treatment "miR-326 is downregulated in the fibrotic lung tissues of silica-treated mice, while increased expression of miR-326 attenuates silica-induced pulmonary fibrosis in vivo" 31642316 3984 Mouse mmu-miR-326-3p miRNA Japanese encephalitis virus (JEV) Japanese encephalitis virus (JEV) infection brain tissues; BV2 cells Japanese encephalitis virus (JEV) infection downregulated 32552669 3985 Mouse mmu-miR-326-3p miRNA cadmium (Cd) toxic effects of cadmium rat kidneys; NRK-52E cadmium (Cd) treatment upregulated 31626960 3986 Mouse mmu-miR-326-5p miRNA "15-deoxy-¦¤12, 14-prostaglandin J2 (15d-PGJ2)" liver damage bone marrow (BM)-derived macrophage (BMM) of liver injury mouse "15-deoxy-¦¤12, 14-prostaglandin J2 (15d-PGJ2) treatment" upregulated 28748390 3987 Mouse mmu-miR-327 miRNA low chromium (Cr) insulin resistance (IR) liver fed a control or LC diet for 13 weeks dysregulatedin liver 29286159 3988 Mouse mmu-miR-328 miRNA isoproterenol cardiac hypertrophy heart tissues ISO treatment upregulated 24631114 3989 Mouse mmu-miR-328 miRNA prion neurodegeneration (ND) the brains tissues prion infection treatment upregulated 18987751 3990 Mouse mmu-miR-328-3p miRNA dietary methionine restriction (MR) diet-induced obesity (DIO) high-fat-diet-induced obesity (DIO) mouse liver tissues dietary methionine restriction (MR) treatment upregulated 30512228 3991 Mouse mmu-miR-328-3p miRNA high fat diet (HFD) diet-induced obesity (DIO) liver tissues high fat diet (HFD) feed downregulated 30512228 3992 Mouse mmu-miR-328-3p miRNA hypoxia hypoxic pulmonary hypertension (HPH) pulmonary artery smooth muscle cells (PASMCs) hypoxia induce "Lower expression of miR-328-3p were observed in iPAH-PASMCs and relevant HPH models. Upregulation of lncRNA-MEG3 sequesters cytoplasmic miR-328-3p, eventually leading to expression of IGF1R, revealing a regulatory mechanism by lncRNAs in hypoxia-induced PASMC proliferation." 31477557 3993 Mouse mmu-miR-328-3p miRNA licochalcone A (LA) lung cancer MLE-12 cells Licochalcone A (lico A) treatment upregulated 32505917 3994 Mouse mmu-miR-328-3p miRNA murine cytomegalovirus (MCMV) murine cytomegalovirus (MCMV) infection cardiac tissue murine cytomegalovirus (MCMV) infection downregulated 33245094 3995 Mouse mmu-miR-329 miRNA D-galactosamine/lipopolysaccharide (D-GalN/LPS) acute liver injury (ALI) liver tissues D-GalN/LPS treatment downregulated 31061003 3996 Mouse mmu-miR-329 miRNA H2O2 Alzheimer's disease (AD) Primary hippocampal neuron cells H2O2 treatment upregulated 24423585 3997 Mouse mmu-miR-329 miRNA H2O2 Alzheimer's disease (AD) senescence accelerated mouse prone 8 (SAMP8) and prone 10 (SAMP10) "different concentrations (0, 100, 200, 400 and 800 ¦ÌM) of H2O2 treatment" upregulated 24423585 3998 Mouse mmu-miR-329 miRNA clozapine (CLZ) psychotic disorders mouse brain clozapine treatment upregulated 23318695 3999 Mouse mmu-miR-329-3p miRNA microcystin-leucine arginine (MC-LR) male infertility GT1-7 cells Microcystin-leucine arginine (MC-LR) treatment downregulated 30064084 4000 Mouse mmu-miR-33 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) Pulmonary microvascular endothelial cells (PMVECs) lipopolysaccharide (LPS) treatment downregulated 30761836 4001 Mouse mmu-miR-33 miRNA farnesoid X receptor (FXR) cholesterol homeostasis hepatic farnesoid X receptor (FXR) treatment upregulated 25593129 4002 Mouse mmu-miR-33 miRNA averrhoa carambola free phenolic extract (ACF) hepatic steatosis leptin receptor-deficient (db/db) mice averrhoa carambola free phenolic extract (ACF) treatment downregulated 29090700 4003 Mouse mmu-miR-33 miRNA lychee pulp phenolics (LPPs) hypolipidemic mechanism high-fat diet (HFD) mouse hepatocytes lychee pulp phenolics (LPPs) treatment downregulated in mouse hepatocytes 28121324 4004 Mouse mmu-miR-33 miRNA glucagon-like peptide-1 (GLP-1) lipotoxic oxidative stress FFA-treated INS-1 cells GLP-1 downregulated 27956176 4005 Mouse mmu-miR-33 miRNA lonicera caerulea berry polyphenols (LCBP) macrophage foam cell formation ox-LDL-treated RAW264.7 Lonicera caerulea berry polyphenols (LCBP) treatment downregulated 31146527 4006 Mouse mmu-miR-33 miRNA oxidized low density lipoprotein (ox-LDL) macrophage foam cell formation RAW264.7 oxidized low-density lipoprotein (ox-LDL) treatment upregulated 31146527 4007 Mouse mmu-miR-33 miRNA high glucose (HG) and cholesterol-lowering drugs atorvastatin and pitavastatin metabolic syndrome Murine macrophage cell line RAW264.7 high glucose and cholesterol-lowering drugs atorvastatin and pitavastatin treatment upregulated 27139226 4008 Mouse mmu-miR-33 miRNA aerobic exercise nonalcoholic fatty liver disease (NAFLD) non-alcoholic fatty liver disease (NAFLD) mouse liver tissues aerobic exercise training (AET) treatment upregulated 28163011 4009 Mouse mmu-miR-33 miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) mouse liver tissues high fat diet (HFD) feed downregulated 28163011 4010 Mouse mmu-miR-33 miRNA high fat diet (HFD) obesity mouse high fat diet (HFD) feed downregulated 28163011 4011 Mouse mmu-miR-33 miRNA training obesity obesity mouse liver continuous endurance training treatment upregulated 28163011 4012 Mouse mmu-miR-33 miRNA fructo-oligosaccharides (FOS) tubulointerstitial fibrosis (TIF) liver tissue of mice ?fructo-oligosaccharides (FOS)treatment treatment upregulated 23203768 4013 Mouse mmu-miR-330 miRNA "7,12-dimethylbenz(¦Á)anthracene (DMBA)" "7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity" liver tissues "7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment" miR-330 was upregulated in the liver tissues of male mice. 32871758 4014 Mouse mmu-miR-330 miRNA "7,12-dimethylbenz(¦Á)anthracene (DMBA)" "7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity" kidneny tissues "7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment" miR-330 was upregulated in the kidney tissues of female mice. 32871758 4015 Mouse mmu-miR-330 miRNA "7,12-dimethylbenz(¦Á)anthracene (DMBA)" "7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity" kidneny tissues "7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment" miR-330 was downregulated in the kidney tissues of male mice. 32871758 4016 Mouse mmu-miR-330 miRNA lipopolysaccharide (LPS) parkinson's disease (PD) primary microglial cells lipopolysaccharide (LPS) treatment The expression of microRNA-330 increased in the first 4 days and reached a plateau subsequently after LPS treatment 33325083 4017 Mouse mmu-miR-330-3p miRNA phenylephrine (PE) cardiac hypertrophy cardiomyocytes phenylephrine (PE) treatment downregulated 30297107 4018 Mouse mmu-miR-330-3p miRNA hypoxia hepatic ischemia/reperfusion injury (HIRI) AML12 cells hypoxia treatment downregulated 30269356 4019 Mouse mmu-miR-330-3p miRNA mineral oil hepatic ischemia/reperfusion injury (HIRI) AML12 cells mineral oil treatment downregulated 30269356 4020 Mouse mmu-miR-330-5p miRNA lipopolysaccharide (LPS) pulmonary vascular endothelial cell (PVEC) injury human pulmonary microvascular endothelial cells (HPMECs) lipopolysaccharide (LPS) treatment "PRNCR1 and TLR4 levels were significantly upregulated in LPS-treated PVEC, both in vivo and in vitro, while miR-330-5p were downregulated. Inhibiting PRNCR1 or overexpressing miR-330-5p markedly attenuated LPS-induced PVEC injury." 33049095 4021 Mouse mmu-miR-330-5p miRNA lipopolysaccharide (LPS) sepsis-induced myocardial injury HL-1 cells lipopolysaccharide (LPS) treatment LncRNA MIAT Promotes Inflammation and Oxidative Stress in Sepsis-Induced Cardiac Injury by Targeting miR-330-5p/TRAF6/NF-¦ÊB Axis 32556678 4022 Mouse mmu-miR-330-5p miRNA high fat diet (HFD) type 2 diabetes mellitus (T2DM) isolated adipose tissue macrophages high fat diet (HFD) feed upregulated 29433065 4023 Mouse mmu-miR-331 miRNA stretch myoblast proliferation C2C12 myoblasts stretch treatment downregulated 27840929 4024 Mouse mmu-miR-331-3p miRNA pilocarpine epilepsy male NMRI mice inject intraperitoneally with pilocarpine treatment downregulated 25078263 4025 Mouse mmu-miR-331-3p miRNA hemin intracerebral haemorrhage (ICH) BV2 cells hemin treatment downregulated 32596340 4026 Mouse mmu-miR-331-5p miRNA gastrodin and rhynchophylline ischemia/reperfusion (I/R) injury hypoxia-induced mouse brain tissues and BV2 cells combination of gastrodin and rhynchophylline treatment upregulated 31610203 4027 Mouse mmu-miR-331-5p miRNA oxygen glucose deprivation (OGD) ischemia/reperfusion (I/R) injury mouse brain tissues and BV2 cells Middle cerebral artery occlusion (MCAO) mice and oxygen glucose deprivation (OGD)-treated BV2 cells were used as in vivo and in vitro models of ischaemia treatment downregulated 31610203 4028 Mouse mmu-miR-33-3p miRNA X-rays bystander effect C57BL/6 mice extracellular vesicles (EVs) otal-body irradiated with X-rays downregulated 28396668 4029 Mouse mmu-miR-335 miRNA C-phycocyanin (CPC) Alzheimer's disease (AD) hippocampal tissues C-phycocyanin (CPC) treatment downregulated 33312721 4030 Mouse mmu-miR-335 miRNA green tea (GT) obesity adipose tissues green tea (GT) treatment GT reverses HFD-induced upregulated of miR-155 and -335 in epididymal adipose tissues. 29734116 4031 Mouse mmu-miR-335 miRNA traditional Chinese medicine Changqin NO. 1 traumatic brain injury (TBI) brain tissues and primary neurons traditional Chinese medicine Changqin NO. 1 treatment Changqin NO 1 promoted neuroprotective effects by inhibiting neuronal apoptosis via the GAS5/miR-335/Rasa1 axis in TBI 30653462 4032 Mouse mmu-miR-335-3p miRNA high fat diet (HFD) hepatic insulin resistance mouse liver tissues high fat diet (HFD) feed upregulated 30820263 4033 Mouse mmu-miR-335-3p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce downregulated 30936699 4034 Mouse mmu-miR-335-5p miRNA high glucose (HG) diabetic osteoporosis MC3T3-E1 osteoblast cell line high glucose treatment downregulated 26986081 4035 Mouse mmu-miR-335-5p miRNA streptozocin (STZ) gestational diabetes mellitus (GDM) pancreatic islet ¦Â-cells streptozotocin (STZ) treatment upregulated 30341900 4036 Mouse mmu-miR-335-5p miRNA spatial learning impairment in long-term memory CD1 male mice spatial learning with morris water maze treatment downregulated in hippocampal 28039088 4037 Mouse mmu-miR-335-5p miRNA dietary methionine restriction (MR) osteoblast differentiation and function "male C57BL/6J mice bone marrow,plasma and liver" fed diets containing 0.86% or 0.12% methionine for 5 weeks "upregulated (miR-31 in plasma and liver, and miR-133a, miR-335-5p, and miR-204 in the bone marrow" 27191548 4038 Mouse mmu-miR-335-5p miRNA tumor necrosis factor alpha (TNF-¦Á) osteogenesis MC3T3-E1 cells; primary calvarial osteoblasts tumor necrosis factor alpha (TNF-¦Á) treatment downregulated 32468044 4039 Mouse mmu-miR-335-5p miRNA ¦Â-elemene oxygen-induced retinopathy (OIR) Retinas tissues ¦Â-elemene treatment upregulated 30664207 4040 Mouse mmu-miR-33-5p miRNA bupivacaine apoptosis dorsal root ganglion (DRG) cells bupivacaine treatment upregulated 30617464 4041 Mouse mmu-miR-337-3p miRNA prion neurodegeneration (ND) the brains tissues prion infection treatment downregulated 18987751 4042 Mouse mmu-miR-337-3p miRNA ganoderma lucidum extract (GLE) hepatocellular carcinoma (HCC) Hepa 1-6 cells Ganoderma lucidum extract (GLE) treatment upregulated 32106374 4043 Mouse mmu-miR-337-5p miRNA clozapine (CLZ) psychotic disorders mouse brain clozapine treatment upregulated 23318695 4044 Mouse mmu-miR-338 miRNA anoxia/reoxygenation (A/R) autophagy cardiomyocytes anoxia/reoxygenation (A/R) treatment miR-338 was significantly downregulated in cardiomyocytes in response to A/R. 29247537 4045 Mouse mmu-miR-338 miRNA oxygen glucose deprivation (OGD) brain vascular dysfunction brain microvascular endothelial cell (BMEC) oxygen-glucose deprivation (OGD) treatment SNHG1 and miR-338 were upregulated in OGD induced BMEC. 30414401 4046 Mouse mmu-miR-338 miRNA bisphenol A (BPA) glucose homeostasis mice (4 wk old) bisphenol A (BPA) treatment downregulated 28774890 4047 Mouse mmu-miR-338 miRNA bisphenol A (BPA) glucose homeostasis mice (4 wk old) bisphenol A (BPA) treatment long-term BPA exposure upregulated miR-338 28774890 4048 Mouse mmu-miR-338 miRNA hypoxia ischemic stroke (IS) Mice primary brain microvascular endothelial cells (BMEC) oxygen/glucose-deprived (OGD)?treatment upregulated 30414401 4049 Mouse mmu-miR-338 miRNA microwave microwave-induced adverse health outcomes mouse hippocampus 7 days after 30 mW/cm microwave exposure treatment downregulated 24748327 4050 Mouse mmu-miR-338-3p miRNA N-acetyl-p-aminophenol (APAP) acute liver injury (ALI) liver tissues N-acetyl-p-aminophenol (APAP) treatment The results revealed that miR-338-3p was significantly upregulated following the intraperitoneal administration of APAP. 32331846 4051 Mouse mmu-miR-338-3p miRNA paeonol (PAE) atherosclerosis (AS) vascular endothelial cells (VECs) Paeonol treatment Paeonol regulated VEC development via downregulating miR-338-3p expression 32770325 4052 Mouse mmu-miR-338-3p miRNA tumor necrosis factor alpha (TNF-¦Á) gluconeogenesis the livers of mice and in mouse HEPA1-6 hepatocytes tumor necrosis factor alpha (TNF-¦Á) treatment downregulated 30132533 4053 Mouse mmu-miR-338-3p miRNA perfluoroalkyl chemicals (PFASs) hepatotoxicity male BALB/c mice liver PFASs treatment downregulated 25181679 4054 Mouse mmu-miR-338-3p miRNA N-acetyl-p-aminophenol (APAP) liver damage liver tissues N-acetyl-p-aminophenol (APAP) treatment upregulated 32331846 4055 Mouse mmu-miR-338-3p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce upregulated 30936699 4056 Mouse mmu-miR-338-3p miRNA prion neurodegeneration (ND) the brains tissues prion infection treatment downregulated 18987751 4057 Mouse mmu-miR-338-3p miRNA dexamethasone (DEX) osteoclast differentiation osteoclast dexamethasone (DEX) treatment downregulated 27706599 4058 Mouse mmu-miR-338-3p miRNA macrophage colony-stimulating factor (M-CSF) and receptor activator of NF-¦ÊB ligand (RANKL) osteoclastogenesis murine RAW264.7 cells macrophage colony-stimulating factor (M-CSF) and receptor activator of NF-¦ÊB ligand (RANKL) treatment upregulated 30716449 4059 Mouse mmu-miR-338-3p miRNA bilateral surgical destabilization of the medial meniscus (DMM) osteoporosis BALB/c mice bone marrow cell ovariectomized (OVX) treatment upregulated 24648262 4060 Mouse mmu-miR-338-3p miRNA bleomycin (BLM) lung fibrosis fibroblast bleomycin (BLM) treatment downregulated 30796204 4061 Mouse mmu-miR-338-3p miRNA high fat diet (HFD) type 2 diabetes mellitus (T2DM) C57BL/6J mice livers high fat diet (HFD) feed downregulated 28467989 4062 Mouse mmu-miR-339 miRNA calorie restriction (CR) hepatic steatosis high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues calorie restriction (CR) treatment upregulated 31863770 4063 Mouse mmu-miR-339 miRNA exercise (Ex) hepatic steatosis high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues exercise (Ex) treatment upregulated 31863770 4064 Mouse mmu-miR-339 miRNA high fat diet (HFD) hepatic steatosis mice thyroid and liver tissues high fat diet (HFD) feed downregulated 31863770 4065 Mouse mmu-miR-339 miRNA low fat diet (LFD) hepatic steatosis high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues low-fat diet (LF) treatment upregulated 31863770 4066 Mouse mmu-miR-339 miRNA quercetin hepatic steatosis high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues quercetin (Que) treatment upregulated 31863770 4067 Mouse mmu-miR-339 miRNA low fat diet (LFD) obesity thyroid low fat diet (LFD) treatment downregulated 31863770 4068 Mouse mmu-miR-339 miRNA low fat diet (LFD) obesity thyroid low fat diet (LFD) treatment upregulated 31863770 4069 Mouse mmu-miR-339 miRNA quercetin obesity thyroid quercetin (QUE) treatment upregulated 31863770 4070 Mouse mmu-miR-339 miRNA ethanol (EtOH) teratogenesis fetal brains of mice Ethanol?treatment downregulated 19091803 4071 Mouse mmu-miR-339-3p miRNA inorganic nitrite acute myocardial infarction (AMI) heart tissues single-dose of nitrite downregulated 28090786 4072 Mouse mmu-miR-339-3p miRNA ischemia/reperfusion (I/R) acute myocardial infarction (AMI) heart tissues ischemia/reperfusion (I/R) treatment upregulated 28090786 4073 Mouse mmu-miR-339-3p miRNA morphine and fentanyl ¦Ì-Opioid receptor (MOR) biosynthesis hippocampal?tissues morphine and fentanyl treatment upregulated 23085997 4074 Mouse mmu-miR-339-5p miRNA folic acid Alzheimer's disease (AD) APP/PS1 mice brains and N2a cells Folic acid deficiency treatment downregulated 26345540 4075 Mouse mmu-miR-339-5p miRNA alcohol brain-inflammation mouse brain tissue and isolated microglial cells alcohol exposure upregulated 25172655 4076 Mouse mmu-miR-339-5p miRNA oxygen glucose deprivation (OGD) hypoxic/ischemic brain damage (HIBD) primary mouse hippocampal neurons cells Oxygen-glucose deprivation (OGD) treatment lncRNA NEAT1 upregulated HOXA1 to alleviate HIBD in mice by binding to miR-339-5p 32163893 4077 Mouse mmu-miR-339-5p miRNA olanzapine (OLP) psychotic disorders brain tissues clozapine treatment upregulated 23318695 4078 Mouse mmu-miR-339-5p miRNA lipopolysaccharide (LPS) sepsis RAW264.7 cells lipopolysaccharide (LPS) treatment downregulated 31852965 4079 Mouse mmu-miR-339-5p miRNA paeonol (PAE) sepsis LPS-treated RAW264.7 cells paeonol treatment upregulated 31852965 4080 Mouse mmu-miR-33a miRNA high fructose adipogenesis white adipose tissue High fructose feed downregulated 31030166 4081 Mouse mmu-miR-33a miRNA lipopolysaccharide (LPS) autophagy RAW 264.7 cells lipopolysaccharide (LPS) treatment downregulated 29845275 4082 Mouse mmu-miR-33a miRNA urolithin A (UA) endothelial dysfunction RAW264.7 cells Urolithin A (UA) treatment Urolithin A attenuated ox-LDL-induced cholesterol accumulation in macrophages partly through regulating miR-33a and ERK/AMPK/SREBP1 signaling pathways 32236173 4083 Mouse mmu-miR-33a miRNA high fat diet (HFD) fatty liver disease liver tissues high fat diet (HFD) feed Treatment with HFD significantly increased the expression of miR-33a in liver tissues. 30324697 4084 Mouse mmu-miR-33a miRNA palmitic acid (PA) fatty liver disease mouse primary hepatocytes palmitic acid (PA) treatment Treatment with palmitic acid (PA) increased the expression of miR-33a in hepatocytes 30324697 4085 Mouse mmu-miR-33a miRNA IL-6 gallbladder cancer (GBC) gastric cancer SGC-7902 cells IL-6 treatment downregulated 27769047 4086 Mouse mmu-miR-33a miRNA TGF-¦Â1 liver fibrosis hepatic stellate cells (HSC) from C57BL/6 mice TGF-¦Â1 treatment upregulated 25155445 4087 Mouse mmu-miR-33a-5p miRNA tumor necrosis factor alpha (TNF-¦Á) osteogenesis mBMSCs tumor necrosis factor alpha (TNF-¦Á) treatment upregulated 26785690 4088 Mouse mmu-miR-34 miRNA xanthomicrol breast cancer 4T1 cells xanthomicrol treatment upregulated 33217075 4089 Mouse mmu-miR-34 miRNA cyclophosphamide embryonic maldevelopment the fore- and hindlimbs of mice cyclophosphamide treatment upregulated 20170545 4090 Mouse mmu-miR-34 miRNA adenoviral and lentiviral lung cancer KrasG12D/?;Trp53 lung epithelial cell lines adenoviral and lentiviral treatment In vivo treatment with miR-34a prevented tumor formation and progression in KrasLSL-G12D/?;Trp53LSL-R172H/?mice. 22964582 4091 Mouse mmu-miR-34 miRNA extra-virgin olive oil rich in phenols (H-EVOO) neuronal function cortex H-EVOO treatment upregulated 26695409 4092 Mouse mmu-miR-340 miRNA repeated social defeat (RSD) gastric cancer (GC) "male C57BL/6 (5 ¨C 6 weeks old) and CD-1 (12 months old, retired breeders) mice" intruder attack mice treatment significantly upregulated expression 25317829 4093 Mouse mmu-miR-340 miRNA hypoxia/reoxygenation (H/R) myocardial ischemia/reperfusion (I/R) injury (MIRI) cardiomyocytes hypoxia/reoxygenation (H/R) treatment downregulated 33164260 4094 Mouse mmu-miR-340 miRNA dexmedetomidine (DEX) neuroinflammation BV2 cells dexamethasone (DEX) treatment upregulated 31631971 4095 Mouse mmu-miR-340 miRNA particulate matter (PM2.5) PM2.5 exposure mosue bronchoalveolar lavage fluid (BALF) "were subjected to intratracheal instillation of 2.5, 10, or 20mg/kg PM2.5 treatment" upregulated in bronchoalveolar lavage fluid (BALF) 29107863 4096 Mouse mmu-miR-340 miRNA particulate matter (PM2.5) pulmonary toxicological lung tissues particulate matter (PM2.5) exposure treatment upregulated 29107863 4097 Mouse mmu-miR-340-5p miRNA high fat diet (HFD) hepatocellular carcinoma (HCC) plasma and hepatic tissues high fat diet (HFD) feed downregulated 26728044 4098 Mouse mmu-miR-340-5p miRNA lipopolysaccharide (LPS) intracerebral haemorrhage (ICH) BV-2 cells lipopolysaccharide (LPS) treatment downregulated 33176298 4099 Mouse mmu-mir-341-3p miRNA second-hand smoke (SHS) asthma lung second-hand smoke (SHS) treatment upregulated 26859758 4100 Mouse mmu-miR-342 miRNA low-protein diet (LP0.5) glucose homeostasis ¦Â cells low-protein diet (LP0.5) downregulated 25180600 4101 Mouse mmu-miR-342 miRNA tumor necrosis factor alpha (TNF-¦Á) microglial neuroinflammation Murine N9 microglia cells tumor necrosis factor alpha (TNF-¦Á) treatment TNF-¦Á stimulation induced the upregulation of miR-342 32488063 4102 Mouse mmu-miR-342-3p miRNA hyperoxia bronchopulmonary dysplasia (BPD) lung tissues hyperoxia treatment downregulated 27484068 4103 Mouse mmu-miR-342-3p miRNA high glucose (HG) diabetic nephropathy (DN) mouse renal mesangial cells (MCs) high-glucose treatment downregulated 31746345 4104 Mouse mmu-miR-342-3p miRNA azilsartan medoxomil (AZL-M) heart failure (HF) plasma azilsartan medoxomil (AZL-M) treatment "MiR-146a, miR-149, miR-150, and miR-342-3p were reproducibly reduced in the plasma of CSQ-tg mice." 27321284 4105 Mouse mmu-miR-342-3p miRNA azilsartan medoxomil (AZL-M) heart failure (HF) calsequestrin (CSQ)-tg mouse azilsartan medoxomil (AZL-M) treatment upregulated 27321284 4106 Mouse mmu-miR-342-3p miRNA carbon tetrachloride (CCl4) liver fibrosis liver CCl4 treatment upregulated 27322257 4107 Mouse mmu-miR-342-3p miRNA X rays ionizing radiation (IR) injury male Kunming mice blood 0.5-2 Gy total-body carbon-ion irradiation treatment dysregulatedin blood 28632432 4108 Mouse mmu-miR-342-3p miRNA prion neurodegeneration (ND) the brains tissues prion infection treatment upregulated 18987751 4109 Mouse mmu-miR-342-3p miRNA metformin (Met) nonalcoholic steatohepatitis (NASH) liver tissues metformin treatment upregulated 25672270 4110 Mouse mmu-miR-342-5p miRNA hyperoxia bronchopulmonary dysplasia (BPD) primary type II alveolar epithelial cell (T2AEC); MLE12 cells and neonatal mouse lungs hyperoxia induce "Hyperoxia decreased miR-342-5p levels in primary T2AECs, MLE12 cells and neonatal mouse lungs." 33434946 4111 Mouse mmu-miR-342-5p miRNA osteogenic differentiation medium cell differentiation MC3T3-E1 cells "n osteogenic differentiation media that consisted of ¦Á-MEM, 10% FBS, 10 mM ¦Â-glycerophosphate, 50 ¦Ìg/mL ascorbic acid treatment" downregulated 31398664 4112 Mouse mmu-miR-342-5p miRNA clozapine (CLZ) psychotic disorders mouse brain clozapine treatment upregulated 23318695 4113 Mouse mmu-miR-343 miRNA dioscorea bulbifera (DB) liver damage livers dioscoreae bulbifera (EF) treatment upregulated 27609015 4114 Mouse mmu-miR-344 miRNA propofol (PPF) propofol-induced developmental neurotoxicity hippocampus propofol treatment downregulated 30242182 4115 Mouse mmu-miR-344f-3p miRNA propofol (PPF) propofol-induced developmental neurotoxicity hippocampus propofol treatment downregulated 30242182 4116 Mouse mmu-miR-344g-5p miRNA delvestidine (DLTD) bone marrow-derived dendritic cells (BMDCs) maturity bone marrow-derived dendritic cells (BMDCs) Delvestidine (DLTD) treatment upregulated 32871480 4117 Mouse mmu-miR-345-5p miRNA lipopolysaccharide (LPS) resistant depression (TRD) BV2 cells lipopolysaccharide (LPS) treatment upregulated 32730696 4118 Mouse mmu-miR-34-5p miRNA ¦¤9-tetrahydrocannabinol (THC) acute respiratory distress syndrome (ARDS) lung-infiltrated mononuclear cells (MNCs) ¦¤9Tetrahydrocannabinol (THC) treatment downregulated 32612530 4119 Mouse mmu-miR-346 miRNA house dust mite (HDM) asthma C57BL/6J mice airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF) HDM treatment dysregulated in airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF) 28859242 4120 Mouse mmu-miR-346 miRNA cigarette smoke (CS) rheumatoid arthritis (RA) Th17 cells cigarette smoke (CS) exposure CS markedly increased the expression of miR-346 in the Th17 cells from the lymph nodes of AIA mice. 33443169 4121 Mouse mmu-miR-346 miRNA cigarette smoke extract (CSE) rheumatoid arthritis (RA) Th17 cells cigarette smoke extract (CSE) treatment upregulated 33443169 4122 Mouse mmu-miR-346 miRNA lipopolysaccharide (LPS) sepsis mouse macrophage cell line RAW264.7 lipopolysaccharide (LPS) treatment "MALAT1 inhibited RAW264.7?cell proliferation, while miR-346 promoted its proliferation." 31494280 4123 Mouse mmu-miR-346-3p miRNA poly(ethylenimine) (PEI) cell death MEF cells poly(ethylenimine) (PEI) treatment upregulated 26158199 4124 Mouse mmu-miR-3472 miRNA cyclophosphamide (CP) chronic ovarian dysfunction ovarian tissues cyclophosphamide (CP) treatment "CP treatment decreased the expression of miR-365-1-5p and miR-574-5p and increased that of miR-3472 and miR-667-3p, whereas SM administration restored the expression levels of these microRNAs to those in the Con mice." 33318603 4125 Mouse mmu-miR-3472 miRNA samul-tang (SM) chronic ovarian dysfunction ovarian tissues samul-tang (SM) treatment "CP treatment decreased the expression of miR-365-1-5p and miR-574-5p and increased that of miR-3472 and miR-667-3p, whereas SM administration restored the expression levels of these microRNAs to those in the Con mice" 33318603 4126 Mouse mmu-miR-3473a miRNA enterovirus 71 (EV71) enterovirus 71 (EV71) infection mouse infect with EV71 downregulated 28469998 4127 Mouse mmu-miR-3473b miRNA bilateral surgical destabilization of the medial meniscus (DMM) osteoarthritis (OA) male C57BL6 mice bilateral surgical destabilization of the medial meniscus (DMM) treatment dysregulated 29255152 4128 Mouse mmu-miR-3473b miRNA hypoxia stroke primary cultured mouse neurons oxygen-glucose deprivation (OGD) treatment upregulated 29317607 4129 Mouse mmu-miR-3473b miRNA lipopolysaccharide (LPS) stroke BV2 microglial cells lipopolysaccharide (LPS) treatment upregulated 29317607 4130 Mouse mmu-miR-3473g miRNA microcystin-leucine arginine (MC-LR) effects of microcystin-leucine arginine (MC-LR) on fertility mouse granulosa microcystin-leucine arginine (MC-LR) treatment MC-LR inhibited miR-3473g expression of mouse granulosa cells both in vitro and in vivo. 31710595 4131 Mouse mmu-miR-3474 miRNA high glucose (HG) diabetic nephropathy (DN) mouse podocytes high glucose (HG) treatment downregulated 33224036 4132 Mouse mmu-miR-34a miRNA staphylococcal enterotoxin B (SEB) acute inflammatory lung injury lung staphylococcal enterotoxin B treatment upregulated 25564423 4133 Mouse mmu-miR-34a miRNA cisplatin (DDP) acute kidney injury (AKI) kidney cisplatin treatment upregulated 24759152 4134 Mouse mmu-miR-34a miRNA hyperoxia acute lung injury (ALI) "whole lungs, isolated endothelial cells (ECs) from lungs" hyperoxia induce upregulated 30512967 4135 Mouse mmu-miR-34a miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lungs tissues;endothelial cells (ECs) lipopolysaccharide (LPS) treatment upregulated 30512967 4136 Mouse mmu-miR-34a miRNA lipopolysaccharide (LPS) acute lung injury (ALI) mouse alveolar type II epithelial (AT-II) cells lipopolysaccharide (LPS) treatment upregulated 28321785 4137 Mouse mmu-miR-34a miRNA lipopolysaccharide (LPS) acute respiratory distress syndrome (ARDS) lung macrophages lipopolysaccharides (LPS) treatment upregulated 32825525 4138 Mouse mmu-miR-34a miRNA ¦Â-cypermethrin (¦Â-CYP) adipogenesis 3T3-L1 cells ¦Â-cypermethrin (¦Â-CYP) treatment downregulated 32637997 4139 Mouse mmu-miR-34a miRNA alcohol alcoholic liver disease (ALD) mouse chronic alcohol administration upregulated 29128099 4140 Mouse mmu-miR-34a miRNA resveratrol allergic asthma (AA) pulmonary inflammatory cells resveratrol (RSV) treatment Resveratrol attenuates allergic asthma by downregulating miR-34a that induces increased expression of FOXP3. 30619345 4141 Mouse mmu-miR-34a miRNA tiaoxin recipe Alzheimer's disease (AD) cortex and hippocampus of APPswe/PS1¦¤E9 (APP/PS1) double transgenic mice Tiaoxin Recipe treatment downregulated 31548147 4142 Mouse mmu-miR-34a miRNA aluminum (Al) Alzheimer's disease (AD) murine microglial cell line aluminum treatment downregulated 23778113 4143 Mouse mmu-miR-34a miRNA amyloid-¦Â (A¦Â) 1-42 Alzheimer's disease (AD) cortical neurons amyloid ¦Â1-42?(A¦Â) treatment downregulated 26459758 4144 Mouse mmu-miR-34a miRNA ketamine apoptosis one-month old C57/BL6 mice hippocampal "received daily intraperitoneal injection of anesthesia (ketamine, 50 mg/kg) for 7 days treatment" upregulated 25400756 4145 Mouse mmu-miR-34a miRNA palmitate apoptosis Min6 pancreatic ¦Â -cell palmitate treatment upregulated 24829923 4146 Mouse mmu-miR-34a miRNA folate apoptosis mouse embryonic stem cells (mESCs) folate deficiency induced upregulated 22828209 4147 Mouse mmu-miR-34a miRNA kanamycin apoptosis inner ear tissues kanamycin treatment strong upregulated of miR-34a and miR-34c 21067520 4148 Mouse mmu-miR-34a miRNA high fat diet (HFD) atherosclerosis (AS) aortic arch high fat diet (HFD) feed upregulated 29704100 4149 Mouse mmu-miR-34a miRNA lipopolysaccharide (LPS) Dendritic cell (DC) maturation ?Mouse Monocyte lipopolysaccharide (LPS) treatment upregulated 24198819 4150 Mouse mmu-miR-34a miRNA melatonin Benzo(a)pyrene (BaP)-induced hepatotoxicity liver tissues melatonin treatment Exposure of mice to 20 mg/kg of melatonin resulted in a significant decrease in hepatic miR-34a expression (1.2-fold) compared with the BaP treated mice. 32247962 4151 Mouse mmu-miR-34a miRNA tumor necrosis factor alpha (TNF-¦Á) bone regeneration bone marrow mesenchymal stromal cells (BMSCs) tumor necrosis factor alpha (TNF-¦Á) treatment downregulated 31308031 4152 Mouse mmu-miR-34a miRNA D-galactose (D-Gal) brain aging brain tissues D-Galactose treatment upregulated 31420820 4153 Mouse mmu-miR-34a miRNA urolithin A (UA) brain aging D-gal-induced brain aging mice brain tissues ?urolithin A treatment downregulated 31420820 4154 Mouse mmu-miR-34a miRNA hyperoxia bronchopulmonary dysplasia (BPD) platelet-derived growth factor receptor (PDGFR)¦Á-expressing myofibroblasts hyperoxia induce upregulated 30770339 4155 Mouse mmu-miR-34a miRNA myostatin browning of white adipocytes C2C12 myoblasts myostatin treatment upregulated 27297797 4156 Mouse mmu-miR-34a miRNA N-ethyl-N-nitrosourea (ENU) tumorigenesis spleen tissues N-ethyl-N-nitrosourea (ENU) treatment upregulated 22297810 4157 Mouse mmu-miR-34a miRNA TGF-¦Â1 cardiac fibrosis cardiac fibroblasts TGF-¦Â1 treatment upregulated 25322725 4158 Mouse mmu-miR-34a miRNA phenylephrine (PE) cardiac hypertrophy cardiomyocytes; cardiac fibroblasts phenylephrine (PE) treatment LncRNA TUG1 alleviates cardiac hypertrophy by targeting miR©\34a/DKK1/Wnt©\¦Â©\catenin signalling 32057178 4159 Mouse mmu-miR-34a miRNA programmed death-1 (PD-1) inhibitor cardiac injury HL-1 cells programmed death-1 (PD-1) inhibitor treatment upregulated 32709878 4160 Mouse mmu-miR-34a miRNA aldosterone cardiovascular disease (CVD) primary mouse cardiomyocytes or mouse heart tissues aldosterone treatment TRIF/miR-34a mediates aldosterone-induced cardiac inflammation and remodeling 32776109 4161 Mouse mmu-miR-34a miRNA quercetin apoptosis HepG2 and Huh7 cells quercetin treatment upregulated 25896587 4162 Mouse mmu-miR-34a miRNA diethylnitrosamine (DEN) chronic cholestasis and cholangiocarcinoma liver tissues diethylnitrosamine (DEN) treatment downregulated 21440549 4163 Mouse mmu-miR-34a miRNA trichostatin A (TSA) chronic obstructive pulmonary disease (COPD) lung tissue of rats trichostatin A (TSA) treatment upregulated 21224215 4164 Mouse mmu-miR-34a miRNA curcumin and 3 acetyl-11-keto-¦Â-boswellic acid (AKBA) colorectal cancer (CRC) colorectal cancer cells curcumin and 3 acetyl-11-keto-¦Â-boswellic acid (AKBA) treatment upregulated 25712055 4165 Mouse mmu-miR-34a miRNA chronic stress depression ouse raphe nuclei chronic stress exposure upregulated 31482401 4166 Mouse mmu-miR-34a miRNA chronic stress depression raphe nuclei chronic stress exposure "microRNA-34a, under chronic stress, is significantly upregulated in the mouse raphe nuclei." 31482401 4167 Mouse mmu-miR-34a miRNA IL-1¦Â and TNF-¦Á diabetes mellitus (DM) MIN6 cells IL-1¦Â and TNF-¦Á treatment upregulated 20086228 4168 Mouse mmu-miR-34a miRNA streptozocin (STZ) diabetes-induced testicular apoptotic cell death (TACD) testes streptozotocin (STZ) treatment upregulated 30030567 4169 Mouse mmu-miR-34a miRNA high glucose (HG) diabetic cardiomyopathy (DCM) H9c2 cells high glucose (HG) treatment miR-34a was upregulated in HG-stimulated H9c2. 30216438 4170 Mouse mmu-miR-34a miRNA high glucose (HG) diabetic cardiomyopathy (DCM) cardiomyocytes high glucose treatment upregulated 32212062 4171 Mouse mmu-miR-34a miRNA high glucose (HG) diabetic cardiomyopathy (DCM) primary mouse cardiac fibroblasts (CFs) high glucose (HG) treatment The HG stimulation of CFs for 48?h significantly downregulated the expression level of miR-34a. 33289184 4172 Mouse mmu-miR-34a miRNA high glucose (HG) diabetic cardiomyopathy (DCM) cardiac tissues high glucose (HG) treatment "The HG stimulation of CFs for 48 h significantly downregulated the expression level of miR-34a and was associated with increased Type I collagen expression, cell viability, and migration and decreased apoptosis." 33289184 4173 Mouse mmu-miR-34a miRNA streptozocin (STZ) diabetic cardiomyopathy (DCM) mouse heart tissues streptozotocin (STZ) treatment HOTAIR protected against DCM via activation of the SIRT1 expression by sponging miR-34a 30216438 4174 Mouse mmu-miR-34a miRNA high glucose (HG) diabetes-associated endothelial dysfunction primary cultured endothelial cells (ECs) high glucose (HG) treatment upregulated 30793480 4175 Mouse mmu-miR-34a miRNA pifithrin-¦Á (PFT-¦Á) diabetes-associated endothelial dysfunction high glucose (HG)-treated primary cultured endothelial cells (ECs) pifithrin-¦Á (PFT-¦Á) treatment downregulated 30793480 4176 Mouse mmu-miR-34a miRNA hyperoside diabetic nephropathy (DN) SV40-MES13 cells hyperoside treatment Hyperoside inhibits the proliferation of SV40-MES13 cells through the suppression of the ERK/CREB/miRNA-34a signaling pathway. 32774360 4177 Mouse mmu-miR-34a miRNA streptozocin (STZ) diabetic nephropathy (DN) serum streptozotocin (STZ) treatment "The expression of acetylated p53 and miR-34a was upregulated, SIRT1was downregulated in glomeruli from patients with DN and STZ induced diabetic mice, as well as in human podocytes treated with advanced glycation end (AGE)" 33932899 4178 Mouse mmu-miR-34a miRNA high glucose (HG) diabetic vasculopathy "MMECs, mouse micro vascular endothelial cells originated from mouse pancreas" high glucose (HG) treatment upregulated 26582729 4179 Mouse mmu-miR-34a miRNA ¦Ã-rays DNA damage Hematopoietic stem cells (HSCs) Mice were exposed to various doses of total bodyirradiation (TBI) in a [60Co]¦Ã-irradiator downregulated 30922079 4180 Mouse mmu-miR-34a miRNA sodium arsenite (NaAsO2) DNA methylation liver tissues sodium arsenite treatment upregulated 32068019 4181 Mouse mmu-miR-34a miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity male B6C3F1 mice were injected intravenously with 3mg/kg doxorubicin treatment upregulated 25448438 4182 Mouse mmu-miR-34a miRNA kainic acid (KA) epilepsy mouse intraamygdala intraamygdala microinjection of kainic acid upregulated 22436728 4183 Mouse mmu-miR-34a miRNA "dibenz[a,h]anthracene" glucose homeostasis liver tissue of mice "dibenz[a,h]anthracene treatment" upregulated 23793610 4184 Mouse mmu-miR-34a miRNA ischemia hepatic ischemia/reperfusion injury (HIRI) HL7702 cells hepatic ischemia-reperfusion (HIR) downregulated 28708282 4185 Mouse mmu-miR-34a miRNA averrhoa carambola free phenolic extract (ACF) hepatic steatosis leptin receptor-deficient (db/db) mice averrhoa carambola free phenolic extract (ACF) treatment downregulated 29090700 4186 Mouse mmu-miR-34a miRNA high fat diet (HFD) hepatic steatosis hepatic high fat diet (HFD) feed upregulated 26608583 4187 Mouse mmu-miR-34a miRNA perfluoroalkyl chemicals (PFASs) hepatotoxicity male BALB/c mice liver PFASs treatment upregulated 25181679 4188 Mouse mmu-miR-34a miRNA perfluorooctanoic acid hepatotoxicity mouse liver tissues Perfluorooctanoic acid (PFOA) exposure treatment upregulated 30342367 4189 Mouse mmu-miR-34a miRNA high methionine diet hyperhomocysteinemia (HHcy) ApoE mice feed with high methionine diet downregulated 28485501 4190 Mouse mmu-miR-34a miRNA hyperoxia hyperoxia-induced acute lung injury (HALI) neonatal mice lungs exposed to hyperoxia upregulated 29079808 4191 Mouse mmu-miR-34a miRNA administering adenine and allantoxanic acid potassium salt hyperuricemia renal tissues administering adenine and allantoxanic acid potassium salt treatment upregulated 25535087 4192 Mouse mmu-miR-34a miRNA Xie-Zhuo-Chu-Bi-Fang (XZCBF) hyperuricemia mouse XZCBF for 15 days treatment upregulated 25535087 4193 Mouse mmu-miR-34a miRNA "bleomycin, cigarette smoke, silica, or sepsis" idiopathic pulmonary fibrosis (IPF) mouse lung tissues caveolin-2 scaffolding domain peptide (CSP) treatment upregulated 28273432 4194 Mouse mmu-miR-34a miRNA caveolin-1 scaffolding domain peptide (CSP) idiopathic pulmonary fibrosis (IPF) mouse lung tissues caveolin-1 scaffolding domain peptide (CSP) treatment downregulated 28273432 4195 Mouse mmu-miR-34a miRNA complete freund's adjuvant (CFA) inflammation spinal cord complete Freund's adjuvant (CFA) treatment upregulated 31296380 4196 Mouse mmu-miR-34a miRNA flaxseed (FS) inflammation mouse exposed to X-ray fed 10% FS or a 0% FS isocaloric control diet treatment dysregulated 24755684 4197 Mouse mmu-miR-34a miRNA lipopolysaccharide (LPS) inflammation J774A.1 (mouse macrophage cell line) lipopolysaccharide (LPS) treatment downregulated 29773953 4198 Mouse mmu-miR-34a miRNA lipopolysaccharide (LPS) inflammatory response Murine macrophage cell line RAW264.7 lipopolysaccharide (LPS) treatment downregulated 22483937 4199 Mouse mmu-miR-34a miRNA cannabinoids innate immune response LPS-treated BV-2 microglial cells cannabinoids treatment upregulated 30742662 4200 Mouse mmu-miR-34a miRNA carbon monoxide (CO) ischemia/reperfusion (I/R) injury hepatocytes carbon monoxide (CO) treatment downregulated 25916635 4201 Mouse mmu-miR-34a miRNA tubulointerstitial spaces kidney fibrosis microvesicles isolated from obstructed kidney tubulointerstitial spaces treatment upregulated 25107369 4202 Mouse mmu-miR-34a miRNA ionizing radiation (IR) leukemia mouse thymus and spleen tissue cells irradiated upregulated 18823940 4203 Mouse mmu-miR-34a miRNA low frequency magnetic fields (LF-MF) Lewis lung cancer lung cancer cells "exposed to a LF-MF (0.4T, 7.5 Hz) for 35 days" upregulated 28389657 4204 Mouse mmu-miR-34a miRNA resistin lipid metabolism male C57BL/6 mice liver resistin treatment upregulated in the liver 29197627 4205 Mouse mmu-miR-34a miRNA dietary methyl deficiency hepatocellular carcinoma (HCC) the liver tissues Dietary methyl deficiency treatment upregulated 20436259 4206 Mouse mmu-miR-34a miRNA bleomycin (BLM) lung fibrosis RLE/Abca3 cells bleomycin (BLM) treatment upregulated 28408209 4207 Mouse mmu-miR-34a miRNA methotrexate (MTX) lung fibrosis RLE/Abca3 cells methotrexate (MTX) treatment upregulated 28408209 4208 Mouse mmu-miR-34a miRNA TGF-¦Â1 lung fibrosis RLE/Abca3 cells TGF-¦Â1 treatment upregulated 28408209 4209 Mouse mmu-miR-34a miRNA crocin myocardial ischemia/reperfusion (I/R) injury (MIRI) I/R-induced primary cardiomyocytes crocin treatment downregulated 29424794 4210 Mouse mmu-miR-34a miRNA ischemia/reperfusion (I/R) myocardial ischaemic injury mouse plasma;Bone marrow-derived macrophage (BMDM);Rat neonatal CMs ischemia/reperfusion (I/R) treatment differently regulated 28768728 4211 Mouse mmu-miR-34a miRNA cadmium (Cd) nephrotoxicity mouse kidney cadmium (Cd) treatment "Furthermore, Cd-caused detrimental changes through inducing inflammation and apoptosis via the miR-34a/Sirt1/p53 axis." 33823310 4212 Mouse mmu-miR-34a miRNA human immunodeficiency virus (HIV)-1 Tat neuroinflammation mouse microglia Human immunodeficiency virus (HIV)-1 Tat treatment upregulated 30872089 4213 Mouse mmu-miR-34a miRNA berberine (BBR) nonalcoholic fatty liver disease (NAFLD) mouse liver berberine (BBR) treatment BBR's beneficial effects are linked with the downregulated of microRNA34a and long noncoding RNA H19 33494295 4214 Mouse mmu-miR-34a miRNA "berberis aristata, elaeis guineensis?and?coffea canephora" nonalcoholic fatty liver disease (NAFLD) mouse liver tissues "Berberis Aristata, Elaeis Guineensis?and?Coffea Canephora treatment" both these miRNAs had similar levels to SD-mice in HFD+E-mice 33924725 4215 Mouse mmu-miR-34a miRNA green tea (GT) nonalcoholic fatty liver disease (NAFLD) liver tissues from Male C57Bl/6 mice were fed with a high-fat diet for 4 weeks green tea (GT) treatment downregulated 31885789 4216 Mouse mmu-miR-34a miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) hepatocytes high fat diet (HFD) feed upregulated 26330104 4217 Mouse mmu-miR-34a miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver tissues high fat diet (HFD) feed upregulated 31885789 4218 Mouse mmu-miR-34a miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) mouse liver tissues high fat diet (HFD) feed both these miRNAs had similar levels to SD-mice in HFD+E-mice 33924725 4219 Mouse mmu-miR-34a miRNA palmitate nonalcoholic fatty liver disease (NAFLD) cholangiocytes of C57BL/6J mice PA treatment upregulated 28250026 4220 Mouse mmu-miR-34a miRNA palmitic acid (PA) nonalcoholic fatty liver disease (NAFLD) C2C12 muscle cells palmitic acid (PA) treatment upregulated 31139863 4221 Mouse mmu-miR-34a miRNA metformin (Met) nonalcoholic steatohepatitis (NASH) liver tissues metformin treatment upregulated 25672270 4222 Mouse mmu-miR-34a miRNA cisplatin (DDP) ochratoxin A (OTA) nephrotoxicity HEI-OC1 auditory cells cisplatin treatment upregulated 24922076 4223 Mouse mmu-miR-34a miRNA ochratoxin A (OTA) ochratoxin A (OTA) toxicity Primary proximal tubular epithelial cell ochratoxin A treatment upregulated 28710020 4224 Mouse mmu-miR-34a miRNA fluid shear stress (FSS) osteoblastic differentiation MC3T3-E1 cells fluid shear stress (FSS)treatment downregulated 23595392 4225 Mouse mmu-miR-34a miRNA tert-butyl hydroperoxide (TBHP) oxidative stress adult male mice strain Balb/c TBHP treatment differently regulated 25141839 4226 Mouse mmu-miR-34a miRNA perfluorooctanoic acid perfluorooctanoic acid (PFOA)-induced liver toxicity mouse liver tissues Perfluorooctanoic acid (PFOA) exposure treatment upregulated 30342367 4227 Mouse mmu-miR-34a miRNA apigenin peritoneal fibrosis mouse mesothelial peritoneal cells (MMCs) apigenin treatment "Apigenin treatment induced a significant decrease in miR34a expression levels in HG-treated MMCs. Moreover, both apigenin treatment and miR34a depletion." 30474876 4228 Mouse mmu-miR-34a miRNA radiation radiation-induced fibrosis (RIF) "CH3 mice muscle, skin, and subcutaneous tissue" the right hind legs of 9-week old CH3 mice by a single-fraction dose of irradiation to 35 Gy treatment dysregulated 24986745 4229 Mouse mmu-miR-34a miRNA lipopolysaccharide (LPS) regeneration of the intestinal epithelia intestinal tissues lipopolysaccharide (LPS) treatment downregulated 29621481 4230 Mouse mmu-miR-34a miRNA SDF-1¦Á analog CTCE-0214 (CTCE) sepsis mouse with polymicrobial sepsis EPC therapy treatment upregulated in endothelial progenitor cells (EPCs) 24707934 4231 Mouse mmu-miR-34a miRNA streptozocin (STZ) smooth muscle cell differentiation mouse liver streptozotocin (STZ) treatment Upregulation of miR-34a and downregulated of miR-122 was found in livers of STZ-induced diabetic mice 19372595 4232 Mouse mmu-miR-34a miRNA lipopolysaccharide (LPS) spinal cord injury (SCI) BV-2 cells lipopolysaccharide (LPS) treatment downregulated 32096191 4233 Mouse mmu-miR-34a miRNA "5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)" teratogenesis mouse and rat limb buds "5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment" miR-34 family members are the most upregulated miRNAs 24623309 4234 Mouse mmu-miR-34a miRNA dasatinib and quercetin uterine fibrosis uterine dasatinib plus quercetin treatment D+Q treatment decreased miR-34a. 31955151 4235 Mouse mmu-miR-34a miRNA H2O2 cardiomyocyte apoptosis bone marrow-derived mononuclear cells (BMCs) H(2)O(2) treatment upregulated 22403243 4236 Mouse mmu-miR-34a miRNA insulin-like growth factor 1 (IGF-1) leukemia bone marrow-derived mononuclear cells (BMCs) ?IGF-1(insulin-like growth factors-1) treatment downregulated 22403243 4237 Mouse mmu-miR-34a-5p miRNA amyloid-¦Â (A¦Â) Alzheimer's disease (AD) primary mouse cortical neurons (MCN) and Neuro2a (N2a) cells amyloid-¦Â (A¦Â) treatment downregulated 32251872 4238 Mouse mmu-miR-34a-5p miRNA 7-chlorokynurenic acid (7-CTKA) antidepressant mouse 7-CTKA intraperitoneal injection downregulated 25034119 4239 Mouse mmu-miR-34a-5p miRNA melatonin anti-inflammatory responses RAW264.7 cells (a murine macrophage cell line) and mouse bone marrow-derived macrophages (BMDMs) metformin treatment Metformin might show anti-inflammatory effects in macrophages through the induction of Dicer and the subsequent upregulation of miR-34a-5p and miR-125b-5p. 31102492 4240 Mouse mmu-miR-34a-5p miRNA doxorubicin (DOX) cardiotoxicity "plasma and heart, HL-1 cells" doxorubicin (DOX) treatment upregulated 30453253 4241 Mouse mmu-miR-34a-5p miRNA total abdominal irradiation (TAI) cognitive deficits mouse small intestine tissues and peripheral blood (PD) TAI treatment upregulated in small intestine tissues and peripheral blood (PD) 28668331 4242 Mouse mmu-miR-34a-5p miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity plasma doxorubicin (DOX) treatment upregulated 30453253 4243 Mouse mmu-miR-34a-5p miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity Plasma doxorubicin (DOX) treatment upregulated 30627229 4244 Mouse mmu-miR-34a-5p miRNA carbon tetrachloride (CCl4) liver fibrosis liver CCl4 treatment upregulated 27322257 4245 Mouse mmu-miR-34a-5p miRNA high fat diet (HFD) hepatic insulin resistance mouse liver tissues high fat diet (HFD) feed upregulated 30820263 4246 Mouse mmu-miR-34a-5p miRNA dexamethasone (DEX) innate immune response immature DCs (iDCs) dexamethasone (DEX) treatment downregulated 30174602 4247 Mouse mmu-miR-34a-5p miRNA X-rays intestinal damage small intestine X-ray exposure upregulated 32323814 4248 Mouse mmu-miR-34a-5p miRNA ischemia/reperfusion (I/R) intestinal hypoxia/reoxygenation injury C57BL/6 mice were induced ischemia/reperfusion (I/R) treatment upregulation 26935288 4249 Mouse mmu-miR-34a-5p miRNA stearic acid lipotoxicity INS-1 cells stearic-acid treatment upregulated 26969487 4250 Mouse mmu-miR-34a-5p miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues carbon tetrachloride (CCl4) treatment downregulated 29957876 4251 Mouse mmu-miR-34a-5p miRNA dioscorea bulbifera (DB) liver damage livers dioscoreae bulbifera (EF) treatment upregulated 27609015 4252 Mouse mmu-miR-34a-5p miRNA "2,2',4,4'-tetrabromodiphenyl ether (BDE47)" mitophagy mouse livers "2,2',4,4'-Tetrabromodiphenyl ether (BDE-47) treatment" upregulated 31838391 4253 Mouse mmu-miR-34a-5p miRNA "2,2',4,4'-tetrabromodiphenyl ether (BDE47)" mitophagy Hepa1-6 cells "2,2',4,4'-Tetrabromodiphenyl ether (BDE-47) treatment" upregulated 31838391 4254 Mouse mmu-miR-34a-5p miRNA hypoxia myocardial infarction (MI) HL-1 cells hypoxia induce upregulated 30312158 4255 Mouse mmu-miR-34a-5p miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) mouse liver tissue high fat diet (HFD) feed upregulated 30898698 4256 Mouse mmu-miR-34a-5p miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver tissues high fat diet (HFD) feed upregulated 31500354 4257 Mouse mmu-miR-34a-5p miRNA melatonin nonalcoholic fatty liver disease (NAFLD) high-fat diet (HFD)-fed mice liver tissues melatonin treatment downregulated 31500354 4258 Mouse mmu-miR-34a-5p miRNA enoxacin obesity white subcutaneous (9W) enoxacin treatment Enoxacin led to a reduction of miR-34a-5p expression. 33268375 4259 Mouse mmu-miR-34a-5p miRNA metformin (Met) type 2 diabetes mellitus (T2DM) RAW264.7 cells metformin (Met) treatment Metformin might show anti-inflammatory effects in macrophages through the induction of Dicer and the subsequent upregulation of miR-34a-5p and miR-125b-5p. 31102492 4260 Mouse mmu-miR-34b miRNA doxorubicin (DOX) cardiotoxicity HL-1 cells Doxorubicin (DOX) treatment upregulated 31627713 4261 Mouse mmu-miR-34b miRNA si-jun-zi-tang (SJZT) melanoma B16 cells Si-Jun-Zi-Tang (SJZT) treatment "Mechanistic investigations revealed that SJZT elevated miR-34b (a tumor suppressing miRNA), and lowered c-Met (a miR-34b target gene) and ¦Â-catenin (a downstream molecule of c-Met signaling) expression levels in the B16 tumors." 32505839 4262 Mouse mmu-miR-34b miRNA extremely low-frequency magnetic fields (ELF-MFs) neurodegeneration (ND) mouse primary cortical neurons ELF-MFs downregulated 29039021 4263 Mouse mmu-miR-34b miRNA extremely low-frequency magnetic fields (ELF-MFs) neurodegenerative diseases mouse primary cortical neurons extremely low-frequency magnetic fields (ELF-MFs) treatment downregulated 29039021 4264 Mouse mmu-miR-34b miRNA high inorganic phosphate (Pi) vascular calcification (VC) primary cultured mouse vascular smooth muscle cells (VSMCs) or mouse arteries derived from 5/6 nephrectomy high inorganic phosphate (Pi) treatment downregulated 31129659 4265 Mouse mmu-miR-34b-3p miRNA high glucose (HG) diabetic cardiomyopathy (DCM) HL-1 cells high glucose (HG) treatment LncRNA GAS5 inhibits NLRP3 inflammasome activation-mediated pyroptosis in diabetic cardiomyopathy by targeting miR-34b-3p/AHR 33092444 4266 Mouse mmu-miR-34b-3p miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity plasma doxorubicin (DOX) treatment upregulated 30453253 4267 Mouse mmu-miR-34b-3p miRNA single dose irradiation ionizing radiation (IR) injury LLC1 cells single dose (SD) irradiation treatment upregulated 28599420 4268 Mouse mmu-miR-34b-3p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce upregulated 30936699 4269 Mouse mmu-miR-34b-5p miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues lipopolysaccharide (LPS) treatment upregulated 29150939 4270 Mouse mmu-miR-34b-5p miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues; primary murine pulmonary microvascular endothelial cells (PMVECs) lipopolysaccharide (LPS) treatment upregulated 32087725 4271 Mouse mmu-miR-34b-5p miRNA pressure overload heart failure (HF) heart sissues pressure overload treatment upregulated 33224746 4272 Mouse mmu-miR-34b-5p miRNA N-ethyl-N-nitrosourea (ENU) hepatocellular carcinoma (HCC) liver tissues N-ethyl-N-nitrosourea (ENU) treatment upragulated 21029445 4273 Mouse mmu-miR-34b-5p miRNA bleomycin (BLM) lung fibrosis lung tissues bleomycin (BLM) treatment upregulated 30915776 4274 Mouse mmu-miR-34b-5p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce upregulated 30936699 4275 Mouse mmu-miR-34b-5p miRNA glyphosate neurodevelopmental disorder prefrontal cortex of mouse offspring glyphosate dysregulated 29467848 4276 Mouse mmu-miR-34c miRNA kanamycin apoptosis inner ear tissues kanamycin treatment strong upregulated of miR-34a and miR-34c 21067520 4277 Mouse mmu-miR-34c miRNA doxorubicin (DOX) cardiotoxicity HL-1 cells Doxorubicin (DOX) treatment upregulated 31627713 4278 Mouse mmu-miR-34c miRNA high glucose (HG) diabetic nephropathy (DN) podocyte high glucose treatment downregulated 26191142 4279 Mouse mmu-miR-34c miRNA streptozocin (STZ) diabetic peripheral neuropathy (DPN) trigeminal ganglion (TG) tissue streptozotocin (STZ) treatment upregulated 30601927 4280 Mouse mmu-miR-34c miRNA extremely low-frequency magnetic fields (ELF-MFs) neurodegeneration (ND) mouse primary cortical neurons ELF-MFs downregulated 29039021 4281 Mouse mmu-miR-34c miRNA extremely low-frequency magnetic fields (ELF-MFs) neurodegenerative diseases mouse primary cortical neurons extremely low-frequency magnetic fields (ELF-MFs) treatment downregulated 29039021 4282 Mouse mmu-miR-34c miRNA ketamine neurotoxicity hippocampal Ketamine treatment upregulated 25052764 4283 Mouse mmu-miR-34c miRNA fluid shear stress (FSS) osteoblastic differentiation MC3T3-E1 cells fluid shear stress (FSS)treatment downregulated 23595392 4284 Mouse mmu-miR-34c miRNA icariin (ICA) osteoporosis (LPS)-induced bone loss via an osteogenic Icariine treatment "MiRNA-34c was dramatically upregulated after LPS stimulation; however, Icariine preincubation reversed miRNA-34c level." 27492554 4285 Mouse mmu-miR-34c-3p miRNA lipopolysaccharide (LPS) acute lung injury (ALI) mouse alveolar macrophages (MH-S) and lung tissues lipopolysaccharide (LPS) treatment lncRNA SNHG14 silencing alleviated inflammation in LPS-induced ALI through miR-34c-3p-mediated inhibition of WISP1. 31660971 4286 Mouse mmu-miR-34c-3p miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity plasma doxorubicin (DOX) treatment upregulated 30453253 4287 Mouse mmu-miR-34c-3p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce upregulated 30936699 4288 Mouse mmu-miR-34c-5p miRNA single dose irradiation ionizing radiation (IR) injury LLC1 cells single dose (SD) irradiation treatment upregulated 28599420 4289 Mouse mmu-miR-34c-5p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce upregulated 30936699 4290 Mouse mmu-miR-34c-5p miRNA high fat diet (HFD) obesity liver tissues high fat diet (HFD) feed upregulated 32593682 4291 Mouse mmu-miR-34c-5p miRNA aldosterone renal fibrosis mouse cortical collecting duct cells aldosterone treatment (10-6 M; 3 days) downregulated 29070573 4292 Mouse mmu-miR-34c-5p miRNA aldosterone renal fibrosis mouse cortical collecting duct cells aldosterone treatment (10-6 M; 3 days) dysregulated 29070573 4293 Mouse mmu-miR-350 miRNA smoking smoking-related interstitial fibrosis (SRIF) C57 mice circulating 6 months of chronic mainstream smoking exposure treatment downregulated 22782705 4294 Mouse mmu-miR-351 miRNA ischemia/reperfusion (I/R) acute myocardial infarction (AMI) heart tissues ischemia/reperfusion (I/R) treatment upregulated 28090786 4295 Mouse mmu-miR-351 miRNA high glucose (HG) diabetic nephropathy (DN) Mouse podocytes (MPC5) high glucose treatment upregulated 30095204 4296 Mouse mmu-miR-351 miRNA streptozocin (STZ) gestational diabetes mellitus (GDM) liver tissues streptozotocin (STZ) treatment downregulated 31287224 4297 Mouse mmu-miR-351 miRNA Schistosoma liver fibrosis primary hepatic stellate cells (HSCs) Schistosoma infection treatment "the expr+B5808:J5808ession of host miR-351 in HSCs was markedly reduced during the early stage of Schistosoma infection However, this expression was significantly increased during the later stage of infection (after 52 d of infection)" 29255036 4298 Mouse mmu-miR-351 miRNA dexamethasone (DEX) muscle atrophy Murine C2C12 myoblast cells dexamethasone (DEX) treatment upregulated 23716137 4299 Mouse mmu-miR-351 miRNA prion pancreatic cancer (PC) The mouse neuroblastoma cell line N2a prion treatment downregulated of mmu-miR-351 and mmu-miR-542-5p 22985096 4300 Mouse mmu-miR-351 miRNA lipopolysaccharide (LPS) sepsis-induced skeletal muscle wasting long extensor muscle tissues of the toes lipopolysaccharide (LPS) treatment downregulated 30040486 4301 Mouse mmu-miR-351-5p miRNA histone deacetylase inhibitor (HDACi) B cell differentiation B cells of C57BL/6J "stimulated with LPS and IL-4 and treated with HDI (VPA, 500 ?M) or nil for 60 h" upregulated 28994753 4302 Mouse mmu-miR-351-5p miRNA brucella.suis innate immune response RAW264.7 cells brucella.suis infection upregulated 29387067 4303 Mouse mmu-miR-351-5p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce downregulated 30936699 4304 Mouse mmu-miR-361 miRNA histone deacetylase inhibitors (HDIs) short-chain fatty acid (SCFA) butyrate antibody-mediated systemic autoimmunity B cells SCFA HDI butyrate treatment upregulated 32265934 4305 Mouse mmu-miR-361 miRNA arsenite atherosclerosis (AS) liver arsenic (As) exposure upregulated 22719926 4306 Mouse mmu-miR-361-3p miRNA nonylphenol (NP) male infertility GC-1 spermatogonia cell line high concentration of NP downregulated 29024157 4307 Mouse mmu-miR-361-5p miRNA histone deacetylase inhibitor (HDACi) B cell differentiation B cells of C57BL/6J "stimulated with LPS and IL-4 and treated with HDI (VPA, 500 ?M) or nil for 60 h" upregulated 28994753 4308 Mouse mmu-miR-361-5p miRNA angiotensin II (Ang II) cardiac hypertrophy Cardiomyocytes isolated from newborn mouse hearts angiotensin II (Ang II) treatment STAT3-inducetd upregulation of lncRNA MEG3 controls cardiac hypertrophy by regulating miR-362-5p/HDAC9 axis. 30679521 4309 Mouse mmu-miR-361-5p miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver tissues high fat diet (HFD) feed upregulated 30309516 4310 Mouse mmu-miR-362 miRNA ethanol (EtOH) teratogenesis fetal brains of mice Ethanol?treatment downregulated 19091803 4311 Mouse mmu-miR-362-3p miRNA curcumin (Cur) anti-inflammatory responses BV2 cells curcumin treatment miR-362-3p expression was upregulated by curcumin. 32472295 4312 Mouse mmu-miR-362-3p miRNA perfluoroalkyl chemicals (PFASs) hepatotoxicity male BALB/c mice liver PFASs treatment downregulated 25181679 4313 Mouse mmu-miR-363 miRNA "anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE)" bronchial epithelial cell cancer 16HBE-T cells "anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE) treatment" downregulated 19462682 4314 Mouse mmu-miR-363 miRNA Staphylococcus aureus inflammation mouse mammary tissue intramammary infection of Globally Staphylococcus aureus treatment differently regulated 25075227 4315 Mouse mmu-miR-363-3p miRNA resveratrol hepatic insulin resistance HepG2 cells resveratrol (Res) treatment RSV improves insulin resistance by upregulating miRNA mmu-miR-363-3p via the PI3K-Akt pathway 32104036 4316 Mouse mmu-miR-365 miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) mouse macrophages atherogenic Evs oxidized low-density lipoprotein (ox-LDL) treatment enrichment in atherogenic EVs 28882869 4317 Mouse mmu-miR-365 miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) peritoneal macrophages; Bone-marrow derived macrophages (BMDMs) oxidized low-density lipoprotein (ox-LDL) treatment upregulated 28882869 4318 Mouse mmu-miR-365 miRNA dexamethasone (DEX) osteoporosis MC3T3-E1 osteoblasts dexamethasone (DEX) treatment downregulated 28471397 4319 Mouse mmu-miR-365 miRNA type II collagen and freund's adjuvant rheumatoid arthritis (RA) synovial tissues type II collagen and freund's adjuvant treatment MiR-365 expression decreased in synovial tissues of RA mice 31881377 4320 Mouse mmu-miR-365 miRNA curcumin (Cur) secondary osteoporosis bone curcumin treatment downregulated 26884838 4321 Mouse mmu-miR-365 miRNA mycobacterium tuberculosis (Mtb) tuberculosis (TB) M(IL-4/IL-13) macrophages Mycobacterium tuberculosis (Mtb) HN878 infection upregulated 30941122 4322 Mouse mmu-miR-365-1-5p miRNA cyclophosphamide (CP) chronic ovarian dysfunction ovarian tissues cyclophosphamide (CP) treatment "CP treatment decreased the expression of miR-365-1-5p and miR-574-5p and increased that of miR-3472 and miR-667-3p, whereas SM administration restored the expression levels of these microRNAs to those in the Con mice." 33318603 4323 Mouse mmu-miR-365-1-5p miRNA samul-tang (SM) chronic ovarian dysfunction ovarian tissues samul-tang (SM) treatment "CP treatment decreased the expression of miR-365-1-5p and miR-574-5p and increased that of miR-3472 and miR-667-3p, whereas SM administration restored the expression levels of these microRNAs to those in the Con mice" 33318603 4324 Mouse mmu-miR-3653-3p miRNA melatonin osteoporosis human bone marrow mesenchymal stem cell (hBMSC) melatonin (MEL) treatment Circ_0003865 expression in BMSCs was significantly decreased by MEL treatment. 33632317 4325 Mouse mmu-miR-365-3p miRNA complete freund's adjuvant (CFA) chronic inflammatory pain spinal cord complete Freund's adjuvant (CFA) treatment A significant increase in miR-365-3p expression was observed from day 1 to day 7 after CFA in- jection. 31914601 4326 Mouse mmu-miR-367 miRNA engrafting E6.5 embryos (wildtype or Gtl2((-/+))) teratomas mice engrafting E6.5 embryos (wildtype or Gtl2((-/+))) treatment downregulated 25355544 4327 Mouse mmu-miR-367-3p miRNA toosendanin (TSN) liver damage mouse serum toosendanin (TSN) treatment upregulated 30844585 4328 Mouse mmu-miR-369-3p miRNA quercetin chronic inflammatory diseases LPS-treated murine bone marrow¨Cderived DCs (BMDCs) quercetin treatment upregulated 31338984 4329 Mouse mmu-miR-369-3p miRNA dextran sodium sulfate (DSS) colitis colon tissues and isolated CD11c+ cells from colon dextran-sulfate-sodium (DSS) treatment downregulated 31338984 4330 Mouse mmu-miR-369-3p miRNA quercetin colitis DSS-induced colitis mice colon tissues and isolated CD11c+ cells from colon quercetin treatment upregulated 31338984 4331 Mouse mmu-miR-369-3p miRNA bleomycin (BLM) idiopathic pulmonary fibrosis (IPF) A549 cells bleomycin (BLM) treatment TRIM2 expression was increased and miR-369-3p expression was decreased in the lung tissues of mice with BLM-induced fibrosis and in TGF-¦Â1-stimulated A549 cells. DLEU2 directly targeted miR-369-3p. 33760118 4332 Mouse mmu-miR-369-3p miRNA TGF-¦Â1 idiopathic pulmonary fibrosis (IPF) A549 cells TGF-¦Â1 treatment TRIM2 expression was increased and miR-369-3p expression was decreased in the lung tissues of mice with BLM-induced fibrosis and in TGF-¦Â1-stimulated A549 cells DLEU2 directly targeted miR-369-3p 33760118 4333 Mouse mmu-miR-3695 miRNA luteinising hormone (LH) functions of Leydig cells mouse TM3 Leydig cells luteinising hormone (LH) treatment upregulated 28762514 4334 Mouse mmu-miR-3695 miRNA luteinising hormone (LH) steroidogenesis mouse TM3 Leydig cells luteinising hormone(LH) treatment dysregulated 28762514 4335 Mouse mmu-miR-369-5p miRNA alcohol fetal alcohol spectrum disorders (FASD) brain tissues alcohol exposure downregulated 23580197 4336 Mouse mmu-miR-369-5p miRNA N-ethyl-N-nitrosourea (ENU) hepatocellular carcinoma (HCC) liver tissues N-ethyl-N-nitrosourea (ENU) treatment downregulated 21029445 4337 Mouse mmu-miR-370 miRNA high glucose (HG) diabetic nephropathy (DN) Mouse podocytes (MPC5) high glucose treatment upregulated 30095204 4338 Mouse mmu-miR-370 miRNA ischemia hepatic ischemia/reperfusion injury (HIRI) male C57BL/6 mice hepatic ischemia-reperfusion (HIR) upregulated 24351048 4339 Mouse mmu-miR-370 miRNA ischemia/reperfusion (I/R) hepatic ischemia/reperfusion injury (HIRI) liver tissues ischemia/reperfusion (I/R) treatment upregulated 28043920 4340 Mouse mmu-miR-370 miRNA glucagon-like peptide-1 (GLP-1) lipotoxic oxidative stress FFA-treated INS-1 cells GLP-1 downregulated 27956176 4341 Mouse mmu-miR-370 miRNA ischemia/reperfusion (I/R) hepatic ischemia/reperfusion injury (HIRI) C57BL/6 mice liver ischemia/reperfusion (I/R) treatment upregulated 28043920 4342 Mouse mmu-miR-370 miRNA hypoxia myocardial ischemia/reperfusion (I/R) injury (MIRI) cardiomyocytes "The left anterior descending coronary artery was ligated with 6-0 sutures ?1.5 mm from the tip of the left auricle with a hollow plastic tube. After 30 min of ischemia, the hollow plastic tube was cut and blood flow was restored" downregulated 30856533 4343 Mouse mmu-miR-370 miRNA sevoflurane (SEV) myocardial ischemia/reperfusion (I/R) injury (MIRI) cardiomyocytes sevoflurane anesthetic preconditioning (SAP) treatment upregulated 30856533 4344 Mouse mmu-miR-370 miRNA salidroside (SAL) type 2 diabetes mellitus (T2DM) liver tissue of mice Salidroside treatment downregulated 26948318 4345 Mouse mmu-miR-370-3p miRNA fructus meliae toosendan (FMT) liver damage serum Fructus Meliae Toosendan water extract (FMT) treatment downregulated 29434260 4346 Mouse mmu-miR-370-3p miRNA lipopolysaccharide (LPS) sepsis RAW 264.7 lipopolysaccharide (LPS) treatment LncRNA NEAT1 promoted the inflammation and apoptosis while restrained the proliferation of LPS-stimulated RAW 264.7 cells through the miR-370-3p/TSP-1 axis. 31957847 4347 Mouse mmu-miR-370-3p miRNA lipopolysaccharide (LPS) sepsis RAW 264.7 cells; HL-1 cells lipopolysaccharides (LPS) treatment downregulated 34004695 4348 Mouse mmu-miR-371 miRNA "5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)" gastric cancer (GC) balb/c nu-nu mice injected with 107 GC cells "5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment" upregulated 25270964 4349 Mouse mmu-miR-371-5p miRNA lipopolysaccharide (LPS) autophagy RAW 264.7 cells lipopolysaccharide (LPS) treatment downregulated 29845275 4350 Mouse mmu-miR-373 miRNA streptozocin (STZ) diabetes mellitus (DM) hearts of diabetic mice streptozotocin (STZ) treatment downregulated 21584493 4351 Mouse mmu-miR-374 miRNA histone deacetylase inhibitor (HDACi) hypercalciuric diseases mouse HDAC inhibitors treatment upregulated 25071082 4352 Mouse mmu-miR-374 miRNA hypoxia myocardial ischemia/reperfusion (I/R) injury (MIRI) heart tissues The left anterior descending branch of LCA was ligated. downregulated 30565678 4353 Mouse mmu-miR-374 miRNA thoracic epidural anesthesia (TEA) myocardial ischemia/reperfusion (I/R) injury (MIRI) myocardial I/R mice heart tissues thoracic epidural anesthesia (TEA) treatment upregulated 30565678 4354 Mouse mmu-miR-374 miRNA anandamide (AEA) pro-inflammatory activity mouse anandamide treatment AEA differentil regulate the expression of miRNA 24699635 4355 Mouse mmu-miR-374 miRNA propofol (PPF) propofol-induced developmental neurotoxicity hippocampus propofol treatment upregulated 30242182 4356 Mouse mmu-miR-374* miRNA polyphenols cell function mice liver cells Polyphenols treatment downregulated 22253797 4357 Mouse mmu-miR-374* miRNA plasmodium chabaudi malaria peak parasitemia liver of mice Plasmodium chabaudi malaria infection treatment downregulated 21085987 4358 Mouse mmu-miR-374-5p miRNA "paraquat (PQ) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" dopaminergic (DA) neuron differentiation neuro-2a cells "paraquat (PQ) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment" dysregulated 29250806 4359 Mouse mmu-miR-374-5p miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" neurodegenerative diseases N2a cells "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" downregulated 29250806 4360 Mouse mmu-miR-374-5p miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" neurodegenerative diseases N2a cells "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" downregulated 29250806 4361 Mouse mmu-miR-374-5p miRNA paraquat (PQ) neurodegenerative diseases N2a cells paraquat (PQ) treatment downregulated 29250806 4362 Mouse mmu-miR-374a-5p miRNA lipopolysaccharide (LPS) neonatal hypoxic-ischemic encephalopathy BV-2 cells lipopolysaccharide (LPS) treatment downregulated 32464126 4363 Mouse mmu-miR-374b miRNA ¦¤9-tetrahydrocannabinol (THC) inflammation total lymph node cells and CD4(+) T cells ¦¤9-Tetrahydrocannabinol (THC) treatment downregulated 27268054 4364 Mouse mmu-miR-374b-5p miRNA amyloid-¦Â (A¦Â) 25-35 Alzheimer's disease (AD) BV2 cells amyloid-¦Â (A¦Â) 25-35 treatment "The expression of MAGI2-AS3 was increased, and miR-374b-5p was decreased in both SH-SY5Y and BV2 cells exposed to A¦Â25-35." 33279663 4365 Mouse mmu-miR-374b-5p miRNA amyloid-¦Â (A¦Â) 25-35 Alzheimer's disease (AD) BV2 cells amyloid-¦Â (A¦Â) 25-35 treatment MAGI2-AS3/miR-374b-5p axis regulates A¦Â-induced neurotoxicity in SH-SY5Y cells and neuroinflammation in BV2 cells. 33279663 4366 Mouse mmu-miR-374c miRNA myelin oligodendrocyte glycoprotein experimental autoimmune encephalomyelitis (EAE) spleen and brain tissues myelin oligodendrocyte glycoprotein treatment downregulated 31756487 4367 Mouse mmu-miR-374c miRNA hypoxia hypoxic pulmonary hypertension (HPH) pulmonary artery smooth muscle cells (PASMCs) hypoxic treatment mmu_circ_0000790 Is Involved in Pulmonary Vascular Remodeling in Mice with HPH via MicroRNA-374c-Mediated FOXC1. 32199127 4368 Mouse mmu-miR-374c-5p miRNA palmitic acid (PA) impaired insulin secretion ¦Â-TC-6 cells palmitic acid treatment upregulated 32302972 4369 Mouse mmu-miR-374c-5p miRNA stearic acid impaired insulin secretion ¦Â-TC-6 cells stearic acid treatment upregulated 32302972 4370 Mouse mmu-miR-375 miRNA streptozocin (STZ) ¦Â-cell death and diabetes mice ?peripheral blood and mice islets ?streptozotocin (STZ) treatment "High-dose STZ administration dramatically increased circulating miR-375 levels, prior to the onset of hyperglycemia" 23321698 4371 Mouse mmu-miR-375 miRNA ovalbumin (OVA) allergic rhinitis (AR) the epithelia of nasal mucosa of allergic rhinitis mice ovalbumin (OVA) treatment downregulated 29677549 4372 Mouse mmu-miR-375 miRNA liraglutide apoptosis "mouse pancreatic ¦Á-cell line, ¦Á-TC1-6, and mouse pancreatic ¦Â-cell line, ¦Â-TC-tet" could increase the level of and cell in pancreatic ¦Á-cells upregulated 29225111 4373 Mouse mmu-miR-375 miRNA high fat diet (HFD) atherosclerosis (AS) heart tissues of ApoE-/- mice high fat diet (HFD) feed upregulated 30870679 4374 Mouse mmu-miR-375 miRNA tanshinone IIA (Tan IIA) atherosclerosis (AS) heart tissues of high-fat diet (HFD) fed ApoE-/- mice Tanshinone IIA (TNA) treatment downregulated 30870679 4375 Mouse mmu-miR-375 miRNA dextran sodium sulfate (DSS) colitis colon tissues dextran sodium sulfate (DSS) treatment downregulated 29867475 4376 Mouse mmu-miR-375 miRNA doxycycline colitis colon tissues doxycycline (DXC) treatment upregulated 30076847 4377 Mouse mmu-miR-375 miRNA minocycline (MNC) colitis colon tissues minocycline (MNC) treatment upregulated 30076847 4378 Mouse mmu-miR-375 miRNA tetracycline (TTC) colitis colon tissues tetracycline (TTC) treatment upregulated 30076847 4379 Mouse mmu-miR-375 miRNA tigecycline (TGC) colitis colon tissues tigecycline (TGC) treatment upregulated 30076847 4380 Mouse mmu-miR-375 miRNA streptozocin (STZ) diabetic nephropathy (DN) proximal colon myenteric plexus streptozotocin (STZ) treatment upregulated 30140011 4381 Mouse mmu-miR-375 miRNA dextran sodium sulfate (DSS) inflammatory bowel disease (IBD) colon tissues dextran sulfate sodium (DSS) treatment downregulated 30236870 4382 Mouse mmu-miR-375 miRNA high fat diet (HFD) inflammatory response skeletal muscle of mice high fat diet (HFD) feed "miR-375, miR-29, miR-320, miR-103/107 and miR-126, play a crucial role in the regulation of glucose and lipid metabolism through the control of pancreatic islet cell function" 22395471 4383 Mouse mmu-miR-375 miRNA high fat diet (HFD) insulin resistance (IR) Fecal exosomes released from intestinal epithelial cells (IECs) ?high-fat diet?feed treatment We report that HFD feeding increased the expression of AhR and inhibited the expression of miR-375 and VAMP7 33754048 4384 Mouse mmu-miR-375 miRNA exenatide (EXA) insulin sensitivity pancreas exenatide treatment "The levels of miRNA-15a, 29c, 124a, and 375 in the pancreas were significantly increased in HFD control mice.These effects were reversed by treatment with exenatide." 26314504 4385 Mouse mmu-miR-375 miRNA exenatide (EXA) insulin sensitivity serum exenatide treatment "the levels of miRNA-15a, 29c, 124a, and 375 in the serum were significantly decreased. These effects were reversed by treatment with exenatide." 26314504 4386 Mouse mmu-miR-375 miRNA high fat diet (HFD) insulin sensitivity pancreas high fat diet (HFD) feed upregulated 26314504 4387 Mouse mmu-miR-375 miRNA high fat diet (HFD) insulin sensitivity serum high fat diet (HFD) feed downregulated 26314504 4388 Mouse mmu-miR-375 miRNA human islet grafts of adoptive lymphocyte transfer (ALT) islets of Langerhans mouse circulation ALT upregulated 27700000 4389 Mouse mmu-miR-375 miRNA concanamycin A (Con A) liver damage primary Kupffer cells concanavalin A (ConA) treatment upregulated 30206980 4390 Mouse mmu-miR-375 miRNA concanamycin A (Con A) liver damage liver tissues concanavalin A (ConA) treatment upregulated 30206980 4391 Mouse mmu-miR-375 miRNA streptozocin (STZ) loss and apoptosis of beta cell mouse blood plasma STZ treatment upregulated in blood plasma 29040320 4392 Mouse mmu-miR-375 miRNA morphine morphine tolerance CD-1 mice dorsal root ganglia (DRG) chronic morphine treatment downregulated in mouse dorsal root ganglia (DRG) 28603428 4393 Mouse mmu-miR-375 miRNA hypoxia myocardial infarction (MI) neonatal mouse ventricular cardiomyocytes (NMCMs) hypoxia treatment LNC_000898 could protect the heart against MI injury by regulating miR-375/PDK1. 32398474 4394 Mouse mmu-miR-375 miRNA cisplatin (DDP) nephrotoxicity mouse kidney proximal tubular cells cisplatin treatment upregulated 28119452 4395 Mouse mmu-miR-375 miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver tissues high fat diet (HFD) feed upregulated 29569260 4396 Mouse mmu-miR-375 miRNA IL-1¦Â osteoarthritis (OA) primary cultured chondrocytes IL-1¦Â treatment upregulated 32045921 4397 Mouse mmu-miR-375 miRNA astaxanthin prostate cancer Pca mouse tumor tissues intragastrically administered 100 mg/kg astaxanthin (HA) upregulated 28282880 4398 Mouse mmu-miR-375 miRNA kainic acid (KA) temporal lobe epilepsy (TLE) hippocampal tissues kainic acid (KA) treatment UCA1 was overexpressed in mice and the overexpression of UCA1 significantly reversed the abnormal proliferation of hippocampal neurons in epilepsy mice. 33829718 4399 Mouse mmu-miR-375 miRNA liraglutide type 2 diabetes mellitus (T2DM) "mouse pancreatic ¦Á-cell line, ¦Á-TC1-6" liraglutide treatment upregulated 29225111 4400 Mouse mmu-miR-375 miRNA liraglutide type 2 diabetes mellitus (T2DM) "mouse pancreatic ¦Â-cell line, ¦Â-TC-tet" liraglutide treatment downregulated 29225111 4401 Mouse mmu-miR-375-3p miRNA X-rays bystander effect C57BL/6 mice extracellular vesicles (EVs) otal-body irradiated with X-rays upregulated 28396668 4402 Mouse mmu-miR-375-3p miRNA solar particle event (SPE) colorectal cancer (CRC) plasma of a colorectal cancer susceptible mouse solar particle event (SPE) treatment downregulated 26432591 4403 Mouse mmu-miR-375-3p miRNA streptozocin (STZ) islets damage serum exosomes streptozocin (STZ) treatment Exosomal mmu-miR-375-3p dramatically increased in serum of STZ treated mouse prior to the disturbance of blood glucose and insulin 30552311 4404 Mouse mmu-miR-375-3p miRNA X-rays vulvovaginal candidiasis (VVC) serum mouse whole body exposure to 7?Gy of X-rays. treatment upregulated 29358747 4405 Mouse mmu-miR-376 miRNA antioxidant of bamboo leaves (AOB) vascular development embryoid bodies (EBs) antioxidant of bamboo leaves (AOB) treatment miR-376 was markedly downregulated following AOB treatment compared with the control. 29207159 4406 Mouse mmu-miR-376a miRNA metformin (Met) nonalcoholic steatohepatitis (NASH) liver tissues metformin treatment upregulated 25672270 4407 Mouse mmu-miR-376b-3p miRNA dihydroartemisinin (DHA) inflammation Mouse aortic vascular smooth muscle cells (VSMCs) dihydroartemisinin (DHA) treatment DHA was observed to directly depress the HG-induced expression of miR-376b-3p. 32753318 4408 Mouse mmu-miR-376b-3p miRNA Japanese encephalitis virus (JEV) Japanese encephalitis virus (JEV) infection BV-2 cells; mouse neuroblastoma cell line NA; mouse brain endothelial cell line bEnd.3 Japanese encephalitis virus (JEV) infection downregulated 32461319 4409 Mouse mmu-miR-376b-3p miRNA FTY-720 parkinson's disease (PD) dopaminergic MN9D cells FTY720 treatment upregulated 30359694 4410 Mouse mmu-miR-376b-3p miRNA FTY720-C2 parkinson's disease (PD) dopaminergic MN10D cells FTY720-C2 treatment upregulated 30359694 4411 Mouse mmu-miR-376b-3p miRNA FTY720-mitoxy parkinson's disease (PD) dopaminergic MN11D cells FTY720-Mitoxy treatment upregulated 30359694 4412 Mouse mmu-miR-376b-3p miRNA FTY720-C2 parkinson's disease (PD) MN9D cells FTY720-C2 treatment upregulated 30359694 4413 Mouse mmu-miR-377 miRNA cyclosporine A (CsA) cardiomyocyte apoptosis cardiomyocytes cyclosporine A treatment the expression of microRNA (miR)-377 was regulated by CsA. 26948033 4414 Mouse mmu-miR-377 miRNA hypoxia cerebral ischemia injury (CII) mouse brain microvascular endothelial cells (BMECs) oxygen-glucose deprivation (OGD) induce "lncRNA NEAT1 facilitated the survival and angiogenesis of OGD-induced BMECs via targeting miR-377 and promoting the expression of VEGFA, SIRT1, and BCL-XL." 30408478 4415 Mouse mmu-miR-377 miRNA oxygen glucose deprivation (OGD) cerebral ischemia injury (CII) brain microvascular endothelial cells (BMECs) oxygen-glucose deprivation (OGD) treatment Upregulation of lncRNA NEAT1 and downregulated of miR-377 were also observed under OGD conditions 30408478 4416 Mouse mmu-miR-377 miRNA high glucose (HG) diabetic nephropathy (DN) mesangial cells high glucose treatment upregulated 18716028 4417 Mouse mmu-miR-377 miRNA high glucose (HG) diabetic nephropathy (DN) Mouse podocytes (MPC5) high glucose treatment upregulated 30095204 4418 Mouse mmu-miR-377 miRNA TGF-¦Â diabetic nephropathy (DN) mesangial cells transforming growth factor-¦Â treatment ?upregulated 18716028 4419 Mouse mmu-miR-377 miRNA plasmodium chabaudi malaria peak parasitemia liver of mice Plasmodium chabaudi malaria infection treatment downregulated 21085987 4420 Mouse mmu-miR-377 miRNA IFN-¦Ã sj?gren's syndrome (SS) salivary gland epithelial cells (SGECs) interferon gamma (IFN-¦Ã) treatment downregulated 31198060 4421 Mouse mmu-miR-377-3p miRNA high fat diet (HFD) atherosclerosis (AS) aorta tissues high fat diet (HFD) feed Deletion of ApoE and HFD treatment significantly downregulated miR-377-3p levels in aorta tissues. 32373927 4422 Mouse mmu-miR-377-3p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce downregulated 30936699 4423 Mouse mmu-miR-378 miRNA coenzyme Q10 (CoQ10) atherosclerosis (AS) mouse J774.A1 THP-1 macrophages CoQ10 treatment downregulated 24675662 4424 Mouse mmu-miR-378 miRNA oxygen glucose deprivation (OGD) autophagy primary neurons; brain tissues oxygen glucose deprivation (OGD) treatment downregulated 32605923 4425 Mouse mmu-miR-378 miRNA fish oil brown adipose tissue thermogenesis brown adipocytes fish oil treatment upregulated 27489163 4426 Mouse mmu-miR-378 miRNA TGF-¦Â1 cardiac fibrosis mouse cardiac fibroblasts (CFs) TGF-¦Â1 treatment downregulated 31220469 4427 Mouse mmu-miR-378 miRNA angiotensin II (Ang II) cardiac hypertrophy cardiate angiotensin II (Ang II) treatment upregulated 25104350 4428 Mouse mmu-miR-378 miRNA high fat diet (HFD) chondrogenesis white adipose tissues high fat diet (HFD) feed downregulated 22496873 4429 Mouse mmu-miR-378 miRNA astragaloside IV (AS-IV) diabetic nephropathy (DN) high glucose-treated the mouse podocyte clone 5 (MPC5) cells astragaloside (AS-IV) treatment upregulated 29792879 4430 Mouse mmu-miR-378 miRNA high glucose (HG) diabetic nephropathy (DN) The mouse podocyte clone 5 (MPC5) cells high glucose (HG) treatment downregulated 29792879 4431 Mouse mmu-miR-378 miRNA fish oil hepatosteatosis mice liver tissues Fisetin treatment downregulated 23818290 4432 Mouse mmu-miR-378 miRNA ischemia intestinal ischemia/reperfusion (I/R) injury ?intestinal mucosal cell intestinal ischemia/reperfusion (I/R) downregulated 29022896 4433 Mouse mmu-miR-378 miRNA electrical stimulation (EleS) ischemic heart disease (IHD) cardiac stem cells (CSCs) electrical stimulation (EleS) treatment miR-378 as a potential Ctgf regulator in (EleS)CSCs 24067999 4434 Mouse mmu-miR-378 miRNA oxygen glucose deprivation (OGD) ischemic stroke (IS) N2A cells oxygen-glucose deprivation (OGD) treatment downregulated 27598143 4435 Mouse mmu-miR-378 miRNA listeria Listeria infection murine ileum tissues Listeria infection downregulated 24327339 4436 Mouse mmu-miR-378 miRNA stretch myoblast proliferation C2C12 myoblasts stretch treatment downregulated 27840929 4437 Mouse mmu-miR-378 miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver tissues high fat diet (HFD) feed miR-378 was significantly increased in fatty livers of dietary obese mice and human hepatoma HepG2 cells with accumulated lipid. 29625129 4438 Mouse mmu-miR-378 miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) mouse liver high fat diet (HFD) feed upregulated 30218679 4439 Mouse mmu-miR-378 miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver tissues high fat diet (HFD) feed upregulated 30281809 4440 Mouse mmu-miR-378 miRNA high glucose (HG) osteogenesis mouse osteoblastic cell line MC3T3-E1 "high glucose (15.5, 25.5 or 35.5 mM) treatment" upregulated 25400823 4441 Mouse mmu-miR-378 miRNA propofol (PPF) propofol-induced developmental neurotoxicity hippocampus propofol treatment upregulated 30242182 4442 Mouse mmu-miR-378 miRNA olanzapine (OLP) psychotic disorders brain tissues clozapine treatment upregulated 23318695 4443 Mouse mmu-miR-378 miRNA mycobacterium tuberculosis (Mtb) pulmonary tuberculosis (PTB) lung tissues mycobacterium tuberculosis (Mtb) treatment downregulated 33089914 4444 Mouse mmu-miR-378 miRNA pSTAT3-specific inhibitor AG-490 pulmonary tuberculosis (PTB) lung tissues pSTAT3-specific inhibitor AG-490 treatment upregulated 33089914 4445 Mouse mmu-miR-378-3p miRNA "paraquat (PQ) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" dopaminergic (DA) neuron differentiation neuro-2a cells "paraquat (PQ) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment" dysregulated 29250806 4446 Mouse mmu-miR-378-3p miRNA morphine morphine tolerance brainstem morphine treatment Chronic morphine treatment significantly increased the miR-378-3p level in the brainstem of the morphine tolerant mice. 31999011 4447 Mouse mmu-miR-378-3p miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" neurodegenerative diseases N2a cells "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" upregulated 29250806 4448 Mouse mmu-miR-378-5p miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" neurodegenerative diseases N2a cells "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" upregulated 29250806 4449 Mouse mmu-miR-378a miRNA lipopolysaccharide (LPS) acute aortic dissection (AAD) aorta lipopolysaccharide (LPS) treatment downregulated 32634201 4450 Mouse mmu-miR-378a miRNA high fat diet (HFD) atherosclerosis (AS) the aorta of ApoE-/- mice high fat diet (HFD) feed downregulated 30929259 4451 Mouse mmu-miR-378a miRNA nano-titanium dioxide (nano-TiO2) cardiovascular function mouse heart tissues Nano-titanium dioxide (nano-TiO2) treatment upregulated 30704319 4452 Mouse mmu-miR-378a-3p miRNA ionizing radiation (IR) abdominal cancer small intestines ionizing radiation (IR) treatment miR-378a-3p was markedly upregulated in the small intestines of mice after total abdominal irradiation. 32800335 4453 Mouse mmu-miR-378a-3p miRNA high fat diet (HFD) adipogenesis mouse high fat diet (HFD) feed upregulated 25529446 4454 Mouse mmu-miR-378a-3p miRNA high fat diet (HFD) adipogenesis and obesity adipose high fat diet (HFD) feed upregulated 25529446 4455 Mouse mmu-miR-378a-3p miRNA Jiang Tang Xiao Ke Granule diabetes mellitus (DM) KKAy diabetic mice Jiang Tang Xiao Ke Granule treatment dysregulated 29163176 4456 Mouse mmu-miR-378a-3p miRNA carbon tetrachloride (CCl4) hepatic fibrogenesis hepatic stellate cells (HSCs) CCl4 treatment downregulated 27001906 4457 Mouse mmu-miR-378a-3p miRNA carbon tetrachloride (CCl4) liver fibrosis liver CCl4 treatment downregulated 27322257 4458 Mouse mmu-miR-378a-3p miRNA high fat diet (HFD) hyperlipidemia fatty livers high fat diet (HFD) feed Activation of microRNA-378a-3p biogenesis promotes hepatic secretion of VLDL and hyperlipidemia by modulating ApoB100-Sortilin1 axis 32226531 4459 Mouse mmu-miR-378a-3p miRNA carbon tetrachloride (CCl4) liver fibrosis primary hepatic stellate cell (HSC) CCl4 treatment downregulated 31272073 4460 Mouse mmu-miR-378a-5p miRNA tanshinone IIA (Tan IIA) atherosclerosis (AS) RAW 264.7 cells Tanshinone IIA (Tan) treatment upregulated 32337768 4461 Mouse mmu-miR-378b miRNA luteinising hormone (LH) functions of Leydig cells mouse TM3 Leydig cells luteinising hormone (LH) treatment upregulated 28762514 4462 Mouse mmu-miR-378b miRNA carbon tetrachloride (CCl4) hepatic fibrogenesis hepatic stellate cells (HSCs) CCl4 treatment downregulated 27001906 4463 Mouse mmu-miR-378b miRNA carbon tetrachloride (CCl4) liver fibrosis liver CCl4 treatment downregulated 27322257 4464 Mouse mmu-miR-378b miRNA luteinising hormone (LH) steroidogenesis mouse TM3 Leydig cells luteinising hormone(LH) treatment dysregulated 28762514 4465 Mouse mmu-miR-378c miRNA tanshinone IIA (Tan IIA) atherosclerosis (AS) RAW 264.7 cells Tanshinone IIA (Tan) treatment upregulated 32337768 4466 Mouse mmu-miR-378d miRNA echinococcus multilocularis metacestodes echinococcus multilocularis infection RAW 264.7 cells E. multilocularis metacestodes treatment upregulated 30322806 4467 Mouse mmu-miR-378d miRNA carbon tetrachloride (CCl4) hepatic fibrogenesis hepatic stellate cells (HSCs) CCl4 treatment downregulated 27001906 4468 Mouse mmu-miR-378d miRNA carbon tetrachloride (CCl4) liver fibrosis liver CCl4 treatment downregulated 27322257 4469 Mouse mmu-miR-378d miRNA E. multilocularis metacestodes infection and immunity of E. multilocularis RAW264¡¤7 macrophage cells E. multilocularis metacestodes for 6 and 12 h treatment "upregulated (mmu-miR-378d,mmu-miR-155-5p, mmu-miR-146a-5p, mmu-miR-21a-5p , mmu-miR-125a-5p) and downregulated(mmu-miR-1981-5p , mmu-miR-let-7c-1-3p)" 28942753 4470 Mouse mmu-miR-378d miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce upregulated 30936699 4471 Mouse mmu-miR-378d miRNA alpinia oxyphylla extract (AOE) type 2 diabetes mellitus (T2DM) db-/db- mouse kidney A. oxyphylla extract (AOE) treatment upregulated 28249617 4472 Mouse mmu-miR-379 miRNA dexamethasone (DEX) duchenne muscular dystrophy (DMD) muscle dexamethasone (DEX) treatment dexamethasone resulted in reduced muscle expression of miR-379. 32499563 4473 Mouse mmu-miR-379 miRNA cigarette smoke (CS) ovarian toxicity ovarian tissues cigarette smoke (CS) treatment downregulated 29377183 4474 Mouse mmu-miR-379-5p miRNA arsenite arsenite-induced liver damage liver tissue arsenite exposure downregulated 30643918 4475 Mouse mmu-miR-379-5p miRNA high glucose (HG) diabetic nephropathy (DN) mouse mesangial cells (MMCs) high glucose (HG) treatment downregulated 31485601 4476 Mouse mmu-miR-380-3p miRNA cigarette smoke (CS) chronic obstructive pulmonary disease (COPD) lung tissue and alveolar macrophages cigarette smoke (CS) exposure upregulated 31819170 4477 Mouse mmu-miR-380-3p miRNA paraquat (PQ) paraquat (PQ)-induced toxicity mouse neuroblastoma (N2a) cells or tert-Butylhydroquinone (TBHQ)-treated N2a cells paraquat (PQ) exposure downregulated 31368498 4478 Mouse mmu-miR-380-3p miRNA tert-butyl hydroperoxide (TBHP) paraquat (PQ)-induced toxicity mouse neuroblastoma (N2a) cells tert-Butylhydroquinone (TBHQ) treatment upregulated 31368498 4479 Mouse mmu-miR-381 miRNA dexmedetomidine (DEX) acute lung injury (ALI) LPS-induced acute lung injury mouse lung tissues dexmedetomidine (Dex) treatment upregulated 30102002 4480 Mouse mmu-miR-381 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues lipopolysaccharide (LPS) treatment downregulated 30102002 4481 Mouse mmu-miR-381 miRNA H2O2 myocardial infarction (MI) Primary cultured cardiomyocyte H2O2 treatment upregulated 30105734 4482 Mouse mmu-miR-381 miRNA hypoxia myocardial infarction (MI) Primary cultured cardiomyocyte hypoxia induce upregulated 30105734 4483 Mouse mmu-miR-381-3p miRNA "2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD)" cleft palate (CP) E13.5 and E14.5 fetal palates "On embryonic day 10.5 (E10.5), the pregnant mice in TCDD group were orally administrated with TCDD at dosage of 28 ¦Ìg/kg, while the pregnant mice in control group received equivalent corn oil. The pregnant mice in each group were sacrificed on E13.5 and E14.5, fetal palates were collected for analysis." downregulated 31512462 4484 Mouse mmu-miR-381-3p miRNA streptozocin (STZ) diabetic retinopathy (DR) retina and serum of diabetic mice streptozotocin treatment upregulated 30883703 4485 Mouse mmu-miR-381-3p miRNA "4,4'-methylene diphenyl diisocyanate (MDI)" occupational asthma (OA) Female BALB/c mice blood "4,4'-methylene diphenyl diisocyanate (MDI) exposure" downregulated 30074411 4486 Mouse mmu-miR-381-3p miRNA "4,4'-methylene diphenyl diisocyanate (MDI)" occupational asthma (OA) bronchoalveolar lavage cells (BALCs) "4,4'-methylene diphenyl diisocyanate (MDI) treatment" downregulated 31609387 4487 Mouse mmu-miR-381-3p miRNA "diisocyanate, 4,4'-methylene diphenyl diisocyanate (MDI)" occupational asthma (OA) Female BALB/c mice blood Female BALB/c mice were exposed to one of three exposure regimens: dermal exposure to 1% MDI in acetone; nose-only exposure to 4580?¡À?1497?¦Ìg/m3 MDI-aerosol for 60?minutes; or MDI dermal exposure/sensitization followed by MDI-aerosol inhalation challenge. downregulated 30074411 4488 Mouse mmu-miR-382 miRNA streptozocin (STZ) diabetic nephropathy (DN) renal tissues streptozotocin (STZ) treatment upregulated 29701296 4489 Mouse mmu-miR-382 miRNA ¦Â-lapachone (BLC) obesity white adipose ¦Â-lapachone (BLC) treatment downregulated 27246910 4490 Mouse mmu-miR-382 miRNA ochratoxin A (OTA) ochratoxin A (OTA) toxicity Primary proximal tubular epithelial cell ochratoxin A treatment upregulated 28710020 4491 Mouse mmu-miR-382-3p miRNA exercise (Ex) insulin resistance (IR) serum from IR mouse swimming upregulated 31479923 4492 Mouse mmu-miR-382-5p miRNA anandamide and norgestimate depression chronic mild stress (CMS) model of depression mouse anandamide and norgestimate treatment upregulated 28716528 4493 Mouse mmu-miR-383 miRNA calorie restriction (CR) hepatic steatosis high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues calorie restriction (CR) treatment upregulated 31863770 4494 Mouse mmu-miR-383 miRNA exercise (Ex) hepatic steatosis high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues exercise (Ex) treatment upregulated 31863770 4495 Mouse mmu-miR-383 miRNA high fat diet (HFD) hepatic steatosis mice thyroid and liver tissues high fat diet (HFD) feed downregulated 31863770 4496 Mouse mmu-miR-383 miRNA low fat diet (LFD) hepatic steatosis high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues low-fat diet (LF) treatment upregulated 31863770 4497 Mouse mmu-miR-383 miRNA quercetin hepatic steatosis high-fat (HF) diet-induced obesity prone (OP) mice thyroid and liver tissues quercetin (Que) treatment upregulated 31863770 4498 Mouse mmu-miR-383 miRNA high glucose (HG) high-fat induced diabetes Islet beta-cell high glucose (HG) treatment miR-383 ameliorates high glucose-induced ¦Â-cells apoptosis and hyperglycemia in high-fat induced diabetic mice. 33058915 4499 Mouse mmu-miR-383 miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated 26639663 4500 Mouse mmu-miR-383 miRNA methyltransferase G9a liver mature liver tissues from liver-specific knockout (Liv-KO) of G9a mice liver-specific knockout (Liv-KO) of G9a upregulated 29912608 4501 Mouse mmu-miR-383 miRNA low fat diet (LFD) obesity thyroid low fat diet (LFD) treatment downregulated 31863770 4502 Mouse mmu-miR-383 miRNA low fat diet (LFD) obesity thyroid low fat diet (LFD) treatment upregulated 31863770 4503 Mouse mmu-miR-383 miRNA quercetin obesity thyroid quercetin (QUE) treatment upregulated 31863770 4504 Mouse mmu-miR-383-5p miRNA delvestidine (DLTD) bone marrow-derived dendritic cells (BMDCs) maturity bone marrow-derived dendritic cells (BMDCs) Delvestidine (DLTD) treatment upregulated 32871480 4505 Mouse mmu-miR-383-5p miRNA resveratrol diabetic nephropathy (DN) db/db mice podocyte resveratrol (RS) treatment downregulated 28374806 4506 Mouse mmu-miR-384 miRNA ovalbumin (OVA) asthma mouse purified airway smooth muscle cells OVA treatment downregulated 28978085 4507 Mouse mmu-miR-384 miRNA hypoxia ischemic brain injury HT22 cells and hippocampal tissues hypoxia induce upregulated 31165722 4508 Mouse mmu-miR-384-3p miRNA streptozocin (STZ) diabetic retinopathy (DR) retinal tissues streptozotocin (STZ) treatment downregulated 30191948 4509 Mouse mmu-miR-384-3p miRNA propofol (PPF) propofol-induced developmental neurotoxicity hippocampus propofol treatment upregulated 30242182 4510 Mouse mmu-miR-384-5p miRNA high fat diet (HFD) atherosclerosis (AS) macrophages high fat diet (HFD) feed upregulated 27158352 4511 Mouse mmu-miR-384-5p miRNA angiotensin II (Ang II) cardiac hypertrophy primary cardiomyocytes (PCM) angiotensin II (Ang II) treatment downregulated 32436661 4512 Mouse mmu-miR-384-5p miRNA streptozocin (STZ) diabetic encephalopathy Inflammatory macrophages were isolated from the brain of the mice streptozotocin (STZ) treatment downregulated 29511445 4513 Mouse mmu-miR-392 miRNA mycobacterium tuberculosis (Mtb) pulmonary tuberculosis (PTB) lung tissues mycobacterium tuberculosis (Mtb) treatment downregulated 33089914 4514 Mouse mmu-miR-392 miRNA pSTAT3-specific inhibitor AG-490 pulmonary tuberculosis (PTB) lung tissues pSTAT3-specific inhibitor AG-490 treatment upregulated 33089914 4515 Mouse mmu-miR-3963 miRNA bilateral surgical destabilization of the medial meniscus (DMM) osteoarthritis (OA) male C57BL6 mice bilateral surgical destabilization of the medial meniscus (DMM) treatment dysregulated 29255152 4516 Mouse mmu-miR-3p miRNA ultraviolet (UV) irradiation skin inflammation epidermis UV exposure treatment upregulated 27250636 4517 Mouse mmu-miR-409-3p miRNA chronic social instability stress embryonic development sperm chronic social instability stress treatment "we found that exposure of male mice to chronic social instability stress, which leads to elevated anxiety in their female offspring across at least three generations through the paternal lineage, elevates sperm miR-409-3p levels not only in exposed males, but also in sperm of their F1 and F2 male offspring." 32333826 4518 Mouse mmu-miR-409-3p miRNA IL-17 experimental autoimmune encephalomyelitis (EAE) astrocytes from EAE mice interleukin-17 (IL-17) treatment upregulated 30294880 4519 Mouse mmu-miR-409-3p miRNA nine hepatotoxic non-genotoxins (NGTXs) genotoxicity liver tissues nine hepatotoxic non-genotoxins (NGTXs) treatment downregulated 29777724 4520 Mouse mmu-miR-409-3p miRNA nine hepatotoxic non-genotoxins (NGTXs) genotoxicity plasma nine hepatotoxic non-genotoxins (NGTXs) treatment upregulated 29777724 4521 Mouse mmu-miR-409-3p miRNA choline- and folate-deficient (CFD) diet liver damage plasma choline- and folate-deficient (CFD) diet treatment upregulated 26878785 4522 Mouse mmu-miR-409-3p miRNA IL-17 multiple sclerosis (MS) Primary mouse astrocytes interleukin-17 (IL-17) treatment upregulated 30294880 4523 Mouse mmu-miR-409-3p miRNA choline- and folate-deficient (CFD) diet nonalcoholic fatty liver disease (NAFLD) plasma choline- and folate-deficient (CFD) treatment upregulated 26878785 4524 Mouse mmu-miR-409-5p miRNA amyloid-¦Â (A¦Â) 1-42 Alzheimer's disease (AD) mice cortexes amyloid ¦Â1-42?(A¦Â) treatment downregulated 31849582 4525 Mouse mmu-miR-409-5p miRNA high glucose (HG) diabetic retinopathy (DR) retinal microvascular endothelial cells (RMECs) high glucose (HG) treatment upregulated 32292119 4526 Mouse mmu-miR-409-5p miRNA high glucose (HG) diabetic retinopathy (DR) retinal tissues high glucose (HG) treatment upregulated 32292119 4527 Mouse mmu-miR-410 miRNA hesperetin acute lung injury (ALI) lung tissues Hesperetin (Hesp) treatment MicroRNA-410 (miR-410) levels were significantly lower in the lung tissues of ALI mice and were reversed after Hesp treatment. 32762101 4528 Mouse mmu-miR-410 miRNA Tangeretin gastric cancer (GC) gastric cancer cells Tangeretin treatment upregulated 25998143 4529 Mouse mmu-miR-410 miRNA choline- and folate-deficient (CFD) diet liver damage plasma choline- and folate-deficient (CFD) diet treatment upregulated 26878785 4530 Mouse mmu-miR-410 miRNA choline- and folate-deficient (CFD) diet nonalcoholic fatty liver disease (NAFLD) plasma choline- and folate-deficient (CFD) treatment upregulated 26878785 4531 Mouse mmu-miR-410 miRNA olanzapine (OLP) psychotic disorders brain tissues clozapine treatment upregulated 23318695 4532 Mouse mmu-miR-410 miRNA hypoxia pulmonary arterial hypertension (PAH) lung tissues hypoxia induce downregulated 31289307 4533 Mouse mmu-miR-410-3p miRNA lipopolysaccharide (LPS) osteoarthritis (OA) chondrocytes lipopolysaccharide (LPS) treatment downregulated 32709223 4534 Mouse mmu-miR-410-3p miRNA lipopolysaccharide (LPS) sepsis-induced myocardial injury cardiomyocytes lipopolysaccharide (LPS) treatment "miR-410-3p was downregulated, while TLR2 was upregulated in LPS-induced mice and cardiomyocytes." 33230433 4535 Mouse mmu-miR-411-5p miRNA Ultra-high molecular weight polyethylene (UHMWPE) particle-induced osteolysis (PIO) mesenchymal stem cells (MSCs) Ultra-high molecular weight polyethylene (UHMWPE) treatment The expression of miR-411-5p was decreased in osteolysis mice and UHMWPE-induced mMSCs 32061766 4536 Mouse mmu-miR-412-5p miRNA oxygen retinopathy of prematurity (ROP) retinas tissue "For OIR model construction, 7-day-old mice and their nursing mothers were maintained in 75% oxygen for 5 continuous days. On postnatal day (P) 12, the pups were returned to normoxic air and kept with their mothers for another 5 days. treatment" downregulated in the OIR samples 31452702 4537 Mouse mmu-miR-421 miRNA hyperoxia bronchopulmonary dysplasia (BPD) lung tissues hyperoxia induce upregulated 31144392 4538 Mouse mmu-miR-421 miRNA ¦¤9-tetrahydrocannabinol (THC) inflammation total lymph node cells and CD4(+) T cells ¦¤9-Tetrahydrocannabinol (THC) treatment downregulated 27268054 4539 Mouse mmu-miR-421 miRNA cortisone rheumatoid arthritis (RA) synovial tissues cortisone treatment downregulated 31646548 4540 Mouse mmu-miR-422a miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) neuron apoptosis primary murine neurons oxygen-glucose deprivation and reoxygenation (OGD/R) treatment upregulated 32999283 4541 Mouse mmu-miR-423-5p miRNA high glucose (HG) diabetic nephropathy (DN) immortalized mouse podocyte cell line (MPC5) high glucose (HG) treatment downregulated 30245133 4542 Mouse mmu-miR-423?5p miRNA carbon tetrachloride (CCl4) hepatotoxicity blood carbon tetrachloride (CCl4) treatment upregulated 32528856 4543 Mouse mmu-miR-423?5p miRNA lipopolysaccharide (LPS) inflammation RAW 264.7 cells lipopolysaccharide (LPS) treatment upregulated 32153563 4544 Mouse mmu-miR-424 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) Mouse pulmonary microvascular endothelial cells (MPVECs) lipopolysaccharide (LPS) treatment downregulated 32818819 4545 Mouse mmu-miR-424 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues lipopolysaccharide (LPS) treatment THRIL accelerates sepsis-induced lung injury by sponging miR-424 and further restoring ROCK2. 32818819 4546 Mouse mmu-miR-424 miRNA tanshinone IIA (Tan IIA) fracture healing mouse pre-osteoblast MC3T3-E1 cells Tanshinone IIA (Tan IIA) treatment downregulated 31306638 4547 Mouse mmu-miR-424 miRNA hypoxia ischemia/reperfusion (I/R) injury Proximal kidney tubular cells hypoxia induce upregulated 31105811 4548 Mouse mmu-miR-424 miRNA ischemia/reperfusion (I/R) transient cerebral ischemia peri-infarct cortex ischemia/reperfusion (I/R) treatment MiR-424 levels in the peri-infarct cortex increased at 1 and 4 hours then decreased 24 hours after reperfusion 25523055 4549 Mouse mmu-miR-424 miRNA transient cerebral ischemia transient cerebral ischemia/reperfusion injury C57/BL6 mice the peri infarct cortex middle cerebral artery occlusion for 1 hour followed by reperfusion (ischemia/reperfusion) treatment upregulated at 1 and 4 hours then downregulated 24 hours after reperfusion 25523055 4550 Mouse mmu-miR-424-5p miRNA saturated fatty acids (SFA) palmitate (PA) obesity-induced hepatic insulin resistance liver tissues saturated fatty acids (SFA) palmitate (PA) treatment miR-424-5p was upregulated in both PA-treated HFD-fed mice 30033101 4551 Mouse mmu-miR-425 miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity heart sissues doxorubicin (DOX) treatment DOX resulted in a remarkable decrease of miR-425 in heart tissues. 32092815 4552 Mouse mmu-miR-425 miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) substantia nigra tissue "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" downregulated 31383850 4553 Mouse mmu-miR-425-3p miRNA coxsackievirus B3 (CVB3) viral myocarditis (VM) myocardial tissues Coxsackievirus B3 (CVB3) infection miR-425-3p was lowly expressed in myocardial tissues of mice with viral myocarditis. 33332750 4554 Mouse mmu-miR-425-5p miRNA oxygen glucose deprivation (OGD) ischemic stroke (IS) mouse brain microvascular endothelial cell (BMEC) oxygen-glucose deprivation (OGD) treatment upregulated 33491845 4555 Mouse mmu-miR-425-5p miRNA lipopolysaccharide (LPS) sepsis liver tissues lipopolysaccharide (LPS) treatment downregulated 32002587 4556 Mouse mmu-miR-4262 miRNA angiotensin-converting enzyme 2 (ACE2) acute lung injury (ALI) lung angiotensin converting enzyme 2 (ACE2) treatment ACE2 appeared to significantly suppress the upregulation of miR-4262 in mouse lung after ALI 26356266 4557 Mouse mmu-miR-429 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) MLE-12 cells; lung tissues lipopolysaccharide (LPS) treatment miR-429 was increased in lung tissues from LPS-induced ALI mice and LPS-treated MLE-12 cells. 31837322 4558 Mouse mmu-miR-429 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) murine alveolar epithelial cell line MLE-12 lipopolysaccharide (LPS) treatment GAS5 suppresses inflammatory responses and apoptosis of alveolar epithelial cell MLE-12 by targeting miR-429/DUSP1 axis. 31837322 4559 Mouse mmu-miR-429 miRNA amyloid-¦Â (A¦Â) 25-35 Alzheimer's disease (AD) primary mouse cortical neurons amyloid-¦Â (A¦Â) 25-35 treatment upregulated 30264333 4560 Mouse mmu-miR-429 miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral ischemia/reperfusion (I/R) injury Mouse brain microvascular endothelial cells (BMECs) oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 32404105 4561 Mouse mmu-miR-429 miRNA dextran sodium sulfate (DSS) colitis colons dextran sulphate sodium [DSS] treatment downregulated 26818658 4562 Mouse mmu-miR-429 miRNA dextran sodium sulfate (DSS) colitis colon tissues dextran sulfate sodium (DSS) treatment downregulated 30334065 4563 Mouse mmu-miR-429 miRNA hypoxia hypoxic/ischemic brain damage (HIBD) mouse primary hippocampal neurons hypoxia induce downregulated 31185248 4564 Mouse mmu-miR-429 miRNA lipopolysaccharide (LPS) microglial neuroinflammation BV-2 microglia lipopolysaccharide (LPS) treatment upregulated 31896511 4565 Mouse mmu-miR-429 miRNA anoxia/reoxygenation (A/R) myocardial infarction (MI) primary cultured cardiomyocytes anoxia/reoxygenation (AR) treatment downregulated 31494170 4566 Mouse mmu-miR-429 miRNA leptin obesity hypothalamus?tissues leptin treatment downregulated 24394757 4567 Mouse mmu-miR-429 miRNA CoCl2 osteoblastic differentiation MC3T3-E1 cells CoCl2 treatment upregulated 27576955 4568 Mouse mmu-miR-429 miRNA lipopolysaccharide (LPS) traumatic brain injury (TBI) BV-2 cells lipopolysaccharide (LPS) treatment LPS and TBI significantly induce the up-expression of miR-429. 31896511 4569 Mouse mmu-miR-429 miRNA insulin-like growth factor 1 (IGF-1) unilateral ureteral obstruction (UUO) mouse renal epithelial cells insulin-like growth factor-1 (IGF-1) treatment downregulated 27301852 4570 Mouse mmu-miR-429-3p miRNA TGF-¦Â breast cancer normal murine mammary gland epithelial (NMuMG) cells transforming growth factor (TGF)¦Â treatment downregulated 30285803 4571 Mouse mmu-miR-429-3p miRNA dioscorea bulbifera (DB) liver damage livers dioscoreae bulbifera (EF) treatment upregulated 27609015 4572 Mouse mmu-miR-429-3p miRNA coix seed Oil (CSO) triple negative breast cancer (TNBC) mouse triple-negative breast cancer (TNBC) tissues coix Seed Oil (CSO) treatment upregulated 33101013 4573 Mouse mmu-miR-431-5p miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity plasma doxorubicin (DOX) treatment downregulated 30453253 4574 Mouse mmu-miR-431-5p miRNA angiotensin II (Ang II) hypertension mesenteric arteries angiotensin II (Ang II) treatment upregulated 30929512 4575 Mouse mmu-miR-432 miRNA propofol (PPF) propofol-induced developmental neurotoxicity hippocampus propofol treatment downregulated 30242182 4576 Mouse mmu-miR-432-5p miRNA angiotensin II (Ang II) cardiac hypertrophy cardiomyocyte angiotensin II (Ang II) treatment downregulated 29966657 4577 Mouse mmu-miR-433 miRNA inorganic nitrite acute myocardial infarction (AMI) heart tissues single-dose of nitrite downregulated 28090786 4578 Mouse mmu-miR-433 miRNA ischemia/reperfusion (I/R) acute myocardial infarction (AMI) heart tissues ischemia/reperfusion (I/R) treatment upregulated 28090786 4579 Mouse mmu-miR-433 miRNA amyloid-¦Â (A¦Â) 1-40 age-related macular degeneration (AMD) C57BL/6 mice eye tissues amyloid-¦Â (A¦Â) 1-40 treatment downregulated 28324113 4580 Mouse mmu-miR-433 miRNA amyloid-¦Â (A¦Â) Alzheimer's disease (AD) SH-SY5Y cells; SK-N-SH cells amyloid-¦Â (A¦Â) treatment downregulated 32871216 4581 Mouse mmu-miR-433 miRNA TGF-¦Â cardiac fibrosis primary adult cardiac fibroblasts TGF-¦Â treatment "Inhibition of miR-433 attenuated cardiac fibroblast proliferation and myofibroblast differentiation in murine post-MI models and in fibroblasts induced by TGF-¦Â and AngII stimulation In contrast, upregulation of miR-433 promoted cardiac fibrotic response CircNFIB acts as a competing endogenous RNA for miR-433" 31316543 4582 Mouse mmu-miR-433 miRNA high glucose (HG) diabetes mellitus (DM) Min-6 pancreatic ¦Â cells high-glucose medium downregulated 28713945 4583 Mouse mmu-miR-433 miRNA "5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)" gastric cancer (GC) balb/c nu-nu mice injected with 107 GC cells "5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment" upregulated 25270964 4584 Mouse mmu-miR-433-3p miRNA ginkgo biloba extract (GBE) hepatocellular carcinoma (HCC) non-tumor (ENT) liver ginkgo biloba extract (GBE) treatment upregulated 32306082 4585 Mouse mmu-mir-434-3p miRNA recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) bacterial infection blood recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) treatment upregulated 25563241 4586 Mouse mmu-miR-434-3p miRNA long-term bed rest disuse muscle atrophy mouse both serum and muscle long-term bed rest downregulated 28329037 4587 Mouse mmu-miR-434-3p miRNA pilocarpine epilepsy blood and brain pilocarpine treatment upregulated 32590288 4588 Mouse mmu-miR-434-3p miRNA Ultra-high molecular weight polyethylene (UHMWPE) particle-induced osteolysis (PIO) mesenchymal stem cells (MSCs) Ultra-high molecular weight polyethylene (UHMWPE) treatment The expression of miR-434-3p was decreased in osteolysis mice and UHMWPE-induced mMSCs 32061766 4589 Mouse mmu-miR-434-5p miRNA olanzapine (OLP) psychotic disorders brain tissues clozapine treatment upregulated 23318695 4590 Mouse mmu-miR-448 miRNA ischemia/reperfusion (I/R) acute ischemic and hemorrhagic stroke mouse circulation ischemia/reperfusion (I/R) treatment upregulated 28193834 4591 Mouse mmu-miR-448 miRNA high fat diet (HFD) atherosclerosis (AS) aortic smooth muscle cell (ASMCs) high fat diet (HFD) feed miR-448 was highly expressed in aortic smooth muscle of AS model mice. 32848826 4592 Mouse mmu-miR-448 miRNA lipopolysaccharide (LPS) endometriosis uterine tissue lipopolysaccharides (LPS) treatment downregulated 31674024 4593 Mouse mmu-miR-448 miRNA bleomycin (BLM) idiopathic pulmonary fibrosis (IPF) lung tissues bleomycin (BLM) treatment downregulated 31506947 4594 Mouse mmu-miR-448 miRNA high fat diet (HFD) type 2 diabetes mellitus (T2DM) T2D mice-derived macrophages high fat diet (HFD) feed downregulated 30536833 4595 Mouse mmu-miR-448 miRNA streptozocin (STZ) type 2 diabetes mellitus (T2DM) T2D mice-derived macrophages streptozotocin (STZ) treatment downregulated 30536833 4596 Mouse mmu-miR-448 miRNA streptozocin (STZ) type 2 diabetes mellitus (T2DM) T2D mice-derived macrophages Type 2 diabetes models in C57BL/6J mice were generated by a combination administration of streptozotocin (STZ) and a high-fat diet (HFD) treatment downregulated 30536833 4597 Mouse mmu-miR-448-5p miRNA ovalbumin (OVA) asthma lung tissues ovalbumin solution treatment downregulated 30362537 4598 Mouse mmu-miR-448-5p miRNA morphine painful or stressful conditions hippocampal Morphine treatment downregulated 25844808 4599 Mouse mmu-miR-449 miRNA cyclopamine regulating the activity of Shh signaling embryonic lung cultures cyclopamine treatment dysregulated 24617895 4600 Mouse mmu-miR-449a miRNA histone deacetylase (HDAC) diabetes mellitus (DM) C2C12 cells histone deacetylase (HDAC) treatment upregulated 27184529 4601 Mouse mmu-miR-449a miRNA bone morphogenetic protein 9 (BMP9) osteogenesis The conditionally immortalized mouse multipotent adipose-derived cells iMADs bone morphogenetic protein 9 (BMP9) treatment downregulated 31825894 4602 Mouse mmu-miR-449a miRNA silica silicosis lung silica treatment downregulated 27351886 4603 Mouse mmu-miR-449a-5p miRNA methimazole (MTZ) liver damage liver tissues methimazole (MTZ) treatment upregulated 27421576 4604 Mouse mmu-miR-449b miRNA bone morphogenetic protein 9 (BMP9) osteogenesis The conditionally immortalized mouse multipotent adipose-derived cells iMADs bone morphogenetic protein 9 (BMP9) treatment downregulated 31825894 4605 Mouse mmu-miR-450b-3p miRNA manganese (Mn) parkinson's disease (PD) MN9D dopaminergic cell exosomes Mn exposure (300¦ÌM MnCl2) for 24h upregulated in exosomes 28450057 4606 Mouse mmu-miR-450b-3p miRNA Silica nanoparticles (SiNPs) reproductive toxicity testis; GC-2spd cells Silica nanoparticles (SiNPs) treatment "The results showed that SiNPs induced the apoptosis of spermatogenic cells, decreased the quantity and quality of the sperm, reduced the expressions of miR-450 b-3p" 33652185 4607 Mouse mmu-miR-450b-5p miRNA bleomycin (BLM) idiopathic pulmonary fibrosis (IPF) lung fibroblasts bleomycin (BLM) treatment downregulated 32848140 4608 Mouse mmu-miR-450b-5p miRNA plasmodium chabaudi malaria peak parasitemia liver of mice Plasmodium chabaudi malaria infection treatment downregulated 21085987 4609 Mouse mmu-miR-451 miRNA aspergillus fumigatus (A. fumigatus) asthma lung tissues Aspergillus fumigatus (DRA) treatment downregulated 32159972 4610 Mouse mmu-miR-451 miRNA hyperoxia bronchopulmonary dysplasia (BPD) mouse lung endothelial cells (MLECs); lung tissues hyperoxia treatment Increased expression of miR-451 was noted in MLECs exposed to hyperoxia and in lungs of BPD mice. 32321512 4611 Mouse mmu-miR-451 miRNA genistein cardiac hypertrophy isoproterenol-treated mice heart tissues genistein treatment upregulated 30798118 4612 Mouse mmu-miR-451 miRNA isoproterenol cardiac hypertrophy heart tissues isoprenaline (ISO) tteatment downregulated 30798118 4613 Mouse mmu-miR-451 miRNA doxorubicin (DOX) cardiotoxicity heart tissues and cardiomyocytes doxorubicin treatment upregulated 31355248 4614 Mouse mmu-miR-451 miRNA complete freund's adjuvant (CFA) chronic inflammatory pain spinal dorsal horn and spinal microglia complete Freund's adjuvant (CFA) treatment downregulated 30069596 4615 Mouse mmu-miR-451 miRNA estrogen (ES) renal fibrosis mouse uterus tissues Estrogen treatment mirn451 was significantly increased by estrogen administration whereas mirn181b and mirn204 expression was significantly reduced 20720260 4616 Mouse mmu-miR-451 miRNA streptozocin (STZ) diabetic cardiomyopathy (DCM) heart tissues streptozotocin (STZ) treatment upregulated 30872181 4617 Mouse mmu-miR-451 miRNA kainic acid (KA) epilepsy hippocampus kainic acid (KA) treatment upregulated 31870266 4618 Mouse mmu-miR-451 miRNA lipopolysaccharide (LPS) bacterial infection "the whole blood, serum and white blood cells (WBCs) of C57BL/6 and Tlr2-/- mice" lipopolysaccharide (LPS) treatment upregulated 23286671 4619 Mouse mmu-miR-451 miRNA high glucose (HG) inflammation glomerular mesangial cells (SV40-MES-13) high glucose (HG) treatment upregulated 31652441 4620 Mouse mmu-miR-451 miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver high fat diet (HFD) feed downregulated 25957914 4621 Mouse mmu-miR-451 miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver tissues high fat diet (HFD) feed downregulated 31396337 4622 Mouse mmu-miR-451 miRNA swimming nonalcoholic fatty liver disease (NAFLD) high fat diet (HFD)-fed mice liver tissues swim training induce treatment upregulated 31396337 4623 Mouse mmu-miR-451 miRNA lipopolysaccharide (LPS) nonalcoholic steatohepatitis (NASH) NCTC1469 cells and Raw264.7 cells LPS (Lipopolysaccharide) treatment downregulated 31816816 4624 Mouse mmu-miR-451 miRNA genistein obesity and diabetes mouse adipose tissues genistein treatment upregulated 32129363 4625 Mouse mmu-miR-451 miRNA monocrotaline (MCT) pulmonary hypertension (PH) plasma monocrotaline (MCT) treatment downregulated 29795360 4626 Mouse mmu-miR-451 miRNA cecal ligation and puncture (CLP) sepsis whole blood cecal ligation and puncture (CLP) treatment upregulated 24205035 4627 Mouse mmu-miR-451 miRNA cortical impact traumatic brain injury (TBI) cortex cortical impact upregulated 26426744 4628 Mouse mmu-miR-451 miRNA high fat diet (HFD) type 2 diabetes mellitus (T2DM) type 2 DM mouse hearts high fat diet (HFD) feed upregulated 25362209 4629 Mouse mmu-miR-451 miRNA whole grain highland barley (WGH) type 2 diabetes mellitus (T2DM) liver tissues whole grain highland barley (WGH) treatment upregulated 33104141 4630 Mouse mmu-miR-451a miRNA lipopolysaccharide (LPS) acute kidney injury (AKI) kidney tissues lipopolysaccharide (LPS) treatment miR-451a was upregulated at 24h. 32727087 4631 Mouse mmu-miR-451a miRNA 3¦Â-hydroxycholest-5-en-7-one anti-inflammatory responses RAW 264.7 cells 3¦Â-hydroxycholest-5-en-7-one treatment upregulated 32771556 4632 Mouse mmu-miR-451a miRNA ovalbumin (OVA) asthma airway epithelium ovalbumin (OVA) treatment downregulated 32234673 4633 Mouse mmu-miR-451a miRNA doxorubicin (DOX) cardiotoxicity "plasma and heart, HL-1 cells" doxorubicin (DOX) treatment downregulated 30453253 4634 Mouse mmu-miR-451a miRNA quercetin chronic inflammatory diseases LPS-treated murine bone marrow¨Cderived DCs (BMDCs) quercetin treatment upregulated 31338984 4635 Mouse mmu-miR-451a miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity plasma doxorubicin (DOX) treatment downregulated 30453253 4636 Mouse mmu-miR-451a miRNA electroacupuncture (EA) electroacupuncture (EA) CD4 T cells electroacupuncture (EA) treatment upregulated 32026263 4637 Mouse mmu-miR-451a miRNA "1,2-Dichloroethane (1,2-DCE)" glucose homeostasis NIH Swiss mice "1,2-dichloroethane (1,2-DCE) treatment" upregulated in the livers 28960355 4638 Mouse mmu-miR-451a miRNA "1,2-dichloroethane (1,2-DCE)" glycerol gluconeogenesis liver tissues "1,2-dichloroethane (1,2-DCE) treatment" "miR-451a was significantly upregulated in the liver tissue of mice exposed to 700 mg m -3 1,2-DCE." 28960355 4639 Mouse mmu-miR-451a miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated 26639663 4640 Mouse mmu-miR-451a miRNA free fatty acids (FFA) nonalcoholic fatty liver disease (NAFLD) AML12 cells "free fatty acids (FFAs; oleate/palmitate, 2:1 ratio) treatment" downregulated 29604329 4641 Mouse mmu-miR-451a miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) liver tissues high fat diet (HFD) feed downregulated 29604329 4642 Mouse mmu-miR-451a miRNA parathyroid hormone (PTH) osteoblastic differentiation mice calvarial osteoblasts (MCOs) parathyroid hormone (PTH) treatment PTH promotes glucose dependent miR-451a expression which stimulates osteoblast differentiation 30218791 4643 Mouse mmu-miR-452 miRNA hypoxia sleep apnea syndrome (SAS) mouse 3T3-L1 cells hypoxia treatment downregulated 31013606 4644 Mouse mmu-miR-454 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues lipopolysaccharide (LPS) treatment upregulated 26741509 4645 Mouse mmu-miR-455 miRNA candida albicans (C. albicans) Alzheimer's disease (AD) mouse macrophages candida albicans infection upregulated 21060679 4646 Mouse mmu-miR-455 miRNA oral gavage anti-inflammatory responses dextran sodium sulfate (DSS)-induced colitis-associated tumorigenesis Apc(Min/+) mouse via oral gavage for 5 weeks treatment upregulated 24817032 4647 Mouse mmu-miR-455 miRNA angiotensin II (Ang II) cardiac fibrosis cardiomyocytes of C57BL/6 mice angiotensin II (Ang II) treatment downregulated 28753062 4648 Mouse mmu-miR-455 miRNA norcantharidin (NCTD) hepatocellular carcinoma (HCC) liver tissues intraperitoneal injection of different concentration of NCTD treatment upregulated 24719559 4649 Mouse mmu-miR-455-3p miRNA bleomycin (BLM) idiopathic pulmonary fibrosis (IPF) pulmonary fbrotic tissues bleomycin (BLM) treatment upregulated 33549106 4650 Mouse mmu-miR-455-3p miRNA TGF-¦Â1 idiopathic pulmonary fibrosis (IPF) Primary mouse lung fbroblasts TGF-¦Â1 treatment downregulated 33549106 4651 Mouse mmu-miR-455-3p miRNA amyloid-¦Â (A¦Â) 1-42 Alzheimer's disease (AD) mouse neuroblastoma cells amyloid ¦Â1-42?(A¦Â) treatment upregulated 28934394 4652 Mouse mmu-miR-455-3p miRNA high glucose (HG) diabetic nephropathy (DN) SV40-MES13 cells high-glucose (HG) treatment downregulated 31934070 4653 Mouse mmu-miR-455-3p miRNA prednisolone duchenne muscular dystrophy (DMD) diaphragm muscle prednisolone treatment downregulated 29883261 4654 Mouse mmu-miR-455-3p miRNA vamorolone duchenne muscular dystrophy (DMD) diaphragm muscle vamorolone treatment downregulated 29883261 4655 Mouse mmu-miR-455-3p miRNA oxygen glucose deprivation (OGD) ischemic stroke (IS) mouse neuronal cells oxygen-glucose deprivation (OGD) treatment downregulated 33738662 4656 Mouse mmu-miR-455-3p miRNA bile duct ligation (BDL) liver fibrosis liver tissues bile duct ligation (BDL) treatment downregulated 31150929 4657 Mouse mmu-miR-455-3p miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues carbon tetrachloride (CCl4) treatment downregulated 31150929 4658 Mouse mmu-miR-455-3p miRNA high fat diet (HFD) liver fibrosis liver tissues high fat diet (HFD) feed downregulated 31150929 4659 Mouse mmu-miR-455-3p miRNA ferric ammonium citrate (FAC) osteoporosis osteoblast cell lines MC3T3-E1 ferric ammonium citrate (FAC) treatment downregulated 29042277 4660 Mouse mmu-miR-455-3p miRNA ferric ammonium citrate (FAC) oxidative stress osteoblast cell lines MC3T3-E1 FAC downregulated 29042277 4661 Mouse mmu-miR-455-3p miRNA morphine painful or stressful conditions hippocampal Morphine treatment downregulated 25844808 4662 Mouse mmu-miR-455-3p miRNA cinnamic acid (CNA) traumatic brain injury (TBI) dendritic spines from TBI mice cinnamic acid (CNA) treatment upregulated 31473194 4663 Mouse mmu-miR-455-5p miRNA prednisolone duchenne muscular dystrophy (DMD) diaphragm muscle prednisolone treatment downregulated 29883261 4664 Mouse mmu-miR-455-5p miRNA vamorolone duchenne muscular dystrophy (DMD) diaphragm muscle vamorolone treatment downregulated 29883261 4665 Mouse mmu-miR-455-5p miRNA cold obesity brown adipose tissue (BAT) cold treatment downregulated 33015181 4666 Mouse mmu-miR-463-3p miRNA hypoxia tibial nerve regeneration primary tibial nerve cells oxygen-glucose deprivation treatment upregulated 31468997 4667 Mouse mmu-miR-464 miRNA plasmodium chabaudi malaria peak parasitemia liver of mice Plasmodium chabaudi malaria infection treatment downregulated 21085987 4668 Mouse mmu-miR-465b-5p miRNA all-trans retinoic acid (ATRA) cleft palate (CP) palate all-trans retinoic acid (ATRA) treatment ?NONMMUT004850.2/NONMMUT024276.2-miR-741-3p/miR-465b-5p-Prkar1¦Á?could potentially serve as an important regulatory mechanism of palatal fusion in the development of the cleft palate. 32042778 4669 Mouse mmu-miR-465b-5p miRNA neuregulin-1£¨NRG1£© cell differentiation murine embryonic stem cell neuregulin-1£¨NRG1£© downregulated 21451102 4670 Mouse mmu-miR-465d miRNA plasmodium chabaudi malaria peak parasitemia liver of mice Plasmodium chabaudi malaria infection treatment downregulated 21085987 4671 Mouse mmu-miR-466 miRNA lipopolysaccharide (LPS) acute respiratory distress syndrome (ARDS) bronchoalveolar lavage fluid (BALF) lipopolysaccharide (LPS) treatment upregulated 31221118 4672 Mouse mmu-miR-466 miRNA cannabinoid receptor 1 (CB1) antagonists SR141716A diet-induced obesity (DIO) mouse adipose tissue macrophage (ATM) SR141716A treatment downregulated 30910812 4673 Mouse mmu-miR-466a-3p miRNA ovalbumin (OVA) allergic rhinitis (AR) nasal mucosa tissues ovalbumin (OVA) treatment downregulated 31081939 4674 Mouse mmu-miR-466a-3p miRNA high glucose (HG) cell differentiation neural stem cells (NSCs) high glucose treatment downregulated 23776576 4675 Mouse mmu-miR-466a-3p miRNA arginine vasopressin osmoregulation mIMCD3 cells exposure to arginine vasopressin treatment downregulated 24389345 4676 Mouse mmu-miR-466b-3p miRNA arginine vasopressin osmoregulation mIMCD3 cells exposure to arginine vasopressin treatment downregulated 24389345 4677 Mouse mmu-miR-466c-3p miRNA dexamethasone (DEX) muscle atrophy Murine C2C12 myoblast cells dexamethasone (DEX) treatment downregulated 23716137 4678 Mouse mmu-miR-466c-3p miRNA arginine vasopressin osmoregulation mIMCD3 cells exposure to arginine vasopressin treatment downregulated 24389345 4679 Mouse mmu-miR-466d-3p miRNA Japanese encephalitis virus (JEV) Japanese encephalitis virus (JEV) infection BV-2 cells; mouse neuroblastoma cell line NA; mouse brain endothelial cell line bEnd.3 Japanese encephalitis virus (JEV) infection downregulated 32461319 4680 Mouse mmu-miR-466d-3p miRNA high glucose (HG) cell differentiation neural stem cells (NSCs) high glucose treatment downregulated 23776576 4681 Mouse mmu-miR-466d-3p miRNA plasmodium chabaudi malaria peak parasitemia liver of mice Plasmodium chabaudi malaria infection treatment downregulated 21085987 4682 Mouse mmu-miR-466d-5p miRNA Japanese encephalitis virus (JEV) Japanese encephalitis virus (JEV) infection BV-2 cells; mouse neuroblastoma cell line NA; mouse brain endothelial cell line bEnd.3 Japanese encephalitis virus (JEV) infection downregulated 32461319 4683 Mouse mmu-miR-466d-6p miRNA Japanese encephalitis virus (JEV) Japanese encephalitis virus (JEV) infection BV-2 cells; mouse neuroblastoma cell line NA; mouse brain endothelial cell line bEnd.3 Japanese encephalitis virus (JEV) infection downregulated 32461319 4684 Mouse mmu-miR-466e miRNA high fat diet (HFD) chronic oxidative stress mouse exposed to X-rays high fat diet (HFD) feed upregulated 25171162 4685 Mouse mmu-miR-466e-3p miRNA arginine vasopressin osmoregulation mIMCD3 cells exposure to arginine vasopressin treatment downregulated 24389345 4686 Mouse mmu-miR-466f miRNA dexamethasone (DEX) muscle atrophy Murine C2C12 myoblast cells dexamethasone (DEX) treatment upregulated 23716137 4687 Mouse mmu-miR-466f-3p miRNA low chromium (Cr) insulin resistance (IR) liver fed a control or LC diet for 13 weeks dysregulatedin liver 29286159 4688 Mouse mmu-miR-466h-5p miRNA H1N1 influenza virus endometriosis and endometrial carcinoma mouse lung?tissues H1N1 influenza virus infection upregulated 24066118 4689 Mouse mmu-miR-466i-5p miRNA carbon tetrachloride (CCl4) liver fibrosis liver CCl4 treatment upregulated 27322257 4690 Mouse mmu-miR-466j miRNA dexamethasone (DEX) muscle atrophy Murine C2C12 myoblast cells dexamethasone (DEX) treatment upregulated 23716137 4691 Mouse mmu-miR-466m-3p miRNA lipopolysaccharide (LPS) acute lung injury (ALI) MLE-12 cells lipopolysaccharide (LPS) treatment Hsp4 alleviates lipopolysaccharide-induced apoptosis of lung epithelial cells via miRNA-466m-3p/DNAjb6 axis. 32976821 4692 Mouse mmu-miR-466p-3p miRNA arginine vasopressin osmoregulation mIMCD3 cells exposure to arginine vasopressin treatment downregulated 24389345 4693 Mouse mmu-miR-467a miRNA arsenite atherosclerosis (AS) liver arsenic (As) exposure upregulated 22719926 4694 Mouse mmu-miR-467a miRNA radiation radiocarcinogenesis mouse thymic lymphoma tissues radiation treatment upregulated 25552935 4695 Mouse mmu-miR-467a* miRNA dexamethasone (DEX) muscle atrophy Murine C2C12 myoblast cells dexamethasone (DEX) treatment downregulated 23716137 4696 Mouse mmu-miR-467a-3p miRNA Japanese encephalitis virus (JEV) Japanese encephalitis virus (JEV) infection BV-2 cells; mouse neuroblastoma cell line NA; mouse brain endothelial cell line bEnd.3 Japanese encephalitis virus (JEV) infection downregulated 32461319 4697 Mouse mmu-miR-467a-3p miRNA ganoderma lucidum extract (GLE) hepatocellular carcinoma (HCC) Hepa 1-6 cells Ganoderma lucidum extract (GLE) treatment upregulated 32106374 4698 Mouse mmu-miR-467a-5p miRNA Japanese encephalitis virus (JEV) Japanese encephalitis virus (JEV) infection BV-2 cells; mouse neuroblastoma cell line NA; mouse brain endothelial cell line bEnd.3 Japanese encephalitis virus (JEV) infection downregulated 32461319 4699 Mouse mmu-miR-467b miRNA high fat diet (HFD) nonalcoholic fatty liver disease (NAFLD) mice liver cells high fat diet (HFD) feed downregulated 21986524 4700 Mouse mmu-miR-467b* miRNA polyphenols cell function mice liver cells Polyphenols treatment downregulated 22253797 4701 Mouse mmu-miR-467c miRNA walnut colorectal cancer (CRC) colorectal tumor tissue walnut-containing diet treatment downregulated 25882694 4702 Mouse mmu-miR-468-3p miRNA enterovirus 71 (EV71) enterovirus 71 (EV71) infection mouse infect with EV71 downregulated 28469998 4703 Mouse mmu-miR-471-3p miRNA advanced glycation end product (AGE) diabetic cardiomyopathy (DCM) RAW264.7 cells advanced glycation end products (AGEs) treatment "Meanwhile, miR-471-3p was significantly upregulated in RAW264.7 cells induced by AGEs and inhibition of miR-471-3p could reduce the inflammatory polarization of macrophages." 33417962 4704 Mouse mmu-miR-483 miRNA ischemia acute kidney injury (AKI) renal tubules ischemia treatment upregulated 27959449 4705 Mouse mmu-miR-483 miRNA recombinant Adeno-Cre viruses (AdV-Cre) lung adenocarcinoma (LUAD) lung recombinant Adeno-Cre viruses (AdV-Cre) treatment downregulated 25359683 4706 Mouse mmu-miR-483* miRNA high fat diet (HFD) acute myocardial infarction (AMI) liver tissue high fat diet (HFD) feed downregulated 19835573 4707 Mouse mmu-miR-483-3p miRNA black raspberry (BRB) anthocyanins colorectal cancer (CRC) colon tissues black raspberry (BRB) anthocyanins treatment downregulated 31763724 4708 Mouse mmu-miR-483-3p miRNA black raspberry (BRB) anthocyanins colorectal cancer (CRC) azoxymethane (AOM)/dextran sulphate sodium (DSS)-induced CRC mouse black raspberry (BRB) anthocyanins treatment downregulated 31763724 4709 Mouse mmu-miR-483-3p miRNA streptozocin (STZ) diabetic cardiomyopathy (DCM) cardiomyocyte streptozotocin treatment upregulated 27346130 4710 Mouse mmu-miR-483-5p miRNA grape seed procyanidin B2 (GSP) adipogenesis 3T3-L1 preadipocyte cell line 3T3-L1 preadipocyte cell line treatment downregulated 28011376 4711 Mouse mmu-miR-483-5p miRNA grape seed procyanidin B2 (GSP) adipogenesis 3T3-L1 cells GSP (dissolved in deionized water) (10¨C200 ug/ml) downregulated 28011376 4712 Mouse mmu-miR-483-5p miRNA rapamycin complex 1 (mTORC1) osteoarthritis (OA) Col2a1TSC1KO mice chondrocytes rapamycin complex 1 (mTORC1) deficiency treatment upregulated 30145794 4713 Mouse mmu-miR-484 miRNA ischemia/reperfusion (I/R) acute myocardial infarction (AMI) heart tissues ischemia/reperfusion (I/R) treatment upregulated 28090786 4714 Mouse mmu-miR-484 miRNA high fat diet (HFD) hepatocellular carcinoma (HCC) plasma and hepatic tissues high fat diet (HFD) feed upregulated 26728044 4715 Mouse mmu-miR-484 miRNA extra-virgin olive oil rich in phenols (H-EVOO) neuronal function cortex H-EVOO treatment upregulated 26695409 4716 Mouse mmu-miR-485 miRNA ovalbumin (OVA) asthma lung tissues ovalbumin (OVA) treatment downregulated 30463065 4717 Mouse mmu-miR-485 miRNA oxygen glucose deprivation (OGD) brain ischemia-reperfusion (I/R) injury N2a cells oxygen and glucose deprivation (OGD) treatment downregulated 32860611 4718 Mouse mmu-miR-485-3p miRNA amyloid-¦Â (A¦Â) Alzheimer's disease (AD) BV2 cells amyloid-¦Â (A¦Â) treatment upregulated 33220166 4719 Mouse mmu-miR-485-3p miRNA amyloid-¦Â (A¦Â) 1-42 Alzheimer's disease (AD) BV2 cells amyloid ¦Â1-42?(A¦Â) treatment upregulated 33220166 4720 Mouse mmu-miR-486 miRNA low frequency magnetic fields (LF-MF) cell proliferation and migration "293T cells and Lung cancer cell lines (A549, LLC)" LF-MFs treatment upregulated 28924214 4721 Mouse mmu-miR-486 miRNA radiation thymic lymphoma (RITL) mouse lymphoma cells line (EL4) radiation treatment "Based on this network, we identified a critical miRNA, miR-486, which was the most downregulated in the radiation-induced carcinogenesis" 33692937 4722 Mouse mmu-miR-486-5p miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues lipopolysaccharides (LPS) treatment upregulated 31940107 4723 Mouse mmu-miR-486-5p miRNA (-)-epigallocatechin gallate (EGCG) aging C2C12 cells (-)-Epigallocatechin gallate (EGCG) treatment EGCG stimulated AKT phosphorylation and inhibited FoxO1a-mediated MuRF1 and Atrogin-1 transcription via up-regulating the expression of miR-486 in skeletal muscle of 40-wk-old SAMP8 mice as well as late passage C2C12 cells. 32710883 4724 Mouse mmu-miR-486-5p miRNA lipopolysaccharide (LPS) osteoarthritis (OA) ATDC5 cells lipopolysaccharide (LPS) treatment miR-486-5p was significantly upregulated in LPS-induced ATDC5 cells. 32705174 4725 Mouse mmu-miR-486a-3p miRNA sublytic complement C5b-9 (sC5b-9) renal inflammatory diseases MPC5 cells sublytic complement C5b-9 (sC5b-9) treatment downregulated 33296289 4726 Mouse mmu-miR-486a-5p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce downregulated 30936699 4727 Mouse mmu-miR-486a-5p miRNA high fat diet (HFD) obesity liver tissues high fat diet (HFD) feed upregulated 32593682 4728 Mouse mmu-miR-486b-3p miRNA lipopolysaccharide (LPS) acute lung injury (ALI) RAW264.7 cells lipopolysaccharide (LPS) treatment miR-476 486b-3p levels decreased with exposure to LPS. 32421439 4729 Mouse mmu-miR-487b miRNA lipopolysaccharide (LPS) macrophage homeostasis mouse bone marrow-derived macrophages (BMDMs) lipopolysaccharide (LPS) treatment downregulated 26936882 4730 Mouse mmu-miR-487b miRNA astaxanthin prostate cancer Pca mouse tumor tissues intragastrically administered 100 mg/kg astaxanthin (HA) upregulated 28282880 4731 Mouse mmu-miR-488 miRNA peritoneal dialysis fluid (PDF) peritoneal fibrosis peritoneal tissues peritoneal dialysis fluid (PDF) treatment upregulated 25827714 4732 Mouse mmu-miR-488-3p miRNA hypoxia acute myocardial infarction (AMI) primary cardiomyocytes;MCM cells hypoxia induce miRNA-488-3p expression decreased in hypoxia-preconditioning primary cardiomyocytes or MCM cells in a time-dependent manner. 31210328 4733 Mouse mmu-miR-488-3p miRNA hypoxia acute myocardial infarction (AMI) mouse heart tissues ligation of the anterior descending coronary artery (LAD) treatment downregulated 31210328 4734 Mouse mmu-miR-489 miRNA isoproterenol cardiac fibrosis heart tissue and cardiac fibroblasts (CFs) isoprenaline (ISO) tteatment downregulated 32104288 4735 Mouse mmu-miR-489 miRNA silica lung fibrosis lung silica treatment downregulated 27506999 4736 Mouse mmu-miR-489 miRNA silica lung fibrosis C57BL/6 male mice lung tissues silica treatment upregulated in lung tissues 28780788 4737 Mouse mmu-miR-490-3p miRNA pilocarpine epilepsy hippocampal tissues pilocarpine treatment "Psmd11 was upregulated by Peg13 at a miR-490-3p dependent way, thus inactivating the Wnt/¦Â-catenin pathway and alleviating epilepsy course in mice" 33437373 4738 Mouse mmu-miR-490-3p miRNA N-methyl-N-nitrosourea (MNU) gastric cancer (GC) gastric cancer cells N-methyl-N-nitrosourea (MNU) treatment downregulated 25503559 4739 Mouse mmu-miR-490-3p miRNA silica silicosis lung tissues silica treatment MiR-490-3p was significantly downregulated in silica-induced fibrotic mouse lung tissues and TGF-¦Â1 treated fibroblasts 33482250 4740 Mouse mmu-miR-490-3p miRNA H2O2 spinal cord injury (SCI) C8-D1A cells; C8-B4 cells H2O2 treatment downregulated 30575927 4741 Mouse mmu-miR-491 miRNA tumour-derived TGF-¦Â anti-cancer therapy mouse CD8+T cells tumor necrosis factor alpha (TNF-¦Á) treatment upregulation 27484289 4742 Mouse mmu-miR-491 miRNA arsenic trioxide (ATO) hepatocellular carcinoma (HCC) mice xenograft models arsenic trioxide (As2O3) treatment upregulated 25304214 4743 Mouse mmu-miR-491 miRNA anandamide (AEA) pro-inflammatory activity mouse anandamide treatment AEA differentil regulate the expression of miRNA 24699635 4744 Mouse mmu-miR-491-5p miRNA anti-fas receptor antibodies acute liver injury (ALI) Hep G2 cells anti-fas receptor antibodies upregulated 20015148 4745 Mouse mmu-miR-491-5p miRNA cold obesity brown adipose tissue (BAT) cold treatment downregulated 33015181 4746 Mouse mmu-miR-493-5p miRNA "anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE)" bronchial epithelial cell cancer 16HBE-T cells "anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE) treatment" downregulated 19462682 4747 Mouse mmu-miR-494 miRNA tumor necrosis factor alpha (TNF-¦Á) inflammation mouse C2C12 myotubes tumor necrosis factor alpha (TNF-¦Á) treatment upregulated 24349514 4748 Mouse mmu-miR-494 miRNA staphylococcal enterotoxin B (SEB) acute lung injury (ALI) lung-infiltrating mononuclear cells staphylococcal enterotoxin B (SEB) treatment upregulated 26818958 4749 Mouse mmu-miR-494 miRNA high fat diet (HFD) acute myocardial infarction (AMI) liver tissue high fat diet (HFD) feed downregulated 19835573 4750 Mouse mmu-miR-494 miRNA tumor necrosis factor alpha (TNF-¦Á) apoptosis vascular smooth muscle cells (VSMCs) tumor necrosis factor alpha (TNF-¦Á) treatment downregulated 30942414 4751 Mouse mmu-miR-494 miRNA "N1-[(4-methoxy)methyl]-4-methyl-1,2-Benzenediamine (FC-99)" arthritis Murine monocyte/macrophage cell line RAW264.7 "N1-[(4-methoxy)methyl]-4-methyl-1,2-Benzenediamine (FC-99) treatment" upregulated 31881378 4752 Mouse mmu-miR-494 miRNA "anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE)" bronchial epithelial cell cancer 16HBE-T cells "anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE) treatment" upregulated 19462682 4753 Mouse mmu-miR-494 miRNA silica nanoparticles (SiNPs) mycin cell toxicity mouse spermatocyte cells (GC-2spd cells) SiNPs treatment "inhibitor of miRNA-494 could attenuate the expression levels of AMPK, TSC, LC3¢ò and alleviate the decreased of AKT, mTOR, p-mTOR induced by SiNPs" 31541822 4754 Mouse mmu-miR-494 miRNA azoxymethane (AOM) colorectal cancer (CRC) mouse colon tissues azoxymethane (AOM) treatment upregulated in colon samples 29066742 4755 Mouse mmu-miR-494 miRNA oxygen glucose deprivation (OGD) ischemic stroke (IS) Primary cultured cortical neuronal OGD treatment miR-494 levels were reduced in neurons but increased in the medium after OGD 31510852 4756 Mouse mmu-miR-494 miRNA cyclosporine A (CsA) nephrotoxicity tubular epithelial cell cyclosporine A treatment upregulated 25854542 4757 Mouse mmu-miR-494 miRNA "FC-99 (N1-[(4-methoxy)methyl]-4-methyl-1,2-Benzenediamine)" rheumatoid arthritis (RA) macrophages "FC-99 (N1-[(4-methoxy)methyl]-4-methyl-1,2-Benzenediamine) treatment" FC-99 relieved macrophages inflammation via the miR-494/TN-C/NF-¦ÊB pathway 31881378 4758 Mouse mmu-miR-494-3p miRNA rice bran phenolic extract (RBPE) alcoholic liver disease (ALD) liver tissues rice bran phenolic extract (RBPE) treatment Rice Bran Phenolic Extract Confers Protective Effects against Alcoholic Liver Disease in Mice by Alleviating Mitochondrial Dysfunction via the PGC-1¦Á-TFAM Pathway Mediated by microRNA-494-3p 33094608 4759 Mouse mmu-miR-494-3p miRNA poly(ethylenimine) (PEI) cell death MEF cells poly(ethylenimine) (PEI) treatment upregulated 26158199 4760 Mouse mmu-miR-494-3p miRNA compression force (CF) cell proliferation "MC3T3-E1, a pre-osteoblastic cell line" Compressive force treatment upregulated 25795570 4761 Mouse mmu-miR-494-3p miRNA lipopolysaccharide (LPS) inflammation RAW264.7 macrophages lipopolysaccharide?(LPS) treatment upregulated 30942409 4762 Mouse mmu-miR-494-3p miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharides (LPS) treatment downregulated 31002148 4763 Mouse mmu-miR-494-3p miRNA high fat diet (HFD) obesity mice heart tissues high fat diet (HFD) feed downregulated 30629164 4764 Mouse mmu-miR-495 miRNA ovalbumin (OVA) allergic rhinitis (AR) CD4+ Th2 cells ovalbumin induction downregulated 32242002 4765 Mouse mmu-miR-495 miRNA alcohol fetal alcohol spectrum disorders (FASD) brain tissues alcohol exposure downregulated 23580197 4766 Mouse mmu-miR-495 miRNA dextran sodium sulfate (DSS) inflammatory bowel disease (IBD) colitis tissues dextran sulfate sodium (DSS) treatment miR-495 was lowly expressed in the DSS-induced colitis tissues. 31251902 4767 Mouse mmu-miR-495 miRNA choline- and folate-deficient (CFD) diet liver damage plasma choline- and folate-deficient (CFD) diet treatment upregulated 26878785 4768 Mouse mmu-miR-495 miRNA choline- and folate-deficient (CFD) diet nonalcoholic fatty liver disease (NAFLD) plasma choline- and folate-deficient (CFD) treatment upregulated 26878785 4769 Mouse mmu-miR-495 miRNA H2O2 spinal cord injury (SCI) mouse SCNs H2O2 treatment "Interestingly, the expression of miR-495 was markedly suppressed when SCNs were exposed to H2O2." 33850858 4770 Mouse mmu-miR-495 miRNA high fat diet (HFD) type 2 diabetes mellitus (T2DM) mouse peritoneal macrophages high fat diet (HFD) feed upregulated 31709454 4771 Mouse mmu-miR-495-3p miRNA ischemia/reperfusion (I/R) intestinal hypoxia/reoxygenation injury C57BL/6 mice were induced ischemia/reperfusion (I/R) treatment upregulation 26935288 4772 Mouse mmu-miR-495-3p miRNA lipopolysaccharide (LPS) sepsis RAW264.7 cells lipopolysaccharide (LPS) treatment downregulated 31812793 4773 Mouse mmu-miR-495-3p miRNA lipopolysaccharide (LPS) sepsis RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated of NEAT1 level and downregulated of miR-495-3p/miR-211 level could aggravate inflammation in LPS-treated RAW264.7 cells. 31812793 4774 Mouse mmu-miR-496 miRNA ethanol (EtOH) teratogenesis fetal brains of mice Ethanol?treatment downregulated 19091803 4775 Mouse mmu-miR-497 miRNA arsenite atherosclerosis (AS) liver arsenic (As) exposure downregulated 22719926 4776 Mouse mmu-miR-497 miRNA melatonin chronic liver disease C57BL/6 wild type (WT) mice pretreat with alcohol melatonin (10 mg/kg body weight) supplemented by daily oral gavage at 09:00 hr during the last 2 weeks upregulated 28095641 4777 Mouse mmu-miR-497 miRNA streptozocin (STZ) diabetic foot ulcer (DFU) wound lesion of diabetic mice streptozotocin treatment downregulated 31707336 4778 Mouse mmu-miR-497 miRNA streptozocin (STZ) diabetic retinopathy (DR) skin tissues streptozotocin treatment downregulated 31707336 4779 Mouse mmu-miR-497 miRNA prednisolone duchenne muscular dystrophy (DMD) diaphragm muscle prednisolone treatment downregulated 29883261 4780 Mouse mmu-miR-497 miRNA vamorolone duchenne muscular dystrophy (DMD) diaphragm muscle vamorolone treatment downregulated 29883261 4781 Mouse mmu-miR-497 miRNA IL-17 encephalomyelitis (EAE) astrocytes in EAE mice IL-17 treatment downregulated 28458392 4782 Mouse mmu-miR-497 miRNA "5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)" muscle cell proliferation and differentiation mouse skeletal myoblast C2C12 cells "5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment" upregulated 28255268 4783 Mouse mmu-miR-497 miRNA plasmodium plasmodium infection exosomes derived from the plasma infect with Plasmodium treatment upregulated 28650446 4784 Mouse mmu-miR-497a-5p miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues lipopolysaccharide (LPS) treatment downregulated 31148190 4785 Mouse mmu-miR-497a-5p miRNA alloxan diabetic retinopathy (DR) renal tissues alloxan treatment downregulated 29312507 4786 Mouse mmu-miR-497a-5p miRNA metformin (Met) diabetic retinopathy (DR) renal tissues metformin treatment upregulated 29312507 4787 Mouse mmu-miR-498 miRNA "anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE)" bronchial epithelial cell cancer 16HBE-T cells "anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide (anti-BPDE) treatment" upregulated 19462682 4788 Mouse mmu-miR-498 miRNA "1,25-dihydroxyvitamin D 3 (calcitriol) analogue EB1089" estrogen-sensitive tumors mouse "1,25-dihydroxyvitamin D 3 (calcitriol) analogue EB1089 treatment" upregulated 25252917 4789 Mouse mmu-miR-499 miRNA influenza virus H9N2 influenza virus infection Dendritic cells (DCs) H9N2 avian influenza virus (H9N2 AIV) treatment upregulated 27285980 4790 Mouse mmu-miR-499 miRNA puromycin aminonucleoside (PAN) minimal change disease (MCD) kidney tissues puromycin aminonucleoside (PAN) treatment PAN exposure reduced miR-499 expression in the kidneys of mice 29448244 4791 Mouse mmu-miR-499 miRNA conjugated linoleic acid (cLA) and nitrite myocardial infarction (MI) myocardial infarction conjugated linoleic acid (cLA) and nitrite treatment upregulated 24363996 4792 Mouse mmu-miR-499 miRNA insulin obesity mouse skeletal muscle satellite cells (SMSCs) insulin treatment downregulated 30097922 4793 Mouse mmu-miR-499-3p miRNA streptozocin (STZ) diabetes mellitus (DM) hearts of diabetic mice streptozotocin (STZ) treatment upregulated 21584493 4794 Mouse mmu-miR-499-5p miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues lipopolysaccharide (LPS) treatment miR-499-5p was upregulated in LPS-treated lung tissues. 33307898 4795 Mouse mmu-miR-499-5p miRNA high glucose (HG) cardiac hypertrophy HL-1 cells high glucose (HG) treatment downregulated 32269707 4796 Mouse mmu-miR-499-5p miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity plasma doxorubicin (DOX) treatment upregulated 30453253 4797 Mouse mmu-miR-499¨C5p miRNA prolonged aerobic exercise muscle hypertrophy plasma "impact of extended-duration, submaximal aerobic exercise treatment" upregulated 24436293 4798 Mouse mmu-miR-499a-5p miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity Plasma doxorubicin (DOX) treatment downregulated 30627229 4799 Mouse mmu-miR-499a-5p miRNA IL-3¦Â intervertebral disc degeneration (IDD) nucleus pulposus (NP) cell ?IL-1¦Â treatment "XIST expression was upregulated in the NP tissues of patients with IDD, and IL-1¦Â treatment resulted in a degradation of NPCs" 33722663 4800 Mouse mmu-miR-500 miRNA stretch myoblast proliferation C2C12 myoblasts stretch treatment downregulated 27840929 4801 Mouse mmu-miR-501 miRNA cardiotoxin (CTX) skeletal muscle regeneration myogenic progenitor cells (MPs) and non-myogenic fibroblast-adipocyte progenitors (FAPs) cardiotoxin (CTX) treatment "In the mdx mouse model, which models a pathological disease state, not only was miR-501 induced in regenerating skeletal muscle, but also its serum levels were increased, which correlated with the disease state of the animals." 27707793 4802 Mouse mmu-miR-501-5p miRNA second-hand smoke (SHS) asthma lung second-hand smoke (SHS) treatment upregulated 26859758 4803 Mouse mmu-miR-503 miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) mouse macrophages atherogenic Evs oxidized low-density lipoprotein (ox-LDL) treatment enrichment in atherogenic EVs 28882869 4804 Mouse mmu-miR-503 miRNA oxidized low density lipoprotein (ox-LDL) atherosclerosis (AS) peritoneal macrophages; Bone-marrow derived macrophages (BMDMs) oxidized low-density lipoprotein (ox-LDL) treatment upregulated 28882869 4805 Mouse mmu-miR-503 miRNA photobiomodulation therapy (PBMT) cell proliferation mouse pre-osteoblast cell line MC3T3-E1 "Photobiomodulation therapy (PBMT) (The PBMT parameters were as follows: 808 nm continuous wavelength, 0.401 W output power, 0.042 W/cm2 power density, 9.6 cm2 spot size, 36 J energy, 3.75 J/cm2 energy density, 90 s irradiation for three times per 12 h, 14.5 cm distance of the laser source and the angle of divergence of the laser beam was 7¡ã) treatment" downregulated 30218348 4806 Mouse mmu-miR-503 miRNA photobiomodulation therapy (PBMT) cell proliferation mouse pre-osteoblast cell line MC3T3-E1 "The PBMT parameters were as follows: 808 nm continuous wavelength, 0.401 W output power, 0.042 W/cm2 power density, 9.6 cm2 spot size, 36 J energy, 3.75 J/cm2 energy density, 90 s irradiation for three times per 12 h, 14.5 cm distance of the laser source and the angle of divergence of the laser beam was 7¡ã. treatment" downregulated 30218348 4807 Mouse mmu-miR-503 miRNA losartan diabetic nephropathy (DN) kidney tissues losartan treatment downregulated 27770539 4808 Mouse mmu-miR-503 miRNA hypoxia ischemic injury mouse bone marrow derived endothelial progenitor cells (EPCs) hypoxia induce downregulated 29800588 4809 Mouse mmu-miR-503 miRNA dexamethasone (DEX) muscle atrophy Murine C2C12 myoblast cells dexamethasone (DEX) treatment upregulated 23716137 4810 Mouse mmu-miR-503 miRNA oleanolic acid (OLA) osteoclastogenesis RANKL-induced RAW264.7 cells oleanolic acid (OLA) treatment upregulated 31176167 4811 Mouse mmu-miR-503 miRNA receptor activator of nuclear factor-¦ÊB ligand (RANKL) osteoclastogenesis RAW264.7 cells RANKL treatment downregulated 31176167 4812 Mouse mmu-miR-503 miRNA silica lung fibrosis mouse lung tissues silica treatment downregulated in 28900284 4813 Mouse mmu-miR-503* miRNA dexamethasone (DEX) muscle atrophy Murine C2C12 myoblast cells dexamethasone (DEX) treatment upregulated 23716137 4814 Mouse mmu-miR-503-5p miRNA "paraquat (PQ) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" dopaminergic (DA) neuron differentiation neuro-2a cells "paraquat (PQ) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment" dysregulated 29250806 4815 Mouse mmu-miR-503-5p miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharide (LPS) treatment downregulated 32955644 4816 Mouse mmu-miR-503-5p miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" neurodegenerative diseases N2a cells "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" downregulated 29250806 4817 Mouse mmu-miR-503-5p miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" neurodegenerative diseases N2a cells "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" downregulated 29250806 4818 Mouse mmu-miR-503-5p miRNA paraquat (PQ) neurodegenerative diseases N2a cells paraquat (PQ) treatment downregulated 29250806 4819 Mouse mmu-miR-504-3p miRNA high fat diet (HFD) compensatory hyperplasia of islets hepatocellular extracellular vesicles (EVs) ?high-fat diet (HFD) feed treatment downregulated 31284955 4820 Mouse mmu-miR-505-5p miRNA streptozocin (STZ) diabetic pregnancy female mice hyperglycemic ED9.5 embryos streptozotocin treatment dysregulatedin hyperglycemic ED95 embryos 27908722 4821 Mouse mmu-miR-505-5p miRNA manganese (Mn) parkinson's disease (PD) MN9D dopaminergic cell exosomes Mn exposure (300¦ÌM MnCl2) for 24h upregulated in exosomes 28450057 4822 Mouse mmu-miR-506 miRNA lipopolysaccharide (LPS) lung fibrosis lung tissues lipopolysaccharide (LPS) treatment downregulated 31214773 4823 Mouse mmu-miR-5097 miRNA stretch myoblast proliferation C2C12 myoblasts stretch treatment downregulated 27840929 4824 Mouse mmu-miR-5107-5p miRNA enterovirus 71 (EV71) enterovirus 71 (EV71) infection mouse infect with EV71 downregulated 28469998 4825 Mouse mmu-miR-5107-5p miRNA oxygen retinopathy of prematurity (ROP) C57BL/6 neonatal mice retinal tissue 7-day-old mice were maintained in 75% oxygen conditions for 5 days treatment dysregulatedin retinal tissue 27922698 4826 Mouse mmu-miR-511 miRNA ¦Ã-rays leukemia the whole blood cells of mice Gy ¦Ã-rays treatment miRNA signatures induced by ionising radiation in mouse blood are radiation type- and radiation dose-specific 21271940 4827 Mouse mmu-miR-5112 miRNA hypoxia ischemic injury bone marrow mesenchymal stem cells (BM-MSCs) hypoxia treatment upregulated 30613290 4828 Mouse mmu-miR-5112 miRNA chronic sleep fragmentation (SF) obstructive sleep apnea (OSA) C57/B6 mice chronic sleep treatment "upregulation(mmu-miR-5128,mmu-miR-6366), downregulated(mmu-miR-5112) in plasma-derived exosomes" 27419627 4829 Mouse mmu-miR-511-3p miRNA angiostrongylus cantonensis (A. cantonensis) angiostrongylus cantonensis (A. cantonensis) infection mouse angiostrongylus cantonensis (A. cantonensis) infection upregulated 24682888 4830 Mouse mmu-mir-511-3p miRNA second-hand smoke (SHS) asthma lung second-hand smoke (SHS) treatment upregulated 26859758 4831 Mouse mmu-miR-511-3p miRNA delvestidine (DLTD) bone marrow-derived dendritic cells (BMDCs) maturity bone marrow-derived dendritic cells (BMDCs) Delvestidine (DLTD) treatment upregulated 32871480 4832 Mouse mmu-miR-5115 miRNA ischemia acute kidney injury (AKI) renal tubules ischemia treatment upregulated 27959449 4833 Mouse mmu-miR-511-5p miRNA angiostrongylus cantonensis (A. cantonensis) angiostrongylus cantonensis (A. cantonensis) infection mouse angiostrongylus cantonensis (A. cantonensis) infection upregulated 24682888 4834 Mouse mmu-miR-5119 miRNA carbon tetrachloride (CCl4) liver fibrosis liver CCl4 treatment upregulated 27322257 4835 Mouse mmu-miR-5128 miRNA chronic sleep fragmentation (SF) obstructive sleep apnea (OSA) C57/B6 mice chronic sleep treatment "upregulation(mmu-miR-5128,mmu-miR-6366), downregulated(mmu-miR-5112) in plasma-derived exosomes" 27419627 4836 Mouse mmu-miR-5128 miRNA oxygen retinopathy of prematurity (ROP) retinas tissue "For OIR model construction, 7-day-old mice and their nursing mothers were maintained in 75% oxygen for 5 continuous days. On postnatal day (P) 12, the pups were returned to normoxic air and kept with their mothers for another 5 days. treatment" downregulated in the OIR samples 31452702 4837 Mouse mmu-miR-5129-5p miRNA dioscorea bulbifera (DB) liver damage livers dioscoreae bulbifera (EF) treatment downregulated 27609015 4838 Mouse mmu-miR-5130 miRNA dioscorea bulbifera (DB) liver damage livers dioscoreae bulbifera (EF) treatment downregulated 27609015 4839 Mouse mmu-miR-51302 miRNA ethyl acetate extract isolated from rhizoma dioscoreae bulbifera hepatotoxicity mouse liver tissues treat with ethyl acetate extract isolated from rhizoma dioscoreae bulbifera (450 mg/kg) dysregulated 27609015 4840 Mouse mmu-miR-5132-5p miRNA ethyl acetate extract isolated from rhizoma dioscoreae bulbifera hepatotoxicity mouse liver tissues treat with ethyl acetate extract isolated from rhizoma dioscoreae bulbifera (450 mg/kg) dysregulated 27609015 4841 Mouse mmu-miR-5132-5p miRNA dioscorea bulbifera (DB) liver damage livers dioscoreae bulbifera (EF) treatment downregulated 27609015 4842 Mouse mmu-miR-515-5p miRNA cigarette smoke (CS) epithelial-mesenchymal transition (EMT) lung tissues Cigarette smoke (CS) exposure downregulated 32768781 4843 Mouse mmu-miR-515-5p miRNA H2O2 ischemia/reperfusion (I/R) injury Primary cardiomyocytes H2O2 treatment LINC00511 accelerates the proliferation of cardiomyocytes after I/R by targeting miRNA-515-5p. 32141575 4844 Mouse mmu-miR-520h miRNA high glucose (HG) diabetic nephropathy (DN) SV40-MES-13?cells high glucose (HG) treatment downregulated 31630796 4845 Mouse mmu-miR-525-5p miRNA angiotensin II (Ang II) cardiac hypertrophy Cardiomyocytes were isolated from the neonatal mouse angiotensin II (Ang II) treatment SP1-induced upregulation of lncRNA SYNE1-AS1 promoted CH via miR-525-5p/SP1 axis. 30652310 4846 Mouse mmu-miR-526b miRNA bleomycin (BLM) idiopathic pulmonary fibrosis (IPF) lung tissues bleomycin (BLM) treatment circTADA2A repressed lung-fibroblasts activation via miR-526b/Cav1 and reduced lung-fibroblasts proliferation via miR-203/Cav2. 32694556 4847 Mouse mmu-miR-526b-3p miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity heart sissues doxorubicin (DOX) treatment Cardiac miR-526b-3p presented the most significant elevation responding to DOX treatment in mice. 31958751 4848 Mouse mmu-miR-532 miRNA high glucose (HG) diabetic foot ulcer (DFU) AC-16 cells high glucose (HG) treatment High glucose significantly upregulated miR-532 expression in the cardiomyocytes after 48 h. 32418060 4849 Mouse mmu-miR-532-3p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce downregulated 30936699 4850 Mouse mmu-miR-532-5p miRNA adiponectin frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) ?adipose tissue (AT) adiponectin (ApN) treatment downregulated 23015294 4851 Mouse mmu-miR-532-5p miRNA schistosoma japonicum liver fibrosis serum exosomes S. japonicum infection treatment "miR-532-5p was decresed on 4 and 6 weeks after S japonicum infection, while increased on 9 weeks" 32443549 4852 Mouse mmu-miR-532-5p miRNA oxygen glucose deprivation (OGD) ischemic stroke (IS) N2a cells oxygen-glucose deprivation (OGD) treatment miR-532-5p level was decreased and the PTEN level was increased in OGD-treated N2a cells in vitro. 32086725 4853 Mouse mmu-miR-532-5p miRNA lipopolysaccharide (LPS) macrophage inflammatory response RAW264.7 macrophage cells lipopolysaccharide (LPS) treatment downregulated 22415194 4854 Mouse mmu-miR-532-5p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) hippocampus chronic unpredictable mild stress (CUMS) treatment MiR-532-5p was significantly reduced in the hippocampus of mice treated with CUMS. 33209030 4855 Mouse mmu-miR-532-5p miRNA lipopolysaccharide (LPS) major depressive disorder (MDD) BV2 cells lipopolysaccharide (LPS) treatment downregulated 33209030 4856 Mouse mmu-miR-532-5p miRNA high fat diet (HFD) obesity liver tissues high fat diet (HFD) feed upregulated 32593682 4857 Mouse mmu-miR-539-5p miRNA lipopolysaccharide (LPS) sepsis-induced acute lung injury primary murine pulmonary microvascular endothelial cells (MPVECs) lipopolysaccharide (LPS) treatment downregulated 31825519 4858 Mouse mmu-miR-540 miRNA augmenter of liver regeneration (ALR) hepatic steatosis mouse liver tissues and primary hepatocytes augmenter of liver regeneration (ALR) treatment upregulated 30540918 4859 Mouse mmu-miR-540 miRNA augmenter of liver regeneration (ALR) steatosis hepatocytes augmenter of liver regeneration (ALR) deficiency upregulated 30540918 4860 Mouse mmu-miR-540-3p miRNA Japanese encephalitis virus (JEV) Japanese encephalitis virus (JEV) infection BV-2 cells; mouse neuroblastoma cell line NA; mouse brain endothelial cell line bEnd.3 Japanese encephalitis virus (JEV) infection downregulated 32461319 4861 Mouse mmu-miR-541 miRNA angiotensin II (Ang II) cardiac hypertrophy mouse cardio myocytes angiotensin II (Ang II) treatment downregulated 24722296 4862 Mouse mmu-miR-541 miRNA microcystin-leucine arginine (MC-LR) decline in sperm quality and damage to testicular structure Mouse GC-1 cells Microcystin-leucine arginine (MC-LR)? treatment upregulated 27608041 4863 Mouse mmu-miR-541 miRNA cortical impact traumatic brain injury (TBI) cortex cortical impact downregulated 26426744 4864 Mouse mmu-mir-541-5p miRNA second-hand smoke (SHS) asthma lung second-hand smoke (SHS) treatment upregulated 26859758 4865 Mouse mmu-miR-542-3p miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues carbon tetrachloride (CCl4) treatment upregulated 30368874 4866 Mouse mmu-miR-542-5p miRNA pristimerin glioblastoma multiforme (GBM) mouse GL261 glioma cells Pristimerin treatment downregulated 31015365 4867 Mouse mmu-miR-542-5p miRNA oleic acid (OA) hyperglycemia and hyperlipoidemia hepatocytes; AML-12 cells oleate treatment downregulated 32882762 4868 Mouse mmu-miR-542-5p miRNA silica suspension lung fibrosis lung tissues silica suspension treatment downregulated 30467286 4869 Mouse mmu-miR-542-5p miRNA TGF-¦Â1 lung fibrosis mouse fibroblast (NIH-3T3) transforming growth factor ¦Â1 (TGF-¦Â1) treatment downregulated 30467286 4870 Mouse mmu-miR-542-5p miRNA L©\arginine severe acute pancreatitis (SAP) lung tissues "the SAP group (WT mice were intraperitoneally injected with 8% L©\arginine (4 mg/g) once per hour, twice in total, with the time of the second L©\arginine injection defined as day 0, and the mice were killed in a humane manner at day 3)" downregulated 30216510 4871 Mouse mmu-miR-542-5p miRNA prion pancreatic cancer (PC) N2a cells prion treatment downregulated of mmu-miR-351 and mmu-miR-542-5p 22985096 4872 Mouse mmu-miR-543 miRNA coxsackievirus B3 (CVB3) viral myocarditis (VM) peripheral blood and myocardial tissues of viral myocarditis mice and in CVB3-infected cardiomyocytes Coxsackievirus B3 (CVB3) infection upregulated 31894309 4873 Mouse mmu-miR-543 miRNA coxsackievirus B3 (CVB3) viral myocarditis (VM) peripheral blood; myocardial tissues; cardiomyocytes. Coxsackievirus B3 (CVB3) infection upregulated 31894309 4874 Mouse mmu-miR-543-3p miRNA nine hepatotoxic non-genotoxins (NGTXs) genotoxicity liver tissues nine hepatotoxic non-genotoxins (NGTXs) treatment downregulated 29777724 4875 Mouse mmu-miR-543-3p miRNA nine hepatotoxic non-genotoxins (NGTXs) genotoxicity plasma nine hepatotoxic non-genotoxins (NGTXs) treatment upregulated 29777724 4876 Mouse mmu-miR-543-3p miRNA "2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD)" inflammation myeloid-derived suppressor cells (MDSCs) "2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) treatment" downregulated 31492743 4877 Mouse mmu-miR-544 miRNA clozapine (CLZ) psychotic disorders mouse brain clozapine treatment upregulated 23318695 4878 Mouse mmu-miR-5622-3p miRNA high fat diet (HFD) compensatory hyperplasia of islets hepatocellular extracellular vesicles (EVs) ?high-fat diet (HFD) feed treatment downregulated 31284955 4879 Mouse mmu-miR-5709-5p miRNA dioscorea bulbifera (DB) liver damage livers dioscoreae bulbifera (EF) treatment downregulated 27609015 4880 Mouse mmu-miR-574-3p miRNA house dust mite (HDM) asthma C57BL/6J mice airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF) HDM treatment dysregulated in airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF) 28859242 4881 Mouse mmu-miR-574-3p miRNA high fat diet (HFD) hepatocellular carcinoma (HCC) plasma and hepatic tissues high fat diet (HFD) feed upregulated 26728044 4882 Mouse mmu-miR-574-3p miRNA curcumin (Cur) nasopharyngeal carcinoma (NPC) mice injected into the tumour centre at a concentration of 150 mg/kg treatment dysregulated 24896104 4883 Mouse mmu-miR-574-3p miRNA morphine painful or stressful conditions hippocampal Morphine treatment downregulated 25844808 4884 Mouse mmu-miR-574-5p miRNA lipopolysaccharide (LPS) acute respiratory distress syndrome (ARDS) lung tissues lipopolysaccharide (LPS) treatment "In ARDS models, microRNA-574-5p (miR-574-5p) expression could be induced by the TLR4/NF-¦ÊB pathway upon LPS stimulation." 33202146 4885 Mouse mmu-miR-574-5p miRNA house dust mite (HDM) asthma C57BL/6J mice airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF) HDM treatment dysregulated in airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF) 28859242 4886 Mouse mmu-miR-574-5p miRNA cyclophosphamide (CP) chronic ovarian dysfunction ovarian tissues cyclophosphamide (CP) treatment "CP treatment decreased the expression of miR-365-1-5p and miR-574-5p and increased that of miR-3472 and miR-667-3p, whereas SM administration restored the expression levels of these microRNAs to those in the Con mice." 33318603 4887 Mouse mmu-miR-574-5p miRNA samul-tang (SM) chronic ovarian dysfunction ovarian tissues samul-tang (SM) treatment "CP treatment decreased the expression of miR-365-1-5p and miR-574-5p and increased that of miR-3472 and miR-667-3p, whereas SM administration restored the expression levels of these microRNAs to those in the Con mice" 33318603 4888 Mouse mmu-miR-574-5p miRNA carbon tetrachloride (CCl4) liver fibrosis liver CCl4 treatment upregulated 27322257 4889 Mouse mmu-miR-574-5p miRNA X rays ionizing radiation (IR) injury male Kunming mice blood 0.5-2 Gy total-body carbon-ion irradiation treatment dysregulatedin blood 28632432 4890 Mouse mmu-miR-574-5p miRNA Japanese encephalitis virus (JEV) Japanese encephalitis virus (JEV) infection BV-2 cells; mouse neuroblastoma cell line NA; mouse brain endothelial cell line bEnd.3 Japanese encephalitis virus (JEV) infection downregulated 32461319 4891 Mouse mmu-miR-574-5p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce downregulated 30936699 4892 Mouse mmu-miR-574-5p miRNA particulate matter (PM2.5) neuroinflammation C57BL/6 mice received oropharyngeal aspiration ofPM2.5 treatment downregulated 28851397 4893 Mouse mmu-miR-575 miRNA l-lysine hemin-insulted mouse cortical neurons cortical neurons l-lysine treatment miR-575 expression was increased in L-lysine treated group. 31987833 4894 Mouse mmu-miR-577 miRNA hypoxia myocardial infarction (MI) myocardial tissues; primary cardiomyocytes;MCM cells hypoxia induce downregulated 31773708 4895 Mouse mmu-miR-582-5p miRNA hypoxia cerebral ischemic stroke (CIS) N2A cells oxygen-glucose deprivation/reoxygenation (OGD/R) induce downregulated 30327244 4896 Mouse mmu-miR-582-5p miRNA hypoxia cerebral ischemic stroke (CIS) N2A cells oxygen-glucose deprivation/reoxygenation (OGD/R) treatment downregulated 30327244 4897 Mouse mmu-miR-582-5p miRNA chronic unpredictable mild stress (CUMS) depression NAc tissue chronic unpredictable mild stress (CUMS) treatment upregulated 31430030 4898 Mouse mmu-miR-582-5p miRNA electroacupuncture (EA) electroacupuncture (EA) CD4 T cells electroacupuncture (EA) treatment upregulated 32026263 4899 Mouse mmu-miR-584 miRNA lipopolysaccharide (LPS) autophagy RAW 264.7 cells lipopolysaccharide (LPS) treatment downregulated 29845275 4900 Mouse mmu-miR-590 miRNA high fat diet (HFD) atherosclerosis (AS) ApoE-/- mice aorta tissues high fat diet (HFD) feed downregulated 30799593 4901 Mouse mmu-miR-590 miRNA zingerone cell differentiation mouse mesenchymal stem cells (mMSCs) Zingerone treatment upregulated 31091349 4902 Mouse mmu-miR-590-3p miRNA lipopolysaccharide (LPS) acute kidney injury (AKI) Mouse podocytes (MPC5) and kidney tissues lipopolysaccharide (LPS) treatment downregulated 30392071 4903 Mouse mmu-miR-590-3p miRNA YKL-40 rheumatoid arthritis (RA) mouse osteoblastic cell line MC3T3-E1 stimulated with YKL-40 for 24 h treatment downregulated 28448439 4904 Mouse mmu-miR-590-5p miRNA "2,4,6-trinitrobenzene sulfonic acid (TNBS)" colitis colon tissues "2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol treatment" downregulated 29912317 4905 Mouse mmu-miR-590-5p miRNA high glucose (HG) diabetic osteoporosis MC3T3-E1 cell high glucose (HG) treatment downregulated 30803283 4906 Mouse mmu-miR-590-5p miRNA lipopolysaccharide (LPS) intracerebral haemorrhage (ICH) Primary microglia cells lipopolysaccharide (LPS) treatment downregulated 30190124 4907 Mouse mmu-miR-592 miRNA arsenite atherosclerosis (AS) liver arsenic (As) exposure downregulated 22719926 4908 Mouse mmu-miR-592-5p miRNA quercetin chronic inflammatory diseases LPS-treated murine bone marrow¨Cderived DCs (BMDCs) quercetin treatment upregulated 31338984 4909 Mouse mmu-miR-592-5p miRNA high fat diet (HFD) hepatic insulin resistance mouse liver tissues high fat diet (HFD) feed downregulated 30820263 4910 Mouse mmu-miR-592-5p miRNA hypoxia hypoxic/ischemic brain damage (HIBD) hippocampal neuronal in a neonatal mouse hypoxia induce downregulated 29402808 4911 Mouse mmu-miR-596 miRNA lipopolysaccharide (LPS) autophagy RAW 264.7 cells lipopolysaccharide (LPS) treatment downregulated 29845275 4912 Mouse mmu-miR-602 miRNA lipopolysaccharide (LPS) autophagy RAW 264.7 cells lipopolysaccharide (LPS) treatment downregulated 29845275 4913 Mouse mmu-miR-6089 miRNA bovine type II collagen rheumatoid arthritis (RA) synovial macrophages bovine type II collagen induction circRNA_09505 can function as a miR-6089 sponge and regulate inflammation via miR-6089/AKT1/NF-¦ÊB axis in collagen-induced arthritis (CIA) mice mice. 33028811 4914 Mouse mmu-miR-615-3p miRNA hypoxia cell proliferation brain tissue of micce hypoxia treatment downregulated 22171942 4915 Mouse mmu-miR-615-5p miRNA adriamycin (ADR) focal segmental glomerulosclerosis (FSGS) kidney tissues adriamycin (ADR) treatment downregulated 32800553 4916 Mouse mmu-miR-615-5p miRNA recombinant Adeno-Cre viruses (AdV-Cre) lung adenocarcinoma (LUAD) lung recombinant Adeno-Cre viruses (AdV-Cre) treatment downregulated 25359683 4917 Mouse mmu-miR-618 miRNA RANKL (receptor activator of nuclear factor ¦ÊB ligand) postmenopausal osteoporosis (PMOP) osteoclastogenesis of RAW264.7 cells 50ng/mL RANKL treatment downregulated 29271983 4918 Mouse mmu-miR-630 miRNA bone morphogenetic protein 4 (BMP4) and TGF-¦Â2 heterotopic ossification (HO) BALB/c-nu mice bone morphogenetic protein 4 (BMP4) and TGF-¦Â2 treatment downregulated 26940839 4919 Mouse mmu-miR-6366 miRNA chronic sleep fragmentation (SF) obstructive sleep apnea (OSA) C57/B6 mice chronic sleep treatment "upregulation(mmu-miR-5128,mmu-miR-6366), downregulated(mmu-miR-5112) in plasma-derived exosomes" 27419627 4920 Mouse mmu-miR-640 miRNA sevoflurane (SEV) sevoflurane-induced abnormal cognition primary hippocampal neurons sevoflurane treatment Overexpression of lncRNA Gm43050 alleviates apoptosis and inflammation response induced by sevoflurane treatment by regulating miR-640/ZFP91 32913509 4921 Mouse mmu-miR-650 miRNA dextran sodium sulfate (DSS) ulcerative colitis (UC) colon tissues dextran sulfate sodium (DSS) treatment upregulated 31399193 4922 Mouse mmu-miR-6516-3p miRNA manganese (Mn) parkinson's disease (PD) MN9D dopaminergic cell exosomes Mn exposure (300¦ÌM MnCl2) for 24h upregulated in exosomes 28450057 4923 Mouse mmu-miR-652 miRNA prednisolone duchenne muscular dystrophy (DMD) diaphragm muscle prednisolone treatment downregulated 29883261 4924 Mouse mmu-miR-652 miRNA vamorolone duchenne muscular dystrophy (DMD) diaphragm muscle vamorolone treatment downregulated 29883261 4925 Mouse mmu-miR-652 miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues intraperitoneal injection of CCl4 upregulated 28768954 4926 Mouse mmu-miR-652-3p miRNA oxygen glucose deprivation (OGD) cerebral ischemia/reperfusion (I/R) injury N2a cells oxygen glucose deprivation (OGD) treatment upregulation of lncRNA HCP5 may exacerbate cerebral ischemic reperfusion injury by sponging miR-652-3p 32657103 4927 Mouse mmu-miR-652-5p miRNA dioscorea bulbifera (DB) liver damage livers dioscoreae bulbifera (EF) treatment downregulated 27609015 4928 Mouse mmu-miR-653-5p miRNA IL-1¦Â chondrocyte apoptosis ATDC5 IL-1¦Â treatment upregulated 32517436 4929 Mouse mmu-miR-6538 miRNA high glucose (HG) diabetic nephropathy (DN) mouse podocytes high glucose (HG) treatment downregulated 33224036 4930 Mouse mmu-miR-654-5p miRNA Tripterysium Glycosides Tablets (TGT) rheumatoid arthritis (RA) peripheral blood Tripterysium Glycosides Tablets (TGT) treatment upregulated 33135351 4931 Mouse mmu-miR-660-3p miRNA carbon tetrachloride (CCl4) liver fibrosis liver tissues carbon tetrachloride (CCl4) treatment It showed that the expression levels of hsa-miR- 660-3p significantly increased over time upon CCl4 injection. 32584784 4932 Mouse mmu-miR-665 miRNA phenylephrine (PE) heart failure (HF) cultured cardiomyocytes phenylephrine (PE) treatment upregulated 31664601 4933 Mouse mmu-miR-665 miRNA dextran sodium sulfate (DSS) inflammatory bowel disease (IBD) C57BL/6 mice colonic mucosal tissues dextran sodium sulfate (DSS) treatment upregulated in colonic mucosal tissues 28333149 4934 Mouse mmu-miR-665 miRNA propofol (PPF) propofol-induced developmental neurotoxicity hippocampus propofol treatment downregulated 30242182 4935 Mouse mmu-miR-665-3p miRNA Sheng-ji Hua-yu (SJHY) formula diabetic foot ulcer (DFU) skin tissues Sheng-ji Hua-yu (SJHY) treatment upregulated 33271241 4936 Mouse mmu-miR-665-3p miRNA Sheng-ji Hua-yu (SJHY) formula diabetic foot ulcer (DFU) ulceration surface sheng-ji Hua-yu (SJHY) formula treatment "RNA-seq identified 11 DE circRNAs and 476 DE mRNAs between SJHY formula-treated and diabetic mice, including 4 upregulated and 7 downregulated circRNAs, 311 upregulated and 165 downregulated mRNAs CircRNA-Krt13/miR-665-3p/Itga3 and circRNA-Krt14/miR-706/Mylk4 pathways were built, which may contribute to the healing of SJHY formula-treated diabetic wounds" 33271241 4937 Mouse mmu-miR-665-3p miRNA oxygen glucose deprivation (OGD) ischemic stroke (IS) BV2 cells oxygen-glucose deprivation (OGD) treatment downregulated 32512270 4938 Mouse mmu-miR-667-3p miRNA cyclophosphamide (CP) chronic ovarian dysfunction ovarian tissues cyclophosphamide (CP) treatment "CP treatment decreased the expression of miR-365-1-5p and miR-574-5p and increased that of miR-3472 and miR-667-3p, whereas SM administration restored the expression levels of these microRNAs to those in the Con mice." 33318603 4939 Mouse mmu-miR-667-3p miRNA samul-tang (SM) chronic ovarian dysfunction ovarian tissues samul-tang (SM) treatment "CP treatment decreased the expression of miR-365-1-5p and miR-574-5p and increased that of miR-3472 and miR-667-3p, whereas SM administration restored the expression levels of these microRNAs to those in the Con mice" 33318603 4940 Mouse mmu-miR-668 miRNA lipopolysaccharide (LPS) bacterial infection "the whole blood, serum and white blood cells (WBCs) of C57BL/6 and Tlr2-/- mice" lipopolysaccharide (LPS) treatment upregulated 23286671 4941 Mouse mmu-miR-668 miRNA smoking smoking-related interstitial fibrosis (SRIF) peripheral blood of mice smoking treatment upregulated 22782705 4942 Mouse mmu-miR-668 miRNA smoking smoking-related interstitial fibrosis (SRIF) C57 mice circulating 6 months of chronic mainstream smoking exposure treatment upregulated 22782705 4943 Mouse mmu-miR-669a-5p miRNA propofol (PPF) propofol-induced developmental neurotoxicity hippocampus propofol treatment downregulated 30242182 4944 Mouse mmu-miR-669b-5p miRNA D-mannose adipogenesis adipose tissue-derived stem cells (ADSCs) D-Mannose treatment miR669b-5p expression level was significantly upregulated in the D-mannose group. 33376493 4945 Mouse mmu-miR-669b-5p miRNA manganese (Mn) parkinson's disease (PD) MN9D dopaminergic cell exosomes Mn exposure (300¦ÌM MnCl2) for 24h upregulated in exosomes 28450057 4946 Mouse mmu-miR-669c-3p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) ischemic stroke (IS) primary microglial cultures oxygen-glucose deprivation and reoxygenation (OGD/R) treatment MiR-669c-3p expression is increased in primary cortical neurons exposed to excitotoxic injury. 32560730 4947 Mouse mmu-miR-669n miRNA enterovirus 71 (EV71) enterovirus 71 (EV71) infection mouse infect with EV71 downregulated 28469998 4948 Mouse mmu-miR-669n miRNA chloroquine macrophage activation LPS-treated RAW264.7 cells Chloroquine (CQ) treatment downregulated 26807181 4949 Mouse mmu-miR-669n miRNA ¦Â-elemene oxygen-induced retinopathy (OIR) Retinas tissues ¦Â-elemene treatment upregulated 30664207 4950 Mouse mmu-miR-669o-5p miRNA X-rays bystander effect C57BL/6 mice extracellular vesicles (EVs) otal-body irradiated with X-rays downregulated 28396668 4951 Mouse mmu-miR-670 miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral ischemia/reperfusion (I/R) injury Mouse N2a cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment "Our results showed that after ischemia/reperfusion injury, miR-670 expression was obviously increased" 33269746 4952 Mouse mmu-miR-671 miRNA lead (Pb) lead (Pb) toxicity mouse neuroblastoma N2a cells PbAc treatment downregulated 27604105 4953 Mouse mmu-miR-671-5p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce downregulated 30936699 4954 Mouse mmu-miR-674 miRNA influenza virus H9N2 influenza virus infection Dendritic cells (DCs) H9N2 avian influenza virus (H9N2 AIV) treatment upregulated 27285980 4955 Mouse mmu-miR-674-5p miRNA Japanese encephalitis virus (JEV) Japanese encephalitis virus (JEV) infection BV-2 cells; mouse neuroblastoma cell line NA; mouse brain endothelial cell line bEnd.3 Japanese encephalitis virus (JEV) infection downregulated 32461319 4956 Mouse mmu-miR-675 miRNA TGF-¦Â1 cardiac fibrosis Cardiac fibroblasts (CFs) transforming growth factor beta 1 (TGF¦Â1) treatment downregulated 30953355 4957 Mouse mmu-miR-675 miRNA synthetic preimplantation factor (sPIF) duchenne muscular dystrophy (DMD) myoblast Synthetic preimplantation factor (sPIF) treatment upregulated 30692507 4958 Mouse mmu-mir-676-3p miRNA recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) bacterial infection blood recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen Staphylococcus aureus (Xen29) treatment upregulated 25563241 4959 Mouse mmu-miR-677 miRNA plasmodium chabaudi malaria peak parasitemia liver of mice Plasmodium chabaudi malaria infection treatment downregulated 21085987 4960 Mouse mmu-miR-677-5p miRNA TGF-¦Â1 ischemia-reperfusion (IR)-induced late fibrosis of kidney kidney tissues TGF-¦Â1 treatment LncRNA (Gm12840) could act as a sponge for miR-677-5p to mediate fibroblast activation induced by TGF-¦Â1 via the WISP1/PKB (Akt) signaling pathway 33351669 4961 Mouse mmu-miR-679 miRNA arsenite atherosclerosis (AS) liver arsenic (As) exposure downregulated 22719926 4962 Mouse mmu-miR-682 miRNA ischemia intestinal ischemia/reperfusion (I/R) injury intestinal epithelial cells intestinal I/R injury upregulation 27124584 4963 Mouse mmu-miR-682 miRNA dioscorea bulbifera (DB) liver damage livers dioscoreae bulbifera (EF) treatment upregulated 27609015 4964 Mouse mmu-miR-687 miRNA lipopolysaccharide (LPS) acute kidney injury (AKI) renal tubular epithelial (PTEC) cells lipopolysaccharide (LPS) treatment upregulated 32655407 4965 Mouse mmu-miR-690 miRNA angiotensin II (Ang II) obesity 3T3-L1 cells angiotensin II (Ang II) treatment upregulated 32466437 4966 Mouse mmu-miR-690 miRNA testosterone prostate cancer female mouse liver Testosterone treatment "upregulation of the 6 miRNAs miR-22, miR-690, miR-122, let-7A, miR-30D and let-7D" 20600201 4967 Mouse mmu-miR-690 miRNA clozapine (CLZ) psychotic disorders mouse brain clozapine treatment upregulated 23318695 4968 Mouse mmu-miR-690 miRNA ¦¤9-tetrahydrocannabinol (THC) ¦¤9-tetrahydrocannabinol toxicity CD11b£«Gr-1£«MDSCs ¦¤9-Tetrahydrocannabinol (THC) treatment upregulated 24202177 4969 Mouse mmu-miR-6906-5p miRNA indole-3-carbinol (I3C) colitis Mesenteric lymph nodes Indole-3-carbinol (I3C) treatment downregulated 32921956 4970 Mouse mmu-miR-691 miRNA cigarette smoke (CS) ovarian toxicity ovarian tissues cigarette smoke (CS) treatment upregulated 29377183 4971 Mouse mmu-miR-691 miRNA particulate matter (PM2.5) PM2.5 exposure mosue bronchoalveolar lavage fluid (BALF) "were subjected to intratracheal instillation of 2.5, 10, or 20mg/kg PM2.5 treatment" upregulated in bronchoalveolar lavage fluid (BALF) 29107863 4972 Mouse mmu-miR-691 miRNA particulate matter (PM2.5) pulmonary toxicological lung tissues particulate matter (PM2.5) exposure treatment upregulated 29107863 4973 Mouse mmu-miR-691 miRNA dextran sodium sulfate (DSS) ulcerative colitis (UC) colonic tissues dextran sulfate sodium (DSS) treatment upregulated 32779953 4974 Mouse mmu-miR-6914-5p miRNA mesalamine inflammatory bowel disease (IBD) DSS-induced IBD mouse colon tissues "Mesalazine (5-aminosalicylic acid, 5-ASA) treatment" "The network analysis of circRNA-miRNA-mRNAs identified an important pathway, i.e., chr10:115386962-115390436+/mmu-miR-6914-5p/Atg7, which is related to autophagy." 33819198 4975 Mouse mmu-miR-692 miRNA dioscorea bulbifera (DB) liver damage livers dioscoreae bulbifera (EF) treatment upregulated 27609015 4976 Mouse mmu-miR-6931 miRNA dicalcium silicate microparticle (C2S) bone and dental tissue regenerative applications mesenchymal stem cells (MSCs) dicalcium silicate microparticle (C2S) treatment downregulated 32463418 4977 Mouse mmu-miR-693-3p miRNA propofol (PPF) propofol-induced developmental neurotoxicity hippocampus propofol treatment downregulated 30242182 4978 Mouse mmu-miR-694 miRNA plasmodium chabaudi malaria peak parasitemia liver of mice Plasmodium chabaudi malaria infection treatment downregulated 21085987 4979 Mouse mmu-miR-696 miRNA resistin ectopic deposition of lipids C2C12 cells resistin treatment upregulated 25962325 4980 Mouse mmu-miR-696 miRNA AICAR metabolic syndrome C2C12 cells AMP-activated protein kinase (AMPK) activator AICAR treatment upregulated 33812060 4981 Mouse mmu-miR-696 miRNA high fat diet (HFD) metabolic syndrome Tibialis anterior (TA) and extensor digitorum longus (EDL) muscles high fat diet (HFD) feed we found that miR-696 was highly expressed in the skeletal muscle of STZ-induced diabetic mice and chronic high-fat-fed mice. 33812060 4982 Mouse mmu-miR-696 miRNA palmitic acid (PA) metabolic syndrome C2C12 muscle cells palmitic acid (PA) treatment upregulated 33812060 4983 Mouse mmu-miR-696 miRNA streptozocin (STZ) metabolic syndrome Tibialis anterior (TA) muscle streptozotocin (STZ) treatment miR-696 was highly expressed in the skeletal muscle of STZ-induced diabetic mice and chronic high-fat-fed mice. 33812060 4984 Mouse mmu-miR-698 miRNA D-galactosamine/lipopolysaccharide (D-GalN/LPS) acute liver injury (ALI) liver tissues D-GalN/LPS treatment downregulated 31061003 4985 Mouse mmu-miR-7 miRNA high fat diet (HFD) Alzheimer's disease (AD) brain tissues high fat diet (HFD) feed upregulated 31501273 4986 Mouse mmu-miR-7 miRNA insulin Alzheimer's disease (AD) N2a cells insulin treatment upregulated 31501273 4987 Mouse mmu-miR-7 miRNA oxygen glucose deprivation (OGD) brain ischemic injury astrocytes oxygen-glucose deprivation (OGD) treatment downregulated 26961366 4988 Mouse mmu-miR-7 miRNA lipopolysaccharide (LPS) brain tissue inflammation (BTI) brain tissues lipopolysaccharide (LPS) treatment upregulated 31959187 4989 Mouse mmu-miR-7 miRNA lipopolysaccharide (LPS) cerebral hemorrhage BV2 microglia lipopolysaccharides (LPS) treatment downregulated 30229834 4990 Mouse mmu-miR-7 miRNA bleomycin (BLM) idiopathic pulmonary fibrosis (IPF) lung lobes bleomycin (BLM) treatment downregulated 31786325 4991 Mouse mmu-miR-7 miRNA trinitrobenzene sulfonic acid (TNBS) inflammatory bowel disease (IBD) intestinal tissues TNBS treatment upregulated 31494796 4992 Mouse mmu-miR-7 miRNA ionizing radiation (IR) leukemia mouse thymus and spleen tissue cells irradiated downregulated 18823940 4993 Mouse mmu-miR-7 miRNA focal brain irradiation radiation induced bystander effect (RIBE) mouse "10 Gy or sham irradiation of mice brains, lung tissues" upregulated 29104495 4994 Mouse mmu-miR-7 miRNA silica silicosis lung tissues silica treatment miR-7 is downregulated in lung tissues during silica-induced pulmonary fibrosis 30202956 4995 Mouse mmu-miR-700 miRNA streptozocin (STZ) diabetes mellitus (DM) hearts of diabetic mice streptozotocin (STZ) treatment upregulated 21584493 4996 Mouse mmu-miR-700 miRNA smoking smoking-related interstitial fibrosis (SRIF) peripheral blood of mice smoking treatment upregulated 22782705 4997 Mouse mmu-miR-700 miRNA smoking smoking-related interstitial fibrosis (SRIF) C57 mice circulating 6 months of chronic mainstream smoking exposure treatment upregulated 22782705 4998 Mouse mmu-miR-7025 miRNA hypoxia ischemic injury bone marrow mesenchymal stem cells (BM-MSCs) hypoxia treatment upregulated 30613290 4999 Mouse mmu-miR-702-5p miRNA house dust mite (HDM) asthma C57BL/6J mice airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF) HDM treatment dysregulated in airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF) 28859242 5000 Mouse mmu-miR-7045 miRNA hypoxia ischemic injury bone marrow mesenchymal stem cells (BM-MSCs) hypoxia treatment upregulated 30613290 5001 Mouse mmu-miR-705 miRNA alcohol alcoholic liver disease (ALD) mouse liver cells Lieber-DeCarli alcohol treatment upragulated 19572984 5002 Mouse mmu-miR-705 miRNA methionine choline-deficient diet (MCD) alcoholic liver disease (ALD) liver tissues methionine-choline-deficient (MCD) diets treatment upragulated 19572984 5003 Mouse mmu-miR-705 miRNA streptozocin (STZ) diabetes mellitus (DM) hearts of diabetic mice streptozotocin (STZ) treatment upregulated 21584493 5004 Mouse mmu-miR-705 miRNA metformin (Met) nonalcoholic steatohepatitis (NASH) liver tissues metformin treatment downregulated 25672270 5005 Mouse mmu-miR-706 miRNA laboratory-attenuated vesicular stomatitis virus apoptosis The baby hamster kidney (BHK-21) cell lin laboratory-attenuated vesicular stomatitis virus treatment upregulated 20625776 5006 Mouse mmu-miR-706 miRNA Sheng-ji Hua-yu (SJHY) formula diabetic foot ulcer (DFU) skin tissues Sheng-ji Hua-yu (SJHY) treatment upregulated 33271241 5007 Mouse mmu-miR-706 miRNA Sheng-ji Hua-yu (SJHY) formula diabetic foot ulcer (DFU) ulceration surface sheng-ji Hua-yu (SJHY) formula treatment "RNA-seq identified 11 DE circRNAs and 476 DE mRNAs between SJHY formula-treated and diabetic mice, including 4 upregulated and 7 downregulated circRNAs, 311 upregulated and 165 downregulated mRNAs CircRNA-Krt13/miR-665-3p/Itga3 and circRNA-Krt14/miR-706/Mylk4 pathways were built, which may contribute to the healing of SJHY formula-treated diabetic wounds" 33271241 5008 Mouse mmu-miR-706 miRNA low glucose (LG) endoplasmic reticulum stress (ERS) NIH3T3 cells low glucose media treatment upregulated 31863666 5009 Mouse mmu-miR-706 miRNA thapsigargin (Tg) endoplasmic reticulum stress (ERS) NIH3T3 cells thapsigargin (Tg) treatment upregulated 31863666 5010 Mouse mmu-miR-706 miRNA thapsigargin (Tg) endoplasmic reticulum stress (ERS) AML12 mouse hepatic cells thapsigargin (Tg) treatment upregulated 31863666 5011 Mouse mmu-miR-706 miRNA tunicamycin (TM) endoplasmic reticulum stress (ERS) NIH3T3 cells tunicamycin (TM) treatment upregulated 31863666 5012 Mouse mmu-miR-706 miRNA H2O2 hepatic fibrogenesis liver fibrogenic cells oxidative stress downregulated 27876854 5013 Mouse mmu-miR-706-5p miRNA ¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) experimental autoimmune encephalomyelitis (EAE) murine brain-derived CD4+ T cells ¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) combination treatment upregulated 31497013 5014 Mouse mmu-miR-708 miRNA dexamethasone (DEX) muscle atrophy Murine C2C12 myoblast cells dexamethasone (DEX) treatment downregulated 23716137 5015 Mouse mmu-miR-708 miRNA dexamethasone (DEX) ovarian cancer (OC) C57BL/6-derived ovarian cancer ID-8 cells dexamethasone (DEX) treatment upregulated 28591224 5016 Mouse mmu-miR-708 miRNA low glucose (LG) ¦Â-cell apoptosis mouse pancreatic islets low glucose concentrations upregulated 28970284 5017 Mouse mmu-miR-708-3p miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharide (LPS) treatment downregulated 32955644 5018 Mouse mmu-miR-708-5p miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharide (LPS) treatment downregulated 32955644 5019 Mouse mmu-miR-709 miRNA cisplatin (DDP) acute kidney injury (AKI) mouse proximal tubular cells (PTCs) cisplatin treatment upregulated 29042455 5020 Mouse mmu-miR-709 miRNA aldosterone argonaute protein induct kidney murine inner medullary collecting duct (mIMCD-3) cell line aldosterone treatment downregulated 24632479 5021 Mouse mmu-miR-709 miRNA sodium arsenite (NaAsO2) arsenic inhibited cellular differentiation pluripotent P19 mouse embryonal carcinoma cells sodium arsenite treatment upregulated 29121352 5022 Mouse mmu-miR-709 miRNA enterovirus 71 (EV71) enterovirus 71 (EV71) infection mouse infect with EV71 downregulated 28469998 5023 Mouse mmu-miR-709 miRNA high fat diet (HFD) high fat diet?influence liver tissue high fat diet (HFD) feed upregulated 19835573 5024 Mouse mmu-miR-709 miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated 27232654 5025 Mouse mmu-miR-709 miRNA cisplatin (DDP) mitochondrial dysfunction proximal tubular cells (PTCs) cisplatin (DPP) treatment upregulated 29042455 5026 Mouse mmu-miR-711 miRNA hypoxia ischemic injury bone marrow mesenchymal stem cells (BM-MSCs) hypoxia treatment upregulated 30613290 5027 Mouse mmu-miR-711 miRNA ionizing radiation (IR) ionizing radiation (IR) injury hippocampus; neurons ionizing radiation (IR) treatment "miR-711 was upregulated in the cortex at all time points and in the hippocampus and isolated neurons at 6 h, 24 h and 7 d after IR exposure." 32718090 5028 Mouse mmu-miR-7116 miRNA ¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) experimental autoimmune encephalomyelitis (EAE) murine brain-derived CD4+ T cells ¦¤9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) combination treatment upregulated 31497013 5029 Mouse mmu-miR-7116-5p miRNA "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)" parkinson's disease (PD) brain tissues "1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment" downregulated 28543680 5030 Mouse mmu-miR-712 miRNA TGF-¦Â1 chronic inflammatory diseases RAW 264.7 mouse macrophages LPS and IFN-¦Ã treatment downregulated 27992764 5031 Mouse mmu-miR-712 miRNA IFN-¦Ã and lipopolysaccharide (LPS) insulin sensitivity RAW 264.7 LPS? treatment downregulated 27992764 5032 Mouse mmu-miR-712 miRNA propofol (PPF) propofol-induced developmental neurotoxicity hippocampus propofol treatment downregulated 30242182 5033 Mouse mmu-miR-712-5p miRNA tanshinone IIA (Tan IIA) inflammation Mouse aortic vascular smooth muscle cell (VSMC) Tanshinone ¢òA (Tan ¢òA) treatment Tan IIA inhibits VSMC inflammation via suppressing miR-712-5p upregulation by TNF-¦Á 32387370 5034 Mouse mmu-miR-7-1-3p miRNA lipopolysaccharide (LPS) autophagy RAW 264.7 cells lipopolysaccharide (LPS) treatment downregulated 29845275 5035 Mouse mmu-miR-714 miRNA clamping the renal pedicle bilateral renal ischemia C57Bl/6 mice plasma and kidneys clamping the renal pedicle treatment upregulated 24695114 5036 Mouse mmu-miR-717 miRNA hypertonicity cellular responses to osmotic stress mouse renal medulla hypertonicity-induced induction upregulated 20852262 5037 Mouse mmu-miR-718 miRNA lipopolysaccharide (LPS) inflammation mouse spleens lipopolysaccharide (LPS) treatment upregulated 28209713 5038 Mouse mmu-miR-718 miRNA dioscorea bulbifera (DB) liver damage livers dioscoreae bulbifera (EF) treatment downregulated 27609015 5039 Mouse mmu-miR-718 miRNA chronic intermittent hypoxia (CIH) obstructive sleep apnoea-hypopnoea syndrome (OSAHS) mouse aortic endothelial cells (MAECs) chronic intermittent hypoxia (CIH) treatment downregulated 29108914 5040 Mouse mmu-miR-719 miRNA arsenite atherosclerosis (AS) liver arsenic (As) exposure downregulated 22719926 5041 Mouse mmu-miR-720 miRNA D-galactosamine/lipopolysaccharide (D-GalN/LPS) acute liver injury (ALI) liver tissues D-GalN/LPS treatment downregulated 31061003 5042 Mouse mmu-miR-720 miRNA high fat diet (HFD) erectile dysfunction (ED) mouse high fat diet (HFD) feed dysregulated 25533598 5043 Mouse mmu-miR-720 miRNA high fat diet (HFD) hepatocellular carcinoma (HCC) plasma and hepatic tissues high fat diet (HFD) feed downregulated 26728044 5044 Mouse mmu-miR-721 miRNA enterovirus 71 (EV71) enterovirus 71 (EV71) infection mouse infect with EV71 downregulated 28469998 5045 Mouse mmu-miR-7218-5p miRNA high fat diet (HFD) compensatory hyperplasia of islets hepatocellular extracellular vesicles (EVs) ?high-fat diet (HFD) feed treatment downregulated 31284955 5046 Mouse mmu-miR-7219-5p miRNA high fat diet (HFD) compensatory hyperplasia of islets hepatocellular extracellular vesicles (EVs) ?high-fat diet (HFD) feed treatment downregulated 31284955 5047 Mouse mmu-miR-7224-3p miRNA high glucose (HG) diabetic nephropathy (DN) mouse podocytes high glucose (HG) treatment downregulated 33224036 5048 Mouse mmu-miR-7239-5p miRNA dextran sodium sulfate (DSS) ulcerative colitis (UC) colonic tissues dextran sulfate sodium (DSS) treatment upregulated 32779953 5049 Mouse mmu-miR-7240-5p miRNA subchronic deoxynivalenol (DON) liver damage liver tissues; Hepa 1-6 cells subchronic deoxynivalenol (DON) exposure treatment downregulated 32439590 5050 Mouse mmu-miR-741-3p miRNA all-trans retinoic acid (ATRA) cleft palate (CP) palate all-trans retinoic acid (ATRA) treatment ?NONMMUT004850.2/NONMMUT024276.2-miR-741-3p/miR-465b-5p-Prkar1¦Á?could potentially serve as an important regulatory mechanism of palatal fusion in the development of the cleft palate. 32042778 5051 Mouse mmu-miR-741-3p miRNA pressure overload heart failure (HF) heart sissues pressure overload treatment downregulated 33224746 5052 Mouse mmu-miR-741-3p miRNA radiation radiation-induced brain injury (RBI) hippocampus radiation treatment "microRNA sequencing was used to discover differential miRNAs in the hippocampus of RBI-modeled mice, which suggested that miR-741-3p was most significantly upregulated" 33544844 5053 Mouse mmu-miR-744 miRNA alcohol alcoholic hepatitis (AH) sera alcohol exposure upregulated 26264599 5054 Mouse mmu-miR-744 miRNA carbon tetrachloride (CCl4) liver cirrhosis sera and livers CCl4 treatment downregulated 31643031 5055 Mouse mmu-miR-744-3p miRNA X-rays bystander effect C57BL/6 mice extracellular vesicles (EVs) otal-body irradiated with X-rays downregulated 28396668 5056 Mouse mmu-miR-7-5p miRNA hyperoxia experimental retinopathy C57BL/6J mice endothelial cells "exposed to hyperoxia (75% oxygen) in an incubation chamber (Stuart Scientific, Redhill, UK) with their nursing mothers for 5 days and then returned to ambient air" upregulated 28353063 5057 Mouse mmu-miR-7-5p miRNA diosbuibin B (DB) gastric cancer (GC) "human gastric cancer cell lines (MGC803, BGC-823 and SGC7901)" Diosbulbin-B (DB)?treatment knock-down of CircRNA CDR1as specifically promoted the cytotoxic effects of low-dose DB on GC cells instead of hepatocytes by regulating miR-7-5p/REG¦Ã axis. 31542615 5058 Mouse mmu-miR-761 miRNA hypoxia/reoxygenation (H/R) acute myocardial infarction (AMI) HL-1 Cells hypoxia/reoxygenation (H/R) treatment ZFAS1 was upregulated and miR-761 was downregulated in the serum of patients with AMI and H/R-induced HL-1 cells. 32833901 5059 Mouse mmu-miR-761 miRNA angiotensin II (Ang II) atherosclerosis and restenosis SMCs angiotensin II (Ang II) treatment downregulated 26444612 5060 Mouse mmu-miR-762 miRNA lipopolysaccharide (LPS) acute kidney injury (AKI) kidney tissues lipopolysaccharide (LPS) treatment miR-762 was upregulated at 6h. 32727087 5061 Mouse mmu-miR-762 miRNA house dust mite (HDM) asthma C57BL/6J mice airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF) HDM treatment dysregulated in airway-secreted EVs (AEVs) were isolated from bronchoalveolar lavage fluid (BALF) 28859242 5062 Mouse mmu-miR-762 miRNA thyroxine T4 cardiac hypertrophy heart tissues thyroxine T4 treatment downregulated 31522342 5063 Mouse mmu-miR-762 miRNA cannabinoid receptor 1 (CB1) antagonists SR141716A diet-induced obesity (DIO) mouse adipose tissue macrophage (ATM) SR141716A treatment downregulated 30910812 5064 Mouse mmu-miR-762 miRNA polychlorinated biphenyls (PCBs) cell differentiation P19 mouse embryonal carcinoma cells polychlorinated biphenyls (PCBs) treatment downregulated 23443104 5065 Mouse mmu-miR-762 miRNA anoxia/reoxygenation (A/R) myocardial infarction (MI) Neonatal mouse cardiomyocytes anoxia/reoxygenation (A/R) treatment miR-762 predominantly translocated in the mitochondria and was significantly upregulated upon anoxia/reoxygenation (A/R) treatment. 31235686 5066 Mouse mmu-miR-764-3p miRNA TGF-¦Â1 treat steroid-related diseases ovarian granulosa cells TGF-¦Â1 treatment upregulated 26676955 5067 Mouse mmu-miR-765 miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral ischemia/reperfusion (I/R) injury N2a cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 33068927 5068 Mouse mmu-miR-7654-3p miRNA high fat diet (HFD) compensatory hyperplasia of islets hepatocellular extracellular vesicles (EVs) ?high-fat diet (HFD) feed treatment downregulated 31284955 5069 Mouse mmu-miR-766-3p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral ischemia/reperfusion (I/R) injury N2a cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment Gm11974/miR-766-3p/NR3C2 axis plays important role in cerebral I/R injury 31556305 5070 Mouse mmu-miR-7670-3p miRNA oxygen glucose deprivation (OGD) ischemic stroke (IS) primary astrocytes oxygen glucose deprivation (OGD) treatment circSHOC2 in IPAS-EXOs suppressed neuronal apoptosis and ameliorated neuronal damage by regulating autophagy and acting on the miR-7670-3p/SIRT1 axis 33230464 5071 Mouse mmu-miR-770-5p miRNA high glucose (HG) diabetic nephropathy (DN) mouse podocytes In vitro podocyte model of DN was conducted by treatment conditionally immortalized mouse podocytes with HG (30 mM D-glucose). upregulated 30779094 5072 Mouse mmu-miR-770-5p miRNA high glucose (HG) diabetic nephropathy (DN) mouse podocytes high glucose (HG) treatment MiR-770-5p was upregulated and TIMP3 was downregulated in DN kidney tissues and HG-stimulated podocytes. 32309847 5073 Mouse mmu-miR-770-5p miRNA streptozocin (STZ) diabetic pregnancy female mice hyperglycemic ED9.5 embryos streptozotocin treatment dysregulatedin hyperglycemic ED95 embryos 27908722 5074 Mouse mmu-miR-770-5p miRNA H2O2 ischemia/reperfusion (I/R) injury cardiomyocytes H2O2 treatment NHG16 accelerates the proliferative ability of cardiomyocytes following IRI by negatively regulating miRNA-770-5p. 32855691 5075 Mouse mmu-miR-784 miRNA indole-3-carbinol (I3C) colitis Mesenteric lymph nodes Indole-3-carbinol (I3C) treatment downregulated 32921956 5076 Mouse mmu-miR-7a miRNA sevoflurane (SEV) effects of sevoflurane during early development mouse embryonic stem cells Sevoflurane treatment upregulated 27535693 5077 Mouse mmu-miR-7a miRNA H1N1 influenza virus endometriosis and endometrial carcinoma mouse lung?tissues H1N1 influenza virus infection upregulated 24066118 5078 Mouse mmu-miR-7a miRNA murine cytomegalovirus (MCMV) murine cytomegalovirus (MCMV) infection NIH 3T3 cells;TCMK-1 cells Murine cytomegalovirus treatment downregulated 22442111 5079 Mouse mmu-miR-7a miRNA dexamethasone (DEX) muscle atrophy Murine C2C12 myoblast cells dexamethasone (DEX) treatment downregulated 23716137 5080 Mouse mmu-miR-7a miRNA curcumin (Cur) myocardial infarction (MI) cardiac myocytes curcumin treatment upregulated 27261602 5081 Mouse mmu-miR-7a miRNA hypoxia myocardial infarction (MI) cardiomyocytes hypoxia treatment upregulated 26998750 5082 Mouse mmu-miR-7a-1 miRNA "3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)" sclerosing cholangitis ngn-3-heterozygous (+/-) mice were subjected to DDC feeding (a model of sclerosing cholangitis) treatment upregulated 24925797 5083 Mouse mmu-miR-7a-2 miRNA "3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)" sclerosing cholangitis ngn-3-heterozygous (+/-) mice were subjected to DDC feeding (a model of sclerosing cholangitis) treatment upregulated 24925797 5084 Mouse mmu-miR-7a-2-3p miRNA chronic unpredictable mild stress (CUMS) major depressive disorder (MDD) nucleus accumbens (NAc) tissues chronic unpredictable mild stress (CUMS) induce downregulated 30936699 5085 Mouse mmu-miR-7a-5p miRNA lipopolysaccharide (LPS) acute respiratory distress syndrome (ARDS) serum lipopolysaccharide (LPS) treatment upregulated 32934950 5086 Mouse mmu-miR-7a-5p miRNA lipopolysaccharide (LPS) cardiomyocytes injury Mouse cardiomyocytes MCM cells lipopolysaccharide (LPS) treatment The expression of miR-7a-5p was significantly reduced in myocardial cells in the LPS group. 33029099 5087 Mouse mmu-miR-7a-5p miRNA butyrate diabetic nephropathy (DN) SV40-MES-13 cells butyrate treatment "miR-7a-5p was significantly decreased in the HG-induced SV40-MES-13 cells, while giving butyrate reversed this change." 32539181 5088 Mouse mmu-miR-7a-5p miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharide (LPS) treatment downregulated 32955644 5089 Mouse mmu-miR-7a-5p miRNA FTY720-C2 parkinson's disease (PD) dopaminergic MN14D cells FTY720-C2 treatment upregulated 30359694 5090 Mouse mmu-miR-7a-5p miRNA FTY720-C2 parkinson's disease (PD) MN9D cells FTY720-C2 treatment upregulated 30359694 5091 Mouse mmu-miR-7a-5p miRNA lipopolysaccharide + ATP traumatic brain injury (TBI) microglia lipopolysaccharide + ATP treatment downregulated 33189612 5092 Mouse mmu-miR-7a-5p miRNA alpinia oxyphylla extract (AOE) type 2 diabetes mellitus (T2DM) db-/db- mouse kidney A. oxyphylla extract (AOE) treatment downregulated 28249617 5093 Mouse mmu-miR-7b miRNA lipopolysaccharide (LPS) acute respiratory distress syndrome (ARDS) serum lipopolysaccharide (LPS) treatment upregulated 32934950 5094 Mouse mmu-miR-7b miRNA angiotensin II (Ang II) chronic heart failure (CHF) NG108 cells angiotensin II (Ang II) treatment upregulated 26699387 5095 Mouse mmu-miR-7b miRNA sevoflurane (SEV) effects of sevoflurane during early development mouse embryonic stem cells Sevoflurane treatment upregulated 27535693 5096 Mouse mmu-miR-7b miRNA curcumin (Cur) myocardial infarction (MI) cardiac myocytes curcumin treatment upregulated 27261602 5097 Mouse mmu-miR-7b miRNA macrophage colony-stimulating factor (M-CSF) and receptor activator of NF-¦ÊB ligand (RANKL) osteoclast-related bone disorders RAW264.7 cells macrophage colony-stimulating factor (M-CSF) and receptor activator of NF-¦ÊB ligand (RANKL) treatment downregulated 25123438 5098 Mouse mmu-miR-7b-5p miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated 32955644 5099 Mouse mmu-miR-7c miRNA coronary artery ligation myocardial ischaemic injury heart subjected to coronary artery ligation downregulated 26655604 5100 Mouse mmu-miR-7c-5p miRNA learning persistent memory C57BL/6J mouse hippocampal Object-location memory task upregulated 28927503 5101 Mouse mmu-miR-7g miRNA coronary artery ligation myocardial ischaemic injury heart subjected to coronary artery ligation downregulated 26655604 5102 Mouse mmu-miR-802 miRNA lipopolysaccharide (LPS) acute respiratory distress syndrome (ARDS) lung tissues and RAW264.7 cells lipopolysaccharide (LPS) treatment downregulated 31696241 5103 Mouse mmu-miR-802 miRNA high fat diet (HFD) insulin resistance (IR) mice liver tissues high fat diet (HFD) treatment upregulated 23389544 5104 Mouse mmu-miR-802 miRNA high fat diet (HFD) insulin resistance (IR) liver tissues high fat diet (HFD) feed upregulated 31173239 5105 Mouse mmu-miR-802 miRNA particulate matter (PM2.5) malignant pulmonary disorders serum PM2.5 treatment downregulated 27144337 5106 Mouse mmu-miR-802 miRNA high fat diet (HFD) obesity renal tissues high fat diet (HFD) feed upregulated 30729676 5107 Mouse mmu-miR-802 miRNA obeticholic acid obesity mouse liver tissue obeticholic acid treatment "In obese mice, activation of FXR by obeticholic acid treatment reduced miR-802 levels and improved insulin resistance and hepatosteatosis" 33328206 5108 Mouse mmu-miR-802 miRNA obeticholic acid obesity-related diseases liver tissues obeticholic acid treatment Activation of FXR by obeticholic acid treatment reduced miR-802 levels. 33328206 5109 Mouse mmu-miR-82-5p miRNA fatty acid amide hydrolase inhibitor (FAAH-II) colitis colitis mouse colon tissues FAAH-II treatment dysregulated 27327245 5110 Mouse mmu-miR-872 miRNA dexamethasone (DEX) muscle atrophy Murine C2C12 myoblast cells dexamethasone (DEX) treatment upregulated 23716137 5111 Mouse mmu-miR-872 miRNA cigarette smoke (CS) ovarian toxicity ovarian tissues cigarette smoke (CS) treatment upregulated 29377183 5112 Mouse mmu-miR-873 miRNA high glucose (HG) diabetic nephropathy (DN) Mouse podocytes (MPC5) high glucose treatment upregulated 30095204 5113 Mouse mmu-miR-873 miRNA IL-17 multiple sclerosis (MS) mouse primary astrocytes stimulat IL-17 treatment upregulated 25183005 5114 Mouse mmu-miR-873-5p miRNA colistin colistin-induced kidney injury Mouse renal tubular epithelial cells (mRTECs) colistin treatment downregulated 31156435 5115 Mouse mmu-miR-873-5p miRNA medium deficient in methionine and choline (MDMC) nonalcoholic fatty liver disease (NAFLD) Mouse primary hepatocytes medium deficient in methionine and choline (MDMC) treatment upregulated 31668391 5116 Mouse mmu-miR-873-5p miRNA oleic acid (OA) nonalcoholic fatty liver disease (NAFLD) Mouse primary hepatocytes oleic acid (OA) treatment upregulated 31668391 5117 Mouse mmu-miR-873a-5p miRNA morphine morphine tolerance spinal cord ?morphine?treatment treatment upregulated 31024249 5118 Mouse mmu-miR-874 miRNA high glucose (HG) diabetic nephropathy (DN) mouse podocyte high glucose treatment downregulated 30171701 5119 Mouse mmu-miR-874 miRNA ischemia intestinal ischemic injury C57BL/6 mice abdomen was opened and the superior mesenteric artery (SMA) treatment upregulated 24462679 5120 Mouse mmu-miR-874 miRNA lipopolysaccharide (LPS) sepsis mice cardiomyocytes UL-1 cells lipopolysaccharide (LPS) treatment upregulated 30021355 5121 Mouse mmu-miR-874-3p miRNA ischemia/reperfusion (I/R) acute kidney injury (AKI) kidney tissues ischemia/reperfusion (I/R) treatment dysregulated 29245971 5122 Mouse mmu-miR-874-3p miRNA doxorubicin (DOX) doxorubicin (DOX)-induced renal podocyte injury mouse primary podocytes; kidney tissues doxorubicin (DOX) treatment upregulated 32908641 5123 Mouse mmu-miR-874-3p miRNA lipopolysaccharide (LPS) major depressive disorder (MDD) prefrontal cortex (PFC) lipopolysaccharide (LPS) treatment LPS upregulated miR-874-3p concomitantly with increase in IDO1 expression in the prefrontal cortex (PFC). 33095942 5124 Mouse mmu-miR-874-3p miRNA testosterone polycystic ovarian syndrome (PCOS) granulosa cell (GC) ?testosterone treatment "Compared with vehicle-treated GCs, miR-874-3p expression levels were significantly increased in testosterone-treated GCs" 33732332 5125 Mouse mmu-miR-875-5p miRNA carbon tetrachloride (CCl4) liver fibrosis Mouse liver tissues and primary hepatic stellate cells (HSCs) carbon tetrachloride (CCl4) treatment downregulated 31617598 5126 Mouse mmu-miR-875-5p miRNA icariin (ICA) liver fibrosis primary hepatic stellate cells (HSCs) icariin treatment upregulated 31617598 5127 Mouse mmu-miR-875-5p miRNA icariin (ICA) liver fibrosis mouse primary hepatic stellate cells (HSCs) Icariin treatment Icariin induced miR-875-5p upregulation. 31617598 5128 Mouse mmu-miR-876 miRNA high fat diet (HFD) atherosclerosis (AS) apoE (-/-) mice endothelial cells high fat diet (HFD) feed upregulated 28723693 5129 Mouse mmu-miR-877* miRNA clamping the renal pedicle bilateral renal ischemia C57Bl/6 mice plasma and kidneys clamping the renal pedicle treatment upregulated 24695114 5130 Mouse mmu-miR-877-3p miRNA H2O2 myocardial ischemia/reperfusion (I/R) injury (MIRI) cardiomyocytes H2O2 treatment upregulated 31284127 5131 Mouse mmu-miR-877-5p miRNA Trovafloxacin liver damage liver Trovafloxacin treatment upregulated 27713024 5132 Mouse mmu-miR-877-5p miRNA IL-1¦Â osteoarthritis (OA) primary mouse chondrocytes IL-1¦Â treatment miR-877-5p expression levels significantly declined in IL- 1¦Â-stimulated chondrocytes in a concentration-dependent manner. 32584470 5133 Mouse mmu-miR-879-5p miRNA chronic unpredictable mild stress (CUMS) depression NAc tissue chronic unpredictable mild stress (CUMS) treatment upregulated 31430030 5134 Mouse mmu-miR-882 miRNA melatonin osteoporosis Raw264.7 cells Melatonin treatment Melatonin downregulates miR-882 expression in RANKL-induced Raw264.7 cells. 33416111 5135 Mouse mmu-miR-882 miRNA propofol (PPF) propofol-induced developmental neurotoxicity hippocampus propofol treatment upregulated 30242182 5136 Mouse mmu-miR-9 miRNA baicalin (BAI) aberrant scar NIH-3T3 cells baicalin (BAI) treatment upregulated 31362535 5137 Mouse mmu-miR-9 miRNA differentiation medium (DM) adipogenesis 3T3-L1 cells "3T3-L1 cells were incubated in differentiation medium (DM) supplemented with 10% FBS, 0.5 mM 3-isobutyl-1-methylxanthine, 250 nM dexamethasone, and 160 nM insulin." upregulated 31759991 5138 Mouse mmu-miR-9 miRNA epigallocatechin-3-gallate (EGCG) Alzheimer's disease (AD) AD mouse serum EGCG treatment groups (2 mg/kg/day) upregulated 28731435 5139 Mouse mmu-miR-9 miRNA osthole Alzheimer's disease (AD) NSCs isolated from the SVZ region of newborn (0¨C2 days) C57BL/6 mice osthole treatment upregulated 28659755 5140 Mouse mmu-miR-9 miRNA arsenite arsenic induted deficits in differentiation prenatal C57BL/6 mouse brain arsenic (As) exposure downregulated 27751817 5141 Mouse mmu-miR-9 miRNA sodium arsenite (NaAsO2) arsenic inhibited cellular differentiation pluripotent P19 mouse embryonal carcinoma cells sodium arsenite treatment downregulated 29121352 5142 Mouse mmu-miR-9 miRNA IFN-¦Ã and lipopolysaccharide (LPS) asthma lung tissues "IFN-¦Ã,LPS treatment" upregulated 25772595 5143 Mouse mmu-miR-9 miRNA isoflurane central nervous system of the developing fetus mouse embryonic stem cell (mES cell) isoflurane treatment upregulated 25892252 5144 Mouse mmu-miR-9 miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral ischemia/reperfusion (I/R) injury mouse primary cortical neurons oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 31837324 5145 Mouse mmu-miR-9 miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral ischemia/reperfusion (I/R) injury primary cortical neurons oxygen-glucose deprivation and reoxygenation (OGD/R) treatment downregulated 31837324 5146 Mouse mmu-miR-9 miRNA "5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)" gastric cancer (GC) balb/c nu-nu mice injected with 107 GC cells "5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment" upregulated 25270964 5147 Mouse mmu-miR-9 miRNA histone deacetylase inhibitor (HDACi) hypercalciuric diseases mouse HDAC inhibitors treatment upregulated 25071082 5148 Mouse mmu-miR-9 miRNA bleomycin (BLM) idiopathic pulmonary fibrosis (IPF) lung tissues bleomycin (BLM) treatment upregulated 30144053 5149 Mouse mmu-miR-9 miRNA lipopolysaccharide (LPS) inflammation Raw264.7 cells lipopolysaccharide (LPS) treatment upregulated 30552873 5150 Mouse mmu-miR-9 miRNA lipopolysaccharide (LPS) inflammation macrophages lipopolysaccharide (LPS) treatment upregulated 30552873 5151 Mouse mmu-miR-9 miRNA lipopolysaccharide (LPS) inflammation Kupffer cells or RAW 264.7 macrophages lipopolysaccharide (LPS) treatment upregulated 31099043 5152 Mouse mmu-miR-9 miRNA aluminum-sulfate inflammatory neurodegeneration C57BL/6J mice blood serum exposure to a standard mouse diet that included aluminum-sulfate upregulated 29354323 5153 Mouse mmu-miR-9 miRNA CCL2 macrophage polarization CC chemokine 2(CCL2) pre-treated mouse bone marrow-derived macrophages (BMDMs) CCL2 treatment upregulated 28242024 5154 Mouse mmu-miR-9 miRNA chronic unpredictable stress (CUMS) and lipopolysaccharide (LPS) major depressive disorder (MDD) plasma; hippocampus chronic unpredictable stress (CUS) and lipopolysaccharide (LPS) treatment upregulated 30413800 5155 Mouse mmu-miR-9 miRNA retinoic acid (RA) cell differentiation Neuro-2A cells retinoic acid? treatment upregulated 31823894 5156 Mouse mmu-miR-9 miRNA green tea polyphenols (GTP) osteoarthritis (OA) LPS treated ATDC5 cells green tea polyphenols (GTP) treatment upregulated 31102286 5157 Mouse mmu-miR-9 miRNA lipopolysaccharide (LPS) osteoarthritis (OA) ATDC5 cells lipopolysaccharide (LPS) treatment upregulated 31102286 5158 Mouse mmu-miR-9 miRNA resveratrol osteoarthritis (OA) mouse chondrocytes resveratrol (Res) treatment The relative expression level of miR-9 significantly increased following treatment with Res in a dose-dependent manner 32104302 5159 Mouse mmu-miR-9 miRNA microwave microwave-induced adverse health outcomes mouse hippocampus 7 days after 30 mW/cm microwave exposure treatment downregulated 24748327 5160 Mouse mmu-miR-9 miRNA bone morphogenetic protein 2 (BMP2) repair of spinal cord injury pre-osteoblast cell line MC3T3-E1 bone morphogenetic protein 2 (BMP2) treatment downregulated 26359086 5161 Mouse mmu-miR-9 miRNA lipopolysaccharide (LPS) sepsis RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated 31174089 5162 Mouse mmu-miR-9 miRNA ethanol (EtOH) teratogenesis fetal brains of mice Ethanol?treatment upregulated 19091803 5163 Mouse mmu-miR-9 miRNA zika virus (ZIKV) Zika virus (ZIKV) infection embryonic mouse cortex Zika virus (ZIKV) infection treatment upregulated 30264295 5164 Mouse mmu-miR-9 miRNA live L. acidophilus ¦Â-lactoglobulin (¦Â-Lg) allergy murine splenocytes live L. acidophilus treatment downregulated 30156972 5165 Mouse mmu-miR-9* miRNA arsenite arsenic induted deficits in differentiation prenatal C57BL/6 mouse brain arsenic (As) exposure downregulated 27751817 5166 Mouse mmu-miR-90-3p miRNA N-ethyl-N-nitrosourea (ENU) hepatocellular carcinoma (HCC) liver tissues N-ethyl-N-nitrosourea (ENU) treatment upragulated 21029445 5167 Mouse mmu-miR-9-1 miRNA "7,12-dimethylbenz(¦Á)anthracene (DMBA)" "7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity" liver tissues "7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment" miR-9-1 was downregulated in the liver tissues od female mice. 32871758 5168 Mouse mmu-miR-9-1 miRNA "7,12-dimethylbenz(¦Á)anthracene (DMBA)" "7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity" liver tissues "7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment" miR-9-1 was downregulated in the liver tissues of male mice. 32871758 5169 Mouse mmu-miR-9-1 miRNA "7,12-dimethylbenz(¦Á)anthracene (DMBA)" "7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity" kidneny tissues "7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment" miR-9-1 was upregulated in the kidney tissues od female mice. 32871758 5170 Mouse mmu-miR-9-1 miRNA "7,12-dimethylbenz(¦Á)anthracene (DMBA)" "7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity" kidneny tissues "7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment" miR-9-1 wasdownregulated in the kidney tissues of male mice. 32871758 5171 Mouse mmu-miR-9-1 miRNA VitB12 methylmalonic acidemia (MMA) newborn BalB/C mice VitB12 treatment downregulated 24390963 5172 Mouse mmu-miR-92 miRNA hyperoxia bronchopulmonary dysplasia (BPD) lung tissues hyperoxia treatment downregulated 33143661 5173 Mouse mmu-miR-92 miRNA contextual fear conditioning contextual fear conditioning mouse hippocampus training mice in contextual fear conditioning treatment upregulated 24990518 5174 Mouse mmu-miR-92 miRNA ischemia/reperfusion (I/R) head and neck squamous cell carcinoma (HNSCC) heart tissues ischemia/reperfusion (I/R) treatment the miR-17-92 cluster may protect the heart by diminishing the apoptosis and alleviating ischemia/reperfusion injury 23639284 5175 Mouse mmu-miR-92 miRNA ¦¤9-tetrahydrocannabinol (THC) inflammation total lymph node cells and CD4(+) T cells ¦¤9-Tetrahydrocannabinol (THC) treatment downregulated 27268054 5176 Mouse mmu-miR-92 miRNA imiquimod (IMQ) psoriasis-like dermatitis the mouse skin tissues IMQ treatment dysregulated 27579777 5177 Mouse mmu-miR-92a miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues; splenocytes; bronchoalveolar lavage fluid (BALF) lipopolysaccharide (LPS) treatment miR-92a was markedly upregulated in the lung tissues of ALI mice. 30138892 5178 Mouse mmu-miR-92a miRNA sodium arsenite (NaAsO2) arsenic inhibited cellular differentiation pluripotent P19 mouse embryonal carcinoma cells sodium arsenite treatment upregulated 29121352 5179 Mouse mmu-miR-92a miRNA high methionine diet atherosclerosis (AS) aorta high-methionine diet treatment downregulated 33045026 5180 Mouse mmu-miR-92a miRNA ML-7 (an inhibitor of myosin light chain kinase) atherosclerosis (AS) atherosclerosis mice aortic vessels ML-7 (an inhibitor of myosin light chain kinase) treatment downregulated 30907506 5181 Mouse mmu-miR-92a miRNA berberine (BBR) beige adipogenesis Mouse 3T3-L1 pre-adipocytes berberine (BBR) treatment downregulated 31234575 5182 Mouse mmu-miR-92a miRNA high glucose (HG) diabetes mellitus (DM) Min-6 mouse pancreatic b cells high glucose (HG) treatment The expression of miRNA-92a was significantly increased. 29660330 5183 Mouse mmu-miR-92a miRNA astragalus polysaccharide (APS) inflammation LPS-treated ATDC5 cells astragalus polysaccharide (APS) treatment downregulated 31302422 5184 Mouse mmu-miR-92a miRNA lipopolysaccharide (LPS) inflammation ATDC5 cells lipopolysaccharide (LPS) treatment upregulated 31302422 5185 Mouse mmu-miR-92a miRNA vesicular stomatitis virus (VSV) innate immune response mice peritoneal macrophages vesicular stomatitis virus (VSV) infection upregulated 30160073 5186 Mouse mmu-miR-92a miRNA hypoxia ischemic injury bone marrow mesenchymal stem cells (BM-MSCs) hypoxia treatment upregulated 30613290 5187 Mouse mmu-miR-92a miRNA hypoxia myogenic-lineage differentiation ?hypoxia-primed embryoid bodies (Hyp-EBs) hypoxia treatment hypoxic priming enhances EB commitment to the myogenic lineage through miR-92a/Sp1/MyoD regulatory axis. 31606324 5188 Mouse mmu-miR-92a miRNA hypoxia myogenic-lineage differentiation embryoid bodies hypoxia induce downregulated 31606324 5189 Mouse mmu-miR-92a miRNA ethanol (EtOH) oxidative stress MH-S cells ethanol treatment downregulated 33278514 5190 Mouse mmu-miR-92a-2-5p miRNA schistosoma japonicum liver fibrosis mouse liver tissues Schistosoma japonicum infection treatment downregulated 30708193 5191 Mouse mmu-miR-92a-3p miRNA hypoxia cell differentiation mouse (GL261 and G422) glioma cell lines hypoxia induce upregulated 30536597 5192 Mouse mmu-miR-92a-3p miRNA reconstituted high-density lipoproteins (rHDL) diabetes-impaired angiogenesis diabetic mice HDL fraction reconstituted high-density lipoproteins (rHDL) treatment upregulated 30206364 5193 Mouse mmu-miR-92a-3p miRNA reconstituted high-density lipoproteins (rHDL) diabetes-impaired angiogenesis diabetic mice plasma reconstituted high-density lipoproteins (rHDL) treatment downregulated 30206364 5194 Mouse mmu-miR-92a-3p miRNA schistosoma japonicum liver fibrosis serum exosomes S. japonicum infection treatment miR-92a-3p was decresed on 6 weeks after S japonicum infection 32443549 5195 Mouse mmu-miR-92b miRNA histone deacetylase inhibitors (HDIs) short-chain fatty acid (SCFA) butyrate antibody-mediated systemic autoimmunity B cells SCFA HDI butyrate treatment upregulated 32265934 5196 Mouse mmu-miR-92b miRNA smoking smoking-related interstitial fibrosis (SRIF) peripheral blood of mice smoking treatment upregulated 22782705 5197 Mouse mmu-miR-92b miRNA smoking smoking-related interstitial fibrosis (SRIF) C57 mice circulating 6 months of chronic mainstream smoking exposure treatment upregulated 22782705 5198 Mouse mmu-miR-92b-3p miRNA angiotensin II (Ang II) cardiac hypertrophy mouse angiotensin II (Ang II) treatment upregulated 29190899 5199 Mouse mmu-miR-92b-3p miRNA angiotensin II (Ang II) cardiac hypertrophy Neonatal mouse ventricular cells (NMVCs) angiotensin II (Ang II) treatment upregulated 31283925 5200 Mouse mmu-miR-92b-3p miRNA advanced glycation end product (AGE) diabetic nephropathy (DN) kidney tissues advanced glycation end products (AGEs) treatment MiR-92b-3p is Induced by Advanced Glycation End Products and Involved in the Pathogenesis of Diabetic Nephropathy. 32215042 5201 Mouse mmu-miR-92b-3p miRNA carbon tetrachloride (CCl4) liver fibrosis hepatic stellate cells (HSCs) carbon tetrachloride (CCl4) treatment "For instance, the expression of circPSD3, a circRNA derived from the Pleckstrin and Sec7 domain-containing 3 (PSD3) gene, was considerably downregulated in primary hepatic stellate cells (HSCs) and liver tissues of mice with CCl4-induced HF compared to those in the vehicle group." 33614234 5202 Mouse mmu-miR-92b-3p miRNA dipogenic differentiation mixture (MDI) liver fibrosis LX-2 cells dipogenic differentiation mixture (MDI) treatment "We found that miR-92b-3p was highly expressed both in fibrotic liver tissues from patients and model mice and in activated LX-2 cells stimulated with TGF-¦Â1. However, the expression of miR-92b-3p was downregulated in inactivated LX-2 cells treated with adipogenic differentiation mixture (MDI)." 33618248 5203 Mouse mmu-miR-92b-3p miRNA TGF-¦Â1 liver fibrosis LX-2 cells TGF-¦Â1 treatment "We found that miR-92b-3p was highly expressed both in fibrotic liver tissues from patients and model mice and in activated LX-2 cells stimulated with TGF-¦Â1 However, the expression of miR-92b-3p was downregulated in inactivated LX-2 cells treated with adipogenic differentiation mixture (MDI)" 33618248 5204 Mouse mmu-miR-93 miRNA red mud biological effects of red mud "CBA/Ca mice liver, spleen, lung, kidney and lymph nodes" "1, 3, 6 and 24 h after a single intraperitoneal injection of red mud treatment" "upregulated , but the level and the peak of the alteration differed according to examined tissue" 24425836 5205 Mouse mmu-miR-93 miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues; bronchoalveolar lavage fluid (BALF) lipopolysaccharide (LPS) treatment downregulated 32468034 5206 Mouse mmu-miR-93 miRNA high fat diet (HFD) brown adipocyte differentiation brown adipose tissues high fat diet (HFD) feed upregulated 23954633 5207 Mouse mmu-miR-93 miRNA isoprenaline cardiac hypertrophy primary cardiomyocytes isoprenaline (ISO) tteatment CHRF expression was upregulated and miR-93 expression was downregulated in mice and cellular models of cardiac hypertrophy. 29747050 5208 Mouse mmu-miR-93 miRNA cigarette smoke (CS) emphysema lung tissues Cigarette smoke (CS) exposure upregulated 33660100 5209 Mouse mmu-miR-93 miRNA high fat diet (HFD) hepatocellular carcinoma (HCC) plasma and hepatic tissues high fat diet (HFD) feed downregulated 26728044 5210 Mouse mmu-miR-93 miRNA influenza A virus (IAV) influenza A virus (IAV) infection MLE- 12 cells influenza A virus (IAV) infection influenza A virus (IAV) infection significantly inhibited miR-93 expression in alveolar epithelial type II cells through RIG-I/JNK pathway. 32652502 5211 Mouse mmu-miR-93 miRNA "3,3'-diindolylmethane (DIM)" multiple sclerosis (MS) activated T cells during the development of experimental autoimmune encephalomyelitis (EAE) "3,3'-Diindolylmethane (DIM) treatment" upregulated 24898268 5212 Mouse mmu-miR-93 miRNA lipopolysaccharide (LPS) osteoarthritis (OA) primary chondrocytes lipopolysaccharide (LPS) treatment downregulated 30569118 5213 Mouse mmu-miR-93 miRNA lipopolysaccharide (LPS) osteoarthritis (OA) primary chondrocytes lipopolysaccharide (LPS) treatment miR-93 levels wsa downregulated in a dose-dependent manner by lipopolysaccharide (LPS) treatment. 30569118 5214 Mouse mmu-miR-93 miRNA ¦Â-elemene oxygen-induced retinopathy (OIR) Retinas tissues ¦Â-elemene treatment upregulated 30664207 5215 Mouse mmu-miR-93 miRNA lipopolysaccharide (LPS) parkinson's disease (PD) BV2 cells lipopolysaccharide (LPS) treatment ?It was found that the expression of miR-93 was downregulated in LPS-exposed BV2 cells. 33900518 5216 Mouse mmu-miR-93 miRNA curcumin (Cur) peripheral arterial disease (PAD) muscle tissues curcumin treatment upregulated 30651865 5217 Mouse mmu-miR-93 miRNA curcumin (Cur) peripheral arterial disease (PAD) ischemic muscle tissues curcumin treatment upregulated 30651865 5218 Mouse mmu-miR-9-3 miRNA "7,12-dimethylbenz(¦Á)anthracene (DMBA)" "7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity" liver tissues "7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment" miR-9-3 was upregulated in the liver tissues of female mice. 32871758 5219 Mouse mmu-miR-9-3 miRNA "7,12-dimethylbenz(¦Á)anthracene (DMBA)" "7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity" liver tissues "7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment" miR-9-3 was downregulated in the liver tissues of male mice. 32871758 5220 Mouse mmu-miR-9-3 miRNA "7,12-dimethylbenz(¦Á)anthracene (DMBA)" "7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity" spleen tissues "7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment" miR-9-3 was upregulated in the spleen tissues of female mice. 32871758 5221 Mouse mmu-miR-9-3 miRNA "7,12-dimethylbenz(¦Á)anthracene (DMBA)" "7,12-dimethylbenz(¦Á)anthracene (DMBA) toxicity" kidneny tissues "7,12-dimethylbenz(¦Á)anthracene (DMBA) treatment" miR-9-3 was upregulated in the lkidney tissues of female mice. 32871758 5222 Mouse mmu-miR-93-5p miRNA high glucose (HG) diabetic nephropathy (DN) Mouse primary kidney GEC (C57-6014G) and mouse glomerular mesangial cells (GMC) (SV40 MES 13)-derived exosomes high glucose (HG) treatment upregulated 31497190 5223 Mouse mmu-miR-93-5p miRNA streptozocin (STZ) diabetic nephropathy (DN) mouse renal tissues streptozotocin (STZ) treatment silenced XIST inducing miR-93-5p-dependent CDKN1A inhibition was beneficial for preventing renal interstitial fibrosis in DN 31545928 5224 Mouse mmu-miR-93-5p miRNA doxorubicin (DOX) doxorubicin (DOX)-induced cardiotoxicity plasma doxorubicin (DOX) treatment downregulated 30453253 5225 Mouse mmu-miR-93-5p miRNA ultraviolet (UV) irradiation skin damage primary murine skin fibroblasts UVB treatment he Meg3 functioned as a competing endogenous RNA (ceRNA) that acted as a sponge for miR-93-5p and thereby modulated the expression of Epiregulin (Ereg) 31761787 5226 Mouse mmu-miR-9-3p miRNA dexamethasone (DEX) innate immune response immature DCs (iDCs) dexamethasone (DEX) treatment downregulated 30174602 5227 Mouse mmu-miR-9-3p miRNA IL-10 innate immune response immature DCs (iDCs) IL-10 treatment downregulated 30174602 5228 Mouse mmu-miR-9-3p miRNA X rays ionizing radiation (IR) injury male Kunming mice blood 0.5-2 Gy total-body carbon-ion irradiation treatment dysregulatedin blood 28632432 5229 Mouse mmu-miR-9-3p miRNA bone morphogenetic proteins (BMPs) osteogenesis pluripotent stem (iPS) cells bone morphogenetic proteins (BMPs) treatment downregulated 22937097 5230 Mouse mmu-miR-9-3p miRNA learning persistent memory C57BL/6J mouse hippocampal Object-location memory task upregulated 28927503 5231 Mouse mmu-miR-943-3p miRNA ovalbumin (OVA) allergic asthma (AA) lung tissues ovalbumin (OVA) induce upregulated 31101982 5232 Mouse mmu-miR-9-5p miRNA amyloid-¦Â (A¦Â) 25-35 Alzheimer's disease (AD) HT22 cells amyloid-¦Â (A¦Â) 25-35 treatment MiR-9-5p was downregulated in A¦Â25-35-induced HT22 cells. 32713252 5233 Mouse mmu-miR-9-5p miRNA oxygen glucose deprivation (OGD) angiogenesis Brain microvascular endothelial cells (BMECs) an oxygen glucose deprivation (OGD) treatment miRNA-9-5p was significantly increased in the traumatic foci after TBI 32502567 5234 Mouse mmu-miR-9-5p miRNA anandamide and norgestimate depression chronic mild stress (CMS) model of depression mouse anandamide and norgestimate treatment upregulated 28716528 5235 Mouse mmu-miR-9-5p miRNA dexamethasone (DEX) innate immune response immature DCs (iDCs) dexamethasone (DEX) treatment downregulated 30174602 5236 Mouse mmu-miR-9-5p miRNA IL-10 innate immune response immature DCs (iDCs) IL-10 treatment downregulated 30174602 5237 Mouse mmu-miR-9-5p miRNA IL-1¦Â osteoarthritis (OA) "CHON-001, ATDC5 cells" IL-1¦Â treatment "MEG3 expression in chondrocytes was downregulated by the stimulation of IL-1¦Â, and MEG3 negatively regulated miR-9-5p expression but positively regulated KLF4 expression." 33776787 5238 Mouse mmu-miR-9-5p miRNA FTY720-C2 parkinson's disease (PD) dopaminergic MN15D cells FTY720-C2 treatment upregulated 30359694 5239 Mouse mmu-miR-9-5p miRNA FTY720-C2 parkinson's disease (PD) MN9D cells FTY720-C2 treatment upregulated 30359694 5240 Mouse mmu-miR-96 miRNA emulsion (proteoglycan) ankylosing spondylitis (AS) cartilage tissues emulsion (proteoglycan) treatment upregulated 31111563 5241 Mouse mmu-miR-96 miRNA angiotensin II (Ang II) atrial fibrosis atrial tissues angiotensin II (Ang II) treatment upregulated 32034721 5242 Mouse mmu-miR-96 miRNA alcohol brain injury and neurodegeneration cerebral cortex chronic alcohol administration downregulated 30374194 5243 Mouse mmu-miR-96 miRNA resveratrol colorectal cancer (CRC) mouse colorectal carcinoma (CRC) tissues resveratrol (RS) treatment upregulated 25280562 5244 Mouse mmu-miR-96 miRNA microcystin-leucine arginine (MC-LR) cytotoxicity GC-1 cells Microcystin (MC)-LR treatment miR-96 was downregulated most dramatically 24803159 5245 Mouse mmu-miR-96 miRNA grape seed proanthocyandin extract (GSPE) dyslipidemia high-fat diet (HFD)-fed mice liver tissues grape seed proanthocyanidins extracts (GSPE) treatment downregulated 30848548 5246 Mouse mmu-miR-96 miRNA high fat diet (HFD) dyslipidemia liver tissues high fat diet (HFD) feed upregulated 30848548 5247 Mouse mmu-miR-96 miRNA TGF-¦Â1 liver fibrosis hepaticstellatecells(HSCs) TGF-¦Â1 treatment Exogenous expression of TGF-¦Â1 in mouse primary HSCs significantly increased expression of miR-96 in a concentration- and time-dependent manner 30406154 5248 Mouse mmu-miR-96 miRNA lipopolysaccharide (LPS) inflammation BV2 cells lipopolysaccharide (LPS) treatment downregulated 31150368 5249 Mouse mmu-miR-96 miRNA triptolide (TPL) inflammation LPS-treated BV2 cells triptolide treatment upregulated 31150368 5250 Mouse mmu-miR-96 miRNA lipopolysaccharide (LPS) innate immune response RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated 30625496 5251 Mouse mmu-miR-96 miRNA pseudomonas aeruginosa (PA) innate immune response RAW264.7 cells Pseudomonas aeruginosa (PA) infection treatment upregulated 30625496 5252 Mouse mmu-miR-96 miRNA narrow band noise noise-induced deafness outer hair cells 2-4 kHz narrow band noise at 100 dB SPL 6h per day for 3 consecutive days treatment downregulated 25026825 5253 Mouse mmu-miR-96 miRNA perfluorooctanoic acid perfluorooctanoic acid toxicity mouse liver tissues Perfluorooctanoic acid (PFOA) exposure treatment upregulated 25092180 5254 Mouse mmu-miR-96 miRNA schistosoma schistosomiasis hepatic fibrosis hepaticstellatecells(HSCs) Schistosoma infection treatment "Schistosoma induces the expression of transforming growth factor ¦Â1 (TGF-¦Â1), which in turn upregulates the expression of miR-96 through SMAD2/3-DROSHA-mediated post-transcriptional regulation" 30406154 5255 Mouse mmu-miR-96 miRNA high fat diet (HFD) type 2 diabetes mellitus (T2DM) pancreatic ¦Â cells high fat diet (HFD) feed upregulated 31506178 5256 Mouse mmu-miR-96 miRNA high glucose (HG) type 2 diabetes mellitus (T2DM) MIN6 cells high glucose treatment upregulated 31506178 5257 Mouse mmu-miR-96 miRNA tumor necrosis factor alpha (TNF-¦Á) type 2 diabetes mellitus (T2DM) MIN6 cells tumor necrosis factor alpha (TNF-¦Á) treatment upregulated 31506178 5258 Mouse mmu-miR-96-5p miRNA lipopolysaccharide (LPS) inflammation RAW264.7 cells lipopolysaccharide (LPS) treatment downregulated 32955644 5259 Mouse mmu-miR-96-5p miRNA FTY720-mitoxy multiple system atrophy (MSA) brain tissues FTY720-Mitoxy treatment downregulated 31751571 5260 Mouse mmu-miR-96-5p miRNA palmitic acid (PA) myogenesis and muscle homeostasis C2C12 cells Long-chain SFA palmitic acid (PA) treatment upregulated 33322515 5261 Mouse mmu-miR-96-5p miRNA lipopolysaccharide (LPS) neonatal sepsis (NS) RAW264.7 cells lipopolysaccharide (LPS) treatment The expression of miR-96-5p was decreased in LPS-induced inflammatory responses. 32618342 5262 Mouse mmu-miR-96-5p miRNA high fat diet (HFD) and streptozotocin (STZ) renal fibrosis kidney tissues high fat diet (HFD) and streptozotocin (STZ) treatment miR-96-5p was downregulated in the renal tissues of DM mice. 31810140 5263 Mouse mmu-miR-96-5p miRNA cyclophosphamide (CP) systemic lupus erythematosus (SLE) C3.MRL-Faslpr/J mice C3.MRL-Faslpr/J mice treatment downregulated 27924862 5264 Mouse mmu-miR-98 miRNA ischemia acute myocardial infarction (AMI) neonatal rat ventricular myocytes (NRVCs) LAD artery downregulated 28784995 5265 Mouse mmu-miR-98 miRNA ischemia/reperfusion (I/R) acute myocardial infarction (AMI) heart tissues ischemia/reperfusion (I/R) treatment upregulated 28090786 5266 Mouse mmu-miR-98 miRNA scopolamine Alzheimer's disease (AD) brain tissues and hippocampal neurons scopolamine treatment downregulated 30365070 5267 Mouse mmu-miR-98 miRNA scopolamine Alzheimer's disease (AD) brain tissues and hippocampal neurons scopolamine treatment downregulated 30365070 5268 Mouse mmu-miR-98 miRNA nicotine asthma lung fibroblast (LF) nicotine treatment downregulated 33082140 5269 Mouse mmu-miR-98 miRNA rosiglitazone asthma lung fibroblast (LF) rosiglitazone treatment upregulated 33082140 5270 Mouse mmu-miR-98 miRNA lipopolysaccharide (LPS) hepatocellular carcinoma (HCC) RAW 264.7 cell line LPS treatment miR-98 expression in macrophages significantly decreased following LPS stimulation 21609717 5271 Mouse mmu-miR-98 miRNA cardiac ¦Á-myosin heavy chain peptides (MyHC-¦Á) myocarditis BALB/c mice B cells isolated from the mouse hearts MyHC-¦Á treatment upregulated in B cells isolated from the mouse hearts 27913008 5272 Mouse mmu-miR-98 miRNA IL-1¦Â osteoarthritis (OA) C57BL/6 mice OA chondrocytes IL-1¦Â treatment upregulated 28765925 5273 Mouse mmu-miR-98 miRNA plasmodium chabaudi malaria peak parasitemia liver of mice Plasmodium chabaudi malaria infection treatment downregulated 21085987 5274 Mouse mmu-miR-98 miRNA propofol (PPF) propofol-induced developmental neurotoxicity hippocampus propofol treatment downregulated 30242182 5275 Mouse mmu-miR-98 miRNA vitamin D prostate cancer LNCaP cells vitamin D treatment "the finding that growth inhibitive miR-98 is induced by 1,25-VD provides a potential therapeutic target for prostate cancer and a potential biomarker for 1,25-VD anti-tumor action" 23188821 5276 Mouse mmu-miR-98 miRNA sevoflurane (SEV) cognitive impairment adult mice 1 or 2 minimal alveolar concentrations sevoflurane for 4 or 8 h treatment upregulated 28260068 5277 Mouse mmu-miR-98 miRNA hypoxia pulmonary hypertension (PH) lung tissues hypoxia treatment downregulated 26098770 5278 Mouse mmu-miR-98-5p miRNA 3¦Â-hydroxycholest-5-en-7-one anti-inflammatory responses RAW 264.7 cells 3¦Â-hydroxycholest-5-en-7-one treatment downregulated 32771556 5279 Mouse mmu-miR-98-5p miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) cerebral ischemia/reperfusion (I/R) injury HT22 cells oxygen-glucose deprivation and reoxygenation (OGD/R) treatment miR-98-5p expression is decreased in response to OGD/R treatment in neurons 30449595 5280 Mouse mmu-miR-98-5p miRNA dextran sodium sulfate (DSS) inflammatory bowel disease (IBD) colonic tissues dextran sulphate sodium (DSS) treatment miR-98-5p expression in the colonic tissues of mice was upregulated. 32242402 5281 Mouse mmu-miR-98-5p miRNA estradiol-17¦Â (E2) systemic lupus erythematosus (SLE) murine B cells estradiol-17¦Â (E2) treatment downegulated 25912736 5282 Mouse mmu-miR-99 miRNA streptozocin (STZ) congenital heart disease (CHD) C57BL/6 mice blood injection of streptozotocin before mating treatment dysregulated 27998767 5283 Mouse mmu-miR-99a miRNA angiotensin II (Ang II) allergic airway inflammation murine bone marrow-derived macrophages (BMDMs) angiotensin II (Ang II) treatment downregulated 32458348 5284 Mouse mmu-miR-99a miRNA TGF-¦Â hepatic genotoxicity normal murine mammary gland cells TGF-¦Â treatment mir-99a and mir-99b may function as modulators within a complex network of factors regulating TGF-¦Â induced breast epithelial to mesenchymal transition 22299047 5285 Mouse mmu-miR-99a miRNA rapamycin HIV-associated nephropathy(HIVAN) mice renal tissues Rapamycin treatment downregulated 23611955 5286 Mouse mmu-miR-99a miRNA nuclear factor kappa-B (NF-¦ÊB) inhibitor Bay11-708211 supraesophageal bile reflux hypopharyngeal mucosa NF-¦ÊB inhibitor (BAY 11-7082) treatment "Pre- but not post-application of NF-¦ÊB inhibitor, significantly blocks overexpression of Il6 and prostaglandin H synthases 2 (Ptgs2), and reverses miR-21, miR-155, miR-99a phenotypes." 32934775 5287 Mouse mmu-miR-99a-5p miRNA high fat diet (HFD) atherosclerosis (AS) Apolipoprotein E knockout mice heart tissues high fat diet (HFD) feed downregulated 31325426 5288 Mouse mmu-miR-99b miRNA lipopolysaccharide (LPS) acute lung injury (ALI) lung tissues lipopolysaccharide (LPS) treatment upregulated 32360624 5289 Mouse mmu-miR-99b miRNA high fat diet (HFD) hepatocellular carcinoma (HCC) plasma and hepatic tissues high fat diet (HFD) feed upregulated 26728044 5290 Mouse mmu-miR-99b miRNA mycobacterium tuberculosis (Mtb) immune responses dendritic cells (DCs) and macrophages Mycobacterium tuberculosis infection upregulated 23233675 5291 Mouse mmu-miR-99b miRNA streptozocin (STZ) nonalcoholic steatohepatitis-hepatocellular carcinoma (NASH-HCC) high fat dietmouse liver STZ treatment upregulated in liver 28345673 5292 Mouse mmu-miR-99b miRNA lipopolysaccharide (LPS) sepsis RAW264.7 cells lipopolysaccharide (LPS) treatment upregulated 27538453 5293 Mouse mmu-miR-99b miRNA TGF-¦Â hepatic genotoxicity normal murine mammary gland cells TGF-¦Â treatment mir-99a and mir-99b may function as modulators within a complex network of factors regulating TGF-¦Â induced breast epithelial to mesenchymal transition 22299047 5294 Mouse mmu-miR-99b-3p miRNA angiotensin II (Ang II) cardiac fibrosis heart tissue angiotensin II (Ang II) treatment We showed that Ang II infusion induced cardiac disfunction and fibrosis accompanied by markedly increased expression level of miR-99b-3p in heart tissues. 32814818 5295 Mouse mmu-miR-99b-3p miRNA angiotensin II (Ang II) cardiac fibrosis heart sissues angiotensin II (Ang II) treatment upregulated 32814818 5296 Mouse mmu-miR-99b-5p miRNA amyloid-¦Â (A¦Â) Alzheimer's disease (AD) Cortexes of the brains amyloid-¦Â (A¦Â) treatment downregulated 26635599 5297 Mouse mmu-miR-9a-5p miRNA lipopolysaccharide (LPS) acute respiratory distress syndrome (ARDS) serum lipopolysaccharide (LPS) treatment upregulated 32934950 5298 Mouse mmu-miR-9a-5p miRNA static water pressure liver fibrosis hepatic stellate cells (HSCs) static water pressure treatment upregulated 26379395 5299 Mouse mmu-miR-9a-5p miRNA liraglutide type 2 diabetes mellitus (T2DM) whole bone marrow exosomes liraglutide 0.2 mg/kg for 2 months dysregulated 29133778 5300 Mouse mmu-miR-BART13 miRNA epstein-barr virus (EBV) nasopharyngeal carcinoma (NPC) Mutu I and Mutu III cell lines infection with EBV treatment upregulated 25213622 5301 Mouse mmu-miR-BART3 miRNA epstein-barr virus (EBV) nasopharyngeal carcinoma (NPC) Mutu I and Mutu III cell lines infection with EBV treatment upregulated 25213622 5302 Mouse mmu-miR-BART7 miRNA epstein-barr virus (EBV) nasopharyngeal carcinoma (NPC) Mutu I and Mutu III cell lines infection with EBV treatment upregulated 25213622 5303 Mouse mmu-miR-PC-5P-12969 miRNA oxygen-glucose deprivation and reoxygenation (OGD/R) ischemic stroke (IS) mouse primary hippocampal neuronal cells (HT22) oxygen-glucose deprivation and reoxygenation (OGD/R) treatment upregulated 30953313